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Introduction We previously showed that erythropoietin (EPO) attenuates 
the morphological signs of spinal cord ischemia/reperfusion (I/R) injury 
in swine [1] without, however, improving neurological function. The 
clinical use of EPO has been cautioned most recently due to serious safety 
concerns arising from an increased mortality in acute stroke patients 
treated with EPO and simultaneously receiving systemic thrombolysis 
[2]. Carbamylated EPO (cEPO) is an EPO derivative without erythropoietic 
activity and devoid of the EPO side eff  ects, but with apparently well 
maintained cytoprotective qualities [3]. We therefore tested the hypothesis 
whether cEPO may be equally effi   cient as EPO in reducing morphological 
as well as functional aortic occlusion-induced spinal cord I/R injury.
Methods In a randomized and blinded trial pigs received either vehicle 
(control, n = 9), EPO or cEPO, respectively (n = 9 each; 5,000 IU/kg over 
30 minutes before and during the fi  rst 4 hours of reperfusion). Animals 
underwent 30 minutes of thoracic aortic balloon occlusion with catheters 
placed immediately downstream of the A. subclavia and upstream of the 
aortic trifurcation. Spinal cord function was assessed by motor evoked 
potentials (MEP as percentage of the amplitude before aortic occlusion) 
and lower limb refl  exes (assessed as the subjective strength of response) 
for a period of 10 hours after reperfusion. Tissue damage was evaluated 
using Nissl staining.
Results  Both EPO-treated and cEPO-treated animals presented with 
attenuated spinal cord injury in the Nissl staining (median (quartile) 
percentage of damaged neurons in the thoracic segments: control 27 
(25,44), cEPO 8 (4,10), and EPO 5 (5,7), P <0.001 vs control group; in the 
lumbar segments: control 26 (19,32), cEPO 7 (5,13), EPO 8 (5,10), P <0.001 
vs control group). However, while only cEPO treatment was associated 
with recovery of the MEP amplitude to pre-occlusion values when 
compared with the control group (P <0.05), lower limb refl  ex response 
was comparably restored stronger in both treatment groups (P <0.05 vs 
control).
Conclusions In a clinically relevant porcine model mimicking aortic cross-
clamping during vascular surgery repair of thoracic aortic aneurysm, cEPO 
protected spinal cord function and integrity as eff  ective as EPO when 
applied at equipotent doses.
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Introduction Unfolded protein response (UPR)-mediated apoptosis plays a 
pivotal role in ischemia-reperfusion injury. Sodium 4-phenylbutyrate (PBA) 
has been reported to act as a chemical chaperone inhibiting UPR-mediated 
apoptosis triggered by ischemia in various organs other than the heart. 
Therefore we investigated whether PBA reduces UPR-mediated apoptosis 
and protects against myocardial ischemia-reperfusion injury in mice.
Methods  C57BL/6 mice were subjected to 30 minutes LAD ischemia 
followed by reperfusion. PBA (100 mg/kg) or PBS (control) was adminis-
trated intraperitoneally just before ischemia. Apoptosis, infarct size and 
tissue protein levels of Grp78 and caspase-12 (UPR-mediated apoptosis-
associated protein) were evaluated by TUNEL, TTC stain and western blot 
analyses, respectively, at 48 hours after ischemia (n = 5 for each group). 
Echocardiography was performed at 3 weeks after ischemia and the 
survival ratio was observed (n = 9 for each group).
Results Compared with PBS, PBA reduced apoptotic cells (30.8 ± 0.2% vs 
20.5 ± 0.5%, P <0.05) and infarct size (32.0 ± 3.8% vs 13.0 ± 2.1%, P <0.01) 
after ischemia-reperfusion. Grp78 and caspase-12 were increased in 
mice with PBS, but PBA attenuated the increase in Grp78 (P <0.05) and 
caspase-12 (P <0.05). PBA inhibited the deterioration of cardiac parameters 
including LVEDD (3.35 ± 0.08 mm vs 2.74 ± 0.11 mm, P <0.01), LVESD 
(2.30 ± 0.08 mm vs 1.54 ± 0.12 mm, P <0.01), and %FS (31.3 ± 2.2% vs 39.4 ± 
2.2%, P <0.05). All mice with PBA survived, but 33% animals with PBS died.
Conclusions  PBA maintained cardiac function and improved survival 
ratio after myocardial ischemia-reperfusion by reducing UPR-mediated 
apoptosis in mice.
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Figure 1 (abstract P2). Phenylbutyrate reduced the unfolded protein 
response.
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Introduction In awake, spontaneously breathing mice, inhaling hydrogen 
sulfi  de (H2S) induced a hibernation-like metabolic state characterised by 
reduced energy expenditure and hypothermia [1], which protected against 
otherwise lethal hypoxia [2] and hemorrhage [3]. In contrast, other authors 
reported that inhibition of endogenous H2S synthesis attenuated post-
hemorrhage organ dysfunction [4,5]. All these data originate, however, 
from unresuscitated models using a pre-treatment design. Therefore we 
investigated the time-dependent eff  ect of intravenous H2S in a clinically 
relevant, long-term model of porcine hemorrhage and resuscitation.
Methods After surgical instrumentation, pigs were subjected to 4 hours 
of hemorrhagic shock induced by removal of 40% of the calculated blood 
volume and thereafter by additional removal or retransfusion of blood boli 
as needed to maintain MAP = 30 mmHg. Animals randomly received vehicle 
(control, n = 14) or the intravenous H2S donor Na2S started 2 hours before 
hemorrhage (pre-treatment, n = 11), at the beginning of blood removal 
(early post-treatment, n = 10) or at the beginning of resuscitation (late 
post-treatment, n = 10). In all groups the Na2S infusion was continued over 
the fi  rst 10 hours of reperfusion. Resuscitation comprised retransfusion of 
shed blood, colloid volume expansion, and noradrenaline titrated to keep 
MAP at pre-shock levels. Systemic, renal and liver perfusion, O2 exchange, 
and organ function were assessed before and at the end of hemorrhage 
as well as at 10 and 22 hours of resuscitation.
Results Survival (71% in the control vs 100, 91, and 90% in the pre-
treatment, early post-treatment and late post-treatment groups, respec-
tively) was signifi  cantly improved in all treatment groups. The noradrenaline 
infusion rate required to maintain hemodynamic targets was signifi  cantly 
reduced in the early post-treatment group only, which coincided with a 
progressive drop in core temperature and attenuated kidney dysfunction 
(blood creatinine levels, creatinine clearance) in these animals.
Conclusions Na2S application improved survival regardless of the drug 
timing. The less benefi  cial eff  ect of pre-treatment on organ function may 
be due to the higher total amount of drug infused, possibly suggesting 
some toxicity at these doses.
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Introduction  Translation of previous animal studies into human ICU 
clinical trials has frequently produced negative results. Most of these 
animal studies have had high baseline mortality and have not employed 
standardised management of sepsis as usually provided in an ICU. The 
aim of this study was to develop a large animal model of septic shock 
receiving standardised intensive care management, thus replicating the 
management of septic shock in humans.
Methods  Eleven Marino ewes (weight 60 to 70 kg, hemiazygous vein 
ligated) were anaesthetised and had radiological guided catheters 
inserted into the iliac, renal, and hepatic veins, coronary sinus, and the 
pulmonary and carotid arteries. Tracheostomy tubes were inserted and 
the animals mechanically ventilated while supported in a sling. Six sheep 
were administered intravenous E. coli (ATCC 25922) 1.0 x 108 orgs/kg over 
1 hour (septic sheep), fi  ve received placebo (nonseptic sheep). For 24 hours, 
animals were monitored and received sedation (midazolam + ketamine), 
ventilation, fl  uids and inotropes according to a protocol. Primary end-point 
was noradrenaline (NA) dose to maintain mean arterial pressure (MAP) 
of 75  mmHg. Secondary end-points included haemodynamic variables, 
respiratory, hepatic, and renal function, haematology, acid–base status and 
global, hind-limb, renal, hepatic and coronary oxygen extraction ratio (OER).
Results Sheep were successfully instrumented, monitored and supported 
for 24 hours. Septic sheep required NA (mean dose 0.28 μg/kg/min vs 0.00, 
P <0.001), developed a higher cardiac index (6.6 l/m2 vs 4.3, P <0.05) and 
lower SVRI (769 dynes/m2 vs 1,804, P <0.05). At 24 hours, septic sheep had 
renal impairment (creatinine 286 mmol/l vs 76, P <0.05; urea 12 mmol/l vs 
7, P <0.05), metabolic acidosis (pH 7.21 vs 7.39, P <0.05; lactate 10.9 mmol/l 
vs 1.2, P <0.01; pCO2 32 vs 31, P = 0.63), coagulopathy (INR 5.9 vs 1.9, 
P <0.05; fi  brinogen 0.9 g/l vs 2.7, P <0.05) but preserved respiratory and 
hepatic function. Global OER was lower in septic sheep (0.16 vs 0.29, 
P <0.05) as was coronary OER (0.36 vs 0.68, P <0.05). OER did not change 
with sepsis in the kidney (0.09 vs 0.11, P = 0.52), liver (0.24 vs 0.31, P = 0.48) 
and hind-limb (0.31 vs 0.42, P = 0.23).
Conclusions We have developed a large animal model of septic shock 
that receives intensive care support and standardised management. This 
model replicates much of the pathophysiology and management that 
occurs in human septic shock. It allows a large range of physiological 
parameters to be assessed when investigating new therapies for sepsis.
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Introduction In awake, spontaneously breathing mice, inhaling hydrogen 
sulfi  de (H2S) induced a hibernation-like metabolic state characterised by 
reduced energy expenditure and hypothermia [1], which protected against 
otherwise lethal hypoxia [2] and hemorrhage [3] as a result of impaired 
cellular energy metabolism [4]. Therefore, we investigated the metabolic 
eff  ects of inhaled H2S in our model of resuscitated murine septic shock.
Methods  Sixteen hours after induction of sepsis by cecal ligation and 
puncture (CLP) or sham operation, anesthetized and mechanically ventilated 
mice received 100 ppm H2S or vehicle over 5 hours at body temperatures 
of 38 and 27°C, respectively. During the observation period, hyperdynamic 
hemodynamics were maintained by colloid resuscitation and noradrenaline 
infusion [5]. Endogenous glucose production was calculated from blood 
13C6-glucose isotope enrichment derived from the rate of appearance of 
stable, non-radioactive labeled 1,2,3,4,5,6-13C6 glucose during continuous 
isotope infusion [6]. Whole-body glucose oxidation rate was derived from 
the total CO2-production rate, the mixed expiratory 13CO2/12CO2 isotope ratio 
and the 13 C6-glucose infusion rate after the steady state was achieved.
Results  While endogenous glucose production was not aff  ected  by 
hypothermia, it was signifi   cantly higher in the septic animals when 
compared with the corresponding sham operated groups, most likely 
due to the ongoing noradrenaline infusion. In contrast, despite the 
catecholamine infusion and higher glucose release, whole body glucose 
oxidation was signifi   cantly reduced in normothermic septic animals. 
During hypothermia, H2S shifted substrate towards preferential glucose 
utilisation, but this eff  ect disappeared in the septic mice.
Conclusions H2S inhalation alone does not infl  uence glucose metabolism 
once temperature is maintained at normothermic levels in anesthetised 
and mechanically ventilated mice. The H2S-related shift of energy meta-
bo  lism towards preferential carbohydrate oxidation present during 
hypothermia is blunted during sepsis, possibly as a result of the ongoing 
catecholamine treatment.
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Introduction Hydrogen sulfi  de (H2S) is a potent inhibitor of cytochrome 
c oxidase (COX) and, thus, of mitochondrial respiration [1]. Since H2S was 
reported to induce a suspended animation-like status characterized by 
reduced energy expenditure and hypothermia [2], we sought to determine 
the eff  ect of hypothermia on mitochondrial respiratory capacity and H2S-
related COX inhibition. We further studied the infl  uence of variations in pH 
on both variables.
Methods All measurements were conducted in digitonin-permeabilised 
cultured peritoneal macrophages using high-resolution respirometry [3] 
(Oxygraph-2k, Oroboros, Austria). Maximum mitochondrial respiration (1 
to 2 Mio cells/ml respiration medium) was achieved in the uncoupled 
state by adding pyruvate, malate, glutamate and succinate as respiratory 
substrates. Then, in one of the two chambers of the oxygraph, mitochondrial 
respiration was inhibited stepwise by incremental concentrations of the 
H2S donor Na2S (1 to 64 μM). In the parallel chamber, the identical inhibitor 
titration sequence was preceded by the inhibition of the respiratory chain 
by rotenone and antimycin A followed by the selective stimulation of the 
COX after addition of ascorbate and TMPD. COX excess capacity (% of 
OXPHOS) was calculated based on the ratio of inhibition of mitochondrial 
respiration with full operating respiratory chain versus the COX-stimulated 
condition. This experimental sequence was repeated at 37°C and 25°C 
with a medium pH of 7.1 and then at 37°C with a pH of 6.8 and 7.7.
Results COX excess capacity (median (quartiles)) was signifi  cantly higher 
at 25°C than at 37°C (134 (113; 140) vs 61 (47; 79)), most likely due to the 
almost halved mitochondrial respiratory capacity at hypothermia (50 (37; 
63) vs 95 (81; 103) pmolO2/s x Mio cells). Changing the medium pH from 
6.8 to 7.7 signifi  cantly increased the COX excess capacity (91 (79; 103) vs 71 
(64; 82) pmolO2/s x Mio cells), which again was related to the signifi  cantly 
lower mitochondrial respiratory capacity with more acidic conditions (80 
(70; 89) vs 94 (85; 98)).
Conclusions Our results suggest that COX excess capacity is temperature 
as well as pH dependent in peritoneal macrophages. This eff  ect may 
protect cells from H2S toxicity at low temperatures and high pH values.
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Introduction Sepsis-induced lymphocyte apoptosis plays a fundamental 
role in the pathophysiology of sepsis. Recent animal models of sepsis have 
identifi  ed anomalies in the extrinsic apoptotic pathway, a key pathological 
occurrence in sepsis [1]. Specifi  cally apoptosis markers such as caspases 
1, 3, 8, 9 and FADD have been shown to be signifi  cant in animal models 
of infection [2].We investigated mRNA transcription of these markers in a 
human model of severe sepsis. We hypothesized that ICU mortality from 
severe sepsis is associated with distinctive gene expression of extrinsic 
apoptosis markers.
Methods A prospective observational study of patients with severe sepsis 
was performed. Mononuclear cells were isolated from 48 patients with 
severe sepsis. Total RNA was extracted from samples for day 1 of admission 
and again on day 7. FADD, caspase 1, 3, 8, and 9 mRNA was quantifi  ed 
with quantitative real-time polymerase chain reaction (qRT-PCR). Standard 
demographic and outcome data were recorded. Between-group 
comparisons were performed by Wilcoxon rank sum test. All values are 
stated as median and interquartile range.
Results Sixteen of the 48 patients died in the ICU. Caspase 9 mRNA copy 
numbers were signifi  cantly increased on day 7 in the survivor group (5.4 x 
106; 7.4 x 106 to 8.9 x 106) compared with death in the ICU group (1.9 x 
106; 3.0 x 106 to 1.2 x 106) P = 0.001. FADD, caspase 1, 3 and 8 mRNA copy 
numbers were not signifi  cantly diff  erent between patients who died and 
those discharged from the ICU on either day 1 or day 7 of admission.
Conclusions  Caspase 9 may be an important regulator of apoptotic 
mechanisms in humans with late sepsis. Pro-apoptotic mechanisms may 
have a role in the resolution of severe sepsis.
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Introduction Toll-like receptor 4 (TLR4) represents an important mediator 
of endotoxin-related signal transduction. The aim of our study was to 
evaluate whether TLR4 inhibition after onset of experimental endotoxemia 
is able to improve the intestinal microcirculation, which is crucial in the 
pathogenesis of septic multiple organ failure.
Methods  We studied four groups of animals (Lewis rats, n  =  10 per 
group): healthy controls (CON group), endotoxemic animals (15  mg/kg 
lipopolysaccharide, LPS group), endotoxemic animals treated with TLR4 
antagonist (1 mg/kg CRX-526, LPS + CRX group), and CRX-526 treated 
controls (CRX group). Intravital microscopy of the intestinal microcirculation 
was performed following 2 hours of observation in all animals. Blood samples 
were taken for cytokine measurements at the end of the experiments.
Results  Following 2 hours of endotoxemia we observed a signifi  cant 
increase of leukocyte adhesion in the intestinal submocosal venules 
(for example, V1 venules: CON 20.4 ± 6.5 n/mm2, LPS 237.5 ± 36.2 n/
mm2, P <0.05). Capillary perfusion of the muscular and mucosal layers of 
the intestinal wall was signifi  cantly reduced (for example, longitudinal 
muscular layer: CON 112.5 ± 5.9 cm/cm2, LPS 71.3 ± 11.0 cm/cm2). TLR4 
inhibition reduced leukocyte activation (V1 venules: 104.3 ± 7.8 n/mm2) 
and improved capillary perfusion (longitudinal muscular layer: 111.0 ± 
12.3 cm/cm2) signifi  cantly. Cytokine release was not aff  ected.
Conclusions  Administration of the TLR4 antagonist CRX-526 improved 
intes tinal microcirculation in a post-treatment model of experimental endo-
toxemia. The TLR4 pathway may be a target in clinical Gram-negative sepsis.
References
1. Cristofaro  et al.: Drugs 2006, 66:15.
2. Fort  et al.: J Immunol 2005, 74:6416.
3. Moue  et al.: Biochim Biophys Acta 2008, 1780:134.
4. Zanotti  et al.: Am J Physiol Lung Cell Mol Physiol 2009, 297:L52.
Critical Care 2010, Volume 14 Suppl 1 
http://ccforum.com/supplements/14/S1
S3P9
Eff  ects of lipopolysaccharide on isolated muscle mitochondrial 
respiration are dose and time dependent
S Brandt1, S Djafarzadeh2, J Takala2, SM Jakob2
1University of Bern, Switzerland; 2Department of Intensive Care Medicine, 
University of Bern, Switzerland
Critical Care 2010, 14(Suppl 1):P9 (doi: 10.1186/cc8241)
Introduction There is evidence that mitochondrial dysfunction plays a 
role in sepsis-related tissue damage. Several studies described the uptake 
and endocytosis of lipopolysaccharide (LPS) by various cells. LPS has been 
localized in diff  erent parts of the cytoplasm, including at close proximity 
to or within mitochondria [1]. Whether eff  ects of LPS on mitochondrial 
respiration are time and/or dose dependent is unknown.
Methods Quadriceps muscle biopsy was taken from seven anaesthetized 
pigs. Mitochondria were isolated using diff  erential  centrifugation 
and immediately incubated with 0.1, 1, 10, 50 and 100 μg LPS per mg 
mito  chondria protein on ice for 2 and 4 hours. Respiration rates were 
determined polarographically using glutamate and succinate as substrates 
to test the function of complex I and II. Respiration Control Ratio (State 3/
State 4) was derived for each substrate. Repeated-measures ANOVA was 
used to analyze time and dose eff  ect of LPS on respiration rates.
Results The results are shown in Figure 1.
Conclusions  In vitro, LPS has time-dependent and dose-dependent 
eff  ects on muscle mitochondrial respiration. This has consequences for 
design and interpretation of experimental studies.
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Introduction Severe sepsis carries high morbidity and mortality. Pre  clinical 
research predominantly utilises animal models although their reproducibility 
may vary, thus impairing understanding of disease. We sought to determine 
the reproducibility of two murine models by assessing clinical severity and 
local immune cell response 24 hours after septic insult.
Methods Intraperitoneal faecal slurry (FS) or zymosan was given to induce 
acute peritonitis in 11 and 12 male C57/Bl mice (8 to 12 weeks, 18 to 
32 g). A control group received saline only (n = 5). In surviving animals at 
24 hours, clinical severity was scored as severe, moderate or mild according 
to appearance and alertness. Peritoneal lavage was performed to obtain 
immune cells. Analysis by antibody labelling (F4/80, GR-1, CD3 and CD19) 
for fl  uorescence-assisted cell sorting identifi  ed numbers of macrophages, 
neutrophils, T and B cells. Logistic regression (odds ratio, OR) was used to 
determine the relationship of cell numbers with severity (reported if P <0.05).
Results Clinical severity varied markedly despite similar dosing (see Table 1). 
At 24 hours, total intraperitoneal immune cells increased in both models and 
with clinical severity (OR 0.83). Neutrophils predominated after septic insult 
and also rose with severity (OR 0.75). Compared with control, macrophage 
populations did not change in either model while B and T lymphocytes fell. 
A cell population that expressed both F4/80 and GR-1 – that is, markers for 
macrophages and neutrophils, respectively – occurred only in the FS model.
Table 1 (abstract P10). Number of animals according to clinical severity (with 
inclusive mortality)
 Severe  Moderate  Mild
Faecal slurry  6 (2)  0  5
Zymosan 4  (2)  5 3
Conclusions  Individual variability occurs in both faecal and zymosan 
peritonitis models as shown by heterogeneous clinical responses and local 
immune cell numbers to the same dose in similar animals. The cellular 
immune response in both models is consistent with current understanding 
of infection-induced infl  ammation. Neutrophils, but not macrophages, rose 
in proportion to worsening clinical severity. The signifi  cance of F4/80+/GR-1+ 
cells in the FS model requires further evaluation.
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Introduction  Although the innate immune response protects the 
host from invading pathogens, an excessive response may also lead to 
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Figure 1 (abstract P9). Mean ± SD. Boxes: μg/mg LPS.
S4collateral damage to normal tissues. Adenosine has been proposed as an 
immunomodulator capable of inhibiting infl  ammation and preventing 
tissue injury. The C34T nonsense mutation in the AMP deaminase 1 
(AMPD1) gene is thought to increase the endogenous adenosine concen-
tration and has been associated with improved prognosis and survival in 
ischemic heart disease. Caff  eine on the other hand, acting as a nonselective 
adenosine receptor antagonist, could diminish adenosine-mediated 
eff  ects. The present study evaluated the endotoxemia-induced adenosine 
response, subclinical renal damage and endothelium dysfunction in 
healthy male subjects. Furthermore, we investigated whether the LPS-
induced infl  ammatory response is attenuated by AMPD1 and enhanced 
by caff  eine, as well as its eff  ects on markers of endothelium activation 
(plasma ICAM, VCAM) and renal damage (urinary excretion of GSTA1-1 and 
GSTP1-1).
Methods Thirty healthy male subjects received 2 ng/kg E. coli LPS. Three 
groups were evaluated in a double-blind randomized controlled setting; a 
LPS-placebo group (n = 10), LPS-placebo in AMPD1 subjects (n = 10), and 
a LPS-caff  eine group (4 mg/kg, n = 10).
Results During endotoxemia, the adenosine concentration increased from 
10.0 ng/ml (9.0 to 15.3) at baseline to 15.5 ng/ml (13.0 to 22.3) 2 hours after 
LPS infusion (P = 0.003; Friedman). The response was similar between LPS 
groups. The increase in proinfl  ammatory and anti-infl  ammatory cytokines 
(TNFα, IL-6, IL-10 and IL1RA) was similar in the three groups. Experimental 
endotoxemia resulted in endothelial dysfunction, measured by an increase 
in adhesion molecules and subclinical renal injury as measured by GSTA1-
1 and GSTP1-1. Infl  ammation induced subclinical end-organ damage was 
not infl  uenced by either the AMPD1 SNP or treatment with caff  eine.
Conclusions Human experimental endotoxemia induces an increase in 
circulating cytokine levels and subclinical endothelial and renal damage. 
Acute systemic infl   ammation is also associated with an increase in 
endogenous adenosine concentrations. Modulation of the adenosine 
metabolism through the presence of the AMPD1 and administration of 
caff  eine does not aff  ect the innate immune response and its subsequent 
subclinical organ dysfunction.
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peritonitis and modulates immunoparalysis of monocytes
S Atmatzidis1, K Louis2, A Pistiki2, I Koutelidakis1, T Adamis2, 
E Giamarellos-Bourboulis2
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Introduction  Peritonitis is the prototype of polymicrobial sepsis with 
kinetics of bacterial growth diff  ering from those of other infections leading 
to sepsis. The eff  ect of the extent of leaking of gut content in the response 
of the host was studied.
Methods A total of 21 rabbits were studied divided into two groups; 
A: high-load peritonitis; and B: normal load peritonitis. After a midline 
abdominal incision, the ileocecal calve was ligated. Three holes were 
performed in the cecum wall of group A followed by masturbation to drain 
cecal content in the peritoneal cavity. Two holes without masturbation 
were performed in group B. After closure of the abdominal cavity, blood 
was sampled at 2, 4, 24 and 48 hours. Peripheral blood mononuclear cells 
(PBMCs) were isolated and stimulated in microplate wells with 10 ng/ml 
LPS. Concentrations of TNFα were estimated in supernatants by a bioassay 
in L929 fi  brosarcoma cell line. In parallel, monocytes were separated from 
lymphocytes by plastic adherence. Apoptosis was estimated after staining 
with ANNEXIN-V and PI and fl   ow cytometric analysis. Tissue bacterial 
growth was estimated after death.
Results  Mortality after 14 days was 84.6% in group A and 62.5% in 
group B (log-rank: 3.83, P = 0.050). Mean respective rates of apoptosis 
of lymhocytes of groups A and B were 32.2 and 44.5% at 2 hours; 33.5 
and 51.9% at 4 hours (P = 0.028); 35.6 and 39.1% at 24 hours; and 28.5 
and 43.7% at 48 hours (P = 0.029). Mean respective rates of apoptosis of 
monocytes of groups A and B were 48.2 and 64.1% at 2 hours (P = 0.036); 
57.9 and 66.3% at 4 hours; 47.3 and 69.9% at 24 hours (P = 0.041); and 
60.5 and 73.5% at 48 hours. Respective TNFα released ex vivo from PBMCs 
isolated at 24 hours from groups A and B after LPS stimulation was 2,579.1 
and 31.3 pg/ml (P = 0.048). Mean respective log10 of enterobacteriaceae of 
groups A and B were 6.52 and 1.39 cfu/ml in liver (P = 0.012); 7.79 and 1.43 
cfu/ml in spleen (P = 0.012); and 7.98 and 1.79 cfu/ml in the right kidney 
(P = 0.012).
Conclusions Experimental peritonitis with enormous bacterial leaking 
from the gut is accompanied by reduced survival, increased tissue 
bacterial growth and reduced apoptosis of lymphocytes and monocytes. 
Peritonitis with low bacterial leaking is characterized by immunoparalysis 
of PBMCs. These results may project in the effi   cacy of immunotherapy in 
abdominal sepsis.
P13
Decreased whole blood TNFα production capacity after acute 
alcohol exposure and LPS stimulation ex vivo
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P Myrianthefs2, G Baltopoulos2
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Nursing, Athens University, Athens, Greece
Critical Care 2010, 14(Suppl 1):P13 (doi: 10.1186/cc8245)
Introduction Acute alcohol exposure is related to increased susceptibility 
to infections [1]. The purpose of the study was to investigate the eff  ect of 
acute exposure to diff  erent alcohol concentrations in whole blood TNFα 
production capacity after LPS stimulation ex vivo in healthy men.
Methods  Whole blood was taken from healthy volunteers and was 
placed in tubes containing EDTA and immediately transferred to the lab. 
Heparinized blood samples diluted 1:10 in RPMI 1640 culture medium 
(100 μl whole blood added in 900 μl RPMI 1640). Samples were pre-
incubated with 0‚ 5‚ 12.5‚ 25‚ 50‚ 100 and 200 mM alcohol (EtOH) for 
10 minutes at room temperature. After incubation, 500 pg LPS was added 
in each sample for 4 hours at 37°C. At the end of the process, samples 
were centrifuged (1,800 rpm, 5 minutes, r.t.). Culture supernatants were 
collected and stored at –70°C until measurements. TNFα levels were 
determined in culture supernatant with ELISA [2].
Results We studied 17 healthy males volunteers aged 36.9 ± 1.6 (X ± 
SEM). TNFα levels are shown in Figure 1. There was no TNFα production 
detected in samples without alcohol in the absence of LPS stimulation 
(control). TNFα production was signifi  cantly decreased at a dose of alcohol 
of 50 mM after LPS stimulation (P <0.05) but more apparently at doses of 
100 and 200 mM alcohol (P <0.001) compared with LPS-induced samples.
Conclusions  Alcohol is related to inhibition of TNFα production of 
whole blood stimulated with LPS ex vivo [3]. This eff  ect occurred shortly 
after alcohol exposure. Our observation indicates a suppression of 
proinfl  ammatory response during acute alcoholic intoxication which may 
be related to increased susceptibility to infections.
References
1.   Brown LA‚ et al.: Alcohol Clin Exp Res 2006, 30:1624-1631.
2.   Myrianthefs P, et al.: Cytokine 2003, 24:286-292.
3.   Nair M‚ et al.: Alcohol Clin Exp Res 1994, 18:602-607.
Figure 1 (abstract P13).
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Introduction  Flow cytometric analysis of leukocyte surface receptors 
has been performed and shown benefi  cial, for example to characterize 
infectious and septic patients [1,2]. For many surface antigens the results 
may vary depending on the sampling temperature, the anticoagulant used 
and the storage of the sample before analysis [3]. In order to obtain reliable 
data on leukocyte immunophenotyping for patient diagnostic purposes, 
we wanted to carry out a thorough evaluation on these methodological 
issues with a wide range of leukocyte surface antigens.
Methods Four blood samples, two using acid citrate dextrose (ACD) and 
two using heparin as an anticoagulant, were taken from fi  ve ICU patients 
with severe sepsis and from fi  ve healthy volunteers. The patients and the 
healthy volunteers were combined into one study population (n = 10). 
The samples were taken, processed and stored either at +4°C or at room 
temperature. The surface antigen staining and fl   ow cytometry were 
performed immediately after sample collection or after 6 or 24 hours 
at the above-mentioned temperatures. Antibodies of interest were for 
monocytes and neutrophils CD11b and CD64, for monocytes CD14, CD40, 
CD80, human leukocyte antigen (HLA)-DR, and for lymphocytes (CD4+ and 
CD8+ T cells, B cells, and NK cells) CD69. The fl  ow cytometry analysis was 
done in three diff  erent time points, after 1, 6 or 24 hours of sampling. Inter-
assay standardization and fl  uorescence quantifi  cations were performed 
using microspheres.
Results The fl  uorescence intensities were higher at room temperature 
compared with +4°C and they increased after storage (Figure 1). The eff  ect 
was observed especially for CD11b-antigen in monocytes and neutrophils 
and for HLA-DR in monocytes.
Conclusions According to our results, fl  ow cytometry leukocyte analysis 
using CD antigens should be performed using +4°C temperature 
throughout the measurement including sample collection, preparation 
and storage, and the analysis should be performed within 6 hours.
References
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2. Nuutila  et al.: Hum Immunol 2009, 70:237-243.
3. Li  et al.: Eur J Haematol 2000, 65:57-65.
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Introduction T lymphocytes are crucial immune cells. We analysed T-cell 
subsets phenotypes and tested, on a single cell level, their ability to 
produce key cytokines in early human sepsis.
Methods  Whole blood was collected from septic patients on ICU 
admission. Peripheral blood mononuclear cells (PBMC) were isolated and 
T-cell subsets analysed. To study cytokine production, PMBC were cultured 
in the presence of PMA/ionomycin (50/750 ng/ml) in supplemented RPMI 
1640 for 5 hours. Intracellular cytokines IL-4, IL-10, IL-17, IFNγ were stained 
in CD3+/CD4+, CD3+/CD8+ cells using fl  ow cytometry for both. The number 
of cytokine producing cells was compared with age/sex-matched healthy 
human volunteers. Data are expressed as mean ± SEM.
Results There were 12 patients (66 years old, six males, APACHE II-24, 
eight survivors) and nine volunteers. We found a relative increase in 
the frequency of Treg cells while the proportion of CD4+ cells remained 
unchanged in septic patients. The PMA/ionomycin lead to maximal 
T-cell stimulation, testing the ability of individual cell subsets to produce 
cytokines. Septic patients displayed reduction of IFNγ (10.5 ± 0.8% vs 
14.7 ± 1.9%, P <0.01) and a tendency to higher number of IL-10 (1.7 ± 
0.3% vs 0.5 ± 0.1%, P = 0.10) producing CD4+ cells, while the proportion 
of IFNγ-positive CD8+ cells increased (42.8 ± 5.8% vs 28.1 ± 4.9%, P = 0.03). 
However, the overall CD8+ T-cell population was reduced (14.29 ± 1.6% vs 
25 ± 1.2%) following ex vivo activation in patients. The number of IL-4 and 
IL-17 staining cells was unchanged (Figure 1).
Conclusions Our results confi  rm a relative increase of Treg [1] and a skew 
towards Th2 lineage in the CD4+ cells. The highly activated CD8+ cells 
appear to be more susceptible to activation-induced cell death.
References
1. Venet  F  et al.: Intensive Care Med 2009, 35:678-686.
Figure 1 (abstract P14). CD11b fl  uorescence intensity for neutrophils 
(n = 10). Figure 1 (abstract P15).
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CD64, a marker of leucocyte activation kinetics after uncomplicated 
cardiac surgery
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Introduction The aim of this study was to assess the CD64 kinetics after 
normal cardiac surgery, an essential step to defi  ne the potential use of 
CD64 as an early and specifi   c infectious marker in this postoperative 
setting. CD64 is a high-affi   nity receptor for the Fc portion of IgG. It is weakly 
expressed on the polynuclear neutrophils (PMNs) at rest [1,2] but increases 
specifi  cally after bacterial stimulation. Thus, CD64 analysis is proposed as 
an early infectious marker.
Methods Prospective study realised in the medico-surgical ICU of CHU 
Charleroi (Belgium). Twenty-two patients (mean age 64  ±  13  years) 
scheduled for cardiac surgery were included in the analysis. The CD64 
expression on neutrophils was quantifi  ed by the haematologic cell dyn 
sapphire method (Abott, USA). C-reactive protein, leukocyte count, white 
blood cells, platelets and temperature were also monitored. Values are 
expressed as median (25th to 75th) percentile.
Results  CD64 index (Figure 1) slightly rose from the day 0, median 
value 0.86 units (1.06 to 1.38 units) to day 5 after the surgery, 1.01 (1.32 
to 1.68  units). However, this increase was moderate, and the median 
values did not exceed the usual threshold of 1.5 units. Conversely, CRP 
showed a large increase from normal values on day 0 to 8, 67 mg/dl (6.64 
to 13.56 mg/dl) on day 5. No signifi  cant correlation (P >0.05) was found 
between CD64 and the others parameters of infl  ammation (CRP, leukocyte 
count, PMNs, platelets and temperature).
Conclusions Our results show that the neutrophil CD64 expression after 
cardiac surgery with ECC is only moderately increased. The role of this new 
biomarker in the early diagnosis of infection (after major surgery) should 
be assessed in prospective studies.
References
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Interferon-gamma reverses sepsis-induced immunoparalysis of 
monocytes in vitro
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Introduction It is currently being understood that most of the agents 
modulating host response in sepsis have failed because they act to 
refrain an over-exaggerated immune response whereas immunoparalysis 
takes place on the time of their administration. The eff  ect of IFNγ on 
immunoparalysis of monocytes in sepsis was assessed.
Figure 1 (abstract P16). CD64 kinetics (units).
Figure 1 (abstract P17). Eff  ect of IFNγ on the release of TNFα.
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of signs of sepsis from 10 healthy donors and from 33 patients; 14 with 
sepsis and 19 with severe sepsis/shock. Peripheral blood mononuclear 
cells (PBMCs) were isolated and stimulated with 10 ng/ml LPS; 5 μg/ml 
Pam3Cys; and heat-killed isolates of Candida albicans, multidrug-resistant 
Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus 
(MRSA). Stimulations were done in the absence and presence of 10 ng/
ml IFNγ. Concentrations of cytokines were estimated in supernatants by 
an enzyme immunoassay.
Results Eff  ects of IFNγ on the release of TNFα are shown in Figure 1. 
Open bars represent stimulation in the absence of IFNγ and solid bars 
stimulation in the presence of IFNγ. Asterisks signify diff  erences compared 
with the absence of IFNγ. IL-6 and IL-1β had similar kinetics to TNFα.
Conclusions  IFNγ reverses in vitro sepsis-induced immunoparalysis of 
monocytes. The type of aff  ected cytokine depends on the agonist and 
probably refl  ects the mechanism of action of IFNγ.
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derangement but not cytokine response in porcine endotoxemia
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Introduction  We evaluated whether treatment with hydrocortisone 
administered just after establishment of endotoxin-mediated circulatory 
dysfunction would have anti-infl  ammatory and shock reversing eff  ects. 
Establishment of endotoxin-mediated circulatory dysfunction was 
defi   ned as the moment when the mean pulmonary arterial pressure 
(MPAP) reached the double baseline value.
Methods  All pigs were anesthetized and given endotoxin infusion 
during the 6 hours of the experiment. Eight pigs were randomized to the 
hydrocortisone group, receiving hydrocortisone at 5 mg/kg intravenously, 
or to the control group, receiving a corresponding volume of saline, as 
soon as the MPAP doubled the baseline value. P <0.05 was considered 
signifi  cant.
Results No diff  erence in baseline data was noted between the groups. 
No diff  erences in TNFα (Figure 1), IL-6 and core temperature were seen 
between the groups. Pigs in the hydrocortisone group had signifi  cantly 
higher mean arterial pressure and systemic vascular resistance index 
during the 6-hour experimental period than pigs in the control group, 
while heart rate was signifi  cantly lower in the hydrocortisone group at 1 to 
6 hours as compared with controls.
Conclusions Early treatment with hydrocortisone, administered after the 
onset of endotoxemia, counteracted circulatory deterioration, but did not 
aff  ect the plasma levels of proinfl  ammatory cytokines in this model. Thus, 
TNFα and IL-6 might not be involved in the development of circulatory 
dysfunction during the early phase of experimental endotoxemia.
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Introduction It has been recently hypothesized that septic microangio-
pathy is caused or at least promoted by the interaction between endo-
thelial surface receptor CD40 and its ligand CD40L, expressed by activated 
platelets. This interaction produces procoagulative changes in endothelial 
cells, endothelial apoptosis, subendothelial matrix exposition and 
microthrombi formation. Since virtually all septic patients show a certain 
degree of coagulation abnormalities, we hypothesized that low platelet 
count is associated with a diff  erent degree of CD40L expression and that 
this could correlate with the severity of disease.
Methods To determine the infl  uence of sepsis on levels of platelet-derived 
CD40L expression, we performed a prospective observational study in a 
polyvalent university hospital ICU. Eighteen consecutively septic patients 
were enrolled in the study, independently of the platelet count and the 
severity of disease (SOFA score). Flow cytometry of fresh blood from septic 
patients (n = 18) and age-matched controls (n = 8) was performed for 
membrane-bound CD40L and CD62P on circulating platelets.
Results Flow cytometry demonstrated low levels of CD62P in controls 
while the levels in patients were high. CD40L+ platelets were selectively 
found from patients with thrombocytopenia (platelet count ≤60,000/
mm3). Furthermore a direct correlation between CD40L expression and 
the SOFA score was found in patients with sepsis and thrombocytopenia 
compared to patients with sepsis without thrombocytopenia.
Conclusions These results suggest that CD40L expression on platelets is 
somehow related to the degree of thrombocytopenia and possibly can 
be a marker of the severity of sepsis. Although the role of endothelial-
derived CD40/platelet-derived CD40L interaction is not fully understood 
during sepsis, the expression of CD40L on platelets could be related to 
the severity of organ disease due to the possible bursting of endothelial 
damage through this pathway. Further investigation is needed to 
determine whether platelets CD40L contributes to endothelial and 
subsequent organ damage, its role in thrombocytopenia and its 
correlation with the outcome of sepsis. The microvascular injury seems 
to be a central event in sepsis, so understanding the mechanisms 
underlying its development is crucial for the individuation of new and 
specifi  c therapeutic strategies.
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Introduction Nitric oxide (NO) plays a central role in the pathogenesis 
of sepsis. Recently, we demonstrated that endothelial NOS (eNOS) 
contributes to endogenous NO-production and modulates infl  ammation, 
associated with preserved cardiac function resulting in prolonged survival 
of eNOS–/– compared with wild-type (WT) mice. The role of neuronal NOS 
(nNOS) in septic cardiomyopathy remains unclear. This study’s aim is to 
elucidate the infl  uence of nNOS in the presence/absence of eNOS on 
cardiac function and survival in a clinically relevant model of sepsis.
Methods Inhibition of nNOS was achieved via continuous application of 
the selective nNOS-inhibitor Vinyl-L-NIO (VL-NIO) (0.02 mg/kg BW/hour) 
using an osmotic mini pump. B6/c57 WT and eNOS–/– mice were rendered 
septic by cecum ligation and puncture (CLP). After 12 hours heart function 
was analyzed using a pressure–volume catheter placed in the left ventricle. 
For catecholamine responsiveness, norepinephrine was applied (0.4 μg/kg 
BW/minute, intraperitoneally). NOx-levels in plasma were measured using 
high-pressure performing liquid chromatography.
Results Inhibition of nNOS via VL-NIO application resulted in signifi  cantly 
reduced nitrate plasma levels and prolonged survival (WT CLP + VL-NIO = 38 
Figure 1 (abstract P18). TNFα over time (mean ± SEM).
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responsiveness were not improved compared with untreated septic WT. 
In contrast to WT, application of VL-NIO in eNOS–/– had no infl  uence on 
plasma nitrate levels, while cardiac function and survival were signifi  cantly 
impaired compared with untreated septic eNOS–/–. Impaired cardiac 
function was accompanied by decreased survival time (eNOS–/– CLP + 
VL-NIO = 29.5 hours vs eNOS–/– CLP = 69.5 hours).
Conclusions  Pharmacologic inhibition of nNOS result in signifi   cant 
reduction of plasma nitrate levels and prolonged survival compared 
with untreated septic WT despite unimproved septic cardiomyopathy. 
In contrast, the signifi  cant survival benefi  t of septic eNOS–/– compared 
with septic WT was abrogated by pharmacologic nNOS inhibition. 
Furthermore, the latter developed severe septic cardiomyopathy. 
Whether eNOS acts as modulator of nNOS in this setting remains to be 
clarifi  ed by further studies.
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Urinary albumin excretion is elevated in sepsis, but does not 
correlate with circulating VEGF-A levels
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Introduction  In critically ill patients admitted with SIRS, endothelial 
dysfunction leads to increased capillary permeability. In the glomerulus, 
it manifests as increased albumin excretion. Microalbuminuria is a 
common fi  nding in various acute conditions like sepsis, trauma and 
surgery. Studies have shown increased levels of vascular endothelial 
growth factor-A (VEGF-A), a potent vascular permeability inducing 
agent, in LPS-induced endotoxemia, severe sepsis and septic shock. 
The pathogenic mechanism of the glomerular leakage of albumin in 
acute infl  ammatory conditions remains to be clarifi  ed. We wished to 
investigate the causative role of VEGF-A, in this regard which might have 
therapeutic implications.
Methods Prospective study in the 43-bed ICU of a tertiary care hospital. Of 
the consecutive patients admitted to the ICUs between September 2008 
and January 2009, 597 patients were included, after excluding patients 
with ICU stay <24 hours, pregnancy, menstruation, anuria, hematuria and 
proteinuria due to renal and post- renal diseases. Of these, 30 consecutive 
patients with sepsis, severe sepsis and septic shock (sepsis group) and 30 
randomly chosen patients without sepsis were recruited for the VEGF-A 
study. Spot urine samples for the albumin–creatinine ratio (ACR, mg/g) 
and serum for VEGF-A (ELISA) were collected on ICU admission. Correlation 
was analyzed using Spearman’s correlation coeffi   cient.
Results Sixty critically ill patients, with a median age (IQR) of 60 years (48 
to 72), 39:21 male:female ratio, median APACHE II score (IQR) of 16 (7 to 
23), and 3 median days of ICU stay, had a median ACR (IQR) of 125 mg/g 
(51.6 to 239.1) and a median VEGF-A (IQR) of 111 pg/ml (54.3 to 286.9) on 
ICU admission. The median ACR on admission in the sepsis group (n = 30) 
of 161.8 mg/g was signifi  cantly higher than the median ACR (78.3 mg/g) 
of the group without sepsis (n = 30) (P = 0.011). On statistical analysis, no 
signifi  cant correlation was obtained between levels of urinary ACR and 
serum VEGF-A (P = 0.327) in the entire group. Analysis for correlation 
between ACR and VEGF-A in the sepsis patients (P = 0.396) and in the 
group without sepsis (P = 0.518) yielded similar results.
Conclusions Despite a strong physiologic rationale, our pilot study did not 
show an association between microalbuminuria and VEGF-A in critically ill 
patients. Larger studies are needed to come to a defi  nitive conclusion.
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and protects human pulmonary and renal cells against hypoxic injury
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Introduction High mobility group box protein-1 (HMGB) is released by 
activated monocytes/macrophages during sepsis. Levels correlated with 
mortality in patients and anti-HMGB antibodies prevented endotoxin-
induced death in animal models [1]. In marked contrast to these fi  ndings 
are reports of cytoprotective eff  ects because HMGB protected liver from 
ischemia/reperfusion (IR) [2] and HMGB-transgenic mice were resistant to 
myocardial infarction [3]. Despite these reports, little is known of the role 
or mechanism of HMGB. We aimed to further evaluate HMGB in rat hearts 
and in pulmonary and renal cell cultures.
Methods  Isolated hearts received HMGB/vehicle before 30 minutes 
ischemia and 120 minutes reperfusion. In separate studies, rats were 
rendered septic by caecal ligation and puncture (CLP) prior to IR. Left 
ventricular (LV) function was measured with a latex LV balloon. Infarct 
size was measured by TTC staining. For human cell culture studies, A549 
alveolar cells or HK-2 renal tubular cells were treated with HMGB/vehicle 
before incubation in normoxia or hypoxia. Fluorimetric caspase-3 activity 
was used as measure of apoptosis. Cytochrome C was measured by ELISA. 
For HK-2 cells, the MTT assay was used to test viability.
Results  HMGB, prior to cardiac IR, preserved developed (d) LVP at 
120 minutes reperfusion compared with controls (44 mmHg vs 27 mmHg, 
P <0.05) and infarct size, expressed as %V weight ± SEM, was reduced (31 
± 5.4 vs 44 ± 4.2, P <0.05), n = 6/group. Hearts from CLP rats had reduced 
baseline dLVP (59 mmHg ± 5.1 vs 97 ± 5.3, P <0.05) but infarct sizes after IR 
were signifi  cantly reduced (27 ± 8.8, P <0.05 vs 44 ± 6.2, P <0.05). In A549 
cells, HMGB inhibited apoptosis (49% reduced caspase-3 activity (8.6 vs 
17.1 a.u., P <0.01)). This was associated with reduced cytochrome C release 
(250 vs 389 pg/ml, P <0.05). Using MTT assay, HMGB protected against 
hypoxia-induced cell death vs controls (viability 75% vs 61%, P <0.05).
Conclusions HMGB, or sepsis, similarly precondition the heart against IR 
injury. HMGB has anti-apoptotic eff  ects that protect against hypoxic renal 
and alveolar cell injury. We conclude that HMGB has potent anti-ischemic 
eff  ects in multiple organs and may function as an innate cytoprotective 
mediator in sepsis.
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Introduction Pentraxin 3 (PTX3) is an infl  ammatory mediator produced by 
a variety of tissue cells, like neutrophils, macrophages, myeloid dendritic, 
endothelial and epithelial cells [1]. During sepsis a massive infl  ammatory 
activation occurs, which often leads to an important coagulation system 
dysfunction. PTX3 upregulates coagulation promoters in vitro [2]. PTX3 
may represent an early marker of severity and outcome and may be 
related to coagulation impairment in septic patients.
Methods  We studied 90 patients aff  ected by severe sepsis or septic 
shock previously enrolled in a prospective trial regarding the impact of 
glycemic control on infl  ammation and coagulation. At enrollment we 
recorded sepsis signs, plasminogen activator inhibitor 1 (PAI-1, an inhibitor 
of fi  brinolysis) activity and concentration, prothrombin fragments 1 + 2 
(F1+2) concentration (a marker of coagulation activation), disease severity 
and organ dysfunctions. We measured plasma PTX3 levels at enrollment 
and everyday until day 7. Mortality was recorded at day 90.
Results Although not diff  erent on day 1, PTX3 remained signifi  cantly 
higher in nonsurvivors than in survivors over the fi  rst 5 days (P = 0.002 by 
general linear model). On day 1, septic shock patients had higher PTX3 
levels than patients with severe sepsis (274.41 ± 321.92 vs 114.95 ± 129.93 
ng/ml, P = 0.029, t test). Day 1 PTX3 was signifi  cantly correlated with SAPS 
II score (R2 = 0.08, P = 0.006, linear regression), platelets count (R2 = 0.14, 
P <0.001) and SOFA score (R2 = 0.16, P <0.001). Day 1 PTX3 was correlated 
with PAI-1 concentration (R2 = 0.211, P <0.001) and activity (R2 = 0.231, 
P <0.001) and with F1+2 concentration (R2 = 0.09, P = 0.045).
Conclusions Persisting high levels of circulating PTX3 over the fi  rst days 
from sepsis onset may be associated with mortality. PTX3 correlates with 
severity of sepsis and with sepsis-associated coagulation dysfunction.
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Introduction The eff  ect of intravenous immunoglobulin preparations – 
immunoglobulin G (IgG), immunoglobulin G enriched with IgA and IgM 
(IgGAM) – on blood–brain barrier (BBB) integrity and survival rate was 
comparatively investigated in septic rats.
Methods  Sepsis was induced by cecal ligation and perforation (CLP) 
in Sprague–Dawley rats. The animals received either IgG (250 mg/kg, 
intravenously) or IgGAM (250 mg/kg, intravenously) 5 minutes before CLP 
surgery. All rats were observed for behavioral changes for 24 hours after CLP 
operation. To show the alterations in BBB integrity, Evans blue (EB; 69 kDa) 
dye extravasation was determined for quantitative measurement of BBB 
permeability, and horseradish peroxidase (HRP; 40 kDa) extravasation was 
evaluated to provide ultrastructural evidence for the transport pathways 
involved in BBB permeability. Immunohistochemistry was performed 
to show the alterations in immunoreactivity for tight junction protein 
occludin.
Results A high mortality rate (34%) was noted in septic animals and 
the mortality rate was decreased to 15% and 3% by IgG and IgGAM, 
respectively. Both IgG and IgGAM alleviated the sickness behavior in 
septic rats and the animals were observed to be healthy and active. 
Increased extravasation of EB dye into brain tissue of septic animals was 
markedly decreased by both IgG and IgGAM. Occludin immunoreactivity 
remained essentially unchanged in all groups including CLP. In addition, 
strong staining for HRP was seen around vessels located in the cerebral 
cortex and the hippocampus in septic animals. Increased luminal and 
abluminal vesicles containing electron-dense HRP reaction product were 
noted in the cytoplasm of endothelial cells in the cerebral cortex and 
hippocampus of septic rats, emphasizing an increased BBB permeability 
predominantly by transendothelial route. In these animals, tight junctions 
were ultrastructurally intact suggesting that paracellular pathway of BBB is 
not responsible for the BBB breakdown in sepsis. Following IgG or IgGAM 
treatment, no ultrastructural evidence of leaky capillaries in brain was 
observed in septic animals indicating the blockade of the transcellular 
pathway.
Conclusions The present study indicates that IgG and IgGAM improve the 
integrity of the BBB and inhibit CLP-induced sickness behavior in rats.
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Introduction In addition to the interventions suggested by the guidelines 
of the Surviving Sepsis Campaign, in the recent years other therapeutic 
options have been proposed and tested for patients with severe sepsis 
and septic shock. Polyclonal intravenous immunoglobulins seem to be 
an interesting and useful option because of its activity in neutralizing 
endotoxin and in modulating the host immune response. In this retro-
spective study we assessed the eff  ects of the early use of polyclonal 
intravenous immunoglobulins enriched with IgA-M (IgGAM) in addition 
to standard therapies on clinical outcome of patients with septic shock.
Methods In January 2008, IgGAM was introduced into our ICU protocol 
for the management of septic shock patients (within 24 hours after shock 
appearance and at the dosage of 5 ml/kg for 3 days). From January 2008 
to September 2009, we studied 52 consecutive patients with septic shock 
admitted to our ICU. In each patient we recorded the SAPS II and SOFA 
scores, the compliance to the 6-hour and the 24-hour sepsis bundles, the 
compliance to IgGAM use, the length of stay in the ICU and the 30-day 
mortality rate.
Results Due to low compliance of medical staff   to protocol application, 
IgGAM has been used only in 27 patients (IgGAM group). At ICU admission, 
the severity scores were similar in patients with and without (Control 
group) IgGAM therapy (SAPS II: control 54 (22 to 99), IgGAM: 59 (39 to 
101); P >0.05 and SOFA: control 9 (2 to 17); IgGAM 9 (4 to 15); P >0.05). 
The compliance to 6-hour and 24-hour bundles was also similar in the 
two groups, apart from compliance to fl  uid therapy that was larger in the 
IgGAM group (85% vs 56% in Control group). The length of stay in the ICU 
was 15 ± 9 days in the IgGAM group and 18 ± 31 days in the Control group 
(P >0.05); the 30-day mortality was lower (P <0.05) in the IgGAM group 
(25%) than in the Control group (52%).
Conclusions These preliminary data indicate that the early use of IgGAM, 
associated with interventions proposed by the SSC guidelines, reduces 
mortality of patients with septic shock.
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Introduction The role of intravenous immunoglobulin therapy in patients 
with sepsis and septic shock is still controversially discussed. In a retro-
spective analysis of the data from the SBITS-trial [1] we investigated 
whether the initial level of serum IgG on admission to the hospital in 
patients with sepsis and septic shock (before the fi  rst administration of the 
fi  rst dose of intravenous immunoglobulins) could be seen as a prognostic 
parameter for the primary outcome, lethality on day 28, or the secondary 
endpoints, lethality on day 7 or on the ICU.
Methods A total of 543 were included in the trial: the patients were 
divided into four groups (quartiles) based on the 25th, 50th and 75th 
percentiles of their initial level of IgG on admission to the hospital. The 
fi  rst group contained 140 patients with a range in the IgG serum level up 
to 6.1 g/dl. The second and third groups contained 134 patients and 136 
patients, respectively, the immunoglobulin G levels were greater than 
6.1 g/dl to 8.4 g/dl and greater than 8.4 g/dl to 11.9 g/dl. The fourth group 
containing 133 patients had IgG levels higher than 11.9 g/dl. In a logistic 
regression model we adjusted for potential confounders (that is, sex, age, 
APACHE II score, presence of shock on admission).
Results On basis of this model we could show that lethality between the 
fi  rst and second groups did not diff  er signifi  cantly with the lethality in the 
third (reference) group with physiologic levels of IgG on day 0. Surprisingly 
the lethality of the fourth group, with IgG levels higher than 11.9 g/dl, was 
signifi  cantly higher compared with the reference quartile (OR 1.69, CI 1.01 
to 2.81, P = 0.047).
Conclusions Our post-hoc analysis did show no prognostic relevance of 
a low level of serum IgG on admission to hospital for the 543 patients 
with sepsis and septic shock. Thus the initial serum level of IgG seems to 
be of no aid in making the decision to initiate therapy with intravenous 
immunoglobulins for these patients. Whether a high level of serum IgG 
on admission is an independent risk factor for an increased lethality in 
critically ill patients, as shown in our analysis, needs to be investigated in 
further studies.
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Introduction The potentially envisaged actions of intravenous immuno-
globulin (IVIg) on severe infectious disease include virus or toxin neutralizing 
action, opsonic eff  ect, complement bacteriolytic activity, and enhancement 
of sensitivity to antibiotics. In the case of severe infectious disease, antibiotics 
are often supplemented with administration of IVIg. The aim of this study 
is that the changes in sepsis markers followed by IVIg administration are 
investigated with severe sepsis or severe septic shock patients.
Methods The subjects were 52 patients admitted to an ICU with a diagnosis 
of severe sepsis or septic shock and from whom informed consent had been 
obtained for the present study. IVIg was administered intravenously for 3 days 
(5.0 g/day) and measurements were undertaken before administration (Day 
1), on the day after completion of administration (Day 4), and on Day 7. The 
items measured were IL-6, C-reactive protein (CRP) and, as indices of vascular 
endothelial cell activation, plasminogen activator inhibitor-1 (PAI-1) and 
adhesion molecules (endothelial leukocyte adhesion molecule-1 (ELAM-1)); 
the eff  ect of IVIg administration on these markers was then studied. The IVIg 
studied was polyethylene glycol-treated human immunoglobulin injection 
fl  uid (2.5 g, 50 ml, one vial).
Results The APACHE II score was 25.3 ± 7.8, the SOFA score 9.5 ± 3.5, and 
the survival rate after 28 days 76.9%. The values before IVIg administration 
were: procalcitonin 28.8 ± 44.5 (median value 13.6) ng/ml, CRP 16.3 ± 8.3 
(median value 16.0) mg/dl, IL-6 8,873 ± 19,362 (median value 744) pg/ml, 
PAI-1 374 ± 428 (median value 178) ng/ml, and ELAM-1 198 ± 359 (median 
value 61) ng/ml. All values were thus elevated. After the completion of IVIg 
administration, the level of mediators other than ELAM-1 (procalcitonin, 
CRP, IL-6, PAI-1) decreased signifi  cantly.
Conclusions The results of the present study found signifi  cant decreases 
of IL-6 and PAI-1 resulting from immunoglobulin administration, but did 
not indicate a protective eff  ect on vascular endothelial cell function.
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Introduction C1INH is the most potent endogenous regulator of compli ment 
as well as intrinsic coagulation pathways and the kallekrein–kinin system.
Methods  C1INH systemic activity was studied in patients who were 
enrolled within 48 hours after onset of sepsis (ACCP, 1992). The analysis of 
C1INH activity in quartiles (Q) was conducted in terms of RCT of human 
purifi  ed C1INH (Bicizar, Russia).
Results Sepsis patients (n = 40) responded with an increase of C1INH 
activity in comparison with healthy individuals (Figure 1). Thirty percent of 
Q1 patients had ARDS and septic shock whereas in Q4 everyone showed 
only signs of sepsis. The CRP level was higher in Q1 patients (243.4 ± 
39.9 mg/l) than in Q4 (144.0 ± 20.07 mg/l; P = 0.04), whereas the C4 subunit 
was lower in Q1 (0.19 ± 0.04 g/l) than in Q4 (0.32 ± 0.04 g/l; P = 0.05).
Conclusions Inability to upregulate C1INH activity in sepsis was associated 
with enhanced systemic infl  ammation, higher number of ARDS and septic 
shock cases.
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Introduction  The purpose of the study is the evaluation of B-type 
natriuretic peptide (BNP) as a predictor of septic complications and ICU 
mortality in patients with a new onset of fever during the fi  rst 3 days of 
hospitalization in the ICU.
Methods Thirty-one ICU patients (21 males and 10 females) with new 
onset of fever and leukocytosis within the fi  rst 3 days of ICU admission 
were prospectively included in the study. Exclusion criteria were heart or 
renal failure, chronic obstructive pulmonary disease and head trauma. 
Serial plasma samples were taken on days 1, 2 and 4 after the onset of 
fever for BNP level measurement. BNP values were correlated with severity 
scores (Acute Physiology and Chronic Health Evaluation (APACHE II) and 
Sequential Organ Failure Assessment (SOFA)), the progression to septic 
shock and the fi  nal outcome.
Results According to the clinical and laboratory fi  ndings within the fi  rst 
3 days of hospitalization, the patients included in the study were divided 
into three groups: Group A = systemic infl  ammatory response syndrome 
(SIRS) (seven patients), Group B = sepsis (14 patients) and Group C = 
septic shock (10 patients). The BNP value on days 1 and 2 was signifi  cantly 
associated with the SOFA Max value (P <0.001). The BNP value on day 4 
was signifi  cantly associated with ICU mortality (P = 0.006). The optimal 
cutoff   BNP value for diff  erentiating between nonsurvivors and survivors 
was estimated to be 203.55 pg/ml (sensitivity = 100%, specifi  city = 61.1%). 
In Group B patients, BNP value on day 2 was signifi  cantly higher in patients 
who fi  nally progressed to septic shock (P = 0.001). The optimal cutoff   BNP 
value for identifying these patients was estimated to be 212.45 pg/ml 
(sensitivity = 85.7%, specifi  city = 64.3%).
Conclusions In ICU patients with new onset of fever during the fi  rst 
3 days of ICU hospitalization, the BNP value on day 4 seems to be a good 
predictor of ICU mortality. In patients with sepsis, a cut-off   BNP value of 
212.45 pg/ml on day 2 could be a predictor of progression to septic shock. 
Due to the small number of patients included in our study, further studies 
are needed to confi  rm these fi  ndings.
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Introduction  The level of microalbuminuria is thought to refl   ect the 
severity of infl  ammation during acute phase response and may have 
prognostic value with regard to survival. This study aimed to describe 
urinary albumin excretion in patients with septic shock and changes in 
microalbuminuria levels in the fi  rst 3 days of treatment.
Figure 1 (abstract P28). C1INH activity in patients with sepsis analyzed in 
quartiles (Q1, Q2, Q3, Q4) in comparison with healthy individuals.
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septic shock admitted to a general ICU. During the fi  rst 24 hours after severe 
sepsis was diagnosed, we collected data to calculate APACHE II and SOFA 
scores and urinary sample to measure urinary albumin. Another sample of 
urine was collected on the third day of septic shock. Microalbuminuria was 
measured by immunoturbidimetry with a limit of detection of 3.5 mg/l. 
The study was approved by the local Ethic Committee.
Results The mean age was 65.8 ± 15 years and male sex was more frequent 
(63.3%). Pneumonia (59.2%) was the most common source of sepsis. Mean 
APACHE II and SOFA scores on the fi  rst day of sepsis were 24.4 ± 7.7 and 
8.7 ± 3.7, respectively. Observed mortality was 71.4%. Median urinary 
albumin was 7.0 mg/l (IQT: 4.7 to 60.3 mg/l) for survivors and 15.5 mg/l 
(IQT: 7.9 to 77.1 mg/l) for nonsurvivors on the fi  rst day of septic shock. 
Urinary albumin decreased from 7.0 mg/l (IQT: 4.7 to 60.3 mg/l) to 3.9 mg/l 
(IQT: 3.6 to 44.1 mg/l) in survivors during the fi  rst 3 days of septic shock, 
and in nonsurvivors remained at the same level from 15.5 mg/l (IQT: 7.9 to 
77.1 mg/l) to 14.5 mg/l (IQT: 3.9 to 45.3 mg/l) in the period of observation.
Conclusions  Patients with septic shock showed high frequency of 
microalbuminuria. Levels of urinary albumin showed a tendency to 
decrease in survivors, suggesting prognostic signifi  cance.
References
1. Thorevska  N,  et al.: Crit Care Med 2003, 31:1075-1081.
2. Abid  O,  et al.: Chest 2001, 120:1984-1988.
P31
Evaluation of automated hematologic VCS parameters in severe 
sepsis and septic shock: a case–control study
A Cortegiani1, A Di Benedetto1, L Marino1, G Virga1, R Chiaramonte1, 
C Sarno2, SM Raineri1, A Giarratano1
1University of Palermo, Italy; 2Fondazione Istituto S. Raff  aele, Cefalù (PA), Italy
Critical Care 2010, 14(Suppl 1):P31 (doi: 10.1186/cc8263)
Introduction A cheap and quick hematologic diagnostic parameter for 
detection of sepsis would have both economic and therapeutic benefi  ts. 
The Coulter LH series hematology analyzer uses the VCS technology 
(Volume, Conductivity, Laser Scatter) providing information about cell 
volume, size, internal structure, and surface morphology. Many authors 
analyzed the clinical usefulness of VCS parameters in reactive neutrophils 
for detection of sepsis. An increase in mean cell volume and a decrease in 
mean light scatter in septic patients have been described. Our aim is to 
verify the correlation between VCS parameters and sepsis.
Methods We enrolled 92 patients admitted in our ICU and divided them 
into two groups: Controls (48) and Sepsis (44). We collected blood samples 
immediately after making the diagnosis. All samples were analyzed by 
Coulter LH 500 hematology analyzer. We realized ROC curves for each V, 
C, S parameter.
Results The AUC was 0.816 (95% CI, 0.722 to 0.889) for mean-V value; 0.546 
(95% CI, 0.439 to 0.650) for mean-C value; 0.604 (95% CI, 0.497 to 0.704) for 
mean S value (Figure 1). The correlation with sepsis was a linear positive 
one for mean-V (strong) and mean-C (weak) instead of a linear negative 
one for mean-S. The best cut-off   value for mean-V was >163 (Sens: 84.09%; 
Spec: 68.75%); >137 for mean-C (Sens: 72.73%; Spec: 41.67%); <134 for 
mean-S (Sens: 56.82%; Spec: 64.58%).
Conclusions Our study shows the high diagnostic performance of mean-V 
and the weak one of mean-C and mean-S in septic patients. The clinical 
usefulness of mean-V is strengthened by the quickness and cheapness of 
its analysis. It could be tested daily or more as a valid laboratorial help for 
critical patient’s clinical assessment.
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Introduction CD64 is the high-affi   nity receptor of IgG. It is upregulated by 
infl  ammatory cytokines on neutrophils. The upregulation of CD64 is linked 
with PMN activation in SIRS or sepsis. Our aim is to verify these correlations.
Methods We enrolled 48 ICU critical patients and three groups were 
created: SIRS– (17), SIRS+ (13), Sepsis (17). We evaluated CD64 X-mean 
values among the three groups as shown in Figure 1. We used a t test to 
check the correlation between uprising CD64 and diff  erent groups. We 
verifi  ed the correlation CD64/SOFA (Figure 2), WBC, NE, and patients’ age 
using r.
Results We found a CD64 higher level in sepsis compared with SIRS– (t = 
8.095; P <0.001) and with SIRS+ (t = 4.938; P <0.001). There were a high 
positive linear correlation between CD64 and SOFA score (r = 0.806; 
Figure 1 (abstract P31).
Figure 1 (abstract P32).
Figure 2 (abstract P32).
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positive correlation with NE count; no correlation with age.
Conclusions Our study shows that CD64 can identify SIRS/sepsis. We 
found a correlation between CD64/SOFA; no infl  uence of WBC, NE and 
age was detected.
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Introduction Endotoxin scattering photometry (ESP) is one of a newly 
developed clinically applicable method for endotoxin assay. Although ESP 
is an analogous assay of turbidimetric method, it enables one to detect very 
small amounts of endotoxin within 1 hour. This is because ESP can directly 
detect clotting enzyme product, coagulin, which is the fi  rst appearance of 
Limulus amebocyte lysate (LAL) cascade and the precursor of gel clots.
Methods  To study the correlates and prognostic signifi   cance of the 
endotoxin assay with ESP, we enrolled a total of 80 people consisting of 
three groups which were normal healthy volunteers (n = 35), patients 
admitted to the emergency department (ED) (n = 21) and patients 
admitted to the ICU (n = 24). To examine whether endotoxin is infl  uencing 
in the severity of disease, we used sepsis/SIRS stratifi  cation which was 
defi  ned by the American College of Chest Physicians/Society of Critical 
Care Medicine (ACCP/SCCM).
Results Of all 80 people, 33.7% (n = 27) was sepsis. The levels of endotoxin 
were signifi  cantly higher in the patients with sepsis (median, 18.4 pg/ml; 
interquartile range, 3 to 54.1 pg/ml) than in the people without sepsis 
(0.227 pg/ml; 0.031 to 0.493 pg/ml). The area under the receiver operating 
characteristic curve was 0.951 in the patients with sepsis. Cut-off   
concentrations for optimum prediction of sepsis with ESP were endotoxin 
>7.06 pg/ml (diagnostic effi   ciency: 92.6%).
Conclusions Endotoxin assay with ESP is one of the diagnostic markers 
of sepsis because the levels of endotoxin in patient with sepsis are clearly 
high. Endotoxin assay with ESP concentration higher than 7.06 pg/ml 
indicates sepsis.
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Introduction The incidence of sepsis is reported around 37% in European 
ICUs [1]. The mortality rate depends on the severity of organ failure, up to 
65% if four or more organs are involved. Multiple organ failure (MOF) is 
due to microcirculatory dysfunction with microthrombosis resulting from 
coagulation disorders including platelets’ activation. An early diagnosis 
should identify the microcirculatory dysfunction before MOF became 
clinically evident. The diagnosis of sepsis is commonly based on clinical 
criteria, pathogen identifi   cation and use of markers like procalcitonin 
(PCT) and C-reactive protein (PCR) associated with infection. The aim of 
our study is to evaluate whether the routine measurement of immature 
platelet fraction (IPF), considered a precocious marker of platelet 
production, is associated with sepsis and its severity and/or whether it 
could be used as a predicting marker of sepsis.
Methods  We enrolled 66 consecutive patients admitted to the ICU, 
dividing them into two groups: septic (n = 44) and no septic (n = 22). The 
severity of sepsis was evaluated. The exclusion criterion was a platelet 
count <150,000/mm3. Blood count, coagulation, PCR, PCT, and IPF were 
collected every day.
Results The IPF values between septic (4.6 ± 3.1) and no septic patients 
(3.3 ± 1.5) did not diff  er (P = 0.16). No correlation was found between IPF 
values and the severity of septic condition (no sepsis 11.7 ± 10.1; sepsis 
14.3 ± 10.5; severe sepsis 10.5 ± 9.1; septic shock 19.5 ± 12.4; P = 0.3). When 
we considered only subjects who did not have sepsis at the ICU admission 
we found that patients who developed sepsis during the recovery had IPF 
values higher than patients who did not develop sepsis (Table 1).
Conclusions From our results IPF cannot be considered a marker of sepsis. 
Conversely it could be used as predictive index of sepsis because it can 
identify patients who will develop sepsis.
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Introduction Sepsis is a serious health problem in the elderly with a high 
degree of mortality. The study of pathophysiology of sepsis has lead to the 
development of cytokine markers which help in establishing diagnosis, 
quantifying the severity and assessing the response to therapy. TNFα and IL-6, 
a pleotropic cytokine, are among the most well-studied proinfl  ammatory 
cytokines in sepsis. However, very limited data are available in elderly 
subjects regarding the markers for sepsis. The present study was undertaken 
to establish the cytokine profi  le in sepsis in the elderly and develop markers 
for prediction. The infl  uence of gender on cytokine production and mortality 
in elderly patients with sepsis was considered in particular.
Methods In this prospective study, 50 elderly patients, age above 65 years, 
satisfying the systemic infl  ammatory response syndrome (SIRS) criteria 
were included. Serial estimations of TNFα and IL-6 were done on days 1, 
3 and 7 of ICU admission.
Results The results were drawn on the basis of gender and survival. A 
correlation of APACHE score, TNFα values and IL-6 values on day 1, day 
3 and day 7 between survivors and nonsurvivors was also documented, 
which showed reducing levels of IL-6 levels from days 1 to 7 in the survivor 
group (P <0.01). The TNFα level was signifi  cantly low on day 1 in the 
nonsurvivor female group (P <0.00001).
Conclusions Cytokine profi  ling for TNFαand IL-6 level in elderly patients 
with sepsis helps in prognosticating the outcome. Female gender was an 
independent predictor of increased morality in critically ill patients with 
documented infection.
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Introduction The role of matrix metalloproteinases (MMPs) and tissue 
inhibitors of matrix metalloproteinases (TIMPs) in sepsis remains unclear. 
Table 1 (abstract P34) 
 No  sepsis  Sepsis  Mann–Whitney 
IPF (%)  5.4 ± 2.9  3.3 ± 1.5  P = 0.04
PCT (ng/ml)  0.68 ± 1.1  0.57 ± 1.3  P = 0.4
PCR (mg/dl)  9.57 ± 10.2  11.7 ± 10  P = 0.46
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patients than in controls [1], higher PAI-1 levels in nonsurviving than in 
surviving septic patients [2], and a positive correlation between TIMP-1 and 
PAI-1 in apparently healthy adult individuals [3]. The objective of this study 
was to determine the association between TIMP-1/MMP-9 ratio and PAI-1, 
and its infl  uence on the severity and mortality of patients with sepsis.
Methods This was a multicenter, observational and prospective study 
carried out in six Spanish ICUs. We included 192 (125 surviving and 67 
nonsurviving) patients with severe sepsis. Serum levels of MMP-9, TIMP-1 
and plasma levels of PAI-1 were measured at the time of diagnosis.
Results Nonsurviving septic patients presented higher levels of TIMP-1 
(P <0.001), higher TIMP-1/MMP-9 ratio (P <0.001), higher levels of PAI-1 
(P <0.001), higher SOFA score (P <0.001), higher lactic acid levels (P <0.001) 
and lower platelet count (P <0.001) than surviving ones. TIMP-1/MMP-9 
ratio positively correlated with PAI-1(P <0.001), lactic acid levels (P <0.001), 
SOFA score (P <0.001), INR ratio (P <0.001), aPTT (P <0.001), and negatively 
with platelet count (P <0.001). The mortality prediction by TIMP-1/MMP-9 ratio 
(AUC = 0.66; 95% CI = 0.58 to 0.74; P <0.001) was similar to that provided by 
other markers of severity such as lactic acid (AUC = 0.67; 95% CI = 0.58 to 
0.75; P <0.001) and SOFA score (AUC = 0.71; 95% CI = 0.64 to 0.79; P <0.001).
Conclusions The TIMP-1/MMP-9 ratio may be of great pathophysiological 
signifi  cance in terms of severity and mortality in sepsis, and may represent 
a biomarker to predict the clinical outcome of septic patients. The novel 
fi  nding of our study is the association between TIMP-1/MMP-9 ratio and 
PAI-1 levels in sepsis, which can contribute in the organ dysfunction and 
mortality of sepsis.
Acknowledgements Study supported, in part, by the grants FUNCIS-
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Introduction  Severe sepsis remains one of the most threatening 
conditions in intensive care. During the progression of sepsis from 
early hit to multiorgan failure proinfl   ammatory and anti-infl   ammatory 
cytokines are released. Cytokines can be used as biomarkers to determine 
the specifi  c patterns of sepsis progression and association with mortality 
[1]. These biomarkers were successfully used as predictors in animal 
studies [2]. Data from humans, especially comparison between children 
and adults, are limited. Hence, in this study we widely describe systemic 
cytokine response in this type of patient population.
Methods  Prospective study of 37 subjects (20 children, 17 adults) 
hospitalized with severe sepsis in intensive care. We measured CRP, 
procalcitonin, TNF, IL-1β, IL-4, IL-6, IL-8, IL-10, IL-12, TREM-1. ANOVA models 
were specifi  ed using Proc Mixed. Study was fully approved by an ethics 
committee.
Results  We identifi   ed a correlation of CRP levels with mortality or 
presence of shock (Figure 1). We found a distinct feature of CRP in adults 
with pronounced dynamic dichotomy in these subjects. Levels of IL-6 
were signifi  cantly diff  erent in adult patients in the context of shock states. 
High IL-6 levels in the beginning of sepsis were associated with shock 
during progression of illness. Highest risk of death was in adult patients 
associated with TREM-1 sustained high after 48 hours after sepsis onset 
(Figure 2). Otherwise, there was no correlation with death, shock states 
and SOFA score for PCT, TNF, IL-1β, IL-4, IL-8, IL-10, and IL-12.
Conclusions Response of circulating factors in patients with severe sepsis 
is heterogeneous in the adult and children population and has some 
distinct features according to the dynamics of CRP, IL-6 and TREM-1.
Acknowledgements Supported in part by the Internal Grant Agency of 
the Ministry of Health NR 9297-3 and NR 9894-4.
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Introduction  The outcome of sepsis in critically ill patients relies on 
rapid identifi  cation and therapy. However, identifi  cation of sepsis in these 
patients is challenging, and focus has shifted towards biological surrogates 
as diagnostic/therapeutic biomarkers. IL-6 and lipopolysaccharide binding 
protein (LBP) may have such a potential.
Methods  Retrospective analysis of daily IL-6 and LBP serum levels 
over the course of a 3-month laboratory feasibility study of large-scale 
chemiluminescent immunometric assays on unused residuals of routine 
patient blood samples from the surgical critical care unit. We determined 
the time course of IL-6 and LBP over septic events defi  ned as 4 days 
before and after the initiation of antimicrobial therapy as day 0 (n = 40).
Variations over time of IL-6 and LBP in both absolute values and amplitude 
were measured between day –4 to day 0 and day 0 to day +4. Candidate 
biomarker variations were assessed for coherence with clinical evolution 
of sepsis to determine biomarker-like behavior.
Figure 1 (abstract P37). SOFA adults. Solid line, SOFA 0 to 12; dashed line, 
SOFA 13 to 24.
Figure 2 (abstract P37). Adults. Solid line, exitus; dashed line, survived.
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of sepsis rather than variations in absolute values or values relative 
to published thresholds. Coherence between patient evolution and 
biomarker time course was 93% for IL-6 and 85% for LBP. IL-6 levels always 
increased to over at least 50% of baseline (51 to 2,523%) before initiation 
of antibiotics. IL-6 decreased by at least 45% (45 to 98%) of the maximal 
value when sepsis resolved successfully with antimicrobial therapy in 92% 
of the cases. Stagnating IL-6 levels always paralleled absence of resolution 
of sepsis. No pre-antimicrobial initiation increase of LBP was observed. 
LBP always decreased by at least 16% (16 to 85%) of the maximal value 
when sepsis resolved successfully with antimicrobial therapy. LBP increase 
after initiation of antimicrobials or LBP stagnation paralleled absence of 
clinical resolution. Concordant patterns of both IL-6 and LBP were always 
coherent with clinical evolution but only concerned 35% of the cases.
Conclusions IL-6 and LBP behave as biomarkers over the course of sepsis 
in surgical critical care patients. Only dynamic monitoring may yield any 
information relevant to diagnosis or treatment follow-up. It remains to be 
shown how well these biomarkers perform through other study designs.
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Introduction  Our objective was to investigate the plasma levels of 
melatonin and the prognostic value of these markers in patients with 
sepsis. This is a prospective study of 131 patients over 22 years old with 
sepsis in the ICU.
Methods  The patients were divided into two groups containing 72 
patients as survivors (Group I) and 59 patients as nonsurvivors (Group II). 
The blood collection was performed in the night (02.00 to 04.00 hours) 
and the Acute Physiologic and Chronic Health Evaluation II (APACHE II) 
score calculated on the day of hospitalisation, second day and the last 
day (discharge or death). The samples were centrifuged methodically 
and plasma samples were preserved at –200°C. After reaching the target 
quantity, all plasma samples were studied with RIA method at room 
temperature.
Results Statistically signifi  cant high APACHE II values were determined 
in Group II compared with Group I on the all days (P <0.05). Statistically 
signifi   cant low nocturnal plasma melatonin values were determined 
in Group II compared with Group I on the last day (P <0.05). In Group II, 
duration of mechanical ventilation and stay of ICU are longer, and at the 
last days of biochemistry parameters failed (elevation of urea, creatinine, 
serum glutamic oxaloacetic transaminase and serum glutamic pyruvic 
transaminase) (P <0.05).
Conclusions  We conclude that from plasma melatonin values it is 
impossible to predict the prognosis but during the follow-up these values 
can demonstrate the status of prognosis in septic patients. There are 
several factors aff  ecting these melatonin values; thereby we propose that 
further research should be performed.
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Introduction Serum C-reactive protein (CRP) is synthesized in response to 
infl  ammatory status. Elevated CRP levels are associated with an increased 
risk of multiorgan failure in ICU patients. Preoperative elevation of serum 
CRP is a prognostic indicator in gastric and colorectal surgery. The aim of 
this study was to determine serum CRP as prognostic variable in patients 
undergoing esophagectomy with gastric tube reconstruction in contrast 
to other ICU admitted patients.
Methods Data were collected retrospectively for a total of 208 patients 
admitted to the ICU following elective surgery from October 2007 to 
December 2008. Patients included underwent esophagectomy with 
gastric tube reconstruction, liver transplantation, hemihepatectomy, 
neuro- and abdominal aneurysm surgery. Postoperative serum markers 
were measured and the relation between the course of postoperative 
serum CRP, development of complications and prognosis of the patients 
was investigated.
Results  Postoperative serum CRP was signifi   cantly higher at T24 in 
patients undergoing esophagectomy with gastric tube reconstruction, 
compared with all other patients. Higher serum CRP levels correlated with 
the occurrence of complications in the heterogeneous ICU population 
but especially in the esophagectomy patients. Within this group, serum 
CRP levels at T24 and T48 were signifi  cantly higher in patients with a 
postoperative pneumonia, which in itself was associated with increased 
1-year mortality.
Conclusions Postoperative serum CRP levels can easily be monitored 
in the ICU in order to identify patients at risk for the development of 
postoperative complications. Especially in the esophagectomy patients, 
the occurrence of postoperative complications is associated with reduced 
survival.
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Introduction An observational study was conducted in a teaching hospital 
to evaluate the diagnostic and prognostic value of procalcitonin together 
with C-reactive protein (CRP) in assessing the presence of infection/sepsis 
in patients arriving in the emergency department (ED). The objective 
was to improve diagnostic and therapeutic time to intervention by the 
emergency physician.
Methods Three hundred and fi  ve patients were studied (145 male, 160 
female, mean age 67.2 years). Vital parameters were recorded during 
patient’s stay in the ED. Hemocultures and biological fl   uids cultures 
were performed before antibiotic therapy. CRP and procalcitonin were 
performed at arrival in the ED, and after 5 days of antibiotic therapy.
Results Median PCT and CRP values at arrival in the ED were 0.3 ng/ml 
and 12.9 mg/dl, after 5 days they were 0.09 ng/ml and 4.2 mg/dl with a 
signifi  cant statistical diff  erence in both markers (P <0.001). PCT was higher 
in sepsis vs infections (respiratory, urinary, gut or skin infections) (3.1 vs 
0.2 ng/ml, P <0.001). PCT pre-therapy was signifi  cantly higher in septic 
nonsurvivors vs septic survivors (1.0 vs 0.2 ng/ml, P <0.001), and there was 
a signifi  cant PCT increase after 5 days in nonsurvivors vs survivors (3.6 vs 
0.07 ng/ml) (P <0.001). CRP results did not show a statistical signifi  cance, 
except for CRP measured after 5 days (3 mg/dl) vs CRP pre-therapy in 
survivors (12 mg/dl, P <0.001). PCT (cut-off   0.5 ng/ml) ROC curve showed 
an AUC 0.72 (P <0.001), with a sensitivity 75% as a diagnostic marker for 
Figure 1 (abstract P40). CRP and complications in all groups.
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if considered as a prognostic factor of death (cut-off   1 ng/ml). Although 
pre-therapy PCT values were not particularly sensitive, nor specifi  c for 
predicting deaths, PCT in therapy (cut-off   0.5 ng/ml) had an AUC 0.79 
(sensitivity 75%, specifi  city 76% in predicting events) (P <0.0001). This was 
higher than CRP (AUC 0.73, P <0.0004).
Conclusions PCT, with CRP, is useful to make an initial rapid infection 
diagnosis for patients presenting to the ED, and also to discriminate it from 
sepsis. Our results are in agreement with other authors [1,2]. A PCT cut-off   
value of 0.5 ng/ml shows high sensitivity as a diagnostic infection marker, 
but also as a prognostic marker for outcomes. PCT with CRP are useful 
tools to assess a fast empiric therapy, and to ameliorate the prognosis of 
infectious/septic in ED patients.
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Introduction  Procalcitonin (PCT) off   ers the possibility of diff  erentiating 
bacterial infection from viral or non-infectious reactions. PCT can be used 
to support decision-making on initiation or discontinuation or change of 
antibiotic therapy. Our aim was to determine the usefulness of PCT in our ICU.
Methods PCT was measured once daily for all patients admitted to the 
ICU. Results were reviewed daily by intensivists and microbiologists and an 
appropriate decision about antibiotic therapy was made. We considered to 
stop antibiotics if the PCT was <0.5 ng/ml or had decreased to 80% of the 
peak value. CRP and clinical progression were also taken into consideration.
Results One hundred and fourteen PCT values were obtained from 27 
patients over 18 ICU days. PCT concentrations were lower than 0.5 ng/ml 
in 49 samples whilst CRP values were higher with a median of 107.5 mg/l. 
Antibiotics were discontinued or not initiated following low PCT values in 
38 of these samples despite high CRP. For two patients who were already 
on antibiotics, a rise in PCT was noticed which prompted us to change 
the antibiotics. No new microbiologically proven systemic infection was 
identifi  ed in any of the patients with low PCT values. See Figure 1.
Conclusions  Frequently, discrepancy between PCT and other 
infl  ammatory markers were noticed, suggesting an infl  ammatory response 
or nonbacterial infection and not necessarily an indication for antibiotics. 
Regular assessment of PCT, when interpreted with clinical context, was 
helpful not only to decrease the duration of antibiotics but also to change 
the antibiotic regimen.
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Introduction The early infl  ammatory response after liver transplantation 
(LTx) could be diagnosed by the simultaneous interpretation of 
procalcitonin (PCT) levels and culture results. The aim of this prospective, 
non-interventional study was to evaluate the prognostic signifi  cance of 
the PCT levels in the term of etiology (infection, colonization and non-
infectious infl  ammatory states).
Methods The PCT measurements and cultures were performed before 
surgery and on the fi  rst fi  ve postoperative days in 114 liver transplanted 
patients. The relationship between the absolute PCT levels (n = 762) and 
culture results (n = 474) was studied. The patients were divided into two 
groups according to the infection or colonization with Gram-positive (GP) 
or Gram-negative (GN) bacteria. Statistical analysis was done with the SPSS 
program.
Results  In 21 patients negative cultures were associated with PCT 
elevation (PCT: 3.77 ± 3.22 ng/ml), positive cultures were found in 107 
patients, in 58 patients this was colonization (PCT <0.5 ng/ml). There 
signifi  cant  diff   erences between the PCT elevation according to the 
etiology culture (GN, n = 36, PCT: 17.55 ± 11.3 ng/ml; GP, n = 222, PCT: 
16.54 ± 6.58 ng/ml; P <0.02).
Conclusions In the early phase after liver transplantation, the GP culture 
occurred more frequently; the GN culture could be associated with higher 
PCT elevation than those found in case of GP culture.
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Introduction To examine whether we can safely shorten the periods 
of antibiotic administration for septic patients with procalcitonin (PCT) 
measurements compared with no PCT measurements.
Methods The participants were septic patients including (1) hospitalized 
to our ICU from February 2009 to November 2009, (2) administered 
antibiotics for 4 days and over, and (3) stopped the antibiotics during their 
ICU stays. We treated the patients from February to June without PCT 
measurements (Group A). On the other hand, we treated the patients from 
July to November referring to serum PCT level (Group B). In group B, when 
Figure 1 (abstract P42). Example 1 (left): sepsis secondary to hydronephrosis. This graph clearly shows the rise in procalcitonin (PCT) during early onset 
of sepsis and its fall during antibiotic treatment. Antibiotics were discontinued when the PCT level fell to 80% of its peak value on day 8. Example 2 (right): 
laparoscopic cholecystectomy complicated by bile peritonitis. Good response to antibiotics initially, but PCT started to rise on day 12 which prompted us to 
change antibiotics. Serial PCT is useful to assess the response to treatment.
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administrations if their systemic conditions were getting better.
Results Twelve patients were in Group A, and 15 patients were in Group 
B. The ages were 65 ± 18 in Group A, and 64 ± 23 in Group B. The APACHE 
II scores were 20.4 ± 6.3 in Group A, and 18.5 ± 7.5 in Group B. There were 
no signifi  cant diff  erences. The periods of antibiotic administrations were 
14.1 ± 7.7 days in Group A, and 9.7 ± 6.0 days in Group B. The periods in 
Group B tended to be signifi  cantly shorter than in Group A (P = 0.049). 
The C-reactive protein (CRP) levels were 3.5 ± 4.2 mg/dl in Group A, and 
6.5 ± 4.1 in Group B when the antibiotic administrations were stopped. 
The CRP levels in Group B were higher than in Group A (P = 0.071). Two 
patients in Group B were repeated antibiotic administrations, while they 
were discharged without any complications.
Conclusions The follow-up PCT measurements safely shorten the periods 
of antibiotic administrations for septic patients. We believe that PCT has 
good cost–benefi  t eff  ects for critically ill patients.
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Introduction The goal of our study is to assess the diagnostic profi  tability 
of procalcitonin (PCT) in septic shock and another biomarker as C-reactive 
protein (CRP).
Methods Case–control study. During 2009 we proceeded to select the 
sample: 54 patients (ICU) and 61 controls. PCT and CRP were set in the 
fi  rst 24 hours besides the diagnosis and other analytical (glucose, lactate, 
leukocytes, platelets, white blood cells, LIC cells and ALY cells) and 
clinical parameters. There were realized diagnostic output curves (ROC), 
area under the curve (AUC), confi  dence interval (95%), cut-off   and the 
comparison between AUC.
Results Fifty-four septic patients were assessed, 66% were males; mean 
age, 63 years. Eighty-eight percent was diagnosed as septic shock and 
11% severe sepsis. Seventy-six percent were medical patients. Positive 
blood cultures in 42.5%. Sepsis origin: respiratory 46%, neurological 5%, 
digestive 37% and urinary 3%. Average SOFA score was 10.4.
Conclusions  PCT and CRP have the same effi     ciency in early sepsis 
diagnosis. The PCT and CRP effi   ciency diagnostic together is signifi  cant 
but small. We suggest using both with the doubt of sepsis.
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Introduction Sepsis is still the major cause of death in the late post-
traumatic period in patients with major burns. Diagnosis of sepsis remains 
diffi   cult in these patients where signs of sepsis may be present in the 
absence of real infection. This study attempted to assess whether the 
plasma procalcitonin (PCT) level was related to sepsis in burned patients.
Methods PCT was measured over the entire course of stay in patients with 
predictive signs of sepsis according to Burn French Society Criteria (SFETB) 
for the presence of infection. The patients were assigned to two groups 
depending on the clinical course and outcome: A = no septic patients, B = 
septic patients. Optimum sensitivity, predictive values, and area under the 
receiver operating characteristic (ROC) curve were evaluated.
Results Over a 6-month period starting from 1 July 2008 to 31 December 
2008, 157 patients were admitted. Sixty-two were investigated, 40 in group 
A and 22 in group B. Procalcitonin was signifi  cantly higher in the septic 
group (7.26 ± 7 ng/ml) compared with the no septic group (0.25 ± 0.32 ng/
ml). Area under the curve was 0.94 on the day of sepsis diagnosis. A PCT 
cut-off   value of 0.75 ng/ml was associated with the optimal combination 
of sensitivity (85%), specifi  city (87%), positive predictive value (91%), and 
negative predictive value (73%). In surviving septic patients the PCT value 
was signifi  cantly lower than in deceased septic patients (3.5 ± 0.87 ng/
ml vs 10.18 ± 9.6 ng/ml). The PCT cut-off   value for optimum prediction 
of outcome in septic patients was 3.66 ng/ml with sensitivity (91%), 
specifi  city (75%), positive predictive value (78%), and negative predictive 
value (90%).
Conclusions Procalcitonin appears to be a powerful marker of sepsis in 
burn patients. It is sensitive, specifi  c, reliable and easy to measure. A high 
PCT concentration (>3.66 ng/ml) would indicate poor outcome in septic 
patients.
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Introduction We hypothesized that the higher risk of severe sepsis and 
mortality observed after infection in prior epidemiologic studies are due 
to age-related diff  erences in immune response.
Methods We analyzed 2,183 subjects from a multicenter observational 
cohort of patients hospitalized with community-acquired pneumonia 
(CAP). We divided subjects into fi  ve age groups (<50, 50 to 64, 65 to 74, 
74 to 84, ≥85). To compare immune response, we measured circulating 
infl   ammatory (IL-6 and IL-10), coagulation-fi   brinolysis (D-dimer, factor 
IX (F-IX), thrombin–antithrombin complex (TAT), antithrombin (AT) and 
plasminogen-activator inhibitor (PAI)), and cell surface markers (TLR2, 
Figure 1 (abstract P45). Comparison between AUC not signifi  cantly 
diff  erent for PCT and CRP (P = 0.445).
Table 1 (abstract P45). Output curve results: PCT/CRP, sensitivity, specifi  city
   PCT  CRP
Mean  24 ng/ml  227 mg/day
AUC 0.983  0.965
95% CI  0.93 to 0.99  0.91 to 0.99
Sensitivity 92.6%  91.1%
Specifi  city  93.1%  100%
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the fi  rst week of hospitalization.
Results Older subjects had higher rates of severe sepsis (14.8%, 23.0%, 
26.3%, 34.0%, 42.3%) and 90-day mortality (1.8%, 3.8%, 9.2%, 18.2%, 19.8%, 
per age group (P <0.001)). However, there were no age-related diff  erences 
in infl  ammatory or cell surface markers and only modest diff  erences in 
coagulation-fi  brinolysis abnormalities on ED presentation and over the 
fi  rst week (P <0.05) (Figure 1).
Conclusions Despite large diff  erences in outcomes, patients hospitalized 
with CAP displayed no age-related diff  erences in circulating infl  ammatory 
or cell surface markers and modest diff  erences in circulating coagulation-
fi  brinolysis markers.
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Introduction  Prompt and accurate pathogen identifi   cation is crucial 
for treatment of severe sepsis and septic shock (SS/SS). Blood cultures 
(BC) require 24 to 48 hours and often yield inaccurate results. Eff  ective 
pathogen identifi  cation allows for timely, targeted antimicrobial therapy.
Methods A SS/SS Markov model [1] was developed to assess the cost-
eff  ectiveness (CE) of a rapid and accurate diagnostic test compared with 
the current standard. In the model, patients can transition between no SIRS, 
SIRS, sepsis, severe sepsis and septic shock or exit the model via discharge 
or death. Key literature assumptions are as follows: 91% eff  ectiveness of 
empiric therapy, 70% BC eff  ectiveness, 90% new test eff  ectiveness, $750 
cost/test, 9.5 years average life expectancy of sepsis survivor, 0.69 quality-
adjusted life-year (QALY) for survivors, and turnaround times of 24 hours 
for the new test and 48 hours for standard BC.
Results  The model shows that the new test would be cost-eff  ective 
when compared with current BC, at a cost of $32,939 per QALY (day 28). 
These results are compelling across a range of assumptions and almost 
all estimates fall below the US CE threshold of $50,000 to $100,000/QALY 
(Figure 1). Varying most assumed values by up to 25% had a moderate 
impact on CE. CE is sensitive to empiric test eff  ectiveness >95%. More 
rapid diagnostic information lowered the cost/QALY.
Conclusions Preliminary results show that a rapid and accurate test would 
be considered cost-eff  ective across many assumptions and would reduce 
the mortality associated with delayed diagnosis.
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Introduction  Bloodstream infection is a life-threatening condition 
with a high mortality rate, especially in intensive care and neutropenic 
patients. Standard diagnostics is based on blood culturing (BC). However, 
limitations of BC include relatively low sensitivities and a long time-to-
result for the identifi  cation of the pathogen, generally over 2 days and 
more. On the grounds of data from a multicentre study using a universal 
16S rRNA gene PCR assay, SepsiTest™, molecular diagnosis is discussed as 
a rapid and sensitive tool for the detection and identifi  cation of pathogens 
supportive of BC. A new commercial PCR test, SepsiTest™, for direct 
detection of bacteria in whole blood was compared with BC in terms 
of sensitivity, specifi  city, predictive values and time to positivity (TTP) of 
bacterial infections of the bloodstream of critically ill patients.
Methods The test, SepsiTest™ (Molzym, Bremen), comprises the extraction 
and 16S rRNA gene PCR detection of bacterial DNA in whole blood 
samples. Bacteria in positive samples were identifi  ed by sequence analysis 
of the amplicon. In a prospective multicentre study, 342 blood samples 
from 187 patients with systemic infl  ammatory response syndrome (SIRS), 
sepsis, or neutropenic fever were included.
Results  Compared with BC, the diagnostic sensitivity and specifi   city 
of PCR/sequencing was 87.0% and 85.8%, respectively. The positivity 
rate of PCR/sequencing (25.7%) was higher than BC (15.8%). Of 31 PCR/
sequencing-positive, BC-negative patients, most of whom received 
antibiotics, the PCR results of 25 were judged as true or possible to 
bacteraemia. Using a routine testing workfl  ow, time to positivity of the 
PCR test was on average decreased by 40 hours for anaerobe/fastidious 
infections and by 54 hours for yeast infections.
Figure 1 (abstract P47). Modest diff  erences in circulating concentration 
of coagulation-fi  brinolysis markers on ED presentation (day 1) and over 
the fi  rst 7 days. P1, day 1 P value from ANOVA model adjusted for sex, race, 
co-morbidity, and smoking status; Tobit models used for censored data. 
P2, day 1 to 7 P value from mixed eff  ects model adjusted for sex, race, co-
morbidity, and smoking status; Tobmit models used for censored data.
Figure 1 (abstract P48). Sensitivity analysis on CE (Base Case CE = 
$32,939/QALY).
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of bacteraemia in blood samples within a few hours. Despite the 
indispensability of BC diagnostics, the rapid detection of bacteria by 
SepsiTest™ appears to be a valuable tool, allowing earlier pathogen-
adapted antimicrobial therapy in critically ill patients.
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Introduction Mortality from sepsis increases with delay in administration 
of antibiotics. The Surviving Sepsis Guidelines suggest that antibiotics are 
administered within 1 hour of diagnosis of severe sepsis and septic shock. 
This retrospective study investigated the time to appropriate antibiotics in 
patients with sepsis and identifi  es reasons for delay where possible.
Methods All adult patients in our institution who had positive blood 
cultures in 2008 were identifi  ed. Included were patients with sepsis, severe 
sepsis, or septic shock. Excluded were the isolation of low-pathogenicity 
organisms from blood culture (for example, coagulase-negative Staphylo-
coccus). Case notes were reviewed to identify the time between diagnosis 
of sepsis and administration of antibiotics. Time zero was taken as the 
time recorded in the notes by the doctor that the patient was seen. Times 
of prescription and administration of antibiotics were taken from the 
prescription chart.
Results There were 1,477 sets of positive blood cultures in 1,098 patients. 
Following exclusions there were 503 episodes of positive blood cultures 
in 494 patients. Three hundred and seventy-fi   ve fulfi   lled the criteria 
and were analysed: 52 did not fulfi  l entry criteria, in 16 cases sepsis was 
not suspected, and 60 sets of notes were incomplete or unavailable. 
Average age was 69 years. Mean time between diagnosis and antibiotic 
administration was 8.1 hours, median 4 hours. A delay of 3 hours or more 
between diagnosis and administration of antibiotics occurred in 218 cases 
(58%). The 28-day mortality for all patients overall was 21%; 19% in the 
no-delay group compared with 24% in the delayed group. The 1-year 
mortality was 35% for both groups. Causes of delay in administration 
included prescription error, awaiting senior review, and patient movement 
between departments.
Conclusions These retrospective data demonstrate that there is a delay in 
administering antibiotics patients with sepsis. These data are likely to be 
an underestimation as an accurate time zero is diffi   cult to ascertain.
References
1.  Kumar A, Roberts D, Wood KE, et al.: Crit Care Med 2006, 34:1589-1596
2.  Dellinger RP, Levy MM, Carlet JM, et al.: Crit Care Med 2008, 36:296-327.
3.  Bone RC, Sibbald WJ, Sprung CL: Chest 1992, 101:1481-1483.
P51
Utility of an antibiotic guideline in hospital-associated infections
M Shankar-Hari, D Wyncoll
Guy’s and St Thomas’ NHS Foundation Trust, London, UK
Critical Care 2010, 14(Suppl 1):P51 (doi: 10.1186/cc8283)
Introduction Prompt initiation of appropriate antibiotic therapy improves 
outcome in critically ill patients [1]. In a tertiary-level ICU, we evaluated 
the appropriateness of, and adherence to an antibiotic guideline (based 
on local bacterial epidemiology) in CDC-defi   ned hospital-associated 
infections.
Methods We conducted a 6-month prospective observational study (April 
2008 to October 2008) in consecutive ICU admissions of patients who 
satisfi  ed investigator-adjudicated classifi  cation of ICU-acquired infections 
according to CDC criteria [2]. We assessed patient characteristics including 
severity of illness at admission, ICU length of stay (LOS), appropriateness 
of initial antibiotic choice as judged by in vitro sensitivity results and 
appropriateness of the current guideline. Results are presented as mean 
(SD) or median as appropriate.
Results During the study period there were 101 antibiotic starts in 65 
patients with sepsis secondary to ICU-acquired infections. Medical patients 
formed 44% of the study cohort; whilst 23% of patients were general 
surgical and the remaining 33% were post cardiothoracic surgery. The age 
and admission APACHE II score of the study cohort was 61.8 (16.3) years 
and 18.4 (5.6). The median LOS and ICU mortality of the cohort was 24 days 
and 27.6%. The most common CDC reportable diagnosis was clinical or 
microbiological confi  rmed pneumonia (PNU1/PNU2/LRI) (n = 57), followed 
by intra-abdominal infection (SSI-GIT) (n = 10) and urinary tract infection 
(SUTI) (n = 8). The culture positivity rate was 71.2%. The appropriateness of 
the ICU antibiotic guideline is summarised in Table 1. Monotherapy was 
used in 52.5% of episodes. The median length of antibiotic treatment with 
positive cultures was 7 days, and 5 days for culture negative episodes. In 
sepsis episodes with negative culture, antibiotics were stopped within 
3 days in 17% of the episodes.
Table 1 (abstract P51). Appropriateness of guideline-based antibiotic therapy
  Septic shock  Severe sepsis  Sepsis
Parameter (n = 35)  (n = 30)  (n = 36)
Positive cultures  23 (66%)  25 (83%)  24 (67%)
Appropriateness  18/23 (78%)  21/25 (84%)  14/24 (58%)
Conclusions The study cohort had a high culture positivity rate (71%) in 
ICU-acquired sepsis. Our antibiotic guidelines gave an optimal empiric 
initial therapy in over 74% of episodes, with more than 50% of antibiotics 
started being monotherapy.
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Introduction In the setting of antimicrobial policy, the French authorities 
recommend assessing the quality of antibiotic therapy [1]. The aim of this 
study is to assess the adequacy of antibiotic therapy in the ICU, to good 
practice guidelines and unit protocols. The three steps of prescription are 
analysed: choice of treatment, modalities of prescription and treatment 
follow-up.
Methods This preliminary observational trial was conducted in two ICUs 
(October 2005 to August 2006 and March to August 2009). All patients with 
curative antibiotherapy were prospectively included. For each patient, we 
collected individual data of treatment and we evaluated them according 
to the recommendations of good use published in the literature [1,2].
Results  One hundred and thirteen patients were included. Infections 
were community-acquired infection in 30% of the cases. Respiratory 
tract infections were the most frequently encountered, followed by intra-
abdominal infections. The three most frequently isolated pathogens were 
P. aeruginosa, E. coli and S. aureus.
Initial antibiotic therapy, n = 113: lack of sample 14%, inadequacy with unit 
protocol 13%, too broad spectrum 7%, not justifi  ed association 8%, wrong 
posology 20%, incorrect route of administration 1%, wrong interval 6%, 
lack of plasmatic dosage (n = 46) 7%.
Treatment follow-up, n = 108: wrong delay of reappraisal 14%, no adap-
tation to microbiological results 10%, lack of de-escalation 5%, no 
reassessment of posology 3%, wrong posology (if change of treatment) 
2%, wrong interval (if change of treatment) 3%, unjustifi  ed duration 10%.
Conclusions The rate of prescriptions that did not conform to at least 
one criterion in this study was over 70%. This high rate is partly explained 
by the high number of assessment criterions (n = 15). The most frequent 
criterion of inadequacy was a wrong initial dosage, followed by the 
initiation of an antibiotherapy without a microbiologic sample, a wrong 
delay of reassessment, and a nonconformity of treatment to unit protocols. 
That last criterion must be assessed in a more qualitative way, as some 
transgressions could be justifi  ed.
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Introduction A continuous pressure of antibiotics and chemotherapeutics 
in ICU patients promotes isolation of multidrug-resistant (MDR) strains. 
Treatment of infections caused by microorganisms resistant to available 
drugs often results in a therapeutic failure. The purpose of this work was 
a retrospective comparison of the rates of isolation of particular MDR 
pathogen groups in 2007 vs 2008 in ICU patients hospitalised in a university 
hospital 11-bed reference department, and of antibiotic consumption in 
the analysed years.
Methods Data concerning microbiological testing were analysed based 
on the WHONET software, version 5.4. The analysis rejected repeated 
identical culture results that did not refl  ect a subsequent case of infection 
with a given MDR pathogen, but only persistence of the same strain in a 
given patient.
Results MDR pathogen stains most frequently were isolated from the 
bronchoalveolar lavage (BAL) material. Carbapenem-resistant Gram-
negative rods represented the highest rate (62% in 2007 and 64% in 
2008); these included Pseudomonas aeruginosa strains (57% and 35%, 
respectively). Escherichia coli (11% in 2007), Klebsiella pneumoniae (12% 
in 2008) and Enterobacter cloacae (9% in 2008) predominated among 
ESBL-producing intestinal rods. A minor increase of the rate of the 
ESBL(+) strains was found in 2008. Single MRSA strains were isolated in 
the analysis period, no VRE were cultured. The highest antimicrobial drug 
consumption (DDD/100 person-days) in 2007 pertained to meropenem 
(20.6), piperacillin/tazobactam (20.0), cephazolin and vancomycin 
(11.6 and 11.1). The respective values for the year 2008 were as follows: 
piperacillin/tazobactam (20.8), voriconazole (19.7), meropenem (14.6).
Conclusions  A 47% increase in the MDR pathogen isolation rate 
was found in the year 2008. MDR nonfermenting rods represent the 
largest therapeutic and epidemiological challenge among the isolated 
MDR pathogens. In the subsequent analysed year, fi  rst emergence of 
carbapenem-resistant Acinetobacter baumanii strains was noted.
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Introduction Secondary peritonitis is the most frequent form of peritonitis, 
characterized by a high disease burden and a high mortality rate. Choice of 
adequate antibiotics is an independent factor for survival. The aim of this 
study was to compare treatment of secondary peritonitis with tigecycline 
(TG) with standard regimens (SR) from an economical standpoint.
Methods  After ethics committee approval, the study was performed 
as prospective, non-interventional cohort trial in 23 medical centers in 
Germany. Patients could be included if suff  ering from severe secondary 
peritonitis treated in an ICU. Patients with pregnancy, aged below 18 years 
and milder forms of diseases (APACHE II score <15) were not eligible. In 
order to compare treatment with TG with SR, the following data were 
documented: demographic data, disease severity scores, causing micro-
organisms, laboratory parameters, and length of stay (LOS). Patients were 
analysed according to initial antibiotic choice except for perioperative 
prophylaxis. In order to balance for diff  erences in co-morbidities and 
severity of disease, a matched-pairs analysis was performed based on 
logistic regression analysis.
Results A total of 178 patients were enrolled (49 TG/129 SR). After logistic 
regression analysis and matching for gender, age ± 3 years, APACHE 
II score ± 1 and (non)existence of liver cirrhosis, arterial sclerosis and 
coronary heart disease, 15 matched pairs were built. Compared with the 
SR group, in the TG group was a tendency for higher creatinine, urea and 
glucose levels, higher number of co-morbidities (3.3 vs 3.0, NS) and higher 
number of pathogens isolated on initial surgery (2.2 vs 1.6, NS). There was 
a higher number of discharges 9/15 in the TG group (vs 7/15 SR, NS) and 
6/15 patients died (vs 4/15 SR, NS). Considering these factors, there was 
a trend for shorter LOS in patients treated with TG (11 days vs 18 days 
and 8 days vs 16 days for survivors and nonsurvivors, respectively, NS) and 
total costs of ICU stay were signifi  cantly lower in the TG group (€8,832 vs 
€15,482, P = 0.023).
Conclusions In our non-interventional study, tigecycline tended to be 
used in patients with more severe co-morbidities. In spite of this, there was 
a trend for shorter LOS and treatment costs were signifi  cantly lower, which 
make tigecycline an attractive treatment, also from a pharmacoeconomical 
standpoint.
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Introduction The purpose of our study was to compare the eff  ectiveness 
of colistin monotherapy and colistin combination in the treatment of 
nosocomial infections with multi-resistant germs.
Methods Retrospective study including 63 patients realized during 3 years 
from January 2006 to December 2008 in the medical ICU of University 
Hospital Ibn Rochd, Casablanca, Morocco. The study includes only the 
patients who suff   er from nosocomial infection with multi-resistant 
germs, all of the sites are concerned. The patients have been divided into 
groups: group 1 including 30 patients treated by colistin only, and group 
2 including 33 patients treated by the association colistin–rifampicin. The 
colistin has been administered intravenously and/or in nebulization and/
or in an intrathecal way according to the considered infectious site. The 
main criterion of judgment was the rate of mortality in the resuscitation 
unit, the second criteria of judgment were the ventilator weaning, the 
introduction of the vasoactive drugs and the supervening of side eff  ects.
Results Sixty-three patients judged as appropriate, have been included. 
The mean age of the patients was about 43.62 ± 17.34 years and APACHE 
2 score at the admission was about 15 ± 5.69. The total mortality caused 
by infection was about 41.27%. The basic characteristics of the two groups 
were similar. The mortality in group 1 was about 36.66%, and about 
69.69% in group 2 (P = 0.001), the rate of introduction of vasoactive drugs 
was about 23.33% in group 1 versus 48.48% in group 2 (P = 0.03). In group 
1, 6,66% of the patients developed renal failure, against 12.12% of the 
patients in group 2 (P = 0,46). With the rifampicin, 27.27% of the patients 
of group 2 presented cytolysis.
Conclusions  This study suggests that colistin represents a good 
therapeutic alternative for the treatment of nosocomial infection with 
multi-resistant germs. However, our study is not without limits; it is a 
retrospective study, absence of randomization and the control group of 
patients.
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Introduction Although colistin has been used extensively in critically 
ill patients infected with multidrug-resistant (MDR) organisms, our 
knowledge about the pharmacokinetic and pharmacodynamic para-
meters correlating with effi   cacy is very limited and little consensus exists 
on the optimum dosing regimen of this agent. In our center, during the 
past 2 years several patients treated with colistin were given the total daily 
dose once every 24 hours. The aim of this study was to analyze the effi   cacy 
and safety of this dosing regimen in critically ill patients.
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in 2008 and who received colistin for an infection due to MDR bacteria 
were retrospectively analyzed. Criteria for inclusion were: dosing regimen 
of colistin 9 million units (MU) every 24 hours (colistin methanesulphonate 
– CMS, Norma, 1 vial = 1 MU, 1 mg = 13,300 U), administration of CMS for at 
least 7 days and normal renal function at initiation of treatment with CMS 
(serum creatinine ≤1 mg/dl or creatinine clearance >80 ml/min). Mortality 
was evaluated at 28 days.
Results Thirteen patients were included in the study (69% male, median 
age 71 years). The underlying diseases were surgical in seven patients and 
medical in six patients. The median APACHE and SOFA scores on the fi  rst 
day of CMS administration were 15 and 10, respectively. Eleven patients 
had nosocomial pneumonia, two had peritonitis and one osteomyelitis. 
Causative bacteria were isolated in 10 patients (six Acinetobacter baumanii, 
three  Pseudomonas aeruginosa and one Klebsiella pneumonia) and 
were all MDR. Of the 10 isolated bacteria, six were susceptible only to 
colistin, while the other four were also susceptible either to aztreonam 
or sulbactam. In cases of susceptibility of the isolate only to colistin, it 
was given in combination with a carbapenem, while in the other cases 
either aztreonam or sulbactam was added. The median length of CMS 
administration was 11 days (mean 19; range 7 to 79 days). Median serum 
creatinine on initiation and completion of treatment with CMS was 0.7 and 
0.9 mg/dl, respectively (P = 0.357). No cases of neurotoxicity were found. 
Mortality at 28 days was 15%.
Conclusions The total daily dose of 9 MU of CMS, given as one dose 
every 24 hours in critically ill patients, seems to be effi   cient and safe, 
without resulting in increased nephrotoxicity or other adverse events. 
A prospective study should be done to confi  rm the fi  ndings we have 
presented herein.
P57
A comparison of the eff  ect on renal function of fl  ucloxacillin and 
vancomycin antibiotic prophylaxis in cardiac surgery patients
TO Brougham, K Giraud, A Vuylsteke
Critical Care Unit, Cambridge, UK
Critical Care 2010, 14(Suppl 1):P57 (doi: 10.1186/cc8289)
Introduction  This study compared the eff   ect on renal function of 
fl   ucloxacillin and vancomycin antibiotic prophylaxis for elective fi   rst-
time coronary artery bypass grafting (CABG) surgery, using both direct 
biochemical markers and indirect clinical outcome measures. Recent 
evidence has suggested that vancomycin may be nephrotoxic in patients 
undergoing cardiac surgery.
Methods  A retrospective observational study of patients undergoing 
elective fi  rst-time CABG was performed, covering a 13-month period. All 
patients received prophylactic antibiotics: fl  ucloxacillin 1 g pre-operatively 
and three 1 g doses post-operatively. Patients who were MRSA-positive, 
MRSA unknown or penicillin allergic received an alternative regimen: 
vancomycin 1 g pre-operatively and 1 g post-operatively. Exclusion criteria: pre-
operative creatinine >133mmol/l, any antibiotics other than prophylaxis 
and haemodynamic support except <5 μg/kg/hour dopamine.
Results Of 1,413 patients in the study period, 415 met the study criteria: 
360 patients received fl  ucloxacillin and 55 patients received vancomycin. 
There were no signifi  cant diff  erences between the two groups in sex, 
age, BMI, euroSCORE, diabetes status, ejection fraction, pre-operative 
creatinine, eGFR, sodium, or potassium. Comparing change in renal 
function pre-operatively to post-operatively, there were no signifi  cant 
group diff  erences in change in: creatinine (mmol/l; VAN median 0 (IQR 
11); FLU –2 (19); P = 0.22), eGFR (ml/min; VAN 0 (14); FLU 2.4 (19.3); P = 
0.22), sodium (mmol/l; VAN 1 (4); FLU 1 (4); P = 0.28). Change in potassium 
diff  ered signifi  cantly (mmol/l; VAN 0.7 (0.9); FLU 0.5 (0.7); P <0.05). In clinical 
outcome measures, the groups were similar. Most patients in both groups 
stayed in ITU for 1 day and there was no signifi  cant diff  erence in the 
number of patients staying for longer than 1 day (VAN 7/55 (13%); FLU 
29/360 (8%); P = 0.30). There was no diff  erence in hospital length of stay 
(days; VAN 7 (4); FLU 6 (3); P = 0.19).
Conclusions In elective fi  rst-time CABG patients, there is no signifi  cant 
diff  erence in change in renal function between those given vancomycin 
antibiotic prophylaxis and those given fl   ucloxacillin prophylaxis, as 
assessed by creatinine, eGFR and sodium levels, and indirect clinical 
outcome measures. Potassium increased more in the vancomycin 
group but the clinical signifi  cance of this is unclear. Our data suggest 
that prophylactic vancomycin does not impair renal function relative to 
fl  ucloxacillin.
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Introduction  Antibiotic dosing recommendations are usually based 
on plasma or cerebral spinal fl   uid pharmacokinetic (PK) studies. 
However, as infections mainly occur in extracellular tissue fl   uid (ECF), 
corresponding unbound ECF antibiotic concentrations are responsible 
for the antimicrobial eff   ect. Because of the blood–brain barrier, the 
cerebral antibiotic distribution is thought to be reduced compared with 
tissues without any physiological barrier. This study aims to determine 
meropenem (MPM) unbound concentrations in the brain and compare 
them with MPM concentrations in plasma to explore cerebral distribution 
of MPM in patients with acute brain injury.
Methods After local ethic approval and written informed consent, two 
brain-injured patients, sedated, mechanically ventilated, receiving MPM for 
an infection and monitored by cerebral microdialysis (CMA 71, membrane 
length 10 mm, membrane diameter 0.6 mm, molecular cut-off   100 kDa; 
CMA, Stockholm, Sweden) were enrolled. The PK study succeeded to 1 g 
meropenem over 30 minutes and brain dialysates and blood samples were 
collected over 420 minutes. Probe recoveries were evaluated individually 
by retrodialysis. MPM was assayed by HPLC coupled with tandem mass 
spectrometry (LC-MS/MS).
Results  For each of the two patients, the MPM brain AUC is much 
lower than plasma AUC and accordingly brain to serum AUC ratios 
are respectively 0.73 for Patient 1 (P1) and 0.14 for Patient 2 (P2). MPM 
concentration versus time curves in brain are delayed (time-to-peak 
in P1 = 100 minutes, in P2 = 80 minutes) and present a smooth peak 
compared with the corresponding curves in plasma (Figure 1). Mean 
probe recoveries are respectively 19 ± 7% for P1 and 29 ± 7% for P2.
Conclusions The MPM brain AUC is much lower than plasma AUC for 
the two patients enrolled, consistent with the PK theory in the presence 
of tissue with effl   ux transporters. More patients are needed to better 
understand MPM brain distribution characteristics.
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Introduction Antibiotic prophylaxis in cardiovascular (CV) surgery has 
greatly reduced the rate of postoperative infections. First-generation or 
second-generation cefalosporines are used for this purpose. Our hospital 
changed its antibiotic prophylaxis protocol for elective CV surgery in June 
2007 from cefuroxime to cefazolin in accordance with national guidelines 
Figure 1 (abstract P58). Individual MPM plasma () and brain () 
concentrations versus time in P1 and P2.
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antibiotic prophylaxis protocol on microbial fl  ora in sputum.
Methods Retrospective study. All patients admitted >10 days on the ICU 
after elective CV surgery between 1 June 2006 and 1 June 2007 (Group 
1) were compared with the same group of patients between 1 July 2007 
and 1 August 2008 (Group 2). Patients received single-dose prophylaxis 
(bypass surgery), or 2 days of prophylaxis (cardiac prosthetic surgery). 
Group 1 received cefuroxime and Group 2 received cefazolin. Patients 
did not receive selective digestive tract decontamination. Isolated 
pathogens from elective sputum cultures of all patients were registered 
and compared between groups after dividing pathogens into six classes 
based on the profi  le of intrinsic antibiotic susceptibility. Comparative data 
between groups were analyzed with Pearson’s Χ test.
Results One hundred and fi  fty-eight patients had positive sputum cultures. 
Comparing total amounts of positive cultures, there was no signifi  cant 
diff   erence between colonization with pathogenic micro-organisms 
between Group 1 (n = 77 patients) and Group 2 (n = 76 patients). In Group 
1 more colonization with pathogens from class 4 (β-lactamase-producing 
Enterobacteriaceae and Pseudomonas aeruginosa) was observed compared 
with Group 2 (45% vs 34%, P = 0.079). This nonsignifi   cant diff  erence 
between groups was mainly attributable to a diff  erence in colonization 
with Pseudomonas. In the other classes of pathogens, no diff  erences were 
observed. No diff  erence in postoperative wound infections was noted 
between groups.
Conclusions  Prophylactic use of cefazolin instead of cefuroxime after 
CV surgery resulted in a trend towards reduction of colonization of the 
respiratory tract with intrinsic β-lactam-resistant microbial fl  ora in patients 
with prolonged ICU stay, without adverse eff  ects on the incidence of 
postoperative wound infection.
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Introduction  The prevalence of infection is high among patients 
admitted to the ICU and one of the main causes of mortality. The aim of 
this study was to determine the burden of infectious diseases in patients 
admitted to ICUs in Nordic countries and the Netherlands in comparison 
with Mediterranean countries.
Methods  The EPIC II 1-day point prevalence study of infections and 
demographics of critically ill patients was performed on 8 May 2007. A 
comparison of severity score, source of infection, co-morbidity and 
patient outcome was done for patients admitted to ICUs in low antibiotic 
resistance countries (LARC) (Denmark, Finland, the Netherlands, Norway, 
Sweden) and high antibiotic resistance countries (HARC) (Greece, Israel, 
Italy, Malta, Portugal, Spain, Turkey).
Results The number of patients included was 2,270 in HARC and 581 in 
LARC. On the day of the study, 45.3% of patients in LARC were considered 
as infected compared with 51.6% in HARC (P = 0.007). The mean SAPS 
II scores were (95% CI) 32.7 (31.6 to 33.8) in LARC and 35.6 (35 to 36.2) 
in HARC (P  <0.001). Of all patients in LARC/HARC, 27.0%/33.9% (P = 
0.002) had a respiratory infection, 10.8%/9.8% (P = 0.45) an abdominal 
infection, 7.2%/10.4% (P = 0.023) a blood infection, 2.8%/3.2% (P = 0.60) 
a skin infection, 2.1%/3.4% (P = 0.09) a catheter infection, 3.8%/6.6% (P = 
0.012) a genitourinary infection and 0.7%/1.7% (P = 0.08) a CNS infection. 
Chronic renal failure was seen in 2.6% of patients in LARC and 7.3% in 
HARC (P <0.001) and the corresponding prevalence of chronic obstructive 
disease was 13.4% and 20.2%, respectively (P <0.001). Admissions were 
more often seen from OR/monitoring and less often from emergency 
rooms among patients admitted to ICUs in LARC compared with HARC. 
Median ICU length of stay (LOS) in LARC (IQR) was 5 days (1 to 19) and 
in HARC was 12 days (3 to 31) (P <0.001). The corresponding hospital 
LOS was 16 days (7 to 38) and 24 days (10 to 54), respectively (P <0.001). 
The ICU mortality rates in LARC/HARC were 14.9%/19.9% (P = 0.008) for 
all patients and for infected patients 21.2%/25.4% (P = 0.17), whereas the 
corresponding hospital mortality rates were 20.8%/26.7% (P = 0.005) for all 
patients and for infected patients 29.6%/34.3% (P = 0.16). The prevalence 
of MRSA was 0.8% among patients in LARC (5.8% in HARC) (P <0.001) and 
the prevalence of P. aeruginosa was 9.9% and 14.0% (P = 0.07), respectively.
Conclusions Infections and serious co-morbidities were more prevalent 
among patients admitted to ICUs in HARC than in LARC. This was 
associated with a longer stay and greater mortality in the ICU.
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Introduction We sought to study the characteristics and outcomes of ICU 
patients with carbapenem-resistant (CRKp) and carbapenem-sensitive 
(CSKp) K. pneumoniae infections.
Methods A retrospective cohort of patients requiring ICU treatment. The 
study was conducted in an eight-bed ICU between January 2006 and 
September 2009.
Results During the study period, 104 patients were diagnosed with 
K. pneumoniae infection. The mean age of patients was 66.3 ± 14.3 years. 
Fifty-one (49%) were males. The mean APACHE II score was 17.9 ± 6.9. The 
median duration of hospital stay until the infection was 28 days. Forty-
eight patients (46.2%) had bacteremia, 27 (30%) urinary tract infections, 15 
(14.4%) pneumonia, seven (6.7%) peritonitis and seven (6.7%) skin and soft 
tissue infections. Fifty-eight (56.9%) and 39 (39%) patients had previous 
and concurrent infections, respectively. Seventy-six patients (73.1%) 
died. The univariate analysis showed that prior hospitalization (P = 0.049), 
dialysis (P = 0.034), and history of urologic neoplasia (P = 0.041) were 
associated with the development of carbapenem-resistant infections. No 
independent risk factors were found in the multivariate analysis. APACHE 
II score (P = 0.003), need for dialysis (P = 0.034), shock prior and after the 
infection (P = 0.006 and P <0.001, respectively), respiratory distress prior 
and after the infection (P = 0.021 and P = 0.032, respectively), multiorgan 
failure prior and after the infection (P = 0.02 and P = 0.003, respectively), 
treatment failure (P  <0.001), and acidosis after the development of 
infection (P = 0.003) were associated with death in the univariate analysis. 
Shock after the infection (P = 0.016) and treatment failure (P = 0.001) 
were independent predictors of mortality in the multivariate analysis. No 
diff  erence in mortality was found between patients with CRKp and CSKp 
isolates.
Conclusions Infection due to K. pneumoniae in the ICU is associated with 
high mortality. Infection treatment and hemodynamic support of the 
patient may be important determinants of the clinical course in critically ill 
patients with such infections.
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Introduction Polymicrobial sepsis is associated with immunosuppression 
caused by the predominance of anti-infl   ammatory mediators and 
profound loss of lymphocytes through apoptosis, and so deaths directly 
related to sepsis are twofold higher in polymycrobial sepsis. The aim of 
study is to compare unimicrobial versus polymicrobial sepsis as regards 
microbiology, complications, length of stay, mortality, factor aff  ecting 
mortality.
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divided into two groups. The fi  rst group: unimicrobial, where one organism 
was isolated from cultures; and the second group: polymicrobial, where 
more than one organism was isolated from the cultures.
Results The fi  rst group (unimicrobial) was 48 cases (47.5%) and the second 
group (polymicrobial) was 53 cases (52.47%). Both groups has similar 
positive sputum cultures (32/48 (66%) versus 38/53 (71%), P value 0.6), but 
positive blood culture was signifi  cantly higher in the second group (27/53 
(51%) vs 7/48 (14%), P value 0.0001). There was also a signifi  cantly higher 
incidence of UTI and wound infection in the second group (49.7% vs 6.3% 
for UTI, P value 0.0001 and 20.7% vs 2.1%, P value 0.004 for wound infection, 
respectively). The commonest detected organisms were Staphylococci 
and Klebsiella (48, 22 out of 101 patients); 16/48 (33%) in unimicrobial vs 
32/53 (60%) in polymicrobial (P value 0.007) for staph, and 7/48 (14.5%) in 
unimicrobial vs 15/53 (28%) in polymicrobial for Klebsiella (P value 0.09). 
Incidence of Acinetobacter, Candida and E. coli in the second group were 
signifi  cantly higher 10/53 in poly vs 2/48 in unimicrobial (P value 0.032), and 
10/53 vs 0/48 (P value 0.002 ) and 6/53 vs 0/48 (P value 0.016), respectively. 
Need for mechanical ventilation in the second group was signifi  cantly 
higher than the fi  rst group (46/53 (86%) vs 31/48 (64%), P value 0.009). The 
mean hospital stay was longer in the second group (26.9 ± 15.4 vs 17.4 ± 
9.3, P value 0.001). Mortality was signifi  cantly higher in the second group 
(P value 0.012). Factors increasing mortality in both groups were DCL 
(P value 0.007 in unimicrobial and 0.036 in polymicrobial); vasopressors 
(P value 0.001 and 0.002, respectively); mechanical ventilation (P value 0.00 
and 0.00, respectively), and severe sepsis and septic shock with signifi  cant 
P value (0.019) and (0.008), respectively, for the fi  rst group and (0.003) and 
(0.002), respectively, for the second group.
Conclusions  Polymicrobial sepsis shows higher risk for complication, 
length of stay and mortality than unimicrobial.
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Introduction  Antibiotic de-escalation is thought to be benefi   cial by 
reducing the selection pressure for resistance. This study was carried out 
to identify variables that infl  uence de-escalation practices.
Methods Prospective observational study during a 1-year period (July 
2008 to June 2009) in a 50-bed ICU in a tertiary care hospital. Any patient 
admitted to the ICU during this period in whom at least one specimen 
was sent for microbiological culture at or before starting antibiotics was 
included in the study and subsequently followed up for antibiotic change 
according to the culture sensitivity report. Antibiotics covering Gram-
negative organisms were ranked as per Figure 1.
Results  Seven hundred and seventy-eight patients were included, of 
whom cultures were positive in 551 (70.8%) and negative in 227 (29.2%)
cases. In 350 (44.9%) patients, neither escalation nor de-escalation of 
therapy was done. Overall escalation of therapy occurred in 192 (24.7%) 
patients and de-escalation in 236 (30.3%). The mortality rate was lowest 
among patients in whom therapy was de-escalated (8.9%) compared 
with categories of no change (14.2%) or escalation (23.4%). De-escalation 
occurred more frequently among patients in whom no pathogen was 
isolated (45.8%) compared with culture-positive cases (23.9%) and in 
18.3% of patients with growth of drug-resistant pathogens, compared with 
38.9% of patients with susceptible pathogens. De-escalation occurred 
most frequently where an antibiotic having only Gram-positive coverage 
was included in the initial empiric therapy (60.3%), and in cases where 
third-generation cephalosporin was the initial empiric therapy (54.4%).
Conclusions This study highlights no change of therapy as the most 
prevalent practice pattern of antibiotic use. Mortality remained low 
in patients in whom therapy was de-escalated. Variables favoring de-
escalation practices were non-isolation of pathogen, growth of susceptible 
organisms, and stopping of Gram-positive coverage.
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Introduction Multidrug-resistant (MDR) pathogens constitute an emerg-
ing threat with increasing incidence and uncertain outcome. On the other 
hand, patients undergoing open heart surgery represent a vulnerable 
population.
Methods Evaluation of the incidence and identifi  cation of MDR pathogens 
after cardiac surgery in 2,803 patients for a 2-year period. Examination of 
the clinical features of patients with MDR infection. Elucidation of the 
impact on the outcome.
Results In 18 patients (0.64%) consisting of 12 males and six females, at least 
one MDR pathogen was isolated. Gram-positive pathogen was certifi  ed in 
fi  ve patients (27.8%) and Gram-negative in 13 patients (72.2%). Specifi  cally, 
four patients were infected with vancomycin-resistant enterococcus (VRE), 
six with Klebsiella pneumoniae, three with Acinetobacter spp., one with VRE 
and Acinetobacter spp., four with Acinetobacter and K. pneumoniae. Low 
output syndrome (CI <2.0l/min/m2) was common in all these patients 
and essentially contributed to the deterioration of clinical situation with 
dependence on inotropic support, prolonged mechanical ventilation 
(>10 days), acute renal failure and need for haemodilution (66.6%). 
Therefore, the ICU and hospital stay is prolonged (>20 days and >30 days, 
accordingly) and pathogenesis of MDR infection is provoked after 20 days 
of ICU stay. Consequently, nine patients with MDR infection (50%) died. 
All were critically ill patients with multiple organ dysfunction syndrome 
under broad-spectrum antimicrobials with hospital-acquired bloodstream 
MDR bacteremia.
Conclusions  Infection with MDR pathogens, while rare, constitutes a 
notable prognostic marker of increased mortality after cardiac surgery. 
It is worth noting that the higher mortality rate is mainly attributable to 
the severe co-morbidity in haemodynamically compromised patients. 
Management must concentrate on the implementation of eff  ective 
preventative strategies.
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Introduction This paper aims to provide reference data for pneumonia 
(PN) and bloodstream infections (BSI) acquired in Belgian ICUs taking 
patients’ characteristics into account. This information could enlighten 
policy decisions. This 2008 set of indicators is the fi  rst yielded by the ICU 
Belgian surveillance (NSIH-ICU) since 2001.
Figure 1 (abstract P63). Antimicrobial therapy ranking.
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set up in 1992 to follow ICU-acquired infections and guide prevention. 
It establishes a national risk-adjusted benchmark for infection rates, 
antibiotics use and invasive device-use ratios through uniform case 
defi  nitions, data-collection methods, data entry and analysis. Only patients 
staying more than 2 days in the ICU are included. These aggregated 
database means are derived from the NSIH-ICU 2008 report.
Results In 2008, 4,355 patients and 35,802 patient-days were reported 
by 19 ICUs. The age mean was 67.2 years; mean length of stay 8.1 days; 
mean SAPS II score 43.8; the proportion of patients with antibiotics at 
admission was 47.1%; medical admissions represented 63.4%, 4.2% were 
immunocompromised patients; trauma was reported in 6.7% of cases. 
Overall ICU mortality was 8.5%. The proportion of intubated patients 
was 44.4%, with central venous catheters (CVC) 68.3% and with urinary 
catheters 58.3%. Invasive-device use rates were: 358.5 intubation-days, 
746.5 CVC-days and 644.2 urinary catheter-days per 1,000 patient-days. 
The ICU-acquired PN/100 patients was 9.8, 16.5/1,000 patient-days and the 
intubation-associated PN was 11.1/1,000 intubation days. ICU-acquired BSI 
was 3.6/100 patients, 5.3/1,000 patient-days and the catheter-related BSI 
was 4.3/1,000 catheter-days.
Conclusions The 2008 report provided Belgian hospitals with comparative 
ICU-acquired infection data adjusted for patients’ intrinsic and extrinsic 
infection risks. The participation changed across time and could cause a 
selection bias. Outlier verifi  cation is ongoing and eff  orts to increase the 
participation are being made. Indicator rates could be related to protocol 
modifi  cation, demographic trends and changes in patient mix linked to 
restructuration of medical services or in clinical practice patterns. Some 
are vulnerable to continuous medical and nursing in-service training, for 
example at surveying the antibiotics use and improving invasive devices 
use. Further studies could assess to what extent modifi  cations in clinical 
practice and/or external interventions might cause changes in the 
patient mix.
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Introduction Prior antimicrobial therapy is one of the most important 
factors leading to the acquisition of MDR organisms. Formulating 
antibiotic policy and choice of empirical antibiotic selection will be helped 
by knowing the association of MDR Gram-negative organisms with a 
previous exposure of particular antibiotic.
Methods Prospective observational study during January 2008 to June 
2009 in a 50-bed ICU in a tertiary care hospital. Specimens sent after 
2 days of the start of the antibiotic and no more than 90 days from the 
stop date have been included in the study. Analyses were based on those 
specimens that resulted in detection of MDR Gram-negative organism. 
Observed relative risk (RR) of an antibiotic class was computed with 
respect to an MDR infection. RR was computed as the ratio of the risk of 
the event (acquiring the infection) occurring in the exposed group vs 
in the nonexposed group. A logistic regression model was used where 
multiple antibiotics were applied.
Results A total of 1,072 specimens from 500 patients met the criteria as 
specifi  ed above. Of these, 423 (39.4%) specimens resulted in detection 
of MDR bacteria, 186 (17.4%) resulted in detection of non-MDR bacteria 
and no bacteria were detected in the remaining 463 (43.2%) specimens. 
Of the total 423 cases of MDR acquisitions, ESBL Enterobacteriaceae (151 
or 35%), MDR Acineto (89 or 21%) and MDR Pseudo (58 or 14%). Risk of 
isolating ESBL Enterobacteriaceae was highly signifi  cant with the prior 
exposure to third-generation cephalosporin (RR = 5.8 and P <0.001). 
Risk of isolating MDR Acinetobacter spp. was highly signifi   cant with 
the exposure to piperacillin-tazobactam (RR = 2.7 and P <0.001). Risk 
of isolating MDR Pseudomonas spp. was signifi  cant with the exposure 
to Group 2 carbapenem (RR = 2.2 and P >0.001). Group 1 carbapenem, 
aminoglycosides have not been found to have signifi  cant association with 
any individual MDR organisms.
Conclusions  Previous exposure to antibiotics leads to increased 
acquisition of MDR organisms. There is a signifi  cant association of isolating 
diff  erent MDR organisms with previous exposure to a particular class of 
antibiotic.
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Introduction  The emergence of multidrug-resistant Acinetobacter 
baumanii (MDRAB) poses a serious threat to patients on the ICU. The 
production of metallo-β-lactamase leaves colistin as the only therapeutic 
option. Outbreaks due to MDRAB can persist for months. Traditional 
decontamination methods fail to deal with this level of colonisation 
and contamination eff  ectively. We tackled a recent outbreak of MDRAB 
eff  ectively using gaseous ozone. To our knowledge it is the fi  rst time ozone 
has been used to control an outbreak of MDRAB.
Methods  An external company (Hydrozone Environmental Ltd) was 
hired to perform the fumigation. The ICU was divided into three 
decontamination areas using heavy-duty polythene sheets. Patients were 
in turn relocated from contaminated to clean areas before each area was 
sealed and fumigated. Humidity levels within were raised to 70 to 80% 
using a humidifi  er. An Ozone Ultra Pro 16 g/hour ozone generator with 
ozone destruct capability, operated remotely, delivered ozone to a target 
concentration of >2.0 ppm for 15 minutes. A fan was used to achieve 
even dispersal. For safety reasons perimeter ozone concentrations were 
monitored with a UV photometer and kept below 0.05 ppm. The effi   cacy 
of the fumigation was measured by environmental microbiological 
sampling before and after fumigation.
Results All fumigated areas received ozone concentrations of 4.62 to 5.66 
ppm for 21 to 32 minutes. Ozone was not detected outside the treatment 
areas. Prior to fumigation, 72 (38%) of 188 environmental samples were 
MDRAB-positive. Following fumigation, nine (5%) of 158 samples were 
positive. Most of these samples were from nontouch areas, for example 
ceiling, above door frame with signifi  cant dust collection and without 
daily cleaning. Considering that dust may impede ozone penetration, 
Figure 1 (abstract P66). Observed relative risk of MDR infections for 
diff  erent antibiotic classes.
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to 30 minutes. Subsequent samples all proved negative and no further 
cross-infections occurred.
Conclusions This is the fi  rst study using ozone fumigation as a disinfectant 
to control an outbreak in an ICU. Ozone fumigation is an eff  ective tool 
for eradicating MDRAB from heavily contaminated clinical sites. Used in 
conjunction with good infection control measures, ozone can be used to 
control outbreaks such as MRSA, Clostridium diffi   cile, Norovirus and swine fl  u.
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Introduction Respiratory viral infections are usually self-limited in adults 
but 4 to 30% can be clinically severe and lead to intensive care needs. 
The aim of this study was to determine the impact of viral respiratory 
infections in an intensive care setting and the role of systematic viral 
testing in patients admitted to an ICU.
Methods  A retrospective analysis of all 114 viral tests of respiratory 
samples of 98 patients admitted to the ICU for four consecutive years was 
performed. Molecular biology test and immunofl   uorescence assay for 
adenovirus, infl  uenza A and B, parainfl  uenza 1 to 3, metapneumovirus and 
syncytial respiratory virus (SRV) were performed in tracheal aspirate (TA) 
(89%) and bronchoalveolar lavage (BAL) (11%). SAPS II was used as the 
severity index. Patients were stratifi  ed according to the primary diagnostic.
Results Viral tests were performed in 98 patients, 60% were male, mean 
age 58 years old and 45% had previous respiratory disease. SAPS II was 
48. Ninety-two percent need mechanical ventilation (MV) for 8.5 days. 
Primary diagnostics were community-acquired pneumonia (CAP) (50%) or 
tracheobronchitis (32%), chronic pulmonary disease exacerbations (6%), 
aspiration pneumonia (3%), nosocomial infection (5%), septic shock (3%) 
and meningitis (1%). Length of stay (LOS) was 11 days and ICU mortality was 
17.5%. Virus identifi  cation was positive in 13 (12.2%) respiratory samples of 
12 patients, 12 in TA and one in BAL. Twelve were identifi  ed in the winter. 
Demographic variables, LOS, co-morbidities and severity index of patients 
with viral infection were similar to the main group. Infl  uenza A (in three 
CAP, one tracheobronchitis, one nosocomial infection and one septic 
shock), metapneumovirus (two tracheobronchitis and one CAP), infl  uenza 
B (one CAP), parainfl  uenza 3 (one CAP) and SRV (one tracheobronchitis) 
were identifi   ed. In these patients, C-reactive protein was higher and 
leucocytes were lower. Bacterial co-infection was identifi  ed in 33% of the 
patients, all of them with acquired community pneumonia. Antibiotic 
step down was done in 62% of the patients with isolated viral infection. 
In these patients LOS and days of mechanical ventilation were 9.6 and 6.2, 
respectively, and invasive ventilation-associated pneumonia was reduced.
Conclusions  Although viral tests should not be required for all ICU 
patients, respiratory samples for viral tests should be performed in patients 
with tracheobronchitis/pneumonia requiring intensive care, especially 
in the winter. Positive identifi  cation of viral agents could be useful in 
antibiotic policy.
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Introduction  In the current pandemic it is likely that some patients 
will be admitted to hospital and require respiratory support including 
mechanical ventilation. These patients are likely to have a profound 
systemic infl  ammatory response syndrome (SIRS); consequently they may 
have multiorgan failure (MOF) requiring renal replacement therapy (RRT) 
with haemofi  ltration. Two questions then arise – what dose of oseltamivir 
(Tamifl  u) should we give these patients to shorten the duration of the 
H1N1 infection? How should we modify the dose in response to altered 
renal drug clearance and in those requiring RRT?
Methods A young adult female patient with H1N1 infection and MOF was 
given oseltamivir 75 mg BD nasogastrically. Failure to respond changed 
the risk: benefi  t ratio and justifi  ed doubling the dose despite uncertainties 
over an overall reduced clearance. Enteral nutrition absorption was 
uncertain, and thus we sampled her blood to ensure adequate oseltamivir 
absorption and that activation of the pro-drug was not inhibited. We 
undertook serial sampling for blood concentration assay to determine the 
pharmacokinetic parameters in this diffi   cult scenario. Blood samples were 
collected in plain serum tubes (without sodium fl  uoride). The samples 
were spun and refrigerated within half an hour, then batched and shipped 
to Bangkok for drug concentration measurement.
Results We report both the parent oseltamivir phosphate (OP) and that of 
the active metabolite oseltamivir carboxylate (OC). OP levels were low at 
10 to 77 ng/ml. but OC concentrations were high at 2,600 to 5,000 ng/ml.
Conclusions The population normal parameter for half-life OP is 1 hour 
and for OC it is 3 to 5 hours. A single dose of 150 mg OP is expected 
to achieve an OP level of 50 to 150 ng/ml and an OC level of 1,000 to 
1,500 ng/ml. Our slightly low OP levels are likely to be due to ex vivo 
hydrolysis in the collection tube due to a lack of esterase inhibitor. The 
high OC levels are most probably due to reduced renal elimination despite 
being on haemofi  ltration. Our concerns were focused on the possibility 
of viral mutation (subsequently shown to be negative) or poor enteral 
absorption/activation. What we found was that 150 mg BD produces 
more than adequate OC levels to treat H1N1 infection.
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Introduction  Invasive candidiasis (IC) is associated with increasing 
morbidity and mortality in critically ill patients. This, in conjunction 
with diffi   culties in diagnosis, underscores the need for novel treatment 
strategies based on the identifi  cation of signifi  cant risk factors for IC. The 
aim of the study was to evaluate the effi   cacy and safety of a protocol for 
pre-emptive antimycotic treatment.
Methods A randomized prospective controlled trial was carried out in a 
general ICU for 2 years. After the implication of the inclusion and exclusion 
criteria, patients were submitted to block randomization and stratifi  ed 
on the basis of their initial SAPS II expanded score. We have developed 
a protocol for pre-emptive antimycotic treatment. Having reviewed the 
current literature, we combined the most signifi  cant risk factors for IC with 
tree major clinical criteria for persistent nonbacterial sepsis and assumed 
this algorithm as an indication for starting pre-emptive therapy. According 
to the protocol, antimycotic therapy was started on the day of inclusion 
in the treatment group and only with proven IC in the control group. 
Initial data were gathered on demographic characteristics of the patients, 
proven risk factors for IC-related mortality (malnutrition, non-albicans 
colonization, creatinine clearance) and severity of infl  ammatory response 
and organ dysfunction. Dynamics of SIRS and SOFA, subsequent Candida 
isolates, ventilator-free days, length of ICU stay, outcome and eventual 
adverse reactions were followed.
Results A total of 110 patients (equal in both groups) were enrolled. 
No statistically signifi  cant diff  erences in the basal characteristics of the 
patients, length of ICU stay and the number of ventilator-free days were 
found. The delta SOFA score was signifi  cantly lower in the treatment group 
(P = 0.019).The in-hospital mortality was 38.2% in the treatment group vs 
61.8% in the control group (P = 0.013). The associated with pre-emptive 
therapy relative risk was 0.62 (95% CI = 0.4 to 0.94). Signifi  cant diff  erences 
between the Kaplan–Meyer estimates of survival were found (log-rank test 
P = 0.007). A total of 15 (13.6%) adverse reactions were observed among 
treated patients in both groups which was not associated with higher 
mortality risk.
Conclusions The implementation of the developed protocol reduced the 
degree of organ dysfunction severity and was associated with signifi  cant 
survival benefi  t.
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Introduction Many patients in an ICU are intestinal carriers of yeasts with 
an inherent risk of infections if bowel perforation occurs. Resistance to 
azoles is increasing, while treatment with conventional amphotericin B 
(AM-B) is associated with potential toxicity. AM-B given in a continuous 24-
hour infusion may be less toxic compared with the conventional 4-hour 
to 6-hour infusion rate of AM-B [1,2]. AM-B given in a continuous 24-hour 
infusion is only evaluated in a tertiary care setting, with a predominance of 
immunocompromised patients. We evaluated the feasibility and safety of 
continuous AM-B treatment in critically patients with suspected or proven 
yeast or fungal infections.
Methods  This is an observational retrospective analysis for the side 
eff  ects in consecutive patients treated with AM-B from January 2003 to 
December 2008 in our ICU department. During the investigation period 
patients received amphotericin B: 40 mg/24 hours or a lower dose if 
the MDRD clearance was less than 60 ml/min. During the treatment the 
dose was adjusted to the desired therapeutic range of 200 to 1,000 μg/l 
according to measured plasma levels.
Results The mean treatment duration was 12.3 ± 6.3 days with a dose of 
32.1 ± 12.2 mg/24 hours. Of the 10 patients who died, seven died after 
the termination of the AM-B therapy, without signs of an active yeast 
or fungal infection. Within the fi  rst week three patients died, necropsy 
was carried out in one case, demonstrating a PCP infection, and in two 
patients a role of antibiotic failure cannot be ruled out. All other patients 
with proven yeast or fungal infection demonstrated a clinical recovery 
of their infection. The AM-B concentration was measured in 113 blood 
samples, nine samples had a level <200 μg/l and 10 a level >1000 μg/l. 
Renal impairment, defi  ned as more than 1.5 times the creatinine at the 
start of the treatment with AM-B, occurred in 9% and was not evaluable 
in 6% due to unresolving renal replacement therapy dependency at the 
start of AM-B. None of the evaluated patients developed a creatinine more 
than 2.0 times the baseline value. Temporary elevation of liver enzymes 
was seen in 23%, without the need for dose modifi  cation. Hypokalemia (K+ 
<3.0 mmol/l) was observed in one patient.
Conclusions Compared with the conventional infusion rate of AM-B, we 
conclude that continuous 24-hour infusion seems a feasible and safer 
treatment alternative in patients with invasive yeast or fungal infections.
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Introduction The 2009 IDSA Treatment Guidelines for Candidiasis favor 
an echinocandin for initial treatment of candidemia in patients with 
severe illness. In a prospective, randomized study anidulafungin resulted 
in improved global response (GR) and a trend toward improved survival 
compared with fl  uconazole [1].
Methods Retrospective analysis in patients classifi  ed as severely ill at study 
entry: treatment initiated in an ICU (Group 1), APACHE II score ≥15 (Group 
2) or presence of severe sepsis (Group 3). Within groups, anidulafungin 
was compared with fl  uconazole for GR rate at the end of intravenous 
therapy and 14-day and 28-day mortality.
Results In Group 1 (n = 89), GR was 63.3% vs 45.0% (95% CI: –2.2 to 
38.8); Group 2 (n = 113), GR was 68.3% vs 46.0% (95% CI: 4.3 to 40.2); and 
Group 3 (n = 118), the GR was 67.7% vs 51.8% (95% CI: –1.6 to 33.5), in 
patients with MOD (n = 45), the GR was 76.2% vs 29.2% (95% CI: 21.3 
to 72.8) anidulafungin versus fl   uconazole, respectively. Across groups, 
an association with anidulafungin use and lower day 14 mortality was 
suggested (12.2% to 14.3% for patients receiving anidulafungin vs 19.6% 
to 28.0% for those receiving fl  uconazole) (P = NS). See Figure 1.
Conclusions In patients with severe illness, anidulafungin was associated 
with greater GR than fl  uconazole, signifi  cantly so for those with APACHE II 
score ≥15 or with MOD, supporting the IDSA Guidelines.
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Introduction  Direct hemoperfusion using a polymyxin B-immobilized 
fi   ber column (DHP-PMX; Toray Industries Inc., Tokyo, Japan) was fi   rst 
developed in 1994 and has since been used for the treatment of septic 
shock.
Methods A total of 47 patients with septic shock who received DHP-
PMX for 2 to 6 hours were retrospectively reviewed to examine any 
improvement in sepsis-related factors after DHP-PMX and to analyze 
the relationship between any such improvement and increase in SBP. 
Figure 1 (abstract P72). Global response to treatment.
Figure 1 (abstract P73). Changes in systolic blood pressure in patients 
treated with DHP-PMX in whom HMBG-1 level increased. P <0.0001.
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6 hours) with respect to improvement in sepsis-related factors.
Results  N-arachidonoylethanolamine (AEA), 2-arachidonoyl glycerol 
(2-AG), and plasminogen activator inhibitor-1 (PAI-1) were signifi  cantly 
improved after DHP-PMX treatment. SBP increased signifi  cantly in the 
group showing improved high mobility group box protein 1 (HMGB-1) 
level (P <0.0122). AEA, 2-AG and HMGB-1 were improved in all four patients 
who were treated with long-term DHP-PMX.
Conclusions  We observed a relationship between hemodynamic 
improve  ment and a decrease in serum HMGB-1 level in septic shock 
patients treated with DHP-PMX. We suggest that long-term DHP-PMX 
improves sepsis-related factors.
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Introduction  Direct hemoperfusion using a polymyxin B-immobilized 
fi   ber column (DHP-PMX) has been used for the treatment of septic 
shock. As an alternative method for acute blood purifi  cation therapy, 
continuous venovenous hemodiafi  ltration (CVVHDF) has been reported 
to be an eff  ective clinical treatment for critically ill patients; however, 
the optimal column for performing CVVHDF remains controversial. On 
the other hand, recently, one of the lipid mediators, endocannabinoids 
(N-arachidonoylethanolamine (AEA) and 2-arachidonoyl glycerol (2-AG)) 
have been reported with a blood pressure decreased eff  ect.
Methods We investigated 14 polymethylmethacrylate (PMMA) membrane 
hemofi   lters and three polyacrylonitrile (PAN) membrane hemofi   lters 
after use in patients with septic shock. Therefore, in clinical study, we 
used CVVHDF after DHP-PMX to treat 32 patients with septic shock. To 
determine the optimal acute blood purifi  cation therapy, we subsequently 
divided the patients into two groups: group A underwent CVVHDF using 
a PMMA membrane hemofi   lter after undergoing DHP-PMX (n = 25); 
group B underwent CVVHDF using a PAN membrane hemofi  lter after 
undergoing DHP-PMX (n = 7). In addition, the levels of endocannabinoids 
(AEA, 2-AG) were measured. The severity scores and the improvement of 
endocannabinoids were compared between the two groups.
Results Endocannabinoids (AEA, 2-AG) were adsorbed more in the PMMA 
column (AEA; 506.3 ± 680.2 ng/column, 2-AG; 23.0 ± 38.5 μg/column) than 
in the PAN column (AEA; 1.5 ± 0.7 ng/column, 2-AG; 0.1 ± 0.1 μg/column). 
The average Acute Physiology and Chronic Health Evaluation (APACHE) II 
score and the average sepsis-related organ failure assessment (SOFA) score 
did not diff  er signifi  cantly between the two groups. Group A showed a better 
outcome compared with Group B (P = 0.05). In addition, only group A showed 
a signifi  cant improvement in the blood AEA level on day 1 (P = 0.0185).
Conclusions Our study suggests that the PMMA column might be the 
better column for performing CVVHDF after DHP-PMX treatment, as 
suggested by the adsorption and blood purifi  cation of endocannabinoids.
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Introduction  Classical biomarkers like C-reactive protein (CRP) or the 
leucocyte count are only inaccurate tools for predicting the severity of 
community-acquired pneumonia (CAP). Procalcitonin (PCT) was found to 
predict 28-day mortality in CAP (area under the curve (AUC) 0.8) similar to 
the combination of PCT and CRB65 score (AUC 0.83) [1]. Novel prognostic 
biomarkers, such as Pro-ET1 and MR-ProADM, were shown to correlate 
with CAP severity [2]. We aimed to compare the diagnostic accuracy to 
predict mortality and ICU admission of clinical severity scores, biomarkers 
and their combination.
Methods  Nine hundred and twenty-fi   ve CAP patients enrolled in the 
ProHOSP trial [3] were analyzed by assessing clinical severity scores (SMART-
COP, PSI, CURB65) and biomarker levels (PCT, MR-ProADM, Pro-ET1). Receiver 
operating characteristic curves for 30-day mortality and ICU admission were 
used to calculate and compare the diff  erent predictive values.
Results The AUC for the prediction of 30-day mortality was 0.84 with 
SMART-COP, 0.82 with PSI, 0.72 with CURB65, 0.59 with PCT, 0.75 with 
MR-ProADM and 0.75 with ProET1. ICU admission was predicted best 
by SMART-COP (AUC 0.83), compared with the other severity scores and 
biomarkers (PSI: 0.68, CURB65: 0.65, PCT: 0.7, Pro-ET1: 0.73, ProADM: 0.72). 
The combination of SMART-COP and MR-ProADM was superior to SMART-
COP alone (AUC 0.84, P = 0.04).
Conclusions  The combination of MR-ProADM with SMART-COP 
signifi   cantly improved the prediction of ICU admission. Prognostic 
biomarkers should complement the clinical assessment of patients with 
LRTI to improve allocation of healthcare resources to high-risk patients.
References
1. Krüger  S,  et al.: Eur Respir J 2008, 31:349-355.
2. Schuetz  P,  et al.: BMC Inf Dis 2008, 8:22-30.
3. Schuetz  P,  et al.:: JAMA 2009, 302:1059-1066.
P76
Current progress in pneumonia research
T Smelaya1, V Moroz1, A Goloubev1, L Salnikova2, A Rubanovich2
1V.A. Negovsky Research Institute of General Reanimatology RAMS, Moscow, 
Russia Federation; 2N.I. Vavilov Research Institute of General Genetics, 
Moscow, Russia Federation
Critical Care 2010, 14(Suppl 1):P76 (doi: 10.1186/cc8308)
Introduction  Diagnosis and treatment of acute pneumonia (Pn) is a 
problem of high signifi   cance in modern medicine. The incidence of 
complicated and lethal acute Pn has increased [1]. Candidate genes are of 
great importance in the course of acute diseases and their complications. 
Cytokines and xenobiotic detoxication genes are the most investigated. The 
aim of the investigation was to study genetic predisposition to acute Pn.
Methods Results of the associative DNA polymorphism studies in 243 
patients with acute community-acquired Pn are presented; 178 healthy 
individuals formed a control group. Genetic variability of the candidate 
loci was studied: renin–angiotensin ACE system gene, chemokine receptor 
CCR5 gene and four genes controlling xenobiotic detoxifi  cation (CYP1A1, 
GSTM1, GSTT1, GSTP1). Multiplex polymerase chain reaction was utilized 
for genotyping of insertion–deletion polymorphism on loci ACE (287 
nucleotide pairs) and CCR5 (deletion of 32 nucleotide pairs). The odds ratio 
index was used to describe the degree of association of the genotypes 
with the diseases. Statistical analysis was done by means of Fisher’s exact 
test and the online program SNPStats (http://bioinfo.iconcologia.net).
Results An increased predisposition to Pn development was registered in 
homozygotes in deletion at the ACE locus (OR = 1.8; P = 0.013), positive 
genotypes of the GSTM1 locus (OR = 1.7; P = 0.010) and homozygotes in 
allele 606T of the CYP1A1 gene (OR = 1.6; P = 0.020).
Conclusions A combination of positive genotypes of the GSTM1 locus and 
homozygotes in allele 606T of the CYP1A1 gene (OR = 1.9, P = 0.006; incidence 
in controls >20%) presented with a most eff  ective prognostic power.
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Introduction Tracheal intubation and mechanical ventilation are often 
associated with infection of the lower respiratory tract (LRT). The morbidity 
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associated tracheobronchitis (VAT) and from VAT to ventilator-associated 
pneumonia (VAP) has been analyzed but not been fully elucidated. We 
endeavored to study the relationship between AC and development of 
infections (VAT and VAP) of the LRT in ICU patients.
Methods Retrospective study of 400 consecutive ICU patients ventilated 
>48 hours in the past 4 years. Patients age, gender, APACHE II, prior illness, 
cause of admittance, length of stay (LOS), time of mechanical ventilation 
(MV), outcome, time of appearance of AC and infection of the LRT were 
registered. MODS and CPIS were measured at onset of infection (VAT–
VAP) and 3 days after. MODS was also calculated on the day AC appeared. 
Bronchial secretions were cultured at admission, at least once a week and 
whenever there was a change in the amount and quality of bronchial 
secretions or clinical infection was suspected. The Mann–Whitney test was 
used for statistical analysis and statistical signifi  cance was set at P <0.05.
Results  From the 400 studied patients 68 (17%) were colonized and 
153 (48.25%) developed infections: 54 (13.5%) VAT and 99 (24.7%) VAP. 
Colonization appeared after 3.1 ± 0.8 days of ICU admission exclusively 
with Gram-negative microorganisms. Twenty-fi  ve (36.7%) of the colonized 
patients developed infections of the LRT (with the same pathogen): 8 
(11.7%) VAT after 4.6 ± 2.7 days and 17 (25%) were diagnosed with VAP 
after 9.8 ± 1.8 days. From the eight VAT patients, four developed VAP (50%) 
after 5.4 ± 0.4 days. None of the colonized patients died. The colonized 
patients who developed infections were elderly (P <0.05), more severely ill 
(P <0.04) and had at the time of infection a diagnosis higher temperature 
(P <0.01), more severe leukocytosis (P <0.02) but not statistically signifi  cant 
organ dysfunction (P >0.3). The appearance of VAP caused more severe 
organ dysfunction (P <0.002), longer MV duration (P <0.01) and longer 
LOS (P <0.001) but did not infl  uence mortality. On the day of AC detection 
MODS was 2.4 ± 0.5, on VAT detection MODS was 4.8 ± 0.9 and on VAP 
appearance MODS was 9.6 ± 0.7. CPIS at VAT detection was 3.9 ± 0.9 and at 
VAP detection 6.1 ± 0.5 (day I) and 7.2 ± 0.8 (on day III).
Conclusions AC resulted in LRT infections in only one-third of our patients 
and the majority of LRT infections are not preceded by AC.
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Introduction In our murine model of infl  uenza, signifi  cant weight loss 
occurs up to day 7 post-infection [1]. We sought to determine whether 
weight loss from infl  uenza could be altered by rehydration and whether 
this aff  ects pulmonary immune responses.
Methods Adult BALB/c mice were infected with X31 (H3N2) infl  uenza (1:80) 
via the intranasal route and randomized to intraperitoneal rehydration 
with 20 ml/kg compound sodium lactate (CSL), normal saline (NS) or 
no rehydration (NR) starting on day 3 following infection and continued 
for 4 days (n = 5/group). On day 7, mice were challenged with 1 x 106 
Streptococcus pneumoniae (serotype 2). Two further cohorts of mice were 
challenged with diff  erent doses of infl  uenza and rehydrated from day 3 to 
7 to investigate pulmonary immune responses in the absence of bacteria. 
Mice were infected with 1:80 (n = 10/group) infl  uenza and rehydrated 
once daily or 1:60 (n = 5/group) infl  uenza and rehydrated twice (1:60) 
daily with 20 ml/kg CSL or not. Daily weight, survival following secondary 
bacterial pneumonia, number of colony-forming units (48  hours after 
bacterial challenge) from peripheral blood, lung, and nasal wash and 
cellularity in lung compartments were measured.
Results Rehydration did not aff  ect weight loss following 1:80 infl  uenza 
infection (naïve mice (+0.3 ± 0.4 g), infl  uenza plus NR (–1.58 ± 0.4 g), 
infl  uenza plus CSL (–1.1 ± 0.7 g) and infl  uenza with NS (–1.3 ± 0.4 g)). A 
repeat experiment with CSL once daily or twice daily did not alter weight 
loss compared with NR (P >0.05). Survival or CFU counts following bacterial 
pneumonia did not diff  er between the groups (P >0.05). The total number or 
activational status of bronchoalveolar, lung macrophages/monocytes and 
lymphocytes was not aff  ected by rehydration following infl  uenza infection 
or 48 hours following bacterial pneumonia (P >0.05; P <0.05 vs naïve mice).
Conclusions Rehydration does not aff  ect immunity or pathophysiology 
in a murine infl  uenza infection model. Assuming these results can be 
extrapolated to the clinical setting, our fi   ndings support the use of 
conservative fl  uid resuscitation strategies in patients with infl  uenza.
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Introduction Bacteremic pneumonia is associated with worse outcome 
including higher mortality. The ATTAIN program compared telavancin 
(TLV), a lipoglycopeptide antibiotic, with vancomycin (VAN) for treatment 
of nosocomial pneumonia (NP) due to Gram-positive pathogens including 
MRSA. This subgroup analysis examined the baseline characteristics and 
clinical outcomes in bacteremic HAP cases.
Methods ATTAIN 1 and 2 were methodologically identical, randomized, 
double-blind, phase 3 studies. Adult patients with NP due to presumed or 
confi  rmed Gram-positive pathogens were randomized (1:1) to TLV 10 mg/
kg intravenously every 24 hours or VAN 1 g intravenously every 12 hours 
(adjusted per site-specifi  c guidelines) for 7 to 21 days. The modifi  ed all-
treated (MAT) population consisted of patients who received ≥1 dose of 
study medication and who had a respiratory pathogen recovered from 
baseline cultures. Bacteremic NP was defi  ned by the identifi  cation of a 
pneumonia-causing pathogen in the blood or of the same pathogen in 
lung and blood with identical susceptibility profi  les. Clinical outcomes 
were assessed at test-of-cure (TOC) 7 to 14 days after end of study 
treatment.
Results All MAT patients with bacteremic NP (n = 73) were included in 
this analysis. At baseline, more TLV patients than VAN patients were in the 
ICU (TLV 74%, VAN 62%) and had ventilator-associated pneumonia (TLV 
59%, VAN 44%); APACHE II scores were similar between groups (mean ± 
SD, TLV 16 ± 6, VAN 17 ± 6). S. aureus was the most common pathogen 
(TLV 76%, VAN 69%) and included MRSA (TLV 41%, VAN 49%). Cure rates for 
TLV and VAN were 44% and 36%, respectively (diff  erence TLV – VAN (95% 
CI) = 7.3% (–15.9%, 30.5%)). On-study mortality was similar, 41% in each 
treatment group. Incidences of adverse events (AE) were similar between 
groups, except for nausea (TLV 21%, VAN 3%) and vomiting (TLV 15%, VAN, 
0%). Proportions of patients who discontinued the study medication due 
to AEs were similar (TLV 12%, VAN 13%).
Conclusions TLV and VAN had similar cure rates in a subgroup of ATTAIN 
patients with bacteremic NP. The safety profi  les of TLV and VAN were 
mostly comparable in these patients.
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Introduction Pneumonia is a leading cause of death associated with 
hospital-acquired infections. Late ventilator-associated pneumonia 
(VAP), defi  ned as disease onset after ≥4 days of mechanical ventilation, 
is associated with worse outcomes than other forms of hospital-acquired 
pneumonia (HAP).
Methods ATTAIN 1 and 2 were methodologically identical, randomized, 
phase 3 studies of telavancin (TLV) 10 mg/kg intravenously every 24 hours 
vs vancomycin (VAN) 1 g intravenously every 12 hours for treatment of 
HAP, including VAP. VAN doses could be adjusted per investigative site 
guidelines. Clinical outcome was assessed at the test-of-cure (TOC) visit 
7 to 14 days after the end of study treatment. Baseline characteristics, 
outcomes, and safety in the late VAP sub-group were analyzed in the 
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pathogen(s) who received ≥1 dose of study medication) and the 
microbiologically evaluable population (ME; protocol adherent MAT 
patients with baseline Gram-positive pathogen(s)). Patients with mixed 
Gram-positive/Gram-negative infections were excluded in this analysis.
Results A total of 197 late VAP cases were analyzed. Baseline characteristics, 
including the APACHE II scores, were balanced between the treatment 
groups (Figure 1). At least one adverse event (AE) was reported by 95% 
(106/112) and 93% (79/85) of MAT patients in the TLV and VAN groups, 
respectively, and 21% (23/112) of the TLV group and 22% (19/85) of the 
VAN group died during the study.
Conclusions In this exploratory sub-group analysis, numerically higher 
cure rates were observed for TLV than for VAN in patients with late VAP. 
Incidences of reported AEs and mortality rates were similar between the 
TLV and VAN groups.
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Introduction  Clinical practice deals highly frequently with patients 
presenting a concomitant occurrence of acute respiratory distress 
syndrome (ARDS) and nosocomial pneumonia (NPn). Timely diagnosis 
of ARDS and NPn in such circumstances is problematic, but it provides 
a possibility of diff  erential treatment. The aim of the investigation was to 
elucidate the value of the oxygenation index (OI), extravascular lung water 
index (EVLWI), pulmonary vascular permeability index (PVPI) and central 
hemodynamics indexes in the diagnosis of ARDS in NPn.
Methods  Thirty-eight cancer and severely traumatized patients were 
enrolled in the prospective clinical investigation. The patients were split 
into three groups according to the ARDS and NPn diagnostic criteria: 
group 1 (ARDS + NPn), group 2 (NPn), group 3 (no ARDS, no NPn). ARDS 
was diagnosed by means of the Lung Injury Score (LIS), the American–
European Consensus Conference on ARDS criteria (1992), and the criteria 
of the V.A. Negovsky Research Institute of General Reanimatology (2006). 
All patients were investigated with a complex protocol, key elements of 
which were EVLWI, PVPI and central hemodynamics indexes measured by 
the transpulmonary thermodilution (Pulsion PiCCO plus, Pulsion Medical 
Systems, Germany). The data were analyzed by Statistica 7.0 (M ± SD, 
Newman–Keuls test, correlations). P  <0.05 was considered statistically 
signifi  cant.
Results Patients of group 1 on the day of enrollment presented with a 
signifi  cantly lower OI (160.9 ± 51.7 mmHg vs 239.5 ± 96.7 mmHg) and static 
pulmonary compliance (46.3 ± 13.7 ml/water cm vs 72.4 ± 23.1 ml/water 
cm) and signifi  cantly higher EVLWI (12.7 ± 4.7 ml/kg vs 7.6 ± 1.6 ml/mg) 
and LIS (2.22 ± 0.67 scores vs 1.68 ± 0.58 scores) in comparison with group 
2 patients. The patients of group 2 presented with an EVLWI within the 
physiological limits over the whole investigation period. PVPI calculated 
by three existing methods was available within the physiological limits 
even in the patients with a profound pulmonary edema. There were no 
signifi  cant  diff   erences between the groups in central hemodynamics 
parameters.
Conclusions The OI, EVLWI, static pulmonary compliance and LIS made it 
possible to timely diagnose ARDS in NPn. Patients with NPn without ARDS 
presented with EVLWI within the physiological limits. A complex analysis of 
these indexes must be performed to diagnose ARDS in NPn. Physiological 
limits of the PVPI require an additional investigation due to an insuffi   cient 
diagnostic value. Volumetric indexes of central hemodynamics should be 
measured to confi  rm the noncardiogenic nature of pulmonary edema.
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Introduction  Genetic variability of the pulmonary surfactant proteins 
A and D may aff  ect clearance of microorganisms and the extent of the 
infl  ammatory response. The genes of these collectins (SFTPA1, SFTPA2 
and SFTPD) are located in a cluster at 10q21-24, near to the gene coding 
for mannose-binding lectin (MBL2), another collectin involved in innate 
immunity. The aim of this study was to evaluate the association of 
variability at SFTPA1, SFTPA2 and SFTPD with susceptibility to and severity 
of community-acquired pneumonia (CAP). Another objective was to 
evaluate the existence of linkage disequilibrium among SFTPA1, SFTPA2, 
SFTPD and MBL2.
Methods Nonsynonymous polymorphisms of SFTPA1, SFTPA2, SFTPD and 
MBL2 were analysed in 682 CAP patients and 769 controls. Haplotypes 
were inferred and linkage disequilibrium (LD) was characterized. The eff  ect 
of genetic variability on SP-A and SP-D serum levels was studied.
Results Haplotypes SFTPA1 6A2 (P = 0.0009), SFTPA2 1A0 (P = 0.0017), and 
SFTPA1-SFTPA2 6A2-1A0 (P = 0.0005) were under-represented in patients, 
whereas haplotypes SFTPA2 1A10 (P = 0.00007) and SFTPA1-SFTPA2 
6A3-1A (P = 0.00065) were over-represented. We observed the existence of 
LD among the studied genes. Chromosomes carrying the SFTP-D aa11-C 
allele with 6A2-1A0 and the XA variant of MBL2 were found to be even 
more under-represented in patients (P = 0.00008). 1A10 and 6A-1A were 
associated with higher mortality, and also with multiorgan dysfunction 
syndrome (MODS) and acute respiratory distress syndrome (ARDS), 
respectively. SFTPD aa11-C allele was associated with development of 
MODS and ARDS.
Conclusions We report for the fi  rst time an association between genetic 
variants of SFTPA1, SFTPA2 and SFTPD with the susceptibility, severity and 
outcome of pneumonia.
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Introduction VAP rates in Brazil are higher than those related in Europe 
and USA. The study objective was to examine the eff  ect of the Institute for 
Healthcare Improvement’s ventilator bundle plus oral decontamination 
with chlorhexidine (ODC) in the incidence of VAP in an ICU.
Methods The study was conducted in a 20-bed, medical-surgical ICU. 
Criteria for nosocomial pneumonia are those from the CDC. Strategy 
was to implement the IHI’s ventilator bundle plus ODC. The goals were 
the ICU team adhesion of 80% achieved in the ninth month after bundle 
implementation and 98% after 1 year of follow-up. These measures 
included fi  ve strategies to prevent ventilator-associated pneumonia: 30 to 
45° elevation of the head of the bed, adequate sedation level (Ramsay 2 or 
3), DVT/PE prevention, peptic ulcer prophylaxis and oral decontamination 
with chlorhexidine 0.12%.
From February 2009 onwards, the ICU nursing staff   and ICT performed a 
daily checklist in order to observe the fi  ve issues accomplishment. If any 
item was found to be inadequate it was promptly corrected.
Figure 1 (abstract P80).
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and 86%, respectively (P <0.001) (Figure 1). VAP density was proportionally 
lower to bundle adhesion in the same period, 20 per 1,000 ventilation/day 
and 4.5, respectively.
Conclusions  Initial VAP rates were extremely high even for Brazilian 
benchmarks. Although we could not implement expensive technologies 
like continuous aspiration of subglottic secretions, the ICU team and ICT 
eff  orts were crucial for satisfactory results, as well the administrative board 
support, which turned this issue into an institutional priority. Our goals are 
to reduce even more, implementing the ‘ventilator bundle – getting to 
zero’ program, and maintaining a continued eff  ort to sustain these results.
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Introduction  An observational study to establish the incidence of 
ventilator-associated pneumonia (VAP), and ventilator care bundle (VCB) 
compliance. Neither has previously been quantifi  ed at our institution. VAP 
is a nosocomial pneumonia presenting in patients mechanically ventilated 
for ≥48 hours [1]. Use of microbiological data in conjunction with the Clinical 
Pulmonary Infection Score (CPIS) improves VAP diag  nostic specifi  city [1]. 
VCBs reduce VAP rates, in some cases to zero. The Department of Health VCB 
is one such collection of evidence-based interventions [2].
Methods A 3-month (April 2009 to June 2009) prospective observational 
study, in an eight-bed critical care unit in a district general hospital. All 
mechanically ventilated patients, age ≥18, intubated >48 hours were 
included. Pregnant or immunosuppressed patients were excluded. Patients 
treated with antibiotics for suspected or confi  rmed VAP were identifi  ed. 
CPIS was calculated on day 0 and day 3 of treatment. VCB compliance was 
recorded weekly in all patients.
Results A total of 190 ventilator-days were identifi  ed with no cases of 
VAP. The VAP rate per 1,000 ventilator-days is 0. Sixty-nine percent of cases 
achieved 100% VCB compliance. Four of the six VCB elements were 100% 
compliant (Table 1). All incidents of noncompliance had valid clinical 
reasons.
Conclusions  The VAP rate at Wansbeck General Hospital is zero. 
Compliance with a recognised VCB is high. The previous VAP rate was 
unknown. The impact of the VCB and the short study duration are unclear. 
Continuous data collection has been implemented to establish whether 
such results are representative and sustainable. Use of the CPIS to limit 
inappropriate antibiotic in suspected VAP is planned.
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Introduction  This systematic review aims to evaluate evidence from 
randomised controlled trials (RCTs) for oral chlorhexidine in preventing 
nosocomial pneumonia in intubated mechanically ventilated critically ill 
adults. Use of oral chlorhexidine appeals since it should reduce bacterial 
aspiration from the orophayrnx. A number of RCTs have recently been 
published on this topic.
Methods Search of Medline, Embase, Cochrane library, grey literature 
registers, conference proceedings and reference lists for RCTs comparing 
chlorhexidine with placebo or standard care for prevention of pneumonia 
in the critically ill. Outcomes: episode of nosocomial respiratory tract 
infection (RTI), mortality, duration of mechanical ventilation (MV) and 
length of ITU stay (ITU LOS). Review Manager 4.2 (Nordic Cochrane Centre) 
was used for data synthesis. Eff  ect estimates (odds ratio for dichotomous 
and weighted mean diff  erence for continuous data) were calculated using 
a random eff  ects model.
Results  Fourteen studies were identifi   ed, three involving patients 
undergoing cardiac surgery (1,841 patients) and 11 involving patients 
in noncardiothoracic ITUs (1,497 patients; see Table 1). Five studies 
(including two cardiac studies) found a signifi  cant reduction in episodes 
of nosocomial RTI in the chlorhexidine-treated group versus placebo or 
standard care. Pooled data indicated a signifi  cant reduction in nosocomial 
RTI in the treatment group among all patients, and among cardiac and 
noncardiac sub-groups (odds ratio 0.57 (95% CI 0.42 to 0.77), 0.52 (0.37 to 
0.75) and 0.6 (0.4 to 0.89), respectively). However, no signifi  cant diff  erences 
in mortality, duration of mechanical ventilation or ITU stay were 
demonstrated. Signifi  cant heterogeneity (I2 statistic >40%) was detected 
for all outcomes except mortality.
Table 1 (abstract P85). Eff  ect estimates
  Number of studies  Participants  Eff  ect
RTI 14  3,338  OR  0.57
Mortality 11  3,233  OR  1.2
MV days  6 noncardiac  1,027  WMD +1.34
ITU LOS days  4 noncardiac  702  WMD –0.51
Conclusions  Use of oral chlorhexidine is associated with reduction 
in nosocomial respiratory tract infection in intubated mechanically 
ventilated critically ill adults.
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Introduction We have shown that a the combination of selective digestive 
decontamination with topical antibiotics (SDD) and a decontamination 
regimen using nasal mupirocin with chlorhexidine bodywashing 
(M/C) markedly reduced acquired infections (AI) in intubated patients 
as compared with SDD alone, M/C alone or none [1]. We report the 
surveillance of AI in our ICU before and after the implementation of 
multiple site decontamination (MSD) as a routine prevention procedure.
Figure 1 (abstract P83). Proportion of bundle adhesion and density of 
incidence of ventilator-associated pneumonia.
Table 1 (abstract P84). Ventilator care bundle compliance
  30 to 40°  Sedation  DVT  GI    Tubing  All
Element head  elevation  hold  prophylaxis  prophylaxis  Humidifi  cation  management  elements
Compliance  (%)  100 88 81 100  100  100 69
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incidence rates of AI (expressed per 1,000 patient-days (‰) or per 1,000 
device-days for device-related AI) between the last 1-year period before 
(period A, 7,723 patient-days) and the fi  rst 1-year period after (period B, 
7,646 patient-days) MSD use was started.
Results In period B (MSD) versus period A (no MSD), there was a reduction 
in the rates of total AI (9.4‰ vs 23.6‰), bloodstream infections (1.0‰ vs 
4.0‰), ventilator-acquired pneumonia (5.6‰ vs 19.1‰) (all P <0.01), and to 
a less extent catheter-related urinary tract infection (1.0‰ vs 2.2‰, P = 0.11). 
Multivariate analysis with the Cox regression model showed that period A 
(OR 2.34 (1.64 to 3.20)) and the presence of a central venous catheter (OR 
2.07 (1.22 to 3.57)) were the two independent risk factors for AI. In period 
B, there was a statistically signifi  cant reduction in the rates of AI involving 
S. aureus (1.0‰ vs 3.0‰), coagulase-negative staphylococci (0.4‰ vs 
1.3‰), Candida (0.4‰ vs 1.3‰) and aerobic Gram-negative bacilli (5.0‰ 
vs 15.8‰), especially Enterobacteriaceae (3.4‰ vs 9.4‰), Pseudomonas 
aeruginosa (1.4‰ vs 3.9‰), S. maltophilia (0 vs 1.7‰) and Acinetobacter sp. 
(0 vs 0.8‰) (all P ≤0.05). MRSA AI rates were also lower (0.3‰ vs 0.9‰, NS) 
and no AI due to VRE occurred during both period. The rates of AI involving 
antimicrobial-resistant Enterobacteriaceae were lower in period B for 12 
antimicrobials tested, especially for ticarcillin (2.1‰ vs 6.5‰), ticarcillin/
clavulanate (0.8‰ vs 4.0‰), cefotaxime (0.3‰ vs 2.2‰) and colistin (0.5‰ 
vs 1.8‰) (all P ≤0.02). Similar fi  ndings were observed for antimicrobial-
resistant P. aeruginosa although diff  erences were not signifi  cant. Overall, 
the rate of AI involving organisms defi  ned as multidrug-resistant (MDROs) 
markedly decreased in period B (2.5‰ vs 9.1‰, P <0.001).
Conclusions Routine use of MDS was associated with a strong reduction 
in ICU AI. The reduction was consistently observed for all principal classes 
of pathogens, including MDROs. No new MDRO emerged.
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Introduction  This study aims to test the association of an increased 
mortality in critically ill patients with ventilator-associated pneumonia 
(VAP) caused by Pseudomonas aeruginosa in patients with a previous 
respiratory tract colonization by Candida spp. compared with that of 
patients with a VAP by P. aeruginosa without Candida spp. isolation.
Methods A retrospective study on all 5,236 critically ills patients admitted 
to the ICU of a university hospital from 2001 to 2008, of which 1,097 
received mechanical ventilation and in whom Pseudomonas and/or 
Candida were isolated in quantitative cultures from the Mini-BAL [1].
Results P. aeruginosa and Candida spp. were present at the same time in 
295 patients (P-C group), P. aeruginosa only in 92 patients (P group) and 
Candida spp. only in the remaining 710 patients (C group). SAPS II was 
44.27 ± 14.8 (mean ± SD), 39.07 ± 14.61 and 39.07 ± 14.61, respectively, 
for P-C, P and C groups. The SAPS II score of the C group was signifi  cantly 
higher than the P group (P <0.05), the SAPS II score of the C group was 
higher than the P-C group (P >0.05), and the SAPS II score of the P group 
was lower than the P-C group (P >0.05). The population with Candida 
spp. isolation alone was older (70.25 years vs 63.17 (group P-C) and 60.22 
(group P), P <0.05). The group with Pseudomonas associated with Candida 
spp. had a mortality rate higher than the P group (57.96% vs 6.05%, 
P <0.05). The length of stay in the ICU of patients with Candida spp. and 
P. aeruginosa was not diff  erent from the group who had P. aeruginosa alone 
(26.22 ± 31.80 vs 29.15 ± 25.66, P >0.05). Duration of hospitalization in the 
group with only P. aeruginosa was longer than the other two groups (79.38 
days vs 51.85 of the group P-C and 28.40 of group C, P <0.05).
Conclusions  Candida colonization seems to increase the risk for 
Pseudomonas infection [2]. Patients who developed VAP due to 
P. aeruginosa with previous colonization of the respiratory tract by Candida 
spp. were older, with a higher SAPS II score and had a high mortality.
References
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Introduction The aim of this study was to analyze the correlation between 
antiviral therapy effi   cacy and the negative profi  le of the RT-PCR made on 
pharyngeal swab, subglottic aspiration, and bronchoalveolar lavage in 
patient aff  ected by ARDS caused by H1N1 infection.
Methods A prospective analysis was performed on 11 patients admitted 
to the ICU of a tertiary referral center (Careggi Teaching Hospital, Florence, 
Italy). All patients underwent daily RT-PCR monitoring on pharyngeal 
swab, subglottic aspiration, and bronchoalveolar lavage. All patients were 
treated with oral administration of oseltamivir (75 mg twice daily) and 
inhaled zanamivir (10 mg twice daily) since ICU admission. Six patients 
were treated with extracorporeal membrane oxygenation (ECMO) due to 
their critical respiratory conditions. Two of them resulted co-infected by 
legionella pneumophila.
Results  As shown in Figure 1, RT-PCR from pharyngeal swab at ICU 
admission failed to demonstrate the viral infection in four patients, 
whereas RT-PCR from bronchoalveolar lavage had a sensibility of 100%. 
Similarly, the time course showed that RT-PCR from pharyngeal swab 
resulted negative in an average time of 3 days after therapy start, while 
RT-PCRs from bronchoalveolar lavage continued to permit infection 
monitoring and therapy regimen conduction. None of RT-PCRs on 
subglottic aspiration samples resulted positive. All patients recovered and 
were discharged alive from ICU in spontaneous breathing.
Conclusions In our experience, the most reliable method to diagnose 
and monitor H1N1 infection was RT-PCR from bronchoalveolar lavage, 
since pharyngeal swab do not off  er enough sensibility, either for antiviral 
therapy initiation or for antiviral therapy management. Samples from 
subglottic aspiration can be avoided due to a low sensibility.
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Introduction  Bedside lung ultrasound is able to identify with high 
sensibility and sensitivity most pulmonary pathological patterns and is 
widely adopted in critically ill patients’ daily management. It is a feasible 
Figure 1 (abstract P88). Time course of RT-PCR positivity for H1N1 
infection.
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caused by H1N1 infl  uenza infection.
Methods The study took place in the ICU of a regional referral center, 
with ECMO availability, for respiratory failure (Careggi Teaching Hospital, 
Florence, Italy). Eight patients admitted for H1N1-induced ARDS 
(September to October 2009) underwent daily LU examination. The 
examination was standardized with a procedure ad hoc in order to 
achieve complete and comparable reports for every patient. Patients were 
examined supine, taking lateral and anterior views and, if possible, on 
one side. Intercostal spaces were used as acoustic windows. Every single 
examination and its fi  nding have been reported in our ICU database.
Results Pleural thickness was present in 100% of cases, mostly related 
to little and multiple pleural consolidations. Anyway, pleural gliding was 
present most of the time (87.5%), even if with a visible decrease of its 
movement. This was replaced with the lung pulse only in the presence 
of important lung consolidation. Alveolar interstitial syndrome (AIS) was 
always present on the whole lung, ranging from moderate to severe (100%), 
with high positivity at the base, posteriorly (100%). White lung appeared in 
every patient, most at the lung base and in the middle fi  elds, posteriorly. 
As far as consolidation is concerned, its presence was confi  rmed in 100% 
of the patients, associated with satellite multiple subpleural consolidations 
in 37.5% of patients. Basal lung was always involved (100%), followed 
by middle (50%) and apical fi   elds(25%). Bronchogram was present in 
100% of patients in bigger consolidations. Their aspect was aerial and 
only in one patient, with severe consolidations, turned into a fl  uid one. 
Anechoic pleural eff  usions were found in 37.5% of patients. No cases of 
pneumothorax were detected.
Conclusions In this group of patients, H1N1 infection shows diff  erent 
lung patterns altogether, where the most frequent seemed to be severe 
basal posterior AIS, multiple subpleural lung consolidations, and multiple 
parenchymal consolidation with bronchogram. The presence of spared 
areas did not seem to belong to H1N1 LU patterns.
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Introduction Pneumocystis pneumonia (PCP) in HIV-negative patients 
frequently presents as fulminant respiratory failure and is associated with a 
high mortality rate when the patient requires mechanical ventilation. The 
aims of this study were to evaluate the outcome and prognostic factors in 
the patients with HIV-negative PCP requiring mechanical ventilation (MV).
Methods We retrospectively reviewed the medical records and collected 
the HIV-negative patients who were microbiologically confi  rmed as PCP 
and required MV in ICU over a 10-year period in a tertiary care teaching 
hospital.
Results A total of 51 patients were identifi  ed. Mean age was 55.4 ± 15.0 
years. Mean APACHE II score at ICU admission was 25.7 ± 5.8. The 28-day 
mortality and in-hospital mortality were 45.8% and 66.7%, respectively. 
Between survivors and nonsurvivors, there were no signifi  cant diff  erences 
in baseline characteristics, APACHE II score, PaO2/FiO2 ratio, and absolute 
neutrophil counts on ICU admission day. Also the mortality was not 
diff  erent in relation to the presence of barotrauma, application of non-
invasive ventilation, timing of susceptible antibiotic administration, 
changing or not to salvage regimens, presence of cytomegalovirus co-
infection and even the microbiologic persistency in follow-up specimens. 
Based on the types and intensity of previous immunosuppressive therapy, 
we classifi  ed patients into three subgroups: patients receiving low-dose 
steroid maintenance ± other immunosuppressive agents (LS), which 
represent previously stable organ transplants; another group consisting 
of patients receiving recent intensive chemotherapy (CTx); and the other 
group refers to patients receiving high dose (defi  ned as >2 weeks at 
least 1 mg/kg dose) steroid therapy ± other immunosuppressive agents 
(HS). Signifi  cant diff  erences of outcome were observed among the three 
diff  erent groups (28-day mortality: LS = 22.2%, CTx = 29.4%, HS = 71.4%, 
P = 0.01; 60-day mortality: LS = 33.3%, CTx = 64.7%, HS = 81.0%, P = 0.04).
Conclusions  Our data showed that the mortality of fulminant HIV-
negative PCP requiring MV was signifi  cantly diff  erent according to the 
types and intensity of previous immunosuppressive treatment despite 
similar clinical features on ICU admission.
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Introduction In the winter of 2009 the infl  uenza A (H1N1) pandemic 
reached Brazil, aff  ecting severely its southern states. A total 68,806 cases 
of suspected pandemic infl  uenza A infection had been reported in Brazil 
and 91% of the specimens tested were positive. Incidence of pandemic 
infl  uenza A in southern Brazil was 137/100,000. In the southern Brazilian 
state of Santa Catarina, Nereu Ramos Hospital is the referral center for the 
treatment of infectious diseases, and it provided eight intensive care beds 
for the management of acute respiratory failure from suspected cases of 
infl  uenza A during the 2009 pandemic.
Methods We collected retrospective data on the epidemiological features, 
clinical course and ventilatory characteristics of patients with laboratory-
confi  rmed infl  uenza A (H1N1) infection who were admitted to our ICU 
during the winter of 2009.
Results Thirty-four adult patients were admitted to our ICU with acute 
respiratory failure and suspected pandemic infl  uenza A infection. Of these, 
14 cases tested positive for infl  uenza A (H1N1). The majority of the patients 
were male (61.5%) with median age of 27.5 years and interquartile range 
(IR) of 26.5 to 48.5. The APACHE II median was 14.5 (IR 10.0 to 18.25) with 
median predicted mortality of 20.0 (IR 10.73 to 27.7). Risk factors were: 
obesity (23.1%), obstructive respiratory diseases (15.4%); pregnancy, 
immunosuppressive and neuromuscular disorders were present in one 
patient each. All 14 patients presented severe respiratory failure, with a 
median lowest PaO2/IOF of 113.3 (IR 83.53 to 159.55) and 92.3% of them 
requiring mechanical ventilation. The patients in mechanical ventilation 
were all ventilated in pressured-controlled mode, demanded high PEEP 
levels (mean of 18.5 ± 5.16 cmH2O), presented high peak inspiratory 
pressure (mean of 37.83 ± 7.35 cmH2O) and required elevated IOF 
(81.15 ± 20.83%). A total of 57.1% of the patients were submitted to lung 
recruitment, while the prone position was used in 42.8% of them. The 
median ICU stay was 13.0 days (IR 4.75 to 23.50) and the median hospital 
stay was 16.5 days (IR 9.75 to 25.0). The ventilatory-associated pneumonia 
(VAP) rate was unusually high (69.2%) as well as the mortality rate during 
the intensive care stay (38.5%).
Conclusions  Patients admitted to our ICU with confi   rmed pandemic 
infl  uenza A infection presented severe acute respiratory failure and an 
unusually high incidence of VAP and mortality rates.
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Introduction The novel infl  uenza A H1N1 virus can cause, in a restricted 
subgroup of infected patients, an acute respiratory failure not responding 
to conventional treatment. In selected cases, extracorporeal membrane 
oxygenation (ECMO) has been applied with a 21% mortality rate. Here we 
report the experience of the ICU of a regional referral center for ECMO 
(Careggi Teaching Hospital, Florence, Italy).
Methods An Emergency Medical Service has been established for the 
novel pandemic infl  uenza to guarantee the possibility of ECMO initiation in 
the peripheral hospitals by our ECMO Team and the subsequent transport 
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composed of an intensivist, a cardiac surgeon, a cardiologist, a perfusionist 
and a nurse. All of the diff  erent fi  gures were properly trained and formed 
on ECMO treatment. According to our internal protocol, eligible patients 
for ECMO treatment are aged 15 to 70 years old with acute respiratory 
failure with one of the following conditions: a ratio PaO2/FiO2 <60 or 
pH <7.20 under protective ventilation conditions. ECMO insertion was 
achieved percutaneously and a high-fl  ow approach (5 to 6 l/minute) was 
initially established according to patient need. ECMO device is a Rotafl  ow 
Maquet Centrifugal Pump with a Quadrox-D oxygenator (Maquet, Rastatt, 
Germany) and biocoated circuits. H1N1 infection was monitored by RT-
PCR examination on pharyngeal swab and bronchial aspirate. Antiviral 
therapy was conducted by oral administration of oseltamivir (75 mg twice 
daily), and inhaled zanamivir (10 mg twice daily).
Results From October 2009 to November 2009, six patients with infl  uenza 
A (H1N1) have been treated with ECMO support. Three patients were 
cannulated in the district hospital and transported safety to our ICU by 
our ECMO Team. Median SAPS II at admission, median age and sex were 
as listed as follows: 46, 35 years old and fi  ve males/one female. All patients 
had an acute respiratory failure accompanied by a multiorgan dysfunction. 
ECMO was established and maintained for 200 hours. All patients were 
successfully weaned from ECMO support, extubated and discharged from 
our ICU. No major procedure-related complications were observed.
Conclusions Well-timed ECMO use in cases of infl  uenza A H1N1 acute 
respiratory failure could improve overall the survival rate.
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Budd–Chiari syndrome complicated by abdominal compartment 
syndrome: evidence of central hypovolaemia?
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Introduction Budd–Chiari syndrome (BCS) is characterised by hepatic 
venous outfl   ow obstruction (HVOO) leading to post-sinusoidal portal 
hypertension, congestion of the liver with caudate lobe hypertrophy. In 
addition to intra-abdominal hypertension (IAH), caused by severe ascites, 
HVOO may aggravate the cardiovascular disturbances seen in patients 
with decompensated disease. The aim was to study the haemodynamic 
response to abdominal decompression in BCS compared with patients 
with decompensated cirrhosis.
Methods  Ten patients with BCS admitted to the Liver ICU, King’s 
College Hospital were studied. Transpulmonary thermodilution cardiac 
output monitoring and calculation of volumetric indices of preload was 
performed with the PiCCO system. Haemodynamic variables and IAP 
were analysed pre and post intervention. The control group comprised of 
cirrhotic patients with IAH requiring abdominal paracentesis (PC).
Results Ten patients with BCS were studied, median age 39 years (range 
(R) 20 to 52); eight had liver transplantation and two had a surgical shunt 
procedure. Eight patients (PC), median age 59 (33 to 65), underwent 
abdominal paracentesis for tense ascites. IAP was raised in both groups 
pre intervention (23, R 17 to 40, BCS vs 26, R 20 to 40, PC). ITBVI remained 
low in the BCS group (632, R 453 to 924) pre intervention despite 
aggressive volume resuscitation (median positive FB10L, R 0.5 to 39). Post 
intervention, a reduction in IAP was seen in both groups (BC P <0.001, 
PC P <0.0001). ITBVI increased (633, R 453 to 924 vs 736, R 512 to 1,110, 
P = 0.001) in BCS patients. No change in ITBVI was noted (pre 870, R 598 
to 1,619 vs post 1,036, R 763 to 1,762) in the CP group despite albumin 
replacement. An increase in CI and SVI was noted in both groups: BCS (CI 
P = 0.003, SVI P = 0.007), CP (CI P = 0.005, SVI P = 0.02). There was an inverse 
relationship between IAP, CI (P = 0.003), SVI (P = 0.004) and ITBVI (P = 0.01) 
in BCS patients. In the CP group, IAP did not correlate with ITBVI.
Conclusions Compared with cirrhotic patients with ascites, patients with 
BCS and IAH have evidence of central hypovolaemia. We postulate that 
in addition to raised IAP, hepatic venous obstruction and caudate lobe 
hypertrophy limit venous return in patients with BCS. Reduction in IAP 
restores preload with improvement in cardiac output.
References
1. Cheatham  et al.: Intensive Care Med 2007, 33:951-962.
2. Malbrain  et al.: Intensive Care Med 2006, 32:1722-1732.
P94
Adenosine signalling has a protective role in intestinal ischemia and 
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Introduction  Gut ischemia and reperfusion (IR), for example in small 
bowel transplantation or following resuscitation, may result in severe 
impairment of the intestinal microcirculation. Potential sequelae are 
mucosal damage, loss of barrier function, bacterial translocation, systemic 
infl  ammation, multiple organ failure and death. We hypothesized that 
extracellular adenosine signalling has a protective role in intestinal IR 
injury. Using intravital microscopy we investigated the eff   ects of the 
adenosine receptor agonist NECA (5΄-N-ethyl carboxamide adenosine) on 
leukocyte–endothelial interactions and capillary perfusion in the intestinal 
microcirculation following intestinal IR.
Methods Six groups of animals (n = 7 per group) were studied: control 
(CON), NECA, IR (30 minutes of intestinal ischemia, 2 hours of reperfusion), 
IR + NECA, IR + NECA + MRS1754 (adenosine A2B receptor antagonist), IR 
+ NECA + DPCPX (adenosine A1 receptor antagonist). All substances were 
administered immediately after declamping of the superior mesenteric 
artery. Intravital microscopy was performed after 2 hours of reperfusion. 
Leukocyte adhesion (rolling/fi   rm adherence) and functional capillary 
density (FCD) were measured offl   ine by blinded investigators.
Results  Following IR we observed a signifi   cant increase of leukocyte 
adherence in the intestinal submucosal venules (for example, V1 venules: 
CON 20.1 ± 5.8 n/mm2, IR 237.8 ± 24.2 n/mm2, P <0.05). Capillary perfusion 
of the muscular layers of the intestinal wall was reduced (for example, 
longitudinal muscular layer: CON 112.3 ± 5.3 cm/cm2, IR 92.4 ± 8.4 cm/
cm2). NECA administration reduced signifi   cantly leukocyte adherence 
(V1 venules: 67.8 ± 6.8 n/mm2, P <0.05) and improved capillary perfusion 
(longitudinal muscular layer: 113.9 ± 8.3 cm/cm2). Administration of the 
adenosine A2B receptor antagonist completely reversed the NECA eff  ects 
(for example, leukocyte adherence V1 venules: 228.8 ± 33.2 n/mm2), 
whereas A1 receptor inhibition only partially abolished the action of NECA 
(for example, leukocyte adherence V1 venules 124.5 ± 14.5 n/mm2).
Conclusions The data support the hypothesis, that adenosine signalling 
is involved in intestinal IR injury. The adenosine A2B receptors are more 
important than adenosine A1 receptors since inhibition of A2B receptor 
by MRS1754 completely reversed the eff  ect of the adenosine receptor 
agonist NECA.
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Introduction Norepinephrine is a standard of care in the hemodynamic 
management of septic shock concomitantly to fl   uid administration. 
However, no guidelines exist concerning norepinephrine weaning. 
Further  more, norepinephrine may rapidly restore macrocirculatory hemo-
dynamics through stressed volume without treating the underlying 
volume defi  cit, especially in the absence of optimal volume expansion. 
Norepinephrine weaning may reveal latent/persisting need for volume 
expansion in apparently stable patients.
Methods  Observational study of norepinephrine weaning in seven 
resuscitated SICU septic shock patients. Weaning was performed in 0.1 mg/
hour decrements every 5 to 15 minutes until hemodynamic instability, 
defi  ned as a mean arterial pressure (MAP) ≤70 mmHg, interrupted the 
process, at which point pulse pressure variation (PPV) was measured 
and transthoracic echocardiography (TTE) performed as per standard 
procedures. Upon instability with PPV ≥13%, 250 ml fl  uid challenge was 
performed and the MAP increase allowed pursuit of weaning, whereas 
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were sought between norepinephrine decrements and variations over 
weaning (and fl  uid challenge) in PPV, arterial compliance, and indexed 
systolic ejection volume (iSEV). Global resuscitation endpoints (serum 
lactate, ScvO2) were compared before and after the entire weaning 
process.
Results  Two behaviors were observed. First, norepinephrine weaning 
unmasked latent preload dependency in steps characterized by marked 
PPV increase (16.5%, 8 to 36), correlated to norepinephrine decrements 
(ρ = 0.971; r2 = 0.745; P = 0.005) resulting in PPV ≥13% and fl  uid challenge 
increasing the MAP and allowing pursuit of weaning. Second, weaning 
revealed norepinephrine dependency in steps halted by instability and 
characterized by slight PPV increases (3.9%, 0.3 to 8.4), resulting in PPV 
<10%, and a decrease in iSEV that was correlated to norepinephrine 
decrements (ρ = 0.943; r2 = 0.830; P = 0.001). Globally, weaning decreased 
serum lactate to under 2 mmol/l with ScvO2 maintained above 70%.
Conclusions  Hemodynamic stability through norepinephrine use in 
septic shock might be at the cost of occulting residual fl  uid requirements 
which can be revealed during norepinephrine weaning.
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Introduction Stroke volume (SV) and cardiac output (CO) are standardized 
into the stroke index (SI) and cardiac index (CI) by dividing by the patient’s 
body surface area (BSA). Commonly used algorithms in hemodynamic 
management suggest diverse therapeutic interventions based on low, 
high, or normal SI or CI. Morbid obesity is increasingly common. When 
morbidly obese patients have their SV or CO indexed, high absolute values 
become low SI and CI, and may be misleadingly low. This would then 
cause therapeutic interventions opposite to their needs.
Methods BSA was derived using the Mosteller formula on the metric 
equivalent of simulated patients ranging from 5 ft to 7 ft and 100 lbs 
to 700 lbs. A priori, we defi  ned normal CO = 4 to 8, normal CI = 2.5 to 
5.0, normal SV = 60 to 100 ml/beat, and normal SI = 33 to 47. Algebraic 
analysis was used to determine BSA levels that would classify an SV or CO 
as abnormal.
Results Critical BSA thresholds (T) are presented in Table 1. For example, 
at SV = 100, a BSA higher than 3.03 (to the second decimal place) would 
classify the patient as having a low SI.
Table 1 (abstract P96)
SV T  CO  T
90 2.72  7  2.80
100 3.03  8  3.20
110 3.33  9  3.60
120 3.64  10  4.00
130 3.94  11  4.40
Conclusions Patients with extreme BSAs are increasingly encountered 
in the ICU, especially larger BSAs related to obesity. We provide threshold 
values where extreme BSAs will classify high SV or CO values as low indexed 
values. The ranges considered normal for SI and CI may be inappropriate for 
patients with extreme BSAs, particularly in the obese. We caution against 
relying solely on the SI and CI to assess hemodynamic performance. 
Instead, the SV and CO along with other physiological parameters should 
also be considered before making therapeutic decisions.
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Introduction It remains a great challenge to measure systemic blood 
fl  ow in critically ill newborns, especially during the transitional period 
with intracardiac and extracardiac shunts. Due to technical restraints, size 
limitations, the necessity for a relatively large amount of blood withdrawn 
and possible indicator toxicity, many methods of cardiac output 
monitoring are not feasible, hence cardiac output is generally estimated 
from indirect parameters of systemic blood fl  ow. In a former study we 
assessed the agreement for cardiac output using the ultrasound dilution 
method (UDCO) and ultrasound transit time-based measurement of main 
pulmonary blood fl  ow in a juvenile piglet model without shunts [1]. In the 
present study we analyzed the infl  uence of a left-to-right shunt on the 
agreement between UDCO and ultrasonic transit time pulmonary blood 
fl  ow in a juvenile lamb model.
Methods  In this prospective, experimental animal study, which 
was approved by the Ethical Committee on Animal Research of the 
Radboud University Nijmegen, we placed a Gore-Tex® shunt between 
the left pulmonary artery and the descending aorta in eight random-
bred newborn lambs (3.5 to 8.3 kg). This aortopulmonary shunt was 
intermittently opened and closed while cardiac output was manipulated 
by creating hemorrhagic hypotension. Ultrasound dilution cardiac output 
(Q-UDCO) – using repeated injection of 1.0 ml/kg isotonic saline at body 
temperature – was compared with pulmonary blood fl   ow (Q-MPA) 
invasively measured by a perivascular fl   ow probe around the main 
pulmonary artery.
Results A total of 220 measurements were performed. Bias, defi  ned as 
Q-UDCO minus Q-MPA, was calculated for each measurement. With an 
open shunt there was a signifi  cant left-to-right shunt (mean Qp-/Qs- ratio 
1.8; range 1.6 to 2.6). Mean bias (SD) was 6.80 (18.0) ml/kg/minute with a 
closed shunt and 11.1 (19.8) ml/kg/minute with an open shunt. Limits of 
agreement (±1.96 SD) were ±35.2 ml/kg/minute and ±38.8 ml/kg/minute, 
respectively. Percentage error was 22.0% and 24.2% for measurements 
with a closed and open shunt, respectively.
Conclusions Cardiac output measurement with the UDCO method is 
reliable and easily applicable in ventilated juvenile lambs, even in the 
presence of a signifi  cant left-to-right shunt.
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Introduction Haemodynamic measurement plays an important role in 
the treatment of patients with acute heart failure and cardiogenic shock 
(CS). The pulmonary catheter (PAC) is a common device for enhanced 
haemodynamic measurement. The aim of this study was to evaluate the 
comparability of the PiCCO device with the PAC during the treatment of 
patients with CS; for example, the use of intra-aortic counterpulsion (intra-
aortic balloon pumping (IABP)), and therapeutic hypothermia after cardiac 
arrest.
Methods  Seventy-seven measurements were taken in 11 critically ill 
patients during the therapy of cardiogenic shock. The cardiac index (CI), 
stroke volume (SVI), and systemic vascular resistance (SVRI) were measured 
by pulmonary catheter and PiCCO device, as well as the pulmonary aortic 
occlusion pressure (PAWP) with a pulmonary catheter and the global 
end-diastolic volume (GEDI) with the PiCCO device, and registered in a 
commercially available computer system.
Results A good correlation between the two techniques in all data, as 
well as during the use of IABP or during hypothermia was shown. The 
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was 24.89%, 26.17% and 19.08%, respectively. There was also a good 
convergence between the measurements of vascular resistance in overall 
data and during IABP. Signifi  cant correlations were found for SVIpa, SVIpi, 
SVRIpa, SVRIpi to CIpa. For GEDI there was a signifi  cant correlation with 
CIpa for data collected during cooling. No signifi  cant correlation between 
PAWP und CIpa was found.
Conclusions The data show interchangeability for the two methods using 
intermitting measurements during therapy of cardiogenic shock even 
during intra-aortic counterpulsation and therapeutic hypothermia. The 
cardiac output seems to be related to the GEDI as a preload parameter; no 
relationship between PAOP and CI can be shown. The usability of the less 
invasive PiCCO device for the enhanced hemodynamic measurement in 
patients with acute heart failure and cardiogenic shock is ensured.
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Introduction We designed this study to compare the performance in 
cardiac output (CO) monitoring capabilities of two devices in refractory 
septic shock patients (RSS Pts): non-invasive transthoracic bioreactance 
(NICOM) and pulse contour analysis (PICCO PC) coupled to transpulmonary 
thermodilution (PICCOTD).
Methods We included RSS Pts in vasopressor/inotrope need monitored 
with both devices. Triplicate measurements of CO by PICCOTD were 
used to measure CO at baseline and to calibrate PulseCO. The CO values 
recorded simultaneously minute-by-minute by the two systems were 
compared at baseline (nonperturbated system), in response to a passive 
leg-raising maneuver (PLR = leg elevation to 45° for 2 minutes starting from 
a supine position) and PEEP test (10 and 15 cmH2O for 10 minutes each) 
(perturbated system). We used PICCOTD/PC as the reference technology 
evaluating the accuracy and estimating the precision of both devices.
Results Continuous CO recording with both devices was performed on 12 
consecutive RSS Pts (Nep + Epi = 0.66 ± 0.15 μg/kg/minute, all ventilated 
with TV <8 ml/kg). At baseline (nonperturbated system), correlation 
analysis of NICOM vs PiCCOTD CO showed r2 of 0.78 (P <0.001). Bland–
Altman analysis evidenced a mean bias of 0.08 l/min (LOA –1.31 to 1.49). 
The mean CO was 6.01 ± 1.48 l/min. In a perturbated system the bias of 
NICOM vs PICCO PC was respectively–0.05 l/min (LOA –1.52 to 1.42) and 
0.3 l/min (LOA –2 to 2.6) during PLR and PEEP test. The percentage error 
was <30% in 92% of patients at baseline (nonperturbated system), in 92% 
of patients during PLR and in 74% during PEEP test. In a nonperturbated 
system the CO precision (calculated as 2 SD/mean over 10 consecutive 
measurements) was 6.5 ± 6% and 6.7 ± 9% for NICOM and PiCCOTD, 
respectively (NS). Precision for NICOM and PICCOPC was respectively 6.8 
± 13% and 4.7 ± 10% during PLR and 7 ± 15% and 7.6 ± 15% during PEEP 
test.
Conclusions Although limited to a small number of patients, NICOM 
and PICCO PC, calibrated by TD, seem to have comparable accuracy and 
precision in CO monitoring in RSS Pts even in a perturbated system.
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Introduction  NICOM (Cheetah) is a new non-invasive cardiac output 
(CO) monitor based on bioreactance. We tested the agreement of NICOM 
vs LiDCO™plus in terms of absolute CO values and of the ability to track 
changes after therapeutic intervention in critically ill patients.
Methods Patients requiring haemodynamic monitoring were monitored 
with LiDCO™plus and NICOM. Three measurements of CO by LiDCO 
were used to measure CO at baseline and to calibrate PulseCO. After 
fl  uid challenges (FC = 250 ml colloid/5 minutes) or inotropic therapy 
alterations, the change in stroke volume (SV) for PulseCO and NICOM CO 
was recorded. Patients able to increase SV ≥10% as measured by PulseCO 
were considered responders (R). Bland–Altman analysis was performed 
for NICOM vs LiDCO CO at baseline. The coeffi   cient of variation (CV) and 
percentage error (PE) were calculated. ΔSV of NICOM vs PulseCO was 
analysed with correlation analysis. In patients receiving FC, a ROC analysis 
was performed to detect the sensitivity and specifi  city of NICOM to track 
ΔSV as measured by PulseCO CO.
Results Baseline haemodynamics in 30 patients enrolled: BA analysis for 
NICOM vs LiDCO CO showed a mean bias of –0.18 l/minute (LOA –2.5 to 
2.16). Mean CO was 5.8 l/minute, PE was 41%. Mean LiDCO CO CV was 
6.8%. A total of 81 pairs of data were collected after FC or inotrope dose 
change. Correlation analysis showed r2 of 0.55 (P <0.0001) for changes post 
FC and r2 of 0.54 (P <0.006) post inotrope dose changes. ROC analysis for 
NICOM CO in R and NR after a FC showed an area under the curve (AUC) of 
0.8 (P <0.0001; Figure 1). An increase in NICOM SV >8% showed a sensitivity 
of 76% and a specifi  city of 75% to predict PulseCO changes >10%.
Conclusions NICOM demonstrated a moderate agreement with LiDCO 
but showed excellent agreement with PulseCO in tracking CO changes 
following therapeutic interventions.
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Introduction  Arrhythmias are common among high-risk surgical and 
ICU patients. The PulseCO pressure waveform algorithm is used for 
both LiDCO™plus and LiDCOrapid hemodynamic monitors, which are 
frequently used to estimate cardiac output (CO) in critically ill patients. 
Cardiac arrythmias could increase the variation of both the lithium dilution 
(LiDCO) and/or the PulseCO measurement. At set-up the algorithm 
is calibrated by comparing the PulseCO CO estimate, averaged over 
30 seconds, with a known CO (normally LiDCO) to generate a calibration 
factor (CF) [1]. This study was designed to explore the eff  ect of arrythmias 
on the accuracy of CF generation in the PulseCO monitor.
Methods LiDCO™plus hemodynamic data fi  les were obtained retro spectively 
from a university hospital medical/surgical ICU. Files were separated into 
those records with and without arrhythmia – defi  ned as heart rate variation 
>5% during at least one additional CF determination after monitor set-up. 
Previous studies have established the coeffi   cient of variation (CV) of a single 
LiDCO determination at 8% [2] and the PulseCO measurement at 2.4% [3]. A 
combined CV, refl  ecting the eff  ect of calibration, is estimated at 8.5%, resulting 
in an expected precision for the CF of 17%. Data were analysed for variation in 
CF against HRV using linear regression and the Student’s t test.
Figure 1 (abstract P100). ROC analysis for NICOM CO in R and NR.
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records contained 32 post set-up calibration events. Of these 17 occurred 
with HRV ≤5% (median = 1%, range: 0 to 5%) and 15 occurred while HRV 
>5% (median: 19%, range: 7 to 26%). The average variation in CF during 
HRV was 5.4 ± 4.0% and for high HRV was 8.9 ± 8.1% of the initial value. 
The t test indicated no diff  erence in the mean variation of CF (P = 0.162) 
or median. There was no correlation between HRV and CF variation (r2 = 
0.002). Ninety-one per cent (29/32) of the observed CF variation were less 
than 17% of the initial CF value.
Conclusions  CF determinations are not signifi   cantly aff   ected by HRV. 
PulseCO estimates CO acceptably in the presence of arrhythmias. 
Interpretation of the data is enhanced by using at least 30 second averaging.
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Introduction The PulseCO pressure waveform algorithm is used for both 
LiDCO™plus and LiDCOrapid hemodynamic monitors to estimate cardiac 
output (CO). The accuracy of this CO estimate is achieved by comparing 
(calibrating) the PulseCO with a known CO, for example from the lithium 
dilution or LiDCO which scales the software algorithm and reduces the 
bias to the actual CO [1]. This calibration/scaling factor (CF) is patient 
specifi  c and should not signifi  cantly change over a period of a few days as 
it refl  ects the patient’s aortic capacitance.
Methods  LiDCO™plus hemodynamic data fi   les were obtained 
retrospectively from a university hospital medical/surgical ICU. Files 
were screened to obtain records with at least 24 hours of continuous 
hemodynamic data and at least one calibration at 24 hours following the 
initial set-up calibration. Data were analysed for change in CF from initial 
calibration over 24 and up to 48 hours. Relative change in CF was analyzed 
for correlation with changes in SVR and CO.
Results  Twenty-one records contained at least 24 hours of data with a 
calibration at 24 hours. Eleven contained at least 48 hours of data and a further 
calibration at 48 hours. The 32 calibrations were reviewed for consistency of 
PulseCO and LiDCO results. The average variation in CF over 24 hours (7.4 ± 
6.9% (mean ± SD)) and 48 hours (6.5 ± 6.2%) were similar (P = 0.362). Average 
changes in SVR were 24.7 ± 27.4% (range: 0 to 130%); average CO changed by 
21.4 ± 17% (range: 0 to 57%) over 24 hours. There was no correlation between 
the variation in CF and changes in either CO or SVR.
Conclusions It is known that the estimated coeffi   cient of variation of 
a single measurement of LiDCO is 8% [2] and PulseCO is 2.4% [3]. An 
orthogonally combined CV, refl  ecting the eff  ects on CF, is estimated at 
8.5%, or precision of 17%. Ninety-one per cent (29/32 ) of the observed 
CF changes were less than 17% of the initial CF. The PulseCO CF remains 
constant despite changes in SVR of up to 130% and CO of up to 57% over 
periods of 24 to 48 hours.
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Introduction  The validity of an arterial waveform-based device for 
measuring cardiac output (CO) without the need for invasive calibration 
(FloTrac/Vigileo) in patients needing large doses of vasoactive medication 
has not yet been thoroughly studied. We performed the present study 
to assess the validity of both the second-generation and the third-
generation software compared with transpulmonary thermodilution 
CO measurement using the PiCCO technology in patients undergoing 
triple-H-therapy (hypertonia, hypervolemia, hemodilution) of cerebral 
vasospasms after subarachnoidal hemorrhage.
Methods  Twenty-three patients (18 females and fi   ve males) were 
included in this study. All of them were suff  ering from a subarachnoidal 
hemorrhage (Hunt&Hess grade I to V) due to rupture of a cerebral 
aneurysm. Triple-H-therapy was initiated for the treatment of cerebral 
vasospasm. Simultaneous CO measurements by bolus thermodilution and 
the FloTrac/Vigileo device were obtained at baseline as well as 2 hours, 
6 hours, 12 hours, 24 hours, 48 hours and 72 hours after inclusion. A 
percentage error of 30% or less was established as the criterion for method 
interchangeability.
Results  Patients received vasoactive support with 0.53 ± 0.46 μg/kg/
minute norepinephrine, resulting in a mean arterial pressure of 104 ± 
13.6 mmHg and a systemic vascular resistance index of 1,741.17 ± 432.50 
dyn·s/cm5/m2. One hundred and fi  fty-one CO-data pairs were analyzed. 
Transpulmonary thermodilution CO ranged from 5.18 to 14.28 l/minute 
(mean 8.61 ± 1.93 l/minute) and FloTrac/Vigileo CO ranged from 4.1 to 
13.7 l/minute (mean 7.62 ± 1.79 l/minute). Bias and precision (1.96SD of 
the bias) were 0.99 l/minute and 2.46 l/minute, resulting in an overall 
percentage error of 28.55%. Subgroup analysis revealed a percentage error 
of 29.53% for 67 data pairs measured using the second-generation FloTrac 
software and 26.44% for 84 data pairs analyzed by the third-generation 
software.
Conclusions  In patients undergoing triple-H-therapy and needing 
extensive vasoactive support, CO values obtained by arterial waveform 
analysis showed good agreement with intermittent transpulmonary 
thermodilution CO measurements, which was improved by the intro-
duction of a new software generation.
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Introduction  Early manipulation of hemodynamic variables has 
been reported to be able to improve the outcome of patients. Cardiac 
output (CO) was an important parameter to understand the status of 
hemodynamics. Recently, the pulse-contour method is widely used to 
estimate CO, because it is non-invasive and easy to use. However, the 
change in the systemic vascular resistance (SVR) aff  ects CO measured 
by the pulse-contour method. In this study, we evaluated the new non-
invasive cardiac output monitor [1] based on pulse pressure analysis 
combined with pulse-wave transition time (estimated continuous CO; 
esCCO) compared with the conventional thermodilution method under 
a clinical setting.
Methods  Twenty-fi   ve surgical patients who underwent cardiac or 
vascular surgery (ASA physical status 2) were enrolled in this study. 
After anesthesia induction, radial arterial catheter and pulmonary artery 
catheter were inserted. Intermittent cardiac output (ICO) was measured 
by thermodilution method in triplicate and averaged (<5°C saline 10 ml 
in each measurement) using Vigilance (Edwards Life Science, Irvine, CA, 
USA). Echocardiogram, pulse oximetry and arterial blood pressure were 
also monitored and connected to personal computer to calculate esCCO. 
Bland and Altman plots were used to evaluate the percentage diff  erence 
in CO in relation to SVR.
Results One hundred matched sets of data were obtained. The limit of 
agreement (bias ± 2SD of bias) was –2.9 ± 31.9%. Only fi  ve measurements 
were exceeded – 30% against ICO. Each SVR was 1,159, 1,376, 1,418, 2,567, 
3,150 dyn·s/m5.
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reference values, although CO was underestimated by esCCO under 
the relative high SVR. COs estimated by esCCO were acceptable under 
the clinical setting. Therefore, we concluded that esCCO was a useful 
algorithm to estimate CO.
References
1.  J Clin Monit Comput 2004, 19:313-330.
P105
Comparison of cardiac output values; pulse contour methods 
against thermodilution technique
R De Wilde, B Geerts, P Van den Berg, J Jansen
Leiden University Medical Center, Leiden, the Netherlands
Critical Care 2010, 14(Suppl 1):P105 (doi: 10.1186/cc8337)
Introduction We evaluated the performance of the FloTrac/Vigileo system 
(FCO) and simultaneously obtained cardiac output (CO) values with the 
PiCCOplus (PCO), LiDCO™plus (LCO), Vigilance continuous pulmonary 
artery thermodilution (CCO) against the intermittent pulmonary artery 
thermodilution technique (ICO).
Methods  Data were collected during standard postoperative care in 
28 cardiac surgery patients. The cardiac output data were collected at 
1 hour (T1), 2 hours (T2), 4 hours (T3), 8 hours (T4), 12 hours (T5), 24 hours 
(T6), 36 hours (T7), and 48 hours (T8) after ICU admission. The number 
of observations per patient varied between four and eight. Data were 
analyzed with Bland–Altman statistics.
Results Reference cardiac output (ICO) ranged from 2.90 to 8.70 l/minute, 
mean value of 5.12 (SD = 1.02) l/minute. Agreement between methods 
against the reference method are also expressed in a percentage (LOA%); 
that is, at low CO a small error and at high CO a higher error is observed. 
The distribution of errors is diff  erent among the methods (Figure 1). This is 
confi  rmed by Levine’s statistics, which showed signifi  cant (F value = 20.5, 
P <0.001) unequal homogeneity of the variances of the four methods. For 
CCO bias and limits of agreement are 0.31 and –0.99 to 1.61. Bias and limits 
of agreement of FCO, LCO and PCO are 0.59, –1.37 to 2.55; –0.05, –1.99 to 
1.89 and –0.16, –2.60 to 2.28 l/minute, respectively.
Conclusions The performance of pulse contour methods has signifi  cantly 
increased in the past few years, which makes comparisons with older 
publications invalid. The auto-calibrated FloTrac/Vigileo system can 
replace the initially PAC-calibrated LiDCO and PiCCO system.
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Introduction Calibration turns pulse contour methods of cardiac output 
measurement from continuous to intermittent. We evaluated the necessity 
to recalibrate pulse contour cardiac output methods; LiDCO™plus (LCO), 
FloTrac/Vigileo (FCO), PiCCO (PCO) and continuous CO measurement with 
pulmonary artery catheter (Vigilance) (CCO).
Methods In 28 cardiac surgery patients, data were collected at 1 hour 
(T1), 2 hours (T2), 4 hours (T3), 8 hours (T4), 12 hours (T5), 24 hours (T6), 
36 hours (T7), and 48 hours (T8) after ICU admission. Devices were only 
calibrated at start of the investigation period. To compute eff  ect against 
time, at each time point, the CO values from LCO, FCO, PCO and CCO were 
subtracted, and compared with COtd (ICO). Eff  ect of time was quantifi  ed 
by calculating the slope values using linear regression. Slope values of the 
regression line were tested against a horizontal line (no eff  ect).
Results No change with time was found for CCO (slope = 0.02 l/minute/
hour, 95% CI –0.12 to 0.17, P = 0.763) nor for LCO (slope = 0.011 l/minute/
hour, 95% CI –0.11 to 0.03, P = 0.322). Time eff  ect for PCO was (slope = 
–0.017 l/minute/hour, 95% CI –0.032 to –0.001, P = 0.036) and for FCO 
(slope = 0.029 l/minute/hour, 95% CI 0.003 to 0.055, P = 0.027). For the 
LCO system, the data range indicated by the 95% CI crosses the threshold 
value of 10% at 2, 12 and 24 hours, implying more than 2.5% of the data 
points are outside the chosen 10% limits at these time points (Figure 1). 
This occurs with PCO from 1 hour to 24 hours, with FCO at 4, 8, 12 and 24 
hours, and with CCO at 4, 12 and 24 hours.
Conclusions PiCCO and FloTrac/Vigileo showed an eff  ect with time. For 
PiCCO, our fi  ndings are in accordance with the publications of Boyle and 
Hanzaoui.
Figure 1 (abstract P105).
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A comparison in cardiac output data: a random eff  ects model for 
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Introduction A random eff  ects model can be used to estimate the within-
subject variation after accounting for other observed and unobserved 
variations, in which each subject has a diff  erent intercept and slope over the 
observation period. On the basis of the within-subject variance estimated 
by the random eff  ects model, Bland–Altman plots can be created.
Methods In 28 cardiac surgery patients, cardiac output data LiDCO™plus, 
PICCO, FloTrac/Vigileo pulse contour and CCO (PAC-Vigilance) was 
collected at 1 hour (T1), 2 hours (T2), 4 hours (T3), 8 hours (T4), 12 hours 
(T5), 24 hours (T6), 36 hours (T7), and 48 hours (T8) after ICU admission and 
compared against intermitted thermodilution COtd (ICO). Within patient 
variation was calculated using Linear Mixed Models (SPSS). Percentage 
error is calculated as: PE = [(2.SD of CO diff  erence) / (COmean)] x 100%.
Results The results of the random eff  ects model on continuous cardiac 
output data are presented in Figure 1.
Conclusions The variation of the diff  erences of the original measurement 
will be underestimated by this practice because the measurement error is, 
to some extent, removed. The bias between these two methods will not 
be aff  ected by averaging the repeated measurements.
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to assess global end-diastolic volume and extravascular lung water
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Introduction The downslope time (DSt) is part of the equation used 
to derive global end-diastolic volume (GEDV) and extravascular lung 
water (EVLW) from a transpulmonary thermodilution curve. DSt may 
be aff  ected by recirculation phenomena of the cold indicator, as those 
observed in case of valvular regurgitation. Our goal was to validate a new 
transpulmonary thermodilution method that does not depend on DSt.
Methods  Eleven anesthetized and mechanically ventilated pigs (90 to 
110 kg) were instrumented with a central venous catheter and a right 
(PulsioCath; Pulsion, Munich, Germany) and a left (VolumeView; Edwards 
Lifesciences, Irvine, CA, USA) thermodilution femoral arterial catheter. The 
right femoral catheter was connected to a PiCCO2 monitor (Pulsion) and 
used to measure COp (cardiac output), GEDVp and EVLWp using the method 
based on the equation: GEDV = COp x (MTt – DSt). The left femoral catheter 
was connected to the EV1000 monitor (Edwards) and used to measure COe, 
GEDVe and EVLWe using the new method based on the equation: GEDVe = 
f (S2/S1) x COe x MTt, where S1 and S2 are respectively the maximum up-
slopes and down-slopes of the dilution curve. One hundred and thirty-seven 
measurements were done during inotropic stimulation (dobutamine), 
during hypovolemia (bleeding), during hypervolemia (fl  uid overload), and 
after inducing acute lung injury (oleic acid).
Figure 1 (abstract P106). Stability range of ±10% indicated by dashed lines.
Figure 1 (abstract P107). Bland–Altman statistics from CO data: random 
eff  ects model (LMM).
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minute, respectively. COp and COe were closely correlated (r2 = 0.99), 
mean bias (± SD) was 0.18 ± 0.29 and percentage error was 7%. GEDVp 
and GEDVe ranged from 701 to 1,629 and from 774 to 1,645 ml. GEDVp 
and GEDVe were closely correlated (r2 = 0.79), mean bias was –11 ± 78 and 
percentage error was 14%. EVLWp and EVLWe ranged from 507 to 2379 
and from 495 to 2,222 ml. EVLWp and EVLWe were closely correlated (r2 = 
0.97), mean bias was –5 ± 72 and percentage error was 15%.
Conclusions In animals, and over a very wide range of values, the new 
transpulmonary thermodilution method is as reliable as the PiCCO 
method to assess cardiac output, cardiac preload and lung water during 
inotropic stimulation, bleeding, volume loading and lung injury.
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uncalibrated analysis vs once-only calibrated analysis
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Introduction As the need for recalibration and the best time point to 
recalibrate has been a matter of debate since the introduction of the PiCCO 
monitor (Pulsion, Germany), we set out to analyze the performance of its 
pulse contour (PC) analysis without recalibration over a 24-hour period.
Methods We studied the cardiac index (CI) over a 24-hour period in 
eight nonoperative patients admitted to our ICU. Seven CI measurements 
(median number; every 4 hours) by thermodilution (TD) were performed 
in each patient (in triplicate), PC-derived data were recorded continuously. 
We used a special PiCCOplus monitor with a disabled auto-recalibrate 
feature; that is, TD did not lead to an automatic calibration of the PC 
analysis. Calibration was only performed manually once at the start of the 
analysis for each patient. Later TD measurements were recorded but had 
no eff  ect on the CIPC. An additional comparison was performed using 
the FloTrac/Vigileo System (Edwards, USA), which does not need manual 
recalibration and instead recalibrates itself every 60 seconds based on 
the arterial waveform. The FloTrac/Vigileo monitor used was a second-
generation device (software version 1.14). Both the pressure transducers 
of the PiCCO and the FloTrac were connected in series to the same femoral 
artery catheter.
Results A total of 59 TD measurements of CI (CITD) were compared with 
FloTrac CI measurements (CIFloTrac) and PC-derived CI measurements 
(CIPC) from the PiCCO device. CITD ranged from 2.1 to 7.6 l/minute/m2 
(mean 4.3 ± 1.39 l/minute/m2). PC (PiCCO) compared with TD: bias and 
precision (1.96SD of the bias) were 0.18 l/minute/m2 and ±1.35 l/minute/
m2, the percentage error was 30.9%. FloTrac compared with TD: bias and 
precision were –0.75 l/minute/m2 and ±1.79 l/minute/m2, the percentage 
error was 46.2%. The mean absolute value of the diff  erence |CITD – CIPC| 
and |CITD – CIFloTrac| was 0.48 ± 0.49 l/minute/m2 for PiCCO pulse contour 
values and 0.97 ± 0.76 l/minute/m2 for FloTrac/Vigileo values, respectively. 
This higher diff  erence of CIFloTrac from CITD was signifi  cant (P = 0.0002) 
and remained signifi  cant even when only data from the last time point 
(24 hours) was analyzed (P = 0.03).
Conclusions PC-derived CI values obtained over a 24-hour period from 
the PiCCO device after only one manual calibration provide signifi  cantly 
better estimates of CI than measurements by the FloTrac/Vigileo device, 
even after a calibration-free interval of 24 hours.
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clamping: a comparison between Vigileo/FloTrac system and 
transoesophageal Doppler
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Introduction Cardiac output (CO) monitoring is one of the key points in 
the hemodynamic evaluation of critically ill patients, and can be useful in 
various settings of high-risk surgery. There is a lack of evidence that the 
extensive use of invasive devices in the hemodynamic monitoring has a 
good impact in terms of outcome [1], and less invasive systems have been 
proposed. Our aim was to compare the CO estimated by Vigileo/FloTrac 
with the blood fl  ow in thoracic aorta as measured by transoesophageal 
Doppler in patients undergoing open abdominal aortic aneurysm 
repair, during the aortic cross-clamping (AoX) phase. We have measured 
the Augmentation Index (AI), a parameter related to vascular stiff  ness, 
using the applanation tonometry method, in order to have a better 
understanding of the eff  ect of AoX on blood pressure waves.
Methods We enrolled 10 consecutive patients (10 men; age 66 ± 6 years) 
undergoing elective open AAA repair (ASA II to III) under general 
anesthesia. Radial arterial access was used for semi-invasive determination 
of blood pressures and CO (APCO) with the Vigileo. An esophageal 
Doppler was positioned after clinical stabilization. Applanation tonometry 
was measured just before and after the aortic clamping.
Results  We found a signifi   cant (P <0.05) increase in CO reported by 
Vigileo/FloTrac system in the post-clamping phase, when compared 
with the pre-clamping and basal phases, while the blood fl  ow in thoracic 
aorta resulted decreased, according with the theory of redistribution of 
fl  uids in the splanchnic venous vasculature [2]. There was an important 
contribution of the wave refl  ection to the aortic pulse pressure wave after 
the AoX, as expressed by a signifi  cant increase in the AI.
Conclusions The Vigileo/FloTrac system appears to overestimate CO after 
AoX when compared with the measure of blood fl  ow in thoracic aorta, 
and this result could be infl  uenced by the pulse pressure wave refl  ection 
occurring after clamping. In high-risk surgical settings, other situations of 
rapid change of systemic resistance vessels could be similarly misread, 
thus suggesting the necessity of a more tailored Vigileo algorithm.
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Introduction Postoperative hemodynamic optimization has been proved 
to reduce morbidity in high-risk patients [1]. Nowadays stroke volume 
index (SVI) monitoring is available with diff  erent less invasive techniques 
that have shown diff  erent levels of agreement and precision with the 
pulmonary artery catheter [2]. The aim of this study was to evaluate 
agreement and precision between SVI obtained with a calibrated 
(LiDCO™plus; LiDCO Ltd, Cambridge, UK) and an uncalibrated pulse 
contour analysis device (FloTrac/Vigileo; Edwards Lifesciences, Irvine, CA, 
USA), in patients undergoing postoperative hemodynamic optimization.
Methods Patients undergoing a hemodynamic optimization protocolized 
care according to a previous published trial [1] to reach an oxygen delivery 
Figure 1 (abstract P111). Bland and Altman analysis.
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calibration of the LiDCO™plus, SVI data obtained from LiDCO™plus, and 
FloTrac/Vigileo (version 1.07) were recorded every 15 minutes for 6 hours. 
Agreement and precision between SVI obtained with LiDCO (SVILI) and 
SVI obtained with Vigileo (SVIFT) were evaluated with Bland and Altman 
analysis.
Results  Thirteen patients (nine males, four females), mean age 68.5 
(± 28.3) years were enrolled into the study. Two hundred and seventy SVI 
data pairs were analyzed. Bias was 1.79 ml/m2, with a precision (1.96SD of 
the bias) of 25.1 ml/m2 (Figure 1).
Conclusions  SVI obtained from the uncalibrated low-invasive, pulse 
contour analysis technique seems as accurate as the calibrated technique 
in a clinical hemodynamic protocolized setting to increase oxygen delivery 
in postoperative high-risk patients.
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Introduction  Continuous noninvasive cardiac output (CO) provides 
valuable information for patient management. Non-invasive cardiac 
output monitoring (NICOM) measures CO based on chest bioreactance 
and is validated in adults [1]. Validated data in children are lacking. Our 
objective was to evaluate NICOM in children with pulmonary artery 
catheter thermodilution (PAC) as reference.
Methods Paired CO values using NICOM and TD were recorded during 
cardiac catheterization in children with congenital heart disease. Children 
with intracardiac or extracardiac shunts were excluded. PAC was inserted 
through the femoral vein and CO was measured after bolus injection 
of 5 ml iced saline. NICOM was connected in accordance with the 
manufacturers’ directrix.
Results  Nineteen pairs of CO measurements were collected in nine 
patients. Mean age was 4.6 years (range: 0 to 12 years) and mean weight 
16.8 kg (range: 4.8 to 34 kg). Cardiac diagnosis was dilated cardiomyopathy 
or interventional procedures. Mean CO values were 2.18 l/minute (PAC) 
and 1.88 l/minute (NICOM). Correlation between two methods was 
signifi  cant (r = 0.826; P = 0.0005). Bland–Altman analysis shows a mean 
diff  erence between the reference method and NICOM of +0.33 l/minute. 
Ninety-fi  ve percent of measurements were inside the limits of agreement 
(±1.96SD) but these limits were broad (–1.24 to 1.96 l/minute) (Figure 1).
Conclusions CO measurements with NICOM and PAC show a signifi  cant 
correlation. Bland–Altman demonstrates an acceptable agreement; 
however, the limits of agreement are broad. Depending on the CO range, 
NICOM reveals a trend to systematically overestimate or underestimate 
CO. Additional studies in larger and more heterogeneous pediatric patient 
populations are warranted for further validation.
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Introduction  Volume responsiveness cannot be predicted by the 
respiratory variation in arterial pressure in hemodynamically unstable 
patients with spontaneous breathing activity. The NICOM device (Reliant®; 
Cheetah) (bioreactance technique) is a totally non-invasive hemodynamic 
monitoring technique for the measurement of stroke volume. Our 
objective was to test whether volume responsiveness could be predicted 
by the response of stroke volume measured by the NCOM device to 
passive leg raising (PLR) in patients with spontaneous breathing activity.
Methods Prospective study in the respiratory critical care of a university 
hospital. Eleven patients with spontaneously breathing activity considered 
for volume expansion. An increase in stroke volume index (SVi) of 15% or 
more after volume expansion defi  ned a responder patient. We measured 
the response of the bioreactance stroke volume to PLR and to saline 
infusion (500 ml over 15 minutes).
Results The proportional changes in NiCOM-SVi induced by PLR were 
correlated with the proportional changes in NICOM-SVi induced by 
volume expansion (r = 0.67, P = 0.02). The proportional changes in 
NICOM-cardiac index (CI) induced by PLR were also correlated with the 
proportional changes in NICOM-CI induced by volume expansion (r = 0.63, 
P = 0.03). A PLR-induced increase in stroke volume of 9% or more predicted 
an increase in stroke volume of 15% or more after volume expansion with 
a sensitivity of 100% and a specifi  city of 80%.
Conclusions The response of NICOM-stroke volume to PLR was a good 
predictor of volume responsiveness. In our hemodynamically unstable 
patients with spontaneous breathing activity, fl  uid responsiveness can be 
assessed totally non-invasively with a bioreactance device.
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Introduction Transpulmonary thermodilution (TPTD)-derived volumetric 
parameters such as global end-diastolic volume (GEDI) and ELWI have 
been established as hemodynamic cornerstones for assessment of 
preload (GEDI) and pulmonary hydration. Normal values of GEDI have 
been created more than a decade ago based on studies in pre-selected 
patients. Therefore, it was the aim of our prospective study to investigate 
the correlation of GEDI to cardiac index (CI) in clinical routine.
Methods Over a 6-month period all 1,574 routine TPTD measurements 
in 78 consecutive patients (APACHE II: 23.5 ± 8.6) of an internal ICU with a 
PiCCO catheter were prospectively documented and analysed: correlation 
(Spearman) and multiple regression analysis; SPSS 17.0.
Results Including all 1,574 measurements, CI was univariately correlated 
to GEDI (r = 0.251; P <0.001), dPmax (r = 0.221; P <0.001) and heart rate (r = 
0.102; P <0.001), but not to CVP (r = 0.001; P = 0.962). The correlation of GEDI, 
dPmax and heart rate to CI was confi  rmed in multivariate analysis (P <0.001 
for all three variables). Changes in CI (Delta-CI) were univariately correlated 
to changes in GEDI (r = 0.414), dPmax (r = 0.240) and ELWI (r = 0.152; P <0.001 
for all comparisons). In a multivariate analysis of all measurements, Delta-
CI was independently associated with changes in GEDI (P <0.001), dPmax 
(P <0.001) and CVP (P = 0.017). Subgroup analysis of all measurements 
Figure 1 (abstract P112). Bland–Altman analysis.
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independent association of CI to GEDI (P <0.001), dPmax (P <0.001) and ELWI 
(P = 0.041) but not to CVP. Similarly, Delta-CI was independently associated 
with changes in GEDI and dPmax (P <0.001). Similar results were found for 
the measurements with GEDI within the normal range (680 to 800 ml/kg/
m2): signifi  cant and independent correlation of CI to GEDI (P <0.017) and 
dPmax (P <0.001). Changes in CI were independently correlated to changes 
in GEDI (P <0.001), dPmax (P <0.001) and CVP (P = 0.035). Interestingly, 
even in measurements with GEDI >800 ml/kg/m2, CI was independently 
correlated to GEDI (P = 0.009) and dPmax (P <0.001). Changes in CI in this 
group were independently associated with changes in dPmax and GEDI 
(P <0.001).In the subgroup of measurements with GEDI >1,000 ml/kg/m2 
there was no correlation of any parameter to CI, however changes in CI 
were independently correlated to changes in GEDI (P <0.001) and dPmax 
(P = 0.003).
Conclusions GEDI and dPmax and their changes have an independent and 
positive correlation to CI and its changes even in patients with increased 
GEDI.
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Introduction  Monitoring intravascular volume in patients with intra-
cranial pathology is often mandatory for maintaining hemodynamic 
stability [1,2]. Cyclic changes in cardiac stroke volume [1,3] and pulse 
pressure induced by positive pressure ventilation as well as target values 
of global end-diastolic volume index (GEDVI) (ml/m2) [2] allow volume 
therapy guidance. The relationship between stroke volume variation (SVV) 
(%) and pulse pressure variation (PPV) (%), as well as between SVV or PPV 
and values of GEDVI has not been established in patients with intracranial 
pathology.
Methods  In this prospective investigation the correlation between 
dynamic and static hemodynamic parameters of 38 patients undergoing 
brain surgery was studied. Measurements were performed using the 
PiCCO technology. For statistical analysis, nonparametric correlation 
analysis and hypothesis testing were applied.
Results SVV correlated signifi  cantly with PPV (r2 = 0.87, P <0.001). Neither 
SVV (r2 = 0.14, P = 0.13) nor PPV (r2 = 0.07, P = 0.81) correlated with GEDVI. 
Threshold values for SVV (9.5%, 11.6%) as well as for PPV (12.5%) allowed 
discrimination between groups with signifi   cantly diff   erent values of 
stroke volume index, while failing to discriminate between groups with 
signifi  cantly diff  erent values of GEDVI. Dichotomizing the patients into 
groups of GEDVI ≤680 ml/m2 and >680 ml/m2 resulted in groups with 
signifi  cantly diff  erent values of stroke volume index as well while failing 
to discriminate between groups with signifi  cantly diff  erent values of SVV 
and PPV.
Conclusions Static (GEDVI) and dynamic (SVV, PPV) parameters of cardiac 
preload may refl  ect diff  erent properties of the cardiovascular system. The 
combination of SVV, PPV, and GEDVI may off  er more precise information 
on the cardiovascular system than either parameter alone.
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Introduction The prediction value of pulse pressure variation (ΔPP) in 
patients ventilated with low VT is not well studied. A ΔPP of 12 to 13% 
is validated as a predictor of volume response in several studies, but in 
patients ventilated with VT >8 ml/kg. One study has shown that the ΔPP 
of 12 to 13% does not predict volume response in patients ventilated with 
a low VT. We hypothesized that a lower cut-off   value for ΔPP can predict 
volume response in patients with low VT.
Methods Thirty-seven adult patients mechanically ventilated with a tidal 
volume <8 ml/kg (PBW), without cardiac arrhythmias, with a pulmonary 
artery catheter and a peripheral arterial catheter were included. An 
increase in cardiac index (thermodilution)) >15% output after a fl   uid 
challenge (Crystalloid 1,000 ml or Colloid 500 ml) was considered a 
positive response.
Results Seventeen patients were responders. The ROC curve showed that 
the best cut-off   value for ΔPP was 10% (ROC area = 0.74, 95% CI: 0.51 to 0.9; 
sensitivity 53%, specifi  city 95%, positive likelihood ratio 9.4 and negative 
0.34).Twelve patients consisted of a heterogeneous group of patients 
(liver transplant, acute pancreatitis, aortic surgery). Among 25 septic 
shock patients, a ΔPP >10% showed a ROC area of 0.84 (sensitivity 78%, 
specifi  city 93%). In any case, the greater ΔPP, the greater the fl  uid response. 
ΔPP >10% was a better predictor than CVP or PAOP.
Conclusions ΔPP has a limited value in patients ventilated with low VT. 
However, a ΔPP >10% may help identify septic shock patients that will 
respond to a fl  uid challenge.
References
1. Vincent  JL,  et al.: Pulse pressure variations to predict fl  uid responsiveness: 
Infl  uence of tidal volume. Intensive Care Med 2005, 31:517-523.
P117
Pre-ejection period is a reliable parameter to estimate cardiac 
preload in a hemorrhagic shock
R Giraud, N Siegenthaler, JA Romand, K Bendjelid
Hôpitaux Universitaires de Genève, Switzerland
Critical Care 2010, 14(Suppl 1):P117 (doi: 10.1186/cc8349)
Introduction  We have already demonstrated that in mechanically 
ventilated patients, the respiratory change in the pre-ejection period 
(ΔPEP) is a reliable dynamic index for the prediction of increase in cardiac 
output after volume infusion [1]. However, in an animal study, Kubitz and 
colleagues showed that the pre-ejection period is not sensitive to the 
changes in intravascular volume status [2].
Methods This study investigated the infl  uence of changes in intravascular 
volume status on ΔPEP. In 17 pigs, ECG, arterial pressure and cardiac output 
derived from a Swan–Ganz catheter were recorded. Measurements were 
performed during normovolaemic conditions, after haemorrhage (25 ml/
kg) and following re-transfusion (25 ml/kg) with constant tidal volume 
(10 ml/kg) and respiration rate (15/minute).
Figure 1 (abstract P117). Box plot representing pulse pressure variations 
(PPV) (%) and pre-ejection period variations (ΔPEP) (%) at the three times 
of the protocol. §P <0.05, †P <0.05.
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were both <12%. PPV signifi  cantly correlated with ΔPEP (r = 0.96, P <0.001). 
Volume loss induced by haemorrhage increased PPV and ΔPEP. Moreover, 
during this state, PPV correlated with ΔPEP with a signifi  cant correlation 
coeffi   cient (r = 0.88, P <0.001). Retransfusion signifi  cantly decreased PPV 
and ΔPEP and PPV signifi  cantly correlated with ΔPEP (r = 0.94, P <0.001) 
(Figure 1).
Conclusions Available correlations between PPV and ΔPEP at each time 
of the study were observed, meaning that ΔPEP is a reliable parameter to 
estimate the changes in intravascular volume status.
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Introduction After the early phase of sepsis, excessive fl  uid administration 
may worsen pulmonary edema and prolong mechanical ventilation [1]. 
Accurately predicting fl   uid responsiveness obviates unnecessary fl   uid 
loading, and helps to detect patients who may benefi  t from a volume 
expansion. Pulse pressure variation (DPP) is a reliable predictor of fl  uid 
responsiveness in mechanically ventilated patients only when tidal volume 
is at least 8 ml/kg [2]. The aim of this study was to evaluate the predictive 
value of DPP for fl  uid responsiveness after a maneuver to change tidal 
volume to 8 ml/kg in patients ventilated with 6 ml/kg.
Methods Prospective clinical study in 40 patients ventilated with 6 ml/kg 
after resuscitation phase of severe sepsis and septic shock. Fluid challenge 
was indicated by the attending physician (7 ml/kg of 6% hydroxyethyl 
starch 130/0.4). Complete hemodynamic measurements including DPP 
(DPP 6 ml/kg) were obtained at baseline. The tidal volume was then 
changed to 8 ml/kg and the DPP (DPP 8 ml/kg) was measured after 
5 minutes. The ventilatory settings were returned to 6 ml/kg before fl  uid 
challenge. Patients whose cardiac output (CO) increased by ≥15% were 
considered to be fl  uid responders. Receiver operating characteristic (ROC) 
curve analysis was used to evaluate the predictive value of DPP.
Results In 19 patients (responders), CO increased by >15% after fl  uid 
infusion. Fluid responsiveness was better predicted with DPP 6 ml/kg (ROC 
curve area 0.92 ± 0.05) than with pulmonary artery occluded pressure 
(0.56 ± 0.09) and right atrial pressures (0.74 ± 0.08). Increasing tidal volume 
to 8 ml/kg did not improved prediction as the ROC curve area with DPP 
8 ml/kg was 0.94 ± 0.03. The best cut-off   values defi  ned by the ROC curve 
analysis was 6.5% and 10.5% for DPP 6 ml/kg and DPP 8 ml/kg, respectively.
Conclusions  The maneuver to change tidal volume to 8 ml/kg in 
patients ventilated with protective ventilatory strategy to better predict 
fl  uid responsiveness is not useful. Fluid responsiveness can be correctly 
predicted in patients ventilated with tidal volume of 6 ml/kg.
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Introduction Major head and neck surgery involving reconstructive free 
fl  aps for oropharyngeal cancers are complex and prolonged operations 
during which appropriate fl   uid management can become diffi   cult. 
Potential adverse eff  ects of fl  uid mismanagement in this group of patients 
include fl   ap hypoperfusion related to hypovolaemia or fl   ap oedema 
and deterioration in alveolar–arterial gradients related to excessive 
fl  uid administration. This study looked at ongoing standard practice, to 
determine whether the use of a cardiac output monitor could improve 
fl  uid management in this subset of patients.
Methods  Single-blinded, prospective observational study conducted 
on consecutive adult patients undergoing major head and neck 
reconstructive free fl  ap surgery. All patients were anaesthetised by the 
same individual, using a standardised technique. Volume-controlled 
positive pressure ventilation was initiated in all patients. Patients received 
maintenance crystalloid fl   uids at a rate of 5 ml/kg/hour. Additional 
fl  uid challenges (250 ml crystalloid boluses given over 5 minutes) were 
administered at the discretion of the anaesthetist. A priori criterion of fl  uid 
responsiveness was defi  ned as an increase in stroke volume (SV) >10% 
as measured with the LiDCOrapid after a fl  uid challenge. The anaesthetist 
was blinded to the LiDCOrapid data and observations were made by an 
independent investigator. Data were collected on: heart rate (HR), mean 
arterial pressure (mAP) and central venous pressure (CVP).
Results Forty-seven fl  uid boluses were assessed. The median age of the 
patients was 72 years (range 68 to 81 years) and their median weight was 
71.2 kg (range 63 to 88 kg). The ventilatory set-up used a median tidal 
volume of 7 ml/kg (range 450 to 600 ml). Fifteen out of 47 (32%) of the 
fl  uid challenges were positive when assessed against the change in stroke 
volume. When comparing the fl  uid responders with the nonresponders, 
there were no diff  erences in HR (62 ± 10 bpm vs 62 ± 10 bpm), mAP (63 ± 
6 mmHg vs 63 ± 7 mmHg) or CVP (8 ± 3 mmHg vs 10 ± 3 mmHg).
Conclusions  This preliminary report suggests that only 32% of fl   uid 
challenges given in theatre were eff  ective in increasing the SV >10% and 
potentially two-thirds of the fl  uid challenges may have been detrimental. 
This can be seen only if SV is monitored continuously. If further data 
confi  rm this, LiDCOrapid may be useful to guide fl  uid administration in 
order to optimise the SV, thereby minimizing the risk of fl  uid overload.
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Introduction  Patients undergoing elective abdominal aortic surgery 
(EAAS) are at risk of developing complications due to preoperative 
co-morbidity, surgical trauma, blood loss and infl   ammatory injury [1]. 
Individualized goal-directed therapy (IGDT) has been proposed to 
improve outcome in patients undergoing high-risk surgery [2]. The aim of 
this study was to investigate whether IGDT, targeting stroke volume (SV) 
and oxygen delivery (DO2), can be performed safely in EAAS.
Methods  Sixty-three EAAS patients were randomized to IGDT or 
conventional therapy. The LiDCO™plus system was used for SV and DO2 
monitoring. SV was optimized by 250 ml fl  uid challenges intraoperatively and 
the fi  rst 6 hours postoperatively. DO2 was optimized 6 hours postoperatively 
targeting a DO2I level of 600 ml/min/m2, by infusion of dobutamine, if 
necessary. Hemodynamic data were collected at baseline (t0) preoperatively 
(t1), before aortic cross-clamping (t2), at the end of surgery (t3), and the fi  rst 
6 hours postoperatively (p1 to p6). All patients were monitored with fi  ve-
lead ECG during dobutamine infusion and dosage was reduced at signs 
of ischemia or heart rate >20% above baseline. Dobutamine dosage was 
limited to a maximum of 10 μg/kg/minute.
Results The mean SVI level was 19.4% higher at p4 to p6 in the IGDT group 
compared with the control group (P = 0.02), and 12.1% higher in the entire 
intervention period (t1 to p6) (P = 0.07). The mean DO2I was 18.0% higher 
at p4 to p6 (P = 0.01) and 12.9% higher in the entire intervention period (t1 
to p6) in the IGDT group (P = 0.03). Mean arterial pressure and heart rate 
did not diff  er signifi  cantly (P = 0.12 and P = 0.21). There was no diff  erence in 
the frequency of postoperative cardiac complications between the groups.
Conclusions The results of this study demonstrate that IGDT targeting SV 
and DO2 can be performed safely in patients undergoing EAAS. Whether 
this intervention is benefi  cial is being evaluated in the current study.
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Introduction  Studies have suggested that tissue oxygenation (StO2) 
measured on the thenar muscle is not sensitive to track acute changes 
in hemodynamics due to reductions in central blood volume. We aimed 
to investigate the feasibility of StO2 measurements in the mouth as a 
quantitative indicator comparable with StO2 measurements obtained 
from the thenar eminence during changes in central blood volume (CBV).
Methods We performed a head-up tilt (HUT) test in 10 healthy volunteers 
as an experimental model to reduce CBV. StO2 was continuously measured 
using two devices (InSpectra model 650): a multiple depth optical probe 
was placed over the thenar eminence (15 and 25 mm) and a 1-mm probe 
was placed in the mouth. Subjects were placed on an electrically driven 
tilt table with a footboard. After 5 minute baseline measurements in the 
supine position, the table was tilted up to 70° and returned to the supine 
position after 10 minutes. StO2 readings were analyzed at the lowest stroke 
volume value.
Results All subjects (mean age: 23 ± 6; six males) tolerated well the supine 
and head-up positions. Cardiac output signifi  cantly decreased in the HUT 
position; simultaneous decrease in StO2 was observed in the mouth, but 
not in the thenar. The general results of the HUT test are shown in Tables 
1 and 2.
Table 1 (abstract P121). Hemodynamics in the baseline and in the head-up 
tilt (HUT)
 Baseline  HUT
HR 69  85*
MAP 91 93
CO 5.6  4.9*
*P <0.05 vs baseline.
Table 2 (abstract P121). StO2 in the baseline and in the head-up tilt (HUT)
Baseline HUT  Baseline  2  StO2 15 thenar
76 ± 6  75 ± 6  78 ± 7  StO2 25 thenar
76 ± 5  75 ± 6  78 ± 8  StO2 buccal
88 ± 3  78 ± 3*  87 ± 3 
*P <0.05 vs baseline 1 and 2.
Conclusions Near-infrared spectroscopy can be used in the mouth to 
track changes in central blood volume. Our results showed that buccal 
StO2 is an earlier indicator of acute hemodynamic responses to the HUT-
induced central hypovolemia than thenar StO2.
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Introduction The aim of the study was to assess the ability of respiratory 
variations in pulse oximetry plethysmographic waveform amplitude 
(ΔPOP) to predict the increase of cardiac output (CO) after fl  uid infusion 
(fl  uid responsiveness).
Methods Two authors independently performed a search iterated until 
November 2009 in MEDLINE, Embase and Cochrane Database using 
keywords: ‘fl   uid OR preload OR volume responsiveness’, ‘cardiovascular 
monitoring’, ‘fl  uid challenge’, ‘functional hemodynamic monitoring’, ‘dynamic 
indices OR indexes’, ‘delta POP’, ‘pleth index’, ‘plethysmographic waveform’. 
Predictive value of ΔPOP was estimated by: diff  erence in mean value of 
ΔPOP between responders and nonresponders; correlation coeffi   cient 
between pre-infusion ΔPOP and CO increase after fl  uids; and sensitivity, 
specifi  city and area under the ROC curve (AUC) for ΔPOP to predict a 
responder state. A meta-analysis was performed using Comprehensive 
Meta-Analysis v. 2.2. Pooled values of diagnostic odds ratio (DOR), sensitivity, 
specifi  city and summary ROC (SROC) curve were calculated using MetaDiSC 
v. 1.4. Heterogeneity was evaluated with Q and I2 tests.
Results From the initial dataset of 839 records we identifi  ed six articles 
[1-6] on 135 patients to whom 195 fl  uid boluses were administered. All 
patients were in sinus rhythm and adapted to a ventilator. An increase 
of cardiac index or stroke volume index >10 to 15% defi  ned responders. 
Mean responder rate was 58.9%. Pooled diff  erence in mean was 10% (95% 
CI 5.8 to 14.2), correlation coeffi   cient 0.59 (0.41 to 0.73), AUC 0.85 (0.76 to 
0.94), sensitivity 81.1% (72.5 to 87.9), specifi  city 78.6% (68.3 to 86.8), DOR 
21.7 (6.3 to 74.4), area under SROC 0.88 (0.80 to 0.96). The best threshold 
value for identifi  cation of responders was 9.5 to 15%. Heterogeneity was 
signifi  cant for all evaluations.
Conclusions ΔPOP is a non-invasive dynamic parameter able to predict 
fl  uid responsiveness with only a moderate level of accuracy. The main 
limitation of this analysis is heterogeneity between included studies.
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Introduction Hemodynamic optimisation based on fl  ow variables allows 
an early detection and correction of possible occult organ hypoperfusion 
in patients undergoing major surgery. Shoemaker described a markedly 
decreased cardiac index (CI) in nonsurvivors, which remained signifi  cantly 
below the values compared with survivors during the surgery. The aim of 
this study was to evaluate the length of ICU stay, overall in-hospital stay 
and the postoperative outcome in a group of patients undergoing major 
urological surgery, while the CI is maintained within the normal range 
during intraoperative period.
Methods  Patients were randomised into groups the day before surgery – 
conventional management group (decision about fl   uid therapy and 
vasoactive support was based on internal guidelines to preserve normal 
macrohemodynamic variables), and protocol group. Each patient in the 
protocol group received an oesophageal Doppler probe (TED) (Hemosonic 
100; Arrow International, USA) after the start of general anaesthesia and 
then hemodynamic optimisation (fl   uid management and vasoactive 
drugs), according to TED variables, was performed to keep CI between 2.6 
and 3.8 l/minute/m2.
Results We enrolled 230 patients. The control group: n = 115 and the 
protocol group: n = 115. High-risk criteria surgery was fulfi  lled in 43% 
patients in protocol group and 45% in control group. There were no 
signifi  cant diff  erences in baseline variables between both groups (age, 
gender, length of surgical procedure, estimated blood loss and also in 
intraoperative values of MAP and CVP). In the protocol group was observed 
a high frequency of CI <2.6 l/minute/m2 after induction of anesthesia 75% 
with fast recovery of CI. The volume of fl  uids (Ringer’s solution and HES 
6% 130/0.4) administered during surgery was lower in the control group 
(medians: 2,800 ml vs 3,800 ml, P <0.05). Amount of used blood units (RBC 
71 vs 133, P = 0.001; FFP 71 vs 142, P <0.001) was higher in control group. 
Signifi  cant diff  erences have also been found in the use of vasoactive 
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stay and overall in-hospital stay (medians: 2 vs 3 days, P = 0.041, and 9 vs 
11 days, P = 0.014), in-hospital mortality (2.6% vs 10.4%, P = 0.029) were in 
favour of the protocol group of patients.
Conclusions Hemodynamic optimisation guided by TED can improve 
postoperative outcome in patients after major urological surgery. 
Maintain  ing normal values of CI is an applicable target of intraoperative 
therapeutic intervention.
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Introduction  Fluid therapy in ICU patients serves to maintain tissue 
perfusion and is directed at increasing cardiac stroke volume (SV) through 
an increase in preload: fl  uid responsiveness. Although there is increasing 
evidence that the regional blood fl  ow cannot be predicted from global 
hemodynamic measurements, the relation between SV and parameters 
of peripheral perfusion is not clear. The aim of our study was to evaluate 
the eff  ect of an increase in preload on commonly used parameters of 
peripheral perfusion.
Methods Hemodynamically unstable patients with clinically suspected fl  uid 
responsiveness underwent a passive leg raising (PLR) test, which consisted 
of 5 minutes of rest in a semirecumbent position of 30°, followed by 5 
minutes PLR (lower limbs elevated at 30° and trunk in supine position). SV 
was measured continuously by pulse contour analysis using PiCCO (Pulsion). 
Peripheral perfusion was measured continuously with sidestream dark fi  eld 
imaging (sublingual area) and laser Doppler fl  owmetry (LDF) (fi  nger).
Results Sixteen patients (age: 63 years (55 to 72), APACHE II: 25 (20 to 28), 
SOFA: 10 (7 to 13)) were included in our study. Of these 16 patients, six (38%) 
increased their SV by >10% in response to a PLR. Flow indices (LDF and 
sublinguale microcirculatory fl  ow) did not change. However, there was a trend 
in increase of the functional capillary density in the responders (see Figure 1).
Conclusions These data suggest that increasing SV in hemodynamically 
unstable patients might improve peripheral perfusion, however only in 
the sublingual area and not in all patients. There was no relation between 
systemic circulation and peripheral perfusion: it remains to be investigated 
whether optimizing SV actually results in improved tissue perfusion.
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Introduction We evaluated the distensibility index of the inferior vena 
cava (dIVC%) in ventilated septic and trauma patients with shock before 
and after fl  uid therapy. There are no data on this index in patients in shock 
post trauma.
Methods  This is a prospective study conducted in two ICUs between 
September 2008 and May 2009. Inclusion criteria were: shock (systolic 
arterial pressure below 90 mmHg and/or perfusion of vasopressor amines) 
related to severe sepsis or to trauma. The inferior vena cava diameter at 
end-expiration (IVCDmax) and at end-inspiration (IVCDmin) was measured by 
echocardiography using a subcostal approach. The distensibility index of 
the IVC was the ratio of IVCDmax – IVCDmin / IVCDmin expressed as a percentage 
(dIVC%). Cardiac index (CI) was calculated by analysis of the arterial pressure 
wave (FloTrac/Vigileo; Edwards). Measurements were performed at baseline 
and after a volume expansion using 7 ml/kg colloid and 20 ml/kg crystalloid 
for septic and trauma patients, respectively. Patients were separated into 
responders (increase in CI ≥15%) and nonresponders (NR) after fl  uid therapy. 
The Wilcoxon and Mann–Whitney tests were used to compare paired values. 
Statistical signifi  cance was tested at an α level of 0.05.
Results Eleven patients in shock (fi  ve septic, six trauma; six responder, fi  ve 
NR) were included. The median age was 62 years (range 28 to 78 years) and 
mean SAPS II score was 52 ± 30 SD. There were no signifi  cant diff  erences 
between responders (R) and NR regarding age, gender, and risk scores. 
Among all patients, at baseline, median CI and dIVC% were 2.6 l/minute/
m2 and 29%, respectively. Volume expansion signifi  cantly increased the 
median CI from 2.6 (2 to 3.3) to 3 (2.1 to 4) l/minute/m2 (P = 0.005) and 
decreased dIVC% from 29.4% to 12.6% (P = 0.003). The median dIVC% in R 
was higher than NR: 31.3% vs 17% (P <0.05). Fluid therapy decreased more 
dIVC% in R than in NR: R 31% to 12% (P = 0.03), NR 17% to 12% (P = 0.04). 
The dIVC% showed similar trend in both groups of septic shock (SS) and 
trauma shock (TS) patients before and after fl  uid therapy: dIVC% 27% in SS 
and 24% in TS before fl  uid therapy; 15% in SS and 11% in TS after therapy.
Conclusions Our data suggest that dIVC% is a sensitive index of fl  uid 
responsive  ness in septic and trauma patients in shock. Limitations: few 
patients.
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Introduction Myocardial depression occurs in 40% of patients presenting 
with sepsis. In critically ill patients, the peak fi  rst derivative of aortic pressure 
(Ao_dP/dtmax) derived from a fl  uid-fi  lled catheter has been commonly used 
by clinicians for decades to assess directional change in left ventricular (LV) 
contractility. However, this parameter remains questionable because of its 
preload sensitivity. The aim of this study was to test whether Ao_dP/dtmax 
represents an accurate method for assessing LV contractility when preload 
independence, based on dynamic indices, is achieved.
Methods  LV pressure–volume data obtained with a conductance 
catheter and invasive aortic pressure obtained with a fl  uid-fi  lled catheter 
were continuously recorded in six anaesthetized and mechanically 
Figure 1 (abstract P124). Functional capillary density. Dotted line, median.
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induce septic shock. Fluid administration was continuously controlled by 
preload responsiveness by holding pulse pressure variation (PPV) <13%. 
Catecholamines were transiently administrated during shock. Ao_dP/dtmax 
was compared with end-systolic elastance (Ees), the gold standard method 
for assessing LV contractility.
Results Endotoxin-induced septic shock and catecholamine infusion lead 
to signifi  cant variations in LV contractility. The best correlation (r2 = 0.76) 
and agreement between Ao_dP/dTmax and Ees were obtained when PPV 
<11% (Figure 1).
Conclusions Ao_dP/dTmax is a minimally invasive and accurate method for 
assessing LV contractility when eff  ective preload independence, defi  ned 
as PPV <11%, is achieved.
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Introduction The pressure recording analytical method (PRAM) is the 
only pulse contour method that does not need any calibration since it 
estimates in vivo, beat to beat, the impedance of the cardiovascular system 
[1-3]. Cardiac cycle effi   ciency (CCE) is a novel parameter that is directly 
related to the cardiovascular impedance. Since the aortic valve contributes 
to impedance, we hypothesized during an aortic valvuloplasty, performed 
for severe aortic stenosis, the cardiovascular impedance may decrease by 
the reduction of the transvalvular gradient.
Methods In a cath lab, fi  ve consecutive patients undergoing aortic valve 
plasty for severe aortic stenosis were monitored by means of PRAM during 
the procedure. Systolic (SAP), diastolic, and mean (MAP) arterial pressures, 
stroke volume (SV), heart rate (HR), cardiac output (SV x HR), CCE, and dP/
dtmax were continuously collected and afterwards analyzed. The stroke work 
(SW = SV x MAP) and minute work (MW = SBP x CO) were also measured.
Results  After the ballooning maneuver (valvuloplasty), the maximal 
gradient measured with intraventricular and intraaortic catheters 
signifi   cantly decreased (146 (37) vs 43 (12) mmHg; P  <0.0001). The 
CCE signifi  cantly improved from –0.72 (0.4) to 0.02 (0.19) U; P <0.0001. 
Peripheral dP/dtmax increased from 0.8 (0.27) to 1.16 (0.23) mmHg/ms; P = 
0.001, while SW and MW did not show substantial modifi  cations (4.06 
(1.03) vs 4.02 (1.4) l x mmHg; NS, and 549.8 (111.5) vs 544.6 (153.4) l x 
mmHg; NS, respectively).
Conclusions  CCE demonstrated to be a very sensitive estimation of 
cardiovascular impedance since it shows a signifi  cant improvement after 
the valvuloplasty in spite of unchanged values of both SW and MW. In 
other words, the energy expenditure of the whole cardiovascular system 
signifi  cantly reduced after the aortic valve stenosis is corrected. Moreover, 
our data strongly suggest that peripheral dP/dtmax is deeply aff  ected by 
aortic valve stenosis.
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Introduction Nonocclusive mesenteric ischemia (NOMI) following cardiac 
surgery carries a high mortality. This disease is diffi   cult to diagnose. Early 
diagnosis is thought to be of paramount importance as the only chance of 
improving the survival rate in these patients. Therefore, we were retrospectively 
studied all cases of NOMI to evaluate what were the sensitive markers and 
what were the risk factors contributing to the occurrence of NOMI.
Methods We retrospectively reviewed 279 patients undergoing cardio-
thoracic surgery from August 2007 to July 2008. Six of these patients 
(2.2%) developed NOMI postoperatively and the data for them were 
retrospectively evaluated in detail.
Results In all cases of NOMI, they were diagnosed at laparotomy. The mean 
age was 69.7 years (50 to 83 years old), and the male:female ratio was 1:1. 
One patient received off  -pump coronary artery bypass surgery, and fi  ve 
underwent thoracic aortic surgery. Hemodialysis was initiated in one of 
six patients before operation, while the continuous hemodiafi   ltration 
was initiated in all patients postoperatively. After operation, high-dose 
catecholamines were necessary in fi  ve of six patients for long periods 
because of severe hypotension. In four of six patients, abdominal pain 
was the presenting symptom. The rest of two patients had a nonspecifi  c 
presentation because they were ventilated and sedated. All patients 
presented abdominal distension and their abdominal X-rays showed 
paralytic ileus features. The serum values of AST, LDH, CK, and lactate 
were slightly elevated in most patients. Five of six patients died from 
septic shock and multiple organ failures, and the mortality rate of patients 
with NOMI was 83%. Potential risk factors contributing to the occurrence 
of NOMI and sensitive markers might be the following: continuous 
hemodiafi   ltration (6/6); hypotension (5/6); high-dose catecholamines 
(5/6); dehydration (6/6); abdominal pain (4/6); paralytic ileus patterns of 
abdominal X-rays (6/6).
Conclusions The increase of NOMI incidence following cardiothoracic 
surgery might be related to continuous hemodiafi  ltration, hypotension, 
dehydration, and uses of high-dose catecholamines. Identifi   cation of 
patients at NOMI risk and prevention of hypovolemic hypotension and use 
of vasodilator may help to reduce the incidence of NOMI.
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Introduction Congestive heart failure (CHF) is a growing public health 
problem in China, mainly because of aging of the population and the 
Figure 1 (abstract P126). Correlation between Ees and Ao_dP/dtmax when 
PPV <11%. Incidence of ICR-BSI in WCNN intensive therapy unit.
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to investigate the major causes, comorbidities and in-hospital mortality of 
patients with CHF.
Methods A retrospective study was performed in 6,960 patients (4,352 
males, 2,608 females) with a validated primary discharge diagnosis of CHF 
hospitalized from 1 January 1993 through 31 December 2007, at Chinese 
PLA General Hospital in Beijing. The patients were divided into fi  ve groups 
based on the number of etiologies and comorbidities from one to fi  ve 
or more than fi  ve. A comparative analysis was performed to explore the 
major causes, comorbidities and in-hospital mortality of patients among 
the groups.
Results The mean (± SD) age of patients was 53 ± 17 years in the one-
comorbidity group, 60 ± 16 years in the two-comorbidity group, 65 ± 
14 years in the three-comorbidity group, 70 ± 13 years in the four-
comorbidity group and 72 ± 11 years in the fi   ve-comorbidity group. 
The major causes of hospitalized patients with CHF were coronary artery 
disease (44.9%), vavular heart disease (27.5%), cor pulmonale (9.6%) and 
cardiomyopathy (7.4%). The comorbidities of CHF were hypertension 
(38.6%), atrial fi  brillation (23.1%), diabetes mellitus (18.3%), pneumonia 
(11.6%) and renal failure (7.1%). The single comorbidity was predominant 
in younger patients while multiple comorbidity was predominant in the 
elderly (P <0.001). The most common single etiology was vavular heart 
disease, the most common triple etiology was coronary artery disease 
complicated with hypertension and diabetes mellitus. Cox regression 
analysis showed higher hospital mortality rates associated with increased 
numbers of etiology and comorbidity (hazard ratio (HR) from 0.98, 95% CI 
0.71 to 1.36 to HR 1.59, 95% CI 1.23 to 2.05, to HR 1.90, 95% CI 1.43 to 2.51, 
to HR 2.47, 95% CI 1.81 to 3.35, P <0.001).
Conclusions  This study demonstrates that the older a hospitalized 
patient with CHF is, the more comorbidities they have. The major 
causes and comorbidities of hospitalized patients with CHF are coronary 
artery disease, vavular heart disease, cor pulmonale, cardiomyopathy, 
hypertension, atrial fi  brillation, diabetes mellitus, pneumonia and renal 
failure. The single etiology or comorbidity is predominant in younger 
patients, while multiple etiology or comorbidity is predominant in the 
elderly. A higher in-hospital mortality rate of CHF is associated with an 
increased number of etiologies and comorbidities.
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Introduction The outcome of surgical repair of tetralogy of fallot (TOF) 
is a useful benchmark for the assessment of congenital cardiac surgical 
programs. The aim of this study was to describe postoperative morbidity 
following TOF repair and assess the factors linked to a longer duration of 
postoperative ventilation.
Methods Retrospective study of all patients admitted to cardiac intensive 
care between January 2003 and December 2008 following classic TOF 
repair. More complex repairs were excluded. Factors were investigated 
for a relationship with intubation hours using linear regression analysis. 
Intubation hours were log transformed for the analysis since the data were 
skewed.
Results A total of 174 children were included, 97 (56%) male, of whom 
31 (18%) had previous palliation with a BT shunt and 23 (13%) had extra 
medical problems. The median age at repair was 8.9 (range 1.6 to 112.8) 
months and the median weight was 8.2 (3.5 to 28.5) kg. The median 
cardiopulmonary bypass (CPB) time was 101 (42 to 292) minutes and 94 
(54%) required transannular patch. The median postoperative intubation 
time was 23 (0 to 566) hours and 11 patients (6%) did not require 
postoperative ventilation. The median ICU stay was 66 (13 to 791) hours 
and there was one early death before hospital discharge. One hundred and 
seventy (95%) patients received an inodilator. Postoperative complications 
included renal failure and fl   uid overload requiring peritoneal dialysis 
(PD) in 31 (17%); junctional ectopic tachycardia (JET) in 29 (16%); other 
arrhythmias in 10 (6%), delayed chest closure in six (3%) of which two had 
emergency mediastinal exploration due to bleeding and ECMO in one 
patient. A multiple regression model for the outcome measure intubation 
hours indicated that younger age at repair (P = 0.03), associated medical 
problems (P = 0.04), longer CPB time (P = 0.057), JET, PD, noradrenalin use 
and adrenaline use (P <0.01 for all) were independently linked with longer 
postoperative ventilation times.
Conclusions Younger children, those with extra medical problems and 
children that required higher levels of inotropes (probably refl  ecting low 
cardiac output syndrome), had longer intubation times. The commonest 
and most important complications that infl  uenced duration of ventilation 
were JET and PD. In our series, mortality and length of stay were 
comparable with other published data.
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Introduction  Sildenafi   l is a phosphodiesterase-type-5 inhibitor and 
selectively decreases pulmonary artery pressure. So far, the mechanism 
underlying sildenafi   l’s eff   ects on pulmonary vascular remodeling and 
potassium channel activity in pulmonary artery smooth muscle cells 
(PASMCs) has not been clearly addressed in pulmonary hypertension 
secondary to increased pulmonary blood fl  ow.
Methods A total of 27 male SD rats were randomly divided into a sham 
group (n = 9), a shunt group (n = 9) and a shunt + sildenafi  l group (n = 9). 
A left-to-right shunt was established by performing an abdominal aorta to 
inferior vena cava fi  stula both in the shunt group and the shunt + sildenafi  l 
group. Rats in the shunt + sildenafi  l group received oral sildenafi  l 10 mg/kg/
day, whereas the rats in the sham group and the shunt group were fed with 
normal saline of the same volume. Eleven weeks later, mean pulmonary 
artery pressure (mPAP) was measured. Meanwhile, the ratio of right 
ventricular mass to left ventricular plus septal mass (RV/(LV+S)) was detected 
as a marker of the degree of right ventricular hypertrophy. The relative medial 
thickness (RMT) of middle and small pulmonary muscularized arteries was 
calculated as a sign of pathological changes of pulmonary vasculature. The 
voltage-gated potassium channel Kv1.5 mRNA expression of pulmonary 
vasculature was detected using real-time PCR.
Results  Eleven weeks later, the rats in the shunt group developed 
pulmonary hypertension as evidenced by signifi   cantly increased 
mPAP, RV/(LV+S), as well as higher RMT of middle and small pulmonary 
muscularized arteries (all P = 0.01). In addition, the rats in shunt group had 
decreased Kv1.5 mRNA expression in pulmonary vasculature (P = 0.01). 
The rats in the shunt + sildenafi  l group had a signifi  cantly decreased mPAP, 
and RV/(LV+S) ratio, and a lower RMT as well (all P = 0.01), whereas the 
levels of Kv1.5 mRNA expression were signifi  cantly upregulated (P = 0.01). 
Furthermore, there were no statistically signifi  cant diff  erence in mPAP, in 
RV/(LV+S) ratio, RMT of middle and small pulmonary muscularized arteries 
and Kv1.5 mRNA expression between the shunt + sildenafi  l group and the 
sham group (all P = NS).
Conclusions Oral sildenafi  l attenuated pulmonary vascular remodeling 
and upregulated Kv1.5 mRNA expression in the rats with pulmonary 
hypertension secondary to left-to-right shunt.
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Introduction Pulmonary vascular resistance (PVR) has been used to assess 
right ventricular afterload; however, this is considered meaningless due to 
several physiologic shortcomings. Echocardiography has often been used to 
assess right ventricular (RV) afterload, but this has never been validated as an 
index of RV afterload. The purpose of this study is to evaluate echocardiographic 
indices of RV afterload in an experimental, open-pericardium pig model with 
induced, variable main pulmonary artery stenosis.
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ment of arterial blood pressure, central venous pressure, RV and pulmonary 
pressure. An ultrasonic fl  owprobe (MA14PAX; Transonic) was positioned on 
the main pulmonary artery to obtain pulmonary fl  ow. Distal to the fl  owprobe, 
a balloon-occluder was positioned facilitating gradual constriction of the 
pulmonary artery. To obtain a stepwise pressure diff  erence increment over the 
banding of 10 mmHg at each measurement, we gradually infl  ated the balloon-
occluder. After 10 minutes, all invasive hemodynamic data were registered 
and an epicardial echocardiography was performed to obtain tricuspid fl  ow 
velocities, isovolumetric and isovolumetric relaxation time. To calculate the 
TEI index during one heartbeat, echocardiographic measurements were 
synchronized with fl  owprobe measurements to obtain ejection time. The 
E/E΄ ratio was obtained with tissue Doppler echocardiography of the lateral 
tricuspid annulus. All echocardiographic measurements were performed in 
triple and averaged. The ejection period and mean pulmonary acceleration 
and cardiac output were calculated from the pulmonary fl  ow curve derived 
from the ultrasonic fl  owprobe. Resistance over the pulmonary banding was 
calculated by pressure gradient divided by cardiac output.
Results Of the 11 pigs, two pigs died prematurely, one inferior caval vein 
rupture, and one due to asystole while inserting the pulmonary artery 
catheter. After pulmonary banding, central venous pressure did not 
increase signifi  cantly. Mean acceleration correlated with the resistance 
over the banding (r = 0.59, P <0.0001). The TEI index and E/E΄ neither 
correlated with the pressure gradient over the banding nor fl  ow.
Conclusions Mean acceleration correlated with RV afterload in this model.
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Introduction The pathobiology of persistent right ventricular (RV) failure 
observed after an acute increase in pulmonary artery pressure (Ppa) 
remains incompletely understood. We hypothesized that these severe 
complications might be related to an activation of apoptotic pathways.
Methods Fourteen anesthetized dogs were randomised to a transient 
90  minutes pulmonary artery constriction or to a SHAM operation, 
followed 30 minutes later by hemodynamic measurements including 
eff  ective arterial elastance (Ea) to estimate RV afterload and end-systolic 
elastance (Ees) to estimate RV contractility, and sampling of cardiac tissue 
to assess apoptosis by real-time quantitative polymerase chain reaction, 
enzyme-linked immunosorbent assay and immunohistochemistry.
Results Transient increase in Ppa persistently increased Ea from 0.75 ± 0.08 
to 1.37 ± 0.18 mmHg/ml, and decreased Ees from 1.06 ± 0.09 to 0.49 ± 0.09 
mmHg/ml, Ees/Ea from 1.44 ± 0.06 to 0.34 ± 0.03 and cardiac output from 
3.78 ± 0.16 to 1.46 ± 0.10 l/minute, indicating RV failure. As compared with 
the SHAM-operated group, and with left ventricular tissue in animals with 
persistent RV failure, there were decreased gene expressions of RV and 
septal Bcl-2, with no changes in the gene expressions of Bax and Bak, and 
an increase in the Bax/Bcl-2 ratio. RV and septal Bcl-XL, and RV Bcl-w gene 
expressions were decreased as compared with the SHAM-operated group. 
There were activations of RV caspases 8 and 9, and of RV and septal caspase 
3. Diff  use RV and septal apoptosis was confi  rmed by TUNEL staining. There 
were also increased RV and septal protein expressions of TNFα.
Conclusions Acute afterload-induced persistent RV failure appears to be 
related to an early activation of apoptotic pathways, and to a myocardial 
increase of TNFα.
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Introduction A prolonged QT interval may be associated with torsades 
de pointes and lead to sudden cardiac death. The aim of this study was to 
determine both the frequency of QT prolongation and administration of 
QT prolonging drugs perioperatively in cardiac surgery.
Methods  This prospective observational study included 82 patients 
(mean age 67 years) undergoing elective cardiac surgery (coronary 
bypass grafting 37, valve surgery 29, combination 16). The QT interval was 
manually measured in lead II and V2 of a 12-lead electrocardiogram (ECG) 
and corrected for heart rate (corrected QT interval, QTc, calculated from 
Bazett’s formula) on the day before surgery, immediately after surgery, 
daily until day 5 and before hospital discharge. A QTc interval >440 ms 
in men and >460 ms in women in either ECG lead II or V2 was defi  ned 
as moderately prolonged. A QTc interval >500 ms was considered to be 
moderately prolonged in patients showing complete left or right bundle 
block, and severely prolonged in patients without complete bundle block. 
All administered drugs that may prolong the QT interval were identifi  ed 
and classifi  ed according to the QTdrugs.org Advisory Board: drugs with 
a defi  nite risk of torsades de pointes (class 1, for example amiodarone, 
sotalol, haloperidol) or with a possible risk (class 2, for example granisetron, 
risperidone).
Results A total of 489 ECG were analyzed (mean six ECG per patient). 
The QTc interval was moderately prolonged in 40/82 patients before 
surgery (48.8%). Five out of 40 patients (12.5%) had received drugs from 
class 1 preoperatively and 1/40 (2.5%) from class 2. The QTc interval was 
severely prolonged in 3/82 patients before surgery (3.7%), of which none 
had received QT prolonging drugs preoperatively. In 38/82 patients 
(46.3%) moderate QTc prolongation was newly discovered in at least 
one postoperative ECG. Seventeen put of 38 patients (44.7%) received 
drugs from class 1, and 3/38 (7.9%) from class 2 perioperatively. In 16/82 
patients (19.5%) severe QTc prolongation newly appeared in at least one 
postoperative ECG. Seven out of 16 patients (43.8%) received drugs from 
class 1 and 1/16 (6.3%) from class 2 perioperatively.
Conclusions Severe QT interval prolongation >500 ms occurs in one-
quarter of cardiac surgical patients in the perioperative period while 
moderate prolongation occurs in most of them. In nearly one-half of 
these cases, QT prolonging drugs like amiodarone and haloperidol may 
be involved. Before and during administration of such drugs in cardiac 
surgical patients perioperatively, assessment of the QT interval from 
routine ECG is recommended.
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Introduction Endothelial protein C receptor (EPCR) is a transmembrane 
glyco  protein primarily localised on vessel endothelium. EPCR binds 
protein C (PC) on the endothelial surface and presents it to the thrombin/
thrombomodulin complex. Thrombin activates PC to APC, which exerts 
anticoagulant and anti-infl   ammatory eff  ect. Proteolysis of membrane-
bound EPCR releases soluble EPCR which can be detected in plasmatic 
circulation. This reaction indirectly correlates with thrombin generation 
and can be interpreted as marker of endothelial activation during 
cardiopulmonary bypass (CPB).
Methods In a prospective study, the group of 35 adult patients (mean age 
68 years) scheduled for cardiac surgery with standard cardiopulmonary 
bypass (duration 80 ± 30 minutes, heparin dose 3 mg/kg, mild hypo-
thermia about 34°C) was evaluated. The markers of endothelial activation 
and coagulation parameters (EPCR, PAI-1, antithrombin, tPA, PTT, aPTT, 
fi   brinogen, platelets and thromboelastography (TEG)) immediately 
before and after surgery were recorded. We hypothesized that the 
EPCR level (detected with ELISA monoclonal antibodies labeled with 
myeloperoxidase, 450 nm reader – detection limit 10 ng/ml soluble 
EPCR) increases after CPB and correlates with other markers of endothelial 
activation.
Results The cut-off   value of EPCR was set down 200 ng/ml. In 17% of 
patients the value above the cut-off   (366 ng/ml before, 209 ng/ml after CPB) 
was detected. The EPCR value decreases after CPB (150.7 ± 124 vs 99.4 ± 
70.6) whereas tPA increases (1.5 vs 9.3 ng/ml) and PAI-1 was unchangeable. 
A trend to hypocoagulation after CPB was noticed (Δfi  brinogen –1.04 g/l, 
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TEG parameters (coagulation index ΔCI –1.46, ΔR +0.22 minutes, Δα΄ –3.9°, 
ΔMA –9.3 mm) was recorded. No correlation between EPCR and CPB 
duration was recorded as well.
Conclusions CPB is not associated with increase of EPCR – a novel endothelial 
marker – measured immediately after operation. We need further studies to 
explain mechanisms of endothelial protection in this clinical setting.
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Introduction  During severe pre-eclampsia (PE), control of blood 
pressure (BP) is crucial in order to prevent systemic complications. 
Currently approved treatments such as nicardipine (N) and dihydralazine 
have drawbacks. Since hypertension in PE is associated with increased 
sympathetic activity, urapidil (U), a peripheral α1 antagonist, has potential 
for BP control in PE, but no controlled comparison of U with N is available. 
This preliminary randomized controlled trial aims to compare effi   cacy and 
safety of U and N to reduce BP in severe PE.
Methods After IRB approval and signed informed consent, 18 women with 
severe PE without previous antihypertensive treatment were randomized 
to U or N groups. The therapeutic goal was to achieve a mean BP (MBP) 
between 105 and 125 mmHg. The U patients fi  rst received U 6.25 mg 
boluses every 5 minutes until the diastolic BP dropped below 105 mmHg, 
followed by a 4 mg/hour infusion adjusted as needed. In the N group, 
patients fi  rst received a N 1 γ/kg/minute infusion until a 15% reduction in 
mean BP, followed by a N 0.75 γ/kg/minute infusion adjusted as needed. 
Non-invasive BP was assessed every 5 minutes during treatment titration 
and then every 15 minutes. The time needed to reach the therapeutic 
goal was registered. The main endpoint was the achievement of the BP 
goal in 2 hours or less. Tolerance was assessed by the number of episodes 
of hypotension (HO) (defi  ned as MBP below 100 mmHg) and side eff  ects. 
Severe HO, defi  ned as MBP below 80 mmHg or two episodes of HO, was 
considered as treatment failure and led to exclusion. Further assessment 
was limited to safety, amount of ocytocics used and neonatal evaluation by 
ICU paediatricians until discharge from ICU. Results were compared using 
analysis of variance. Side eff  ects were compared with the chi-square test.
Results One U patient was excluded from the effi   cacy assessment due to 
a protocol violation. The main endpoint was reached in all 17 patients, after 
50 minutes in both groups. During the fi  rst 2 hours, the needed treatment 
adjustment median value was 1 (0 to 10) in the U group and 1 (0 to 13) in 
the N group. Side eff  ects attributable to the study treatment were observed 
in six of the nine cases in the N group and in one of the nine cases in the U 
group (P <0.02). There were no severe side eff  ects or neonatal side eff  ects.
Conclusions No diff  erence in effi   cacy could be shown in this preliminary 
series. Both treatments were easy to titrate. Fewer side eff  ects were recorded 
in the U group. Further studies are needed in order to compare U and N.
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Comparison of the eff  ects of furosemide, captopril and lorazepam on 
noncomplicated hypertensive patients in the emergency department
A Uzun, L Yamanel, O Cinar, H Hasman, B Comert
Gulhane Military Medical Academy, Ankara, Turkey
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Introduction Patients frequently refer to the emergency department with 
hypertension and related disorders. If hypertensive crisis is not diagnosed 
in these patients, urgent treatment is not necessary. However, taking 
patient satisfaction into consideration, the emergency physicians usually 
discharge these patients after lowering the blood pressure with various 
medications [1]. This prospective, randomized, placebo-controlled study 
is designed in order to compare the eff  ects of captopril, furosemide and 
lorazepam on lowering blood pressure and increasing patient satisfaction.
Methods One hundred patients with uncomplicated hypertension were 
included in the study. All were randomized into four groups: (1) captopril 
group, (2) furosemide group, (3) lorazepam group, (4) placebo group. The 
blood pressure was measured at baseline, 30th, 60th and 90th minute. 
The patient satisfaction was assessed with a visual analog scale (VAS) at 
baseline and 90th minute.
Results  Captopril (23.64 mmHg), lorazepam (24.90 mmHg) and 
furosemide (24.10 mmHg) were found similarly eff  ective in lowering blood 
pressure when we compare baseline and 90th minute, but all three drugs 
were superior to placebo (15.94 mmHg) (P <0.05) (Table 1). When patient 
satisfaction was assessed with the VAS, captopril (30.12 mm), furosemide 
(28.04 mm) and lorazepam (32.88 mm) were statistically similar and all 
three drugs were superior to placebo (22.76 mm).
Table 1 (abstract P137). Mean arterial pressure
Group  MAP (mmHg)  SD (mmHg)  Level of signifi  cance
Furosemide  24.1  10.7  19.9 to 28.5
Captopril  23.6  11.7  18.8 to 28.4
Lorazepam  24.9  10.1  20.7 to 29.1
Placebo  15.9  10.1  11.7 to 20.1
Total  22.1  11.1  19.9 to 24.3
Conclusions In conclusion, all three drugs can be used in subjects referred 
to the emergency department with uncomplicated hypertension. They 
are similarly eff  ective in both lowering the blood pressure and increasing 
patient satisfaction.
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critically ill patients: a retrospective survey
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Introduction  Hypertensive crises (HC) are common among patients 
admitted to emergency rooms [1]. However, data are lacking about 
prevalence in the critically ill admitted to the ICU. The aim of the study 
was to assess the rate of HC in a cohort of patients admitted to a medical–
surgical ICU, to look for risk factors for HC and to assess outcome of 
patients with HC.
Methods  Data have been collected from clinical charts of patients 
consecutively admitted to a mixed ICU (1 January 2008 to 31 January 
2009). HC diagnosis was made based on JNC defi  nitions [2]. Patients were 
divided into two groups, the HC group and the control group. Diff  erences 
between groups were evaluated regarding age, gender distribution, 
admission diagnosis, SAPS II score, ICU length of stay, ICU mortality, and in-
hospital mortality (P <0.05). Clinical and behavioural conditions associated 
with HC were considered in the two groups and diff  erences tested for 
statistical signifi  cance (P <0.05).
Results  Of a total of 409 patients, 63 had one or more HC (15.4%). 
Conditions signifi  cantly associated with HC were age, cigarette smoking, 
cancer surgery, vasculopathy, medical indication to ICU admission, 
coronary artery disease, and chronic atrial fi  brillation. HC patients showed 
higher ICU length of stay and ICU mortality.
Conclusions  HC were common among critically ill patients admitted 
to the ICU, irrespective of their admission diagnosis. Conditions strongly 
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associated with worse outcomes.
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intensive care unit
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Introduction  The blood pressure is an important variable in medical 
practice. A mistaken measurement can change the management of some 
diseases, modifying the patient’s prognosis. Therefore a correct defi  nition 
and control of blood pressure is an essential item in an ICU environment.
Methods A prospective and comparative study of the blood pressure 
assessed by arterial catheterization (pressure referenced to atmospheric 
pressure at mid-chest level and adequate curve in the monitor) and by 
non-invasive blood pressure device (using the cuff   of the monitor with 
automatic oscillometric measurement) in the upper and lower limbs.
Results Included were 52 patients with average age of 54.7 years. In the 
right arm (RA), a diff  erence between IBP and NIBP larger than or equal 
to 20 mmHg in systolic blood pressure (SBP) (plus or minus) occurred in 
26.5% of the patients; 14.3% in diastolic blood pressure (DBP) and 8.7% in 
mean blood pressure (MBP). In the left arm (LA), 30.6% for SBP; 4.1% for 
DBP and 4.2% for MBP. In the left leg (LL), 40% for SBP, 17.8% for DBP and 
17.8% for MBP. In the right leg (RL), 47.8% for SBP; 8.7% for DBP and 17.4% 
for MBP.
Conclusions There were diff  erences between BP measured by invasive 
and non-invasive methods mainly in SBP. Lower limbs presented a larger 
diff  erence, which means that non-invasive methods in this place are not 
reliable. The DBP in both methods presented less diff  erence.
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Introduction Chronic atrial fi  brillation is known to be an important co-
morbidity factor in critically ill patients admitted to the ICU. The aim of 
this study was to evaluate whether electrical cardioversion in the ICU can 
reduce mortality of patients with chronic atrial fi  brillation.
Methods From January 2005 to November 2009, 50 patients with history of 
chronic atrial fi  brillation admitted to the ICU were retrospectively studied. 
Patients were divided into two groups: the fi  rst group included patients 
who underwent electrical cardioversion (CVE group, n = 10) and were 
discharged in sinus rhythm; the second included patients who did not 
undergo electrical cardioversion and were discharged with chronic atrial 
fi  brillation (CAF group, n = 40). In both groups, mortality, antiarrhythmic 
drug therapy and oral anticoagulation regimen were monitored. The fi  rst 
group’s follow-up evaluated maintenance of sinus rhythm. The number of 
DC shocks required for the maintenance of sinus rhythm in patients of the 
CVE group was also collected. The main outcome parameter considered 
was 28-day mortality.
Results  Patients of both groups resulted in similar demographic and 
clinical parameters. In patients included in the CVE group, the maintenance 
of sinus rhythm was achieved with one DC shock in 66.6%, two DC shocks 
in 22.2% and three DC shocks in 11.1% of cases. The mortality rate at 24 
hours was 0% while at 28 days was 11.1%, whereas patients in the CAF 
group had a 28-day mortality rate of 35%. See Figure 1.
Conclusions Our pilot study indicates that the improvement of ventricular 
performance with the contribution of atrial systole might improve critically 
ill patients’ outcome. Considering the small number of cases, a prospective 
study, based on these preliminary results, is ongoing.
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Applanation tonometry application in ICU patients with acute 
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Introduction  The incidence of acute cardiogenic pulmonary edema 
(ACPE) is increasing and it is now one of the leading causes of morbidity 
and mortality in our society. As the global population of European 
countries is getting older, the impact of arterial stiff  ness is becoming more 
and more important in the pathophysiology of ACPE, besides coronary 
vascular disease and valvular disease. The aim of the study was to evaluate 
whether acute modifi  cations in elastic artery distensibility can be involved 
in the pathogenesis of ACPE.
Methods Six consecutive patients (four men and two women; age 76 ± 
7.1 years) were admitted to our ICU with the clinical diagnosis of ACPE. All 
patients were studied with transthoracic echocardiography (TTE) and by 
evaluation of pulse wave analysis (PWA) and pulse wave velocity (PWV) 
with the applanation tonometry method, performed at admission and 
after clinical stabilization.
Results In all patients, left ventricular systolic function was not signifi  cantly 
reduced when evaluated with transthoracic echocardiography, while 
a diastolic dysfunction was always demonstrated. We have recorded 
a signifi  cant (P <0.05) decrease in blood pressure values after clinical 
stabilization. Estimation of the central aortic pressure waveform by 
mathematical transformation of radial tonometry pressure was similarly 
reduced. Other tonometric parameters, such as the Augmentation Index, 
which represents the contribution of the wave refl  ection to the global 
pulse pressure wave, and PWV, which is inversely correlated to the arterial 
compliance, were also signifi  cantly decreased, when compared with the 
values at the admission time. The subendocardial viability ratio (SEVR), 
an indirect index of myocardial perfusion relative to cardiac workload, 
increased after treatment with vasodilatators.
Conclusions  Our data confi  rm the determining role of the increased 
arterial stiff  ness in the pathogenesis of ACPE, and how a therapeutic 
strategy able to ameliorate this target can be associated with a clinical 
improvement for the patient. The applanation tonometry could be an 
interesting method to evaluate these patients in the ICU setting.
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Figure 1 (abstract P140).
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A better prognosis for septic patients with left ventricular 
dysfunction?
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Introduction Several studies using angiographic or echocardiographic 
methods have shown that in septic shock (SSh) or severe sepsis (SeS), 
cardiac abnormalities, which are often documented [1], seem to have a 
relevant prognostic signifi  cance [2,3].
Methods A retrospective study was conduced during 6 months (April 
to September 2009) in an ICU of a university tertiary hospital, identifying 
all patients with SSh or SeS and reviewing their echocardiographic data. 
All the patients with known or clinical/echocardiographic evidence of 
signifi  cant prior cardiac disease were excluded from this analysis.
Results Forty-nine patients were identifi  ed with SSh or SeS from a total 
of 211 ICU patients (23.2%). Among these, 26 had echocardiograms 
done during their ICU stay (53.1%). We analyzed 19 echocardiograms 
from 15 patients. The remaining 11 patients were excluded, having 
ischemic heart disease (seven patients) and signifi   cant valvular heart 
disease (four patients). Within the SSh/SeS group of patients, those with 
echocardiograms were younger (mean age 56.3 vs 64.4) and more often 
women (53.3% vs 36.7%). The ICU mortality was nevertheless similar 
in the two groups (46.7% vs 46.9%). The primary sites of infection were 
the lungs and abdomen (26.7% each) or unknown (20%). The agents 
most frequently isolated were Gram-negative bacilli (26.7%). In 53.3% 
of cases there was no identifi   ed agent. Echocardiographic evaluation 
revealed signifi  cant changes in 26.7% of the patients, with the remaining 
being considered normal. Of those with signifi  cant changes, 75% (n = 3) 
showed impairment of left ventricular (LV) systolic function with global 
hypokinesia simultaneously with diastolic dysfunction. Either abnormality 
was not found in any other patients. The mortality rate during ICU stay was 
lower in the group of patients with systolic and diastolic LV dysfunction 
compared with those with no apparent modifi  cation of LV function (0 vs 
58.3%). The right ventricle was dilated and showed high systolic pressures 
present in only one patient.
Conclusions This study reinforces the concept that changes in systolic 
and diastolic functions are common in septic shock and severe septic 
patients, and that the development of these changes (as an adaptation 
mechanism) seems to correlate inversely with the acute mortality rate 
during ICU stay [2,4].
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Introduction  While advantages of pulsatile perfusion (PP) during 
cardiopulmonary bypass (CPB) in terms of clinical outcome remain the 
subject of debate, possible benefi  ts are generally thought to occur via 
improvements in microvascular fl  ow [1]. However, this is currently not 
supported by human clinical data. Therefore we used real-time human 
microvascular imaging to test our hypothesis that pulsatile perfusion 
would enhance microvascular perfusion.
Methods We used sidestream dark fi  eld imaging to record video clips 
of the human microcirculation in 16 patients undergoing routine CPB 
for cardiac surgery. Following administration of cardioplegia, CPB was 
continued in either pulsatile (PP, n = 8) or nonpulsatile (NP) mode. After 
10 minutes, microvascular recordings were made. The perfusion mode was 
then switched from PP to NP or vice versa. Ten minutes later, a second series 
of microvascular video recordings were obtained. Global hemodynamic 
and laboratory data were recorded and the energy equivalent pressure 
(EEP) and pulse pressure (both mean ± SD) were calculated to quantify 
PP generated surplus energy. Microvascular analysis was performed both 
for smaller and larger microvessels with a diameter cut-off   of 20 μm. 
Assessments included perfused vessel density (PVD) (mean ± SD, 95% 
confi  dence intervals of the diff  erence between NP and PP (95% CID)) and 
the Microvascular Flow Index (MFI) (mean ± SD and interquartile range).
Results Pulsatile perfusion resulted in higher pulse pressure (27 ± 6 vs 7 ± 
2 mmHg, P <0.0001) and CPB circuit EEP (184 ± 33 vs 150 ± 27 mmHg, P 
<0.0001) as compared with NP while MAP was similar between these 
perfusion modes (52 ± 11 vs 56 ± 13 mmHg, P = 0.09). Both for small and 
larger microvessels, we found no diff  erences in indices of microvascular 
perfusion between PP and NP. Small microvessel PVD was similar between 
PP and NP (6.65 ± 1.39 vs 6.83 ± 1.23/mm; 95% CID –0.50 to 0.87/mm, P = 
0.58). The same was true for larger microvessel PVD (2.16 ± 0.64 vs 1.96 ± 
0.48; 95% CID –0.50 to 0.11, P = 0.20). Similarly, the MFI did not diff  er between 
groups either for smaller (3.00 (2.83 to 3.00) vs 3.00 (2.75 to 3.0), P = 0.41) and 
larger microvessels (3.00 (2.75 to 3.00) 3.00 (3.00 to 3.00), P = 0.50).
Conclusions PP during CPB does not alter human microvascular perfusion 
using standard equipment in routine cardiac surgery despite yielding 
higher CPB circuit energy equivalent pressure and patient pulse pressure.
Reference
1. Murphy  GS,  et al.: Anesth Analg 2009, 108:1394.
P144
Microcirculation and intravascular coagulopathy in patients with 
severe sepsis and septic shock
R Wimmer, S Franz, S Siebelist, M Uschner, C Seidelmann, H Ebelt, 
S Hettwer, J Wilhelm, H Loppnow, K Werdan
Universitätsklinikum Halle (Saale), Halle, Germany
Critical Care 2010, 14(Suppl 1):P144 (doi: 10.1186/cc8376)
Introduction Sidestream darkfi  eld imaging (SDF) technology is a new 
method to visualize directly microcirculation. In this study we examined 
the perfusion of the oral mucosa in patients with severe sepsis and 
septic shock in order to evaluate the link between the severity of illness, 
microcirculation and intravascular coagulopathy.
Methods Microcirculation was analysed in 46 ICU patients with clinical 
suspicion for sepsis and procalcitonin >2 ng/ml. Microcirculation was 
recorded daily over a 7-day period (d0 to d6). Each day, at least fi  ve single 
fi  lm clips were taken by SDF and analysed with special software on a PC. We 
used the functional vessel density and distribution of the vessel diameters 
as well-established parameters to qualify microcirculation. Laboratory 
parameters, hemodynamic data and vital signs were also registered. The 
degree of disseminated intravascular coagulopathy was evaluated by 
calculating the overt DIC score (according to ISTH), and severity of illness 
was determined using SAPS II and the SOFA score.
Results During the stay in the ICU we observed a continuous descent of 
the DIC score (1.82 ± 1.91 on d0 vs 1.3 ± 1.94 on d6) as well as a decline 
of SAPS II (63.1 ± 14.1 on d0 vs 57.1 ± 18.4 on d6) and SOFA score (12.2 ± 
3.9 on d0 vs 9.2 ± 5.8 on d6). The percentage of smallest vessels below 
25 μm diameter decreased initially from 79.5 ± 21.9% (d1) to rise up then 
persistently 86.2 ± 10.3% (d6). Nonsurvivors (n = 11) had, compared with 
survivors (n = 35), a signifi  cantly higher initial DIC score on day 0 (1.3 ± 1.6 
vs 2.05 ± 4.1; P <0.05).
Conclusions Our data show a clear relation between the time courses of 
DIC and microcirculation in patients with severe sepsis and septic shock. 
This fi  nding is in line with previous reports stating the profound impact of 
DIC on microcirculation and fi  nally on patient outcome.
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Prevalence and prognostic signifi  cance of cardiac abnormalities in 
the ICU: an echocardiographic study
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Introduction The aim was to describe the prevalence and type of cardiac 
abnormalities in ICU patients detected using echocardiography and to 
assess whether those abnormalities are correlated with ICU survival.
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UCSC medical–surgical ICU for >24 hours were evaluated using transthoracic 
echocardiography (TTE). Patients admitted for postoperative monitoring 
or in an agonal state were excluded. Transesophageal echocardiography 
(TEE) was used when TTE was technically impossible. Measured parameters 
included: volume, thickness, global and regional kinesis of the left ventricle 
(LV), systolic function of the right ventricle (RV), and valvular function.
Results From 1 March to 30 June 2009 a total of 100 patients (median age 
68.5 years (IQR 50 to 77.5)) were included in the study. Medium SAPS II was 
46 ± 15. ICU mortality rate was 29%. Median LOS in ICU was 14 days. TTE 
was technically feasible in 97 patients; the other three patients underwent 
TEE. Signifi  cant cardiac abnormalities were found in 66 patients, 41 of 
whom had no history of cardiac disease. The most frequent abnormalities 
were: tricuspidal regurgitation (45.3%), regional asynergies of LV (32%), 
left heart failure (30.2%) and mitral regurgitation (28%). The median left 
ventricular ejection fraction (EF) in our population was 50% (IQR 15 to 
72%). Left ventricular end-diastolic volume was 100 ml (IQR 78 to 130 ml). 
Mean tricuspid annular systolic excursion (TAPSE) was lower in patients 
who died (18.9 vs 20.8 mm; P = 0.09). TAPSE was signifi  cantly correlated 
to EF (r coeffi   cient = 0.48; P <0.0001). Pulmonary artery systolic pressure 
was signifi  cantly higher in patients who died than in those who survived 
to the ICU (49.8 ± 13.0 mmHg vs 35.0 ± 12.8 mmHg; P = 0.045). On logistic 
regression, prediction of ICU mortality was better (AUC = 0.901 vs 0.787) 
when cardiac abnormalities detected by echocardiography were added to 
a model based on age and SAPS II.
Conclusions  In our study, a complete echocardiographic assessment 
was possible using TTE in 97% of patients. Two-thirds of our population 
had echocardiographic abnormalities, 62.1% of whom were previously 
unknown. The presence of LV asynergies and reduced RV systolic function 
were associated with a worse prognosis. Detection of cardiac abnormalities 
increased prediction of ICU mortality based on logistic regression.
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Introduction B-type natriuretic peptide (BNP) and N-terminal proBNP 
(NT-proBNP) are routine diagnostic and monitoring markers in patients 
with heart failure. LV function and prognosis of these patients have been 
shown to be refl  ected by BNP and NT-proBNP levels. However, in patients 
with cardiogenic shock after myocardial infarction, the relationship and 
relevance of these markers has not been elucidated.
Methods The IABP Shock trial was as a monocentric, randomised and 
prospective clinical trial to determine the role of therapeutic intraaortic 
balloon pump (IABP) counterpulsation after primary percutaneous 
transluminal coronary angioplasty (PCI) in acute myocardial infarction 
(AMI) complicated by cardiogenic shock. Cardiac catheterization was 
performed in 40 patients within 12 hours of onset of hemodynamic 
instability. Creatinine, hemodynamic parameters and survival were deter-
mined. Further, BNP and NT-proBNP levels were measured on admission as 
well as 24, 48 and 72 hours afterwards.
Results  BNP levels detected diff   erences in treatment regarding LV-
unloading under IABP (632 ± 194 pg/ml vs 1,370 ± 475 pg/ml, P <0.05). 
However, there was no signifi  cant diff  erence between the group treated 
with IABP and no IABP with regard to NT-proBNP levels. Interestingly, NT-
proBNP levels clearly diff  erentiated between survivors and nonsurvivors 
(4,590 ± 1,230 pg/ml vs 14,370 ± 4,886 pg/ml, P <0.05), contrary to no 
signifi  cant diff  erence between survivors and nonsurvivors with regard to 
BNP levels (NS). Elevated levels of NT-proBNP in patients with cardiogenic 
shock might be more dependent on impaired renal function, which might 
refl  ect additional organ dysfunction (creatinine >200 μmol/l vs creatinine 
≤200 μmol/l: 24,965 ± 9,567 pg/ml vs 7,246 ± 2,650 pg/ml, P <0.05).
Conclusions In myocardial infarction complicated by cardiogenic shock, 
levels of BNP and NT-proBNP both provide valuable additional information. 
BNP seems to closely refl  ect the cardiac status and eff  ects of therapy, 
while NT-pro-BNP seems a good indicator for prognosis in patients with 
cardiogenic shock by its dependency on organ dysfunction.
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Introduction  We have previously shown how a data fusion index, 
based on the integration of vital signs continuously monitored in a step-
down unit (SDU), can identify the cardiorespiratory instability that often 
precedes adverse events [1]. We show how the correlations between vital 
signs, captured in a data fusion index based on a probabilistic model of 
normality [2], change during times of cardiorespiratory instability.
Methods  An observational study was carried out in a 24-bed SDU, in 
which vital signs from 326 patients were continuously recorded [1]. 
The existing standard of care used single-channel Medical Emergency 
Team (MET) activation criteria to determine when individual vital signs 
became abnormal. Retrospective evaluation of the continuous vital sign 
data identifi   ed that MET criteria were exceeded on 238 nonartefactual 
occasions. One hundred and eleven of these were indicative of suffi   cient 
cardiorespiratory instability that they should have required an MET call 
(critical events). Vital-sign dynamics during these events were compared 
with data from stable periods, using order statistics and covariance analysis.
Results We found the probability distributions of the most extreme and 
the median data for each parameter over 1-minute intervals. The bivariate 
Gaussian distributions of best fi  t for data from critical events (abnormal 
respiratory rate (RR) or heart rate (HR)) show signifi  cant diff  erences in 
covariance when compared with those calculated for data intervals from 
stable patients (see Figure 1, in which covariance is indicated by ellipse 
orientation). Under normal conditions (black ellipses), RR is correlated with 
HR. During critical events, tachycardia occurs with little or no variation in 
RR (red ellipses); tachypnoea occurs with little or no variation in HR (blue 
ellipses).
Conclusions Dynamics and correlations that exist in vital signs during 
periods of stability change signifi  cantly during periods of abnormality. A 
statistical approach that integrates vital signs and captures correlations 
between them will be sensitive to cardiorespiratory deterioration.
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Introduction In vivo microdialysis (MD) is a bedside sampling method that 
permits continuous analysis of a patient’s extracellular tissue chemistry 
without consuming blood. MD is performed by implanting a commercially 
available catheter that mimics a blood capillary at the site of interest.
Figure 1 (abstract P147).
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having a median age of 60 years were studied. All patients met the ACCP/
SCCM consensus criteria for sepsis. Upon sepsis onset, a microdialysis 
catheter (CMA 60; CMA, Solna, Sweden) was inserted into the subcutaneous 
adipose tissue of the upper thigh. The dialysate samples were collected in 
microvials and were analyzed immediately for glucose, pyruvate, lactate, 
and glycerol using a mobile CMA ISCUS analyzer. The lactate/pyruvate 
(L/P) ratio was automatically calculated. Measurements were performed 
six times per day during the fi  rst 6 days from sepsis onset. The daily mean 
values of MD measurements were calculated for each patient.
Results Sepsis severity of the study group was graded as follows: sepsis 
(n = 5), severe sepsis (n = 2) and septic shock (n = 28). APACHE and SOFA 
scores at study entry were 23 ± 4 and 8 ± 3, respectively. Overall, 18 
patients died yielding an ICU mortality rate of 51%. MD revealed that at 
study entry patients with septic shock had higher lactate (3.5 ± 1.6 vs 1.8 ± 
0.9, P = 0.01), and higher pyruvate (204 ± 137 vs 95 ± 68, P = 0.04) levels 
compared with septic patients without shock. In contrast, the two groups 
had similar values for glucose (5.9 ± 2.7 vs 4.3 ± 2.9, P = 0.18), glycerol (369 
± 225 vs 252 ± 171, P = 0.21), and L/P ratio (83 ± 289 vs 75 ± 150, P = 0.92). 
Septic shock correlated with SOFA on day 1 (r = 0.55, P = 0.001), APACHE II 
(r = 0.42, P = 0.01), lactate on day 1 (r = 0.48, P = 0.004), lactate on day 2 (r = 
0.50, P = 0.002), pyruvate on day 1 (r = 0.040, P = 0.018), and with pyruvate 
on day 2 (r = 0.35, P = 0.04). Nonsurvivors had higher glycerol (426 ± 236 vs 
253 ± 157, P = 0.01) at study entry and on day 1 (437 ± 260 vs 282 ± 169, 
P = 0.04) compared with survivors. Nonsurvivors also had higher pyruvate 
levels on day 1 (170 ± 99 vs 104 ± 65, P = 0.03) and on day 2 (150 ± 81 vs 
97 ± 61, P = 0.04). Logistic regression analysis showed that APACHE II (OR = 
1.312, P = 0.06) and glycerol on day 1 (OR = 1.005, P = 0.04) independently 
predicted patient outcome.
Conclusions MD seems to be a safe and promising tool in grading sepsis 
severity and in predicting early mortality in critically ill patients.
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Introduction The muscle-specifi  c infl  ammatory response after strenuous 
exercise has some similarity with those observed in sepsis and it is 
used as a mirror of sepsis-specifi  c infl  ammatory response. Near-infrared 
spectroscopy (NIRS) has been used to quantify sepsis-induced metabolic 
alterations by measuring variations of tissue oxygen saturation (StO2) 
during a vascular occlusion test (VOT). We aimed to investigate whether 
NIRS dynamic variables could refl   ect the magnitude of infl   ammatory 
process that follows strenuous exercise in marathon runners.
Methods VOT-NIRS (InSpectra Model 650) measurement was performed 
before, at the fi  nish line and on the day after the marathon in 13 runners 
(10 males/three females). VOT-derived NIRS traces were analyzed for StO2-
downslope (RdecStO2) and StO2-upslope (RincStO2). Blood samples were 
collected to measure C-reactive protein (CRP), procalcitonin (PCT), white 
blood cells (WBC), creatine kinase (CK), and lactate. Data are mean ± SD 
(in Table 1, median (IQR)). P <0.05 was considered statistically signifi  cant.
Results  The results of NIRS dynamic and hemodynamic variables are 
shown in Table 1. RdecStO2 was signifi  cantly increased in the day after the 
marathon. Signifi  cant increases in lactate (2.7 ± 0.5 vs 1.2 ± 0.3) and WBC 
(14 x 103 ± 4 vs 5 x 103 ± 2) were observed after the completion of the 
marathon. Serum CRP, PCT and CK were signifi  cantly increased on the day 
after the marathon (0.6 ± 0.6 vs 12 ± 8; 0.09 ± 0.2 vs 0.7 ± 0.9; 398 ± 198 vs 
1,932 ± 1,620), indicating the muscle-specifi  c infl  ammatory response as a 
result of muscle damage.
Conclusions Delayed increase in thenar VO2 is associated with muscle-
specifi  c infl  ammatory response after strenuous exercise as a result of the 
muscle damage.
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Introduction Current clinical parameters on effi   ciency of resuscitation 
are often insuffi     cient, and unable to reliably assess tissue hypoxia. 
Considerable interest has been aimed to direct monitoring of tissue oxygen 
tension (ptO2). However, no golden standard has yet been found. Animal 
experimental models have shown interesting results in hypovolemic and 
septic shock and have lead to some interesting clinical studies. The purpose 
of this review is to evaluate the current value of ptO2 monitoring in animal 
experimental studies under various pathophysiological conditions.
Methods  An electronic literature search on Pubmed and Embase 
databases was conducted to fi  nd relevant articles on tissue oxygenation 
and hemorrhage, trauma and endotoxemia. An initial amount of 7,876 
articles were retrieved. After applying inclusion and exclusion criteria and 
critical appraisal, 48 articles were ranked on their level of evidence.
Results After screening of the 48 articles, 19 articles were found to be 
suitable to answer our goal. Ten articles discussed tissue oxygenation in 
a hemorrhagic model and nine articles in a model of endotoxemia. No 
relevant articles concerning ptO2 and experimental trauma were found. 
Eight articles compared splanchnic ptO2 measurements in relation to 
ptO2 measured in several peripheral sites, like subcutaneous and skeletal 
muscle tissue. A positive correlation between these locations was found 
in seven articles. A decrease in both peripheral and central tissue oxygen 
pressure (ptO2) was found during hemorrhage. Importantly, peripheral 
ptO2 changed earlier during hemorrhage before any hemodynamic 
parameter did. In contrast, only one article found an earlier change in 
hemodynamic parameters than in peripheral ptO2. Nine articles discussed 
ptO2 in a model of septic shock. Only two studies compared peripheral 
ptO2 measurements with splanchnic ptO2 measurements. Both sites had 
decreased ptO2 values in endotoxemia and both were found to change 
before any changes in hemodynamic parameters.
Conclusions A signifi  cant relation between intestinal ptO2 and peripheral 
ptO2 was found in studies on experimental models of hemorrhagic and 
septic shock. This suggests that peripheral sites like the subcutaneous 
tissue or skeletal muscles tissue are reliable locations for measurements 
of ptO2.
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Introduction Tissue oxygen saturation (StO2; normal value 87 ± 6% [1]) 
measured with NIRS has been associated with disease severity in trauma 
[1]. The incidence of StO2 <75% that has been associated with organ failure 
[2] and its clinical consequences for ICU patients are unknown.
Methods StO2 was measured on the thenar eminence (InSpectra StO2 
Monitor Model 650; Hutchinson Technology) of all patients present in the 
ICU during 1 week. All patients were measured only once (on Monday 
when already admitted, or on the day of admission). Data are presented as 
mean ± SD unless otherwise specifi  ed.
Results Forty-one patients (age 53 ± 19 years; 63% males) were included. 
Fifty-nine percent of the patients were admitted following surgery. Median 
Table 1 (abstract P149). NIRS and hemodynamic variables
  Baseline  End line  Day after
StO2  80 (8.0)  69 (8.0)*  81 (7.0)
RdecStO2  9.5 (7.0)  9.4 (9.0)  13 (7.0)*
RincStO2  4.1 (3.0)  2.3 (3.0)*  4.0 (3.4)
HR  58 (24)  87 (60)*  62 (26)
MAP  93 (14)  88 (29)  87 (20)
Data are median (IQR). *P <0.05.
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day of admission and measured StO2 (Figure 2). Thirty-one patients (76%) 
had StO2 below normal (Figure 2, top line). Twelve (29%) patients had StO2 
≤75% (Figure 2, dotted line). Seven patients had StO2 <70; mortality of 
these patients was 29% vs 9% in patients with StO2 >70% (NS).
Conclusions The incidence of an abnormal StO2 in critically ill patients is 
high. Also very low StO2 values are frequently found and may be associated 
with increased mortality.
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Introduction  Adequate volume expansion for hypovolemia should 
improve cardiac preload and stroke volume leading to improved 
microvascular blood fl  ow, tissue perfusion and oxygenation. The dynamic 
recovery slope of tissue oxygen saturation (StO2) during a standardized 
vascular occlusion test (VOT) is proposed to refl   ect microvascular 
reactivity. We aimed at evaluating the dynamic StO2 variations during fl  uid 
challenge in high-risk surgical patients.
Methods  Thirteen adult Caucasian patients, ASA II to III, undergoing 
major abdominal surgery, were included. In all, cardiac output (CO), stroke 
volume (SV), pulse pressure variation (PPV), and standard hemodynamic 
parameters were continuously recorded. Fluid responsiveness was defi  ned 
as an increase in SV >15%, after a 500 ml colloid (HEA 130/0.4) infusion 
over 10 minutes. StO2 measurements and VOT (sphygmomanometer 
infl  ated until >50 mmHg above systolic pressure and kept infl  ated until 
StO2 decreased to 40%) were performed after anaesthesia induction 
(baseline), and before (PPV >13%, therefore defi  ning hypovolemia) and 
after fl  uid challenge.
Results At baseline, no patient was preload dependent (mean PPV 7.9 ± 2%), 
and none required vasopressors during the procedure. Baseline mean StO2 
was 85 ± 6%, while CO and SV were 4.9 ± 0.9 l/minute and 68 ± 21 ml, 
respectively. During hypovolemia, compared with baseline, there was no 
diff  erence in both StO2 (85 ± 6 to 84 ± 9%, P = 0.76) and StO2 desaturation 
rate (–9.6 ± 1.6 to –11 ± 2.7%/minute, P = 0.10), while the StO2 recovery 
slope was lowered (5.1 ± 1.6 to 3.8 ± 1.5%/second, P = 0.04). Patients were 
all responders to fl  uid challenge. After volume expansion, SV (84 ± 20 vs 
62 ± 12 ml, P <0.01) and CO (6.5 ± 2 vs 4.8 ± 1.2 l/minute, P <0.01) were 
higher, with no signifi  cant changes in both StO2 and StO2 desaturation 
rate. Fluid challenge induced a 46% increase in StO2 recovery slope 
(P <0.01; Figure 1), which was comparable with baseline.
Conclusions  Whilst redistribution of blood fl   ow may occur during 
circulatory failure (vasoconstriction of lesser vital organs), impairment 
of microcirculation and tissue hypoperfusion indicators are of particular 
importance. Both hypovolemia and intravascular volume expansion are 
associated with signifi  cant modifi  cations in the dynamic recovery slope 
of StO2. Future studies are needed to better clarify its potential clinical 
applications.
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Introduction Although the adverse eff  ects of mechanical ventilation on 
circulation and intestinal organ perfusion are well known, the infl  uence of 
assisted breathing versus controlled ventilation has not been investigated. 
We hypothesized that pressure support ventilation causes less decrease 
in gut perfusion and less neutrophil adhesion than controlled ventilation.
Methods Male SD rats (n = 40) were anesthetized and tracheotomized 
and 10 animals each ventilated in pressure support (PSV) or pressure 
controlled (PCV) mode. PCV animals were paralyzed. After 5 hours of 
ventilation, intravital microscopy was performed. Endotoxin (15 mg/kg 
lipopolysaccharide) was given to 20 rats, 20 animals served as controls.
Figure 1 (abstract P151). Frequency distribution of StO2.
Figure 2 (abstract P151). Day of admission at time of measurement vs 
StO2.
Figure 1 (abstract P152).
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exchange. Animals were stable over the whole observation period 
with minimal changes in blood pressure and oxygenation. In PCV, the 
percentage of functional capillaries in the longitudinal mucosal layer was 
lower (57 ± 39%) than in PSV (87 ± 33%). In sepsis, there was a further 
decrease in PCV and a major decrease in PSV. Leukocyte adhesion in the 
intestinal submocosal venules (for example, V1 venules) was higher in PCV 
(228 ± 119) than in PSV (93 ± 65) in controls, but not in septic animals.
Conclusions In septic rats with preserved macrohemodynamic stability, 
intestinal perfusion was impaired after LPS infusion. Pressure-controlled 
ventilation had a signifi  cant infl  uence on microcirculation and neutrophil 
adhesion in controls. In septic animals, pressure support ventilation did 
not attenuate these adverse eff  ects as compared with PCV.
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Introduction Central venous oxygen saturation (ScvO2) has been shown 
to be a useful therapeutic target in septic shock or high-risk surgery. The 
central venous-to-arterial carbon dioxide diff  erence (Pcv-aCO2) has been 
proposed as a complementary tool for goal-directed therapy (GDT) in 
septic shock. We tested the hypothesis that both ScvO2 and Pcv-aCO2 
could be used as complementary tools for GDT during high-risk surgery.
Methods Seventy adult patients, ASA I to III, undergoing major abdominal 
surgery, were randomly assigned to 6 ml/kg/hour (R-GDT group, n = 36) 
or 12 ml/kg/hour (C-GDT group, n = 34) of crystalloids. Additional boluses 
of HES (130/0.4) were given to maintain respiratory variation in peak aortic 
fl  ow velocity (ΔPV) below 13%. In both groups, ScvO2, cardiac output (CO), 
oxygen delivery (DO2i), Pcv-aCO2 and postoperative complications were 
blindly recorded.
Results At baseline, there were no diff  erences in hemodynamic variables, 
ScvO2 (79 ± 7 vs 80 ± 6, P = 0.37) and Pcv-aCO2 (6 ± 3 vs 6 ± 2, P = 0.95). 
The total volume of fl  uid perfused was larger in the C-GDT group than 
in the R-GDT group (P <0.01). The two groups showed no diff  erences in 
intraoperative blood loss, blood transfusion, mean CO and mean DO2i 
values. Overall, postoperative complications were increased in the R-GDT 
group (P <0.01), especially postoperative sepsis occurred more often (P = 
0.0064).
Minimal ScvO2 (minScvO2) was higher in the C-GDT group (72 ± 6 vs 69 ± 
6%, P = 0.04). In patients with complications, minScvO2 was signifi  cantly 
reduced (72 ± 6 vs 67 ± 6%, P = 0.0017). minScvO2 <70% was independently 
associated with sepsis (OR 4.2 (95% CI 1.1 to 14.4), P = 0.025). Intraoperative 
mean Pcv-aCO2 was higher in the R-GDT group (7 ± 3 vs 5 ± 2 mmHg, 
P <0.01). In patients who develop sepsis, Pcv-aCO2 was higher than in 
patients who did not (8 ± 2 vs 5 ± 2 mmHg, P <0.01). In patients with 
ScvO2 >70% and who develop sepsis, Pcv-aCO2 was also signifi  cantly 
higher (P <0.01). The area under the ROC curve was 0.758 (95% CI 0.71 to 
0.81) for discrimination of patients with ScvO2 >70% who did and did not 
develop sepsis, with 5 mmHg as the best threshold value.
Conclusions  ScvO2 refl   ects important changes in oxygen delivery in 
relation to oxygen needs during the perioperative period and might 
help guiding GDT better than ΔPV alone. Pcv-aCO2 appears a useful tool 
to identify persistent hypoperfusion when GDT is associated with ScvO2 
>70%.
P155
Prognostic value of central venous–arterial pCO2 diff  erence in 
severe sepsis and septic shock patients
F Machado, A Guarnieri, FG Freitas, M Assuncao, B Mazza, M Jackiu
Federal University of São Paulo, Brazil
Critical Care 2010, 14(Suppl 1):P155 (doi: 10.1186/cc8387)
Introduction  Global indices of tissue perfusion include lactate and 
central venous oxygen saturation (SvcO2). The mixed venous–arterial 
pCO2 diff  erence (ΔCO2m) cannot serve as a marker of tissue hypoxia. It 
is a marker of venous fl  ow adequacy to remove the total CO2 produced 
by peripheral tissues [1]. Substitution of a central for a mixed venous–
arterial pCO2 diff  erence is acceptable [2]. The objective was to assess the 
relationship between ΔCO2 and SOFA score variation in patients with 
severe sepsis and septic shock. Lactate and ScO2 were also evaluated.
Methods Prospective observational study in patients with severe sepsis 
and septic shock admitted to an adult tertiary ICU. The management 
of sepsis was carried out as proposed by Surviving Sepsis Campaign 
guidelines. The earliest simultaneous measurement of lactate, SvcO2, and 
ΔCO2 were obtained when clinically indicated (T0) and after 8 to 12 hours 
(T8-12). The SOFA score was determined at T0 and after 24 hours (T24) and 
ΔSOFA (T24-T0) was calculated. The patients were classifi  ed according to 
their parameters at T0 (ΔCO2 ≥6 vs <6, lactate ≥28 mg/dl vs <28 mg/dl, 
SvcO2 ≥70% vs <70%) and their trends after 8 to 12 hours (adequate vs 
not adequate). Those groups were compared regarding their ΔSOFA score. 
The Student’s t test was used for analysis and results were considered 
signifi  cant if P <0.05.
Results Forty-three patients were included with mean of 60.2 ± 18.6 years, 
time from intensive care admission to T0 10.3 ± 9.3 hours and duration 
of organ dysfunction before enrollment 21.4 ± 15.6 hours. APACHE II, 
SOFA T0, and SOFA T24 scores were 18.8 ± 6.5, 7.9 ± 3.8, and 8.0 ± 4.3, 
respectively. ΔCO2 at T0 (P = 0.60) and its trend (P = 0.36) are not related to 
ΔSOFA. The analysis of SvcO2 also showed no signifi  cant fi  nding. Patients 
with high (≥28 mg/dl) blood lactate concentration at T0 (P = 0.03) and 
not adequate in blood lactate concentration at T8-12 (P = 0.04) had an 
increase in SOFA score.
Conclusions Patients with hyperlactatemia in the beginning of admission, 
which persists with increased levels of lactate, evolve to a worsening of 
SOFA score in 24 hours. ΔCO2 and SvcO2 and its trends are unrelated to the 
SOFA score in 24 hours.
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Introduction The measurement of cardiac output and its adequacy to 
tissue needs are essential for hemodynamic evaluation. In a recent review 
it was stated that the venous-to-arterial carbon dioxide diff  erence (dPCO2) 
could be considered a marker of adequacy of venous blood fl   ow to 
remove the total CO2 produced by the peripheral tissues. Several studies 
have already shown that dPCO2 and the cardiac index (CI) are inversely 
correlated in critically ill patients. However, the dPCO2 can be infl  uenced 
not only by CI, but also by other factors governing CO2 production and 
CO2 elimination. The aim of this work was to study the behaviour of dPCO2, 
measured from central venous blood, and its evolution during the early 
stage of septic shock.
Methods Forty-six patients with septic shock were prospectively included. 
dPCO2 was calculated by the diff  erence between the arterial PCO2 and 
the PCO2 from central venous blood. A value of dPCO2 >6 mmHg was 
considered high. The CI was measured by transpulmonary thermodilution. 
ScvO2 and serum lactate were obtained. Patients were separated into a 
normal dPCO2 group and a high dPCO2 group. The results were compared 
by Student t test or Mann–Whitney test. P <0.05 was chosen as signifi  cance.
Results At inclusion 24 patients (52%) had a high dPCO2. These patients 
had a lower CI (3.5 ± 1.1 vs 4.2 ± 0.99 l/min/m2, P = 0.04) and lower ScvO2 
(57 ± 17 vs 71 ± 8%, P <0.001) than patients with normal dPCO2. No 
diff  erence was found in PaCO2 or PaO2/FiO2 levels between both groups, 
suggesting a similar CO2 elimination. Thirteen patients had a decrease in 
dPCO2 from above to below 6 mmHg (from 8 ± 2 to 5 ± 1 mmHg, P = 
0.001) associated with an increase in CI (from 3.7 ± 1.3 to 4.2 ± 1.3 l/min/
m2, P = 0.003). Conversely, 11 patients had an increase in dPCO2 from 
below to above 6 mmHg (from 3.8 ± 2.4 to 7.7 ± 2.6 mmHg, P = 0.002). 
In these patients, CI decreased (from 4.3 ± 1.3 to 3.5 ± 1 l/min/m2, P = 
0.013) equally. A negative correlation was established between dPCO2 and 
CI (r2 = 0.40, P <0.001) and between changes in dPCO2 and change in CI 
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groups. The ScvO2 was correlated with CI (r2 = 0.44, P <0.001).
Conclusions  dPCO2 patients with septic shock seem to be related 
principally to CI. dPCO2 might be a marker of tissue perfusion adequacy to 
patient’s metabolism and could be a resuscitation target for management 
of septic shock patients.
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Introduction The early identifi  cation and scrupulous monitoring of tissue 
dysoxia can improve the management of critical patient. In this light, 
the fi  nal product of aerobe and anaerobe metabolism (that is, carbon 
dioxide) can provide useful information on adequacy of tissue perfusion 
and metabolism [1,2]. The aim of our study was to evaluate whether 
the venous–arterial PCO2 gradient provides useful information on tissue 
dysfunction in patients admitted to the ICU.
Methods We retrospectively studied 135 patients admitted to our ICU in 
2006 with a length of stay >24 hours and a gas analysis from arterial and 
central venous blood at admission. Venous–arterial PCO2 gradient (ΔpCO2), 
organ dysfunction in the fi  rst 24 hours and ICU mortality were collected. 
Organ dysfunction was defi  ned as a SOFA score ≥2 for each organ. The 
patients were subdivided and compared on the basis of ΔpCO2 value: 
ΔpCO2 ≥ 6 mmHg (High group) and ΔpCO2 <6 mmHg (Normal group).
Results Thirty-nine patients (29%) showed a ΔpCO2 ≥ 6 mmHg (ΔpCO2 
9.6 ± 3.1). In the Normal group the mean ΔpCO2 value was 1.2 ± 4.1. The 
High group showed a larger rate (44%) of respiratory failure than the 
Normal group (25%) Similarly, cardiovascular dysfunction was observed 
in 49% of the patients of the High group and only in 19% of the Normal 
group (P <0.05). Renal failure was also slightly larger in the High group 
(31%) than in the Normal group (22%) (P >0.05). As expected, patients of 
the High group showed an ICU mortality (33%) three times larger (P <0.05) 
than patients of the Normal group (12%).
Conclusions The above data support the hypothesis that ΔpCO2 can 
provide useful information on the tissue perfusion and metabolism in ICU 
patients and can be used as a reliable biomarker for early prediction of 
organ dysfunction.
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Introduction Lactate (LCT) is used to identify critically ill patients at risk 
of death. Low central venous oxygen saturation (SvO2) is also associated 
with increased mortality. It is physiologically plausible that patients with 
low SvO2 and high LCT do worse versus those with only one of SvO2 or 
LCT abnormal, or with both normal. However, the prognostic value of 
combining LCT and SvO2 is unknown. We studied the association between 
ICU mortality and combinations of SvO2 and LCT abnormality.
Methods  We used a retrospective single-centre cohort methodology 
using data obtained from the comprehensive electronic clinical infor-
mation system (CareVue™). All patients who underwent LCT and SvO2 
measurement (from internal jugular or subclavian vein) during the fi  rst 
24 hours after ICU admission (2004 to 2009) were included. Baseline 
(demographic, physiological), daily follow-up (physiological, SOFA) and 
30-day mortality data were recorded. Worst admission values were used 
to combine SvO2/LCT into four groups (SL groups: 0 to 3) dichotomised by 
mean (SvO2) and median (LCT): 0 – N/N; 1 – L/N; 2 – N/H; 3 – L/H. Descriptive 
analysis used standard statistical techniques. Variables individually 
associated (P <0.20) with SvO2 and/or LCT, and mortality were included in 
a multivariate logistic regression model (with mortality as the dependent 
variable) using forward stepwise inclusion. Variables with adjusted P <0.05 
remained in the fi  nal model.
Results A total of 1,544 patients were included. Mean (SD) SvO2 was 
63.6 (11.3) and median (IQR) LCT 3.85 (4.3). Overall mortality was 20.2%. 
Univariate analysis showed a statistically signifi  cant association between 
SL group and mortality (P  <0.001). This association did not remain 
signifi  cant in multivariate analysis: only LCT (not SvO2) was associated with 
mortality when adjusted for other variables.
Conclusions In this population LCT but not SvO2 predicts 30-day ICU 
mortality. These data does not support the hypothesis that patients with 
low SvO2 and high LCT do worse compared with when only one of SvO2 or 
LCT is abnormal, or if both are normal.
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Introduction High lactate (LCT) identifi  es critically ill patients, predicts 
risk of mortality and guides resuscitation. Low central venous oxygen 
saturation (SvO2) is associated with mortality and is used as a resuscitation 
target. A change in LCT, but not in SvO2, has been shown to relate to 
outcome. It is physiologically plausible that those with low SvO2 and high 
LCT do worse versus those with only one of SvO2 or LCT abnormal, or with 
both normal. Early changes in these combinations may also determine 
subsequent changes in organ performance. We hypothesised that 
changes in combinations in SvO2 and LCT from day 1 to day 2 predicted 
changes in total SOFA between day 2 and day 4.
Methods  We used a retrospective cohort methodology using data 
obtained from the electronic clinical information system. All included 
patients underwent LCT and SvO2 measurement (from internal jugular 
or subclavian vein) in the fi   st 24 hours after ICU admission. Baseline 
(demographic, physiological), daily follow-up (physiological, SOFA) and 
30-day mortality data were recorded. Worst admission values were used 
to combine SvO2/LCT into four groups (SL groups: 0 to 3) dichotomised by 
mean (SvO2) and median (LCT): 0 – N/N; 1 – L/N; 2 – N/H; 3 – L/H. Variables 
individually associated (P <0.20) with a change in total SOFA between day 
2 and day 4 were included in a multivariate linear regression model (with 
change in total SOFA as the dependent variable) using forward stepwise 
inclusion. Variables with adjusted P <0.05 remained in the fi  nal model.
Results A total of 1,544 patients were included. Complete data on all 
change variables were available for 675 patients. Mean (SD) SvO2 was 
63.6 (11.3) and median (IQR) LCT 3.85 (4.3). Mean (SD) APACHE II and age 
were 22.4 (6.2) and 64.9 (15.9), respectively, and 61.9% were male. The 
mean fall (SD) in total SOFA from day 2 to day 4 was 1.05 (2.78). APACHE 
II (adj. P <0.001), day 1 SL group (adj. P = 0.019) and SOFA (adj. P <0.001), 
and C-reactive protein >209 mg/l (adj. P = 0.006) were independently 
associated with Δ-SOFA. Changes in SL group were not associated with 
improvements in organ function (adj. P = 0.12).
Conclusions APACHE II, SL group and total SOFA (both on day 1) and 
C-reactive protein >209 mg/l were associated with worsening organ 
function between day 2 and day 4. Improvement in combinations of SvO2 
and LCT were not associated with changes in organ performance.
P160
Regional lactate and oxygen saturation gradients: 
preliminary experimental data
A Pereira, P Rehder, C Dias, L Poli de Fugueiredo, E Silva
Universidade de São Paulo, Brazil
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Introduction  Regional diff   erences among blood fl   ow and oxygen 
uptake are widely cited but not well explained. The lactate shuttle 
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our comprehension about oxygen delivery and consumption. Recent 
studies have shown the prognostic value of oxygen and lactate gradients 
measured from central venous to pulmonary artery circulation. Our data 
represent one sample of our 4-year experimental research, trying to 
build a conceptual framework related to oxygen and lactate dynamic in 
diff  erent hypoxic states.
Methods Sixteen large white pigs (35 kg) and seven shams were studied. 
After anesthesia and full monitorization (EKG, MAP, etCO2, continuous gas 
analysis, Doppler portal fl  ow, small bowel tonometry, liver tpO2 and urine 
output), abdominal sepsis was induced by fecal peritonitis.
Results See Figures 1 and 2.
Conclusions Our preliminary data show high rates of oxygen extraction 
rates in coronary circulation and suggest apparent lactate consumption 
by heart and lactate production by the lung, during experimental sepsis.
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Introduction Serum lactate and base defi  cit are markers of tissue ischemia 
and are used to assess the adequacy of resuscitation. Recent reports have 
shown that they are also useful markers associated with the severity and 
prognosis of sepsis and trauma; however, there are few reports regarding 
their use in hemorrhagic shock. We examined the utility of serum lactate 
and base defi  cit about the patients with upper gastrointestinal hemorrhagic 
shock. We thought that upper gastrointestinal hemorrhage cases refl  ected 
hemorrhagic clinical conditions of hemorrhagic shock rather than trauma.
Methods We retrospectively reviewed the cases of 152 consecutive patients 
with upper gastrointestinal hemorrhage and analyzed the relationships 
between levels of serum lactate, base defi  cit and hemorrhagic shock on 
admission. We divided the patients into two groups according to whether 
their shock index (systolic blood pressure/pulse) was less than 1 (shock 
group, n = 57; 37.5%) or greater than 1 (nonshock group, n = 95; 62.5%).
Results Among the 152 patients included in the analysis, 97 had gastric 
ulcers, 18 had esophageal varices, 17 had duodenal ulcers, seven had 
acute gastric mucosal lesions, six had gastric carcinoma, fi  ve had Mallory–
Weiss syndrome, and two had gastric varices. The study cohort comprised 
27% women (n = 41) and 73% men (n = 111). The median age was 62.2 ± 
15.1 years. On admission, the average serum lactate level was 3.4 ± 4.2 
mmol/l, and the base defi  cit was –2.4 ± 5.1 mmol/l. The serum lactate level 
and base defi  cit were signifi  cantly higher in the shock group than in the 
nonshock group (5.8 ± 5.5 vs 2.0 ± 2.4 mmol/l, P <0.001, and –4.4 ± 5.8 vs 
–1.0 ± 4.1 mmol/l, P = 0.002, respectively).
Conclusions  We observed a relationship between serum lactate 
level, base defi  cit value and hemorrhagic shock in patients with upper 
gastrointestinal hemorrhage.
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Introduction  Metformin improves glucose control by inhibiting 
hepatocyte mitochondrial complex I [1]. The pathogenesis of metformin-
associated lactic acidosis is poorly understood and whether drug 
accumulation per se can cause hyperlactatemia remains unclear. The aim 
Figure 1 (abstract P160). Oxygen saturation gradients – heart and lung. Figure 2 (abstract P160). Lactate gradients – heart and lung.
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lactate production by inhibiting mitochondrial function in tissues other 
than the liver.
Methods  Platelet-rich-plasma (PRP) from healthy volunteers was 
incubated for 72 hours with diff  erent doses of metformin. The plasma 
lactate concentration was then measured. The proportion of normally 
polarized vs abnormally depolarized platelet mitochondria (FL2/FL1) was 
assessed by fl  ow cytometry after staining with JC-1. Platelet respiratory 
chain complex I activity and citrate synthase (CS) activity, a marker of 
mitochondrial content, were measured by spectrophotometry. Data are 
presented as means ± SD. Analysis was performed with one-way ANOVA.
Results Main results are reported in Table 1.
Conclusions Metformin can cause hyperlactatemia by impairing platelet 
mitochondrial function.
Reference
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Introduction A patient presented with severe acidosis, point-of-care (POC) 
lactate of 42 mmol/l. This led to suspicion of mesenteric ischemia and 
potential need for laparotomy. However, plasma lactates were <4 mmol/l, 
and ethylene glycol (EG) ingestion was subsequently diagnosed. We 
therefore wished to determine why discrepant lactates occur and whether 
this lactate gap (that is, the diff  erence between lactate measured using 
two common methods) could be clinically useful.
Methods We phlebotomized blood, added various concentrations of EG 
metabolites, and tested with the fi  ve most common lactate analyzers.
Results  Glycolate caused massive artifactual lactate elevation with the 
Radiometer 700 POC analyzer even at low concentrations. Another major 
EG metabolite, glyoxylate, but not oxalate (or formate), caused similar 
elevation. The iSTAT and Bayer POC analyzers and Beckman and Vitros 
laboratory analyzers caused minimal lactate elevations. The lactate gap was 
determined by comparing the Radiometer with any of the other analyzers.
Conclusions  We demonstrated how inappropriate laparotomy or 
delayed-therapy might occur if clinicians are unaware of this phenomenon 
(now dubbed the lactate gap) or if hospitals only have access to a single 
analyzer. We also showed how the lactate gap can be exploited: to 
expedite treatment, diagnose late EG ingestion, and terminate dialysis. By 
comparing lactate results from the iSTAT or Bayer versus the Radiometer, 
EG ingestion can be diagnosed at POC, thereby further expediting 
diagnosis and treatment ahead of plasma EG.
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Serum lactate on admission to intensive care and outcome: 
an observational cohort study
A Mackay, H Simpson, L Strachan, T Quasim, M Booth
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Introduction Lactate is an important substrate for intermediary metabo-
lism and allows movement of carbon and reducing power between cells 
[1]. Its use as a measure of end organ perfusion and as a marker of tissue 
hypoxia in the critically ill is well established. It is suggested that a rise 
in serum lactate is a sensitive indicator of poor prognosis in this group 
[2]. We wished to identify whether or not this was the case in our patient 
population.
Methods A retrospective case note review of 504 consecutive admissions 
to Glasgow Royal Infi  rmary ICU was undertaken over an 18-month period. 
Serum lactate on initial blood gas analysis following admission to intensive 
care was retrieved from the clinical information system. Demographic, 
APACHE II score and outcome data were retrieved from the Ward Watcher 
system in the ICU.
Results Complete data were available for 454 patients. Demographics of 
the patient group were as follows: 65% were male with a mean age of 
53.8 ± 1.5 years. Average length of stay was 6.1 ± 0.46 days with a median 
APACHE II score of 18 (IQR 12 to 24). Crude ICU and hospital mortalities 
were 28% and 34.7%, respectively. Mean lactate was 2.46 ± 0.24 mmol/l. 
We constructed an ROC curve for admission lactate vs ICU mortality with 
an area under the curve (AUC) = 0.66, P <0.001. ROC curve for APACHE 
II vs ICU mortality gives AUC = 0.80, P <0.001. Using univariate analysis 
and chi-square testing we found that, using diff  erent thresholds for lactate 
level, we were able to establish a relative risk of death for those exceeding 
this level as follows (RR, P value): >2 mmol/l (RR 1.29, P <0.001), >4 mmol/l 
(RR 1.63, P <0.001), >6 mmol/l (RR 2.08, P <0.001), >8 mmol/l (RR 3.43, 
P <0.001), >10 mmol/l (RR 3.43, P <0.001).
Conclusions  While using ROC analysis suggests serum lactate is of 
moderate predictive value for ICU mortality, applying serial increasing 
lactate cutoff   points and comparing those above and below these points 
suggests a strong relationship between increasing lactate level and 
increased risk of ICU mortality.
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Introduction Acid–base disorders are common in ICU patients and are 
associated with increased mortality and morbidity. A physicochemical 
(PHYSCO) approach to acid–base abnormalities based on principles 
described by Stewart and Figge may explain various derangements better 
than traditional approaches. Recent data suggest an increased inorganic 
ion diff  erence is associated with lower mortality in septic patients. We 
determined the eff  ects of baseline and changes in PHYSCO parameters 
suggested by Stewart and Figge on 30-day mortality in a large cohort of 
unselected ICU patients.
Methods We performed a retrospective cohort study using data obtained 
from the electronic clinical information system. All patients who underwent 
lactate and SvO2 measurement (from internal jugular or subclavian vein) 
during the fi  rst 24 hours after ICU admission were included. Baseline, daily 
follow-up and 30-day mortality data were recorded. The worst recorded 
were used to calculate, for each day and for the change from day 1 to 
day 3, the following PHYSCO parameters: apparent strong ion diff  erence 
(SIDa), inorganic SIDa (iSIDa; excludes lactate), eff  ective SID (SIDe: includes 
pCO2, albumin, pH and phosphate) and strong ion gap (SIG; SIDa minus 
SIDe). Descriptive analysis used standard statistical techniques and 
univariate logistic regression (dependent variable 30-day mortality) 
assumed statistical signifi  cance at P <0.05.
Table 1 (abstract P162)
  No metformin  Metformin 0.01 mM  Metformin 1 mM  Metformin 100 mM  P value
Lactate (mM)  5 ± 1  5 ± 1  10 ± 2  21 ± 4  <0.001
FL2/FL1  5.6 ± 1.5  4.6 ± 1.1  4.6 ± 0.7  1.8 ± 0.7  <0.001
Complex I (nM/minute/mg)  6.8 ± 2.5  6.8 ± 2.3  4.0 ± 1.6  1.6 ± 1.4  <0.001
CS (nM/minute/mg)  102 ± 27  94 ± 15  99 ± 20  105 ± 10  0.74
PRP was incubated with metformin at the reported fi  nal concentrations (n = 4).
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day 1 and day 3 parameters were available in 1,070 and 656 patients, 
respectively. Overall 30-day mortality was 21.3%. Mean (SD) age and 
APACHE II score were 63.0 (16.4) and 21.6 (6.9), respectively. For survivors 
versus nonsurvivors there were signifi  cant diff  erences in baseline SIDa (P = 
0.03), iSIDa, SIDe, lactate and base excess (all P <0.001), but not in SIG (P = 
0.1). An increased SIDa (P = 0.015) and SIDe (P <0.001), and decreased iSIDa 
and lactate (all P <0.001) but not SIG (P = 0.09) were predictive of mortality.
For day 1 to day 3, only Δ-SIG was weakly predictive of mortality (OR 1.03 
per 1 unit increase, P = 0.04, 95% CI = 1.00 to 1.05, n = 656) but there was 
no diff  erence between survival groups (P = 0.051).
Conclusions  This study confi   rms recent data suggesting baseline 
diff  erences (but not changes over 3 days) in the relationships between 
strong and weak ions and pCO2 (refl  ected in SIDa, lactate, and impacts on 
mortality). The diff  erent eff  ects observed for SIG and BE imply a signifi  cant 
unmeasured acid load infl  uencing mortality. Bias and confounding may 
aff  ect these fi  ndings and they should therefore be confi  rmed prospectively.
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Introduction Clinicians adjust mechanical ventilator (MV) in critical care 
units to optimise arterial blood gases (ABG). The present study evaluates 
their accuracy in predicting ABG values following MV adjustment.
Methods Thirty-one sets of data were collected from 16 patients requiring 
mechanical ventilation on the ICU. Each set consisted of two subsets – 
before and after MV adjustment. Each of subset consisted of the following 
variables: FIO2, respiratory rate (breaths/minute), tidal volume (ml/kg), 
body temperature (°C), haemoglobin concentration (g/dl), and ABG values 
(pH, PaCO2, PaO2, base excess). All data, with the exception of ABG values 
after MV adjustment, were presented to clinicians. Thirty-three clinicians 
(11 respiratory therapists (RTs), 11 nurses, and 11 medical staff  ) were asked 
to predict the new ABG values as they would in clinical settings. All data 
are presented as mean ± SD unless stated otherwise.
Results  All datasets include changes in FIO2, while only 13 datasets 
include changes in minute ventilation. Increases in FIO2 were 0.19 ± 0.04 
and decreases were –0.12 ± 0.04. Size of change of minute ventilation was 
1.38 ± 0.95 l/minute. The absolute magnitudes of change for measured 
pH, PaCO2, and PaO2 were 0.024 ± 0.027, 0.40 ± 0.37 kPa and 5.91 ± 3.35 
kPa, respectively. The magnitudes of change for predicted pH, PaCO2, and 
PaO2, respectively, were 0.025 ± 0.033, 0.34 ± 0.23 kPa, and 3.45 ± 2.03 kPa 
for medical staff  ; 0.024 ± 0.021, 0.40 ± 0.41 kPa, and 3.91 ± 1.75 kPa for RTs; 
and 0.022 ± 0.015, 0.32 ± 0.22 kPa, and 3.21 ± 2.1 kPa for nurses. The 95% 
limits of agreement between predicted and measured size of changes for 
pH, PaCO2, and PaO2, respectively, were 0.043 to –0.041, 0.724 to –0.596 
kPa, and 3.22 to –8.14 kPa for medical staff  ; 0.036 to –0.036, 0.66 to –0.66 
kPa, and 2.64 to –6.64 KPa for RTs; and 0.036 to –0.076, 0.74 to –0.9 kPa, 
and 3.91 to –9.31 kPa for nurses. Correlation between duration of clinicians’ 
clinical experience and errors in predicting size of change for pH, PaCO2, 
and PaO2 (–0.0225, –0.054, and 0.173, respectively) were weak and not 
statistically signifi  cant.
Conclusions Clinicians show considerable variation in predicting ABG 
values. Medical staff   and nurses underestimate the magnitude of PaCO2 
changes whereas RTs show some accuracy. All clinicians have a large bias 
in predicting the size of PaO2 changes.
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Introduction Provisional data from the 4th National Audit Project of the 
Royal College of Anaesthetists has identifi  ed that at least 20% of major 
airway events take place on the ICU and that these are more frequently 
fatal than events elsewhere (TM Cook, personal communication). Over 
23% of these incidents relate to the instigation or maintenance of an 
artifi   cial airway [1]. Both the use of capnography and the immediate 
availability of airway rescue devices to avert or manage such incidents 
have been recommended. This study seeks to determine the adherence 
to these recommendations, the availability of such equipment on UK ICUs 
and to identify areas for safety improvement.
Methods Every adult general, hepatobiliary and satellite ICU (grouped 
together as GICU), neurointensive care unit (NICU) and cardiac intensive 
care unit (CICU) in the UK was telephoned, thereby covering every area 
in the UK where ventilated adult patients are routinely cared for outside 
the operating theatre. Data were obtained from the nurse in charge over 
a 3-month period in 2009.
Results In total, 315 of 328 contacted units responded (96% response). 
Capnography during intubation: 32% units use always, 43% sometimes 
and 25% never. Capnography for continuous monitoring of intubated 
patients: 25% units use always, 35% sometimes and 40% never. Of 
note, 45% of NICUs never use capnography for continuous monitoring 
(where doing so may prove most benefi  cial). Basic airway equipment 
(oropharyngeal airways, laryngoscopes and bougies), alternative means of 
patient ventilation and equipment checking procedures are seen on 97 to 
100% of ICUs. A standard laryngeal mask (LMA) is available on 97% of ICUs. 
More advanced airway rescue devices are seen less commonly: 71% have 
a McCoy laryngoscope and 55% have a bougie through which ventilation 
is possible. Forty-three per cent have an intubating LMA and 21% have 
supraglottic airway with a gastric port immediately available. Forty-nine 
per cent of units have a bronchoscope on the ICU. Seventy per cent of 
units have equipment for emergency trans-tracheal access. CICUs are least 
likely to use capnography or have airway rescue equipment immediately 
available.
Conclusions Basic standards of airway safety are not being met on UK 
ICUs and are far from the standards being routinely employed in the 
operating theatre. The potential airway diffi   culties presented by the ICU 
patient, together with the lack of routine use of capnography, exposes 
these patients to signifi  cant risks that may be easily addressed.
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non-invasive monitoring in patients after cardiac surgery
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Introduction The aim of this study was to validate the revised V-Sign™ 2 
ear lobe sensor for combined assessment of pulse rate (PR), pulse oximetry 
(SpO2) and transcutaneous carbon dioxide tension (PtcCO2) in adults after 
cardiac surgery.
Methods In 20 patients coevally readings of blood gases were compared 
with values of the V-Sign™ 2 ear lobe sensor. Measurements were 
performed during periods of hypercapnia, normocapnia and hypocapnia 
and then in intervals of 30 minutes up to 5 hours. Agreement was assessed 
by Bland–Altman analysis and single regression analysis.
Results Two hundred and ninety-six data pairs were analysed. Detection 
failures for PtcCO2 were 1.3%, for SpO2 10% and for PR 5%. PtcCO2 and 
PaCO2 ranged between 3.58 and 7.70 kPa. Mean bias and limits of 
agreement (LOA) between PtcCO2 and PaCO2 was excellent (Table 1). The 
best agreement between PtcCO2 and PaCO2 was found during periods of 
Table 1 (abstract P168). Agreement between V-Sign™ 2 sensor and 
co-oximetry and ECG
       Limits  of
Parameter  n (data pairs)  r2 Mean  bias agreement
PtcCO2–PaCO2 (kPa)  296  0.92  +0.14  –0.45/+0.73
V-Sign™ SpO2–SaO2 (%)  270  0.59  –1.68  –6.81/+3.45
V-Sign™ PR-ECG (bpm)  285  0.98  +1.22  –3.31/+5.75
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(–0.31/+0.67 kPa) and 0.07 kPa (–0.45/+0.59 kPa), respectively. At about 5 
hours no relevant drift was observed between PtcCO2 and PaCO2. V-Sign™ 
2 SpO2 moderately agreed and slightly underestimated SaO2 determined 
by direct oximetry, whereas pulse rate values detected by the V-Sign™ 2 
ear lobe sensor agreed well with those of the ECG (Table 1).
Conclusions  Transcutaneous capnography using the V-Sign™ 2 ear 
lobe sensor reliably detects the ventilation state of patients after cardiac 
surgery. This non-invasive approach has the potential to reduce the 
number of arterial blood gas samples.
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Introduction  Intubation and mechanical ventilation impair secretion 
clearance and can lead to lung collapse, consolidation and ventilator-
associated pneumonia [1]. There is, however, no valid diagnosis of 
secretion retention in the intubated and ventilated patient. Vibration 
response imaging (VRI) is a commercially developed acoustic lung 
imaging system that displays breath sound distribution [2]. VRI should be 
able to identify relationships between specifi  c breath sound distributions 
and secretion retention. This preliminary study investigated the changes in 
VRI measurements before and after chest physiotherapy in adult intubated 
and mechanically ventilated patients.
Methods Intubated and ventilated adult patients who were receiving 
chest physiotherapy were investigated. Lung sound amplitude at 
peak inspiration was measured immediately before and after chest 
physiotherapy using two arrays of sensors attached to the patient’s back in 
a supine position. Chest physiotherapy included combinations of closed 
airway suctioning, saline lavage, postural drainage, manual techniques 
and/or lung hyperinfl  ation, dependent upon clinical indications. Means 
are compared with the Wilcoxon matched-pairs signed-ranks test.
Results  A total of 16 patients were included in the study (12 males, 
four females, age 65 ± 14). Patients were predominantly ventilated with 
continuous positive airway pressure and pressure support. Following 
physiotherapy, total lung sound amplitude at peak inspiration decreased 
twofold from 37 ± 58.106 to 18 ± 23.106 arbitrary units (AU), with signifi  cant 
reduction in the left lung (P = 0.03). Furthermore, the diff  erence in sound 
amplitude between right and left lungs signifi   cantly decreased post-
treatment compared with pretreatment (P = 0.03).
Conclusions  Computerized lung sound monitoring may be useful to 
assess secretion retention and the eff   ectiveness of secretion removal 
in mechanically ventilated patients. Further investigation is, however, 
necessary in order to distinguish between secretion-related eff  ects and 
changes due to other factors such as airfl  ow rate and pattern.
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Introduction Posterior auscultation of mechanically ventilated patient 
is challenging. Environmental ICU noises make the detection of subtle 
auscultatory features diffi   cult. Digitalized pulmonary acoustic monitoring 
has recently been introduced in the ICU. We explored the possibility to 
listen to sound waves recorded by the VRI system.
Methods Lung sounds were recorded for 20 seconds using two arrays of 
17 piezoelectric contact sensors attached to the patient’s back in a supine 
position. Sound fi  les were archived in a WAV format for offl   ine analysis. 
Three physicians and one trained respiratory therapist, blinded to the 
patient’s clinical status, provided their fi  ndings while listening to sound 
waves recorded by 12 sensors distributed from apex to base, six from 
each lung. Breath sounds were categorized as normal versus abnormal 
and adventitious lung sounds were characterized as wheezes, rhonchi or 
crackles. Findings were compared with anterior stethoscope auscultation 
performed at the time of the recording by one of the physicians.
Results Eighteen critically ill mechanically ventilated patients (age 65 ± 
17) were enrolled in this study. Chest radiography (CXR) fi  ndings included 
consolidation in 13 patients. There was an agreement among at least 
three clinicians in the normal/abnormal classifi   cation. Furthermore, in 
10 out of these 15 patients (67%), this assessment based on sound wave 
analysis was in agreement with anterior stethoscope auscultation. Finally, 
the physician who performed both sound wave analysis and stethoscope 
auscultation reported crackles/rhonchi in fi  ve out of 13 patients with 
consolidation (38%) during sound wave analysis but only in one patient 
during auscultation (8%).
Conclusions  The level of interobserver variability for sound wave 
characterization was comparable with levels usually reported during 
stethoscope auscultation. However, in patients with consolidation, 
a higher number of crackles/rhonchi was reported during posterior 
sound wave analysis than during anterior stethoscope auscultation. This 
discrepancy may be either due to the anterior/posterior orientation or to 
the higher sensitivity of the offl   ine sound wave analysis.
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Introduction Knowledge of micromechanical properties of lung paren-
chyma is essential for understanding macroscopic lung mechanics. The 
fi  rst results of in vivo and in situ measurements using an endomicroscopic 
device [1] are reported. The degree of local lung deformation in 
dependence of locally applied pressure is shown.
Methods An endoscopic system including two concentric trocars was 
constructed to apply a defi  ned local pressure within the fi  eld of view (Pfov). 
Figure 1 (abstract P171).
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ventilated rats with the tip placed on the pleura. Pfov was applied to 
a circular area on to the lungs’ surface and led to a local deformation. 
By adjusting the fl  ow rate of the fl  ushing fl  uid from the outer trocar to 
the inner trocar, Pfov was varied. The resulting local deformation of lung 
parenchyma was optically measured by estimating the diameter of 
ceramic particles, fi  xed on the pleura for that purpose. Deformation was 
measured at diff  erent levels of airway pressure (Paw) with Pfov ramped from 
0 to –40 mbar.
Results The healthy lung (Figure 1A) parenchyma showed less deformation 
caused by fl  uidic pressure compared with the lavaged lung (Figure 1B). In 
contrast to the lavaged lung, the deformation of the healthy lung was less 
when higher Paw was present.
Conclusions Micromechanical properties of lung parenchyma can be 
analyzed in vivo at an alveolar level. The healthy lung parenchyma appears 
to be stiff  er (less deformation) at higher Paw. The stronger deformation 
and less dependence on airway pressure in the lavaged lung support the 
hypothesis that small lung compliance in lavaged lungs might not be 
reasoned by stiff   lung parenchyma, but rather by regional collapse.
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Introduction  Combined monitoring of functional residual capacity 
(FRC) and compliance of the respiratory system (Crs) at the bedside may 
allow alveolar recruitment and detect hyperinfl  ation [1]. The aims of this 
study were to evaluate the FRC by a modifi  ed nitrogen multiple washout 
technique (NMBW) combined with the study of Crs, to set best PEEP on 
data of FRC and Crs, and to evaluate by echocardiography study the 
cardiac response to diff  erent levels of PEEP.
Methods Thirty patients with ALI/ARDS were ventilated with an Engstrom 
carestation ventilator (GE Healthcare, Helsinki, Finland) in accordance with 
the ARDS net guidelines. FRC measurement was carried out with the COVX 
module integrated within the ventilator (GE Healthcare) by the NMBW 
technique. Every patient had a basal FRC measurement and then three 
measurements at PEEP 15/10/5 cm H2O during a de-recruiting maneuver. 
At every step we studied the changes of FRC, Crs, PaO2/FIO2 ratio and 
performed a transthoracic echocardiography (Agilent 5500; Hewlett and 
Packard) to evaluate the integral of velocity time of left ventricular outfl  ow 
tract (LVOT VTI). All data are reported as mean ± SD. ANOVA was used to 
compare changes during the time.
Results Table 1 presents the main results of the study. Best PEEP was set 
at 10 cmH2O, at which level the decrease of FRC and improvement of Crs 
indicates the start of de-recruitment and end of overdistention.
Table 1 (abstract P172)
  PEEP 15  PEEP 10  PEEP 5
FRC ml  2,975 ± 644  2,412 ± 585*  2,059 ± 556**
Crs ml/cm   33 ± 8  39 ± 9*  45 ± 10**
PaO2/FIO2  310 ± 62  291 ± 78  185 ± 89†
LVOT VTI cm  16.3 ± 2  20 ± 3*  22 ± 6**
*P <0.05. **P <0.01 vs PEEP 15. †P <0.001 vs PEEP 15 and 10.
Conclusions Increased levels of PEEP improve FRC. Combined monitoring 
of FRC and Crs may detect hyperinfl  ation. Hyperinfl  ation impairs LV systolic 
function.
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Introduction Electrical impedance tomography (EIT) is a promising new 
tool for bedside monitoring of regional lung ventilation. Several studies 
have focused on the ventilation distribution and relationship with regional 
lung volume on a lower, caudal lung level. However, no information is 
available at a higher, cranial lung level.
Methods EIT (EIT Evaluation Kit 2; Dräger, Lübeck, Germany) was measured 
at cranial and caudal lung levels in 10 patients after cardiothoracic surgery. 
Patients were fully sedated and mechanically ventilated and a PEEP trial 
was performed at four PEEP levels (15, 10, 5 and 0 cmH2O).
Results The center of gravity index decreased after lowering the PEEP 
level at both the caudal and cranial lung levels (Figure 1 right). Whereas 
the tidal volume impedance variation divided by tidal volume increased 
at the cranial lung level and decreased at the caudal lung level during the 
step-wise reductions in PEEP (Figure 1 left).
Conclusions During decremental PEEP steps, the ventilation distribution 
not only shifts from a dorsal to ventral direction, but also from the caudal 
to cranial direction.
Figure 1 (abstract P173).
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in an experimental model of acid-induced acute lung injury
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Introduction Electrical impedance tomography (EIT) is a promising bedside 
tool for monitoring regional lung ventilation during mechanical ventilation 
[1]. The purpose of this study was to assess regional lung ventilation by 
EIT in a pig model of acid-induced acute lung injury (ALI) during pressure-
controlled (PCV) and volume-controlled ventilation (VCV).
Methods Ten anesthetized and tracheotomized female pigs (25 to 30 
kg) were randomized into two groups: mechanical ventilation by PCV 
(pressure adjusted to achieve and maintain 8 ml/kg tidal volume, n = 
5) or VCV (8 ml/kg, n = 5) in FiO2 50%. ALI was induced in both groups 
by intratracheal instillation of 4 ml/kg hydrochloric acid (HCl) 0.1 N. 
Impedance changes (Draeger, Germany) were recorded by a 16-electrode 
belt placed at the level of the sixth intercostal space, and four horizontal, 
equally-sized regions of interest (ROIs) were defi   ned for offl   ine  data 
analysis. Measurements were performed before (T-BL) and after lung 
injury (T-ALI). Lung tidal volume (Vt), pulmonary static compliance (Cstat), 
pulmonary mean artery pressure (mPAP), peak pressure (Pp), respiratory 
rate (RR) and PaO2/FiO2 ratio were also recorded. Statistical analysis was 
based on two-way ANOVA followed by the Tukey test for analysis of data 
within and between groups, and a t test was used analysis of impedance 
changes induced by ALI.
Results After ALI, both PCV and VCV groups showed signifi  cant decreases 
in the PaO2/FiO2 ratio (479.6 ± 46.5 to 244.5 ± 64.7 and 428.8 ± 22.9 to 
212.4 ± 26.7) and Cstat (29.2 ± 5.1 to 13.2 ± 2.3 and 26.6 ± 3.4 to 12.3 ± 3.2) 
and signifi  cant increases in Pp (14.2 ± 1.9 to 25.6 ± 2.6 and 13.8 ± 0.8 to 
24.6 ± 4.16) and mPAP (19.6 ± 0.5 to 35.2 ± 5.8 and 19.4 ± 1.5 to 26.8 ± 
4.5). Between groups, only mPAP was statistically diff  erent at T-ALI. Global 
impedance decreased slightly after ALI in both groups, with no statistical 
signifi  cance. At T-ALI, there were statistically signifi  cant diff  erences in tidal 
distributions of ROIs 2 (38.9 ± 2.6% to 42.4 ± 3.9%) and 3 (39.7 ± 3.1 to 
35.1 ± 4.3%) of animals in the VCV group, when compared with T-BL. No 
signifi  cant diff  erence was found in the PCV group.
Conclusions EIT assessment of ventilation revealed a ventral shift in the 
tidal distribution in the VCV group after ALI, while PCV preserved tidal 
distribution observed at baseline.
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Introduction Electrical impedance tomography (EIT) is a non-invasive 
bedside imaging tool with the potential to assess regional lung ventilation 
reliably [1]. The purpose of this study was to monitor changes in lung 
impedance in a pig model of severe shock followed by fl  uid resuscitation.
Methods Twelve anesthetized, mechanically ventilated (8 ml/kg, PEEP 
5 cmH2O), supine pigs were submitted to acute hemorrhagic shock with 
infusion of endotoxin. Animals were allocated to positive control (PC, n = 
6) or treatment group with lactated Ringer’s to achieve and maintain pulse 
pressure variation 13% and mean arterial pressure 65 mmHg (PPV, n = 6). 
Ventilatory and hemodynamic parameters were recorded at baseline, 
1 hour after hemorrhagic shock (Tshock), and hourly for 3 hours (T1 to T3). 
A 16-electrode belt was placed at the level of the sixth intercostal space 
for EIT measurements (Dräger, Germany). Offl   ine analysis was based on 
four horizontal regions of interest (ROIs) over the ventrodorsal lung area. 
Statistical analysis was based on two-way ANOVA followed by the Tukey 
test (P <0.05).
Results  At Tshock there was hemodynamic compromise, statistical 
decrease in lung compliance (Cstat) and signifi  cant increases in pulmonary 
vascular resistance index, mean pulmonary artery pressure and peak 
pressure (Ppeak), with no statistical diff  erence between groups. Endpoints 
and hemodynamic stability were achieved in the PPV group in 117 ± 
28 minutes. Cstat continued to deteriorate and Ppeak continued to rise in 
both groups from T1 to T3. When compared with PC, the PPV group had 
signifi  cant impedance increases in ROIs 1 and 2 at T2 and T3 and, at T3 
the increase in ROI 1 was also statistically greater than Tshock within the 
group. Statistical decrease in the percentage tidal distribution in ROI 3 and 
increase in ROI 2 of the PPV group, in relation to the PC group, were also 
noted.
Conclusions Despite re-establishment of hemodynamic adequacy in PPV 
group and although ventilatory parameters were similar in both groups 
over time, resuscitation as performed in the study induced signifi  cant 
changes in tidal impedance toward nondependent lung regions, implying 
greater lung impairment in treated animals.
Acknowledgements Grants from FAPESP 08/50063-0, 08/50062-4 and 
LIM08/FMUSP.
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Introduction At the bedside, but even in most research work, the analysis 
of respiratory system mechanics is limited to quasi-static conditions 
excluding any insight into what happens during the breath. The new 
gliding-SLICE method helps looking into the breath. It is a further 
development of the SLICE method for calculating compliance and 
resistance of subsequent intratidal volume ranges (slices) of the pressure–
volume (PV) loop by multiple linear regression analysis in a continuous 
way. This allows for detecting intratidal compliance and resistance 
nonlinearity during ongoing ventilation. Our objective was to determine 
whether the nonlinear intratidal compliance profi  le hints at what level to 
set PEEP and tidal volume (VT) to make lung ventilation protective.
Methods In 12 piglets, atelectasis was induced by application of negative 
pressure. The PV relationship and the ECG signal were recorded during 
mechanical ventilation at diff  erent levels of end-expiratory pressure (PEEP: 
0, 5, 10 and 15 cmH2O) and a VT of 12 ml/kg BW. Using the gliding-SLICE 
method [1], intratidal compliance profi  les were calculated and compared 
with the conventional quasi-static compliance.
Results In contrast to quasi-static compliance, the gliding-SLICE method 
revealed pronounced intratidal nonlinearity of the compliance profi   le 
under ongoing ventilation (Figure 1). At low levels of PEEP, intratidal 
compliance increased in the low volume range, remained at a high level 
while further volume was delivered, and fi  nally decreased with volume 
>6 ml/kg BW. With higher levels of PEEP, intratidal compliance decreased 
from the onset of inspiration.
Conclusions The gliding-SLICE method gives detailed insights into the 
intratidal course of compliance during uninterrupted ventilation. From 
Figure 1 (abstract P176).
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recruitment and/or overdistension can be identifi  ed.
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Introduction Heartbeats transfer mechanical energy to the lungs causing 
fl  ow and pressure disturbances that appear as cardiogenic oscillations (COS) at 
the airway opening. Here we adopt a new approach for analyzing respiratory 
system mechanics. We consider the beating heart as a natural intrathoracic 
mechanical oscillator transferring mechanical energy to the lungs that travels 
across the lung parenchyma. COS therefore convey information on the 
mechanical conditions of the lung parenchyma that they cross.
Methods In 25 piglets with either healthy or atelectatic lungs, the pressure–
volume relationship and the ECG signal were recorded during mechanical 
ventilation at diff  erent levels of end-expiratory pressure (PEEP: 0, 5, 10 and 
15 cmH2O). The heartbeat-related disturbance of the PV loop was quantifi  ed 
as the maximal compliance following an R-wave in the ECG signal, as 
determined by the gliding-SLICE method. Atelectasis was assessed by CT.
Results The intratidal pattern of heartbeat-induced CCOS changed with PEEP 
and atelectasis in a characteristic way. With PEEP and tidal volume levels 
assumed to be lung protective CCOS was high with little intratidal changes, 
compared with atelectasis and overdistension that were signaled by low CCOS 
that either increased (atelectasis) or decreased (overdistension) intratidally. 
The systolic pressure variations did not parallel the CCOS pattern, hinting at a 
negligible impact of hemodynamics on the inspiratory CCOS pattern.
Conclusions  Heartbeats induce fl   uctuations in the PV loop and, as a 
consequence, peaks in compliance, which show characteristic patterns 
depending on the presence of atelectasis or overdistension. The gliding-SLICE 
method has the potential to detect those intratidal nonlinearities without 
requiring additional technical equipment making use of the ECG signal and 
the pressure and fl  ow signals already required for controlling the ventilator.
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with EIT during a PEEP trial in porcine acute lung injury
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Introduction Setting the optimal level of positive end-expiratory pressure 
(PEEP) in the ICU is still a matter of debate. Talmor and colleagues used 
the transpulmonary pressure calculated from the oesophageal balloon to 
set PEEP in a recent randomized controlled study. This strategy aims at 
preventing alveolar collapse by counterbalancing the gravitational force 
of the lung by an equal or higher PEEP. We evaluated the relation between 
ventilation distribution measured by EIT and transpulmonary pressure 
during a PEEP trial in porcine ALI.
Methods  Eight pigs (30 kg) were studied during a PEEP trial before 
and after the induction of acute lung injury (ALI) with oleic acid. Global 
lung parameters, regional compliance, and oesophageal pressure 
were recorded at the end of each PEEP step. Regional compliance was 
calculated by dividing the tidal impedance variation (EIT Evaluation Kit 2; 
Dräger, Lübeck, Germany) by the applied driving pressure.
Results Transpulmonary pressures were negative at 0 cmH2O PEEP and 
became positive during the stepwise increase of PEEP at 5 cmH2O before, 
and 10 cmH2O PEEP after the induction of ALI (Figure 1). Optimum regional 
compliance was diff  erent between the ventral (nondependent) and dorsal 
(dependent) regions of interest (ROI). In the healthy lung, optimum PEEP 
was 10 in the dorsal ROI and 5 in the ventral ROI, whereas after ALI this was 
15 in the dorsal ROI and 5 in the ventral ROI.
Conclusions If EIT is measured at a caudal lung level, optimal EIT PEEP in the 
dependent lung exceeds the PEEP required for positive transpulmonary 
pressures as used in the Talmor study, whereas in the nondependent lung 
optimal EIT PEEP is equal before ALI and lower after ALI. We speculate that 
this is probably infl  uenced by the location of the EIT slice in the cranial to 
caudal direction.
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Introduction Some cases of pneumonia may lead to hypoxemia with 
acute respiratory failure, acute lung injury (ALI) or acute respiratory distress 
syndrome (ARDS), which may require intensive management. Neutrophil 
elastase is thought to be one of the causes of ALI/ARDS, because it raises 
the pulmonary capillary permeability, lyses of pulmonary connective 
tissue proteins, and produces leukocyte chemotactic factors. However, 
a causal relationship between the plasma neutrophil elastase level and 
changes in the pulmonary capillary permeability has not been established 
in patients with pneumonia, one of the most serious diseases underlying 
ALI/ARDS. Therefore, the objective of this study was to determine whether 
an increase in plasma neutrophil elastase is related to elevation of the 
pulmonary capillary permeability in patients with pneumonia.
Methods  Patients with pneumonia who were hospitalized from 
November 2008 to April 2009 and had PaO2 ≤60 in room air with no need 
for mechanical ventilation were prospectively enrolled in the study. Plasma 
neutrophil elastase levels were collected via blood samples at baseline; 1, 
3, and 7 days after the start of the study. Of those enrolled, patients with 
Figure 1 (abstract P178).
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pulmonary vascular permeability index (PVPI) monitored using the PiCCO 
system (Pulsion, Munich, Germany) when required by their attending 
physician. Statistical analysis was performed using the Spearman 
correlation coeffi   cient (Rs) with P ≤0.05 assumed to be signifi  cant.
Results  Fourteen patients were enrolled in the study. In six of these 
patients, the EVLWi and PVPI were measured simultaneously. At baseline, 
the elastase level and the PVPI showed a strong and signifi  cant correlation 
(Rs = 1.000, n = 6, P <0.05). All of the plot data of the six patients showed 
strong correlations of the elastase level with the EVLWi (Rs = 0.750, n = 25, 
P <0.01) and the PVPI (Rs = 0.811, n = 25, P <0.01).
Conclusions The plasma neutrophil elastase level and the PVPI measured by 
PiCCO were strongly correlated in patients with pneumonia. This suggests 
that a rise in the blood level of elastase may elevate the PVPI, resulting in an 
increased EVLWi. (UMIN Clinical Trials Registry: ID UMIN000002803.)
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Introduction Acute lung injury (ALI), and its more severe subset acute 
respiratory distress syndrome (ARDS), are a major cause of mortality in the 
ICU [1]. Mechanical ventilation, a supportive therapy necessary to sustain 
life in many cases, may contribute to and worsen ALI, termed ventilator-
induced lung injury (VILI). Fibroproliferation is an early response to lung 
injury [2]. Indeed, dysregulated repair resulting in pulmonary fi  brosis may 
be at the heart of ventilator dependence in ARDS. Characterising the role 
of excessive lung stretch in contributing to aberrant repair mechanisms 
would assist in developing strategies to hasten recovery from ARDS.
Methods Male Sprague–Dawley rats were anaesthetized, orotracheally 
intubated and subjected to injurious ventilation until a defi  ned worsening 
of compliance was noted. The rats were then recovered and extubated. 
The level of ongoing injury/repair was characterised at time periods of 
6, 24 and 48 hours and at 4, 7 and 14 days. Systemic oxygenation, lung 
compliance, wet/dry ratio, BAL total protein, cytokines and cell count and 
histological analysis was carried out at each time point.
Results  The results demonstrated a time-course-dependent improve-
ment in compliance and oxygenation, together with clearance of 
neutro  philic infi   ltration at 96 hours. TNFα, and IL-1β, IL-6 and IL-10 
were signifi  cantly elevated in BAL fl  uid early post injury. Although total 
lung collagen remained similar at all time points, evidence of an early 
fi   broproliferative response was present in the form of transforming 
growth factor-β activation and pro-collagen I and III peptide mRNA levels. 
Matrix metalloproteinase 3 and 9 zymography demonstrated increased 
levels of these matrikines. Histologic assessment of injury revealed 
increased alveolar tissue fraction up to and including 96 hours post injury. 
Myofi  broblasts were present in α-smooth muscle actin stained sections in 
signifi  cantly increased numbers post injury.
Conclusions  This rat model of repair of VILI demonstrates some of 
the mechanisms by which excessive lung stretch can contribute to 
fi  broproliferation in ARDS and will serve to improve our knowledge of 
aberrant lung tissue remodelling as well as provide a useful paradigm for 
testing strategies to hasten recovery in ALI.
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Introduction The eff  ects of hemorrhagic shock on respiratory system 
mechanics have rarely been investigated and published data are 
controversial. Pulmonary compliance depends in part on intrapulmonary 
blood and interstitial fl  uid volume. When compliance is severely reduced, 
small modifi  cation of these components may have important eff  ects. The 
present analysis explored the eff  ect of hemorrhagic shock on respiratory 
system mechanics and oxygenation parameters in a model of pigs with 
ARDS.
Methods We evaluated the dynamic respiratory system compliance (Crs = 
VT / (inspiratory airways pressure – PEEP)) of 14 domestic pigs. Animals 
were mechanically ventilated: tidal volume (VT) set at 10 ml/kg; respiratory 
rate at 15 bpm; PEEP at 0 cmH2O. Animals were separated into a control 
group (n = 9) and an ARDS group (n = 5). ARDS was induced by lung lavage 
with NaCl 0.9%. During hemorrhage 40% of the total blood volume was 
removed. The blood was then infused during the re-transfusion phase.
Results  In the control group, Crs (ml/cmH2O) did not change during 
hemorrhage or re-transfusion (Figure 1). In the ARDS group, Crs decreased 
with lung lavage (31.2 ± 5.7 (baseline) to 16.4 ± 3.0; *P <0.01). After 
hemorrhage Crs increased (21.5 ± 2.9; **P <0.001 compared with lavage) 
and then decreased again after re-transfusion (18.7 ± 2.7; ***P <0.05). 
In the same group PaO2/FiO2 (mmHg) decreased after ARDS (469 ± 50 
(baseline) to 105 ± 38; P <0.001), increased during hemorrhage (218 ± 
105; P <0.05) and did not change after re-transfusion (207 ± 125; P = 0.82). 
The shunt fraction (%) decreased during hemorrhage in the ARDS group 
(26.2 ± 14.9 (lavage) to 6.4 ± 6.6; P <0.05) but did not change signifi  cantly 
after re-transfusion (13.9 ± 17.0; P = 0.3).
Conclusions  Acute reduction of blood volume is associated with an 
increase of respiratory system compliance and oxygenation parameters. 
Reduction of intrapulmonary blood and interstitial fl   uid volume or 
thoracic cage compliance could be responsible for this eff  ect.
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Introduction  Trials comparing higher versus lower levels of positive 
end-expiratory pressure (PEEP) in adults with acute lung injury or acute 
respiratory distress syndrome (ARDS) were underpowered to detect small 
but important eff  ects on mortality, overall or in any subgroups.
Methods  We searched MEDLINE, Embase, and the Cochrane Central 
Register for trials randomly assigning adults with acute lung injury 
or ARDS to higher versus lower levels of PEEP (minimal diff  erence of 
3 cmH2O over fi  rst 3 days), while using low tidal volume ventilation, and 
comparing mortality. Data from 2,299 individual patients in three trials 
Figure 1 (abstract P181). Respiratory system compliance. Tidal volume, 
10 ml/kg.
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eff  ect modifi  ers using multivariable hierarchical regression, adjusting for 
important prognostic factors and clustering eff  ects.
Results Overall, there were 374 hospital deaths (32.9%) in the higher PEEP 
group and 409 (35.2%) in the lower PEEP group (adjusted relative risk, 0.94; 
95% confi  dence interval (CI), 0.86 to 1.04; P = 0.25). Treatment eff  ects varied 
with the presence or absence of ARDS, defi  ned by a ratio of partial pressure 
of oxygen to fractional inspired oxygen concentration equal to or less than 
200 mmHg (interaction P = 0.02). The relative risks of hospital mortality for 
patients with and without ARDS were 0.90 (95% CI, 0.81 to 1.00, P = 0.049) 
and 1.37 (95% CI, 0.98 to 1.92, P = 0.065), respectively. Patients with ARDS 
were more likely to achieve unassisted breathing earlier (hazard ratio, 1.16 
(95% CI, 1.03 to 1.30, P = 0.01); whereas the hazard ratio for time to unassisted 
breathing was 0.79 (95% CI, 0.62 to 0.99, P = 0.04) in patients without ARDS 
at baseline. Rates of pneumothorax and the use of neuromuscular blockers, 
vasopressors and corticosteroids were similar.
Conclusions  Higher levels of PEEP are likely to improve survival for 
patients with ARDS, but not for patients with less severe acute lung injury.
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Introduction Experimental and clinical studies have shown benefi  cial 
eff  ects of recruitment maneuvers (RMs) (sustained infl  ation (SI) or SIGH) 
on ventilatory and gas exchange parameters. In this study we investigated 
the eff  ect of diff  erent RMs on bacterial translocation from lung to blood.
Methods  Thirty-two rats were anesthetized, after tracheotomy was 
performed ventilation was started with 10 cmH2O Paw, 0 cmH2O PEEP, 60 
breaths/minute, I/E: 1/2 on pressure-controlled ventilation (PCV) mode. 
After cannulation of the carotid artery was performed, a baseline blood 
gas sample was taken. Subsequently 0.5 ml of 105 cfu/ml Pseudomonas 
aeruginosa was inoculated through the tracheotomy tube and PEEP was 
increased to 3 cmH2O and ventilated for 30 minutes before randomization. 
Then rats were randomized into four groups: G1; SI was performed as 
40 cmH2O PEEP and 0 Paw for 20 seconds, four times in an hour (15-minute 
intervals), G2; SI was performed as 20 cmH2O PEEP and 0 Paw for 40 seconds, 
four times in an hour (15-minute intervals), G3; SIGH was performed four 
times in 1 hour (15-minute intervals) as 40 cmH2O Paw, 3 mH2O PEEP for 
60 seconds, G4; control group that was ventilated with Paw 10 cmH2O, PEEP 
3cmH2O during the study period. Multiplication of pressure and pressure 
performing time for each study group were equal. Blood cultures were 
taken at baseline, 15 minutes after randomization, which is after each 
RM for the fi  rst hour, and last blood culture was taken after 60 minutes 
from the fourth RM. Then rats were sacrifi  ced with intra-arterial sodium 
thiopental, and the lungs were extirpated; the left lung was taken for 
measurement of the wet weight/dry weight ratio (WW/DW).
Results There were no diff  erences in baseline pH, PaO2, PaCO2, MAP, HR 
among groups. But PaO2 were decreased in groups G1, G2, and G3, but 
only in G3 was statistically signifi  cant to compared baseline values. The 
WW/DW ratio was found higher in G3 when compared with G1, and G2, 
but this diff  erence was not signifi  cant. The amount of positive blood 
culture was higher in G3 at early study periods.
Conclusions SIGH as a recruitment maneuver causes a high probability of 
bacterial translocation from the lung to the bloodstream.
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Introduction Alveolar recruitment/de-recruitment (R/D) seems to play an 
important role in the development of VILI [1]. Many clinicians base their 
determination of PEEP settings during mechanical ventilation of ARDS/
ALI patients on an estimate of alveolar recruitability [2]. This project aims 
to establish an online tool that provides estimates of R/D in patients at 
the bedside.
Methods In volume-controlled ventilated piglets as ARDS models, the 
airway pressure Paw (SI-Special Instruments, Nördlingen, Germany) and the 
fl  ow rate Q (F + G GmbH, Hechingen Germany) were continuously recorded 
at 200 Hz. The pressure curve shows high nonlinearity being a suspect 
of recruitment eff  ects during inspiration and a relaxation process during 
the end inspiratory pause. Based on the obtained data, the parameters 
of the linear viscoelastic model [3] are calculated by a LSE fi  tting process. 
As the parameter C1 represents a static constant compliance of the lung, 
this model is not capable of reproducing the nonlinear eff  ects during 
inspiration. To improve on this, the constant compliance C1 is replaced by 
a nonlinear pressure-dependent compliance describing recruitment and 
dilatation as proposed by Hickling [1].
Results Since the nonlinear model has far more variable parameters to 
be optimized in the fi  tting process than the linear model, an approach via 
fi  tting the linear model fi  rst is helpful. Therefore, the estimated parameters 
of the linear model fi  t can be used as starting values for fi  tting the nonlinear 
model where the focus can be put on the recruitment phenomena. With 
the new nonlinear model, using the estimated values of R1, R2, C2 from the 
linear model (Figure 1 left), it is now possible to reproduce the nonlinear 
characteristics (Figure 1 right).
Conclusions Using this new model it is possible to fi  t nonlinear behavior 
due to alveolar recruitment separately from viscoelastic eff  ects  with 
minimized error.
Figure 1( abstract P184).
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Introduction Starting in April 2009 the swine-origin infl  uenza (H1N1) virus 
is considered a worldwide pandemic and is associated with a large number 
of patients admitted to intensive care. In a proportion of these patients, 
acute respiratory distress syndrome (ARDS) can develop. We described the 
case of two patients that presented ARDS related to H1N1 virus confi  rmed 
by a nasal swab tested with real-time reverse transcription-polymerase 
chain reaction. Using a lung CT scan we measured the potential of lung 
recruitment and the response to positive end-expiratory pressure (PEEP) in 
terms of gas exchange and respiratory mechanics.
Methods Patients underwent a lung CT scan at an airway pressure of 5 
and 45 cmH2O; lung profi  les were outlined and quantitative analysis was 
performed with custom-made software. The potential of lung recruitment 
was computed as the amount of nonaerated lung tissue at 5 cmH2O in 
which aeration can be restored at an airway pressure of 45 cmH2O. The 
PEEP test was performed at two PEEP levels (5 and 15 cmH2O), maintaining 
constant the minute ventilation and the inspiratory oxygen fraction; gas 
exchange and respiratory mechanics were recorded 20 minutes after each 
PEEP change.
Results Two sedated and paralyzed subjects with acute lung injury (ALI)/
ARDS (age 46 ± 5 years, BMI 38.6 ± 5.5 kg/m2, PaO2/FiO2 187 ± 30 mmHg, 
PEEP 17 ± 1 cmH2O; both patients were obese and one of them suff  ered 
from diabetes) were enrolled. One patient required extracorporeal 
membrane oxygenation support for 5 days. Lung CT scans were performed 
5 ± 3 days after ICU admission. The total lung weight at 5 cmH2O was 
1,598 ± 142 g. The percentage of potentially recruitable lung was 24 ± 
8% of the total lung weight, corresponding to an absolute weight of 371 
± 109 g recruitable lung tissue. A 15 cmH2O compared with 5 cmH2O of 
PEEP improved the compliance of the respiratory system from 42.2 ± 7.0 to 
46.6 ± 2.1 ml/cmH2O and the gas exchange from PaO2 62.7 ± 0.1 to 123.2 ± 
61.8 mmHg and PaCO2 47.1 ± 0.9 to 45.9 ± 3.2 mmHg, respectively.
Conclusions The ARDS-related H1N1 virus presented, in the early phase, 
a high potentially recruitable lung in which elevated PEEP levels can be 
benefi  cial.
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Introduction The maximal recruitment strategy (MRS) is considered an 
effi   cient maneuver to reverse nonaerated lung in ARDS patients. There is 
no information regarding tidal recruitment during MRS.
Methods  Early and severe ARDS patients were submitted to MRS 
guided by thoracic CT: A – recruitment phase (PEEP 10 to 45 cmH2O and 
constant driving pressure 15 cmH2O); B – PEEP titration phase (PEEP 25 
to 10 cmH2O). Images were obtained at end expiration and inspiration. 
Global and regional quantitative CT analyses from each step of PEEP were 
compared [1].
Results Analyses of 12 patients showed that MRS reduced signifi  cantly 
the global amount of nonaerated tissue (54 ± 8% to 7 ± 6%, P <0.01), tidal 
recruitment (4 ± 4% to 1 ± 1%, P = 0.029) (Figure 1). Most dependent 
regional tidal recruitment signifi  cantly increased from PEEP 10 to 20 cmH2O 
(2 ± 3% to 11 ± 7%, P <0.01), but signifi  cantly decreased after MRS (11 ± 
7% to 2 ± 2%, P <0.01). High PEEP (25 cmH2O) was necessary to sustain 
recruitment.
Conclusions  MRS decreased nonaerated areas and tidal recruitment. 
Increasing PEEP without full recruitment may cause lung injury exacer-
bation in the severe ARDS population.
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Introduction In patients with acute respiratory distress syndrome (ARDS) 
tidal ventilation is always inhomogeneous, with atelectasis in dependent 
lung and overdistention in nondependent lung. The aim of our study was 
to develop a fl  ow pattern that simultaneously produces locally diff  erent 
alveolar pressures, in order to recruit collapsed alveoli and at the same 
time to prevent hyperinfl  ation of already open alveoli.
Methods  We modifi   ed Horsfi   eld’s model of the canine lung [1] to 
predict alveolar pressure diff  erences between the collapsed and opened 
alveoli. The morphometric model has an asymmetrical branching airway 
system with 47 orders, whereby order 47 corresponds to the trachea. 
Each branch is terminated with a viscoelastic tissue unit and there are in 
total 150,077 acini for the whole model. Using this model, atelectasis of 
alveoli was simulated by reducing the diameter of small airways (order 
1, 2 and 3) up to 90% of their original sizes. The tissue damping factor G 
was 104 times higher in the collapsed alveoli than that in normal alveoli. 
The shunt gas compression compliance Cg for the alveolus was 106 times 
smaller. Diff  erent percentages of atelectatic area from 0 to 90% were 
simulated. Flow distribution and airway input impedance were calculated 
at diff  erent frequencies from 0.1 to 5 Hz. Alveolar pressure diff  erences were 
obtained by analyzing the products of fl  ow distribution and alveolar input 
impedance.
Results The alveolar pressure Palv reduced as the frequency increased 
(for both collapsed and open alveoli). Compared with the situation at 0.2 
Hz, Palv reduced to 9.1 ± 1.0% at 4 Hz. On the other hand, Palv increased 
as the percentage of atelectatic area increased (for all frequencies). Palv 
increased to 267 ± 6% when 70% of alveoli collapsed compared with 10% 
of collapse. The pressure diff  erences between collapsed and open alveoli 
increased as the frequency increased. At 0.2 Hz the diff  erences were <3%, 
while at 4 Hz the diff  erences were >20% (relative to the lower value).
Figure 1 (abstract P186). Percentage of regional (I to IV) tidal recruitment 
during all steps of the MRS protocol.
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fl  ow pattern may help to develop a pressure diff  erence between collapsed 
and open alveoli. The low-frequency contents of the fl  ow pattern, however, 
may be still needed to guarantee the minimum ventilation.
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Introduction Low tidal volumes (Vt) are thought to protect the lung 
by avoiding overdistension. We recently have shown that Vt may also 
infl  uence repeated opening and closing (O/C) [1]. The goal of this study 
was to determine whether decreasing Vt from 6 to 4 ml/kg was eff  ective to 
reduce O/C, and whether it was possible to maintain alveolar ventilation 
at such low Vt.
Methods Cross-over study at two Vt levels: 6 versus 4 ml/kg IBW. We 
included ALI/ARDS patients, ventilated <48 hours, and who would have a 
chest computed tomography (CT) scan. For the 4 ml/kg arm: we replaced 
the heat and moisture exchange fi  lter by a heated humidifi  er, and the 
respiratory rate was increased to keep minute ventilation constant. The 
protocol had two parts: one bedside and other in the CT room. Both Vts 
were applied in a random order. For the bedside protocol each Vt arm 
was applied for 30 minutes. Data on lung mechanics and gas exchange 
were taken at baseline and 30 minutes. For the CT scan protocol each Vt 
arm was applied for 5 minutes and then a dynamic CT (4 images/second 
for 8 seconds) was taken at each Vt at a fi  xed transverse region at the 
lower third of the lungs. Afterwards, CT images were analyzed by software 
(MALUNA) and repeated O/C was determined as nonaerated tissue 
variation between inspiration and expiration, expressed as a percentage 
of lung tissue weight.
Results We analyzed nine patients (six male), who had a median age of 39 
(21 to 72) years, APACHE II score 14 (5 to 23) and SOFA score 9 (6 to 15). All 
patients had a pulmonary origin of their ARDS and were on their fi  rst day 
of ventilation. At baseline patients had a PaO2/FiO2 ratio of 141 (71 to 280), 
compliance of 32 (17 to 43) ml/cmH2O, and PEEP of 12 (10 to 16) cmH2O. In 
the Vt arms 4 and 6 ml/kg, Vts were 260 (210 to 300) and 350 (310 to 400) 
ml, respectively (P <0.01), respiratory rates were 37 (31 to 42) and 25 (21 to 
28) breaths per minute (P <0.01), and PaO2 levels were 84 (54 to 148) and 
83 (61 to 162) mmHg (P = 0.3). PEEP and FiO2 were kept constant. PaCO2 
did not signifi  cantly increase with Vt 4 but repeated O/C (delta nonaerated 
tissue) consistently decreased (Figure 1).
Conclusions Decreasing Vt from 6 to 4 ml/kg reduces repeated O/C. 
Hypercapnia can be eff  ectively prevented by decreasing the instrumental 
dead space and increasing the respiratory rate.
Acknowledgements Grant was Fondecyt 11060350.
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Introduction  Acute lung injury (ALI) and acute respiratory distress 
syndrome (ARDS) are associated with signifi  cant morbidity and mortality. 
Mechanical ventilation is the cornerstone of supportive therapy. However, 
the optimal strategy of ventilation and adjunctive therapies are still 
evolving. There is evidence to support the use of volume-limited and 
pressure-limited lung-protective ventilation but practice variability in 
the clinical management is still a concern mainly in sicker patients. The 
purpose of this study was to examine the ventilatory prescriptions of 
clinicians caring for patients with ALI/ARDS.
Methods  We prospectively examined demographic characteristics, 
APACHE II score and choice of ventilatory settings at the day of diagnosis 
of ALI/ARDS (AECC criteria) of 84 mechanically ventilated patients from 
May 2007 through October 2009 in a mixed medical–surgical critical care 
unit.
Results  ALI/ARDS occurred in 7.1% of admissions and 16.1% of all 
mechanically ventilated patients. Sepsis was the main cause. All patients 
were ventilated with pressure control mode. Median tidal volume/
predicted body weight was 6.1 (3.5 to 9.9) ml/kg, plateau pressure was 
26 (15 to 55) cmH2O and mean PEEP was 12 (5 to 25) cmH2O. Univariate 
analysis showed sepsis-related ALI/ARDS (P = 0.026) and APACHE II score 
>18 (P  <0.001) were barriers to initiate lung-protective ventilation. In 
multivariate analysis, APACHE score >18 was an independent predictor. 
Ventilatory settings were signifi  cantly diff  erent in this subset of patients 
(n = 26). The tidal volume/predicted body weight (6.2 (3.5 to 9.9) vs 5.1 
(4.3 to 8.5) ml/kg), PEEP (15 (10 to 25) vs 7 (6 to 12) cmH2O) and plateau 
pressure (38 (32 to 55) vs 22 (15 to 30) cmH2O) were higher in the group 
with APACHE II score >18 (P <0.001). PaO2/FiO2 pH and paCO2 did not diff  er 
between groups. As expected, mortality was higher in this group, 60% vs 
22% (P <0.001).
Conclusions Protective mechanical ventilation is not completely feasible 
in the subset of ALI/ARDS patients with higher risk of mortality (APACHE 
II >18).
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Introduction Studies evaluating the relationship between the severity of 
hypoxemia in patients with acute respiratory distress syndrome (ARDS) 
Figure 1 (abstract P188).
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We hypothesized that severity of hypoxemia on admission after optimal 
ventilation may predict hospital outcome if the ARDS patients are 
categorised based on the primary etiology: pulmonary ARDS (ARDSp) and 
extra pulmonary ARDS (ARDSexp). Our aim was therefore to ascertain the 
relationship between hospital outcome and the severity of hypoxemia 
in patients with early ARDS (days 1 to 3 following admission) after 
categorising based on etiology.
Methods We used a prospective cohort study design and enrolled 151 
consecutive patients with a primary diagnosis of ARDS on the day of 
admission, admitted over a 2-year period to our adult general ICU. Patients 
enrolled in other clinical interventional trials were excluded from the 
study. Protocol-based management of mechanical ventilation was used 
to achieve optimal ventilation. Two authors independently designated 
patients as ARDSp or ARDSexp and a third reviewed any confl  icts (only 
four cases). Patients were then subcategorised by severity of hypoxaemia 
based on PaO2/FiO2 ratio (P/F ratio) intervals. All other clinical interventions 
were at the discretion of treating clinician.
Results The hospital mortality in all patients included in the study (n = 
151) with ARDS was 44.1%. The patients classifi  ed as ARDSp had a higher 
hospital mortality (50.6%) compared with ARDSexp (36.4%), but the 
diff  erence was not statistically signifi  cant (P = 0.12). Nonsurvivors with 
ARDSp had a signifi  cantly lower P/F ratio on day 1 of ARDS diagnosis 
compared with survivors (12.05 ± 4.46 vs 15.39 ± 4.97 kPa; P = 0.002), 
a relationship not observed with ARDSexp. This association between 
mortality and hypoxaemia in early ARDSp persisted at even more serve 
levels of hypoxaemia (<15 kPa, <12.5 kPa, and <10 kPa; P = 0.01, P = 0.003 
and P = 0.002, respectively), while in ARDSexp the eff  ect of hypoxaemia on 
mortality was not observed.
Conclusions  Our fi   ndings indicate that the hypoxaemia burden as 
assessed by P/F ratio intervals despite optimal ventilatory support on 
the day of ICU admission predicts increased risk of death in ARDSp; but 
not in ARDSexp. Interventional trials need to account for the infl  uence of 
etiology and hypoxaemia burden on outcome prior to concluding this as 
a negative intervention.
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Introduction The pathological organ dysfunction that occurs in patients 
with SIRS or sepsis is believed to be related to vascular endothelial damage. 
We investigated the role of vascular endothelial damage in the occurrence 
of acute lung injury in severe TBI patients with SIRS.
Methods The subjects were 20 severe TBI patients with SIRS. The P/F ratio 
was calculated from arterial blood gas analysis data obtained for seven 
consecutive days from the time of admission. Peripheral blood samples 
were collected four times to measure the serum levels of IL-6 and IL-8, and 
the levels of ICAM-1 and granulocyte elastase (GE) as markers of vascular 
endothelial damage.
Results The P/F ratio decreased with time and was below 300 from day 
4 onwards. However, the survivors maintained a P/F ratio of 300 or more. 
In the patients with a fatal outcome, the ratio continued to decline and 
the subjects developed acute lung injury on day 3. From day 5 onward, 
they showed a signifi  cant decrease of the ratio, with values of 200 or 
less and symptoms of adult respiratory distress syndrome. The levels of 
IL-6, IL-8, ICAM-1, and GE increased after admission, but then decreased 
again in the survivors. In the patients who died, these levels continued 
to rise and there was a signifi  cant increase of IL-6, IL-8, and ICAM-1 after 
1 week. The correlation between the blood level of IL-6 and the level of 
IL-8, ICAM-1, or GE was strong, while that between the IL-8 level and the 
ICAM-1 or GE levels was also strong and that between the ICAM-1 and GE 
level was weaker. In contrast, the correlations between the P/F ratio and 
the blood levels of IL-6, IL-8, ICAM-1, or GE were moderate and negative. 
Therefore, inverse correlations were noted between the P/F ratio and all 
these parameters.
Conclusions  By determining the changes of humoral mediators, we 
demonstrated that vascular endothelial damage was involved in the 
occurrence of the pathological state of acute lung injury, which occurs in 
severe TBI patients with SIRS.
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Introduction Transfusion-related acute lung injury (TRALI) occurs more 
often in critically ill patients than in a general hospital population, possibly 
due to the presence of underlying infl  ammatory conditions that may 
prime pulmonary neutrophils. Mechanical ventilation (MV) may be a risk 
factor for developing TRALI. We determined the infl  uence of MV on the 
development of TRALI, combining a murine MV model causing ventilator-
induced lung injury with a model of antibody-induced TRALI [1,2].
Methods BALB/c mice (n = 84) were ventilated for 5 hours with low 
(7.5  ml/kg) or high (15 ml/kg) tidal volume, a positive end-expiratory 
pressure of 2 cmH2O and a fraction of inspired oxygen of 50%. After 
3 hours of MV, TRALI was induced by infusion of MHC-I antibodies (4.5 mg/
kg), controls received vehicle. Nonventilated animals receiving vehicle, 
isotype or MHC-I antibodies served as additional controls.
Results  All animals receiving MHC-I antibodies developed TRALI 
within 2 hours. In mice in which TRALI was induced, MV with low tidal 
volumes aggravated pulmonary injury as evidenced by an increase in 
neutrophil infl  ux, pulmonary and systemic levels of cytokines and lung 
histopathological changes compared with unventilated controls. The use 
of high tidal volume ventilation resulted in a further increase in protein 
leakage and pulmonary edema.
Conclusions  MV synergistically augmented lung injury during TRALI, 
which was even further enhanced by the use of injurious ventilator 
settings. Results suggest that MV may be a risk factor for the onset of TRALI 
and may aggravate the course of disease.
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Introduction With adaptive support ventilation (ASV), a microprocessor-
controlled mode of mechanical ventilation, the ventilator adapts tidal 
volume (VT) size based on the Otis least work of breathing formula. In 
recent studies in patients with ALI/ARDS, ASV applied VT of 7.3 (6.7 to 
8.8) ml/kg ideal body weight (IBW). It is unclear whether an open–lung 
approach was used in these studies. Lung recruitment improves lung 
compliance, and as a consequence may allow the ventilator to apply too 
large a VT with ASV.
Methods  Ten consecutive patients with ALI/ARDS, ventilated in 
accordance with our local protocol dictating frequent recruitment 
maneuvers, were observed while the ventilator was switched from pressure 
control ventilation (PC) to ASV. Thereafter, all patients were subjected to an 
additional standard recruitment procedure. The primary endpoint was VT 
before and after switch of the ventilator, and after standard recruitment.
Results Four patients suff  ered from ALI, six patients from ARDS. Seven 
patients had an extrapulmonary cause for ALI/ARDS. VT increased from 
6.5 ± 0.8 ml/kg IBW to 9.0 ± 1.6 ml/kg IBW (P <0.01) after switch from PC 
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VT size (9.3 ± 1.4 ml/kg IBW, P >0.05). In seven patients ASV applied VT 
>8 ml/kg IBW, in one patient VT even increased to >12 ml/kg IBW.
Conclusions Patients with ALI/ARDS may be ventilated with too large a VT 
when subjected to ASV. Our results contrast fi  ndings of previous studies 
on ASV in patients with ALI/ARDS, probably because we frequently use 
recruitment maneuvers.
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Introduction Receptor for advanced glycation end products (RAGE) is an 
acute phase infl  ammatory mediator primarily expressed by alveolar type I 
cells in the lung. The association between circulating RAGE and severity of 
acute lung injury and acute respiratory distress syndrome (ALI/ARDS) has 
been recently suggested by both experimental and human studies. The 
purpose of our study is to study the signifi  cance of plasma RAGE levels 
over time and of bronchoalveolar lavage fl  uid (BALf) RAGE in ALI/ARDS 
patients.
Methods We enrolled 21 patients admitted to a single general ICU of 
a university-affi   liated  hospital  aff   ected by ALI/ARDS (1994 Consensus 
Conference criteria). We measured plasma RAGE levels twice on the fi  rst 
2 days from intubation, then every 3 days for the fi  rst month and then 
once a week, until ICU discharge or death (n = 188). We also measured 
RAGE levels in BALf obtained by means of a standardized technique when 
clinically indicated (n = 22). At each sampling time we recorded data on 
ventilator settings, gas exchange, organ function and blood cell counts.
Results Day 1 plasma RAGE levels (normal values <170 pg/ml) were high 
(median 1,588 pg/ml, IQR 780 to 2,398 pg/ml) and then lowered over time. 
When all samples were considered, plasma RAGE levels were signifi  cantly 
higher in patients with blood platelet count <100 x 103/μl, with plasma 
creatinine level ≥2 mg/dl and with SOFA score ≥5 (P = 0.029, P = 0.001 
and P = 0.045, respectively). Plasma RAGE increased also with the number 
of organ failures (P = 0.004). Moreover, circulating RAGE was signifi  cantly 
higher in patients with PaO2/FiO2 <150 and with PEEP ≥10 cmH2O (P = 
0.045 and P <0.001, respectively). RAGE was present in BALf (median 174 
pg/ml, IQR 46 to 1,476 pg/ml). Interestingly, plasma and BALf RAGE levels 
were not correlated (P = 0.2). BALf RAGE was signifi  cantly higher in patients 
with PaO2/FiO2 <150 mmHg and with administered tidal volume:ideal 
body weight ratio >6 ml/kg (P = 0.021 and P = 0.009, respectively). Patients 
with culture-positive BALf had higher BALf RAGE levels in comparison with 
culture-negative BALf (P = 0.014).
Conclusions  In ALI/ARDS patients, circulating RAGE is high on day 
1, decreases over time and may be related to systemic and lung injury 
severity. BALf RAGE obtained from these patients may be associated with 
lung dysfunction and infection.
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reducing the respiratory rate
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Introduction In animal models of ventilator-induced lung injury (VILI), 
mild hypothermia was found to be protective by reducing pulmonary 
infl  ammation and possibly by reducing mechanical strain by applying 
lower respiratory rates. However, models are hampered by severe alkalosis 
or an ex vivo design. In a physiological model of VILI, we investigated 
whether hypothermia protects from VILI by reducing respiratory rates, or 
by reducing infl  ammation.
Methods In rats, VILI was induced using a peak inspiratory pressure (PIP) of 
23 cmH2O and zero PEEP. Controls were ventilated with a PIP of 12 cmH2O 
and PEEP of 5 cmH2O. Hypothermia (32ºC) was induced by external 
cooling, controls were maintained at 37ºC. Normo-pH (7.3 to 7.4) or strict 
normocapnia (4.5 to 5.0 kPa) was achieved by adjusting the respiratory 
rate according to blood gases drawn every 30 minutes. After 4 hours of 
Figure 1 (abstract P195).
Figure 2 (abstract P195).
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Kruskal–Wallis and Mann–Whitney U tests.
Results A physiological model of VILI was established. In the normo-pH 
group, hypothermia decreased pulmonary IL-6 and neutrophil infl  ux and 
tended to decrease pulmonary protein leak (Figure 1). In the normocapnia 
group, hypothermia allowed for lower respiratory rates compared with 
normo-pH (11 ± 1 vs 17 ± 2 breaths/minute) (Figure 2). However, this did 
not further reduce parameters of lung injury.
Conclusions Hypothermia was protective in a physiological model of VILI, 
by reduction of infl  ammation, but not by reducing the repetitive strain of 
respiratory cycles.
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Introduction  Therapeutic hypothermia is applied to reduce hypoxia-
induced organ injury. In the past decades, the use of hypothermia has 
increased in critically ill patients who are mechanically ventilated (MV). 
Data on the eff  ect of hypothermia on gas exchange and lung mechanics 
in these patients are limited. In this retrospective study, we describe the 
eff  ect of induced hypothermia and rewarming on respiratory parameters 
in patients after a cardiac arrest.
Methods Patients with a Glasgow Coma Scale <8 after resuscitation for 
a cardiac arrest in whom hypothermia was applied (32 to 34°C), were 
enrolled. Patients with PaO2/FiO2 ratio <200 or MV with positive end-
expiratory pressure (PEEP) >15 cmH2O were excluded. Ventilator settings 
and arterial blood gasses were retrieved from the electronic patient 
database during hypothermia and at every °C grade increase during 
rewarming. Statistics include z paired t test.
Results From a cohort of 98 patients, 35 patients were excluded, leaving 
62 patients for analysis. During hypothermia, arterial pCO2 decreased, 
while end tidal (et) CO2 was low at unchanged minute volume ventilation 
(Figure 1). Hypothermia increased the P/F ratio from 255 ± 55 to 283 ± 
12 at unchanged PEEP (P <0.05), while fl  uid balances were positive in all 
patients (2.5 ± 1.6 l). After rewarming, arterial pCO2 was unchanged while 
etCO2 increased. The P/F ratio after rewarming was unchanged compared 
with the start of hypothermia, while lower PEEP levels were applied (7.0 ± 
0.4 cmH2O vs 6.1 ± 0.3 cmH2O, P <0.05).
Conclusions Induced hypothermia improved ventilation and oxygenation 
in critically ill patients. Hypothermia may be considered in patients with 
acute lung injury, in whom low minute ventilation results in severe 
hypercapnia.
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Introduction Extracorporeal life support (ECLS) represents a therapeutic 
choice in cases of acute reversible lung and/or heart failure. An emergency 
ICU can safely manage both veno-arterial (V-A) and veno-venous (V-V) 
ECLS.
Methods In our experience, the ECLS treatment implementation started 
on April 2008. The ECLS team is composed of intensivists, cardiac surgeons, 
cardiologists, perfusionists and nurses. All of these fi  gures were trained in 
ECLS management. An Emergency Medical Service has been equipped 
to guarantee rapid and safe ECLS positioning in peripheral hospitals and 
transportation to our referral center by the ECLS team. According to our 
internal protocol, eligible patients for V-V ECLS treatment are aged 15 
to 70 years old and aff  ected by ARDS with a PaO2/FiO2 ratio <60 or pH 
<7.20, under a protective ventilation setting. The use of ECLS for cardiac 
support is reserved for those cases of cardiac shock refractory to standard 
treatments and cardiac arrest not responding to advanced cardiac life 
support (ACLS). The ECLS device used is a Rotafl  ow Maquet Centrifugal 
Pump with a Quadrox-D oxygenator (Maquet, Rastatt, Germany) and 
biocoated circuits.
Results From April 2008 to November 2009, 21 patients were treated 
with ECLS. In 13 patients V-V ECLS was established due to severe ARDS 
not responding to conventional treatment. Median SAPS II at admission 
was 49 and median duration was 235 hours. Three out of 13 patients 
were cannulated by the ECLS team in peripheral hospitals and safety 
transported. The intra-ICU survival rate was 62%. ECLS for cardiac support 
was performed in eight patients: four cases of intrahospital cardiac arrest, 
four cases of cardiogenic shock. Median stay of V-A ECLS was 110 hours. In 
cases of V-A ECLS due to cardiac arrest, no positive outcome was observed. 
The median stay of ACLS maneuvers before ECLS start was 62.5 minutes 
In cases of cardiogenic shock undergoing ECLS, two out of four patients 
were discharged from our ICU.
Conclusions A complete competence acquisition for ECLS management 
makes this system a safe and feasible technique. The possibility to 
guarantee a safe treatment must involve diff  erent specialists and properly 
trained nurses. We found the importance of a well-timed start of ECLS.
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Introduction  Severe acute respiratory distress syndrome (ARDS) 
patient transportation is an extremely high-risk procedure. We report 
our experience in transferring these patients to our centre while on 
extracorporeal membrane oxygenation (ECMO).
Methods  After telephone referral and bed availability confi   rmation, 
patients matching entry criteria for ECMO are evaluated for transportation 
to our centre. A skilled crew consisting of two expert plus one training 
physician, one expert plus one training ICU nurse and one ECMO specialist 
reaches the referral hospital for re-evaluation. If eligible, cannulation, 
ECLS circuit set up and ECLS start are accomplished. Ground transport 
is performed with a specially equipped ambulance, endowing enlarged 
oxygen, fuel and energy supplies. The ambulance is loaded with all of the 
items required for cannulation and ECMO circuit set up, additional oxygen 
and a nitric oxide tank. Entry criteria are: potentially reversible respiratory 
failure, Murray Score ≥3 or respiratory acidosis with pH <7.2, no intracranial 
bleeding and absolute contraindication to heparinization.
Figure 1 (abstract P196).
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15 ARDS patients (10 males), age 38 ± 15 years, BMI 28 ± 7, APACHE II 
score 26 ± 9, SOFA score 9 ± 4, Oxygenation Index 39 ± 17. The average 
distance was 133 ± 124 km. Two patients improved after NO trial and were 
transferred without ECMO. All of the other patients underwent venovenous 
ECMO: 11 with cannulation of femoral veins, one femoral–jugular veins 
and one with a DL cannula in the jugular vein. ECMO settings were 
(mean ± SD) BF 2.9 ± 0.8, GF 3.6 ± 1.6, GF FiO2 1. Data have been recorded 
30 minutes before and 1 hour after ECLS began: vv-ECMO granted a better 
clearance of pCO2 (75 ± 20.5 vs 49.7 ± 7.9 mmHg, P <0.01), thus improving 
the pH (7.279 ± 0.10 vs 7.41 ± 0.06, P <0.01) and mean pulmonary arterial 
pressure (41 ± 11 vs 31 ± 5 mmHg, P <0.05) and allowing a reduction in 
respiratory rate (28 ± 11 vs 9 ± 4, P <0.01), minute ventilation (10.2 ± 4.6 
vs 3.3 ± 1.7 l/min, P <0.01) and mean airway pressure (26 ± 6 vs 22 ± 5 
cmH2O, P <0.01). Arterial pO2, mean blood pressure and heart rate did not 
show signifi  cant variations. After ECMO began, vasoconstrictor therapy 
(being administered to fi  ve patients) was quickly tapered. Neither clinical 
nor technical major complications were reported.
Conclusions  ECMO employment at referral centers enabled long-
distance, high-risk ground transportation.
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Introduction Controversy exists over the possible benefi  cial eff  ects of 
hypertonic saline (HS) in pulmonary infl  ammatory response, particularly 
in neutrophil immunomodulation [1,2]. This study was designed to 
investigate possible benefi  ts of HS in the treatment of pigs submitted to 
experimental acute lung injury.
Methods Twelve anesthetized, tracheotomized pigs (25 to 30 kg) were 
mechanically ventilated by pressure, adjusted to 8 ml/kg tidal volume, 
with FiO2 50%, and submitted to intratracheal instillation of 4 ml/kg 
hydrochloric acid (HCl) 0.1 N. They were then randomized to ALI group 
(n = 7) or ALI + HS group (n = 5), where animals of the latter group 
received 4 ml/kg intravenous hypertonic saline, 15 minutes after injury. 
Hemodynamic parameters, pulmonary compliance (Cstat), peak pressure 
(Ppeak), plateau pressure (Pplat) and tidal volume (Vt) were analyzed at 
baseline (TBL), 15 minutes after HCl instillation (TALI) and hourly thereafter 
for 4 hours (T0 to T3). Bronchoalveolar lavage was performed at the end 
of the observation period for fl  ow cytometry analysis of neutrophil burst 
activity. Postmortem histopathology of the right diaphragmatic lung was 
also performed in all animals.
Results After TALI, animals of both groups presented signifi  cant increases 
in Ppeak and Pplat, and a decrease in Cstat, at all time points, when compared 
with TBL. Vt was preserved in both groups over time. There were signifi  cant 
diff  erences between groups ALI and ALI + HS, respectively, in: central 
venous pressure (T0, T1 and T2), pulmonary artery occlusion pressure 
(T1 and T2) and pulmonary vascular resistance index (TALI). In the ALI 
group, signifi  cant diff  erences related to TBL were found in mean arterial 
pressure (T1), mean pulmonary artery pressure (TALI, T0, T1, T2 and T3) and 
pulmonary vascular resistance index (TALI, T0, T3). In the ALI + HS group, 
there were signifi  cant diff  erences related to TBL in mean arterial pressure 
(T0, T1, T2), mean pulmonary artery pressure (TALI, T0, T1, T2, T3), cardiac 
index (T0, T1, T2) and pulmonary vascular resistance index (T1, T2, T3). No 
diff  erences were found between groups regarding histopathology and 
fl  ow cytometry analyses.
Conclusions HS produced no signifi  cant benefi  t in the studied parameters 
regarding the lungs, in the proposed model of ALI.
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Introduction  Conventional mechanical ventilation (MV) may cause 
additional lung injury in ALI/ARDS due to overdistention of aerated 
lung regions (high Vt) and cyclic lung reopening (low PEEP level). 
Hyperproduction of infl  ammatory mediators is one of the side eff  ects in 
these cases. This factor could delay or prevent resolution of respiratory 
failure [1,2]. However, it is not clear whether conventional mechanical 
ventilation damages intact lungs. The aim of this study was to evaluate the 
eff  ects of conventional and protective mechanical ventilation on intact 
lungs in patients with severe trauma.
Methods A prospective, randomized controlled trial in trauma patients 
with mechanical ventilation for extrapulmonary indications. The protocol 
was approved by the local ethics committee. Seventy-eight patients were 
randomized to conventional (Vt 10 to 12 ml/kg IBW, PEEP 5 cmH2O – n = 
39) or protective (Vt 5 to 6 ml/kg IBW, PEEP 10 cmH2O – n = 39) mechanical 
ventilation. TNFα, IL-1β  and IL-6 levels in plasma and BAL fl  uids were 
measured on 1, 2, 3, 5 and 7 days of MV. Frequency of ALI (AECC criteria) 
and VAP were evaluated. The endpoints of this study were the length of 
MV, LOS in ICU and outcome on 28 days.
Results In fi  rst 3 days ALI was revealed in 26 patients (66.6%) in the 
conventional and 10 patients (26.5%) in the protective MV groups (P = 
0.001; OR 4.375, 95% CI 2.227 to 8.189). ARDS occurred in four patients 
(10,2%) of the conventional MV group (LIS >2) and no one in the protective 
MV group (P <0.0001). Levels of TNFα, IL-1β and IL-6 in BAL fl  uids were 
signifi  cantly higher in the conventional MV group from 1 to 7 days with 
maximal increase on day 3 (542 ± 44/91 ± 11; 315 ± 35/86 ± 10; 1,092 ± 
160/111 ± 18, P <0.0001). No diff  erences were found in levels of TNFα, 
IL-1β and IL-6 in plasma samples. VAP occurred in 31 patients (83.7%) of 
the conventional and nine patients (23%) of the protective MV groups (P = 
0.0001; OR 17.2, 95% CI 5.5 to 54.3). The length of MV was 17.4 ± 6 vs 12.8 
± 3 (P = 0.0001; OR 4.2, 95% CI 1.5 to 11.5), LOS in the ICU was 21.9 ± 5.6 vs 
15.75 ± 2.9 (P = 0.0002; OR 2.0, 95% CI 0.18 to 23.6). The 28-day mortality 
was not signifi  cantly diff  erent in the groups.
Conclusions Conventional MV for more than 72 hours in patients with 
severe trauma and intact lungs can cause lung injury, and increase 
duration of MV and LOS in the ICU.
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Introduction Administration of 80 mg/kg methylprednisolone has been 
shown to prevent controlled mechanical ventilation (CMV) diaphragm 
dysfunction in rats, partly by inhibiting the calpain system [1]. The current 
experiments determined whether lower doses of corticosteroids will also 
provide protection against ventilator-induced diaphragm dysfunction.
Methods Rats were assigned to a control group or to 24 hours of CMV 
receiving a single injection of saline or 5 mg/kg (low MP) or 30 mg/kg 
(high MP) of methylprednisolone.
Results  Diaphragm force production was decreased after CMV but 
signifi  cantly more in the low MP group while similar to controls in the high 
MP group. Atrophy of the type IIa fi  bers was only present in the low MP 
group. Atrophy of the type IIx/b fi  bers was more severe in the low MP 
group than in the CMV group while no atrophy was observed in the high 
MP group. Diaphragm calpain activity was increased after CMV (+93%, 
P <0.05 vs C) and in the low MP group (+83%, P <0.05 vs C), while it was 
similar to controls in the high MP group. Expression of calpastatin was 
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level was preserved to control levels in the high MP group. Analysis of the 
caspase-3 mediated cleavage of αII-spectrin revealed that CMV induced 
a signifi  cant rise in caspase-3 activity when compared with C (+194%, 
P <0.001). Caspase-3 activity was similarly increased in the MP-5 and the 
MP-30 groups (+96% and +78% respectively, P <0.05 vs C) but this increase 
was signifi  cantly less compared with that of CMV. Signifi  cant negative 
correlations were found between calpain activity and diaphragm force 
(–0.50 <r <–0.41, P <0.05) as well as with CSA of the type IIx/b fi  bers (r = 
–0.57, P <0.02). Signifi  cant positive correlations were observed between 
calpastatin and diaphragm force (0.43 <r <0.54, P <0.05) and calpastatin 
and CSA of the type IIx/b fi  bers (r = 0.57, P <0.02).
Conclusions The ability of corticosteroids to protect against CMV-induced 
diaphragmatic contractile dysfunction and atrophy are dose dependent 
with only high doses of corticosteroids providing protection.
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Introduction Non-invasive mechanical ventilation (NIMV) is able to reduce 
reintubation especially in patients with exacerbation of COPD. Results have 
not been reached in critically ill patients with nonobstructive respiratory 
failure (NORF). However, the NIMV in most of these studies has been applied 
without making an eff  ort to open the lung and adjusting the C-PAP after 
opening up the lung using a clinical approach. Our aim was to evaluate the 
eff  ects of applying recruitment manoeuvres (RM) with C-PAP and titrate it 
according to clinical decremental C-PAP trial in patients with NORF.
Methods NORF patients for whom NIMV was indicated between January 
2008 and July 2009 were included and submitted to the NIMV-RM protocol 
when a trained team was available. Bi-PAP and a full face mask were used. 
The inclusion criteria were at least two of the following: respiratory rate 
(RR) >30, accessory muscle activity, saturation ≤90% with FiO2 ≥50% and 
consolidation areas on thorax X-ray. Gradual increasing of C-PAP (2 cmH2O) 
was used from 10 to 20 cmH2O. Each level of C-PAP was sustained for 5 
minutes according to tolerance. The C-PAP after RM was adjusted when 
the maximal tidal volume (VT) was reached, pulse oximetry (PO) did not 
show any substantial change and when the patient was comfortable. 
Demographic data, APACHE II score and lung injury score (LIS) were 
measured. Cardiac rate (CR), RR, arterial pressure (AP), PO, minute ventilation 
(VE) and percentage of mask leak (PML) were recorded through the RM. 
Arterial blood gases were measured pre-RM, 1, 12 and 24 hours after RM. 
Variables are expressed as median (range). ANOVA by repeated measures or 
Kruskal–Wallis was used, P <0.05 was considered signifi  cant.
Results Fourteen patients were included. Age, APACHE II and LIS were: 56 
(17 to 80); 14 (4 to 21) and 2 (1.3 to 2.7). The PaO2/FiO2 ratio increased from 
169.1 ± 69.7 (basal) to 261 ± 106 after 1 hour of RM (P = 0.02).Improvement 
was preserved at 12 and 24 hours, 280 ± 69 and 295 ± 73, respectively. The 
C-PAP level 1 hour after RM was 14.9 ± 2.4, and 14.1 ± 1.9 at 24 hours post 
RM. The hemodynamic stability, RR, AP, PML and VE did not change during 
and after the RM.
Conclusions RM with gradual increments of C-PAP is safe. RM in patients 
with NORF could be an alternative to rescue patients with poor outcome 
with NIMV alone.
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Introduction  Controlled mechanical ventilation (CMV) results in 
diaphragmatic dysfunction. Oxidative stress is an important contributor 
to ventilator-induced diaphragm dysfunction, since 18 hours of CMV 
lead to increased protein oxidation and increased lipid peroxidation. We 
hypothesized that administration of an antioxidant, N-acetylcysteine 
(NAC), would restore the redox balance in the diaphragm and prevent the 
deleterious eff  ects of CMV.
Methods Anesthetized rats were submitted for 24 hours to either spon-
taneous breathing while receiving 150 mg/kg NAC (SBNAC) or saline 
(SBSAL) or to CMV while receiving 150 mg/kg NAC (MVNAC) or saline 
(MVSAL).
Results  After 24 hours, diaphragm forces were signifi   cantly lower in 
MVSAL compared with all groups. Administration of NAC completely 
abolished this decrease such that forces produced in the MVNAC group 
were comparable with those of both SB groups. Protein oxidation was 
signifi  cantly increased in MVSAL (+53%, P <0.01) and was restored in 
MVNAC. Diaphragm caspase-3 activity was signifi   cantly increased in 
MVSAL compared with SBSAL (+279%, P  <0.001). Caspase-3 activity 
was also increased in the MVNAC group (+158.5%, P <0.01) but to a 
signifi  cantly lesser extent compared with that of MVSAL. Calpain activity 
was signifi  cantly increased after CMV (+137%, P <0.001 vs SBSAL), while 
it was similar to SB groups in the MVNAC group. Signifi  cant negative 
correlation was found between calpain activity and diaphragm tetanic 
force (r = –0.48, P = 0.02).
Conclusions These data show that the administration of NAC was able to 
preserve the diaphragm from the deleterious eff  ects of CMV. NAC inhibits 
the increase in oxidative stress and proteolysis and reduces the decrease 
in force generating capacity of the diaphragm.
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Introduction Inactivity of the diaphragmatic muscles during mechanical 
ventilation leads to atrophy and contractile dysfunction. Up to now, in 
vitro force measurements were performed only on single diaphragmatic 
muscle strips. Our intention was to fi  nd out how mechanical and electrical 
stimulation infl  uences the condition of the diaphragm as a whole organ. 
To determine the status of the diaphragm, muscle contraction forces were 
measured on entire rat diaphragms.
Methods We used an earlier described bioreactor [1] as the cultivation 
and measurement device for the whole rat diaphragm. The bioreactor 
consists of a pressure chamber and a supply chamber that are separated 
by a very fl  exible and soft membrane [2]. On this membrane the sample 
diaphragm is placed. By application of certain gas volumes (0 to 1.5 ml) 
in the pressure chamber, diaphragms are defl  ected to various levels of 
pretension. Diaphragms were electrically stimulated at each defl  ection 
level 10 times (750 ms duty cycle, 100 ms stimulation time, 5 ms pulse 
width, 200 Hz frequency). Pressure changes caused by muscle contraction 
were recorded inside the pressure chamber and muscle contraction 
forces were calculated. After initial force measurements, diaphragms were 
exposed for 6 hours to one of four diff  erent treatments: nonstimulated 
storage (control), cyclic mechanical defl  ection, electrical stimulation every 
20 minutes, combination of cyclic defl  ection and electrical stimulation. 
After 6 hours another force measurement was performed. Supernatants 
were collected after 6 hours and investigated for IL-6 activity.
Results Depending on the level of defl  ection of the diaphragms, muscle 
contraction force increased from 0.1 N (volume 0.6 ml) to 0.7 N (volume 
1.5 ml). A larger pretension of the diaphragm resulted in larger muscle 
contraction force. After treatment, muscle contraction force decreased in 
all groups. Muscle contraction force was smallest in the passive control 
group (0.05 N), larger and similar in the electrically stimulated (0.1 N) and 
combination (0.09 N) groups and largest in the mechanically defl  ected 
group (0.15 N). IL-6 activity increased after 6 hours of treatment.
Conclusions  We conclude that it is possible to perform force 
measurements on whole rat diaphragms in our in vitro model. Additionally, 
the diaphragms can kept alive for >6 hours to apply diff  erent stimulation 
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pretension level of the diaphragm as well as on the treatment history.
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Introduction  Neurally adjusted ventilatory assist (NAVA) is a new 
mode of assisted mechanical ventilation that uses the signal obtained 
from electromyography activity of the diaphragm (EAdi) to control 
the mechanical ventilator that delivers assist in proportion to the 
patient’s respiratory drive. This study evaluated the monitoring Edi on 
conventional mode response, during the switch to pressure support 
assist and during the change to NAVA: a mode of predicting weaning 
from ventilation.
Methods  Sixteen adult patients ventilated with SERVO-I (Maquet) on 
pressure control or Bivent were randomized; we placed the specialized 
naso/orogastric tube (Edi catheter) and watched the Edi signal. PSV was 
set to obtain a Vt/kg of 6 to 8 ml/kg with an active inspiration. Were studied 
the peak airway pressure (Paw) and breathing pattern. Were registered the 
Edi minimum and Edi maximum for determining PEEP and peak pressure, 
respectively, Vt, respiratory rate, FiO2 and blood gases serially.
Results  We observed synchrony between Edi signal and ventilator 
breaths in pressure control or Bivent, and when the patients have started 
spontaneous breaths (T signal) we move to pressure support. Low Edi 
minimum (0 to 1) was associated with overdistending the diaphragm 
and required decreasing the PEEP, contrary to high Edi minimum that was 
associated with higher tonic activity and dictated to raise the PEEP.
During NAVA, the pressure delivered was proportional to the Edi. The 
NAVA level was continuously readjusted in proportion to the predicted 
inspiratory eff  ort from the Edi signal. At the highest assist level, we found 
lower Vt/kg (6.1 ± 3 ml/kg vs 8.1 ± 1.8, P <0.001), and higher breathing 
frequency (19 ± 6.9 vs 11 ± 7, P <0.001) and peak EAdi (11.8 ± 8.5 vs 8.1 ± 
7.7, P <0.002) in NAVA than in PSV.
Conclusions The asynchrony during mechanical ventilation increases the 
cost of care, length of days on mechanical ventilation, and other morbidities 
associated with increased ICU stay. The Edi monitoring helps to understand 
other modes of ventilation and has been a great tool to decide the timing 
of a switch to NAVA and predict an early weaning. Systematically increasing 
the NAVA level reduces the respiratory drive, unloads respiratory muscles, 
and off  ers a method to determine an assist level that results in sustained 
unloading, low Vt, and stable respiratory function when implemented for 3 
hours. NAVA gives us the opportunity to augment these patients’ own drive 
to breathe enough to recover more quickly.
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Introduction  Sepsis and muscle inactivity may lead to neuromuscular 
dysfunction. Neurally adjusted ventilatory assist (NAVA) converts diaphragm 
electrical activity (EAdi) into airway pressure (Paw) and preserves respiratory 
muscle activity [1]. We hypothesised that respiratory neuromuscular 
function would be better preserved with NAVA compared with volume 
cycled ventilation (VCV) in early sepsis.
Methods Twenty-eight pigs (40.0 (37.6; 41.8) kg; median (quartiles)) were 
randomized (n = 7 per group) to fecal peritonitis or nonseptic controls 
ventilated for 24 hours with either NAVA or VCV (nonparalyzed, Vt 6 to 
8 ml/kg, rate adjusted to suppress EAdi). Fluids and norepinephrine (NE) 
were used based on protocols to keep mean arterial pressure (MAP) 
>50 mmHg. Before sepsis and after 24 hours, transcutaneous supramaximal 
stimulations of the cervical phrenic nerve (tPNS) and expiratory occlusion 
manoeuvres (eOM) were performed. Latency and amplitude of diaphragm 
compound muscle activity potentials (CMAP) were measured during 
tPNS; maximal defl   ections of Paw (ΔPaw), esophageal (ΔPes), and 
transdiaphragm (ΔPdi) pressures were measured during repetitive tPNS 
(40 Hz, 100 stimuli) and eOM.
Results  Hemodynamic parameters were not diff   erent among groups 
before sepsis and remained stable in controls. MAP did not change in septic 
NAVA but decreased in septic VCV animals from 91 (74; 95) mmHg before 
sepsis to 58 (57; 68) mmHg at 24 hours (P <0.001, MANOVA t-g interaction). 
The heart rate increased (P <0.001) and stroke volume decreased (P = 
0.034) in both septic groups. Fluid balance was not diff  erent among septic 
groups. Three septic NAVA and six septic VCV animals received NE. CMAP 
latency and amplitude, as well as ΔPaw, ΔPes, and ΔPdi were not diff  erent 
among all groups during repetitive tPNS and eOM before sepsis and after 
24 hours (P = NS).
Conclusions Respiratory neuromuscular function is not aff  ected by the 
mode of ventilation during the fi  rst 24 hours of abdominal sepsis. Early 
eff  ects of sepsis on neuromuscular function are not refl  ected in respiratory 
muscle strength. NAVA may reduce the need for hemodynamic support 
in early sepsis.
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Introduction This study aimed to evaluate the eff  ect of high versus low 
tidal volumes (VT) during volume control (VC) ventilation and neurally 
adjusted ventilatory assist (NAVA) in spinal cord injured (SCI) patients. 
We hypothesized that VC with higher VT would signifi  cantly unload and 
deactivate the diaphragm, whereas NAVA would not.
Methods Seven intubated C3 to C7 SCI patients (age: 28 ± 12 years) 
were studied. Using VC (Servo300), VT was increased progressively (not 
exceeding 40 cmH2O or 2 l VT) (high volume) and then lowered until 6 
ml/kg or intolerance (low volume). NAVA was then progressively adjusted 
targeting similar peak pressures. Finally subjects received 15 minutes each 
of: high VC, low VC, high NAVA, and low NAVA in randomized order.
Results  Despite comparable increases in peak airway pressure (Pmo), 
VT increased with VC but was unaltered with NAVA. Inspiratory and 
total breath durations were lower and respiratory rate higher with NAVA 
compared with VC during both assist levels. VC resulted in signifi  cant 
diaphragm unloading and deactivation whereas both were maintained 
during high and low NAVA. Complete diaphragm deactivation in more 
than 80% of breaths was observed during VC in fi  ve of the patients.
Table 1 (abstract P207)
 Low  High  Low  High  P VC  P
  volume  volume  NAVA  NAVA  vs NAVA  level
VT (l)  0.6 ± 0.2  1.3 ± 0.2  0.6 ± 0.2   0.6 ± 0.2  <0.001  <0.001
Peak Pmo (cmH2O)  19.2 ± 3.2  34.9 ± 2.6  18.4 ± 5.9  31.5 ± 5.9   NS   <0.001
Mean EAdi (%)  3.3 ± 4.3  0.8 ± 1.7  6.8 ± 4.2  4.6 ± 3.0   0.004   0.03
Mean Pdi (cmH2O)  2.5 ± 3.1  -1.3 ± 2.1  4.3 ± 3.4  2.6 ± 2.6  0.02   0.009
VT, tidal volume; EAdi, diaphragm activation; Pdi, transdiaphragmatic pressure.
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and deactivation especially at high assist levels, whereas diaphragm 
activation (EAdi) is maintained with NAVA.
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ventilation in patients preparing to be extubated from mechanical 
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Introduction Neurally adjusted ventilator assist (NAVA) is a new mode 
of mechanical ventilation which delivers ventilator assist in proportion to 
electrical activity of the diaphragm (EAdi), as assessed by trans-esophageal 
electromyography, and an adjustable supporting level called the NAVA 
level. NAVA can be used as a supporting and weaning mode of ventilation 
[1-3]. However, a level of NAVA corresponding to continuous positive 
airway pressure (CPAP) and pressure support ventilation (PSV) in patients 
ready for extubation has not been established.
Methods  We carried out a prospective study in the medical ICU at 
Phramongkutklao Hospital involving patients who were considered 
by their physicians to be ready for extubation. Patients initially received 
PSV of 5 cmH2O, PEEP of 5 cmH2O, and FiO2 of 40% for 15 minutes (PS). 
Subsequently, each patient received a trial of NAVA mode with PEEP of 
5 cmH2O, and FiO2 of 40% for 15 minutes (NAVA), and, fi  nally, a 30-minute 
spontaneously breathing trial without ventilatory support (SBT). During 
these trials, the minute volume (MV), respiratory rate, EAdi, and airway 
pressure were measured. We determined the corresponding NAVA level 
with the level of PSV of 5 cmH2O and PEEP of 5 cmH2O using the NAVA 
level matching MV (±10%) received from the PSV.
Results The NAVA level corresponding to the PSV of 5 cmH2O and PEEP 
of 5 cmH2O was 0.52 cmH2O/μV (0.2 to 1.2). The airway pressure during 
NAVA was 5.97 cmH2O (3.2 to 8) above PEEP level. The peak EAdi was not 
signifi  cantly diff  erent between the PS, NAVA, and SBT (11.58, 12.06 vs 
12.65 μV; P = 0.6). Also, there was no signifi  cant diff  erence in MV during 
the PS, NAVA, and SBT.
Conclusions NAVA mode can be used as a weaning mode by decreasing 
the NAVA level. The reduced level of NAVA to 0.5 cmH2O/μV did not load 
respiratory muscle more than a low level of PSV and SBT. Thus, a NAVA level 
of 0.5 cmH2O/μV might be the level that is safe to discontinue ventilator 
support in patients without problems for resuming spontaneous 
breathing.
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Introduction  A novel methodology is proposed to adapt decision-
making strategies into our fuzzy-based expert system, AUTOPILOT-BT [1]. 
The special features of this approach are: knowledge from clinical experts 
can be extracted in a setup simulating daily ICU routine; an automated 
process serves to obtain the required information and to create new fuzzy 
sets; and the fuzzy controller from AUTOPILOT-BT employs the newly 
derived fuzzy rules. Thus, the knowledge base can easily be modifi  ed 
and the resulting mechanical ventilation therapies may be adapted to 
individual preferences of the clinician.
Methods The methodology consists of: (i) Acquisition of decision-making 
strategies from single or groups of anesthesiologists. This can either be 
done with a questionnaire or with a PC-based program simulating the 
doctors every day situation in diagnosis. (ii) Defi  nition of fuzzy membership 
functions based on the acquired knowledge (fuzzifi  cation of the input). 
(iii) Construction of fuzzy inference rules and defuzzifi  cation or calculation 
of change in ventilator settings (controller action). This approach allows 
implementing clinician-dependent decision-making that refl   ects 
individual preferences. Thus guidelines from EBM can be used but as well 
ICU specifi  cs can be realized, for example diff  erent levels of acceptable 
hypercapnia in patients with acute respiratory distress syndrome (ARDS).
Results  Exemplarily Figure 1 shows, for healthy and ARDS lungs, the 
diff  erence between two fuzzy sets for our paCO2 controller given from two 
clinicians (C10 and C51) with diff  erent expertise in mechanical ventilation. 
With the newly designed fuzzy sets, our AUTOPILOT-BT reacts according to 
the clinicians’ preferences, but still minimizes the time in which the patient 
is not ventilated within the specifi  ed limits.
Conclusions  The system automatically implements the know-how of 
medical experts in ventilation management if the clinicians are willing to 
interact with the query system. The resulting strategy is mainly infl  uenced 
by the expertise, experience and demands of the clinician. Thus the 
AUTOPILOT-BT, has the potential to select established guidelines or to 
adapt the system to modifi  ed ventilation therapies. Further clinical trials 
will test the actual clinical effi   ciency of diff  erent controllers.
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Introduction Postoperative pulmonary complications (PPCs) are asso-
ciated with adverse outcomes and added resource use. However, PPCs 
vary in severity, and so may have very diff  erent outcomes.
Methods We selected adult elective surgical cases from the Premier database 
for 2008. The PPC conditions identifi  ed were: pneumonia; respiratory failure; 
bronchospasm; tracheobronchitis; pleural eff   usion; pulmonary collapse; 
ARDS; and pneumothorax. We stratifi  ed PPC cases into levels: those with 
bronchospasm and no other PPC (BS), those with respiratory failure (RF) 
and all remaining (NRF). We examined incidence, length of stay, hospital 
mortality, and total cost. US national projections were made using Premier 
supplied projection weights. We calculated incremental resource use and 
outcomes by comparing cases with and without PPCs for each surgical 
condition and summarizing across all conditions.
Results There were 738,039 cases in our cohort. At least one PPC was 
identifi  ed in 85,435. BS occurred on 6.4% of cases (45,005), NRF in 3.8% 
(27,796) and RF in 1.7% of cases (12,634). BS was not associated with an 
increase in the risk of death (one added death per 5611 cases), but had 
signifi  cant increases in resource use: one added ICU admission per 14 cases; 
one added ICU day per fi  ve cases; and one added hospital day and $1,563 
added cost per case. NRF was associated with a modest increase in risk of 
death (one added death per 157 NRF cases) and substantial increases in 
resource use: one added ICU admission for every six cases; 0.66 ICU days 
per case; and three hospital days and $5,771 added cost per NRF case. RF 
was associated with greatly increased risk of death (one added death per 
Figure 1 (abstract P209). Normal ventilation for healthy vs ARDS patients – 
fuzzy sets for paCO2 given from two clinicians: (left) C10, (right) C51.
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two cases; 5 ICU days, 8 hospital days and $24,000 in added cost per RF case. 
Projecting to the US population there were 583,300 PPC cases, associated 
with 9,500 added deaths, 92,200 added ICU admissions, 584,200 added ICU 
days, 867,400 added fl  oor days and $3.42 billion US in added costs. PPC add 
$717 to the average cost of elective surgery in the US.
Conclusions PPCs are very common, occurring in one in eight elective 
postoperative patients. While BS was not associated with added deaths, all 
three PPC strata were associated with substantial increase in resource use. 
Better strategies for the prevention and management of PPCs could lead 
to greatly improved outcomes and substantial savings.
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Introduction Respiratory muscle weakness is an important risk factor 
for prolonged mechanical ventilation, and may be part of critical illness 
related polyneuropathy and myopathy. Animal data also strongly point to 
atrophy and weakness of the diaphragm due to mechanical ventilation 
itself, called ventilator-induced diaphragmatic dysfunction. Recently, 
measuring transdiaphragmatic pressure following magnetic stimulation 
(TwPdi BAMPS) was introduced in the ICU to evaluate diaphragm function 
[1,2]. We aimed to evaluate reproducibility of twitch TwPdi BAMPS in 
critically ill, mechanically ventilated patients. We also aimed to describe 
the relationship between TwPdi and duration of mechanical ventilation.
Methods Prospective observational study in a medical ICU of a university 
hospital. TwPdi BAMPS was measured in critically ill and mechanically 
ventilated patients. Briefl   y, the phrenic nerves were stimulated 
bilaterally from the anterior approach, at the posterior border of the 
sternocleidomastoid muscle, at the level of the cricoids using two fi  gure-
of-eight 45 mm magnetic coils (Magstim, Dyfed, Wales) and a bistim 
(Magstim, Dyfed, Wales). A custom-built occlusion valve was used to create 
isometric conditions during stimulation. Oesophageal and abdominal 
pressure changes were measured using balloon catheters (UK Medical, 
Sheffi   eld, UK) inserted through the nose after local anaesthesia.
Results Nineteen measurements were made in a total of 10 patients at 
various intervals after starting mechanical ventilation. In seven patients, 
measurements were made on at least two occasions with a minimal 
interval of 24 hours. The between-occasion coeffi   cient of variation of 
TwPdi was 9.7%, which is comparable with data from healthy volunteers. 
Increasing duration of mechanical ventilation was associated with a 
logarithmic decline in TwPdi (R = 0.69, P = 0.038). This association was also 
found when cumulative time on pressure control ventilation (R = 0.71, P = 
0.03) and pressure support ventilation (P = 0.05, R = 0.66) were considered 
separately, as well as for cumulative dose of propofol (R = 0.66, P = 0.05) 
and piritramide (R = 0.79, P = 0.01).
Conclusions Increased duration of mechanical ventilation is associated 
with a logarithmic decline in diaphragmatic force. These fi   ndings are 
compatible with the concept of ventilator-induced diaphragmatic 
dysfunction. The observed decline may also be due to the cumulative 
dose of sedatives/analgesics or other co-factors, such as sepsis.
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Introduction The aim of the investigation was to study the parameters 
of haemodynamics, gas exchange and volhaemic status in patients with 
severe thermal injury.
Methods The trial has covered 30 injured patients aged from 21 to 
60 years with 25 to 78% skin burns and PO2/FiO2 <300. Patients were 
randomized into two groups. The fi  rst group was n = 13, PO2/FiO2 <300, 
24 to 72 h after burn. The second group was n = 17, PO2/FiO2 <300, 4 
to 11 days after burn. Injured persons were subjected to evaluation of 
cardiac index (CI), intrathoracic blood volume index (ITBI), extravascular 
lung water index (ELWI0 and pulmonary vascular permeability index 
(PVPI) by single transpulmonary thermodilution (PiCCOplus; Pulsion 
Medical Systems, Germany), calculation of oxygen delivery (DO2), and 
colloidal osmotic pressure of plasma. Grade of pulmonary damage was 
evaluated by Murrey, severity of dispragia by SOFA. Correlation analysis 
was performed using Pearson and Spearman criteria (r; P). Diff  erences 
were signifi  cant at P <0.05.
Results Hypoxaemia (PO2/FiO2 = 259 ± 19) in the injured of the fi  rst group 
was developing at the background of reduction of CI = 3.2 ± 0.5; ITBI = 751 
± 114; DO2 = 596 ± 124 (r = –0.92; P = 0.02). ELWI level was normal (7.3 ± 
0.8). In the second group, reduction of PO2/FiO2 has been developing at 
the background of burn sepsis (average SOFA point = 7.0 ± 1.9, Murrey 
= 1.6 ± 0.4) and was caused by increasing of ELWI up to 9.0 ± 1.4 (r = 
–0.66; P = 0.002) and correlated with PVPI (r = 0.57; P = 0.01). There was 
no statistically signifi  cant correlation ELWI with ITBI and colloidal osmotic 
pressure of plasma (r = 0.13, r = –0.42).
Conclusions Gas exchange disorders in patients of the fi  rst group were 
caused by lack of perfusion and misbalance between oxygen delivery and 
demand. Reduction of oxygenation index in patients from the second 
group was accompanied by ELWI at the background of alteration of 
intravascular penetration and sepsis.
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Introduction Prior non-invasive ventilation (NIV) is associated with an 
increased mortality in patients with haematological malignancies and 
acute respiratory failure treated by invasive mechanical ventilation (IMV).
Methods  We have assessed whether NIV failure is an independent 
prognostic factor for hospital discharge in a general cancer population 
treated by IMV. One hundred and six patients with solid tumours and 
58 patients with haematological malignancies were eligible for this 
retrospective study; 41 were treated by NIV before IMV.
Results  The main indications for mechanical ventilation were sepsis/
shock (35%), acute respiratory failure (33%), cardiopulmonary resuscitation 
(16%) and neurologic disease (10%). Respectively, 35%, 28% and 24% 
of the patients were extubated, discharged from the ICU and from the 
hospital. For patients treated with NIV prior to IMV, the rates were 22%, 
17% and 10%, respectively. In multivariate analysis, three variables 
were independently associated with a decreased probability of being 
discharged from the hospital: NIV use before IMV (OR = 0.30, 95% CI: 0.09 
to 0.95; P = 0.04); leucopenia (OR = 0.21, 95% CI: 0.06 to 0.77; P = 0.02) and 
serum bilirubin >1.1 mg/dl (OR = 0.38, 95% CI: 0.16 to 0.94; P = 0.04).
Conclusions NIV failure before IMV is an independent poor prognostic 
factor in cancer patients treated by IMV.
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Introduction Laryngeal angioedema (AE) could be life-threatening and 
is frequently due to allergic reactions. Other causes, that is bradykinin-
mediated conditions, have to be taken into account. The aim of our survey 
is to provide information on the incidence, diagnosis and potentially new 
treatment options for laryngeal AE.
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larynx at the Department of Otorhinolaryngology of Ludwig-Maximilians-
University of Munich from 2004 to 2008 were evaluated in a retrospective 
survey.
Results Causes of laryngeal AE were in 26 patients an allergic reaction, 
in 33 cases were due to radiotherapy after cancer, 32 patients took 
an angiotensin-converting enzyme inhibitor (ACEI), one patient had 
a hereditary angioedema (HAE) and in 10 patients are unknown. All 
patients independent from the underlying cause were treated with 
high-dose intravenous steroids, 69 patients with antihistamines, 33 with 
epinephrine (inhalation or i.m.), two patients with ACEI-induced AE were 
successfully treated with icatibant. Ten patients needed an intubation, 11 a 
tracheotomy, one patient an emergency coniotomy to preserve the airway. 
All 11 tracheotomy patients suff  ered from cancer. Nine out of 10 intubated 
patients took an ACEI and were extubated on the ICU after 2 to 7 days.
Conclusions  According to our experience 80% of the patients with 
laryngeal swelling and upper airway obstruction react well to the standard 
therapy with steroids, epinephrine and antihistamines, indicating that the 
AE is histamine induced. In contrast these drugs have almost no eff  ect 
on bradykinin-induced angioedema; that is, AE induced by ACEI. There is 
preliminary evidence that the bradykinin B2 receptor antagonist icatibant 
that is approved for treatment of HAE type I and II may also be eff  ective in 
ACEI-induced edema.
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Introduction  This study compared two insertion techniques of the 
ProSeal laryngeal mask airway in pediatric patients.
Methods  A total of 92 pediatric patients (American Society of 
Anesthesiologists physical status I or II; age 3 to 12 years) undergoing 
ophthalmologic surgery were randomly allocated to the standard or 
rotational technique groups. In the standard technique group (n = 46), 
ProSeal laryngeal mask airway insertion was performed by a single 
experienced user using digital manipulation. In the rotational technique 
group (n = 46), the ProSeal laryngeal mask airway was rotated counter-
clockwise through 90° in the mouth and advanced until the resistance of 
the hypopharynx was felt, and then straightened out in the hypopharynx 
(n = 80). The ease of insertion was assessed by the success rate at the fi  rst 
attempt. Heart rate and mean blood pressure were recorded 1 minute 
before and 1 minute after insertion. Postoperative complications were 
noted.
Results The success rate of insertion at the fi  rst attempt was higher for the 
rotational technique (95.7% vs 76.1%, P <0.001). The overall success rate – 
that is, successful insertion within three attempts – was 100% for the both 
techniques. Systolic, diastolic and mean blood pressure and heart rate 
increased signifi  cantly with the standard technique (P <0.001). Systolic 
blood pressure and heart rate increased signifi  cantly with the rotational 
technique (P <0.01). The incidence of blood staining (8.7% vs 23.9%, P = 
0.048) was lower with the rotational technique.
Conclusions  The rotational technique is more successful than the 
standard technique and is associated with less pharyngeal mucosal 
trauma, as evidenced by a lower incidence of mucosal bleeding.
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Introduction Intubation in the ICU is associated with a high complication 
rate. No data exist about how frequently intubation aids are used in the 
ICU. In our ICU we have the availability of diff  erent intubation aids, and 
perform an annual training course on diffi   cult intubation strategy. We 
wanted to evaluate the incidence of diffi   cult intubation, together with the 
complication rate and the use of intubation aids in our ICU.
Methods We performed a prospective cohort study in a 56-bed academic 
tertiary care hospital of all patients requiring intubation during their 
ICU stay during a 5-month observation period in 2008. Standardized 
data forms were used to collect detailed information on the intubating 
physicians, supervisors, techniques, medications and complications.
Results  We enrolled 120 patients requiring immediate intubation in 
37.5%, semi-urgent (<30 minutes) intubation in 50.8%, and semi-elective 
intubation in 11.7%. All intubations were successful. Diffi   cult intubation 
was anticipated in 17.5% of all cases, although only 28% of these eff  ectively 
proved to be diffi   cult. Immediate intubation was possible in 74.2% of 
all cases, and diffi   cult intubation (at least three attempts) occurred in 
6.6%. Furthermore, 4.2% of intubations required 10 minutes or more. 
Nonexperts experienced more complications, and performed successful 
intubation in only 37.7%. One-third of all intubations were supervised 
by an intensive care physician, although this was not associated with a 
decrease of complication rate (65% vs 57.5%). Techniques most commonly 
used for diffi     cult intubation management were change in intubator 
(48.4%), change in patient position (29%), BURP maneuver (19.3%) and use 
of a Gum elastic bougie (19.3%). Overall risk of complications occurring 
was 76.6%. Hypoxia was most common (40%), followed by hypotension 
(31.6%), heart rhythm disorders (4.1%) and oesophageal intubation (3.3%). 
Neuromuscular blockade was used in all but one patient. Hypnomidate 
was used in 31.6% of intubations, preferentially in patients with shock. The 
rate of complications or mortality did not signifi  cantly diff  er according to 
the hypnotic drug used.
Conclusions  Intubation in the ICU is frequently associated with 
complications, most commonly hypoxia and hypotension. The use of the 
Gum elastic bougie is required in 19.3% of cases, and results in achieving a 
100% successful intubation rate.
P217
Intensity and adequacy of laryngoscope light in seven intensive 
care units
J Hodd, S Gupta, N Rahman, P Young
Cleveland Clinic, Cleveland, OH, USA
Critical Care 2010, 14(Suppl 1):P217 (doi: 10.1186/cc8449)
Introduction The objective of the study was to determine the adequacy 
of illumination of laryngoscopes in seven critical care units (CCU) (two 
Figure 1 (abstract P214). Eff  ect of 30 mg icatibant s.c. on a laryngeal 
edema due to ACEI.
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Cleveland Clinic are routinely checked twice daily by healthcare workers. 
Confi  rmation of the presence of bulb illumination in ambient room light, 
however, may not be a suffi   cient test. In the CCU environment successful 
tracheal intubation may be time sensitive, and failure of adequate 
illumination of the larynx impedes visualization. Adequacy of lighting is 
subjective; however, the Health and Safety Executive suggests 500 Lux as 
a minimum for work requiring the perception of fi  ne detail [1].
Methods In a single-day spot audit, all clinically available laryngoscopes were 
evaluated for brightness. Battery voltage was measured with a voltmeter 
(Innova 3320; Fountain Valley, CA, USA), then the batteries were replaced for 
new prior to re-measuring of illumination. The bulb was then replaced for 
new and the illumination measured again. Illumination measurements were 
taken from tip of the blade at 90° using a luxometer (Model CA813; AEMC 
instruments, Foxborough, MA, USA) in a lightproof box.
Results Forty-six laryngoscopes were tested. All had traditional vacuum 
incandescent bulbs. Twelve (26%) fell below 1,000 Lux and six (13%) fell 
below the 500 Lux minimum. The failures were corrected by battery replace-
ment in 25% and by bulb replacement in the remaining 75% (see Figure 1).
Conclusions  Simply checking laryngoscopes for the presence of 
illumination on a regular basis is insuffi     cient to ensure best or even 
adequate function. Poor function is as frequently related to bulb 
dysfunction as battery fatigue. Institutions should consider quality control 
and maintenance programs or consider more advanced laryngoscopic 
lighting (for example, LED or halogen bulbs).
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Introduction A novel single-use indirect laryngoscope, the Airtraq (A), has 
been demonstrated to be of promise in the normal and simulated diffi   cult 
airway [1]. We compared the ease of awake intubation using the A against 
the fi  beroptic bronchoscope (F) in patients at increased risk for diffi   cult 
tracheal intubation [2].
Methods In this randomised, controlled, clinical trial we enrolled patients 
at increased risk for diffi     cult tracheal intubation, undergoing surgical 
operations requiring tracheal intubation. With ethics committee approval 
and written, informed consent, patients were randomly assigned to 
Fibroscope-guided tracheal intubation (F group) or Airtraq-guided 
intubation (A group). All patients, maintained in spontaneous breathing 
all through the procedure, received awake intubation performed by 
one of three anesthetists expert in diffi     cult airway management. All 
patients received a topical airway anesthesia with 2% lidocaine and total 
intravenous anesthesia (TIVA) performed with propofol c.i. with an eff  ecter 
site concentration of 1.5 μg/ml.
Results We enrolled 30 patients, 15 in the F group and 15 in the A group. 
All patients were successfully intubated in both groups. In group A we 
assessed a short time and a small amount of attempts of intubation with 
a statistically signifi  cant diff  erence between the two groups (P <0.05). No 
diff  erence was noted between the two groups in hemodynamic setting, 
saturation, Ramsey score and airway-trauma-related side eff  ects.
Conclusions  Our experience demonstrated that the Airtraq could be 
used during awake sedations and may be a promising alternative device 
for diffi   cult airway management as a valid alternative to the traditional 
fi  beroptic bronchoscope.
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Introduction  Tracheostomy in morbidly obese patients is generally 
performed by surgical technique. Although PDT has a low complication 
rate in nonobese patients, it is not technically possible to use standard 
PDT kits in morbidly obese patients with thick necks. The skin to trachea 
distance renders traditional-length tracheostomy tubes or dilators too 
short. Recently a tracheostomy kit (Uniperc, Smith Medicals, UK), designed 
for obese patients has become available. This kit consists of an S-shaped 
dilator and a long adjustable reinforced tracheostomy tube. The objective 
of this study was to evaluate the safety and complications of this new 
technique in morbidly obese patients.
Methods The study was approved and patients’ relatives were informed of 
the use of the new device. A total of 32 (male:female 21:11) morbidly obese 
(BMI mean 36 ± 4.3) patients (aged 27 to 57 years) were enrolled. Patients 
were anaesthetised and ventilated with 100% oxygen. PDT was carried 
out under endoscopic control with stomal dilation using the single stage 
S-shaped dilator and a reinforced adjustable fl  ange tracheostomy tube size 
7 to 9 mm ID as required. Measurements were taken including the distance 
from skin to the trachea using the graduated introducer needle and the 
initial small dilator, neck circumference, and length of the tracheostomy 
tube at the skin. Complications including accidental extubation, para-
tracheal placement, pneumothorax, major or minor bleeding, hypoxia, 
transient hypotension, subcutaneous emphysema or death were recorded. 
Patients were followed up with the inner cannula changed every day.
Results Thirty-two patients underwent PDT using this new kit. Patients 
were ventilated for a mean of 10 days (range 3 to 37) prior to tracheostomy. 
The mean neck circumference was 46.3 mm (37 to 55). The depth of the 
trachea from skin was a mean of 39 mm (15 to 80). The operators had 
no problem in stomal dilation using the single-stage dilator. The length 
of the tracheostomy tube adjusted at the skin ranged from 8 to 20 cm 
with a mean of 12 cm. No major complications were observed except two 
minor bleeding episodes and transient desaturation in one patient. The 
tracheostomy tube was decannulated after a mean of 25 days (6 to 82).
Conclusions  Bedside PDT can be performed in morbidly obese ICU 
patients using this new single-stage dilator and the adjustable fl  ange 
reinforced tracheostomy tube with a low rate of complications. Further 
studies with longer-term follow-up are required.
P220
Our percutaneous tracheostomy experiences using the rotation-
dilatation screw method
C Kaymak, N Ozcan, H Basar, A Ozcan
Ankara Training and Research Hospital, Ankara, Turkey
Critical Care 2010, 14(Suppl 1):P220 (doi: 10.1186/cc8452)
Introduction A tracheostomy procedure is indicated for urgent airway 
control, to avoid complications of lengthened endotracheal intubation 
Figure 1 (abstract P217). Laryngoscope illumination.
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techniques are preferred to classical surgical tracheostomy and the use 
is spreading. Ciaglia’s multiple dilatation technique, the Blue Rhino single 
dilatation technique, the Griggs dilatation forceps technique and the 
rotation-dilatation screw technique are the most preferred techniques for 
percutaneous tracheostomy [1,2]. The aim of this study is to retrospectively 
assess the techniques used for tracheostomy, tracheostomy time after 
intensive care admittance, length of intensive care stay and tracheostomy 
complications in our clinic.
Methods After approval of the hospital ethics committee, fi  les of the 
patients on whom the tracheostomy was performed between 2007 and 
2009 were evaluated retrospectively. Demographic data of the patients, 
tracheostomy time after intensive care admittance, length of total 
intensive care stay and related complications were registered.
Results Files of 35 patients were evaluated on whom tracheostomy was 
performed between 2007 and 2009. The male-to-female ratio was 17/18, 
mean age of the patients was 57.4 ± 20.1 years (16 to 81 years, min to max), 
mean intensive care stay was 33.4 ± 26.4 days (5 to 103 days, min to max). 
Mean tracheostomy time after intensive care admittance was 13 ± 8 days (2 
to 45 days, min to max). The rotation-dilatation screw technique was used 
for 34 patients and the Griggs dilatation forceps technique was preferred for 
one of the patients. No complication was observed for any of the patients.
Conclusions  Studies comparing the ease of performance, early and 
late complications and long-term results of diff  erent  percutaneous 
tracheostomy techniques do not exist. Diff  erent advantage/disadvantage 
ratios are reported in literature related to early and late tracheostomy 
performance time after admittance. In our clinic practice, the decision for the 
tracheostomy time is diff  erent for each patient. The mean tracheostomy time 
shows our clinic prefers late tracheostomy. In the aspect of complications, 
we did not observe complications reported in the literature.
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Introduction  The Ciaglia Blue Rhino percutaneous dilatational 
tracheostomy (PDT) technique, introduced in 1998 as a modifi  cation of 
the original procedure described in 1985, has been indicated as procedure 
of choice (level 2C) because of its technical simplicity and short procedure 
time. Recently, a modifi   ed balloon dilatation technique (Ciaglia Blue 
Dolphin) has been introduced with the intention to increase feasibility 
and safety. Here we report our initial experience in Ciaglia Blue Dolphin 
tracheostomy in comparison with a prospective control group of Ciaglia 
Blue Rhino procedures, which are actually the goal-standard in our ICU.
Methods  Twenty consecutively admitted patients in the Emergency 
Department ICU (Careggi Teaching Hospital, Florence, Italy) requiring 
percutaneous dilatational tracheostomy (PDT) were treated with Ciaglia 
Blue Dolphin (fi  rst 10, group D) and Ciaglia Blue Rhino (second 10, group 
R). Demographic, clinical and procedural data were collected. PDTs were 
all performed with bronchoscopic video guidance. The Mann–Whitney 
test was used to compare continuous variables.
Results Patients of the two groups were similar for mean age (51.2 and 
53.4 years old, respectively), body mass index (25.1 vs 24.8, respectively) 
and severity of illness (SAPS II: 44.3 vs 45.4, respectively). Group D showed a 
signifi  cant higher procedural duration (measured from tracheal puncture 
to tracheostomy tube positioning) than group R (4.3 minutes vs 2.6 
minutes; P <0.01).
Conclusions  Despite recent reports in literature, we did not found 
substantial advantage in the use of Ciaglia Blue Dolphin with respect to the 
wider accepted Ciaglia Blue Rhino. Moreover, the higher cost of the new 
kit should be taken into consideration. In our opinion, complications such 
as tracheal posterior wall injury, pneumothorax, and pneumomediastinum 
can be avoided using the bronchoscopic video guidance.
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Recruitment maneuver for prevention of alevolar derecruitment 
during percutaneous dilation tracheostomy
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Introduction  Alveolar derecruitment is an early complication of 
percutaneous dilational tracheostomy (PDT). The aim of this prospective 
study was to evaluate the effi   cacy of performing a recruitment maneuver 
(RM) before tracheostomy, in order to prevent the alveolar derecruitment 
in critically ill patients.
Methods We enrolled 16 patients admitted to the ICU between December 
2008 and July 2009, with PaO2/FiO2 ratio ≤3 who underwent PDT. We used 
the Ciaglia/Blue Rhino technique with endoscopic guidance throughout 
the procedure. Patients were ventilated before and during PDT on volume-
controlled mechanical ventilation (tidal volume of 6 ml/kg body weight) 
and FiO2 set at 1. Patients were randomized into two groups: MRa group 
(seven patients who underwent RM 10 minutes before PDT) and no-MRa 
group (nine patients without application of RM before PDT). RM was 
performed by imposition of continuous positive airway pressure (CPAP) 
of 40 cmH2O for 40 seconds. We collected gas exchange, respiratory and 
hemodynamic data at four times: 1 hour before RM (T1), 5 minutes after 
RM (T2), 5 and 30 minutes after PDT (T3 and T4, respectively).
Results The average duration of the technique was similar in both groups: 
20 ± 3.5 minutes (MRa) vs 17.5 ± 3.2 minutes (no-MRa). MR induced 
a statistically signifi   cant increase (P  <0.05) in PaO2/FiO2 ratio of MRa 
patients at T2, T3, T4 (Table 1). We did not fi  nd signifi  cant diff  erences of 
respiratory and hemodynamic data between groups; MR did not induce 
cardiovascular instability: the mean cardiac output was 5.2 ± 2.2 vs 4.9 ± 
1.5 l/min (MRa vs no-MRa, respectively).
Table 1 (abstract P222). PaO2/FiO2 in MRa and in no-MRa groups
PaO2/FiO2  T1 T2 T3 T4
MRa  182.8 ± 121.5  464.1 ± 119.7*  360 ± 138.8*  360.4 ± 79.7*
no-MRa  247.1 ± 121.9  228.1 ± 116.3  126.5 ± 76.9  163.5 ± 84.5
*P <0.05.
Conclusions RM with CPAP performed before PDT could be performed 
safely to prevent alveolar derecruitment due to PDT.
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Introduction In neurosurgical patients requiring ventilation on the ICU, 
a tracheostomy is frequently formed to facilitate airway protection and 
weaning from the mechanical ventilator. However, the issue of when to 
form a tracheostomy remains contentious. In order to better inform our 
decision-making processes we audited practice within our own institution.
Methods A retrospective study was conducted in which the ICU charts 
of all neurosurgical patients admitted to a tertiary referral ICU during 
the calendar year 2007 were reviewed. Patients who did not require 
mechanical ventilatory support or who died within 7 days of admission 
were excluded. Demographic data, diagnosis, duration of mechanical 
ventilation, ICU day of stay on which tracheostomy was formed, and ICU 
length of stay were recorded and the data analysed accordingly.
Results A total of 106 patients were included, 65 male and 41 female. The 
mean age was 49 years. Sixty-three patients were able to be separated from 
the mechanical ventilator within 7 days of commencement of ventilation 
via a cuff  ed oral endotracheal tube. Of the remaining 43 patients, 34 
(79%) went on to undergo tracheostomy formation as determined by 
the attending intensivist. In this group the median time of tracheostomy 
formation was 13 days. The median time from tracheostomy formation to 
separation from the mechanical ventilator was 3 days. Of those patients 
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(14%) were successfully separated from the mechanical ventilator without 
the need for a tracheostomy. There were no signifi  cant diff  erences in age 
or diagnosis between the two groups.
Conclusions Our data suggest that the failure of a neurosurgical patient 
to separate from the mechanical ventilator within 7 days is predictive of 
the eventual requirement for tracheostomy formation. In light of this we 
intend to expand our sample size over a 5-year period and subject the 
data to multivariate regression.
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Introduction  Few studies have focused on the safety and potential 
benefi  ts of tracheotomy in burn patients. The purpose of this study is to 
determine the safety and effi   cacy of percutaneous dilational tracheotomy 
(PDT) in patients with burn injury.
Methods  A retrospective chart review was completed for patients 
admitted to Baskent University Burn Institute, from January 2003 through 
December 2008, who underwent tracheotomy during their hospitalization. 
Parameters recorded included demographics, extent of burn, timing of 
tracheotomy and presence of inhalation injury. Other variables measured 
were the arterial blood gas fi  ndings and lung compliance before and after 
PDT and PDT-related complications and mortality.
Results Out of 325 patients, 17 patients (67% male) with a mean age of 
33.1 ± 15.9 years and a mean total body surface area involvement of 51 ± 
16% with a 40% of inhalation injury underwent PDT. Tracheotomies were 
performed within 48 hours after endotracheal intubations. All PDTs were 
performed at bedside by experienced staff   anesthesiologists with direct 
bronchoscopic guidance. The site of intended tracheotomy was aff  ected 
in 52% of patients. There were no procedural failures and no PDT-related 
complications and deaths. The calculated lung compliance and PaO2:FiO2 
ratio improved after PDT (36.2 ± 12.9 vs 47.3 ± 16.5 ml/cmH2O and 243 ± 
81 vs 350 ± 104, respectively).
Conclusions  The results suggest that PDT is an effi   cacious  and  safe 
technique for airway management in patients with burn injuries. Besides 
improved ventilatory mechanics, PDT may also benefi  t the patient with 
severe burns by earlier mobilization and ease of suctioning, oral intake and 
ability to communicate by mouthing words.
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Introduction  Percutaneous tracheostomy is a common procedure in 
many trauma ICUs. A concern about the safety of performing percutaneous 
tracheostomy in patients with no cervical spine clearance or cervical 
spine injury has limited its adoption for some surgeons. Most experts 
recommend the use of fi  beroptic bronchoscopy during the insertion of 
percutaneous tracheostomy.
Methods: From January 2001 to December 2007 we retrospectively 
evaluated the medical records of all patients with blunt trauma who 
required tracheostomy in a level II trauma center. Data were gathered from 
a trauma registry database and medical records. Patients were divided in 
two groups, open tracheostomy (OT) and percutaneous tracheostomy 
(PT). Patient age, Injury Severity Score (ISS), type of tracheostomy insertion 
method, cervical spine clearance status prior to tracheostomy, presence 
of cervical spine injury, use of bronchoscopy assistance in percutaneous 
tracheostomy, and immediate complications post tracheostomy were 
recorded for each patient.
Results The total number of tracheotomies during the study period was 
220, of which 125 (56%) were PT and 95(44%) were OT. Both groups were 
similar in age, sex and ISS distribution. Of the OT group, 60 (63%) were 
done in patients with no cervical spine clearance or cervical spine injury. 
There were no immediate complications reported in the OT group. The 
PT group had 63 cases (50.4%) done with no preoperative cervical spine 
clearance or positive for cervical spine injury. The PT group underwent 
the procedure without bronchoscopy assistance in 95% of the cases. Two 
cases (1.5%) in the PT group were reported with postoperative bleeding 
from the tracheostomy site that did not required intervention. Both 
cases were PT done without bronchoscopy assistance and did not have 
preoperative cervical spine clearance. No other immediate complications 
were reported.
Conclusions The results of this study suggest that PT is safe in trauma 
patients without preoperative cervical spine clearance or with cervical 
injuries as compared with the OT group. Most of the PT cases were done 
without bronchoscopy assistance (95%). This fi  nding suggests the need 
for further study to clarify the role of bronchoscopy assistance in PT.
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Introduction Percutaneous dilatational tracheostomy (PDT) has gained 
widespread acceptance in many ICU and trauma centers as a viable 
alternative approach. Numerous investigative reports show that all 
traditional techniques for PDT have similar complications. The most 
dangerous complication is posterior tracheal wall damage during insertion 
of the dilational device employing downward pressure. The Ciaglia Blue 
Dolphin (CBD) is an innovative device for PDT using radial balloon dilation. 
This technique has the potential advantage of less tracheal damage over 
other methods by avoiding downward pressure to enter the trachea [1,2].
Methods Case series of consecutive ICU patients with acute respiratory 
failure who required tracheostomy for failure to wean and continued 
mechanical ventilatory support. We report our clinical experience of 
22 percutaneous tracheostomies performed using the CBD system 
(Cook, Bloomington, IN, USA). Informed consent was obtained from 
each patient, or family member. All procedures were performed under 
direct visualization using a fi   breoptic bronchoscope on anaesthetised 
patients. The technique relies on the employ of a balloon-tipped catheter 
loaded over the guidewire. The balloon was infl  ated with saline up to 
11 atmospheric pressure for 30 seconds to create a tracheostoma. A 
preloaded tracheostomy tube was then inserted through the stoma 
following balloon defl  ation.
Results Bedside PDT with the CBD system was successfully performed in 
the ICU for all 22 patients. Tracheostomies were performed within a mean 
time of 4.1 ± 1.4 minutes of the tracheal needle entry and with negligible 
blood loss in all patients. The procedure was not associated with a 
decrease in SpO2 at the time of balloon infl  ation. Procedural complications 
were limited to one patient requiring the repetition of balloon infl  ation for 
tracheostomy tube placement. There were no other immediate medical 
or technical problems.
Conclusions The CBD has been shown to be a safe, quick and successful 
alternative to the traditional PDT (PercuTwist, guidewire dilating forceps, 
and so forth) that have a tendency to go too far and perforate the tracheal 
rings: the intensivist performing PDT should be aware when making the 
decision as to which approach to use. In our hospital, the CBD method has 
become the procedure of choice.
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Introduction  Because recovery of an effi     cient swallowing refl   ex is a 
determining factor for patient’s spontaneous rehabilitation of airway 
protective refl  exes, we have studied the infl  uence of cuff   pressure of the 
tracheostomy tube on the swallowing refl  ex elicited in tracheostomized 
ICU patients.
Methods  Twelve conscious eupneic adult patients were studied. 
Simultaneous electromyography of submental muscles [1] and 
acceleromyography of laryngeal elevation [2] were measured during 
refl  ex swallows elicited by pharyngeal injection of distilled water. After cuff   
defl  ation, instrumental characteristics of the swallowing refl  ex (latency 
time, electromyography and acceleromyography peak and amplitude) 
were measured at 10, 15, 20, 25, 30, 40, 50, and 60 cmH2O of air-fi  lled 
induced randomly imposed cuff   pressure.
Results Cuff   pressure was inversely correlated to both electromyography 
and acceleromyography characteristics of the swallowing refl  ex. Latency 
time of the swallowing refl  ex and cuff   pressure were linearly correlated. 
Instrumental characteristics of the swallowing refl  ex deteriorated for a cuff   
pressure threshold >22 cmH2O (extremes 15 to 40).
Conclusions We have demonstrated that instrumental characteristics of 
the swallowing refl  ex were infl  uenced by cuff   pressure in the tracheostomy 
tube. Increasing cuff   pressure aff  ected both the setting and the muscular 
activity of submental muscles during refl  ex swallows. Our data suggest that 
peripheral mechanical constraints and centrally controlled inhibition may 
be involved in cuff   pressure rise induced deterioration of the swallowing 
refl  ex. Our report has several implications for intensive care daily clinical 
practice. In case of dysphagia, swallowing function should be evaluated 
and re-educated with a cuff   pressure tidily controlled at 20 cmH2O.
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Introduction Mechanically ventilated (MV) patients are prone to develop 
ventilator-associated pneumonia. One of the major risk factors is micro-
aspirations of supraglottic secretions past the endotracheal tube cuff   
(usually in polyvinyl (PV)). A novel polyurethane (PUE) cuff   was designed 
to minimize these leakages. We therefore compared the sealing capacities 
of the two tubes in MV patients.
Methods Twenty-nine consecutive MV patients (mean age ± SD: 68 ± 
13, 21 males), were randomly allocated to receive either a PV (HI-LO 
Evac, Mallinckrodt) or a PUE (SEALGUARD Evac, Mallinckrodt) cuff  ed 
endotracheal tube (size: 9 for men; 8 or 8.5 for women, as a rule). We 
excluded patients with emergency intubation, unstable haemodynamics, 
severe respiratory failure or patients with history of tracheal/laryngeal 
disease. In each patient, cuff    pressure was maintained at 30 cmH2O, 
and ventilator parameters were set to plateau pressure ≤30 cmH2O; 
patients were fasting and placed in a strict semirecumbent position 
(45°). Radioactivity of tracheal aspirates was assessed sequentially (hourly 
samplings from T0 to T6 hours, then T8 hours and T12 hours) after injection 
of 74 MBq 99mTc-DTPA diluted in 5 ml of 0.9% NaCl just above the cuff   via 
the aspiration channel of the tube. Additionally, kinetics of respiratory tract 
contamination was followed by simultaneous pulmonary images using a 
scintillation camera. Data were blindly analysed by nuclear physicians. 
The study was approved by the hospital ethics committee and informed 
consent was obtained from relatives.
Results Sixteen PUE and 13 PV cuff  ed tubes were compared. The study 
was performed 3.2 ± 2.8 days after intubation and 8.3 ± 9.6 days after ICU 
admission (mean ± SD). Ventilator parameters were the following: volume 
control or pressure support but one on T tube, FiO2 was 0.43 ± 0.14, PEEP 
6 ± 2 cmH2O. Leakages were observed in 11/29 patients (38%), with similar 
rate of aspiration in PUE (5/16) and PV (6/13) groups (P = NS). Leakages 
were more frequently observed in female (7/8) than in male patients 
(4/21) (P <0.001). There was a trend to decreased frequency of aspiration 
in patients with larger tubes (size 9 vs 8.5: P = 0.062).
Conclusions  Both PUE and PV cuff  ed endotracheal tubes are poorly 
eff  ective in preventing microaspirations in MV patients. Tube size and/or 
gender may be more important than cuff   composition in the prevention 
of aspiration during MV.
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Introduction For decades it was assumed that cuff  ed endotracheal tubes 
prevented aspiration. However, currently used cuff  ed tubes do not prevent 
the development of post-intubation pulmonary complications caused by 
microaspiration [1,2]. A new taper-shaped cuff  ed tube (TaperGuard (TG)) 
has recently been introduced. The aim of this study was to compare this 
tube with a traditional tube (Hi-Lo (HL)) in an aspiration pig model.
Methods Fourteen pigs between 65 and 75 kg were studied. The pigs 
were randomly intubated with either TaperGuard (tapered cuff  ) or Hi-
Lo (barrel cuff  ) tubes. The tube size was either 7.0 or 8.5 depending on 
weight. Cuff   pressures were maintained between 24 and 27 cm water. 
After intubation, 0.3 ml/kg acidic blue dye (ph 2.5) was placed on top of 
the cuff  . The animals were ventilated for 3 hours. The animals were then 
sacrifi  ced and the tracheobronchial tree and lungs examined. Aspiration 
was characterized as follows: dye leak, ulceration/erosion, hemorrhagic 
pneumonia, bronchitis/bronchiolitis.
Results Of the 14 pigs, one had to be excluded due to accidental cuff   
defl  ation. Tube sizes were evenly distributed amongst the groups. Cuff   
pressures were equal: TG 23.7, HL 25.2 – P <0.2. As seen in Table 1, the 
incidence of microaspiration was signifi  cantly less for TG in the Blue Dye 
and bronchitis groups.
Table 1 (abstract P229). Incidence of microaspiration
 Hi-Lo  TaperGuard  P value
Dye leak  7/7  1/6  0.005
Ulceration 5/7  1/6  0.07
Hemorrhagic pneumonia  5/7  1/6  0.07
Bronchitis 5/7  0/6  0.016
Conclusions  The TG provided signifi   cant microaspiration protection 
compared with the conventional tube in the dye and bronchitis 
categories. Although not statistically signifi  cant, the diff  erence in the other 
two categories may be of clinical signifi  cance. Further clinical studies are 
necessary to confi  rm this point.
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Introduction The cuff  -leak test has been proposed as a clinical method 
for predicting stridor or respiratory distress caused by laryngeal edema 
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in postoperative patients is not clear. We assessed the relationship 
between upper airway obstruction and the values of cuff  -leak pressure in 
postoperative patients.
Methods  One hundred and fi   fty-eight postoperative patients (123 
elective, 35 emergency) were included. After ventilator weaning was 
accomplished, we measured the airway pressure at which a sound of cuff   
leakage was audible by a cuff   pressure monitor. In 28 cases, the cuff   leak 
pressure was measured during both awake and sedated states.
Results The cuff   leak pressure value was 12.8 ± 10.1 (median 10) mmHg 
for elective cases and 12.6 ± 10.0 (median 10) for emergency cases (NS). 
Six patients (3.8%) were not extubated because of high leak pressure 
and the value was 40.5 ± 16.0 (24 to 60) mmHg. One hundred and forty-
three patients were extubated and nine of those (6.3%) were diagnosed 
as laryngeal edema by laryngoscopy. Seven of those (5.0%) needed 
reintubation, one was for the reason of massive sputa, three were for 
granuloma formation, and three (2.1%) were diagnosed as severe laryngeal 
edema. Patients who developed severe laryngeal edema had a higher 
leak pressure (27.2 ± 22.7 mmHg) than those who did not, and all of such 
patients had pressure above 20 mmHg. The sensitivity and the specifi  city 
of the test using a threshold value of 20 mmHg for severe laryngeal edema 
were 97.2% and 40.0%, respectively. The occurrence of severe laryngeal 
edema was not associated with age, gender, perioperative weight gain, 
duration of translaryngeal intubation, inner diameter of the endotracheal 
tube, or serum albumin concentration. However, the cuff   leak pressure 
value >20 mmHg was associated with gender (female, P = 0.02) and inner 
diameter of the endotracheal tube (P = 0.0017) by multivariate regression. 
In 28 patients, the cuff   leak pressure was 17.8 ± 10.6 during the awake 
state and 9.9 ± 4.6mmHg under sedative. Because tonus of larynx is 
considered to be related to cuff   leak pressure, it is useful to measure the 
cuff   leak pressure in a sedated state if the patient had a high value in the 
awake state.
Conclusions Cuff   leak pressure values <20 mmHg at any time are useful to 
rule out severe laryngeal edema. It may be useful to measure the pressure 
in a sedated state if the value in the awake state is high.
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Introduction It takes an experienced multiprofessional team to handle 
emergent airway situations. We created a Code Critical Airway team to 
manage airway emergencies. Critical (diffi   cult) airway emergencies are 
increasing due to advances in medical treatments, obesity and sleep 
apnea. Diffi   cult airway events are low volume and high risk, requiring 
expert skill and communication. In the United States a leading level I 
adverse patient safety event is ‘death or serious disability associated with 
airway management’ [1].
Methods Utilizing a complex framework with the goal of successful airway 
management outcomes, the project was divided into six components: 
patient safety, includes the development of an airway management 
plan focused on improved team effi     ciency and culture change from 
Panic Button to Bridge to Safety; patient assessment, includes the 
development of educational programs focusing on early recognition of 
potential critical airway patients; teamwork, includes the development of 
improved communication, paging and handoff   processes; performance 
improvement, includes after-action reviews of each event to assess and 
address system and process issues; equipment, includes the development 
of standardized airway equipment at the bedside; and team simulation 
training, includes consistency in communication, handoff  , teamwork and 
equipment use.
Results The average time to establish an airway across all techniques 
has been drastically reduced (55 minutes to 22 minutes), of special note 
is the dramatic improvement in the time to reintubation (18 minutes to 
5 minutes). The number of surgical airways required reduced from fi  ve 
pre-project to zero in phase two. Thirty-one percent of the airway patients 
were obese or had a short thick neck. We have seen an increase in our 
respiratory distress calls versus respiratory arrest calls, reinforcing the 
benefi  t of proactive over reactive calling. Code Critical Airway education 
programs improved the number of appropriate Code Critical Airways 
being called, as well as improved overall Code Critical Airway Team 
response time. As a by-product of this process, reliability of available 
appropriate airway equipment is now 100%.
Conclusions This project made signifi  cant process improvements in the 
areas of patient safety, team communication, equipment availability and 
response effi   ciency. Hospitals should develop a specialized airway team to 
decrease adverse airway events.
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Introduction  Weaning from mechanical ventilation represents an 
important issue after cardiac surgery because a delayed extubation can 
burden the patient’s recovery health, increasing the risk of infections 
and the length of hospital stay. Recognized parameters such as minute 
ventilation, negative inspiratory force, maximal inspiratory pressure ratio, 
and Tobin index do not predict very well the success of extubation in 
these patients. We tested whether hemodynamic parameters and indexes 
predict better successful extubation after cardiac surgery.
Methods We prospectively evaluated 100 patients undergoing cardiac 
surgery with pump admitted to the InCor ICU and monitored with 
Swan–Ganz. Exclusion criteria were congenital diseases, transplantation 
procedures, chronic renal failure, and ejection fraction lower than 20%.
Results Patients were considered for extubation if they tolerated a T-piece 
for 30 minutes. From 100 patients, 88 were successfully extubated and 12 
patients failed. There was no diff  erence between groups regarding baseline 
characteristics, including ejection fraction and co-morbidities. Univariate 
analysis showed in the successful group a lower duration of pump (55 
minutes x 90 minutes, P = 0.038), a lower length of stay in ICU (12 x 32 days, 
P <0.0001), a lower BNP level (144 x 422, P = 0.002), and a higher PO2/FiO2 
(312 x 266, P = 0.043) and a higher VeRT (time recovery minute ventilation) 4 
x 2, P <0.01. Multivariate analysis showed high levels of BNP and of PO2/FiO2 
at admission are strong predictors of successful weaning.
Conclusions After cardiac surgery, lower levels of BNP and higher PO2/
FiO2 are predictors of successful weaning. This suggests that adequate 
hemodynamic optimization must be achieved in patients to improve 
outcomes as early weaning of mechanical ventilation.
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Introduction The rapid shallow breathing index (RSBI) has been shown to 
be a parameter that predicts successful weaning. A RSBI of less than 105 
is a predictor for successful weaning. We investigated whether the RSBI 
could be a useful parameter in our patient population.
Methods From June 2008 until March 2009 all patients who had been 
mechanically ventilated on our six-bed ICU were studied. Only the patients 
who were invasively mechanically ventilated, for longer than 6 hours, who 
had no missing information and did not die whilst on the ventilator were 
included in this study. RSBIs were measured by these patients at two 
diff  erent time points of weaning, fi  rstly at the point of reduction in pressure 
support and then at the point of extubation. The RSBI was measured using 
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zero and adjusting the PEEP to 5 cmH2O. A signifi  cance level <0.05 was 
considered signifi  cant. The nonparametric Kruskall–Wallis test was used to 
analyse the collected data.
Results One hundred and nineteen patients were ventilated over this time 
period: 74 patients did not meet the inclusion criteria; 45 were included. At 
the time point of further reduction in pressure support, the RSBI showed 
signifi  cant diff  erences (P = 0.038) between the group who was ready for 
weaning and the group who was not ready for weaning. In the group with 
successful reduction of PS (n = 28) the RSBI was 83.54 ± 32.12, and in the 
group without successful reduction of PS (n = 2) the RSBI was 158.50 ± 
38.89. At the point of extubation the RSBI was signifi  cant in predicting 
successful extubation (P <0.001). In the group who was successfully 
extubated (n = 24) the RSBI was 75.25 ± 21.62, and in the group who was 
unsuccessfully extubated (n = 5) the RSBI was 155.20 ± 25.23.
Conclusions At the moment of extubation, the RSBI showed signifi  cant 
low values in the successful group. This was also for the time point further 
reduction in pressure support level.
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Introduction  ICU inpatients are susceptible to events of transient 
hypoxemia. The physical therapist makes use of bronchial hygiene 
techniques to solve or alleviate this problem. The goal of this paper was 
to compare two physiotherapy techniques: vibrocompression versus 
vibrocompression plus increase of 10 cmH2O in inspiratory pressure (IP) 
during pressure support ventilation (PSV).
Methods After being placed in the supine position in bed, with head angle 
elevation at 30°, patients were randomized to: group 1 (G1): vibrocompression 
for 10 minutes in the chest, or group 2 (G2): vibrocompression plus increase 
of 10 cmH2O in IP in PSV for 10 minutes in the chest. Clinical variables and 
APACHE II score were registered. Parameters analyzed at the beginning (1) 
and at the end (2) of the protocol were: variation of peak pressure (ΔPP = 
Pp2 – Pp1), variation of tidal volume (ΔVT = VT2 – VT1), variation of dynamic 
compliance (ΔCdyn = Cdyn2 – Cdyn1). The amount of variation of mucus 
secretion aspirated (ΔSa = Sa2 – Sa1) at the end was also measured. The 
results are showed in mean ± SD.
Results Both groups (G1: n = 30 and G2: n = 39) were similar in clinical 
characteristics and APACHE II score. The variation of variables in G1 and G2, 
were respectively: ΔPp (cmH2O) = 0.58 ± 1.41 and –0.10 ± 0.98, P = 0.02; ΔVT 
(ml) = 28.90 ± 119.40 and 64.26 ± 93.82, P = 0.96; ΔCdyn (cmH2O) = 3.03 ± 
9.56 and 4.26 ± 8.24, P = 0.89; ΔSa (g) 0.29 ± 1.73 and 0.93 ± 2.28, P = 0.36.
Conclusions We found no diff  erences between groups, except in peak 
pressure (Pp2 >Pp1) that was greater in G1. This result could be probably 
due to decreased airway resistance.
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Introduction  Failure in weaning from mechanical ventilation (MV) is 
frequent (25 to 30%) and associated with high mortality. Indexes predicting 
success can be helpful clinically. However their predictive capacity can be 
low, principally in patients with cardiac disease. The goal of this study is 
to evaluate weaning predictor indexes in patients with cardiac disease 
during weaning from MV.
Methods We included patients with and without cardiac disease under 
MV for at least 48 hours, submitted to spontaneous breathing trial (SBT) 
for 30 minutes, extubated according to clinical decision and followed for 
48 hours. They were evaluated concerning age, sex, clinical characteristics, 
length of hospital and ICU stay and of MV. At the fi  rst and 30th minutes 
from SBT there were analyzed: arterial blood gases, hemodynamic and 
respiratory parameters as respiratory rate (f), tidal volume (VT), rapid 
shallow breathing index (f/VT), maximal inspiratory and expiratory 
pressures. Comparisons were done between this group of patients and 
success x failure, defi  ning failure as a return to MV in the fi  rst 48 hours.
Results Four hundred and thirteen patients were studied, 81 with cardiac 
disease and 332 without. Overall mortality rate was 14%. Return to MV 
occurred in 19.7%. The most important diff  erences comparing patients 
with cardiac disease with the control group were: lower mortality rate 
(21% x 13.5%, P <0.006), shorter length of ICU stay (9 ± 3 x 16 ± 13 days). 
Comparing patients who failed in the weaning process with and without 
heart disease (20% x 20%, P <0.55). Comparing f/VT in 30th minute of 
patients who have had success with those who failed the weaning process 
(60 ± 38 x 74 ± 47, P <0.012), a lower increase in f/VT (Δf/VT) (4 ± 27 x 11 ± 
33, P <0.075) during the test.
Conclusions In this group of patients a great number failed in the weaning 
process, showing, as expected, a higher mortality rate. Parameters most 
related to failure in the literature were higher age, longer length of ICU 
stay, mortality and f/VT. In this study, just the last parameter was sensitive 
principally in the 30th minute, and higher increase in f/VT (Δf/VT) during 
the test, demonstrating that patients with cardiac disease not fail more 
than others during the weaning process, as well as the effi   ciency of the 
test to predict success in weaning.
Members of Weaning Study Group R Wickert, LG Borges, ME Alves, ACT 
Silva, R Condessa, MB Blom, R Zancanaro, F Callefe, KB Pinto, K Hartmann, P 
Pinheiro, ES Oliveira, C Trevisan.
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Introduction Due to the improvement of nearly all fi  elds of acute care in 
the past decades, the burden of long-term dependency from mechanical 
ventilation (MV) increases incessantly. The aim of this study was to 
implement and test a standardised weaning protocol in patients suff  ering 
from long-term mechanical ventilation.
Methods After approval by the local ethics committee and informed 
consent, 644 patients were enrolled in a prospective cohort study in 
1 year. The mean time on the ventilator before inclusion was 39.4 (6 to 357) 
days. The reasons for long-term MV were: cerebral 33.1%; cardiovascular 
31.5%; pulmonary 28.7% and 5.6% neuromuscular diseases. The weaning 
protocol started with 6 x 5 minutes spontaneous breathing (intermission 
of mechanical ventilation) on day 1 and was increased stepwise up to 
24 hours spontaneous breathing on day 22. If there was no improvement 
in weaning steps over 5 days or there were more than three steps 
backwards the patient was switched to the individual weaning approach. 
The weaning protocol was carried out by the previously trained ICU staff   
as well as by specialized physiotherapists.
Results A total of 77.3% (n = 498) of the patients could be weaned off   
the ventilator by the fi  rst eff  ort. Out of these, 85.9% of the patients were 
weaned by the protocol whereas 14.1% needed an individual approach. 
The mean time of weaning was 17 (5 to 67) days using the protocol and 
29 (1 to 88) days due to the individual approach. In 12.6% both weaning 
procedures failed and these patients were discharged from the hospital 
into a home-care ventilation program. In total, 10.1% of the patients died 
on mechanical ventilation during their ICU stay. Patients who had needed 
a second weaning eff  ort (n = 111) were weaned in 36.4% by the protocol, 
transferred to home-care ventilation (28.8%) or died (35.1%).
Conclusions  Using the standardised weaning protocol, more than 
three-quarters of the prolonged mechanically ventilated patients could 
be weaned off   the ventilator in a mean of 17 days. Only 14.1% needed 
an individual strategy that takes 29 days until complete release from the 
ventilator. Therefore we suggest this kind of weaning protocol as a useful 
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care facility.
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Introduction  Non-invasive positive pressure ventilation (NIPPV) has 
generally been accepted as benefi   cial to use in acute hypercapnic 
respiratory failure (AHcRF), but it is not still standardized how to perform it, 
and with which ventilation modes. In this study it was aimed to compare 
the effi   ciency of pressure control (PCV) and pressure support ventilation 
(PSV) modes on patients with AHcRF.
Methods A prospective randomized controlled study, performed in a 
pulmonary ICU of a university hospital. Patients who were admitted with 
the diagnosis of AHcRF were included in the study consecutively and they 
were randomized to have either NIPPV with PSV or PCV for the fi  rst 2 hours. 
Then NIPPV was stopped for 4 hours to achieve a basal PaCO2 level, and 
after this waiting period NIPPV was continued with the other mode. The 
mode that leads to a greater decrease in PaCO2 value was accepted as the 
successful mode.
Results A total of 40 patients with mean age of 69 ± 12 years were 
included in the study. In only two (5%) patients were endotracheal 
intubation and mechanical ventilation needed. Among them, only one 
(2.5%) patient died. After NIPPV there was a signifi  cant decrease in PaCO2 
level with both PSV and PCV modes. But when ΔPaCO2 (PaCO2 after 
NIPPV – PaCO2 baseline) of both groups was compared, no statistically 
signifi  cant diff  erence was identifi  ed. Among the 20 patients that NIPPV 
was started with PSV, in nine (45%) of them PSV was assessed as successful 
and continued; in 11 of them (55%) NIPPV was switched to PCV (P >0.05). 
Among the 20 patients in which NIPPV was started with PCV, in one of 
them NIPPV was unsuccessful ending up with intubation, in 16 of them 
PCV (84%) was successful (P = 0.051). The presence of apnea and apnea 
plus hypopnea with the initial mode was found as the factor aff  ecting the 
assessment of PCV as the successful mode (P <0.05).
Conclusions Both PSV and PCV can be used effi   ciently in the treatment 
of AHcRF of various causes. But in the presence of apneas and hypopneas 
(either central or obstructive) PCV can be preferred instead of PSV.
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Introduction  This study compared the reliability and the effi   cacy  of 
three diff   erent non-invasive CPAP systems, Ventumask® low fl   ow (LF), 
Ventumask® high fl  ow (HF) and Boussignac® CPAP valve (B), both in a lung 
model and in healthy subjects.
Methods Lung model: pneumatic simulator fi  rst set at respiratory rate 16/
minute with 400 ml tidal volume (L1), then RR 40/minute with 800 ml tidal 
volume (L2). Human study: 10 healthy subjects were asked to make an 
expiratory pause (T1), fi  ve breaths at tidal volume (T2), and a short sequence 
of tachypnea (T3). The diff  erences between set and eff  ective PEEP and FiO2 
were used as indexes of reliability. The minimum airway pressure below the 
PEEP level and the airway pressure swing around PEEP were used as indexes 
of effi   cacy. In the lung simulator protocol, the pressure–time product was 
measured and then correlated to the other effi   cacy indexes.
Results Lung model: HF showed a tendency towards a more stable PEEP 
(P = 0.067). In B a signifi  cant fall in the FiO2 value from L1 (96.9 (95.5; 97.6)%) 
to L2 (54.2 (50.4; 56.9)%) was observed (P <0.001). The airway pressure swing 
around PEEP was greater in LF and B compared with HF in L1 (P <0.001), while 
during L2 it was lower in B (P = 0.007). The pressure–time product was better 
described by the airway pressure swing around PEEP (r2 = 0.95) rather than 
the minimum airway pressure below the PEEP level (r2 = 0.85). Human study: 
a lower diff  erence between set and eff  ective FiO2 was registered with HF 
(P <0.001). Ventumask® systems showed an overall higher minimum airway 
pressure below the PEEP level compared with B (P <0.001). During T3, HF 
(+10.1 (+7.4; +13.2) cmH2O) showed a smaller airway pressure swing around 
PEEP relative to LF (+11.9 (+10.1; +16.6) cmH2O, P <0.001) but not to B (+12.2 
(+6.6; +15.1) cmH2O, P = 0.40). During the whole respiratory sequence, an 
increase in end-expiratory pressure was observed. This increase was greater 
in B valve than in HF and LF (P <0.001).
Conclusions  According to observations, HF seemed to be the most 
reliable device. In conditions of high fl  ow demand, B reached FiO2 values 
lower than expected. The dynamic hyper-pressurization, higher with 
B, is probably due to the relationship between expiratory fl  ow and the 
resistance off  ered by the expiratory valve. B, even if handy and lightweight, 
is less reliable in terms of fl  ow supply and PEEP stability.
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Introduction Non-invasive mechanical ventilation (NIV) has been used in 
hypoxic postoperative cardiac patients but more studies are necessary to 
clarify its respiratory and hemodynamic eff  ects. Therefore, our objective 
was to study its eff   ects in the oxygenation index (PaO2/FiO2) and in 
hemodynamic variables in this group of patients.
Methods This is a randomized trial in which all postoperative cardiac 
patients having a pulmonary artery catheter and showing a PaO2/FiO2 
between 150 and 300 (with FIO2 0.31), 1 hour after extubation, were 
included. The intervention group used NIV with a bilevel positive airway 
pressure (an inspiratory pressure to generate a tidal volume of 6 ml/kg and 
an expiratory pressure of 7 cmH2O) with FIO2 0.4 during 3 hours. The control 
group used oxygen by Venturi mask in order to keep good oxygenation. In 
both groups, measurements were done in a basal situation (FiO2 0.31), in 
the fi  rst hour after beginning the treatment (FiO2 0.4) and 1 hour after the 
end of the intervention (FiO2 0.31). Variables studied included: pH, PaO2, 
PaCO2 and PaO2/FiO2 ratio, heart rate (HR), mean arterial pressure (MAP), 
pulmonary capillary wedge pressure (PCWP), central venous pressure 
(CVP), mean pulmonary arterial pressure (MPAP) and cardiac output (CO).
Results Forty-two patients were included in the study period. The mean 
age was 65.7 ± 10 years. The basal variables were similar in the two groups. 
There was an increase in the PaO2/FiO2 ratio in the NIV group in the fi  rst 
hour (P <0.05, 95% CI 74.8 to 6.6) and 1 hour after stopping the treatment 
(P <0.05, 95% CI 90.7 to 10.8) compared with the control group. There were 
no signifi  cant changes in hemodynamic parameters, pH and PaCO2 during 
NIV compared with the control group.
Conclusions There were no changes in hemodynamic variables during 
the NIV period. However, these results suggest that NIV improved 
oxygenation even 1 hour after stopping the treatment.
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Introduction  Acute respiratory failure is a common complication of 
severely burn-injured patients. Non-invasive positive pressure ventilation 
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respiratory failure. However, the outcome of NIPPV with burn patients is 
less well documented. The purpose of this study is to report our experience 
with NIPPV in a series of burn-injured patients.
Methods The records of all burn patients from July 2008 to September 
2009, in whom NIPPV was used in the intensive burn care unit, were 
reviewed. The criteria for selecting patients for NIPPV included a 
combination of the following factors: patients with acute respiratory 
failure, haemodynamically stable, conscious and cooperative with their 
treatment. There had to be no need for endotracheal intubation.
Results  Thirty-one patients were treated with NIPPV. Nineteen were 
female. Mean age was 44.22 years, mean total body surface area (TBSA) 
was 38.37%. NIPPV was used to treat hypoxia in 21 patients, hypercapnia 
in four patients and both of them in six patients. The mean PaO2/FiO2 ratio 
before NIPPV was 188.53. NIPPV was used to treat ARDS in 12 patients, 
pneumonia in eight patients, atelectasis in six patients and cardiogenic 
oedema in fi  ve patients. The mean PaO2/FiO2 ratio after NIPPV was 256.43. 
Intubation was successfully avoided in 12 out of the 31 (38.7%) patients. 
All of these patients progressed to self-ventilation status following NIPPV.
Conclusions  The use of NIPPV with burn-injured patients is, as yet, 
unclear because little work has been documented. In our experience, the 
use of NIPPV can lead to avoid the need for endotracheal intubation and 
mechanical ventilation.
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Introduction  The purpose of this prospective study is to describe 
the hemodynamic and cardiac variation during a trial of non-invasive 
ventilation (NIV) in the process of weaning from ventilatory support. A 
continuous hemodynamic monitoring was performed with a pulse contour 
method, the MostCare (Vytech Health, Laboratoires Pharmaceutiques 
Vygon, Ecouen, France). This device could be used to identify the early 
warnings of cardiovascular dysfunction, which may contribute to 
unsuccessful weaning.
Methods Fourteen patients, admitted to our ICU between January and 
July 2009, were included in the study: six intubated on respiratory failure 
due to cardiogenic pulmonary edema (CPE; 52 ± 18 years, four male 
(M), two female (F)), eight intubated on chronic obstructive pulmonary 
disease (COPD; 71 ± 16 years, four M, four F). The NIV trial was performed 
with a face mask: pressure support (PS) = 5 to 10 cmH2O, positive end-
expiratory pressure (PEEP) = 5 to 7 cmH2O. Cardiovascular variables and 
gas exchange data were measured at three defi  ned points in time: 1 hour 
before the extubation (T1), continuously during the NIV trial (a mean value 
was calculated and expressed as T2), and at the end of the NIV trial with 
the patient in spontaneous breathing (T3).
Results The variation of cardiac index (CI) was: T1 2.53 ± 0.43 ml/minute/m2 
CPE vs 3.2 ± 0.64 ml/minute/m2 COPD; T2 2.93 ± 0.93 ml/minute/m2 CPE vs 
2.9 ± 1.33 ml/minute/m2 COPD; T3 1.96 ± 0.61ml/minute/m2 CPE vs 3.3 ± 
1.37 ml/minute/m2 COPD. The variation of CI depended on the variation of 
stroke volume (SV), while the heart rate (HR) did not change during the trial. 
We calculated the oxygen delivery (DO2) by the correlation of CI and gas 
exchange: T1 767 ± 218 ml/minute CPE vs 839 ± 134.3 ml/minute COPD, 
T2 917 ± 417 ml/minute CPE vs 701 ± 349 ml/minute COPD, T3 760 ± 404 
ml/minute CPE vs 753 ± 340 ml/minute COPD. The variation of CI and DO2, 
observed within and among the two groups was never signifi  cant.
Conclusions  Both groups of patients were successful in achieving 
spontaneous ventilation. In our opinion, continuous hemodynamic 
monitoring may provide helpful beat-to-beat information and it might 
be used, combined with the gas exchange and oxygen saturation 
monitoring, during the weaning process as a predictor of cardiovascular 
instability or respiratory failure. Moreover, continuous hemodynamic 
monitoring enables one to be aware of the variation of systemic oxygen 
delivery, and these data could be used to value critically ill patients during 
the weaning process.
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Introduction Obesity rates are increasing in the general population and 
it is also prevalent in ICUs. Patients are sometimes admitted to ICUs for 
hypercapnic respiratory failure or cor pulmonale but in general they are 
admitted for pneumonia, excessive daytime sleepiness, heart failure, 
COPD or asthma attacks or pulmonary embolism; and hypercapnic 
respiratory failure is noticed during this period. On the other hand, optimal 
non-invasive mechanical ventilation strategy is not known during their 
ICU treatment. The aim of this study is to assess the diff  erences between 
NIV strategies and outcomes between obese and nonobese patients with 
acute hypercapnic respiratory failure.
Methods In this retrospective cohort study, 73 patients were studied 
and all of them were ventilated with a face mask. Patients divided into 
two groups as obese (BMI >35 kg/m2) and nonobese (BMI <35 kg/m2), 
and whether necessary pressure, volume, mode, ventilator and time to 
reduce PaCO2 below 50 mmHg were signifi  cantly diff  erent in obese and 
nonobese patients was investigated.
Results Mean age of the patients was 66 ± 14 years and mean admission 
APACHE II score was 18 ± 4; 41 (56%) of them were female. ICU admission 
reasons for the obese patients were signifi   cantly more frequently 
pulmonary edema and less frequently pulmonary infections (P = 0.003 
and 0.043, respectively) than the nonobese patients. While there were 
no signifi   cant diff   erences across the groups between the ventilators, 
modes, and inspiratory pressure levels, obese patients required higher 
end-expiratory pressure levels and more time to reduce the PaCO2 level 
below 50 mmHg than the nonobese group. Length of NIV and ICU stay, 
intubation and the mortality rate were similar across the groups.
Conclusions These results suggest that improvement of hypercapnia in 
obese patients may require higher PEEP levels and longer times than the 
non-obese ones during acute hypercapnic respiratory failure attack.
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Introduction  Prolonged mechanical ventilation (MV) is associated 
with high morbidity and mortality in septic patients. However, limited 
data are available on the prediction of prolonged MV. We conducted 
an observational cohort study aimed at developing a prolonged MV 
predictive scoring system for severe sepsis and septic shock.
Methods  We retrospectively analyzed 120 consecutive patients with 
severe sepsis or septic shock who were ventilated for more than 72 hours 
between January 2005 and October 2009. Clinical features and physiologic 
parameters were examined for more than 15 days for use as predictors of 
MV. Patients were divided into two groups: group 1, those requiring MV for 
<15 days; group 2, those requiring MV >15 days.
Results The mean (± SD) age and SOFA scores were 65.3 ± 16.7 years and 
10.0 ± 3.9, respectively, and 35% required prolonged MV. Univariate analysis 
indicated that the length of ICU and hospital stays, hospital mortality, the 
rate of transfusion, incidence of ARDS, ventilator-associated pneumonia 
(VAP), other nosocomial infection (NI) and drug-resistant bacteria, the ratio 
of steroid therapy and muscle relaxant use, and the mean PaO2/FiO2 ratio 
during the fi  rst 3 days after admission were signifi  cantly diff  erent between 
the two groups. The independent predictors for prolonged MV were ARDS 
(OR 5.24 (P = 0.001; 95% CI: 1.9 to 14.1)), VAP (OR 7.75 (P <0.001; 95% CI: 
2.7 to 22.0)), and transfusion (OR 2.84 (P = 0.036; 95% CI: 1.0 to 7.5)) Using 
these results, we were able to develop a prolonged MV predictive scoring 
system. This simplifi  ed clinical risk assessment tool was developed from 
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cut-off   point related to the adjusted odds ratio. Prolonged MV score: VAP 
= 7 points; ARDS = 5 points; transfusion = 2 points; incidence of drug-
resistant bacteria, steroid therapy, muscle relaxant use, other NI, the mean 
PaO2/FiO2 ratio during the fi  rst 3 days after admission <220 = each 1 point. 
The area under the receiver operating characteristic curve for prolonged 
MV in this scoring system was 0.866 (P <0.001; 95% CI: 0.802 to 0.931).
Conclusions The simple predictive scoring system for prolonged MV in 
severe sepsis/septic shock developed here will therefore help in planning 
the long-term care of such patients.
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Simplifi  ed approach to ICU severity scoring with MPM and 
EUROSCORE
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Introduction Severity scoring is a powerful tool for quality control in the 
ICU. We introduced a new severity scoring system to our ICU. The aim of 
this report is to describe the database and present the results of the fi  rst 
12 months.
Methods We analysed needs for database and severity scoring. We chose 
on-admission scoring with EUROSCORE for cardiac surgical patients, 
and Mortality Prediction Model II time zero for other patients. Data were 
collected via highly simplifi  ed forms onto a spreadsheet. Demographic 
entry was by ward clerk, on-admission severity scoring was by resident 
medical staff  , and risk of death calculation and data cleaning was by senior 
attending medical staff  . Individual patient risk of death was presented as a 
logit. Combined risk of death for the whole cohort was calculated from the 
arithmetic mean of individual logits. We estimated the time to completion 
of each step in data acquisition to calculate a total time spent per patient.
Results There were 1,355 admissions, mean (SD) age 69.2 (15.9) years, 
57.1% male; median (range) length of stay 23.1 (1.7 to 1,882.5) hours. Fifty-
four per cent of patients were ventilated for a median (range) 7.5 (0.8 to 
1,877) hours. Predicted mortality for cardiothoracic and noncardiothoracic 
patients combined was 8.64% and the observed mortality was 2.8%. 
EUROSCORE-predicted mortality for the 535 cardiothoracic patients 
was 5.72% and the observed mortality was 0.75% (four patients). MPM-
predicted mortality for the 820 noncardiothoracic patients was 11.23% 
and the observed mortality was 4% (34 patients). Estimated time to 
complete the severity scoring form was 30 seconds, to enter a new patient 
on the database was 90 seconds and to calculate risk of death and check 
data integrity was 90 seconds. Total was 3.5 minutes per patient.
Conclusions Data collection/analysis is essential for quality management 
in the ICU. Proprietary systems are expensive. Traditional scoring systems 
(APACHE II) are poorly calibrated to some case mixes. To overcome these 
problems, we devised a simple, inexpensive and highly valuable ICU 
database. The key features were well calibrated, on-admission severity 
scoring, highly simplifi  ed forms, a basic spreadsheet and collaborative 
staff   involvement. Senior medical staff   performed the fi  nal data checking. 
The project provided abundant high-quality data with a total input of 
3.5 minutes per patient. We are trialling the database in a large ICU in 
China and we would welcome input from other ICUs that would like to 
copy our methods.
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Introduction The sequential organ failure assessment (SOFA) score was 
introduced with the aim of quantifying the severity of illness, based on 
organ dysfunction, serially over time. A previous study has suggested that 
the reliability and accuracy of SOFA scoring by intensive care physicians 
is good but there may be room for improvement [1]. Manual calculation 
of the score can be time consuming. We developed a computer program 
that derives a SOFA score from the electronic patient record, the Innovian 
system (Draeger, Germany). To date, no automated method for SOFA score 
calculation has been validated. We validated the automated SOFA score 
collection method in order to assess its accuracy and reliability. We also 
measured the time for manual collection of SOFA scores in order to assess 
the resource saving potential of the computer system.
Methods  Fifty patient records were selected from the database as a 
stratifi  ed random sample in order to represent the patient population of 
our teaching hospital adult ICU. Two ICU physicians calculated a total SOFA 
score and an individual organ score on each of the 50 patient records. A 
gold standard SOFA score was then generated after discussion between 
the two physicians with the aid of a third adjudicating ICU physician. SOFA 
scores generated by the computer were compared with the gold standard 
to assess accuracy. Reasons for inaccurate scoring were recorded.
Results SOFA scores varied from 1 to 15 in this sample, the mean SOFA 
score for the Gold standard was 8.1 and the standard deviation was 
2.9. The agreement between the diff  erent ratings was very good. The 
computer score had a better agreement with the gold standard score 
(Pearson correlation coeffi     cient 0.92), compared with the individual 
physician scores (Pearson correlation coeffi     cient 0.890 and 0.895).
The computer calculated the SOFA score correctly in 41 cases and the 
physicians calculated the SOFA score correctly in 32 cases. The average 
time to calculate a SOFA score was 4.91 minutes and was not signifi  cantly 
diff  erent between the physicians.
Conclusions  The results show that this computer system is highly 
accurate at calculating SOFA scores from the electronic patient record and 
is more accurate than physicians. The time saved is considerable.
Reference
1.  Arts DGT, de Keizer NF, Vroom MB, de Jonge E: Reliability and accuracy of 
Sequential Organ Failure Assessment (SOFA) scoring. Crit Care Med 2005, 
33:1988-1993.
P246
Sequential Organ Failure Assessment scores and mortality
C Borni, L Meynaud-Kraemer, G Laplatte, HL Lessire
CH Pasteur, Colmar, France
Critical Care 2010, 14(Suppl 1):P246 (doi: 10.1186/cc8478)
Introduction In 2005, in a multicenter study in 79 ICUs in Spain, Cabré 
and colleagues [1] found patients older than 60 years and with SOFA score 
higher than 9 for at least 5 days unlikely to survive, suggesting that it could 
provide a basis for deciding whether to withhold or withdraw life support. 
We tried to control their hypothesis in our patient population.
Methods We reviewed the data of the patients older than 60 years and 
with a LOS higher than 5 days admitted to our ICU in 2007. We calculated 
the daily SOFA score of the patients with an initial SOFA score higher than 
9. IGSII, LOS and mortality were compared between patients with a SOFA 
score higher than 9 for at least 5 days (SOFA(+) group) and the other 
selected patients (SOFA(–) group).
Results In 2007, 430 patients were admitted to our ICU. One hundred and 
forty were older than 60 years and remained more than 5 days in the ICU. 
Eleven of these patients had a SOFA score higher than 9 during 5 days 
or more. In the SOFA(+) group, LOS (22.6 ± 13.1 vs 10.8 ± 6.9 days) and 
mortality (55% vs 33%) are signifi  cantly higher (P <0.05). The mortality of 
55% is in good agreement with the predicted IGSII mortality but far less 
than the 100% predicted by Cabré and colleagues.
Conclusions A SOFA score higher than 9 for at least 5 days in patients older 
than 60 years seems useless to defi  ne futility in our patient population. It 
is applicable to only less than 3% of the 430 patients admitted in 2007. 
The mortality rate of the SOFA(+) group increased but remained far from 
values permitting to withdraw or withhold intensive care. A weakness 
of the use of sequential SOFA score to predict outcome is that some 
therapeutic options can infl  uence the value of the SOFA score.
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Introduction Our objective was to determine what physiological and 
biochemical factors predict development of bacteremia in transplanted 
cirrhotic patients (TP) and, upon diagnosis of bacteremia, what is the 
natural history of bacteremic patients (BTP) versus controls (TP).
Methods  Data collected prospectively and entered into a dedicated 
physiology database for all transplanted cirrhotic patients admitted to a 
specialist liver intensive therapy unit (LITU) were examined from January 
2003 to July 2005 for incidence of bacteremia and survival.
Results  In total, 362 patients were transplanted for decompensated 
cirrhosis (64% elective, 36% in-hospital). Thirty-eight (10%) suff  ered 
bacteremia (BTP) while 324 (90%) patients did not (TP). Forty-nine per 
cent of isolates were Gram-positive organisms, 45% Gram-negatives 
and 6% fungemia. Median time to fi  rst bacteremia was 11.5 days. On 
admission (univariate), BTP patients had signifi  cantly higher APACHE II 
scores (23 vs 11, P <0.001), worse acidosis (pH 7.27 vs 7.35, P <0.001) and 
greater degrees of encephalopathy (GCS 12 vs 15, P <0.001). During their 
LITU course BTP patients had signifi  cantly greater requirements for renal 
replacement therapy (RRT) (68% vs 17%, P <0.001), mechanical ventilation 
(median 15 days vs 2 days, P <0.001) and a longer median LITU stay (21 
vs 3 days, P <0.001). Survival to hospital discharge was worse in the BTP 
group (55% vs 95%, P <0.001). Multivariate analysis (logistical regression) 
was performed modelling with APACHE II. APACHE II (odds ratio 1.06), 
bacteremia (4.01) and requirement for RRT pre or post transplant (12.5) 
were independent predictors of mortality. The APACHE II model performed 
well (AUROC 0.817).
Conclusions In transplanted cirrhotic patients, bacteremia was associated 
with increased severity of illness on admission, greater requirements for 
organ support and independently adversely impacted on survival. Higher 
APACHE II score and the requirement of RRT during LITU stay were also 
independently predictive of mortality.
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Introduction  This study investigates the prognostic quality of six 
prediction models (APACHE II score, SAPS II, SAPS II (Expanded), SAPS 3, MPM 
and MPM II0) for assessment in an adult surgical ICU in the Netherlands.
Methods Of all single admissions to the surgical ICU of the St Elisabeth 
Hospital between 1995 and 2000, data to calculate the results of 
six prediction models were prospectively documented. To evaluate 
discrimination and calibration, receiver operating characteristic (ROC) 
curves, area under the characteristic (AUC) curve and the Hosmer–
Lemeshow goodness-of-fi  t test were performed.
Results The data of 1,821 patients were applied to all six models. Accurate 
overall mortality prediction was found for the APACHE II, SAPS II, SAPS 
3 and MPM models. Discrimination was best for the SAPS 3 model and 
worst for the APACHE II and MPM models with AUC of 0.81, 0.77 and 0.77, 
respectively (Figure 1). Calibration was poor for the six prediction systems, 
varying between 23 (SAPS 3) and 233 (SAPS II (Expanded)).
Conclusions The SAPS 3 prediction mortality model is the best validated 
model for a Dutch surgical ICU population of six models tested. The other 
general prognostic models for ICU patients underestimate the risk of 
dying.
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Introduction  Prolonged ICU stay is associated with high morbidity, 
mortality and costs [1,2]. Prediction of this prolonged stay will provide 
information for physician and family and help with resource allocation. 
Even though, available severity scoring system ie. APACHE II, APACHE III, 
MPM, SAPS II, MODS  scores are widely accepted for evaluating outcomes 
in the ICU population. But these models might be inaccurate when apply 
to subpopulation and might not predict prolonged length of stay. The 
objective of this study was to refi  ne ASA physical status and fi  ve severity 
scores (APACHE II, APACHE III, SOFA, SAPS, MOFS) in order to predict 
prolonged length of stay in the adults patients admitted to the general 
surgical ICU.
Methods This prospective observational study was done in 948 adult 
surgical patients admitted to the general surgical ICU at Siriraj Hospital 
during 1 January 2005 to 31 December 2005. A prolonged length of stay 
was defi  ned as staying in the ICU >72 hours. Preoperative ASA physical 
status and fi  ve severity scores as APACHE II, APACHE III, SOFA, SAPS, MOFS 
on day 1 were registered and calculated. We analyzed the relationship of 
each severity score and outcome as prolonged ICU length of stay.
Results Prolonged length of stay represented 20.1% of ICU admissions. 
Among severity scores, ASA physical status IV (P  <0.001), emergency 
ASA (P <0.001), APACHE III (P = 0.025) were signifi  cantly associated with 
prolonged ICU length of stay (>72 hours) while MODS was most likely 
associated with this prolonged length of stay (P = 0.059). From multivariate 
analysis, only ASA physical status IV (OR 6.503 (2.314 to 18.275), P <0.001) 
and emergency ASA (OR 4.52 (2.86 to 7.12), P <0.001) were signifi  cantly 
associated with prolonged ICU length of stay (>72 hours).
Conclusions The study was conducted in 948 adult surgical patients admitted 
to the general surgical ICU at a 3rd referral university hospital. Among all of the 
severity scores, ASA physical status IV and emergency ASA were signifi  cantly 
correlated with prolonged ICU length of stay >72 hours.
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Figure 1 (abstract P248). Receiver operating characteristic curves for all 
six prediction models.
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patients: a review of 1,362 cases
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Introduction  Surgical outcomes depend on many factors, including 
baseline characteristics and diff   erences in surgical and anesthetic 
practices. Few data are available in general surgical oncological patients. 
We aimed to evaluate the predictive value of Porthsmouth POSSUM and 
American Society of Anesthesiologists (ASA) scores in oncologic patients 
submitted to surgical procedures.
Methods Data were collected from a database fi  lled with demographic 
characteristics, neoplasm defi   nitions, co-morbidities and data from 
intraoperative room and hospital mortality. The predicted mortality risk was 
calculated using Porthsmouth POSSUM and ASA physical status grading.
Results  From 1,362 surgical patients, the observed general hospital 
mortality was 2.34%. ASA grading underestimated the mortality for 
low-complexity patients, overestimated in patients with severe systemic 
disease (ASA III), and was a strong predictor of mortality in patients with 
life-threatening conditions (ASA IV) (Table 1). On the other hand, the 
Porthsmouth POSSUM scoring system overestimated mortality in all 
groups (Table 2).
Table 1 (abstract P250). Observed and predicted mortality of oncologic 
patients evaluated through ASA physical status grading
ASA Number  Observed  Predicted
ASA I  209  4 (1.91%)  1 (0.05%)
ASA II  867  10 (1.15%)  1 (0.4%)
ASA III  247  7 (2.83%)  11 (4.5%)
ASA IV  39  11 (28.2%)  10 (25%)
Total 1,362  32  (2.34%)
Table 2 (abstract P250). Observed and predicted mortality of oncologic 
patients evaluated through Portsmouth POSSUM scoring
Number  Observed  Predicted  0 to 5
0  0  0 (3.1%)  5 to 30
1,055  15 (1.42%)  142 (13.5%)  30 to 100
307  17 (5.53%)  149 (48.7%)  0 to 100
1,322 32  (2.34%)
Conclusions In surgical oncologic patients, Porthsmouth POSSUM and 
ASA are not good predictors of mortality. These data suggest that a more 
sensible and specifi  c score is needed in this population.
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Introduction  Several scores exist for characterization of critically ill 
patients, developed in part for septic patients especially for the ICU patient 
(for example, Acute Physiology and Chronic Health Evaluation, APACHE II; 
Sequential Organ Failure Assessment, SOFA), but also for the septic patient 
in the emergency department (ED) (Mortality in Emergency Department 
Sepsis, MEDS). The practicability of these scores in the ED is discussed 
controversially. The aim of our study was to directly compare these scores 
in the setting of an ED on a cohort of patients with suspected infection.
Methods  Patients with suspected severe infection from which blood 
cultures were taken were included in the study. Procalcitonin (PCT) levels 
were determined, and APACHE II, MEDS and SOFA scores were calculated 
at admission. Endpoints were 28-day-mortality and necessity for therapy 
on an ICU. Receiver operating characteristic (ROC) curve analysis was 
performed to compare the ability of the three scores to predict the 
endpoints.
Results We analyzed 211 patients. Eighty-two patients (43.6%) had a PCT 
value ≥2 ng/ml and were considered septic. Mean values of APACHE II, 
MEDS and SOFA score were 16.1 ± 8.5, 7.4 ± 4.7, and 3.4 ± 3.1 respectively. 
Tables 1 and 2 show the area under the curve (AUC) values of the ROC 
curves for mortality (Table 1) and ICU therapy (Table 2).
Table 1 (abstract P251). ROC analysis for mortality
Score AUC  Standard  error  Signifi  cance
APACHE II  0.804  0.045  <0.001
MEDS 0.785  0.048  <0.001
SOFA  0.708 0.051 0.006
Table 2 (abstract P251). ROC analysis for ICU therapy
Score AUC  Standard  error  Signifi  cance
APACHE II  0.757  0.038  <0.001
MEDS  0.648 0.042 0.001
SOFA 0.731  0.039  <0.001
Conclusions All three scores are useful prognostic factors for mortality 
and for ICU therapy in the ED, with usually lower patients’ severity of 
infection than in the ICU. The ICU-validated APACHE II and SOFA scores 
were of similar prognostic value as the ED-specifi  c MEDS score.
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Introduction Recently, Raum and colleagues [1] generated and validated 
a new trauma score (Emergency Trauma Score, EMTRAS) based on age, 
prehospital GCS, prothrombin time and base excess. Each parameter is 
subdivided into four classes, scored from 0 to 3 points. Scores of each class 
are summed to obtain the EMTRAS, ranging from 0 to 12. Here we present 
preliminary results of a study with the aim to validate this new scoring 
system and to compare it with other commonly used illness scores.
Methods One hundred and fi  fty trauma patients admitted to the regional 
referral trauma center (Careggi Teaching Hospital, Florence, Italy) were 
studied. Predictive value of the EMTRAS score was compared with the 
Injury Severity Score (ISS), Revised Trauma Score (RTS), Trauma Injury 
Table 1 (abstract P252). Area under the curve (AUC) for EMTRAS and other 
scoring systems
Variable AUC  95%  CI
EMTRAS  0.809  0.74 to 0.87
ISS  0.758  0.68 to 0.83
RTS  0.818  0.74 to 0.88
TRISS  0.909  0.84 to 0.96
SAPS II  0.845  0.78 to 0.90
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Logistic regression analysis was performed with MedCalc version 10 
(MedCalc Software, Mariakerke, Belgium).
Results The areas under the curves confi  rmed a good reliability of the 
EMTRAS score if compared with other validated trauma scores and with 
nontrauma-specifi  c scores such as SAPS II (Table 1). In particular, patients 
with EMTRAS scores of 5, 6 and 7 had a more major risk of death (odds ratio) 
of 2.3, 4 and 16, respectively, than patients with EMTRAS score below 5.
Conclusions Our preliminary results confi  rm that EMTRAS has a good 
correlation with mortality risk. All four parameters of the score are simply 
available in a small amount of time, allowing physicians to quickly 
estimate trauma patients’ severity, before other examinations like CT scan 
are performed.
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Introduction Community-acquired pneumonia (CAP) is one of the most 
common diseases encountered in the emergency department (ED). For 
the ED physician, it is quite diffi   cult to estimate the severity of CAP patients 
in the ED because most CAP patients present at an earlier stage of disease. 
Although several societies such as ATS, IDSA and BTS have established 
severity scores for CAP, those scores are too complicated to calculate 
easily, especially in a busy department such as the ED. Therefore, a new 
simple and useful severity score for CAP is necessary for ED physicians. 
The purpose of our study is to develop a new severity score for CAP using 
30-day mortality or patients needing more than 2 weeks oxygen therapy 
as the main outcomes.
Methods We derived a prediction rule for outcomes by analyzing data on 
243 adult inpatients with CAP between March 2006 and November 2008 
in our hospital. Patients’ charts were abstracted to collect data relating 
to demographics, history, coexisting illnesses, laboratory results, and 
radiographic fi  ndings. Signifi  cant predictors of outcomes were identifi  ed 
through logistic regression analyses.
Results The following were independently associated with outcomes: 
presence of pleural eff  usions (P) (OR 5.0 (95% CI: 1.70 to 14.85)); albumin 
(A), <3.0 g/dl (OR 8.7 (1.43 to 53.29)); respiratory rate (R), >30/minute (OR 
8.0 (1.62 to 39.64)); BUN (B), >25 mg/dl (OR 3.4 (1.07 to 11.07)). Patients 
were assigned according to whether they had these factors or not from 
class 0 to class IV (class 0 means the CAP patient had no these factors, class 
IV means the CAP patient had all these factors). Patients in risk class 0 to IV 
had a predicted probability of death or >2 weeks oxygen therapy of 0.03%, 
0.08%, 52.2%, 75.0% and 100%, respectively. The sensitivity and specifi  city 
of this model were 36.0% and 99.0%, respectively. Accuracy of this model 
was 91.9%. The area under the ROC curve was 0.8705.
Conclusions The PARB score can accurately predict patients with CAP 
who are at risk for death or who will need more than 2 weeks oxygen 
therapy. This score may help ED physicians provide adequate treatment 
for patients with CAP.
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Introduction The early identifi  cation of patients with severe sepsis is a 
key point to provide the correct treatment and is actually based on clinical 
evaluation. In hospital wards, the Modifi  ed Early Warning Score has been 
proposed as a system to identify early signs of deterioration and for 
outreach team activation. However, MEWS sensibility in early recognition 
of septic patients is still unknown. The aim of this study was to evaluate 
whether MEWS ≥4 is an adequate threshold for early identifi  cation of 
patients with severe sepsis.
Methods In 51 patients with severe sepsis (no septic shock) evaluated 
by our sepsis team, between November 2007 and December 2008 in the 
emergency department and no ICU wards, we collected the SOFA score 
and MEWS at the time of fi  rst evaluation, the ICU admission rate and the 
30-day mortality rate. We subdivided and compared patients into two 
groups on the basis of a MEWS value ≥4.
Results In the 22 (43%) patients with a MEWS value ≥4, the SOFA score 
(5.9 ± 2.9) was similar to that measured in the 29 (57%) patients with 
MEWS value <4 (5.24 ± 2.6) whereas the ICU admission rate was larger 
(54%) than in patients with MEWS value <4 (24%) (P = 0.03). In patients 
with MEWS value ≥4 the 30-day mortality rate was slightly lower (15%) 
than in patients with MEWS value <4 (24%) (P >0.05).
Conclusions The above data indicate that a MEWS value ≥4 has a very 
low sensitivity (43%) for identifi  cation of patients with severe sepsis and 
therefore it should be used with caution for this aim and also as a criterion 
for ICU admission of septic patients (7/19 of patients admitted to the ICU 
with a MEWS value <4; sensitivity 63%, specifi  city 68%).
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Introduction The Modifi  ed Early Warning Score (MEWS) has been used 
in medical wards as a decision-making instrument. Here we show a pilot 
study on MEWS introduction as a routine method for care improvement in 
urgency/emergency surgical patients.
Methods Patients enrolled underwent urgent/emergency surgery due 
to trauma, appendicitis, cholecystitis, gut perforation or ischemia. Data 
collection with MEWS involved patients admitted for between April 
and October 2009. It was measured during preoperative evaluation and 
within 24 hours after surgery. To evaluate the role of MEWS utilization we 
use as outcome criteria: hospital length of stay (LOS), mortality, ICU or 
subintensive care unit (SCU) need. The MEWS group was compared with a 
control historical group (January 2008 to March 2009).
Results  Groups were similar in surgical diagnosis and demographic 
characteristics. Patients of the control group showed a higher mortality 
rate compared with the MEWS group (6.7 vs 3.7). The number of 
SCU admissions after surgery passed from 9.6% to 15.4% after MEWS 
Table 1 (abstract P255)
    Age, years  ASA  Hospital LOS,   Mortality,   ICU admission,   SCU admission, 
  Number  (mean)  (mean)  days (mean)  % (n) %  (n) %  (n)
Control group  714  54.8  1.9  9.6  6.7% (48)  9.6% (69)  12.9% (92)
MEWS group  432  53.9  1.9  8.75  4.4% (19)  14.8% (64)  10.2% (44)
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(Table 1). Linear regression between high MEWS score and hospital LOS 
resulted signifi  cant (P <0.001).
Conclusions  These preliminary results indicate that MEWS, used in 
preoperative evaluation and follow-up in urgent/emergency surgical 
patients, can have an important impact on patient care and mortality.
References
1. Cei  M,  et al.: Int J Clin Pract 2009, 63:591-595.
2. Gardner-Thorpe  J,  et al.: Ann R Coll Surg Engl 2006, 88:571-575.
3. Subbe  CP,  et al.: QJM 2001, 94:521-526.
P256
Clinical predictors of physiological deterioration
M Shehata, A Hussein, A Farouk, H Khaled Nagi
Cairo University, Cairo, Egypt
Critical Care 2010, 14(Suppl 1):P256 (doi: 10.1186/cc8488)
Introduction To study the ability and the feasibility of the Modifi  ed Early 
Warning Score (MEWS) as a screening tool to predict the high-risk critically 
ill patients who may develop cardiorespiratory arrest, and to compare 
between the MEWS and the Simplifi  ed Acute Physiology Score II (SAPS II) 
regarding the sensitivity, specifi  city and more easy to be applied.
Methods Randomized, prospective study in the critical care medicine 
department in the Cairo University Hospitals including 100 critically ill 
patients newly admitted to the ICU. The MEWS is calculated daily during 
the period of the stay in the ICU with determination of the score Max, and 
SAPS II is calculated during the fi  rst 24 hours.
Results The MEWS score max grade of 8 or more was associated with the 
highest rate of arrest at which the sensitivity was 78.9%, specifi  city was 
93.5%, effi   cacy was 88.00%, with area under the curve (AUC) = 0.928. The 
SAPS II – Expanded grade of 50 or more was associated with the highest 
rate of arrest at which the sensitivity was 71.1%, specifi  city was 100%, 
effi   cacy was 89.00%, with AUC = 0.872. Comparing the MEWS and SAPS II 
reveals that the MEWS has more sensitivity but less specifi  city than SAPS II 
and effi   cacy is almost the same. Regarding the simplicity and applicability: 
MEWS is easier, faster and simpler.
Conclusions The MEWS score is a useful screening tool to predict the 
high-risk patients who have high probability to develop cardiorespiratory 
arrest among the critically ill patients in the ICU. It is simple and practical, 
has more sensitivity than SAPS II and therefore should be recommended 
in clinical practice.
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Introduction Modifi  ed Early Warning Scores (MEWS) have been utilised 
to improve the recognition and medical response to patient deterioration. 
Their usefulness is, in part, dependent upon their accuracy and to date 
only small datasets have been analysed to determine the accuracy of 
MEWS [1]. The aim of our study was to determine the accuracy of MEWS 
and the reasons for any inaccuracies found in a large dataset.
Methods A prospective observational study of 9,672 vital sign sets and 
MEWS recordings in 315 adult medical and surgical patients admitted to 
four wards in both a tertiary and a metropolitan hospital over a 4-month 
period. Individual vital sign MEWS and total MEWS was assessed for 
accuracy against a computer-generated individual vital sign MEWS and 
total MEWS using the vital sign dataset and a modifi  ed MEWS algorithm.
Results Of the 9,672 total MEWS recorded, 3,504 (3,504/9,672, 36%) had 
discrepancies between the nurse-recorded and computer-generated total 
MEWS. Of these, 3,029 (3,029/3,504, 86%) underestimated the computer-
generated total MEWS. In the majority of the total MEWS inaccuracies 
(2,443/3,504, 69.7%), the summation of the total MEWS from the individual 
MEWS was correct but the individual vital sign MEWS assignment 
was inaccurate. In 711 (711/3,504, 20.3%) cases the individual vital sign 
MEWS assignment was correct but the summation for a total MEWS was 
incorrect, and in 350 (350/3,504, 10%) cases both the individual vital sign 
MEWS assignment and summation for a total MEWS was incorrect.
Conclusions The underscoring between nurse-recorded and computer-
generated MEWS indicates that the paper-based MEWS system is less 
likely to trigger a timely medical review and appropriate treatment of 
a deteriorating patient. Further education and regular auditing on the 
assignment of the individual vital sign MEWS may improve the accuracy of 
the score given that the summation of the score was not the predominant 
issue. Equally, an electronic system to calculate and summate the 
individual vital sign MEWS may reduce the total MEWS error.
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Introduction  Severe sepsis is an important cause of morbidity and 
mortality following major surgery. Factors that are associated with an 
increased risk of sepsis following surgery include emergency surgery, 
patient co-morbidities, allogeneic blood transfusion and degree of 
surgical insult [1]. Physiological track-and-trigger systems are widely 
used to identify deteriorating patients. The Modifi   ed Early Warning 
System (MEWS) is one such system, but has not been studied in regard to 
predicting the development of sepsis after surgery. Although high MEWS 
scores are associated with increased hospital mortality, the sensitivity 
of MEWS and other physiological track and trigger scores for predicting 
death or admission to intensive care is low [2].
Methods We carried out a prospective cohort study on 101 patients 
undergoing elective major surgery in a large university teaching hospital. 
The patients were followed up for 10 days, and the incidence of sepsis and 
septic shock was documented. MEWS scores were recorded daily for each 
patient. Admissions to critical care were documented, along with critical 
care length of stay.
Results Twenty-seven (27%) patients developed sepsis and nine (9%) 
developed septic shock. Factors associated with the development of 
sepsis were intraoperative blood transfusion (P = 0.013), duration of 
operation (P = 0.004) and a postoperative MEWS score greater than 3 
(P = 0.0003). Using multivariate logistic regression analysis, a MEWS score 
greater than 3 after surgery was the only factor that remained signifi  cantly 
associated with sepsis (odds ratio 4.89, P = 0.003). Although a high MEWS 
score was associated with sepsis after surgery, only fi  ve (19%) patients who 
developed sepsis had an abnormal MEWS score prior to (mean 4.6 days) 
sepsis being diagnosed.
Conclusions The routine use of MEWS scores in postoperative elective 
surgical patients may help to identify those patients at risk of developing 
sepsis.
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Introduction We evaluated temporal variability of telephone calls to the 
medical emergency team (MET), as well as patient outcome.
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November 2009 were included. The time of telephone calls was noted, 
and occurrence throughout the day was studied. We compared the 
number of calls between 8:00 and 20:00 and between 20:00 and 8:00, 
using a Wilcoxon test. Patient’s age, gender, reason for call, and outcome 
were entered into the ICU’s database.
Results In the 4-year period, there were 136 calls, amongst which 17 were 
erroneous (12.5%). Figure 1 shows the occurrence of calls throughout 
the day. Between 8:00 and 20:00 and between 20:00 and 8:00, there 
were respectively 93 and 43 calls (P = 0.02). The immediate causes of 
intervention were cardiac arrest in 35%, respiratory depression in 8%, and 
decreased level of consciousness in 43% of cases (other: 14%). Eighteen 
percent of patients died during MET intervention. Amongst survivors, 31% 
were transferred in the ICU. Involved patients’ age was 67 ± 17 (male: 53%).
Conclusions  Reporting data might have less accuracy during nights. 
Nevertheless, despite diffi   culty of capturing such data, our series suggests 
that there is a temporal variability of medical emergency team calls. 
The fact that the majority of calls occurred between 8:00 and 20:00 
may probably be a refl  ection of the level of supervision and the general 
amount of patient activity within the hospital during the day.
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Introduction  Medical emergency teams (METs) are widespread in 
Australian public hospitals and are becoming more common in private 
hospitals. The epidemiology of MET calls and patient outcomes post MET 
have not been well studied in the private hospital setting.
Methods Prospective observational study of all inpatient MET calls in a 
510-bed private teaching hospital for a 9-month period ending in August 
2009. Information was collected on a standard data form after each MET 
call. Admission, discharge and mortality data were obtained from the 
hospital administrative database.
Results There were 302 MET calls and 17,419 admissions with a MET 
call rate of 1.7% of admissions. Mean (SD) age was 72.9 (17.0) and 42.9% 
of patients were male. The rate of Code Blue calls was 0.26% and of 
unexpected (non-NFR) deaths 0.09% of admissions. The MET call rate was 
higher for medical than surgical patients (2.4% vs 1.1%, P <0.005). Inpatient 
mortality was 24.8% and patients receiving a MET call had an increased 
mean length of stay compared with the hospital average (16.1 vs 5.4 days, 
P <0.005). Activation of MET calls was delayed by more than 15 minutes in 
7.6% of calls. Of the patients who died, only 16/69 (23%) were transferred 
to the ICU post MET call. Median (range) time from MET call to death was 
1.8 (0 to 76.6) days.
Conclusions The MET rate in our hospital overall is consistent with a 
maturing MET system. The higher MET rate in medical vs surgical patients 
is unexpected compared with the published experience in Australian 
public hospitals. This may refl  ect a diff  erence in the patient population 
or a diff  erence in the pre-MET ward management in our hospital. Whilst 
inpatient mortality was high, patients who died were mostly managed 
without transfer to the ICU and the non-NFR death rate was low. This is 
consistent with a signifi  cant overlap between MET and end-of-life care. 
Alternatively the high mortality could refl  ect that MET as an intervention 
occurs too late in these patients to favourably aff  ect outcomes. A more 
detailed understanding of patients dying after MET calls is required to 
determine the best ongoing strategy to manage this high-risk group of 
patients.
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Introduction  Resulting from the Dutch VMS Safety Program ‘Prevent 
injury, work safely’, we recently started to implement a rapid response 
system (RRS) in our hospital. The RRS consists of: a warning signs pocket 
card, a Rapid Response Team (RRT) and an evaluation system. The purpose 
of the RRS is to recognize and treat the patients with clinical warning signs 
early on the ward to reduce preventable hospital-wide avoidable injury. 
We present the fi  rst results of the implementation of the RRS.
Methods Data regarding the RRT calls and the evaluations were collected 
from 1 May 2008 until 30 April 2009 (total: 114 calls). We were interested 
in: the cause of the RRT call, the results of the call and the advice following 
the evaluation of the calls.
Results The main reasons for the calls were respiratory failure (47%), hemo-
dynamic problems (31%), neurological problems (7%) or a combination of 
problems in 15%. In 45% of the calls the patient was admitted to the ICU, 
medium care unit (MCU) or cardiac care unit (CCU). In 55% of the calls the 
patient stayed on the ward. During the call 14% of the patients who stayed 
on the ward obtained a do-not-resuscitate or a do-not-transfer-to-the-ICU 
order. These decisions were always taken in close cooperation with the 
doctor taking care of the patient on the ward. Evaluations were performed 
in 76% of the calls. In 45% of the calls the warning signs were recognized in 
time. Problems identifi  ed were late identifi  cation of clinical deterioration 
of the patient (30%) and failure to treat to a patient with clinical warning 
signs due to failures in planning (6%) or communication (26%).
Conclusions In 45% of the RRT calls, transfer of the patient to the ICU/MCU/
CCU is required. Hospital-wide improvement initiatives should focus on: 
timely recognition of clinical deterioration of the patient; failures in planning 
and communication; and timely agreed restrictive measurements on the 
ward.
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Introduction Hematological malignancy patients admitted to the ICU due 
to complications are at high risk of death. In the second half of 2008 we 
started Critical Care Outreach (CCO) activity. The purpose of this team was 
to start intensive care early as possible for avoiding mechanical ventilation 
and multiorgan failure for improving intensive treatment outcome.
Methods One hundred and twenty-six hematological patients from 2003 
to November 2009 were included in the study. We divided patients into 
three groups: (1) pre-CCO group: 56 patients from 2003 to 31 December 
2007; (2) transition group (2008): 22 patients admitted to the ICU and 
three treated in the hematology ward; (3) post-CCO group (January to 
November 2009): 18 patients admitted to the ICU and 27 patients treated 
in the haematology ward. In the post-CCO group 10 of the 27 patients 
were admitted to the ICU and 17 of these were treated in hematology 
ward, and nine of these received NIV (Figure 1). We defi  ned six criteria 
for activation of the CCO team: radiological signs of pneumonia, organ 
Figure 1 (abstract P259). Occurrence of calls throughout the day.
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SIRS progression, and Modifi   ed Early Warning Score (MEWS) >3 [1]. 
Primary outcome is the ability of the CCO to provide the intention to treat 
hematological malignancies.
Results  After CCO introduction, intention to treat was guaranteed at 
90% in 2008 and at 41% in 2009. Comparing the number of criteria of 
activation, during 2008 and 2009 intensivists were activated earlier, with 
a lower number of criteria. The ICU mortality rate passed from 60% in 
2003 to 54.5% in 2008 and 33.3% in 2009. Also the need for mechanical 
ventilation decreased after CCO introduction.
Conclusions The introduction of CCO and activation criteria improves the 
intention to treat and reduces ICU admissions and mortality.
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Introduction  Delay in recognition and treatment of deteriorating 
patients is a signifi  cant contributor to mortality of emergency admissions 
to intensive care (ICU) [1]. Rapid response systems (RRS) seek to improve 
this process. Service evaluation of RRS might be hampered by the lack 
of comparative quality assurance tools. The aim of this international 
collaborative audit was to test a benchmarking tool for the process of 
emergency admissions to the ICU in analogy to the door-to-needle time 
in cardiology.
Methods  Data were collected in August and September 2009. 
Collaborators were asked to audit data from a minimum of fi  ve emergency 
admissions to the ICU (range 3 to 35 admissions). The Score 2 Door time 
was defi  ned as the time between fi  rst trigger of the local track-and-trigger 
system and time of admission to intensive care. Collaborators were asked 
to give possible causes for delays in transfer to the ICU. Observations 
were risk-stratifi  ed with an age-adjusted Modifi  ed Early Warning Score 
(MEWS-A) [2]. Data were anonymised and hospitals were coded in a 
random fashion.
Results Up to 22 September, data for 125 patients from 17 hospitals had 
been submitted. Of these, four were non-UK hospitals (US x 1, Denmark x 
1, Australia x 2) using medical emergency team type of systems and UK 
hospitals used a summary score. Median age was 67 years. Mean APACHE II 
score on admission to the ICU was 18 (SD 8). The median Score 2 Door time 
was 3:15 (range 0:09 to 19:45). Median time was shorter in the four non-UK 
hospitals (1:29 vs 4:05). Sicker patients (as evidenced by a higher MEWS-A 
trigger) did not have shorter Score 2 Door times. The main quoted causes 
for delays in ICU admission were transient improvement of condition (n = 
4), immediate treatment on the ward (n = 9), a procedure (n = 12; that is, 
surgery, computer tomography), a shortage of intensive care beds at the 
time of referral (n = 11) or waiting for a senior review (n = 14).
Conclusions  Organisational and other delays in ICU admission might 
reduce the impact of RRS on care of deteriorating patients on general 
wards. The Score 2 Door time is a pragmatic tool to quantify and 
benchmark these delays in order to identify obstacles to patient fl  ow and 
improve care.
References
1. McQuillan  P,  et al.: Br Med J 1998, 316:1853-1858.
2. Subbe  CP,  et al.: QJM 2001, 94:521-526.
P264
A comparison of injected lidocaine 2% and no analgesia for 
peripheral intravenous cannula insertion in the emergency 
department
G Papakitsos1, T Papakitsou2, A Kapsali1
1General Hospital Arta, Greece; 2General Hospital Messologi, Greece
Critical Care 2010, 14(Suppl 1):P264 (doi: 10.1186/cc8496)
Introduction Many patients who present to the emergency department 
require placement of a peripheral intravenous line, which frequently 
causes pain and anxiety. We compare pain and anxiety associated with 
peripheral intravenous cannula insertion after pretreatment with no local 
anaesthesia or subcutaneously injected, buff  ered 2% lidocaine.
Methods In a randomized study, peripheral intravenous cannulas were 
inserted in 185 patients arriving in the emergency department. In random 
order, insertion sites were pretreated with nothing or injected, buff  ered 
lidocaine. After each intravenous insertion, subjects recorded pain, anxiety, 
and preference (as patient and provider) for each technique on a 10-point 
numeric rating scale. Higher scores indicated greater pain, anxiety and 
preference.
Results Median pain scores were 7 (5 to 8) without local anaesthesia and 1 
(1 to 2) with injected, buff  ered lidocaine. Median anxiety scores were 4 (3 to 
7) without local anaesthesia and 2 (1 to 3) with injected, buff  ered lidocaine. 
Most intravenous placement attempts were successful, regardless of 
technique. Eighty-seven per cent of subjects indicated they would always 
request buff  ered lidocaine for peripheral intravenous insertion. In the 
emergency department or other busy practice setting, injected, buff  ered 
lidocaine has the advantage of being immediately eff  ective.
Conclusions  Pain and anxiety associated with peripheral intravenous 
insertion is signifi   cantly reduced by using topical injected, buff  ered 
lidocaine. Injected, buff  ered lidocaine reduces intravenous insertion pain 
more than pretreatment with no local anaesthesia, without aff  ecting 
success.
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Introduction Highly precise laboratory methods have been developed 
to determine cardiac troponin levels (cTn) according to the universal 
defi  nition of acute myocardial infarction (MI). We examined the impact 
of lowering the level of detection of cTn measurement in consecutive 
patients presenting to the emergency department (ED) of a large German 
community hospital.
Methods cTnT levels were measured using a standard assay (Roche cTnT 
fourth generation; cutoff   ≥0.04 ng/ml) and a high-sensitive assay (Roche 
cTnThs; cutoff   ≥0.014 ng/ml). Patients were categorized to have an acute 
MI according to the universal defi  nition using the old or the new cutoff   
point of cTnT levels (cTnT ≥0.04 ng/ml or cTnThs ≥0.014 ng/ml).
Results We analyzed 137 consecutive patients with chest pain admitted 
to the ED (age: 65.7 ± 15.5 years; 63.5% male; in-hospital mortality: 0.7%). 
Totals of 36%, 22% and 42% of patients presented within 2 hours, 2 to 
6 hours and >6 hours of chest pain. Using the old cutoff   point, 30 patients 
have been classifi  ed as acute MI (type 1 MI: 67%; type 2 MI: 33%). Using the 
new cutoff   point (TnThs ≥0.014 μg/l), diagnosis of acute MI signifi  cantly 
Figure 1 (abstract P262).
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1 MI increased by 75%, which was refl  ected by a 57% decrease of patients 
formerly classifi  ed as instable angina. Of note, increases of MI diagnosis 
were mainly refl  ected by a 200% increase of type 2 MI (for example, acute 
heart failure, tachycardia or hypertensive crisis). Numbers of patients with 
noncardiac chest pain were not signifi  cantly changed with the use of the 
new cutoff   point. AUC of admission cTnT levels were 0.76 and 0.96 for the 
cTnT fourth generation and cTnThs (P <0.05). At admission, sensitivity and 
specifi  city of cTnThs were 93% and 94% for the detection of acute MI, 
while they were 32% and 96% using cTnT fourth generation.
Conclusions Using lower cutoff   points for the defi  nition of MI as suggested 
by current recommendations, the rate of chest pain patients with acute MI 
doubled. Because the increased rate of patients categorized as acute MI is 
mainly refl  ected MI type 2, the ED triage decision at lower cutoff   levels of 
cTnT levels should include patient history, physical examination, 12-lead 
ECG and cardiac imaging.
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Introduction The aim of this study was to determine the correlation 
between B+ line score and blood gas analysis (BGA) parameters in patients 
with acute cardiogenic pulmonary edema (ACPE). The presence of B+ 
line artifacts on lung US is correlated with increased extravascular lung 
water. In patients with acute decompensated heart failure the resolution 
of B+ lines can be used to monitor resolution of pulmonary congestion. 
A simple nine-point comet score has been proposed to quantify B+ lines 
and monitor ACPE treatment [1].
Methods Twenty-one patients with ACPE were submitted to lung US and 
BGA on presentation at 2 and 24 hours after admission. Lung US was done 
in nine thoracic areas and scored one point if B+ lines were present. A 
score of 10 was given for the presence of multiple coalesced comets in all 
fi  elds (white lung). BGA values were used to calculate PO2/FiO2 (P/F) and 
A–a gradient.
Results  A total of 64 scans were performed with simultaneous BGA. 
Ninety-eight percent of patients presenting with white lung were severely 
hypoxic (PO2 <50 mmHg; P/F <200). Figure 1 illustrates a strong linear 
correlation between reduction in comet score and improvement in P/F 
(r = –0.73; P <0.001). A decrease in comet score of 2 points corresponded 
to a minimum increase of 20 points in P/F (P <0.05). The correlation 
between comet score and A–a gradient was less striking signifi  cant (r = 
–0.51; P = 0.05), perhaps because patients with underlying lung disease 
were not excluded from this pilot study.
Conclusions There is a strong negative correlation between lung comet 
score and gas exchange in patients with ACPE. In these patients, serial 
thoracic US may reduce the need for repeated invasive BGA monitoring 
and further help tailor therapy.
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Introduction  Numerous STEMI patients are treated successfully in 
the Central PCI on call system. Up until this time we do not have data 
about the fi  rst medical contact’s – National Emergency Service or other 
medical staff   – impact on long-term prognosis. It is also unknown how the 
method of transport to the PCI center (direct or secondary) infl  uences the 
prognosis. Our aim was to evaluate the magnitude of fi  rst medical contact 
and the type of transport in the short-term and long-term prognosis.
Methods We evaluated the 30-day and 1-year mortality data of 1,890 
consecutive patients who were treated with primary PCI due to STEMI. 
We selected the patients according to the fi  rst medical contact: National 
Ambulance Service or other medical staff  , and according to the type of 
transport: direct or secondary transport. At the follow-up procedure we 
used the university’s and the National Health Insurance Found’s database.
Results The 1,890 patients’ follow-up rate was 100%. First, 34.7% of the 
patients (656/1,890) called for Emergency Service directly. This rate was 
even lower in working hours (30.6% – 205/671). It was also observed 
that as the time delay was increasing from the onset of symptoms, 
the number of people who called for Emergency Service was lower. 
Between 10 and 12 hours it was just 12.2% (19/155). Thirty-day mortality 
(Ambulance Service versus other staff  ): 7.3% (48/656) vs 9.5% (117/1232) 
– P = 0.1. One-year mortality: 12.7% (83/656) vs 16.1% (199/1232) – P = 
0.04. Second, 44.4% of the patients (838/1,890) were transported directly 
to the PCI center (direct transport). Thirty-day mortality (direct versus 
secondary transport): 60/838 (7.2%) vs 105/1,052 (9.9%); 1-year mortality: 
106/838 (12.6%) vs 176/1,052 (16.7%). The diff  erence is signifi  cant at 30 
days and at 1 year also. The 30-day mortality rate is higher with 24%, the 
1-year mortality rate is higher with 15% among those patients who were 
admitted after a secondary transport.
Conclusions The long-term prognosis is signifi  cantly better among those 
STEMI patients who are transported directly to the PCI center and where 
the fi  rst medical contact is the National Ambulance Service.
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Introduction The conventional treatment for most distal radial fractures is 
closed reduction and cast immobilization. Conventionally the hematoma 
block is used to reduce the fractures but it is done blindly and radiographic 
techniques have been essential and eff   ective in monitoring these 
reductions [1]. Radiation-free ultrasonography, however, can provide both 
real-time and dynamic multiple-plane images with a small and simple-
to-use transducer that can be operated with only one hand. We therefore 
wanted to see whether the real-time and dynamic multiple-plane 
Figure 1 (abstract P267). Correlation between reduction in comet score 
and improvement in P/F.
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to perform under direct vision a hematoma block and closed reduction 
without multiple attempts of either as are frequently required when only 
conventional techniques are used.
Methods Sonographically guided hematoma block and closed reduction 
was performed in three patients in the emergency department for an 
acute distal radial fracture. The effi   cacy of this method was evaluated and 
compared with that of conventional techniques.
Results  The ultrasound images helped giving the hematoma block 
under direct vision and delineated the fractures as accurately as did the 
conventional radiographs. All parameters measured on the ultrasound 
images showed substantial restoration of anatomic alignment after 
reduction. Under direct vision, the hematoma block helped reduce the 
number of attempts and was less painful and achieved more patient 
satisfaction.
Conclusions Sonography is an accurate, simple, time-saving, less painful 
and radiation-free tool. Reducing badly displaced or angulated forearm 
fractures in the emergency department can be diffi   cult. Multiple attempts 
at reduction may be required, with repeated trips to the radiology 
department, before an adequate reduction is achieved [2]. Therefore 
ultrasound-guided hematoma block and reduction of diffi   cult forearm 
fractures reduces the number of needle attempts and allows the physician 
to assess the adequacy of the reduction at the patient’s bedside.
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Introduction Patients with acute cardiogenic pulmonary edema require 
rapid assessment and therapy to prevent progression to respiratory failure 
and cardiovascular collapse. Lisbon city has emergency medical teams 
that respond to situations where the life of the patient is at risk and whose 
goal is to begin treatment if indicated and assure transport to the hospital 
in the best conditions possible. We studied the intervention of one of 
these teams on patients with acute pulmonary edema.
Methods Medical records of the activity of our prehospital emergency 
vehicle from April 2005 to October 2009 were analyzed. All records of 
patients having a clinical diagnosis of acute pulmonary edema at the 
scene were considered. Incomplete records were excluded.
Results In the 55 months considered our emergency vehicle attended 
9,856 calls, from which 493 (5%) were for acute pulmonary edema. Patients 
ages range from 20 to 99 years, with a mean age of 75.8 years, and 47.8% 
were males. A total of 58.6% of calls were made on the night period (from 
8 pm to 8 am), most between 8 pm and 0 pm. Risk factors included arterial 
hypertension (62.3%), ischemic heart disease (43.2%), diabetes mellitus 
(31.8%), heart failure (23.3%), atrial fi  brillation (13.2%) and renal failure 
(9.9%). On arrival of the prehospital medical team at the scene, 24 patients 
(4.9%) required immediate intubation and fi  ve evolved to cardiac arrest, 
four of whom were successfully resuscitated and transported to hospital.
Conclusions Our prehospital medical teams attended a large number of 
patients with pulmonary edema during this period. We recorded a small 
number of patients requiring mechanical intubation and a high rate of 
survival on those suff  ering from cardiac arrest in this context. We believe 
this is largely because of the decreased response time that prehospital 
emergency off   ers in this situation, allowing the institution of early 
treatment.
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Introduction We designed our study to fi  nd a useful USG pattern for 
diagnosis and assessment of dyspnea. We also compared utilities of chest 
radiograms in a supine position, thorax CT and bedside USG techniques.
Methods In Selcuk University Meram Medical Faculty, during the year 
2009, 60 patients who had acute dyspnea were included in our study (30 
patients with chest trauma and 30 patients with nontraumatic causes). We 
designed our study as prospective. We tried to determine pathologies that 
have positive and negative Sliding Lung Sign (SLS) in USG examinations. 
We also investigated its reliability in diff  erential diagnosis of acute dyspnea.
Results  First of all we performed chest radiograms on all patients in 
a supine position. After that we performed CT scans. All of the results 
were interpreted by a detached radiologist. Then we performed bedside 
thoracic USG to fi  nd SLS by physicians in the ER. We conceded CT results as 
the golden standard and compared the results with chest radiograms and 
USG fi  ndings. The SPSS 13.0 program and Χ2 test were used for statistical 
analysis (P <0.05). According to our fi  ndings, SLS in USG examinations has 
a sensitivity of 84% and a specifi  city of 97% with a 97% positive predictive 
value and 83% negative predictive value.
Conclusions  Throughout the years, USG examinations were defi   ned 
as inappropriate in lung examinations but in our study we reached a 
conclusion that they are a necessity. Bedside sonographic examination 
allows impetuous diagnosis. But every respiratory failure has its own 
sonographic pattern so mistakes are inevitable. Nevertheless we believe 
that if profound studies like ours keep coming and if more and more 
clinicians begin to use USG examinations, the SLS diagnostic value will rise 
and become a routine element in the ER.
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Introduction Many air medical transport programs use pulse oximeters, 
end-tidal carbon dioxide monitors and other devices as indirect measures 
of respiratory and cardiac status. Thus, these methods do not replace 
cardiac auscultation during fl  ight, which may be needed to identify sudden 
critical change. And the ability to compare left-sided and right-sided 
breath sounds may be essential to confi  rm the appropriate placement 
of endotracheal tubes as well as to diagnose pneumothorax. The ability 
for auscultation during air medical transport is compromised by high 
ambient noise levels. The aim of this study was to assess the capabilities of 
a traditional and an amplifi  ed stethoscope (which is expected to reduce 
background and ambient noise) to assess heart and breath sounds during 
medical transport in a FALCON 50 plane.
Methods A prospective, double-blind, randomized study was performed. 
We tested one model of traditional stethoscope (Littman® cardiology 
III) and one model of amplifi  ed stethoscope (Littman 3100). The sound 
level was amplifi   ed in six of the eight increments of the amplifi   ed 
stethoscope. Practitioners on board were all experienced in air medical 
transport. They had normal audiologic testing. We studied 18 heart and 
lung auscultations, during real medical evacuations on board the Falcon 
50 (medically confi   gured; Dassault aviation). For each, the quality of 
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10, 0 corresponding to ‘I hear nothing’, 10 to ‘I hear perfectly’). Comparisons 
were accomplished using a t test for paired values.
Results Age of patients was 42 ± 11 years, 78% were males. The body mass 
index was 29.5 ± 4.7. For cardiac auscultation, the value of the rating scale 
was 5.7 ± 1.4 and 6.5 ± 1.8, respectively, for the traditional and amplifi  ed 
stethoscope (P = 0.027). For lung sounds, quality of auscultation was 
estimated at 3.6 ± 2.3 for the traditional stethoscope, at 3.9 ± 2.9 for the 
amplifi  ed stethoscope (P = 0.193).
Conclusions We concluded that fl  ight practitioners in the Falcon 50 are 
more able to hear cardiac sounds with an amplifi  ed than with a traditional 
stethoscope, whereas there is no signifi  cant diff  erence concerning breath 
sound auscultation. These fi  ndings suggested to the investigators that 
Falcon 50 noise and human breath sounds might share a common or 
substantially overlapping frequency spectrum, with amplifi  cation of one 
necessarily amplifying the other. To assess this hypothesis, further studies 
are needed to evaluate the sound frequency spectrum in the medically 
confi  gured Falcon 50.
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Introduction We studied the performance of two respirators employing 
an advanced turbine delivery system: LTV 1000, Tbird VSO2. We assessed 
the ability of the ventilators to deliver to a normal lung model a set fraction 
of inspired oxygen (FiO2) at diff  erent simulated cabin altitudes.
Methods We used a decompression chamber to mimic the hypobaric 
environment at a range of simulated cabin altitudes of 1,500, 2,000 and 
3,000 meters (4,000, 5,333, 8,000 feet). A model of normal lung was used. 
Concerning the Tbird VSO2, cabin altitude was input. Ventilators were 
tested with FiO2 set at 50% and Vt set at 700 ml. We noted the eff  ective FiO2 
assessed by the ventilators (paramagnetic analysis). We measured the FiO2 
really delivered with a dedicated instrument of the French physiological 
laboratory of aviation and space medicine of the Air Force. Comparisons 
of preset and assessed FiO2 to actual measured FiO2 were accomplished 
using a t test for each altitude.
Results Figure 1 shows the data with FiO2 set at 50%.
Conclusions On one hand, both ventilators showed a moderate variation 
between FiO2 set and delivered. On the other hand, variations between 
FiO2 delivered and assessed are high, suggesting ineffi   cacity of ventilators’ 
paramagnetic analysis in hypobaric conditions.
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Introduction The Military Medical Service of the French Forces insures the 
support of 29,000 French servicemen spread around the world each year 
and performs as such their medical evacuation by air towards France to 
guarantee their adequate treatment as soon as possible. This knowledge is 
sometimes also used for a national civilian abroad. We propose to describe 
the epidemiology of medical evacuation (MEDEVAC) made in the past 
10 years.
Methods We analysed data for every patient evacuated since 1 January 
2000 and noted the destination, the number of patients per fl  ight, the age, 
the gender, the status (military or civilian), the pathology, the presence of 
a specialist in the medical team (intensivist, cardiologist, psychiatrist) and 
the recipient hospital. The presence of an intubated ventilated patient or 
transfusion in fl  ight was studied.
Results A total of 420 strategic MEDEVACs were carried out in 10 years (per 
year: 42 ± 6.9) in favor of 529 patients, among whom 90% were French 
servicemen. Each fl  ight carried between one and 15 patients. Europe 
represents 42% of the original location of evacuation, Africa 39% and the 
Middle East 17%. An anesthetist–resuscitator reinforced the medical team 
in 51.7% of the evacuations. The patients with respiratory assistance are 
present in 19.8% of the fl  ights and transfusion occurred in 3.1% of the 
fl  ights. Traumatic pathology is predominant (49.5% of patients), divided 
into three major causes nearly equally: road traffi   c accident, ballistic and 
others. Burns represent a signifi  cant proportion (6.8%) of the causes of 
evacuation. Other causes are represented by 30.2% for medical conditions 
(n = 160 among which 59 cardiac aff  ections), 10.2% for nontraumatic 
surgical aff  ections and 2% for psychiatry. Finally 25.5% of the patients were 
accommodated in an ICU, 6% in a specifi  c center for treatment of burns, 
35.3% in a service of surgery and 24.6% in medicine.
Conclusions If the number of MEDEVACs is relatively stable over the past 
decade, destinations and causes are changing. Africa remains an usual 
location of evacuation, the part of Europe tends to decrease for the benefi  t 
of the Middle East, which became in 2009 the predominant destination 
(21/47) stretching out the duration of fl  ights. The causes of evacuations 
testify to the intensity of the commitment of French forces through 
traumatic aff  ections, and in particular of ballistic origin, which are in 2009 
the main traumatic aff  ections (15/31). The corollary is an increase of the 
appeal to the resuscitators to deal with trauma patients.
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Introduction The aim of this report is to compare two disaster exercises’ 
management of students with diff  erent backgrounds. To our knowledge 
nobody has ever compared two exercises, probably because of the 
diffi   culty in their evaluation. We implemented a tool for an objective 
evaluation [1] and we used it for this purpose.
Methods Both drills represented a ceiling collapse over a crowded room 
with a similar amount of casualties and similar severity index. The START 
triage system was used.
The trained students (T) were attending the European Master in Disaster 
Medicine (EMDM), while the not-trained students (NT) were at the 
beginning of an introductory course in disaster medicine. During the 
exercises we recorded key victim–provider interaction times [2] using 
victim-based data collection. Each victim had their own data card to 
record triage and time information.
Results In this preliminary report we present data regarding the scene 
length of stay (LOS) and triage to collecting area/advanced medical post 
time (T-AMP). The LOS was 67.5 (50.0 to 111.0) minutes (25 to 75 IQR) for 
T as compared with 145.0 (110.0 to 150.0) minutes (25 to 75 IQR) for NT 
Figure (abstract P273).
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diff  erence for high-priority codes (reds and yellows) as opposed to the 
green code (55.0 (47.0 to 75.0) minutes for T vs 145.0 (141.0 to 155.0) 
minutes for NT with P <0.01). T-AMP was 10.0 (3.0 to 34.5) minutes for T as 
compared with 63.5 (19.5 to 104.3) minutes for NT (P <0.001). Stratifi  cation 
according to triage code showed no diff  erence for red codes between T 
and NT but showed a diff  erence for yellow codes (36.5 (15.0 to 82.0) vs 71.0 
(30.0 to 99.0) minutes) and green codes (7.0 (3.0 to 12.0) vs 85.0 (17.3 to 
115.0) minutes) with P <0.01.
Conclusions Both teams evacuated red codes before the yellow ones 
in similar time. T-AMP was shorter considering global, yellow and green 
codes for T as opposed to NT. Global and green LOS was also shorter in 
the T group as opposed to NT. Training seems to infl  uence global exercise 
management, less aff  ecting red codes but with an impact on yellow and 
green evacuation strategies.
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Introduction Exacerbation of asthma can appear during air transport. 
Severe patients, not responding to conventional therapy can require 
ventilator support. We evaluated the performance of two transport 
ventilators, built with turbine technology – the T-bird VSO2 and the LTV 
1000 – for use during aeromedical evacuation of acute severe asthma. We 
have assessed the ability of both ventilators to deliver to an acute severe 
asthma model a tidal volume (Vt) set at diff  erent simulated altitudes, by 
changing the ambient air pressure.
Methods We used a decompression chamber to mimic the hypobaric 
environment at a range of simulated cabin altitudes of 1,500, 2,500 
and 3,000 meters (4,000, 6,670, 8,000 feet). Ventilators were tested with 
realistic parameters. Vt was set at 700 ml and 400 ml in an acute severe 
asthma lung model. The protocol included three measurements for each 
simulated altitude. Comparisons of preset to actual measured values were 
accomplished using a t test for each altitude.
Results  Figure 1 summarizes the data. With altitude, the T-bird VSO2 
showed a decrease in volume delivered. Comparisons of actual delivered 
Vt and set Vt demonstrated a signifi  cant diff  erence starting at 1,500 m for 
a Vt set of 700 ml, at 2,500 m for Vt set of 400 ml, with a negative variation 
of more than 10% compared with tidal volume set at respectively 3,000 
and 2,500 m. With decreasing barometric pressure, the LTV 1000 showed 
mostly an increase in volume delivered. Comparisons of actual delivered 
Vt and set Vt demonstrated a signifi  cant diff  erence at 1,500 m for a Vt set 
of 700 ml, at 2,500 m for a V test of 400 ml. The delivered tidal volume 
remained within 10% of the set Vt.
Conclusions The T-bird VSO2 progressively delivered lower volumes as 
barometric pressure decreased; whereas the LTV 1000 showed a moderate 
increase in volume delivered for the acute severe asthma lung model, with 
increasing altitude, but maintained the delivered volume within 10% of 
the set Vt up to 3,000 m.
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Introduction For some time, most emergency departments have been 
experiencing severe overcrowding which could lead to reductions in the 
quality of care. Consequently, nurse triage tools have been developed 
with the aim of getting ‘the right patient to the right resources, at the right 
place and at the right time’. However, diff  erences in emergency medical 
services in diff  erent countries have limited the generalisation of pre-
existing triage systems; for this reason, specifi  c algorithms corresponding 
to local characteristics are needed. Accordingly, we developed a specifi  c 
French-language triage system called ELISA (Echelle Liegeoise d’Index de 
Sévérité à l’Admission – Liege admission severity scale). We aimed to test 
its validity in the present study.
Methods The ELISA is a fi  ve-category (U1 to U5) nursing triage algorithm, 
using fl  ow charts based on vital signs and anamnestic data. Each category 
is associated with a pre-established time delay for fi  rst medical contact. 
We tested inter-rater and intra-rater agreement respectively. As concerns 
inter-rater agreement, nine triage nurses sorted the same 100 patients. 
The assigned classifi  cations compared the reference assignment and were 
analyzed with Cohen’s kappa coeffi   cient. Intra-rater agreement was tested 
by asking 30 triage nurses to sort the same 10 patients at two diff  erent 
times (T1 was early morning and T2 was late night). We compared the 
classifi  cation at T1 and T2 with the null hypothesis being no diff  erence and 
determined whether diff  erences were nurse dependent.
Results  Statistical analysis of intra-rater agreement revealed that the 
mean diff  erence between classifi  cation at T1 and T2 did not signifi  cantly 
depend on the nurse (P = 0.3487). This result allowed pooling of the data 
and testing to determine whether the mean was diff  erent from zero. We 
used the Sign test and found that classifi  cation at T1 was not diff  erent from 
classifi  cation at T2 (P = 0.581). As concerns inter-rater agreement, we used 
Cohen’s kappa coeffi   cient, which revealed an almost perfect agreement 
between classifi  cation by nurses and the reference.
Conclusions  The need for a specifi   c triage tool in our emergency 
department led us to develop a new French-language triage scale. The 
present study demonstrates that this scale is a valid triage tool with very 
good inter-rater and intra-rater agreement. Such results now allow a future 
study to evaluate its effi   ciency.
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Introduction In 1996, a UK audit suggested suboptimal involvement of 
consultant care in acute medicine [1]. Acute medicine has since evolved 
as a specialty to improve medical inpatient care in the fi  rst 48 hours [2]. 
Many hospitals now incorporate an acute short stay unit through which 
up to 70% of medical admissions can be directed [3]. These units reduce 
the length of hospital inpatient stay [4].
Methods  We conducted a review of case notes for 100 consecutive 
medical admissions to the Emergency Short Stay ward (ESS). Data collected 
included diagnoses on admission and discharge, length of stay on ESS 
and discharge destination. On reviewing each initial medical clerking, an 
assessment was made regarding the suitability of the admission to ESS, 
standardized against local criteria.
Results Data on 100 patients (age 17 to 89) were collected. Eighty-nine per 
cent were admitted from the medical admissions unit, most commonly 
Figure 1 (abstract P276). Acute severe asthma, Vt delivered in altitude.
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2 days. Twenty-fi  ve per cent of patients remained on the ward for over 
72 hours and 6% for over 5 days. Whilst 68% of patients were discharged 
home from ESS, 32% of patients were later transferred to a diff  erent 
ward. When compared with the available admissions criteria, 27% of all 
admissions to ESS were found to be inappropriate. Most (18/27) of these 
patients were later transferred to a diff  erent inpatient ward. Twenty-six per 
cent of inappropriate admissions remained on ESS for >48 hours. The total 
number of medical admissions to the hospital on each day of the study 
did not aff  ect the number of inappropriate transfers to ESS.
Conclusions The 24-bed Emergency Short Stay Ward at our UK hospital 
is for assessment and treatment of selected acute conditions requiring an 
inpatient stay <48 hours. ESS was not always being used appropriately 
according to the admission criteria defi   ned by the ward managers. 
Hospital admissions of >72 hours are associated with signifi  cant increase 
in workload [5]. It is important that a short stay ward does not increase 
the length of admission by becoming a transit lounge for patients before 
transfer to a specialty lead ward.
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Introduction We analysed triage reliability among nursing students at an 
Italian university before and after a course on a new Triage Emergency 
Method, TEM v2, which showed good reliability in a previous study [1]. Few 
studies compared triage reliability in nursing students. To our knowledge 
there are no Italian studies on this topic.
Methods This is an observational study conducted in the University of 
Parma using a triage scenarios database used in previous studies [1,2]. 
Fifty students attending the third year of a nursing course were selected 
to assign a triage level to 105 paper scenarios, without triage protocols 
(before course) and with TEMv2 (1 month after a 2-hour course on triage 
and TEMv2). To prevent communication between participants, they 
assigned triage codes in diff  erent rooms, and in the presence of two 
investigators. The triage scenarios were given randomly to the participants. 
We measured: the inter-reliability using the weighted kappa statistics; the 
complete disagreement (when nurses of the same group assigned to the 
same scenario triage codes that diff  ered in more than two priority levels); 
the complete agreement (when all fi  ve nurses assigned the same triage 
code) before and after the course.
Results Of the 105 patients included in triage scenarios, 66 (63%) were 
women, the mean age was 43.7 years (SD ± 26.3), and 22 were under the 
age of 18 years. The most frequent presentation at triage was minor trauma 
(30%). There were 30 hospital admissions: 27 in non-intensive wards and 
three in ICUs. The mean age of students was 24 ± 3 SD. Few participants 
attended triage training before (18%) and they declared scarce triage 
knowledge. Inter-rater reliability was k = 0.42 (95% CI: 0.37 to 0.46) and 
k = 0.61 (95% CI: 0.56 to 0.67) before the course (without triage protocol) 
and after the course (with TEMv2), respectively. Complete disagreement 
occurred in 98% of scenarios evaluated before and in 64% after the course. 
Complete agreement was always zero.
Conclusions Our data suggest that TEM v2 improves triage reliability 
among nursing students. It seems to be easy to understand and to use.
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Introduction Aggression and violence in the workplace have increasingly 
become topical for various professions in the past years. Studies, however, 
are mostly published for the areas of psychiatry and education. The fi  rst 
part of the study investigates the question of how emergency services in 
general deal with aggressive assaults against their staff  . In the second part, 
the monitoring system for aggression incidents of the Vienna Ambulance 
Service will be presented and evaluated.
Methods  By the means of an email questionnaire, 35 emergency 
medical services and EMS training facilities were interrogated about their 
procedures in case of aggression incidents. The monitoring system of the 
Vienna Ambulance Service, which is based on the SOAS-R questionnaire, 
was statistically evaluated.
Results  Emergency medical services survey: 21 of the 35 included 
organizations returned the questionnaire with usable answers. For 80% of 
the responding organizations, aggression against their staff   is an issue; 50% 
installed a staff   reporting system and 58% off  er de-escalation courses to 
their staff  . Vienna Ambulance Service: during the analysis period of 2 years, 
203 aggressive and/or violent assaults were reported within the Vienna 
Ambulance Service. In relation to the total number of 268,528 treated 
patients, the rate of incident is 0.08%. Males committed, with 71.7%, most 
of these aggressions. With regard to diagnoses, the diagnostic group of 
alcohol-related incidents was most frequent with 59 cases. Most events 
took place on weekends and in the evening hours. Verbal aggression was 
with 86.2% predominant; however, more than 20% of the incidents lead to 
physical injuries of the medical personnel.
Conclusions  Aggression against emergency medical service staff   
is brought up for discussion in many organizations. Despite several 
approaches in diff  erent states of development, standardized reporting 
systems are the exception. The aggression incident reporting formula of 
the Vienna Ambulance Service was proved to be practical for recording 
aggression events as well as for evaluation of de-escalation education. The 
study showed that aggression is a serious problem in emergency medical 
services and appropriate precautions need to be institutionalized.
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Introduction To investigate the data of patients treated by this fi  eld hospital, 
and to analyze the rule of spectrum of diseases in Wenchuan earthquake.
Methods Sexes, ages and diagnoses of the patients were collected and 
the percentage was respectively calculated. The amount tendencies of the 
time distribution of patients were also analyzed.
Results Sex diff  erences of patients were not obvious in the total 2,331 
cases. The amount in the group 15 to 60 years old, 1,535 (65.9%) cases, was 
signifi  cantly higher than those of other groups, but the relative ratios of the 
group 0 to 14 years old, 382 (16.4%) cases, and the group >60 years old, 
414 (17.7%) cases, were higher than that of 15 to 60 years old. The top four 
diseases consist of respiratory system 601 (25.8%), trauma (fracture, wound 
or injury) 586 (24.9%), dermatology system 295 (12.7%) and others 243 
(10.4%). The amount of internal medicine patients exceeded that of surgery.
Conclusions The reasonable allocations of medical personnel and drugs 
after earthquake may help to improve the remedy results and to prevent 
waste of medical resource during future disasters.
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Introduction In 2003 the outbreak of severe acute respiratory syndrome 
(SARS) in some jurisdictions around the world highlighted a number of 
areas in healthcare planning that could be improved for dealing with 
such disasters. In Canada, one of the noted system challenges was the 
signifi  cant impact that an increase in the number of critically ill patients 
had on access to care and to other hospital services. Many jurisdictions 
have undertaken large-scale pandemic planning; however, there is a 
paucity of tools available to help hospitals deal with the day to day 
challenges of surges in patient volumes. As part of a larger comprehensive 
Critical Care Strategy designed to improve access to care, improve the 
quality of care and improve health system integration, and in partnership 
with hospitals and healthcare workers, the Ontario Ministry of Health and 
Long-Term Care designed and implemented a critical care Surge Capacity 
Management Program.
Methods A review of the literature was completed to determine existing 
models for surge capacity planning. Surges were then classifi  ed as minor, 
moderate or major, depending upon the increase in demand above 
available services and the length of time a surge situation persisted. A 
framework was built to incorporate surge planning on fi  ve key elements: 
management, physical space, human resources, equipment and 
technology, and processes. A demonstration project to test the model 
was carried out in 18 hospitals. Hospitals collected data on patient fl  ow 
processes across the organization in conjunction with daily data capture in 
the Critical Care Information System. Based on initial success, the program 
was approved for a province-wide implementation.
Results  Critical Care Surge Resource Teams that included front-line 
care providers, and a senior team sponsor and a physician champion 
were formed to implement surge capacity plans using the standardized 
framework and tools. Hospitals developed plans to handle minor surges 
that involved increasing to 115% above their normal operating capacity. 
This program has involved 201 critical care units in 150 hospitals across 
the province.
Conclusions This program represents one of the largest implementations 
of a standardized Surge Capacity Program for managing critical care 
resources in a time of crisis. The program has seen practical use during the 
recent experience with H1N1 with improved access to care for patients.
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Introduction International guidelines for trauma care still recommend 
the traditional advanced trauma life support investigations for the primary 
survey: plain radiographs of the chest, cervical spine and pelvis with 
FAST ultrasounds. However, an increasing amount of data suggest that 
plain X-rays have excessively low sensitivity. Cervical X-ray may miss up 
to 35% of the spine injuries, chest X-ray may miss as many as many as 
50% of traumatic pneumothorax and a signifi  cant percentage of pelvic 
fractures may not be detected on the pelvis X-ray. CT scan and extended 
emergency ultrasound (EUs) have a much higher sensitivity if compared 
with plain X-rays. Moreover, EUs is even less time consuming. Therefore 
since 2004 we have adopted EUs and/or total body CT scan as the fi  rst-
line diagnostic tools for major trauma (MT) victims. In a benchmarking 
analysis of Italian trauma centers (TCs), our hospital ranked fi  rst for patient 
mortality and long-term disability [1]. These results were associated with 
the shortest diagnostic time. The aim of this study is to assess whether 
these results were associated with a real change in the diagnostic process.
Methods  In order to evaluate the diagnostic approach to MT we 
retrospectively analyzed all MT cases (ISS >15) admitted to our TC over 
a 2-year time span. All investigations performed in the emergency 
department (ED) are entered in an electronic shift just before being 
performed. Data for all investigations requested within 2 hours from 
admission were analyzed.
Results From 1 November 2007 to 31 October 2009, 743 MT patients were 
admitted to the ED. EUs was performed in 515 patients (69%), total body 
CT scan in 679 (91%). Patients who were not submitted to CT either died 
soon after admission or were rushed to the operating room on the basis of 
EUs results. Thirty-eight patients had a chest X-ray taken in the ED (5.1%), 
11 (1.5%) a pelvic X-ray and only three a cervical spine X-ray.
Conclusions Although many international guidelines for trauma care still 
recommend traditional plain radiographic investigations, our TC as well as 
many other European institutions with a high volume of trauma patients 
have adopted a diff  erent strategy based on the extended use of EUs and 
CT scan. This may improve the accuracy of the diagnosis in the stabilized 
patients and reduce time to the operating room in the highly instable 
ones. We suggest that a change in the recommended guidelines should 
be considered.
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Introduction  Previous studies have focused on the accuracy of the 
focused assessment with sonography for trauma (FAST) examination 
performed in the emergency department (ED), but have not evaluated 
FAST performed in the fi  eld setting (fi  eld FAST). We aimed to evaluate the 
accuracy of fi  eld FAST by comparison with FAST performed in the ED.
Methods A total of 1,380 trauma patients were admitted to our hospital 
by air ambulance between April 2005 and October 2009. We compared 
the sensitivity and specifi   city of fi   eld FAST with those of FAST in the 
hospital setting. The presence of pericardial and intraperitoneal fl  uid was 
confi  rmed by the medical records.
Results Of these patients, 317 blunt trauma patients (mean age, 43.9 ± 
23.8 (SD) years) were examined by fi  eld FAST and enrolled in the study; all 
participants were also examined by FAST in the ED. The mean Injury Severity 
Score was 16.1 ± 15.4 (SD). Forty-seven patients (14.8%) were ultimately 
diagnosed with pericardial and intraperitoneal fl  uid. Field FAST detected 
12 of these cases. The sensitivity of fi  eld FAST was signifi  cantly lower than 
that of FAST in the ED (P <0.01), whereas the specifi  cities of FAST in the two 
settings were not signifi  cantly diff  erent. Emergency surgery was performed 
in nine of the 12 patients who were positive with fi  eld FAST.
Table 1 (abstract P284)
  Field FAST  ED FAST  P value
Sensitivity 28.9%  66.7%  <0.01
Specifi  city  97.0%  96.6%  0.76
Conclusions  Because the sensitivity of fi   eld FAST is low, repeated 
examination in ED is needed to improve diagnostic sensitivity. However, 
fi  eld FAST may be an eff  ective tool for early detection of critical blunt 
trauma and as a rapid indicator for surgery.
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Introduction  The aim of the study was identifi   cation of common 
regularities and pathogenetic signifi   cance of changes in the ratio 
between primary and secondary infl  ammatory mediators in development 
of systemic infl  ammatory response syndrome (SIRS) in polytrauma.
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hospitalized to the ICU were examined. There was infection confi  rmed 
by microbiology in 175 (pneumonia, bronchitis, osteomyellitis, acute 
urethritis, and so forth); 212 patients had no infection (acute respiratory 
distress syndrome, disseminated intravascular coagulation, fat embolism, 
and so forth). In 87% two or more signs of SIRS were noted according to 
the criteria of the Consensus Conference ACCP/SCCM (2003). C-reactive 
protein (CRP) in venous blood serum was measured on 1, 3, 5, 7, 10, 15 and 
17 days after admission using the biochemical analyzer HITACI-912 with 
reagents Tina-Quant CRP (Roche Diagnostic GMBH), lipopolysaccharide-
binding protein (LPSBP) and cytokines TNFα, IL-2R, IL-6, IL-8, IL-10 using 
the immunochemiluminescent analyzer IMMULITE with the reagents DPC 
(USA). Constant variables were compared using Student’s t test and the 
Mann–Whitney U test. The diff  erences were signifi  cant at P <0.05.
Results  On admission, increased serum LPSBP and TNFα  were noted 
in all patients with infection compared with the patients without it (1.8 
and 3 times respectively, P <0.01). Moreover, the infectious patients had 
the apparent increase of IL-2R, IL-6, IL-8 and CRP: 5, 13, 18 and 5 times, 
respectively (P <0.05). At that, generalized manifestation of infl  ammatory 
reaction in the infectious patients was characterized by at mean fi  vefold 
increase in IL-8 on day 3 of the follow-up. It was not accompanied by 
adequate anti-infl  ammatory response that was indicated by an absence 
of IL-10 dynamics. A direct correlation was found between an increase 
in infl  ammatory mediator concentration (IL-6, IL-8, IL-10) and respiratory 
rate (r = 0.73; 0.46; 0.59), CRP and heart rate (r = 0.48, P <0.05), and an 
inverse correlation between infl  ammatory mediators (TNFα, IL-2R, LPSPB) 
and arterial pressure level (r = –0.42; –0.63; –0.48) and respiratory function 
values (vital lung capacity and forced expiratory volume, r = –0.42).
Conclusions Hyperproduction of proinfl  ammatory cytokines is closely 
connected with ventilation disturbances and clinical variants of the post-
traumatic period course in patients with polytrauma.
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Introduction The aim of the investigation was to analyze the diagnostic 
and prognostic signifi   cance of serum proapoptosis and antiapoptosis 
markers in the patients with severe trauma injury.
Methods Thirty-three patients with severe trauma injury were enrolled 
into our investigation (we excluded patients with severe brain injury, the 
middle age was 39 ± 8, initial TRISS scale 7.8 ± 1.8, APACHE II 14 ± 5). All of 
the patients demonstrated signs of systemic infl  ammatory response, in 12 
patients the infectious pulmonary complications were revealed and in 21 
patients the infectious complications were not developed. Venous blood 
serum EDTA samples were investigated every day during a week in the 
–25°C freeze. We investigated antiapoptotic markers (soluble Fas-L, soluble 
APO-1/Fas, Cu/Zn superoxide dismutase), proapoptotic markers (protein 
p53, protein Bcl-2), and high-sensitivity CRP (ELISA, Bender Medsystem).
Results We observed an increase in proapoptotic markers in patients 
with infectious complications from the fi  rst day in the ICU, antiapoptotic 
markers (Cu/Zn superoxide dismutase) were lower with regard to 
reference points. The patients demonstrated a maximum of Fas-L, protein 
p53, and protein Bcl-2 (near 50% relative to fi  rst day) on the second day. In 
patients without infection complications we identifi  ed a decreased level 
of proapoptotic markers and an increased level of antiapoptotic markers 
(SOD, soluble Fas-L, soluble APO-1/Fas). High-sensitivity CRP correlated 
with the severity of infectious complications.
Conclusions  Serum proapoptotic and antiapoptotic markers have 
demonstrated diagnostic and prognostic signifi  cance in the patients with 
severe trauma injury.
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Introduction  It is important to predict the need for mechanical 
ventilation (MV) in burn patients in order to improve their management 
and also to optimize resource ultilization. However, there are scant data 
on the predictors of MV in burn patients. The purpose of this study was to 
determine the risk factors for MV in a cohort of our burn patients.
Methods  A retrospective chart review was completed for patients 
admitted to Baskent University Burn Institute, from January 2003 through 
December 2008. Patients were divided into two groups based on whether 
they required MV during their fi  rst 3 days of hospitalization or not. After 
comparing the two groups for the recorded variables, a binary logistic 
regression model was developed using statistical and clinical signifi  cance 
to identify the risk factors for MV.
Results Out of 160 patients, 33 patients (21%) required MV during their fi  rst 
3 days of hospitalization. Patients who required MV were similar to those 
who did not in terms of demographic features. Patients who required MV 
were signifi  cantly diff  erent from those who did not regarding the mean 
burn percentage (56% ± 23% vs 19% ± 15%, P <0.001), mechanism of burn 
(fl  ame, 73% vs 37%, P = 0.001), inhalational injury (27% vs 3%, P <0.001), 
and burn aff  ecting head and neck (72% vs 37%, P <0.001). Binary logistic 
regression revealed that inhalational injury (OR, 8.4; 95% CI, 1.1 to 66.1; 
P = 0.042) and burn percentage (OR, 1.1; 95% CI, 1.1 to 1.2; P <0.001) were 
independent risk factors for MV.
Conclusions Our results demonstrate that inhalational injury and burn 
percentage are predictors of MV in our series of burn patients. Particularly, 
patients with inhalational injury were eight times more likely to require MV 
during their fi  rst 3 days of hospitalization in our series.
P288
Impact of regional imaging guidelines for head injury and 
unconscious polytrauma patients
R Gibbs1, R Walker2, E Thomas3
1Musgrove Park Hospital, Taunton, UK; 2Torbay Hospital, Torbay, UK; 3Derriford 
Hospital, Plymouth, UK
Critical Care 2010, 14(Suppl 1):P288 (doi: 10.1186/cc8520)
Introduction Inadequate or delayed imaging of the unconscious patient 
with traumatic brain injury or of the unconscious polytrauma patient may 
lead to catastrophic consequences. The need for comprehensive imaging 
needs to be balanced against the patient’s condition, the resources 
available and excessive radiation exposure. We have introduced regional 
evidence-based guidelines in the Southwest region of the UK. The aim of 
these guidelines was to standardise practice, minimise delayed or missed 
diagnosis of serious injuries, facilitate treatment of associated injuries 
(such as head injuries) and to obviate the need for repeated imaging.
Methods The notes of all unconscious polytrauma patients transferred 
from the emergency department or other hospitals and all patients trans-
ferred to our institution for ongoing neurosurgical care were retrospectively 
reviewed over a 1-year period. Adherence to the imaging protocol was 
assessed and the need for any further radiological investigations within 
48 hours was also documented.
Results A total of 46 patients were identifi  ed who fulfi  lled the criteria 
for the introduced guidelines. Of these patients, 21% were transferred 
from other hospitals while the remainder was admitted from the onsite 
emergency department. Eighty-three per cent of all eligible patients 
adhered to the protocol. Two patients (4%) required further radiological 
investigation in the 48 hours following admission. Both had isolated head 
injury and required further imaging to exclude cervical injuries following 
inadequate imaging which did not follow protocol. One further patient 
(2%) required repeated imaging to exclude mesenteric injury.
Conclusions Regional adoption of imaging guidelines aimed at obtaining 
early comprehensive imaging of both head-injured and polytrauma 
patients results in high compliance and a low rate of re-imaging.
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Introduction  Blunt cerebrovascular injuries (BCVI) are more common 
than previously reported and, if not promptly recognized and treated, may 
have devastating sequelae. When these injuries are diagnosed before the 
onset of stroke, and patients receive early antiplatelet or anticoagulation 
therapy, a substantial reduction in BCVI-related neurologic events has 
been demonstrated [1].
Methods The study setting was a level 1 trauma center with a catchment 
population of more than 2 million people, admitting 350 major traumas 
yearly. To assess the incidence of asymptomatic BCVI in the severely 
injured patients, we planned a prospective cohort study. According to the 
study design, all of the severely injured patients presenting with at least 
one of the following criteria [2] were submitted to a screening 16-channel 
CT angiography within 24 hours from admission: diff  use axonal injuries; 
fracture of the cervical vertebrae or of the skull base; Lefort II or III or other 
severe facial fractures.
Results During the fi  rst 5 months of the study, 24 major trauma patients 
(ISS >15) with at least one of the above listed risk factors were submitted 
to a screening CT angiography for BCVI. All of the patients were sedated 
and artifi   cially ventilated. None of them was symptomatic for stroke. 
Three patients (12.5%) in this high-risk group had an asymptomatic BCVI: 
pseudoaneurysm (one), traumatic stenosis (one) or dissection (one) 
of the carotid artery. They were immediately treated with antiplatelet 
therapy (clopidogrel + aspirin). They experienced no episodes of cerebral 
infarction and no cerebral haemorrhage.
Conclusions There are limited data in the literature on traumatic BCVI. The 
available data as well as the preliminary results of our prospective study 
show that BCVI are more common than previously recognized. Aggressive 
screening and earlier therapy may signifi  cantly reduce complications and 
improve patient outcomes.
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Introduction The aim of this study was to determine the effi   cacy of 
8.4% sodium bicarbonate for intracranial pressure (ICP) reduction in 
adult patients with severe traumatic brain injury (TBI) and intracranial 
hypertension.
Methods The study examined 10 episodes of ICP >20 mmHg in seven 
patients with severe TBI. Eighty-fi  ve milliliters of 8.4% sodium bicarbonate 
was infused over 30 minutes when osmotherapy was indicated after 
standard care. ICP, mean arterial pressure (MAP), and cerebral perfusion 
pressure (CPP) were recorded at baseline and then continuously for 
6  hours. Serum pH, pCO2, (Na+), and (Cl–) were measured at baseline, 
30 minutes, 60 minutes and then hourly for 6 hours. Serum osmolality was 
measured at baseline and at 6 hours in three patients. All other care was 
identical to the institutional protocol for the management of raised ICP.
Results At the completion of the infusion, the mean ICP was reduced to 
36.2% of baseline, from 28.5 mmHg (±2.62) to 10.33 mmHg (±1.89). Mean 
ICP remained below 20 mmHg for 6 hours (Figure 1). CPP was increased 
after the infusion due to the eff  ect on ICP. MAP did not change. Mean 
pH was elevated at t = 30 minutes (from 7.45 ± 0.02 to 7.50 ± 0.02) and 
remained elevated for the duration of the study period. Serum (Na+) 
increased (from 145.4 ± 1.9 mOsm/l to 147.1 ± 1.9 mOsm/l) at 30 minutes. 
pCO2 did not change. Osmolality was elevated.
Conclusions Eighty-fi  ve milliliters of 8.4% sodium bicarbonate infused 
over 30 minutes is eff  ective at reducing sustained ICP >20 mmHg to within 
accepted treatment targets (ICP <20 mmHg) for at least 6 hours.
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Introduction  Water–electrolyte imbalance and endocrine disorders 
make the problem of maintaining patients with severe traumatic 
brain injury (TBI) more diffi   cult. A plasma sodium level ≥160 mmol/l is 
associated with 75% mortality. The purpose of this investigation was to 
fi  nd the relationship between hypernatraemia and the rate of unfavorable 
outcomes in children with TBI.
Methods A total of 77 children <18 years of age with TBI (admission 
GCS score <8) were divided retrospectively into three groups: Group A 
included children without hypernatraemia (n = 51), Group B children with 
hypernatraemia (n = 14) and Group C (n = 12) children with hypernatraemia 
and polyuria. Group C was considered the group of patients with central 
diabetes insipidus (CDI). Hypernatraemia was defi  ned as a twice elevation 
of the plasma sodium level over 149 mmol/l within 24 hours, while 
polyuria was defi  ned as an increase in the hourly diuresis of more than 
3 ml/kg/hour in no less than 6 hours.
Results  The mean sodium level at admission was 140.1 ± 4.1 mmol/l. 
Hypernatraemia was detected in 26 patients (33.8%). The mean duration of 
the period of hypernatraemia in Group B was 4 days (3 to 6 days), while the 
mean sodium level during the period of hypernatraemia was 158.3 ± 3.3 
mmol/l (max 176.8 mmol/l). The duration of the period of hypernatraemia in 
Group C was 4.5 days with max 181.1 mmol/l and average 161 ± 4.7 mmol/l. 
Polyuria was diagnosed in 15.5% of the cases. The highest diuresis in this 
group was 4.1 mmol/kg/hour, mean 3.7 ± 0.5 ml/kg/hour. Such changes 
were considered a manifestation of CDI. All 12 patients in Group C received 
desmopressin (DDAVP) for more than 48 hours (mean 56.8 ± 4. 5 hours). The 
doses were 0.025 to 0.2 mg/day. In four out of 14 children in Group B (29%), 
an increase hourly diuresis up to 3 ml/kg/hour was considered the onset 
of CDI; thus, they were also prescribed DDAVP. Unfavorable outcomes (GOS 
score 1 to 3) during a 30-day assessment were observed only in Groups B 
and C. In a comparison of unsuccessful outcomes between Groups B and C, 
there was an increase in the unfavorable outcome rate in patients of Group 
C (with hypernatraemia and polyuria) – 10 children (84%) and Group B – 
four children (28%). The risk factor in the comparison between patients of 
Groups B and C was 0.3, P <0.05.
Conclusions Our results demonstrate that hypernatraemia increases the 
rate of unfavorable outcomes in children with TBI. Thirty-day outcomes 
were worse with CDI patients. Presumably, the used of DDAVP prevents 
dehydration and CDI advance.
Figure 1 (abstract P290).
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Introduction Secondary ischemic insult after severe traumatic brain injury 
(TBI) is correlated with poor outcome. Transcranial Doppler sonography 
(TCD) permits a non-invasive measurement of cerebral blood fl  ow. The 
purpose of this study is to determine the usefulness of TCD in patients 
with severe TBI.
Methods TCD was performed on 73 patients with severe TBI, defi  ned 
as a Glasgow Coma Scale of 8 or less on admission. All patients were 
on mechanical ventilation. TCD was performed on hospital days 1, 2, 
3 and 7. Hypoperfusion was defi  ned by having two out of three of the 
following: mean velocity of the middle cerebral artery less than 35 cm/
second, diastolic velocity of the middle cerebral artery less than 20 cm/
second and a pulsatility index greater than 1.4. Vasospasm was defi  ned 
by the following: mean velocity of the middle cerebral artery greater than 
120 cm/second and/or Landegaard index greater than 3.
Results Thirty-four patients (64%) had normal measurements. Thirteen 
were discharged home, 16 were discharged to a long-term care facility 
and fi  ve died. Two of these patients were comatose and their families 
requested withdrawal of care. The other three died from brain death. 
Eighteen patients (25%) had hypoperfusion and all 18 progressed to brain 
death. Twenty-one patients (29%) had vasospasm. Four of these patients 
were discharged home, 11 to a long-term care facility and six died. The 
vasospasm was detected on hospital day 1 in three patients, hospital 
day 2 in seven patients, hospital day 3 in four patients and hospital day 
7 in seven patients. Nimodipine was administered in six patients and all 
six were discharged to a long-term care facility. However, in one patient, 
nimodipine caused hemodynamic instability and was discontinued. In 
15 patients, nimodipine was not given. Six of these patients expired from 
brain death. Twelve of 21 patients (57%) with subarachnoid hemorrhage 
on computed tomography had vasospasm.
Conclusions Most patients with normal measurements can be expected 
to survive. Patients with hypoperfusion have a poor prognosis. In patients 
with vasospasm, the use of nimodipine should be considered; however, 
further studies are needed to determine safety and effi   cacy. TCD may be 
useful in determining early prognosis. Further studies are also needed to 
determine whether TCD can improve outcome in patients with severe TBI.
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Introduction How hyperbaric oxygen (HBO) aff  ects injured brain tissue 
is not yet confi  rmed. We suppose that HBO could make the oxygen stay 
longer in the injured tissue, because of poor circulation or perfusion of 
blood in the injured area. This mechanism may help to explain the longer 
eff  ect of HBO, after HBO treatment. That is the purpose of our study.
Methods  Patients suff   ering from sub-acute traumatic brain injury, 
who would be treated with HBO, were enrolled in the study. They were 
divided into two groups: frontal lobe lesion and nonfrontal lobe lesion 
groups (n = 20) depending on their iconography check (X-CT or MR). The 
regional cerebral oxygen saturation (rSO2) was measured by a Somanetics 
INVOS 5100 monitor before and after 90 minutes treatment with HBO 
(15 minutes compression, 40 minutes breathing oxygen of FiO2 99% by 
mask, 10 minutes rest, 15 minutes decompression). Meanwhile, the arterial 
blood was sampled to measure blood gas analysis and cytokine.
Results The parameter of rSO2 showed no signifi  cant diff  erence following 
HBO treatment in two groups (t = 0.352, P >0.05); however, there were 
inconceivable results in blood gas analysis. Partial pressure of oxygen 
(PaO2) was signifi  cantly decreased after HBO treatment (P <0.05), although 
these changes did not take eff  ect on the clinical manifestation. Otherwise, 
the measurement of cytokines (TNF, IL-1) before and after HBO has no 
diff  erence (P >0.05) in all groups.
Conclusions HBO has no eff  ect on brain oxygen saturation, after HBO 
treatment. But PaO2 was signifi   cantly decreased following HBO. The 
mechanism needs to be studied further.
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Introduction This study evaluated relationships between CSF levels of 
brain biomarkers, glial fi  brillary acidic protein (GFAP), ubiquitin C-terminal 
hydrolase (UCH-L1) and αII-spectrin breakdown (SBDP145), partial pressure 
of brain tissue oxygen (ptiO2) and brain temperature (Licox system) during 
the fi  rst 24 hours and for up to 10 days following severe TBI.
Methods We studied 27 severe TBI patients having CSF drainage and 
invasive monitoring of partial brain tissue oxygen tension (PbtO2) and 
brain temperature using the Licox (Integra Neurosciences, Plainsboro, NJ, 
USA) probe. CSF SBDP145, UCH-L1 and GFAP levels were measured by 
quantitative ELISA assay on admission and every 6 hours thereafter for a 
maximum of 10 days. Using a double lumen bolt, ptiO2 and temperature 
were measured with the Licox. This study focused on the recordings of the 
fi  rst 24 hours following injury (27 patients), as well as preliminary data from 
four patients for 10 days.
Results The total duration of monitoring was 1,512 hours. During the fi  rst 
24 hours, biomarker levels decreased while levels of PbrO2 increased. All 
three biomarkers correlated with PbrO2 (P <0.0001, P = 0.016 and P = 0.023, 
respectively). After the fi  rst 24 hours, there were statistically signifi  cant 
changes in levels of brain biomarkers (SBDP145, UCH-L1 and GFAP) as 
well as in levels of ptiO2 (respectively, P = 0.025, P <0.0001, P = 0.033, 
P <0.0001). However, the correlation between biomarkers and brain tissue 
oxygenation was sustained, and for UCH-L1 improved (P <0.0001). No 
signifi  cant correlations between biomarker levels and brain temperature 
were found. There were no complications from the monitoring.
Conclusions  Our fi   ndings show that CFS levels of SBDP145, UCH-L1 
and GFAP are related to brain tissue oxygenation in acute and possibly 
the subacute (≤10 days post injury) phases of severe TBI. Future studies 
will more directly address relationships between changes in tissue 
oxygenation and biochemical markers of injury following severe TBI. CSF 
levels of biomarkers and brain tissue oxygenation could yield insights 
into pathophysiological events following severe TBI and aid in clinical 
assessments of severe TBI patients.
Table 1 (abstract P294)
 pH  PaO2 (mmHg)  PaCO2 (mmHg)
Group  Pre Post  Pre Post    Pre Post
Frontal lobe lesion   7.42 ± 0.02   7.45 ± 0.04  135.4 ± 29.77  102.12 ± 9.08  43.69 ± 4.58  40.81 ± 7.53
Nonfrontal lobe lesion   7.41 ± 0.03  7.42 ± 0.04  128.2 ± 34.22  107.2 ± 24.00  43.93 ± 4.88  43.00 ± 4.80
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Introduction  After traumatic brain injury (TBI), structural lesions are 
heterogeneous, but the spatial heterogeneity of consequences of insults 
as hypoxia-hypotension (HH) and/or TBI has never been studied. The 
objective of this study was to compare the eff  ect of standardized insults 
(HH, TBI and both) on brain energy metabolism in two diff  erent regions: 
frontal cortex and thalamus.
Methods Twenty-eight Sprague–Dawley rats were randomized into four 
groups: Sham, TBI (impact acceleration alone, 450 g weight drop from 
1.8 m), HH (blood depletion to mean arterial pressure 40 mmHg, FiO2 10%, 
15 minutes) and TBI-HH (TBI followed by HH, 45 minute delay). Cerebral 
perfusion pressure (CPP) was continuously and invasively measured. Brain 
microdialysis and PtiO2 probes were both inserted stereotaxically in the 
right thalamus and frontal cortex.
Results  Except during the HH phase, CPP was always greater than 
60 mmHg. During the hour following the HH period, a signifi  cant increase 
in cerebral lactate/pyruvate ratio (Figure 1), glycerol and glutamate was 
observed. This increase was higher in the cortex than in the thalamus in 
all groups subjected to HH (P <0.001). In the TBI-HH groups, the increase 
in glycerol in the cortex was signifi   cantly higher compared with the 
HH group (P <0.001), as well as thalamic and cortical glutamate. During 
15 minutes following the HH phase (after reinjection and reoxygenation), 
an increase in PtiO2 was observed in the cortex and thalamus, but with 
diff  erent profi  les (lower increase in the cortex) (Figure 1).
Conclusions Diff  erent profi  les of cerebral response to HH and TBI were 
observed with higher sensitivity in the cortex than in the thalamus. The 
post-ischemic hyperemia seems to be altered in the traumatized cortex 
but conserved into the thalamus and nontraumatized brain.
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Introduction The purpose of this study is to describe a single institutional 
experience in diagnosis and management of patients with blunt cerebro-
vascular injury (BCVI) after severe traumatic brain injury (TBI).
Methods  We considered blunt major trauma patients consecutively 
admitted from January 2008 to October 2009 to our ICU of a regional referral 
hospital (Careggi Teaching Hospital, Florence, Italy). Patients were screened 
on the basis of Memphis criteria to identify risk factors for BCVI: complex 
cervical spine fractures, neurological conditions not sustained by imaging, 
Horner’s syndrome, LeFort II/III fractures, basilar skull fractures with petrous/
neck soft tissue injury. We modifi  ed this protocol to investigate all petrous 
fracture and to consider also cervical spine fractures (subluxation, transverse 
foramen, upper cervical spine involvement). In all patients judged at risk for 
BCVI, a 64-slice angio-CT scan (CTA) was performed.
Results During the study period, 266 patients were admitted to the ICU 
for BMT with an ISS >15; 162 patients (60.9%) presented TBI or cervical 
spine fracture. According to our proposed modifi  ed Memphis criteria, 46 
patients showed risk factors for BCVI (17.3% of the total of BMT; 28.4% of 
TBI), and six of them had carotid injury (2.2% of all BMT; 13.0% of patients 
with risk factors). No vertebral injury was detected. Anticoagulant therapy 
within 72 hours was initiated in all patients. No complications occurred 
and all patients were discharged from the ICU. Clinical examination during 
the 6-month follow-up showed no neurological defi   ciency related to 
previous vascular injury.
Conclusions  A higher percentage of BCVI was observed using the 
proposed modifi   ed Memphis criteria if compared with other studies 
(2.2% vs 1%). The mortality rate was lower than previously reported for 
patients with BCVI (0% vs 13%) and it could be explained by the early 
diagnosis and anticoagulant therapy initiation. An extended screening 
protocol application allows prompt recognition of BCVI. In regard of the 
higher percentage of BCVI found in our population, an advanced study on 
protective devices (for example, helmets) is actually in progress with the 
aim to reduce biomechanical eff  ects of head injury on extracranial vessels.
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Introduction Decompressive craniectomy is indicated for treatment of 
severe intracranial hypertension. However, this procedure is invasive and 
potentially associated with complications. We present a preliminary result 
of a study comparing early and late decompressive craniectomy in severe 
traumatic brain injury.
Methods  Patients studied were all admitted to the ICU of a tertiary 
referral center (Careggi Teaching Hospital, Florence, Italy) during 4 years 
(2005 to 2009). In total, data of 62 brain-injured patients, who underwent 
decompressive craniectomy, were retrospectively examined and included 
in two groups based on decompressive craniectomy execution: 
Figure 1 (abstract P296). Brain lactate/pyruvate ratios and PtiO2 in the thalamus and cortex.
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performed within 24 hours after brain injury, group A; n = 41) and late 
decompressive craniectomy (later than 24 hours, group B; n = 21). For 
all patients, demographic, scores, clinical data, length of stay and fi  nal 
outcome were collected from the institutional database. Traumatic lesions 
were compared at admission using the Marshall score and 24 hours 
after decompressive craniectomy execution with CT scan. The Glasgow 
Outcome Scale (GOS) at 6 months was also collected.
Results Demographic and clinical characteristics of groups are shown 
in Figure 1 (data expressed as mean ± SD). Patients who underwent 
decompressive craniectomy within 24 hours after injury (group A) had a 
signifi  cant worst Marshall score if compared with group B (3.1 ± 0.7 vs 
2.4 ± 0.8, respectively; P <0.05), but also showed a signifi  cant enlargement 
of contusions compared with group B (52.7% vs 16.6%; P <0.01). ICU/
hospital length of stay and mortality were not signifi   cantly diff  erent 
between groups. The GOS evaluated at 6 months showed a good recovery 
of surviving patients in both groups (3.7 ± 1.0 in group A and 3.2 ± 0.9 in 
group B).
Conclusions Our data, limited by the retrospective nature of the study, 
do not encourage an early decompressive treatment of severe intracranial 
hypertension. Decompressive craniectomy should be considered in case 
of lack of response to a medical, even intensive, approach.
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Introduction The purpose of this study is to verify the reliability of optic 
nerve ultrasound (ONU) for detecting intracranial hypertension (IH). IH 
is a frequent and potentially fatal complication of severe head injury. 
Actually, intraventricular catheters represent the gold standard for ICP 
measurements. Unfortunately they present serious complications and 
relative contraindications like thrombocytopenia or coagulopathy. 
Computed tomography and transcranial Doppler (TCD) represent non-
invasive methods to evaluate ICP but they present drawbacks. ONU has 
been recently suggested as a non-invasive tool to diagnose IH. Its reliability 
has been showed in patients with severe head injury or with intracranial 
hemorrhage [1,2].
Methods  The study was conducted on 10 patients admitted to the 
neurointensive care unit for moderate/severe head injury in the period 
January to June 2009 (Group 1). Ten healthy subjects were enrolled as 
the control group (Group 2). Estimated ICP (eICP) was calculated with 
TCD using the equation proposed by Czosnyka and colleagues [3]. It was 
measured twice a day for 3 consecutive days. In the same sonographic 
session, the optic nerve sheath diameter (ONSD) was measured in the 
sagittal and transverse plane 3 mm behind the papilla, in both eyes.
Results  No signifi   cant diff   erences have been found between groups 
regarding age and sex. The ONSD distribution is shown in Figure 1. 
ONSD, eICP and ICP values were signifi  cantly higher in Group 1 than in 
Group 2. Linear regression analysis identifi  ed a signifi  cant relationship 
Figure 1 (abstract P298). Demographic and clinical characteristics of 
both groups.
Figure 1 (abstract P300). ONSD distribution in patients with ICP less 
than and more than 20 mmHg.
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characteristic curve, an ONSD value of 5.35 mm resulted as the optimal 
cut-off   point with a sensitivity of 95.1% and a specifi  city of 96.2%.
Conclusions  ONSD measurements correlated with invasive and non-
invasive (TCD) measurements of ICP. It is a useful, non-invasive bedside tool 
to diagnose IH. It is safe, easy to perform and can rapidly give reproducible 
information on patients’ ICP.
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Introduction  Traumatic brain injury (TBI) is a multiphasic disease. 
Follow  ing the initial impact, secondary injury, including oxidative stress 
and infl  ammation, is thought to contribute signifi  cantly to death and 
disability. This ongoing damage in the penumbra of the brain leads to the 
demise of neuronal populations, and ultimately decreased brain function. 
Identifi  cation of various neural markers such as neuronal specifi  c enolase 
(NSE) at various time points following TBI may help us better understand 
the magnitude of secondary injury following TBI, and may help predict 
outcome in these patients.
Methods Early serial cerebrospinal fl  uid (CSF) samples were collected 
from patients with severe TBI (GCS 3 to 8) who required placement of a 
therapeutic ventriculostomy. Following ventriculostomy placement, CSF 
samples were obtained every 4 hours for the fi  rst 24 hours post-injury, 
then every 8 hours for post-injury days 2 to 5. The levels of NSE were then 
measured using the ELISA method.
Results Following sample analysis in 11 patients, we found that in TBI 
patients that had a good neurological outcome, the levels of NSE in the 
CSF rose early (between 25 and 60 ng/ml) within 12 to 16 hours following 
the initial injury. The NSE levels then rapidly decreased to normal levels 
(~5 ng/ml) at approximately 20 hours following injury, with these levels 
persisting until day 5 (day of fi  nal sample collection). Patients with a poor 
outcome (lack of ability to return to pre-injury activities or death) showed 
signifi  cantly higher levels of NSE persisting out to 5 days post injury, with 
late levels ranging from 35 to 50 ng/ml.
Conclusions In TBI patients with a good outcome, there was an increase 
in NSE levels in the CSF noted at early time points (~16 hours), which 
abated at approximately 20 hours after injury. In TBI patients with a poor 
clinical outcome, CSF levels of NSE were signifi  cantly elevated at later time 
points over the fi  rst 5 days post injury.
P302
Hyperphosphorylated neurofi  lament NF-H, S100β and NSE as 
indicators of severity of brain injury in children
J Žurek, L Marek, P Košut, M Fedora
Faculty of Medicine, Masaryk University, University Children´s Hospital, Brno, 
Czech Republic
Critical Care 2010, 14(Suppl 1):P302 (doi: 10.1186/cc8534)
Introduction The aim of the study was to determine whether serum 
levels of biomarkers – hyperphosphorylated neurofi  lament NF-H, S100β 
protein and NSE – correlate with severity of brain injury and outcome in 
children with traumatic brain injury (TBI).
Methods Thirty-eight patients with TBI were enrolled in the prospective 
study. TBI was verifi   ed by computerized tomography according to 
the Marshall classifi   cation. Venous blood samples were taken after 
admission and every 24 hours for a maximum of 6 consecutive days. 
Serum NF-H concentrations were quantifi  ed by ELISA, S100β and NSE 
by electrogenerated chemiluminescence. The outcome was evaluated 
6 months after TBI using the Glasgow Outcome Scale (GOS) in all patients.
Results Serum concentrations of NF-H (median 86 vs 12; P = 0.01), S100β 
(median 3.47 vs 0.54; P = 0.001), and NSE (median 193.2 vs 37.03; P = 0.001) 
were higher in nonsurvivors than survivors. Serum NF-H (median 86 vs 12; 
P = 0.004), S100β (median 3.47 vs 0.54; P = 0.001) and NSE (median 193.2 
vs 37.03; P = 0.001) was signifi  cantly higher in patients with unfavourable 
outcome (GOS ≤3 vs GOS >3). Spearman’s rank correlation coeffi   cient on 
fi  rst day of hospitalization S100B x NSE = 0.58 (P <0.05), GCS x GOS = 0.50 
(P <0.05), GOS x Marshall classifi  cation = 0.46 (P <0.05).
Conclusions Plasma levels of hyperphosphorylated neurofi  lament, S100β 
and NSE correlate with severity of TBI and may be useful as predictors of 
outcome in children with TBI.
P303
A simple hospital discharge score predicts Glasgow Outcome Scale 
at 12 months in patients with traumatic brain injury
GW Fuller, P Yeoman
Queens Medical Centre, Nottingham, UK
Critical Care 2010, 14(Suppl 1):P303 (doi: 10.1186/cc8535)
Introduction This study examines whether a hospital discharge score 
predicts future Glasgow Outcome Scale (GOS) following traumatic brain 
injury (TBI). Loss to follow-up is a major problem in TBI studies and an early 
prediction score could be used for interpolation of missing outcome data 
or as a surrogate outcome measure.
Methods Adults admitted to the Queens Medical Centre between 1993 
and 2002 with TBI and GCS <12 were included prospectively in the 
Nottingham Head Injury Register. At hospital discharge the modifi   ed 
Barthel Index was recorded by nursing staff   and a Discharge Disability 
Score (DDS) calculated: 1. Independent, 2. Dependent <24 hour care, 3. 
Fully dependent, 4. Dead [1]. Glasgow Outcome Scale (GOS) was calculated 
at 12 months by the patient’s general practitioner [2]. Unfavourable 
outcome was defi  ned as DDS 3, 4 or GOS 1, 2, 3. Correlation between 
DDS and GOS was measured and the ability of DDS to predict GOS at 
12 months in survivors was assessed using logistic regression. Sensitivity 
and specifi   city of dichotomised DDS for prediction of unfavourable 
outcome at 12 months was also calculated.
Results Data were available on 1,227 patients. A highly correlated linear 
relationship was evident between DDS and GOS (spearman correlation 
coeffi   cient 0.77, P <0.0001). Unfavourable outcome measured by DDS 
showed sensitivity of 73% (95% CI 69 to 76%) and specifi  city of 56% (53 
to 59%) for prediction of unfavourable outcome at 12 months defi  ned by 
GOS. DDS showed a strong association with GOS at 12 months for survivors 
at discharge, with fully dependent patients having 15 times higher odds 
of an unfavourable outcome. Adjusting for known TBI prognostic factors 
attenuated the strength of the association, however DDS remained a 
statistically signifi  cant strong predictor of outcome.
Conclusions DDS is strongly associated with 12-month GOS and could 
potentially be used to replace missing data or provide a surrogate 
outcome measure in TBI trials. A valid prediction score may also aid the 
clinician’s ability to discuss patient prognosis at hospital discharge.
References
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Y Moriwaki, M Iwashita, Y Tahara, S Arata, N Harunari, T Kosuge, H Toyoda, 
N Suzuki
Yokohama City University Medical Center, Yokohama, Japan
Critical Care 2010, 14(Suppl 1):P304 (doi: 10.1186/cc8536)
Introduction The outcome of patients with cardiac arrest due to blunt 
trauma (BT-CPA) and penetrating trauma (PT-CPA) is very poor. The aim 
of this study is to clarify the outcome of patients with CPA on arrival due 
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department thoracotomy (EDT).
Methods This study is a population-based case series observational study. 
We have taken three approaches to these patients: our private aggressive 
treatment strategy (resuscitation for 30 minutes, aggressive infusion using 
sheath introducer into the subclavian vein, and EDT); in-hospital system 
supporting this aggressive resuscitation (logistic issue such as the close 
location between ED and the room for catheter intervention and CT, 
and direct entrance to the OR by exclusive lift, and common instruments 
interchangeable between ED and OR including the bed); and prehospital 
EMS in our city (CPA patients are transferred in about 7 minutes to the 
nearest of selected 11 hospitals which can receive and treat CPA patients).
Results For the past 10 years, of 478 BT-CPA and 30 PT-CPA patients, 76% 
and 70% were witnessed, and 21% and 37% were CPA after scene. A 
total of 85% and 77% underwent EDT. Although 34% and 60% achieved 
ROSC, only 18% and 40% went to the ICU, TAE room, and OR (admitted), 
and only 2.7% and 17% were discharged (survivors). Restricted in eight 
witnessed patients showing VF as the initial cardiac rhythm in BT-CPA, 
38% were admitted and 13% survived. No PT-CPA patients showed VF. 
Restricted in 134 witnessed patients showing PEA in BT-CPA and 10 in PT-
CPA, 28% and 70% were admitted and 1% and 30% survived. Two hundred 
and twenty witnessed patients showing no life sign (asystole) in BT-CPA 
and 12 in PT-CPA, 8% and 25% were admitted, and 3% and 17% survived. 
The initial rhythm of survivors was asystole in 70% in BT-CPA and 40% in 
PT-CPA. Although the time interval from arrival at the hospital to ROSC of 
survivors tended to be shorter than for nonsurvivors in BT-CPA, there was 
no diff  erence in this interval in PT-CPA. The longest interval was 43 and 
30 minutes in BT-CPA and PT-CPA.
Conclusions The expected outcome of BT-CPA and PT-CPA patients is 
hopeless. However, we cannot and should not give up on resuscitating 
them merely because they are CPA and they do not show any life sign at 
the scene. We consider the indication of aggressive resuscitation in every 
individual case by his/her individual condition.
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Using fl  ow-rate limiting bag–valve–mask device without training
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Introduction  The Smart Bag (SB, O-Two Medical Technologies Inc., 
Canada) is a bag–valve–mask resuscitator (BVM) equipped with a valve 
limiting fl  ow-rate and peak airway pressure to decrease hyperventilation 
and gastric insuffl   ation. We studied this device used by hospital staff   
without training to evaluate the possibility to change the standard BVM 
to the SB in hospital wards where positive pressure ventilation is rarely 
needed and training is sporadic.
Methods The participants (12 physicians, 38 nurses) were randomised to 
use the standard BVM or SB to ventilate a resuscitation training manikin 
over 1 minute. The mechanism of the SB was shortly described in the SB 
group but no hands-on training was provided. Participants were asked to 
ventilate the patients as they would do if patients have a pulse but do not 
breathe. Tidal volumes were registered to a computer connected to the 
manikin.
Results The medians of minute ventilation were 6.1 (interquartile range 
2.6 to 8.1) and 3.9 (IQR 1.7 to 5.4) litres per minute in the SB and control 
groups, respectively (Figure 1). Hyperventilation >10 l/minute occurred 
only in the control group (P = 0.23).
Conclusions  Using the SB without previous hands-on training is 
possible for the majority of nursing and medical staff   and decreases 
hyperventilation in comparison with the standard BVM.
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Out-of-hospital cardiac arrest and resource utilisation in the ICU
A Manning, M Purcell-Jones, A Saayman, M Wise
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Introduction  Survival rates for out-of-hospital cardiac arrests (OHCA) 
remain poor and typically of the order of 10% or less [1]. In the community, 
bystander CPR and public automated external defi  brillators have been 
promoted, whilst in hospital therapeutic hypothermia and coronary 
reperfusion are employed to improve outcome. Few studies have assessed 
how this group of patients impacts on critical care resources [2].
Methods  Patients with a spontaneous circulation following OHCA 
admitted to the critical care unit of a university teaching hospital between 
1999 and 2009 were analysed retrospectively.
Results A total of 1,656 patients presented to the emergency department 
following OHCA, of which 217 were admitted to the ICU. The ICU and 
hospital survivals were 41% and 32.7%, respectively. In the period 1999 to 
2003, ICU and hospital survival rates were 37.5% and 22.9%, respectively. 
In the period 2004 to 2009, ICU and hospital survival rates were 43.8% and 
40.5%, respectively. At admission to the ICU, the mean APACHE II score 
was 22.82, mean pH 6.87 and FIO2 52.6%. In those patients who survived 
hospital discharge, the mean APACHE II score was 19.71, mean pH 6.97 
and FIO2 47.1%, whilst in nonsurvivors they were 24.33, 6.83 and 55.4%, 
respectively. Overall ICU and hospital lengths of stay (LOS) were 5.41 and 
13.72 days and the average TISS score was 221. In those who survived to 
hospital discharge, ICU and hospital LOS were 10.1 and 32.4 days and the 
average TISS score was 380. Amongst patients who died in hospital, the 
mean ICU and hospital LOS were 3.1 and 4.7 days, the average TISS was 
144.
Conclusions Overall one-third of patients admitted to the ICU in the period 
1999 to 2009 with OHCA were discharged from hospital. This increased 
to 40.5% in the period from 2004 with almost all patients discharged 
from the ICU surviving to hospital discharge. Nonsurvivors amongst the 
cohort are unsurprisingly more seriously ill with higher APACHE II scores 
and deranged physiology. The cost of treating survivors of OHCA in ICU is 
considerably higher for survivors compared with nonsurvivors. However, 
as patients who are discharged from ICU usually leave hospital (2004 to 
2009), this would appear to be an appropriate utilisation of resources.
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Comparison of external cardiac compression on the fl  oor and in a 
dental chair
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Introduction Dental treatment is often stressful for patients and causes 
accidental systemic symptoms. In such situations, cardiopulmonary 
resuscitation (CPR) may be required. If external cardiac compression (ECC) 
in the dental chair is not eff  ective, the patient should be moved onto the 
fl  oor, which needs at least two or three persons and 10 to 15 seconds. 
Figure 1 (abstract P305). Minute ventilation (ml) in the Smart Bag group 
and the control group.
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dental chair in comparison with ECC on the fl  oor.
Methods Two dentists and two nurses with experience of ECC participated 
in this study; 30 ± 5 years old, 160 ± 5 cm in height, 65 ± 7 kg in weight. 
Before the study, they were educated about CPR and performed ECC for 
5 minutes on the resuscitation manikin in two diff  erent situations; on 
the fl  oor and in the dental chair. On separate days, they repeated these 
ECC procedures on the fl  oor and in the dental chair again. The depth 
of compression and the percentage of adequate compression were 
evaluated. In addition, each participant commented on the preferable 
situation in the questionnaire after each set of ECC.
Results Four dental personnel performed ECC fi  ve times on the fl  oor and 
fi  ve times in the dental chair and commented on the preferable setting 
fi  ve times. The effi   cacy of ECC was evaluated by the average depth and the 
percentage of ECC with adequate depth; 39.8 ± 8.2 mm and 46.8 ± 48.8% 
on the fl  oor and 34.4 ± 6.9 mm and 41.7 ± 42.7% in the dental chair. The 
percentage of ECC with adequate depth was higher for the fl  oor setting 
than that of the dental chair setting, although it did not reach statistical 
signifi  cance (P = 0.079). In the 20 questionnaires, three of them preferred 
the dental chair setting, two of them were no diff  erence between both 
settings and 15 of them preferred the fl  oor setting.
Conclusions ECC on the fl  oor can be performed eff  ectively and easy and 
we can start CPR immediately after moving the patient onto the fl  oor.
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Introduction Today, the emergency medical service (EMS) system has 
been developing in each country. However, it is not known whether 
people are willing to perform CPR and whether they are prepared to 
perform CPR under telephone CPR advice. In this study, we examined how 
Japanese citizens are interested in the importance of immediate CPR and 
defi  brillation, and how they understand this importance.
Methods Patients with out-of-hospital cardiac arrest due to nontraumatic 
etiology treated in our center for the past 2 years were enrolled. Cardiac 
arrest after the scene was excluded. Patients’ records from our emergency 
department were reviewed. In Japan, the ambulance service, dispatch 
service and emergency life-saving technician (ELST) belong to the fi  re 
department. ELSTs perform not only advanced CPR for CPA patients on 
the job but also education of call takers in the central operation center 
under medical control about the importance of the recognition of CPA 
and advice for immediate bystander CPR.
Results  A total of  747 patients were enrolled. Telephone CPR advice 
was performed for bystanders of 336 (45%) patients and 304 bystanders 
actually performed CPR (90%). Five percent (40) of all 747 cases underwent 
voluntarily bystander CPR before telephone advice, 40% underwent 
bystander CPR according to telephone advice, and 4% (32) did not 
undergo CPR against telephone CPR advice. In 344 patients with bystander 
CPR, 33% reached ROSC, 11% survived more than 24 hours, and 3% were 
discharged, and in 391 patients without bystander CPR, 30%, 11%, and 6%, 
respectively. Restricted in 302 witnessed patients, of 125 with bystander 
CPR, 52% reached ROSC, 16% survived more than 24 hours, and 3% were 
discharged, and in 177 without bystander CPR, 44% reached ROSC, 14% 
survived more than 24 hours, and 1% were discharged, respectively.
Conclusions  Most people are willing to perform CPR. Bystanders are 
prepared to perform CPR with telephone CPR advice to help them. 
However, bystander CPR is not always adequate, resulting in no distinct 
eff  ect of CPR on survival rate. We should educate citizens beforehand and 
guide bystanders with more proper and quick advice by telephone.
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Time factors rather than type and/or nature of CPR modify 
the prognosis of out-of-hospital cardiac arrests witnessed by 
bystanders
H Inaba, T Yachida, M Enami, Y Takei, Y Goto, K Ohta
Kanazawa University Graduate School of Medicine, Kanazawa, Japan
Critical Care 2010, 14(Suppl 1):P309 (doi: 10.1186/cc8541)
Introduction The purpose of the study was to analyze the eff  ects of the 
type and nature of CPR on the prognosis of out-of-hospital cardiac arrests 
(OHCAs).
Methods We analyzed 1,612 OHCAs, witnessed by citizens and handled 
by the dispatch system in Ishikawa, Japan, from 1 April 2003 to 31 March 
2008. Bystander CPR was classifi  ed into four groups according to type (CC 
only or CC + MMV) and nature (under one’s own initiative or telephone-
assisted instruction).
Results  The presence of bystander CPR signifi   cantly augmented the 
1-month survival rate. However, there were no signifi   cant diff  erences 
among the four groups of CPR. The multivariate logistic regression analysis 
identifi  ed three time factors including intervals of collapse-to-call, call-to-
fi  rst CPR, call-to-arrival to patients as independent factors associated with 
1-month survival. See Figures 1 and 2.
Conclusions Signifi  cance of correctable time factors rather than type of 
CPR should be considered in the future guideline revision.
Figure 1 (abstract P309). Eff  ect of bystander CPR on the 1-month 
survival rate. Figure 2 (abstract P309). Factors associated with 1-month survival
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Use of the laryngeal tube by paramedics during prehospital 
resuscitation: an observational study
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Introduction In the current guidelines of the ERC, tracheal intubation has 
become less important for persons not trained and diff  erent supraglottic 
airway devices are recommended. The present investigation deals with 
the application of the laryngeal tube (LT) during prehospital resuscitation 
by paramedics.
Methods The study was observational during a period of 2 years (2007 
to 2009). We registered all cardiac arrest situations in which the LT had 
been applied according to the ERC guidelines 2005. All participants had 
completed an obligatory course in emergency medicine, but had not 
been specifi  cally trained in endotracheal intubation; they were therefore 
designated as unfamiliar in using the endotracheal tube to secure the 
airway. Primary outcome measures were placement time and successful 
placement. Study endpoint was the total ‘no fl  ow time’, which is defi  ned 
as the time without chest compression in the fi  rst period of cardiac arrest.
Results During the defi  ned period, 53 resuscitation attempts recorded 
on standardised data sheets were included. The LT was used in 87% of all 
cardiac arrest situations. Overall, the LT was successfully and signifi  cantly 
faster inserted (about 9.4 seconds) in more than 96% of all cases, on the 
fi  rst attempt. In 99% of all cases, no problems concerning ventilation of the 
patient were described. During the cardiac arrest simulation, establishing 
and performing fi  rst ventilation took an average of 12.5 seconds with the 
LT. Use of the LT during cardiac arrest signifi  cantly reduced the ‘no fl  ow 
time’ about 87.6 seconds.
Conclusions As an alternative airway device recommended by the ERC, 
the LT may enable airway control rapidly and eff  ectively. Additionally, 
by using the LT, a reduced ‘no-fl  ow-time’ and a better outcome may be 
possible. LT may be a good alternative airway device for providing and 
maintaining a patent airway during resuscitation.
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The i-gel supraglottic airway as an alternative in the preclinical 
emergency medical aid? A comparative study on a manikin
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Introduction  Endotracheal intubation (ET) is the recognised gold 
standard for securing an airway in the realm of preclinical emergency 
medical aid. Supraglottic airway devices present a valid alternative in the 
case of an elevated incidence of diffi   cult airway securing and intubation 
preconditions. Due to positive experiences with the i-gel supraglottic 
airway, we – through a joint paramedic (PM) and doctor (DR) team – have 
compared its use under standardised conditions with the classic laryngeal 
mask (cLMA) and the laryngeal tube (LT) using an airway simulator.
Methods Seventy-one probands (40 PM and 31 DR) took part in this study. 
The airway simulator used was the Ambu® Airway Man. Timekeeping 
started with the laying aside of the anaesthesia bag after successful 
ventilation of the airway simulator and ended after having ensured 
suffi   cient ventilation. Participants used three diff  erent devices (i-gel size 4, 
cLMA size 3 and LT size 4) each fi  ve times. Additionally, an interval time was 
measured after successful ventilation with the i-gel. Without interruption, 
participants continued the experiment with two interval ventilations and 
conducted a secondary ET through the i-gel. Timekeeping ended in this 
case after the fi  rst ventilation.
Results Prior to the study 95% of PM had previous experience with the 
cLMA, 77.5% with the LT and 0% with the i-gel. Respective percentages 
for DR were 61.2% for the cLMA, 38.7% for the LT and 32.2% for the i-gel 
(P <0.001 respectively). Across the entire group of 71 study participants, 
users required an average of 16.6 seconds for the successful insertion 
of the cLMA, 15 seconds for the LT and 8.48 seconds for the i-gel. When 
comparing the PM with the DR, the PM required 16.5 seconds for the cLMA 
(vs 16.9 seconds, P = 0.693), 14.9 seconds for the LM (vs 16.8 seconds, P = 
0.08) and 7.8 seconds for the i-gel (vs 9.4 seconds, P = 0.001). The total time 
needed for secondary ET was on average 25.8 seconds (PM 24.2 seconds, 
DR 27.9 seconds, P <0.001). Error-free insertion at all fi  ve incidents was 
achieved by 73.3% of DR and by 46.1% of PM (P <0.001).
Conclusions Suffi   cient ventilation was achieved 50% faster through the 
i-gel when compared with the cLMA and the LT. The correct usage of the 
i-gel can be learnt quickly. The i-gel allows the options of secondary ET.
Reference
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a 12-month follow-up
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Introduction Besides the gold standard endotracheal tube, supraglottic 
airway devices are alternatives for emergency airway management [1]. The 
goal of the study was to identify airway devices that provide successful 
ventilation, even 12 months after training in manikins.
Methods In 2008, 288 medical students were trained to use laryngeal mask 
airways (LMAs) Unique, ProSeal, Supreme, I-Gel and bag–mask ventilation 
(BM) on manikins (Ambu). Students successful on the fi  rst attempt (n = 
190) for all devices in random order were included and tested 12 months 
later without further training. The insertion time to fi   rst successful 
ventilation, tidal volume (TV) and gastric infl  ation were assessed.
Results The time (in seconds) needed for the I-Gel and the Unique was 
signifi  cant longer in 2009 (BM 2008 8.2 ± 4.7 vs 2009 8.4 ± 5.4, P = 0.882; 
I-Gel 2008 10.2 ± 2.7 vs 2009 11.7 ± 4.9; P = 0.008; Supreme 2008 15 ± 3.7 
vs 2009 15.5 ± 4.6, P = 0.147; Unique 2008 16.5 ± 3.6 vs 2009 18.2 ± 5.5; P = 
<0.001; ProSeal 2008 17.7 ± 4.9 vs 2009 17.7 ± 5.2, P = 0.856). A higher rate 
of gastric infl  ation for BM and the I-Gel was seen in comparison of 2008 
with 2009 (BM 10.5% vs 18.6%, P = 0.012; I-Gel 0.5% vs 4.2%, P = 0.039; 
Supreme 0.5% vs 2.2%, P = 0.375; Unique 3.7% vs 5.8%, P = 0.607; ProSeal 
4.7% vs 1.2%, P = 0,18). About 60% of the TVs were insuffi   cient with little 
improvement for the Supreme and Proseal (Figure 1).
Conclusions One year after training, time for successful ventilation for all 
devices was lower than 25 seconds. This is acceptable compared with the 
gold standard endotracheal tube, but due to the rising gastric infl  ation 
rate and high amount of insuffi   cient tidal volume, shorter intervals of 
training maybe necessary.
References
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Figure 1 (abstract P312). Tidal volume (correct range 0.4 to 0.6 l).
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Factors correlated with the advanced life support simulation 
performance of senior medical students
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Introduction  Even though medical education using simulation for 
medical students is increasing and suggests positive outcomes, little is 
known about factors associated with the performance of advanced life 
support simulation. We investigated the correlation between various 
factors and simulation performance using senior medical students.
Methods Fourth-year medical students were enrolled and divided into six 
groups. Each group underwent a 2-week emergency medicine training. 
This study was conducted consecutively with a 2-week break between 
each group from March to July, 2009. Every student had an advanced 
cardiac life support (ACLS) simulation performance test as a moderator, 
scored by two ACLS instructors certifi   ed by the American Heart 
Association. The following data were examined: basic life support (BLS) 
practice, personality characteristics survey, case presentation, one post-
training written test, and two plan tests for the Korean Medical Licensing 
Examination (KMLE). The statistical signifi  cance was defi  ned as P <0.05.
Results Forty-six students participated. No correlation was found between 
ACLS performance scores and personality type or medical knowledge as 
measured by the post-training written test and the two plan tests for the 
KMLE. However, scores of the BLS examination and the case presentation 
were moderately correlated with the ACLS performance scores: r = 0.390, 
0.402, respectively (P <0.01).
Conclusions The ACLS simulation performance was correlated with the 
BLS skills and the case presentation. This supports the idea that the ability 
to manage resuscitation is associated with BLS skills and the capability 
to analyze and coordinate patient management. This result provides 
guidance for education of medical students.
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Aging augments unwllingness to the initial three links in chains of 
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Introduction The purpose of the study was to clarify the infl  uence of 
aging on attitudes toward the initial three links in chains of survival.
Methods We gave questionnaires to attendants of compulsory programs 
for basic life support (BLS) or driving technique at the beginning in 
authorized driving schools. The questionnaires included their backgrounds. 
We studied their willingness in four hypothetical scenarios related to the 
initial three links: early emergency call, cardiopulmonary resuscitation 
(CPR) under one’s own initiative, telephone-assisted chest compression 
and use of AED. The respondents were divided into young (17 to 29 years, 
n = 6,122), middle-aged (29 to 59 years, n = 827), older person (>59 years, 
n = 15,743) groups.
Results  There were signifi   cant diff   erences in gender, occupation, 
residential area and experience of BLS training, and knowledge of AED 
use between the three groups. The proportions of respondents who 
are willing to perform the desirable BLS actions were lowest in the older 
person group (Table 1). Multiple logistic regression analysis confi  rmed 
that aging is one of the independent factors relating to negative attitude 
in all the scenarios. Gender, occupation, resident area, experience of BLS 
training, and knowledge for AED use were other independent factors 
relating to negative attitude to some of the scenarios.
Conclusions  The aged population is more negative to the chain of 
survival. More are willing to follow the telephone-assisted direction for 
chest compression. The BLS training should be modifi  ed for them to gain 
confi  dence and to be aware of the signifi  cance and benefi  t of early call.
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Prediction of the success of cardiac resuscitation: a pattern 
classifi  cation approach based on ECG spectral and temporal 
features
M Baronio1, F Baronio2, M Campi2, G Amicucci1, A Caré2, A Sorgato3, 
G Perone4, A Candiani4
1Ospedale S. Orsola Brescia, Italy; 2Department of Information Engineering, 
University of Brescia, Italy; 3Division of Cardiology, Ospedale S. Orsola, Brescia, 
Italy; 4Spedali Civili, University of Brescia, Italy
Critical Care 2010, 14(Suppl 1):P315 (doi: 10.1186/cc8547)
Introduction The ECG tracings recorded during a ventricular fi  brillation 
(VF) using an automated external defi   brillator (AED) contain useful 
information predictive of shock outcome. The focus is on the VF 
waveforms’ morphology. The amplitude and the spectral properties of 
VF may predict the likelihood of successful defi  brillation [1-4]. In almost 
all previous studies, the amplitude or the spectral properties of the ECG 
tracings have been singularly used. However, these approaches have led 
to methods lacking suffi   cient predictive power.
Methods Five hundred patients with out-of-hospital cardiac arrest on 
arrival in an emergency room were examined. The rhythm was identifi  ed 
as VF and confi  rmed by two trained investigators. ECG data were stored in 
modules in digitized form over a period of 20 minutes and were analyzed 
retrospectively. ECG traces containing CPR artefacts were removed by 
digital fi  ltering. Times of collapse, dispatch, scene arrival, CPR, and initial 
defi  brillation were determined from dispatch records, recordings of arrest 
events, interviews with bystanders, and hospital records. The preshock VF 
waveform morphology was studied and diff  erent parameters of VF ECG 
signals were extracted. We then introduced a pattern classifi  cation machine 
that combines the amplitude and spectral features simultaneously.
Results The use of the pattern classifi  cation machine which combines 
amplitude and spectral features of VF ECG signals shows an improved 
predictive power as compared with other methods.
Conclusions  This technique could help to determine which patients 
should receive shock fi  rst and which should receive a period of CPR prior to 
shock, thereby increasing the probability of survival. The potential impact 
of this research is high in the direction of generating a new methodology 
able to increase the probability of survival after a cardiac crisis.
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Table 1 (abstract P314). Diff  erence among the three age groups in the proportion of respondents who are willing to perform the desirable BLS actions
   Age  group
Scenario  17 to 29 years  29 to 59 years  >59 years  Chi-square test P value
CPR under their own initiative  78.9% (4,810/6,094)  71.9% (589/819)  57.1% (8,186/14,346)  <0.001
Telephone-assisted chest compression  94.6% (5,766/6,898)  92.5% (757/818)  84.6% (12,112/14,316)  <0.001
Early 119 call  91.2% (5,556/6,092)  91.2% (747/819)  79.4% (12,130/15,270)  <0.001
Use of AED  56.8% (3,386/5,963)  48.4% (388/801)  21.4% (2,832/13,285)  <0.001
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Introduction  Although early bystander-initiated cardiopulmonary 
resuscitation (CPR) is a key factor in survival improvement from out-of-
hospital cardiac arrest, only one-third of victims actually receive CPR before 
arrival of emergency medical services. Dispatcher-assisted telephone CPR 
might improve the frequency and performance of bystanders’ resuscitation 
eff  orts. Due to the recent interest in hands-only CPR protocol [1] and the 
lack of any French validated algorithm, we designed the present study in 
order to validate a new French protocol called ALERT (Algorithme Liègeois 
d’Encadrement à la Réanimation par Téléphone).
Methods We tested the effi   cacy of the ALERT protocol on CPR performances 
in a manikin model of cardiac arrest. Participants (n = 110) were divided into 
four groups. Previously untrained subjects, distributed into two sub-groups 
depending on whether they were benefi  ciating from telephone assistance 
(PUG group, n = 30) or not (PUNG group, n = 30), were compared with 
previously trained nurses students distributed in two other sub-groups: with 
(PTG group, n = 25) or without (PTNG group, n = 25) telephone assistance.
Results Global evaluation of CPR performances in untrained volunteers 
benefi  ting from telephone assistance revealed a signifi  cant improvement 
as compared with unguided untrained volunteers. Indeed, they 
approached CPR performance levels of previously trained nurse students 
with no dispatcher’s guidance. Previously trained nurses with telephone 
assistance gained the best CPR scores, notably because of an improvement 
in the quality of airway management.
Conclusions  Our results indicate that use of the ALERT algorithm by 
dispatchers may improve the CPR performance in both previously untrained 
volunteers and in volunteers with prior basic life support training.
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Introduction  The concerns about allowing family members to be 
present during resuscitation are a matter of debate in many countries. The 
purpose of this study was to determine the opinions of Iranian health-care 
providers about family-witnessed resuscitations.
Methods  The study population consisted of CPR team members in 
four teaching hospitals. We developed a questionnaire, assessing their 
opinions, using 20 questions and also considering their comments.
Results  Of the total 200 participants, 77% oppose family-witnessed 
resuscitation. There was no signifi  cant diff  erence among opponents about 
FWR based on sex, age, number of CPR exposures and the experience of 
respondents (P >0.05). Emergency physicians were more likely advocates 
for FWR than other specialties (P = 0.004). All of the anesthesiologists 
opposed FWR. Most reasons for opposition were fear of psychological 
trauma to family members, interference with patient care, increased staff   
stress and violation with patient confi  dentiality.
Conclusions CPR team members in Iran do not believe in the presence 
of relatives during resuscitation. Informing healthcare providers on the 
benefi  t of witnessed resuscitation and public education of CPR would be 
a fundamental element for implementing a formal program.
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Introduction Recent studies report an increase of asystole and pulseless 
electrical activity (PEA) as the fi   rst monitored cardiac arrest rhythms 
after arrival of the Emergency Medical Services [1]. The asystolic patients 
presumably undergo ischaemia for a longer time and may benefi  t from 
treatment reducing hypoxic brain injury. Therapeutic hypothermia (TH) 
has expanded into prehospital care to be initiated as soon as possible. 
Rapid cold crystalloid infusion is the most frequent method; however, 
severe haemodynamic instability is its contraindication. The aim of the 
study was to assess the adverse eff  ects of prehospital volume expansion 
in patients with initial nonshockable rhythms when used in a setting with 
only restricted cardiovascular monitoring.
Methods The nonshockable patients enrolled in a prospective nonrandomized 
PRE-COOL trial (PRE-hospital COOLing in cardiac arrest patients) were rapidly 
administered cold normal saline (5 to 30 ml/kg) intravenously and analysed 
for body temperature, haemodynamic variables (blood pressure, heart rate, 
shock index), incidence of circulatory complications (recurrence of cardiac 
arrest, pulmonary oedema), and outcome. Hypothermic patients (group A, n 
= 19) were compared with matched historic controls (group B, n = 22).
Results In treatment group A, 1,021 ± 526 ml (13.2 ± 6.3 ml/kg) of 4°C 
cold normal saline was administered before hospital admission. Body 
temperature decreased by 1.32 ± 0.71°C until arrival at hospital (calculated 
rate 1.08 ± 0.44°C/30 minutes). The incidence of hypotension requiring 
vasopressors (noradrenaline or dopamine) signifi   cantly decreased in 
patients given cold intravenous fl   uids compared with control group 
B: 31.6% vs 63.6% (P = 0.04). No patient developed pulmonary oedema 
within 24 hours. Recurrence of cardiac arrest was comparable in both 
groups (3/19 vs 3/22), shock index at hospital arrival was 0.92 vs 0.97 (P = 
0.78), and favorable outcome (cerebral performance category 1 or 2) 
26.3% vs 13.6% (P = 0.31).
Conclusions  The early prehospital administration of cold infusions 
is safe and contributes to haemodynamic optimization in patients 
resuscitated from nonshockable rhythms. Incidence of hypotension 
requiring vasopressors was signifi  cantly reduced in the treated group. No 
pulmonary oedema was observed.
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Introduction  Trans-nasal cooling started during cardiopulmonary 
resuscitation (CPR) has shown to improve the return to spontaneous 
circulation (ROSC) and survival rate in an experimental prolonged cardiac 
arrest model. A multicenter randomized trial (PRINCE) has also suggested 
an improved neurological outcome in patients receiving trans-nasal 
cooling during CPR in the prehospital setting when compared with those 
treated by conventional hypothermia on hospital arrival, provided a delay 
between collapse and CPR of less than 10 minutes.
Methods Patients with witnessed cardiac arrest and a downtime less than 
20 minutes were randomized to prehospital intra-arrest cooling versus 
standard ACLS care. Trans-nasal cooling (RhinoChill, BeneChill Inc., CA, 
USA) was initiated using a mixture of volatile coolant fl  uid with oxygen 
delivered into the nasopharynx for rapid evaporative heat transfer. Cooling 
was continued during CPR and, for patients who achieved ROSC, until 
initiation of systemic cooling at hospital. Resuscitation was continued for 
at least 30 minutes. All patients were then cooled at the hospital.
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group was excluded from the per-protocol analysis because of DNR 
orders. Patients randomized to treatment group (n = 9) or standard care 
(n = 14) had similar demographics, initial rhythm, time from collapse to 
CPR and ALS arrival. Median time from collapse to cooling initiation was 
19 minutes. In total, 6/9 (66%) treated and 6/14 (42%) control patients 
achieved ROSC. Three patients (33%) in the treatment group survived 
to hospital discharge with CPC 1 to 2, while only one (7%) of the control 
group patients had good neurological outcome. No serious adverse 
events occurred in treated patients.
Conclusions  Trans-nasal cooling seems to be safe and feasible in a 
prehospital setting. These single-center data confi   rm that trans-nasal 
cooling may improve the ROSC rate as well as good neurological outcome 
if started in patients with a short delay between collapse and CPR.
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Introduction  Recent investigations have demonstrated improved 
neurological outcome after therapeutic hypothermia in patients after 
successful resuscitation. The time course and duration to achieve target 
temperature may be an important factor to infl  uence patient’s outcome. 
To determine the safety and effi   cacy of intranasal cooling during ongoing 
resuscitation, for immediate induction of therapeutic hypothermia, 
the Pre-Resuscitation Intra-Nasal Cooling Eff   ectiveness (PRINCE) study 
involved 200 patients in Europe, using a non-invasive nasal catheter 
that sprays evaporating coolant liquid into the nasal cavity. Here we 
demonstrate data from all German participating sites.
Methods All patients who were deemed eligible for advance cardiac life 
support (ACLS) were included as long as the arrest was witnessed and 
cardiopulmonary resuscitation (CPR) was initiated within 20 minutes 
of collapse. Patients were randomized to treatment or control groups. 
The trial was designed to determine the safety and eff  ectiveness  of 
early cooling initiated at the site of arrest. Survival and time to target 
temperature were documented.
Results Data are presented as the mean ± SD or median (interquartile 
range (25, 75%)). Mean age was 67.8 ± 14 years in the intervention group 
and 65.4 ± 13.9 years in the control group. On average, cooling therapy 
was started in 33 ± 12 minutes in the RhinoChill™ group and 170 ± 97 
minutes in the control group. Temperatures at hospital admission were 
signifi   cant lower in the RhinoChill™ group. Time to target tympanic 
temperature, refl  ecting brain temperature, were signifi  cant faster in the 
RhinoChill™ group (211 ± 124 minutes vs 424 ± 217 minutes; P <0.05). 
Adverse events occurred in 12 patients. None was related to the cooling 
therapy. In the intervention group fi  ve patients (20%) survived and three 
patients (12%) had a CPC of 1 to 2. In the control group only four patients 
(12.5%) survived and one patient (3.1%) had a CPC of 1 to 2.
Conclusions Using the intranasal cooling method, cooling was much 
faster and earlier in treated patients. Neurologically intact survival and 
discharge rates were higher in treated patients. Transnasal cooling for the 
induction of therapeutic hypothermia during prehospital resuscitation is 
feasible and highly eff  ective in lowering brain temperature rapidly. The 
method off  ers the possibility for immediate introduction and realization 
of mild hypothermia in the fi  eld.
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Introduction In 2003 the International Liaison Committee on Resusci-
tation (ILCOR) published guidelines recommending all patients admitted 
comatose to hospital following an out-of-hospital cardiac arrest (OHCA) 
with an initial rhythm of ventricular fi  brillation should be treated with 
therapeutic hypothermia for a period of 12 to 24 hours [1]. We aimed to 
determine how many units are using hypothermia as part of their post-
cardiac arrest management and when each of the ICUs implemented the 
therapy. Other objectives were to determine what cooling techniques are 
being used, the target temperature and the duration of cooling used.
Methods The 248 UK ICUs listed in the Directory of Critical Care Services 
were contacted by telephone by one of the authors. The duty ICU 
consultant or nurse in charge was asked a standardised set of questions.
Results We obtained responses from 244 of 248 (98.3%) of ICUs. Currently, 
209 (85.6%) ICUs are using hypothermia as part of post-cardiac arrest 
management. Since 2003, there has been an increase annually in the 
number of units using hypothermia, with the majority of units starting in 
2007 or 2008 (Figure 1). Of the units who use hypothermia as part of their 
post-cardiac arrest management, 99% are using it to treat patients after 
OHCA from shockable rhythms, 60.6% are using it to treat patients after 
OHCA from nonshockable rhythms, and 63.5% are using it after in-hospital 
cardiac arrest. Cooling is initiated with intravenous cold fl  uid in 71%. The 
commonest technique to maintain hypothermia is to use ice; used by 55% 
of units. Most ICUs (89.9%) aim for a temperature of 32 to 34°C and the 
duration of hypothermia is 24 hours in 141 ICUs (67.5%).
Conclusions  Generalised implementation of this clinical guideline in 
the UK has taken about 5 years but now the majority of ICUs are using 
therapeutic hypothermia as part of post-cardiac arrest management.
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Introduction Therapeutic hypothermia (TH) is a reliable, evidence-based 
modality to improve neurological outcome following out-of-hospital 
cardiac arrest. Often TH is induced in the ICU and as a result the time 
from cardiac arrest (CA) to induction of TH (THst) and achieving target 
temperature (CAta) is delayed. Preliminary data have shown that delaying 
TH may worsen outcome [1]. We sought to investigate whether a hospital-
wide approach to TH after CA would reduce delays and result in improved 
outcomes.
Methods We conducted a retrospective analysis of all TH interventions 
from 2007 to 2008. Following this we implemented a hospital-wide 
approach to TH and re-evaluated in 2008 to 2009. The hospital-wide 
approach included an educational programme, TH guidelines in the 
resuscitation room in the ED, and a cooling pack stored in the ICU which 
could be taken immediately to the post-CA patient.
Results CA-ROSC and CA-Hosp delays were similar between groups. The 
hospital-wide approach signifi  cantly reduced the time to initiate TH and 
time to achieve target temperature (see Table 1). The small sample size 
may have prohibited demonstration of outcome diff  erences.
Figure 1 (abstract P321). Implementation of therapeutic hypothermia in 
UK ICUs by year.
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  2007 to 2008  2008 to 2009  P value
n 16  26
CA-ROSC  28.5 minutes  24.1 minutes
CA-Hosp  59.1 minutes  50.1 minutes
CA-THst  306.2 minutes  133.2 minutes  <0.0001
CA-THta  527.3 minutes  252.7 minutes  0.005
HospSurv 7  13  0.69
Conclusions  A hospital-wide approach to TH following cardiac arrest 
signifi  cantly reduces delays to achieve the target temperature, although 
this did not improve outcomes at our institution. Initiation of prehospital 
TH may be an ideal solution to further reduce this delay, and ongoing trials 
may demonstrate improved outcomes.
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Introduction Induced hypothermia (IH) for 12 to 24 hours is a standard 
part of post-resuscitation care. We present a cohort of patients with out-
of-hospital or in-hospital cardiac arrest (OHCA, IHCA) from our ICU who 
underwent 12 to 14 hours of IH. Moreover we aimed at neurological 
outcome in a subgroup of patients with initial ventricular fi  brillation (VF) 
and ST-elevation acute myocardial infarction (STEMI) undergoing coronary 
intervention (PCI).
Methods  We retrospectively evaluated patients with nontraumatic 
cardiac arrest admitted to our ICU from 2006 to 2009. A standardised 
therapeutic protocol including IH was implemented. IH (32 to 34°C) was 
started within 30 minutes after restoration of spontaneous circulation 
(ROSC), before PCI, if performed. IH was maintained for 12 to 14 hours, 
than passive rewarming followed. Endovascular cooling device was not 
used. Cerebral performance category (CPC) at hospital discharge was 
evaluated as a main outcome.
Results Total number of patients was 88 (OHCA n = 63; IHCA n = 25), mean 
age 57 years, 65% men. ICU mortality was 32% and hospital mortality 
53%. Initial ECG rhythm was VF in 59%, asystole in 32% and pulseless 
electrical activity in 9%. Coronary angiography was performed in 59% 
and intervention in 41% of all cases. The required target temperature was 
achieved in 76%. Complications were ventilator-associated pneumonia 
in 6%, tracheobronchitis in 15% and gastrointestinal bleeding in 2%, 
no severe bradyarhythmias or iontogram dysbalance was recorded. 
In a group of 23 patients with VF/STEMI, PCI after initiation of IH was 
performed. The required target temperature was achieved in 91%. The 
ICU survival rate was 87% and survival to discharge from hospital was 
78%. Good neurological outcome (CPC 1 or 2) in this group at hospital 
discharge was in 83% (n = 15).
Conclusions Induced hypothermia has to be started as soon as possible 
after ROSC. Cooling of patients after cardiac arrest should continue during 
all therapeutic interventions. Twelve hours of induced hypothermia after 
cardiac arrest could off  er comparable neurological outcomes to 24 hours, 
especially in the subgroup of patients with VF/STEMI.
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Introduction This study aims to provide survival data for adult patients 
following attempted cardiopulmonary resuscitation (CPR) in critical care 
units. We hope objective data can facilitate dialogue and decision-making.
Methods We retrospectively reviewed CPR records from 1 January 1 2000 
to 30 April 2005 from all critical care units of the tertiary care hospitals 
of Edmonton, Canada. Full inpatient medical records were reviewed for 
further details.
Results  Of 529 arrests, 59.4% had return of spontaneous circulation, 
29.5% survived to critical care unit discharge, 26.3% survived to hospital 
discharge, 20.5% survived to 3 months, and 19.9% to 6 months. Pulseless 
electrical activity (PEA) represented 29.7%, ventricular tachycardia (VT) 
20.8%, asystole (ASY) 15.7%, bradycardia 15.5%, ventricular fi   brillation 
(VF) 13.4%, supraventricular tachycardia 2.8%, and respiratory arrest 2.1%. 
A total 36.7% of arrests occurred between 08:01 and 16:00 hours, 33.0% 
occurred between 00:01 and 08:00 hours and 30.3% between 16:01 and 
24:00 hours. There was no signifi  cant association between arrest time and 
survival. There was a signifi  cant association between longer CPR duration 
and increased mortality (P <0.001). GSICU cardiac arrest patients had 
statistically higher critical care unit mortality than CCU or CVICU patients 
(75.5% vs 70.0% vs 45.7%; P = 0.002). ASY/PEA were signifi  cantly more 
common in GSICUs, whereas VF and VT were more common in CVICU (P = 
0.001). Mortality was signifi  cantly higher following PEA/ASY regardless of 
location. Multivariate analysis showed no signifi  cant association between 
survival and age, gender or arrest time. In contrast, survival was signifi  cantly 
lower with increased APACHE II score (O.R 1.07, P <0.001), prolonged CPR 
(O.R.1.03, P <0.01), and ASY/PEA (O.R. 5.44, P <0.001). No patient with an 
APACHE II ≥30 survived to hospital discharge following PEA.ASY, and no 
patient, regardless of arrest type, survived to hospital discharge with an 
APACHE II >45.
Conclusions Initial survival following in-hospital cardiac arrest is higher 
than from noncritical care units, and therefore should be considered 
diff  erently. Survival was higher still from cardiac ICUs compared with other 
critical care units. Admission APACHE II, type of arrest, and resuscitation 
duration provide useful prognosticators, especially in combination. In 
contrast, age, gender, and arrest time do not. Despite encouraging early 
survival, less than one-quarter survived to hospital discharge, and less 
than one-in-six were alive at 1 year.
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Introduction The 2005 International Liaison Committee on Resuscitation 
gave a detailed update on best practice for CPR with a discussion around 
appropriate patient and rescuer position, based largely on expert opinion 
[1]. The objectives of this study were: to demonstrate a diff  erence in chest 
compression eff  ectiveness with bed height, and provide a suggestion for 
an optimal and achievable bed height for eff  ective chest compressions; 
and to demonstrate fatigue during chest compressions, and provide a 
suggestion for an upper time limit for eff  ective chest compressions.
Methods Exclusion criterion for this trial; no previous basic life support 
training in the past 4 years, or refused consent to participate. A modifi  ed 
Laerdal manikin was connected to a Dragor ventilator (to measure 
intrathoracic pressures generated). The manikin was placed on a hospital 
trolley, and CPR was performed by candidates at three diff  erent bed 
heights: mid thigh; anterior superior iliac spine; and xiphisternal area. 
Chest compressions were continuous and asynchronous with ventilation, 
and allowed to continue for 30 seconds before recordings were taken.
Results  One hundred and one subjects took part. The diff  erences in 
intrathoracic pressures generated at diff  erent bed heights were compared 
using ANOVA variance testing for multiple groups, and were statistically 
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CPR decreased 17% over a 2-minute period (Figure 2).
Conclusions The most eff  ective bed height position, allowing rescuers 
to achieve the highest intrathoracic pressures during CPR, was with the 
patient chest in line with the rescuer’s mid-thigh. The rescuer performing 
CPR should change every 2 minutes.
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Introduction Therapeutic hypothermia is defi  ned as controlled cooling of 
body temperature for therapeutic purposes. At present, the use of mild–
moderate hypothermia (32 to 34°C) in patients with neurological damage 
is increasing in the ICU. In this regard, recent studies suggest that it is able 
to improve the neurological outcome in patients with anoxic cerebral 
damage following sudden cardiac death (SCA) [1]. The aim of this study 
is to assess the role of therapeutic hypothermia on neurological outcome 
in patients who experienced SCA with ensuing return of spontaneous 
circulation (ROSC).
Methods Ninety adult patients, aged between 18 and 85, referred to our 
ICU after SCA due to cardiac disease with following ROSC were randomly 
allocated to the following treatment groups: patients in group 1 were 
treated immediately after admission with therapeutic hypothermia plus 
standard treatment, patients in group 2 received only standard treatment. 
All patients at entry presented with GCS 3. Neurological outcome was 
assessed on discharge and after 6 months, by means of GOS scale (0 = 
dead, 1 = vegetative, 2 = severely disabled, 3 = moderately disabled, 4 = 
good recovery). We consider scores 0 to 1 as unfavourable outcome, 
scores from 2 to 4 as favourable outcome. To compare the two groups we 
used the Mann–Whitney U test of for continuous variables, the chi-square 
test for qualitative variables.
Results Patients in group 1 (45 patients) and in group 2 (45 patients) 
resulted statistically comparable for sex (P = 0.14) and age (P = 0.68) and 
presentation ECG rhythm (P = 0.42) and APACHE II score (P = 0.34). At 
discharge from the ICU, 66.6% of patients in group 1 presented favourable 
neurological outcome (GOS 2 to 4) versus 35% of patients in group 2. At 
6 months, 70% of patients in group 1 presented favourable neurological 
outcome (GOS 2 to 4) versus 38.3% of patients in group 2. The mortality 
was 16.6% in group 1 versus 36.6% in group 2 (P = 0.003). The patients 
who improved their GOS values were 64% in group 1 and 18% in group 
2 (P <0.005).
Conclusions Our study demonstrated that early treatment with therapeutic 
hypothermia in the patient who had SCA improves neurological outcome. It 
is independent of the rhythm of presentation. Besides, we reached statistical 
signifi  cance.
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Introduction We conducted a retrospective study looking at infection 
rates in patients treated with therapeutic hypothermia (TH) following 
cardiac arrest who were admitted to the ICU of the Bristol Royal infi  rmary 
since May 2007. TH is recommended in all patients presenting with 
persistent coma following cardiac arrest. One complication of TH is the risk 
of infection. Hypothermia suppresses the immune system by inhibiting the 
release of proinfl  ammatory cytokines and by suppressing the chemotactic 
migration of leukocytes and phagocytosis [1]. In patients with traumatic 
brain injury, TH for more than 48 hours is associated with a higher risk of 
infection, but not if the period of hypothermia is less than 24 hours [2]. In 
patients following cardiac arrest, infection is common, reported in up to 
73% of patients [3].
Methods  Data were collected retrospectively, and information about 
ICU length of stay, whether they had a protected catheter (PC) specimen 
taken, whether they had any positive cultures and whether they were 
treated with antibiotics was extracted. Data for ICU length of stay was 
also obtained. Infections were defi  ned as >105 colony-forming units (cfu) 
grown from either PC specimens or from peripheral blood cultures.
Results We identifi  ed 82 patients treated with TH post cardiac arrest. 
Nineteen (29%) had proven infection either on PC or on peripheral blood 
cultures. PC specimens were taken in 21 (25%) patients. Of the 21 patients 
who had PC specimens taken, 16 (76%) had proven infection. We also 
found that an increase in ICU length of stay was associated with increased 
infection rates, 44% in patients with a length of stay of greater than 3 days 
and 55% in patients with a length of stay of greater than 4 days.
Conclusions  We have shown, in our ICU, that of patients who were 
treated with TH following cardiac arrest, 29% had a proven infection. 
On PC sampling, there was a much higher rate of infection with 76% of 
patients with positive cultures. This suggests that the risk of infection in 
patients treated with therapeutic hypothermia post cardiac arrest is higher 
than that for patients who are cooled post traumatic brain injury.
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Introduction In this presentation we will review the process used for 
developing a therapeutic hypothermia program and our outcomes 
during the fi  rst year. Despite the fact that therapeutic hypothermia has 
been shown to improve survival and neurologic outcome after cardiac 
arrest [1], it is underused [2] and has been only slowly introduced in many 
institutions. One of the reasons that it is not more widely used may be the 
diffi   culty of implementation of a program.
Methods A multidisciplinary team was assembled in 2007 to explore 
the opportunity for therapeutic hypothermia in patients after cardiac 
arrest. Pertinent literature was reviewed and a guideline and electronic 
orders were drafted. The team investigated all available options for 
cooling and chose a method that was non-invasive and did not require 
a large fi  nancial investment by the institution. Nurses were sent to an 
international program to learn about hypothermia and become advocates 
Figure 1 (abstract P325). Eff  ects of bed height position on intrathoracic 
pressure generated after 30 seconds of CPR. n = 101. *Statistically 
signifi  cant (P <0.05).
Figure 2 (abstract P325). Mean intrathoracic pressures generated during 
CPR at 30 seconds as compared with 2 minutes. *Statistically signifi  cant 
(P <0.05).
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setting, emergency department, cardiac catheterization laboratory, and 
adult ICUs. Advertising to community and other hospitals was done by 
newspaper, radio, and television. The team continued to meet regularly to 
assess and modify the program based on experience.
Results Prior to the start of this program, therapeutic hypothermia was 
essentially not utilized at the institution. Twenty-one patients were cooled 
after cardiac arrest and resuscitation at our institution in the fi  rst year 
(2008), with few missed opportunities. Fifteen (71%) survived, and 12 
(57%) had good neurologic outcome. (Post-cardiac arrest survival rates 
without hypothermia in the literature range from less than 5% to 35% [1].) 
Challenges included altering historic practice patterns, integrating sectors 
of the healthcare delivery system that had historically drifted apart, and 
interacting with extra-institutional regulations governing prehospital care.
Conclusions  The therapeutic hypothermia program at our institution 
is successful in improving patient outcome after cardiac arrest. The 
elements that contributed to a successful program included: teamwork; 
multidisciplinary nature of the team; promoting awareness of the 
program; buy-in by nurses who championed the program in the ICU; 
positive patient outcomes; and low fi  nancial investment for the institution.
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Introduction  Measurement of body temperature using the tympanic 
method (TTM) represents a standard non-invasive method which best 
approximates core temperature (CTM). However, published evidence 
increasingly casts doubt on the agreement between TTM and CTM. The 
aim of this study was to assess the agreement of these two methods of 
temperature measurement in critically ill patients.
Methods We recruited 20 consecutive critically ill patients, who required 
indwelling thermistor-tipped arterial catheters for haemodynamic monitor-
ing. For each patient we simultaneously collected the core temperature, 
obtained from the arterial catheter, and tympanic temperatures in the left 
and right ears, in the supine position. Tympanic temperature was recorded 
using the ear setting (TTMe) and the core setting tympanic temperature 
(TTMc) in accordance with the manufacturer’s instructions (Genius™ 2; 
Kendall, Tyco Healthcare, MA, USA). Local ethics committee approval was 
waived and the study was conducted as a service improvement audit. 
Bland–Altman analysis was used to measure agreement between the two 
set of measurements.
Results  From the 20 patients we made 102 paired measurements. 
Comparison of the TTM in the right and left ears resulted in high variability 
in the recorded temperature with a percentage error of 34.4%. In view of 
this observed large variability, the mean TTM between the two ears was 
used for subsequent comparison with core temperature. Comparison of 
core measurements against tympanic measurements using ear settings 
(TTMe) showed a small positive mean bias (limits of agreement (LOA); 
percentage error) of 0.3°C (–0.4 to 1.1°C, 2.4%). However, when the CTM 
and TTM were compared using the core temperature setting of the 
thermometer, the bias (LOA) increased to –0.97°C (–1.6 to –0.4°C), creating 
a larger bias than the unadjusted TTM.
Conclusions  Tympanic temperature measurements showed a large 
random variability compared with core temperatures and suggest bilateral 
averaged tympanic measurements may be necessary. In our series, using 
the core setting increased error and increased the bias between the two 
methods. Our fi  ndings raise the possibility that the diagnosis of fever 
and the need for further investigation may be aff  ected by the choice of 
temperature measurement site and device setting used.
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Introduction  Noncontrast computed tomography (CT) is often used to 
evaluate a primary catastrophic brain injury after cardiac arrest. On day 3 after 
resuscitation, cerebral damage presents as swelling on CT; however, there is no 
strong evidence associated with how prognosis is predicted on CT performed 
just after resuscitation. We assessed whether the ratio (in Hounsfi  eld units 
(HU)) of grey matter (GM) to white matter (WM) on CT performed just after 
resuscitation can be used as a predictor of patient outcome.
Methods We utilized the electronic medical record to examine admission 
to the ICU after resuscitation from out-of-hospital cardiac arrest. Brain CTs 
performed just after resuscitation were re-evaluated. Patients were excluded 
if they had head trauma, cerebral vessel disease and were 16 years of age or 
younger. Clinical outcome was assessed at the time of discharge using the 
Pittsburgh cerebral performance category (CPC). On noncontrast CTs, HU 
were measured as GM in the regions of bilateral caudate head, putamen, 
globus pallidaus and cortical layer of the precentral sulcus, and as WM in the 
regions of the periventricular WM. We defi  ned good neurological prognosis 
as CPC 1 to 2 and an unfavorable prognosis as CPC 3 to 5. Each ratio of 
average GM to WM was calculated, and they were compared with a good 
outcome and an unfavorable outcome.
Results  In 1,057 episodes of out-of-hospital cardiac arrest, 296 were 
resuscitated and admitted to our ICU; 64 were excluded, and the fi  nal study 
sample consisted of 232 patients. CPC 1 to 5 at hospital discharge was 
16%, 6%, 6%, 12% and 60%. The mean time from arrival to perform brain 
CT was 66 (25 to 330) minutes. The HU of caudate head, putamen and 
globus pallidaus were much higher in good outcome than in unfavorable 
outcome (P <0.001, t test). The HU of cortical layer of the precentral sulcus 
and periventricular WM were not signifi   cantly diff  erent.  The  caudate 
head/WM ratio and globus pallidaus/WM ratio were much higher in 
good outcome (P <0.01, t test). Using ROC analysis, we determined that 
a caudate head/WM ratio >1.21 or a globus pallidaus/WM ratio >1.17 was 
90% predictive of a good outcome in this study.
Conclusions  The caudate head/WM ratio and globus pallidaus/WM 
ratio by brain CT just after resuscitation are useful to predict the post-
resuscitation neurological prognosis.
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Introduction  Technological improvements in ventilator design may 
confound the diagnosis of brain death. We describe a series of patients 
clinically perceived to be breathing spontaneously even though they 
satisfi  ed the criteria for brain death. The misdiagnosis of cerebral function 
in these patients delayed the diagnosis of brain death and subsequent 
organ donation. Resource utilization, patient/family suff  ering, and staff   
morale are all negatively impacted when this occurs.
Methods The ventilator triggering mode was recorded in all patients. 
Patients were identifi  ed by the authors with a high likelihood of brain 
death and receiving pressure support ventilation. Patients without cranial 
nerve function underwent formal apnea testing.
Results Seven patients were identifi  ed with cessation of cranial nerve 
function, but thought to have spontaneous breathing activity. All patients 
were on pressure support ventilation with fl  ow triggering. Formal apnea 
testing was performed (Table 1).
Conclusions Improvement in triggering ventilation may confound the 
diagnosis of brain death. Considering the unmet need for transplantation 
and the negative impact of not recognizing death on families, staff  , 
resource utilization and both patients and potential recipients of organs 
mandates a simple solution to eliminate these problems. We propose that 
Critical Care 2010, Volume 14 Suppl 1 
http://ccforum.com/supplements/14/S1
S111in all patients being evaluated for brain death once cranial function has 
ceased an apnea test should be carried out promptly with the patient 
disconnected from the ventilator.
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Introduction Brain death (BD) is defi  ned as the total and irreversible loss 
of brain function, including the brain stem. According to current Greek 
guidelines, low BD diagnosis is determined only by clinical criteria, thus 
electroencephalogram (EEG), cerebral angiography or transcranial Doppler 
are not considered mandatory for BD confi  rmation. The Bispectral Index 
Scale (BIS) is a multifactorial parameter derived from the EEG, which allows 
monitoring of the hypnotic component of anaesthesia. Furthermore, 
it has been reported that there is a good correlation between BIS and 
neurological status in unsedated coma patients. In addition, it has been 
recently suggested that BIS is associated with the Glasgow Coma Score 
(GCS) and could serve as a good predictor tool for the outcome after 
head trauma. Moreover it has been reported that BIS can be used in the 
early detection of BD. The aim of the present study was to record the BIS 
alterations in BD patients.
Methods  Thirty brain injury patients (24 males and six females, with 
a mean age of 48.4 ± 12.3 years) who were considered as being BD 
according to the standard clinical criteria were included in the study. 
Eleven of them became organ donors. Continuous BIS monitoring (BIS; 
Aspect Medical Systems Inc., Natick, MA, USA) was performed for 24 to 
32 hours (mean 26.7 hours).
Results  All patients were haemodynamically stable, normothermic 
and without any electrolytical disturbance. Ten patients showed BIS 0 
continuously. In the remaining 20 patients (66.6%) BIS fl  uctuations over 
30 continuing for more than 30 minutes were recorded. These values then 
dropped to the BIS 0 level after diff  erent time periods. These alterations 
were compatible with EEG activity and not associated with external 
stimulus such as surgical or other manipulations.
Conclusions  BIS monitoring is a continuous, simple method, easily 
interpreted. Although it has been suggested to be a good predictor tool 
of early detection of BD, there is a possibility of increased BIS values in BD 
patients. The anaesthesiologist should be aware of these situations and in 
no case should the BIS fi  ndings decrease the validity of standard clinical 
criteria of BD determination.
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Introduction Studies of patients presenting with coma are limited and 
little is known about the prognosis of these cases [1-3]. The aim of this 
study was to investigate the acute and long-term prognosis after an 
episode of nontraumatic coma.
Methods Adults admitted consecutively to an emergency department 
in Stockholm, Sweden between February 2003 and May 2005 with 
a Glasgow Coma Scale (GCS) score of 10 or below were enrolled 
prospectively. All available data were used to explore the cause of the 
impaired consciousness on admission. Patients surviving hospitalization 
were followed up for 2 years regarding survival.
Results The fi  nal study population of 865 patients had the following eight 
diff  erent coma etiologies: poisoning (n = 329), stroke (n = 213), epilepsy 
(n = 113), circulatory failure (n = 60), infection (n = 56), metabolic disorder 
(n = 44), respiratory insuffi   ciency (n = 33), and intracranial malignancy (n = 
17). The hospital mortality rate among the 865 patients was 26.5%, varying 
from 0.9% for epilepsy to 71.7% for circulatory failure. The accumulated 
total 2-year mortality rate was 43.0%, varying from 13.7% for poisoning 
to 88.2% for malignancy. The level of consciousness on admission also 
infl  uenced the prognosis: a GCS score of 3 to 6.
Conclusions  The prognosis in patients presenting with nontraumatic 
coma is serious and depends largely both on the level of consciousness on 
admission and on the etiology of the coma. Adding the suspected coma 
etiology to the routine coma grading of these emergencies may more 
accurately predict their prognosis.
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Introduction Recently, near-infrared time-resolved spectroscopy (TRS), 
which is quite eff  ective in quantitative monitoring tissue oxygenation, 
because it off  ers the actual measurement of photon migration in the 
tissues, and the photon mean path length is easily obtained from the 
center of gravity of the temporal profi  le, has been developed. In this study, 
we investigated whether the changes in the cerebral oxygen saturation 
(T-SO2) obtained with the TRS and the jugular venous oxygen saturation 
(SjvO2) predicted cognitive decline after cardiac surgery.
Methods  With institutional approval and informed consent, we 
studied 10 patients (68.7 ± 6.1 years) undergoing cardiac surgery under 
cardiopulmonary bypass (CPB). T-SO2 was continuously monitored using a 
TRS-10 (Hamamatsu Photonics KK, Hamamatsu, Japan). For measurement 
of SjvO2, a 5.5 Fr oximetry catheter was inserted by retrograde cannulation 
of the right internal jugular vein. The values of T-SO2 and SjvO2 were 
compared with each point: before CPB, 5 minutes after the onset of CPB, 
before aorta clamp, after aorta clamp, rewarming, aorta declamp, end 
of rewarming, and end of CPB. The cognitive decline was evaluated by 
Mini Mental State Examination before and 7 days after the operation. The 
statistical analysis was performed by repeated-measures ANOVA followed 
by Fisher’s PLSD. P <0.05 was considered statistically signifi  cant.
Results Four of 10 cases showed postoperative cognitive decline. The 
mean values of T-SO2 and SjvO2 during operation in patients without 
postoperative cognitive decline (n = 6) were 63.9 ± 4.6% and 60.5 ± 9.7%, 
respectively, and there were no statistical signifi  cances between these 
values. However, the mean values of T-SO2 and SjvO2 during operation 
in patients with postoperative cognitive decline (n = 4) were 62.8 ± 5.6% 
(T-SO2) and 70.4 ± 14.9% (SjvO2), and showed signifi   cant diff  erences 
between two values (P = 0.0024), and at the rewarming period, the values 
of SjvO2 was signifi  cantly higher than those of T-SO2 (87.9 ± 6.3% vs 65.0 ± 
5.3%, P = 0.0014).
Table 1 (abstract P331)
Patient Injury  Apnea  Outcome
42 years old, male  Gunshot  Yes  Donor
27 years old, male  TBI  Yes  DCD
73 years old, male  TBI  Yes  Donor
52 years old, female  ICH  Yes  No
66 years old, male  Anoxia  Yes  No
56 years old, female  Anoxia  Yes  Donor
43 years old, male  Gunshot  Yes  Donor
DCD, donor after cardiac death; TBI, trauma brain injury; ICH, intracranial 
hemorrhage.
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SjvO2 and T-SO2 for monitoring cerebral oxygenation at the occurrence 
of postoperative cognitive decline. Therefore, we conclude that the two 
methods are not interchangeable, and the TRS instrument may be useful 
for obtaining accurate values for cerebral oxygen saturation under CPB.
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Introduction The pathophysiology of sepsis-associated encephalopathy 
(SAE) is not entirely clear. One of the possible underlying mechanisms 
is the alteration of the cerebral microvascular function induced by the 
systemic infl  ammation. The aim of the present work was to test whether 
cerebral vasomotor reactivity is impaired in patients with SAE.
Methods  Patients fulfi   lling the criteria of clinical sepsis and showing 
disturbance of consciousness of any severity were included. Nonseptic 
persons without previous diseases aff  ecting cerebral vasoreactivity served 
as controls. Transcranial Doppler blood fl  ow velocities were measured at 
rest and at 5, 10, 15 and 20 minutes after intravenous administration of 
15 mg/kg BW acetazolamide. The time course of the acetazolamide eff  ect 
on cerebral blood fl  ow velocity (cerebrovascular reactivity, CVR) and the 
maximal vasodilatory eff  ect of acetazolemide (cerebrovascular reserve 
capacity, CRC) were compared among the groups.
Results  Fourteen patients with SAE and 20 controls were included. 
Absolute blood fl  ow velocities after administration of the vasodilator drug 
were higher among control subjects than in SAE. Assessment of the time 
course of the vasomotor reaction showed that patients with SAE reacted 
slower to the vasodilatory stimulus than control persons. When assessing 
the maximal vasodilatory ability of the cerebral arterioles to acetazolamide 
during vasomotor testing, we found that patients with SAE reacted to a 
lesser extent to the drug than did control subjects (CRC SAE: 46.2 ± 15.9%, 
CRC controls: 29.4 ± 15.8%, P <0.01).
Conclusions We conclude that cerebrovascular reactivity is impaired in 
patients with SAE.
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Introduction Cerebral aneurysms aff  ect between 1 and 5% of the adult 
population and are responsible for signifi   cant rates of morbidity and 
mortality. The treatment of intracranial aneurysms evolved substantially 
since the introduction of endovascular neurosurgery by Guglielmi 
detachable coils (GDC) in the 1990s. The ablation overtook a clipping as 
the initial method in many centers, including Brazil, because of the safety 
and feasibility of this method.
Methods This cohort retrospective study analyses clinical and epidemio-
logical variables. It was conducted from the database of patients submitted 
to ablation in the neurosurgery department of São José do Avaí Hospital in 
the period of December 2006 to November 2009.
Results We studied 1,504 patients submitted to ablation. There 1,120 were 
females (74.46%) and 384 males. The average age was 52 years. Hunt–Hess 
scale prevalence: 1 – 67.88%, 2 – 18.62%, 3 – 8.19, 4 – 4.92%, 5 – 2.32%, 
and Fisher: 1 – 62.58%, 2 – 7.91%, 3 – 17.08%, 4 – 7.58%. The main risk 
factors involved in the cerebral vascular accident were: systemic arterial 
hypertension 40.4% (n = 608) and smoking 30.8% (n = 463). The arteries 
more involved were: posterior communicant = 381 (25.33%), median 
cerebral = 296 (19.61%) and anterior communicant = 254 (16.87%). A 
total 72.67% of patients presented only one aneurysm (n = 1,093) and 
27.33% two or more aneurysms (n = 411). We observed an occurrence 
of 1,217 (80.91%) ruptured aneurysms and 287 incidental. The sizes of the 
aneurysms were: 46.30% standard aneurysms (between 5 and 25 mm), 
47.95% smaller than 5 mm and 5.75% giant. The aneurysms were narrow 
neck in 37.78% of the cases (n = 1,082), and large in 14.34% (n = 412). 
Among the 218 events that occurred, there were coils into the vascular 
lumen in 96 cases (6.38%), bleeding in 58 (3.85%) and others. The materials 
used were: 334 balloons and 136 stents. Angiographic vasospasm 
occurred in 178 patients.
Conclusions There was a predominance of females for the occurrence of 
cerebral vascular aneurysmatic accident. The average age was 52 years. 
Systemic hypertension and smoking showed strong association with the 
rupture of intracranial aneurysms. The arteries of the previous segment 
were those that had higher incidence of aneurysms. More than one-
half of the patients did not have complications during the procedure. 
Embolization of cerebral aneurysms was revealed to be a low lethality 
method.
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Introduction Subarachnoid hemorrhage (SAH) is a catastrophic clinical 
event in which 2/3 of spontaneous SAH are characterized by rupture and 
bleeding of cerebral aneurysm.
Methods  After institutional approval and informed consent, this 
prospective observational study took place from April 2008 to November 
Figure 1 (abstract P337).
Critical Care 2010, Volume 14 Suppl 1 
http://ccforum.com/supplements/14/S1
S1132009, involved all adult patients with spontaneous SAH admitted to the 
ICU, evaluating the frequency/prevalence of some factors such as: gender, 
age, skin color, arterial hypertension (AH), smoking habit, diabetes mellitus 
(DM), alcoholism, dyslipidemia, sedentary and use of oral contraceptive 
method.
Results We observed a total of 128 patients, average age of 55.3 years, 
and obtained as the main results of frequency with respective confi  dence 
intervals (CI): gender, female 73.4% (n = 94) (CI 64.9 to 80.9), male 26.6% 
(n = 34) (CI 19.1 to 35.1); skin color, white 46.2% (n = 54) (CI 36.9 to 55.6), 
black 24.8% (n = 29) (CI 17.3 to 33.6), brown 29.1% (n = 34) (CI 21.0 to 38.2); 
AH, yes 72.7% (n = 93) (CI 64.1 to 80.5), no 27.3% (n = 35) (CI 19.8 to 35.9); 
smoking habit, yes 44.5% (n = 57) (CI 35.7 to 53.6), no 55.5% (n = 71) (CI 
46.4 to 64.3); diabetes mellitus, yes 14.8% (n = 19) (CI 9.2 to 22.2), no 85.2% 
(n = 109) (CI 77.8 to 90.8); alcoholism, yes 12.6% (n = 16) (CI 7.4 to 19.7), 
no 87.4% (n = 112) (CI 87.4 to 92.6); dyslipidemia, yes 10.9% (n = 14) (CI 6.1 
to 17.7), no 89.1% (n = 114) (CI 82.3 to 93.9); sedentary, yes 25.8% (n = 33) 
(CI 18.5 to 34.3), no 74.2% (n = 95) (CI 65.6 to 81.5); obesity, yes 11.7% (n = 
15) (CI 6.7 to 18.6), no 88.3% (n = 113) (CI 81.4 to 93.3); oral contraceptive 
method (analysis obtained only for female gender population), yes 5.3% 
(n = 5) (CI 1.7 to 12.0), no 94.7% (n = 89) (CI 88.0 to 98.3). See Figure 1.
Conclusions We can show that among all RF, female gender, AH and 
smoking habit had greatest prevalence index; the factor skin color 
had a wide distribution from its variants; other RF as DM, alcoholism, 
dyslipidemia, sedentary, and use of oral contraceptives had not obtained 
signifi  cant prevalence on patients with aneurysmal SAH.
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Introduction The objective of this work was to assess the usefulness of 
monitoring regional brain oxygen saturation (rSO2) in the identifi  cation of 
intraoperative episodes of cerebral ischemia during the surgical clipping 
of brain aneurysms. Moreover it aimed to verify whether this kind of 
monitoring aff  ects the incidence of postoperative neurological defi  cits.
Methods  We monitored 50 patients undergoing cerebral aneurysm 
clipping with the use of Somanetics INVOS Cerebral Oximeter 4100. The 
alarm threshold of rSO2 was defi  ned as a minimum of 20% drop from 
baseline, triggering intervention aimed at increasing rSO2 values.
Results  Eleven cases of postoperative deterioration of neurological 
status were noted, of which six were reversible. Additional intraoperative 
events, such as numerous surgical clip displacements, temporary clipping, 
aneurysm ruptures, and trapping occurred in 16 cases. On the operated 
side, a rapid, lasting increase of rSO2 values was noted in nearly one-half 
of the cases; implying an artifact caused by the neurosurgical procedure. 
On the nonoperated side, seven cases of rSO2 values dipping below the 
alarm threshold were noted. In all cases intervention led to an increase 
and normalization of rSO2 values in a relatively short time. Since the values 
registered in the frontal lobe on the nonoperated side were considered 
representative of the entire brain, the balance of cerebral oxygen supply 
and consumption was seen as intraoperatively preserved. The comparison 
between two groups of patients, with and without neurological defi  cits 
developed in the postoperative period, revealed no disparities in cerebral 
oximetry values on the nonoperated side, nor in the range of other 
monitored physiological parameters. In 10 out of 16 cases involving 
additional intraoperative events, deterioration of neurological status was 
noted (62.5%), while in the remaining cases only one such occurrence was 
registered (2.95%).
Conclusions  Monitoring regional brain oxygen saturation on the 
operated side is a method hampered by a large percentage of false results, 
and thus is a monitoring tool of little prognostic value. Assuming that the 
frontal lobe on the nonoperated side is representative of the entire brain 
with regard to rSO2 measures, the maintenance of oxygen supply and 
demand balance does not safeguard the brain against ischemic lesions in 
the supply area of the operated artery.
P339
Early prognosis value of the fi  rst 24 hours mean plasma S100β 
protein level after subarachnoid aneurysmal hemorrhage
D Frasca, A Proust, C Millet, B Debaene, O Mimoz, C Dahyot-Fizelier
University Hospital, Poitiers, France
Critical Care 2010, 14(Suppl 1):P339 (doi: 10.1186/cc8571)
Introduction  Plasma S100β protein (PS100β) was described as a 
biological marker of white substance damage and brain ischemia. Studies 
of new neuroprotective approaches in patients with traumatic brain 
injury and subarachnoid aneurysmal hemorrhage would benefi  t from 
the development of such markers. The aim of this study was to evaluate 
the fi  rst 24 hours mean plasma PS100β for predicting outcome at ICU 
discharge after subarachnoid aneurysmal hemorrhage (SAH).
Methods From August 2006 to August 2008, 100 patients (46 men and 
54 women; mean age 52 ± 11 years) were admitted for SAH and treated 
by surgical clipping or coiling within 2 days after admission. SAPS II, 
World Federation of Neurological Surgeons (WFNS), Fisher and Glasgow 
Outcome Scale (GOS) were scored at ICU discharge. Plasma S100β 
concentrations were assayed at admission (hours 0, 6 and 24) and daily up 
to day 12 (routine procedure). Statistical analysis relied on the mean fi  rst 
24 hours PS100β and the main outcome criterion was the GOS score at 
discharge dichotomized as poor (GOS 1 to 3) or good (GOS 4 to 5).
Results  Poor outcome was associated with high mean fi  rst 24 hours 
PS100β, high initial WFNS and Fisher scores in univariate analysis 
(P <0.0001). The best cut-off   for the mean fi  rst 24 hours S100β value 
was 0.15 μg/l (specifi  city 0.60, 95% confi  dence interval (CI) 0.52 to 0.67; 
sensitivity 0.85, 95% CI 0.79 to 0.89; area under the curve 0.83, 95% CI 0.69 
to 0.92; Figure 1).
Conclusions The mean PS100β value assessed during the fi  rst 24 hours 
is a prognostic tool complementary to initial clinical evaluation in SAH 
patients.
P340
Altered aortic stiff  ness associated with stress cardiomyopathy in 
patients with aneurysmal subarachnoid haemorrhage
I Papanikolaou1, M Fragou2, P Zotos2, D Karakitsos2, A Patrianakos3, 
E Zakinthinos1, A Karabinis2
1University Hospital of Larissa, Greece; 2General Hospital of Athens, Greece; 
3University Hospital of Heraklion, Crete, Heraklion, Greece
Critical Care 2010, 14(Suppl 1):P340 (doi: 10.1186/cc8572)
Introduction  We investigated whether possible alterations in aortic 
stiff  ness were associated with stress cardiomyopathy (SC) in patients with 
subarachnoid haemorrhage (SAH).
Methods Thirty-seven patients with SAH (aged 42.65 ± 13.07, 23 males) 
were included in the study. The severity of SAH was estimated by Hunt-
Hess and Fisher scales, respectively. The left ventricular ejection fraction 
(LVEF) was measured by the Simpson’s biplane method of disks; aortic 
Figure 1 (abstract P339). ROC curve of the fi  rst 24 hours mean PS100β 
value and outcome at ICU discharge.
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femoral pulse wave velocity (PWV). The above sonographic measurements 
along with BNP measurements were obtained upon admission and 
repeated measurements were performed 20 ± 2 days following the acute 
phase of SAH. All patients were mechanically ventilated under the same 
conditions during all measurements.
Results  Patients with severe SAH showed depressed LV function and 
increased aortic stiff  ness. Both Hunt–Hess and Fisher scales were associated 
with LVEF (r = –0.460, P = 0.004 and r = –0.512; P = 0.001, respectively) and 
PWV values (r = 0.359, P = 0.029 and r = 0.363; P = 0.027, respectively). 
On admission, 14 patients (38%) manifested SC with increased BNP values 
as compared with those without cardiac alterations (841.43 ± 561.04 vs 
145.04 ± 106.02 pg/ml, P <0.001). These subjects exhibited increased PWV 
as compared with patients with normal LV function (12.79 ± 2.02 vs 9.63 
± 2.89 m/second, P = 0.001). PWV correlated to BNP values (r = 0.489, P = 
0.002). Follow-up measurements revealed a signifi  cant increase in LVEF 
and decrease in PWV as compared with baseline measurements (62.64 ± 
9.18 vs 57.94 ± 12.55%, P = 0.005 and 9.37 ± 2.07 vs 10.71 ± 2.96 m/second, 
P = 0.001, respectively). In this series, brain death was documented 
clinically in seven cases. An ongoing study including a larger number of 
patients with SAH analyzes the prognostic value of echocardiographic and 
BNP measurements.
Conclusions  Alterations of the heart–vessel coupling may be due to 
catecholamine-induced mechanisms. Stress cardiomyopathy associated 
with altered aortic stiff   ness during the acute phase of SAH may be 
transient phenomena.
P341
Eff  ect of packed red blood cell transfusion on cerebral oxygenation 
and metabolism after subarachnoid hemorrhage
P Kurtz, R Helbok, J Claassen, J Schmidt, L Fernadez, R Stuart, ES Connoly, 
K Lee, SA Mayer, N Badjatia
Columbia University Medical Center, New York, USA
Critical Care 2010, 14(Suppl 1):P341 (doi: 10.1186/cc8573)
Introduction Anemia is frequently encountered in critically ill patients 
and adversely aff  ects cerebral oxygen delivery and metabolic function. 
However, there is limited evidence to support the use of packed red blood 
cell (PRBC) transfusion to optimize brain homeostasis after subarachnoid 
hemorrhage. The objective of this study was to investigate the eff  ect of 
PRBC transfusion on cerebral oxygenation and metabolism in patients 
with subarachnoid hemorrhage.
Methods  Prospective observational study in a neurological ICU of a 
university hospital. Nineteen PRBC transfusions were studied in 15 
consecutive patients with subarachnoid hemorrhage that underwent 
multimodality monitoring (intracranial pressure, brain tissue oxygen 
and cerebral microdialysis). Data were collected at baseline and during 
12 hours after transfusion. The relationship between Hb change and 
lactate/pyruvate ratio (LPR) and brain tissue oxygen (PbtO2) was tested in 
univariate and multivariable analyses.
Results PRBC transfusion was administered on median post-bleed day 
8. The average Hb concentration at baseline was 8.1 g/dl and increased 
by 2.2 g/dl after transfusion. After transfusion initiation, PbtO2 increased 
between hours 2 and 4 and this rise was maintained until hour 10. LPR 
did not change during the 12 hours of monitoring. Multivariable analysis 
demonstrated that, after adjusting for peripheral oxygen saturation, 
cerebral perfusion pressure and LPR, the change in Hb concentration was 
independently and positively associated with change in PbtO2 (adjusted 
b estimate = 1.39 (95% confi  dence interval 0.09 to 2.69); P = 0.036). No 
relationship between change in LPR and change in Hb was found.
Conclusions Transfusion of PRBC results in PbtO2 improvement without a 
clear eff  ect on cerebral metabolism after subarachnoid hemorrhage.
P342
Comparison of surgical or endovascular treated aneurismal SAH 
patients with a special emphasis on cerebral vasospasm
I Akinci, C Kamar, E Guresti, A Sencer, S Sencer, T Kiris
Istanbul Medical Faculty, Istanbul, Turkey
Critical Care 2010, 14(Suppl 1):P342 (doi: 10.1186/cc8574)
Introduction The aim of this study was to evaluate the incidence of 
delayed cerebral ischemia (DCI) and outcome in SAH patients who 
were admitted for surgical or endovascular procedures to treat cerebral 
aneurysm.
Methods One hundred consecutive patients were evaluated according 
to their demographic data, severity of illness on admission, incidence of 
DCI, outcome and choice of treatment. The t test, Mann–Whitney U, and 
chi-square tests were used for statistical evaluation.
Results Patients’ demographic data were as shown in Table 1. Clinical 
vasospasm diagnosis was made by the existence of three signs which are 
headache, neurological defi  cit, and worsening of Glasgow Coma Score 
(GCS). Due to this evaluation 28 of the patients demonstrated DCI. While 
14 of them were in the clipping group (23.3%), the other 14 were in the 
coiling group (35%). But HHH therapy and CSF drainage with lumber 
puncture was started more liberally, in 57 and 35 patients respectively, due 
to at least two of the following fi  ndings or clinician’s decision: headache, 
agitation, elevated leukocyte level (without infection), new motor defi  cit 
and worsening in GCS. The severity of cases on admission in the clipping 
and coiling groups were similar for both. Although mortality and morbidity 
rates were higher in the coiling group there was no statistical diff  erence in 
both groups (Table 2).
Table 1 (abstract P342). Demographic data
Age  51 ± 11.2
WFNS  1.3 ± 0.6
Fisher  2.0 ± 1.0
H&H  1.8 ± 0.9
Rankin  1.3 ± 1.5
GOS  4.4 ± 1.1
Hospital stay  16.1 ± 12.0
HHH therapy  58%
Clipping 60%
Coillin 38%
Clip + Coil  2%
Mortality 5%
GOS, Glasgow outcome score; H&H, Hunt and Hess.
Figure 1 (abstract P341).
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 Clipping  Coiling  P
Age  50.3 ± 11.6  52.6 ± 10.2  NS
WFNS  1.2 ± 0.6  1.3 ± 0.7  NS
Fisher  2.0 ± 1.1  2.0 ± 0.8  NS
H&H  1.8 ± 0.4  1.7 ± 1.0  NS
Rankin  1.1 ± 1.2  1.7 ± 1.8  NS
GOS  4.6 ± 0.9  4.3 ± 1.2  NS
Hospital stay  17.1 ± 12.2  15.1 ± 11.7  NS
DCI 23.3%  35%  0.25
Mortality   3.4%  7.5%  0.38
GOS, Glasgow outcome score; H&H, Hunt and Hess.
Conclusions This study demonstrated that although mortality, morbidity 
rates and DCI incidence were lower in the surgical group, there was no 
statistical signifi  cance.
P343
Prediction of cerebral vasospasm in patients with aneurysmal 
subarachnoid hemorrhage using jugular bulb oximetry monitoring: 
preliminary results
R Souissi1, A Boubakker1, H Souissi2, A Abdelrazek1, M Badri1, S Bziouech1, 
H Jemel1
1National Institute of Neurology, La Rabta, Tunisia; 2La Rabta Hospital, La 
Rabta, Tunisia
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Introduction Cerebral vasospasm (CV) is the leading cause of death and 
disability in patients with subarachnoid hemorrhage (SAH). We suppose 
that clinical vasospasm disturbances could be detected by the increase 
in cerebral oxygen extractions (AVDO2), so in this study we tried to predict 
clinical CV appearances using jugular bulb oximetry monitoring.
Methods Open prospective clinical study, from July 2009 to November 
2009, in which 23 consecutive patients who underwent surgery for 
ruptured aneurysms were included; a jugular bulb catheter was placed in all 
patients. To calculate AVDO2, arterial and jugular bulb blood samples were 
taken every 12 hours. Demographics, neurological examination, WFNS 
grade, Fisher modifi  ed classifi  cation, aneurysm characteristics, vasospasm, 
and hemodynamic changes were collected. All patients presenting clinical 
vasospasm were treated by hypertensive, hemodilution and hypervolemic 
therapy (3H therapy). Adequate statistical tests were used.
Results From 23 patients, eight had neurologic defi  cits (35%), in all these 
patients AVDO2 signifi  cantly increased approximately 12 hours before the 
onset of clinical defi  cits (P <0.01) and it was improved after administering 
3H therapy. Two patients (8%) had clinical vasospasm but did not 
demonstrate a signifi  cant rise in AVDO2 (P <0.68), all other patients (57%) 
did not present clinical vasospasm nor signifi  cant rising in AVDO2.
Conclusions Increases in AVDO2 using jugular bulb oximetry monitoring 
could predict clinical vasospasm in aneurysmal SAH hours before its onset. 
A larger number of patients would confi  rm these results.
P344
Magnesium use on prophylaxis of vasospasm morbidity and 
mortality rate in subarachnoid hemorrhage
S Kiff  er Macedo, CM Primo de Siqueira, S Boechat Primo de Siqueira, 
R Mendoza Nuss, L Carvalho Dias, A Cedro Souza, G Vieira Rangel Pereira
Hospital São José do Avaí, Itaperuna, Brazil
Critical Care 2010, 14(Suppl 1):P344 (doi: 10.1186/cc8576)
Introduction Cerebral aneurysms are an important cause of morbidity 
and mortality of which the most severe consequence is their rupture. 
Subarachnoid hemorrhage (SAH) has arterial vasospasm as one of the 
most serious complications.
Methods After institutional approval and informed consent, a prospective, 
randomized, single-blind study was carried out between February 2008 
and November 2009. The study evaluated Mg use on patients from Beds 1 
to 4 and the control group from Beds 5 to 8. The serum measure of Mg was 
made by colorimetric method in order to reach a measurement between 
2.5 and 3.5 mg/dl, using a solution of Mg 2% (SG 5%, 400 ml + MgSO4 
10%, 100 ml/24 hours), during the fi  rst 14 days of the event (aneurysm 
rupture). Admission criteria: patients diagnosed with SAH confi  rmed by 
CT or cerebral angiography and Δt <96 hours. Exclusion criteria: patients 
with SAH and ΔT >96 hours; patients who presented a vasospasm episode 
in less than 24 hours of Mg solution infusion.
Results In a previous study evaluation a total of 107 patients were analysed 
with n = 55 in Group 1 and n = 52 in Group 2 (Figures 1 and 2). The main 
results were: Group 1 – vasospasm frequency 20.0%, confi  dence interval 
(CI) = 10.4% to 33.3%; and mortality 16.4% in 28 days, CI =7.8% to 28.8; 
Group 2 – vasospasm frequency 51.9%, CI = 37.6% to 66.0%; and mortality 
23.1% in 28 days, CI = 12.5% to 36.8%. The analysis for the vasospasm 
showed odds ratio (OR)= 0.23, CI = 0.098% to 0.544% and P = 0.0011, and 
for mortality: OR = 0.65, CI = 0.24% to 1.70% and P = 0.5284.
Conclusions According to the outcome, we can conclude that Group 1 
obtained a greater protection on the vasospasm incidence in comparison 
with Group 2 but showed no diff  erence in mortality. The P value was 
signifi  cant for vasospasm but was still not signifi  cant for mortality.
References
1. Veyna  RS,  et al.: J Neurosurg 2002, 96:510-514.
2. Knobel  E,  et al.: Condutas no Paciente Grave. São Paulo: Atheneu; 
2006:871-883.
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Eff  ects of sinvastatin in prevention of vasospasm in nontraumatic 
subarachnoid hemorrhage: preliminary data
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Introduction Vasospasm is the main cause of death and cognitive defi  cits 
in patients with subarachnoid hemorrhage after rupture of the aneurysm 
(aSAH). Some trials have shown that statins in the acute phase of aSAH 
reduces the incidence, morbidity and mortality of cerebral vasospasm.
Methods We realized a prospective, randomized, nonblind study, with the 
use of 80 mg SVT (at night) in the fi  rst 72 hours of the beginning of bleeding, 
and a control group that did not use SVT, for 21 days, between January and 
December 2008. Informed consent was obtained for all patients. CT scans 
was performed as control and another CT scan in patients with altered 
neurological signals. In the presence of changes suggestive of vasospasm 
or correlation in clinical and CT scans, the patients were taken for cerebral 
arteriography examination followed by an angioplasty procedure if 
necessary. Liver and renal function, LDL cholesterol evaluated weekly, and 
CK total evaluated every 3 days. Exclusion criteria: liver and renal disease, 
pregnant elevation of serum transaminases (three times the value of 
normal), creatinine ≥2.5, rhabdomyolysis or CK total ≥1,000 U/l.
Results  We excluded two patients with bleeding for more than 72 
hours. There was no signifi  cant change in the levels of CK total, renal or 
liver function. We included 20 patients, 11 in the SVT group and nine in 
the control group. Mortality was eight patients (38%), six patients in the 
control group and two from the SVT group. Vasospasm was confi  rmed by 
Figure 1 (abstract P344).
Figure 2 (abstract P344).
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and one patient in the SVT group. All patients who died had Fisher scale IV.
Conclusions  SVT at a dose of 80 mg was eff   ective in reducing the 
mortality (18.1% against 66%) compared with the group that did not use 
SVT, and also decreased the incidence of cerebral vasospasm despite 
higher APACHE II score in the group that used SVT (14.3 vs 10.7). There 
was less morbidity in the SVT group with an average of scale of Glasgow 
3.25 vs 2.1.
Reference
1.  Lynch JR, Wang H, et al.: Simvastatin reduces vasospasm after aneurysmal 
subarachnoid hemorrhage: results of a pilot randomized clinical trial. 
Stroke 2005, 36:2024-2026.
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Introduction Sequential Organ Failure Assessment (SOFA) was originally 
created for sepsis, but their quality is now used in other medical 
conditions. Therefore, we add some criteria to the index to assess patients 
with subarachnoid hemorrhage.
Methods Informed consent for each patient/family; APACHE II (criteria for 
admission) and SOFA weekly, serum glucose, lactate, calcium, sodium and 
magnesium; and measurement of axillary temperature and diuresis hourly 
as the additional prognostic index SOFA. The study enrolled 103 patients 
diagnosed with SAH, confi  rmed by computed tomography. These patients 
were divided into two groups according to their development in the ICU: 
Group I – patients who had good evolution (out of ICU), and Group II – 
patients who progressed to death in the ICU.
Results Among 103 patients, 74 (71.84%) were female and 29 (28.16%) 
were male. The APACHE II for admission varied from 2 to 34, with an 
average of 15.5. The spent time maximum in the ICU was 49 days (two 
patients). Group I had 64 patients (62.14%) and the 39 remaining patients 
(37.86%) were classifi  ed as Group II. See Figures 1 and 2.
Conclusions We can conclude that the group with patients with SAH is 
predominantly female (74:29). The APACHE II in Group I was 10.9, while 
Group II was 17.9. Regarding the criteria used to assess patients with SAH 
was observed that the only criterion which showed statistical signifi  cance 
in the prediction of death was the serum sodium (P = 0.002). The other 
criteria evaluated did not have statistical signifi  cance in predicting the 
prognosis of patients.
Reference
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Introduction The objective of this study was to investigate the relationship 
between cardiac output response to a fl  uid challenge and changes in 
brain tissue oxygen pressure (PbtO2) in patients with severe brain injury.
Methods Prospective observational study conducted in a neurological ICU 
in a university hospital. Seventy-eight fl  uid challenges were administered 
to 17 consecutive comatose patients that underwent multimodality 
monitoring of cardiac output, intracranial pressure (ICP), and PbtO2. The 
relationship between cardiac output and PbtO2 was analyzed with logistic 
regression utilizing GEE with an exchangeable correlation structure.
Results Of the 78 fl  uid boluses analyzed, 34 (44%) resulted in a ≥10% 
increase in cardiac output. Median absolute (+5.4 vs +0.7 mmHg) and 
percentage (20% vs 3%) changes in PbtO2 were greater in cardiac output 
responders than in nonresponders within 30 minutes after the end of the 
fl  uid bolus infusion. In a multivariable model, a cardiac output response 
was independently associated with PbtO2 response (adjusted odds ratio 
15.4, 95% CI 1.9 to 122.0, P = 0.01) after adjusting for mean arterial pressure, 
Figure 1 (abstract P346).
Figure 2 (abstract P346).
Figure 1 (abstract P347).
Figure 2 (abstract P347).
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a good ability to predict cardiac output response with an area under the 
ROC curve of 0.85 with a best cutoff   value of 8%. See Figures 1 and 2.
Conclusions Bolus fl  uid resuscitation resulting in augmentation of cardiac 
output can improve cerebral oxygenation after severe brain injury.
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Introduction  ICM+ software encapsulates our 20 years’ experience 
in brain monitoring. It collects data from a variety of bedside monitors 
and produces time trends of parameters defi   ned using confi   gurable 
mathematical formulae. To date it is being used in nearly 40 clinical 
research centres worldwide. We present its application for continuous 
monitoring of cerebral autoregulation using near-infrared spectroscopy 
(NIRS).
Methods Data from multiple bedside monitors are processed by ICM+ 
in real time using a large selection of signal processing methods. These 
include various time and frequency domain analysis functions as well as 
fully customisable digital fi  lters. The fi  nal results are displayed in a variety 
of ways including simple time trends, as well as time window based 
histograms, cross histograms, correlations, and so forth. All this allows 
complex information from bedside monitors to be summarized in a 
concise fashion and presented to medical and nursing staff   in a simple way 
that alerts them to the development of various pathological processes.
Results  One hundred and fi  fty patients monitored continuously with 
NIRS, arterial blood pressure (ABP) and intracranial pressure (ICP), where 
available, were included in this study. There were 40 severely head-
injured adult patients, 27 SAH patients (NCCU, Cambridge); 60 patients 
undergoing cardiopulmonary bypass (John Hopkins Hospital, Baltimore) 
and 23 patients with sepsis (University Hospital, Basel). In addition, 
MCA fl  ow velocity (FV) was monitored intermittently using transcranial 
Doppler. FV-derived and ICP-derived pressure reactivity indices (PRx, Mx), 
as well as NIRS-derived reactivity indices (Cox, Tox, Thx) were calculated 
and showed signifi  cant correlation with each other in all cohorts. Error-
bar charts showing reactivity index PRx versus CPP (optimal CPP chart) 
as well as similar curves for NIRS indices versus CPP and ABP were also 
demonstrated.
Conclusions ICM+ software is proving to be a very useful tool for enhancing 
the battery of available means for monitoring cerebral vasoreactivity and 
potentially facilitating autoregulation guided therapy. Complexity of data 
analysis is also hidden inside loadable profi  les, thus allowing investigators 
to take full advantage of validated protocols including advanced 
processing formulas.
P349
Cerebral oxygen saturation and cerebral blood fl  ow are relatively 
stable during single-lung ventilation, if normocapnia is maintained
T Végh, S Szatmári, M Juhász, I László, I Takács, B Fülesdi
University of Debrecen, Hungary
Critical Care 2010, 14(Suppl 1):P349 (doi: 10.1186/cc8581)
Introduction Previously a report has suggested that administration of a 
lung-protective strategy for one-lung ventilation (OLV) results in oxygen 
desaturation of the brain parenchyma. The aim of the present work was 
to test whether the maintenance of normocapnia during a protective OLV 
strategy results in alteration of cerebral blood fl  ow and cerebral oxygen 
saturation.
Methods  Data were obtained from 15 patients undergoing thoracic 
surgery and necessitating OLV of more than 1 hour. Cerebral oxygen 
saturation (Satcereb) was continuously monitored by the INVOS 5100C 
Cerebral Oxymeter System along with measurement of cerebral blood 
fl  ow velocity (MCAV) by transcranial Doppler sonography. Arterial blood 
samples were taken for blood gas analysis in the awake state, in the supine 
position after induction during DLV, in the lateral decubitus position 
during DLV and every 15 minutes during OLV.
Results Satcereb increased signifi  cantly when DLV was started with FiO2 
1.0 and remained stable during the course of the study. When ventilation 
was changed from DLV to OLV, no signifi  cant change was observed. A 
signifi  cant decrease of cerebral oxygen saturation was found compared 
with the value observed during DLV in the lateral decubitus at the time 
point of 60 minutes after the start of OLV. No signifi  cant changes in the 
MCAV were observed throughout the course of the thoracic surgical 
procedure.
Conclusions  OLV does not result in clinically relevant decreases in 
cerebral blood fl  ow and cerebral oxygen saturation during application of 
lung-protective ventilation if normocapnia is maintained.
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Factors aff  ecting the transient hyperaemic response test of the 
cerebral autoregulation
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Introduction The transient compression of the internal carotid artery 
(ICA) results in dilatation of cerebral arterioles by eff  ect of autoregulation. 
In the THR test, the increase in middle cerebral artery (MCA) blood fl  ow 
immediately after release of transient compression of the ICA is measured, 
which is proportional to cerebral autoregulation. The aim of the study was 
to determine the signifi  cance of several factors of the test – blood fl  ow 
inertia (acceleration), dimensions (length and radius) of ICA, patency of the 
Circle of Willis (WC), and asynchrony between release of ICA compression 
and arterial pressure pulsations (phase shift).
Methods We constructed a mathematical model of the elements included 
in the THR test and simulated, using various parameters, blood fl  ow in 
cerebral vessels and the increase in fl  ow velocity in the MCA after release of 
ICA compression. We simulated two extreme situations – a perfectly patent 
(all aff  erent and eff  erent arteries meet in one point) and a completely 
isolated Circle of Willis (ICA bifurcates into only the anterior and middle 
cerebral arteries). The series of ordinary diff  erential equations describing 
the THR test was solved by MATLAB R2008a. The solution assumed an 
absence of autoregulation (eff  ect of studied factors is independent of 
autoregulation) and the rigidity of all vessels.
Results The eff  ects of acceleration (inertia), dimensions of ICA and patency 
of WC are negligible. The eff  ect of phase shift (Figure 1) can signifi  cantly 
decrease the immediate post-release MCA fl  ow, which can entirely nullify 
the increase in post-release MCA fl  ow caused by autoregulation.
Conclusions The eff  ect of phase shift can signifi  cantly alter the results of 
the THR test. For practical purposes we recommend calculation of THR test 
parameters from the second peak of post-release MCA fl  ow, or using the 
highest post-release MCA fl  ow from several THR tests.
Figure 1 (abstract P350). Dependence of THRR on phase shift.
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Introduction The purpose of this study was to evaluate the total drainage 
time, the risk of infection associated with external ventricular derivation 
(EVD) and the most prevalent infective agent during the use of EVD 
drainage in patients on the ICU.
Methods During 15 months (8 August 2008 to 28 October 2009), all 
patients on the neurovascular ICU who had an EVD inserted were studied 
prospectively. Each 3 days we analysed cerebral spinal fl  uid (CSF) samples 
for cell count, biochemistry and sputum. CSF cultures were evaluated 
three times a week combined with an antibiogram. Not included were 
the cultures that persisted with the same result (agent), considering only 
a new agent until negativity of the culture and clinical resolution. We 
excluded patients admitted with EVD from another hospital.
Results Were included 46 patients, in which were obtained a total number 
of 66 EVDs. Thirty-fi   ve EVDs (53,03%) had associated ICP monitoring. 
A total 65.21% of patients were female. The mortality of patients was 
36.95% (17 deaths). Among infected catheters, infection was confi  rmed 
in approximately 7.1 days after the EVD was installed. However, the 
catheters discharged with negative culture or without growth of a new 
agent remained approximately 6.15 days on the brain ventricle of patients. 
Registered were 20 positive bacteriological cultures of CSF (30.30%) 
among the total EVDs. The most prevalent organisms were Acinetobacter 
baumanii on nine cultures (45%), Pseudomonas aeruginosa on six cultures 
(30%), Serratia rubidaea on one culture (5%), Streptococcus oralis on one 
culture (5%), Klebsiella ornithinolytica on one culture (5%), Estafi  lococcus 
coagulase negative on one culture(5%), Stenotrophonas maltophylia on 
one culture (5%).
Conclusions  Some previous studies show a substitution from positive 
Gram agents to negative Gram agents on infections associated with EVD. 
The study has shown a prevalence of P. aeruginosa and A. baumanii on 
infection associated with the EVD catheter, which are also more prevalent 
in the ICU environment. This study reinforces that, in case of suspected CNS 
infection associated with catheter EVD (meningitis, ventriculitis, or abscess), 
we can start empirical antimicrobial coverage for Gram-negative infections, 
including intraventricular administration (intrathecal) as Polymixin B.
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Introduction The aim of this study is to assess fMRI resting-state cerebral 
connectivity in vegetative state and locked-in syndrome patients by means 
of a user-independent method. Resting baseline (or default mode) activity 
is thought to be related to awareness of the internal world (that is, mind 
wandering, and so forth) and encompasses posterior cingulate/precuneal, 
anterior cingulate/mesiofrontal and posterior lateral parietal cortices.
Methods  We here present a novel clinical application for a user-
independent default mode network analysis. Resting state data were 
acquired for seven vegetative state patients (age range 16 to 87 years), one 
locked-in syndrome patient (aged 24 years) and seven healthy subjects 
(25 to 65 years). Patients’ diagnosis was based on Coma Recovery Scale 
assessment prior and following scanning. Data were pre-processed and 
analyzed using independent component analysis as implemented in 
Brain Voyager. Connectivity studies employed 13 target regions of interest 
defi  ned on an average default mode map calculated from an independent 
dataset of 20 controls (21 to 60 years). Resting state connectivity was 
assessed by calculating the number of functional connections within 
the default mode map for each subject. Next, Student t tests compared 
patients with controls at the group level (P <0.05).
Results  Compared with controls, vegetative patients showed a lower 
total number of edges (that is, connections; 24 ± 4, range 19 to 31 and 
13 ± 3, range 8 to 15, P <0.001) and less functional connections with the 
precuneus (6 ± 1 and 2 ± 2; P <0.001). The default mode network shows 
a reduced connectivity in vegetative patients as compared with controls 
mainly between the precuneus and medial prefrontal cortex ventral. 
Finally, for the locked-in syndrome patient the connectivity graph counted 
21 total number of eff  ective connections and fi  ve eff  ective connections 
with the precuneus, which was not signifi  cantly diff  erent from healthy 
controls.
Conclusions The connectivity study showed no overlap between the 
number of eff  ective connections or edges in vegetative state patients 
and in controls. Connectivity graph analysis identifi  ed anterior–posterior 
midline disconnections in the vegetative state, in line with previous studies 
emphasizing the critical role of the precuneus/PCC and mesiofrontal 
cortices in the emergence of conscious awareness.
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Introduction Cerebral salt wasting syndrome (CSWS) is characterized by 
severe hyponatriemia, caused by the reduction of sodium reabsorption at 
the level of proximal tubule, with associated polyuria and hypovolemia. For 
decades, this syndrome was confused with the syndrome of inappropriate 
secretion of antidiuretic hormone (SIADH), but in CSWS the antidiuretic 
hormone is physiologically secreted. The only way to make a diff  erence 
in the diagnosis is the assessment of the extracellular volume, not easily 
measurable in critical care patients. We designed this study to assess 
the frequency, the onset and the duration of the symptoms of CSWS in 
patients hospitalized in post-neurosurgery critical care.
Methods In the 2-year period 2008 to 2009 in the post-neurosurgery ICU, 
131 patients were studied retrospectively; 63 patients had subarachnoid 
haemorrhage (SAH) caused by the rupture of a cerebral aneurysm and 68 
patients had severe head trauma (HI). CSWS diagnosis was done evaluating 
sodiemia, serum osmolality, sodiuria 24 hours and central venous pressure. 
The time from the onset of hyponatriemia during ICU stay and duration of 
symptoms was also evaluated.
Results  Patients developed CSWS in 12.7%, of whom 7.9% within 1 
week from admission and 4.8% after. Among the patients with HI, 5.8% 
developed CSWS, of whom 2.9% within the fi  rst week while the other 2.9% 
after. CSWS symptoms lasted for more than 1 week in 11.1% of patients 
with SAH, and less only in 1.6%, while in HI the symptoms lasted less than 
1 week in 2.9% and more than 1 week in 2.9% of patients.
Conclusions Diff  erential diagnosis of ICU hyponatriemia is important in 
determining patient outcome. CSWS treatment required an appropriate 
fl  uid and salt replacement to normalize hydroelectrolytic balance. CSWS 
has a diff  erent distribution in patients with subarachnoid haemorrhage 
compared with traumatic head injury. Furthermore, the syndrome starts 
earlier and lasts longer in SAH compared with HI.
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Introduction  Sodium dysbalances represent important complications 
in neurointensive care. The aim of this study was to analyse sodium 
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neurosurgical care unit (NNICU) over a period of 5 years.
Methods We prospectively evaluated patients with brain diseases, who 
developed serum sodium below 135 mmol/l (hyponatremia) or above 
150 mmol/l (hypernatremia). We compared the incidence of cerebral 
complications, Glasgow Outcome Scale upon discharge from the NNICU 
and mortality in the NNICU between these two groups.
Results  In the 5-year observation period, serum sodium dysbalances 
occurred in 378 (24%) patients. The majority of them had hyponatremia 
(245 patients, 65%); hypernatremia was less frequent, in 133 (35%) 
patients. Hypernatremic patients stayed in the NNICU longer (P = 0.035), 
onset of hypernatremia arose in patients with signifi  cantly lower Glasgow 
Coma Scale (P = 0.001). These patients had more cerebral complications 
(P  <0.001), worse Glasgow Outcome Scale upon discharge from the NNICU 
(P <0.001), higher mortality in the NNICU (P = 0.003) and higher incidence 
of pulmonary edema (P = 0.021). They received more antiedematic therapy 
(P <0.001) and diuretics (P <0.001). On the other hand, hyponatremia was 
more frequent upon entry to the NNICU (P <0.001) and arose later after 
brain damage (P <0.001) in comparison with hypernatremia.
Conclusions In neurointensive care, hypernatremia was a prognostically 
more serious and less frequent sodium dysbalance than hyponatremia.
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Introduction Hypernatremia is frequently encountered in the 
neurocritical ICU and its eff  ect can badly aff  ect mortality. The objective of 
this study was to verify whether the occurrence of hypernatremia during 
the ICU stay increases the risk of death in patients with severe traumatic 
brain injury (TBI).
Methods  Randomized prospective study of 100 patients with TBI in 
neurocritical care units at Cairo University Hospital. Hypernatremia is 
defi  ned as serum sodium above 145 mmol/l. The major outcome was death 
in the ICU. Logistic regression models were used to assess independent 
factors that could aff  ect patients’ mortality including hypernatremia, age, 
desmopressin and Glasgow Coma Score.
Results We included in the study 100 TBI patients (mean age 35.8 ± 21.3 
years); males 86%. Extradural hematoma (EDH) was documented in 27 
patients (27%), subarachnoid (SAH) in 20 patients (20%), intracerebral 
(ICH) in 19 patients (19%), cerebral contusion in 17 patients (17%), brain 
oedema in 15 patients (15%), and subdural hematoma in two patients 
(2%). Glasgow Coma Scores (range 3 to 10); 60 patients were mechanically 
ventilated; 10% were diabetic and 22% were hypertensive. Hypernatremia 
was documented in 40 patients (40%) of the total TBI patients. The total in-
hospital mortality was 36/100 (36%), 10 of them had normal sodium levels 
all through their in-hospital course and 26 patients were hypernatremic. 
After adjustment for the baseline risk, the incidence of hypernatremia over 
the course of the ICU stay was signifi  cantly related to increased mortality 
(hazard ratio 3.2 (P = 0.0001)). However, there was positive correlation 
between serum sodium levels and duration of the ICU stay (Spearman 
correlation coeffi   cient 0.5 and P = 0.002).
Conclusions  Hypernatremia in patients with severe TBI is associated 
with an increased risk of death, and a longer ICU stay. This association is 
independent of other outcome predictors including age and Glasgow 
Coma Score. Strategies to prevent hypernatremia in neurocritical ICUs 
should be encouraged.
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Introduction  The syndrome of inappropriate secretion of antidiuretic 
hormone (SIADH) is a very important disorder in neurosurgery, and it is 
one of the most common causes of hyponatriemia in acute brain injury. 
SIADH should be suspected in any patient with hyponatremia, hypo-
osmolarity, urine osmolality above 100 mosmol/kg H2O, concentration of 
sodium in the urine usually above 40 mEq/l, and clinical euvolemia. This 
study was designed to assess the frequency of this syndrome in the post-
neurosurgery ICU, the time of onset and the duration of symptoms.
Methods In a 2-year period (2008 to 2009), 131 patients, hospitalized 
in a post-neurosurgery ICU for TBI or ESA were retrospectively studied. 
According to the previous defi   nition, 63 patients had subarachnoid 
haemorrhage (SAH) from rupture of aneurysm and 68 patients had severe 
head trauma (HI). Diagnosis of SIADH was confi  rmed by pH, sodiemia, 
plasmatic and urinary osmolality, sodiuria of 24 hours and central venous 
pressure. The time to onset of hyponatremia during hospitalization in 
ICU was evaluated, and its duration despite adequate treatment (fl  uid 
restriction and eventually hypertonic saline).
Results  Patients developed SIADH in 5.34%. Three patients had a 
subarachnoid hemorrhage and four patients were hospitalized for head 
trauma. The onset of this syndrome was within the fi  rst week in two 
patients with SAH and in only one with traumatic head injury. With regard 
to the duration of symptoms, SIADH lasted more than a week in the most 
of patients, with no diff  erences between the two groups.
Conclusions In patients with hyponatriemia, an adequate diagnosis of 
SIADH is very important in order to improve the outcome, especially in the 
ICU. In this study we found no diff  erences in the SIADH setting between 
patients with subarachnoid haemorrhage and in patients with traumatic 
head injury. But, owing to the small number of patients with this syndrome 
enrolled, this trend has to be confi  rmed in further studies.
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Introduction Venous thromboembolism (VTE) is a common complication 
after major trauma, and has a high rate of morbidity and mortality. 
However, racial disparities in incidence of as well as risk factors for VTE 
exist between Asian and western populations. The risks for VTE after 
major trauma in Japanese patients remain unknown. Our objective was to 
identify risk factors for VTE after severe blunt trauma in Japanese patients.
Methods We conducted a prospective cohort study to investigate risk 
factors for VTE in patients who were admitted to our hospital because 
of blunt trauma between April 2008 and July 2009. We performed VTE 
screening by duplex ultrasonographic scan for all blunt trauma patients 
who had bed rest ≥3 days and recorded Injury Severity Score (ISS) ≥9 
within the fi  rst 7 days after admission. We initiated pharmacologic VTE 
prophylaxis, fi  rst with low-dose unfractionated heparin and then with low-
dose warfarin. The chi-square test was used for categorical variables and 
the t test for continuous variables.
Results A total of 101 patients (69 males, 32 females) with blunt trauma 
(median age 48.48 ± 20.5 (SD) years and mean ISS of 20.0 ± 10.2) were 
enrolled in this study. Pharmacologic VTE prophylaxis was initiated in 61 
of these patients (60.4%). Ten patients (10.0%) experienced VTE. Univariate 
analysis of potential factors for VTE identifi   ed signifi   cant associations 
between thrombosis and the following factors: transfusion, major surgery, 
the presence of a central venous line in the femoral vein, and direct 
traction of lower limb (P <0.05 for all these factors).
Conclusions The incidence of VTE in Japanese patients with severe blunt 
trauma was 10.0%. These risk factors have all been given in the results 
above.
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Introduction Patients with neurotrauma are at high risk for VTE. The safety 
of early anticoagulation for neurotrauma has not been established. Our 
study was based on the hypothesis that unfractionated heparin can be 
safely administered to most patients with neurotrauma for VTE prophylaxis.
Methods  Prospective, single-cohort, observational study. All adult 
patients with neurotrauma admitted to a tertiary care teaching hospital 
in India from March to December 2007 received unfractionated heparin 
beginning approximately 24 hours after hospital admission until discharge. 
Brain CT scans were performed at admission, 24 hours after admission, 
and at variable intervals thereafter based on clinical course. Patients were 
excluded for coagulopathy, expected brain death or discharge within 48 
hours. Complications of heparin prophylaxis were defi  ned as expansion of 
existing intracranial haemorrhage or development of a new haemorrhagic 
lesion on follow-up CT after beginning heparin use.
Results  Twenty-one of 57 (36.8%) adult neurotrauma patients were 
eligible for heparin therapy. Their distribution of CT fi  ndings is presented 
in Table 1. Serial CT scan had progression of lesion in four of the 26 patients 
not on heparin therapy and in two of the 21 patients on heparin (P >0.05). 
No diff  erence in complications between patients with ICH on heparin 
(2/14) and not on heparin (1/13) were identifi  ed (P >0.05). The mortality 
in the heparin group was 3/21(14.3%). Both the patients who developed 
worsening of CT fi   ndings after initiation of heparin therapy survived 
hospitalization. None of the patients suff  ered from DVT.
Table 1 (abstract 358). Distribution of CT fi  ndings and heparin therapy
CT No  heparin  Heparin
Normal 8  0
DBE 8  3
Contusion 13  3
Hge 27  14
# Skull  1  1
Conclusions Heparin can be safely used for VTE prophylaxis in patients 
with head injury when started 24 hours after hospital admission.
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Introduction The epidemiology of DVT in critically ill medical patients 
has not been studied in Thailand. The aim of this study was to assess the 
prevalence and incidence rate of proximal DVT in these patients and to 
determine the factors associated with the development of this condition.
Methods A single-center, prospective observational study was performed 
in critically ill medical patients who developed sepsis or new organ failure 
requiring organ support. DVT was detected by ultrasonography with 
color Doppler imaging performed within 48 hours after the patients met 
the inclusion criteria, and serial studies at days 7, 14 and 28 (or earlier if 
clinically indicated) were carried out.
Results Of the 170 patients, 87 were male (51.2%). The mean age was 59.95 
years (range 18 to 94), and the mean APACHE II score was 21.34 (range 
4 to 42). Acute respiratory failure and sepsis were the leading diagnoses. 
Prevalence and incidence of proximal DVT were 14.1% (95% CI 9.6 to 20.15) 
and 8.82% (95% CI 5.4 to 14.0), respectively. Univariate analysis of factors 
associated with DVT showed female sex (P = 0.017), age ≥50 years (P = 
0.017), renal replacement therapy (P = 0.005) and femoral venous catheter 
(P = 0.002) while multivariate analysis showed female sex (P = 0.007; OR = 
4.43, 95% CI 1.5 to 13.08), age ≥50 years (P = 0.027; OR = 6.12, 95% CI 1.23 
to 30.49), femoral venous catheter (P <0.001; OR = 11.77, 95% CI 3.11 to 
44.53) and the absence of platelet transfusion (P = 0.015; OR = 0.056, 95% 
CI 0.005 to 0.58). Clinical probability at the fi  rst 48 hours but not at days 7, 
14 and 28 was strongly correlated with the development of proximal DVT. 
The duration of mechanical ventilation, the hospital length of stay and the 
ICU mortality were not aff  ected by the presence of DVT.
Conclusions Proximal DVT of lower extremities in critically ill medical 
Thai patients are not uncommon. Thromboprophylaxis study is needed in 
order to investigate the risk and benefi  t.
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Introduction Trauma patients at high risk of thrombosis and bleeding often 
have a retrievable inferior vena cava fi  lter (IVCF) inserted prophyl  actically 
shortly after admission for the prevention of pulmonary embolism. Despite 
their increasing use in trauma, controversy exists regarding patient selection, 
benefi  ts and safety. In addition, chemical prophylaxis should be initiated as 
soon as determined to be safe to do so. Limited data exist describing the use 
of chemical prophylaxis and the timing of it in relation to IVCF placement in 
this patient population. We aim to describe such use and timing in relation 
to IVCF placement.
Methods All trauma patients with a retrievable prophylactic IVCF inserted 
over 3.5 years with an age ≥18 and an ISS ≥15 were enrolled into the 
descriptive study. Patients were identifi  ed using the local trauma registry 
and data collected from the registry and patient chart.
Results  One hundred and three patients with a prophylactic IVCF are 
described. Mean age was 42.8 ± 17.9 years, 68% were male and they had a 
mean ISS of 38.6 ± 12. A total of 36.9% had ≥3 injuries. A total of 60.2% had 
an injury with maximum AIS score ≥5 and the type of injury associated 
with maximal AIS was head (53.4%), pelvic (19.4%), thoracic (15.5%) and 
spinal cord injury (11.7%). Shock was present on admission in 8.7% patients, 
98.1% required ICU admission, 88.4% required intubation and 27.2% patients 
required ≥4 PRBC over the fi  rst 24 hours. The retrievable IVCF was inserted 
prophylactically after a mean of 1.7 ± 1.9 days (range 0 to 9 days) of hospital 
admission. Chemical prophylaxis was initiated 5.7 ± 5.1 days after IVCF in 
77.7% patients, and dalteparin or enoxaparin were the initial agents of choice 
in 93.8% while heparin was chosen in 6.2% of cases. The time from hospital 
admission to the start of chemical prophylaxis ranged from 6.3 to 8.5 days.
Conclusions  Chemical prophylaxis was initiated in the majority of 
trauma patients with an IVCF, albeit 22% still did not receive any. When 
administered, a low-molecular-weight heparin was selected. Although 
rapidly inserted after admission, there was considerable delay between 
insertion of IVCF and initiation of chemical prophylaxis. The reasons for this 
delay require further investigation.
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Introduction  The background of our research was to conduct a 
retrospective analysis of clinical signs and risk factors for acute deep vein 
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and safety of therapy of LMWH bemiparin and UFH in patients after 
abdominal surgery for cancer.
Methods For the period from 2008 to 2009 the diagnosis of ADVT was set 
for 362 patients, among them 179 (49.4%) men and 183 (50.6%) women. 
Among patients with ADTV with primary localization in ileofemoral and 
popliteal segments treated in the department of vascular surgery, senior 
persons more than 60 years old prevailed (63.9%). All patients with ADVT 
received therapy with anticoagulants. Bemiparin sodium was prescribed 
in 257 (70.9%) cases, UFH in 71 (19.6%) and in 34 (9.5%) others LMWH. We 
analysed effi   ciency and complications after antithrombotic therapy in a 
hospital period. A complete coagulation screen, activated clotting time, 
thromboelastography and low-frequency haemoviscoelastography (HVG) 
were performed to reveal coagulation disturbances.
Results In 83.7% of cases the most frequent symptoms of disease are 
edema of an extremity (in 78.1%) and pain syndrome 74.7%, which at a 
monosymptomal variant (39.4% patients) are marked in 66.3% and 44.4% 
accordingly. The most frequent risk factors (RF) were prolonged (more 
than 8 days) immobilization and malignant tumors. Therapy of UFH and 
LMWH was eff  ective enough (on average, a good result obtained in more 
than in 77% cases). Bemiparin treatment was related to considerably 
less hemorrhagic complications than treatment of UFH (P <0.05), which 
concerned all of types of such complications.
Conclusions  Treatment of with bemiparin as compared with UFH 
accompanied reduced frequency of all hemorrhagic complications by 2.1 
times, serious 2.7 times and moderate 3.1 times. HVG is an eff  ective point-
of-care monitor for routine clinical practice and clinical research.
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Introduction Critically ill patients are at high risk for deep vein thrombosis 
(DVT). Among ICU DVT risk factors, the role of muscle relaxant (MR) has 
been clearly shown [1] but the possible infl  uence of sedative medications 
(SM) is still under debate. This study was aimed at investigating whether 
the use of diff  erent SM may aff  ect DVT incidence in ICU patients.
Methods We retrospectively enrolled all patients admitted to a mixed 
medical–surgical trauma ICU from January 2007 to August 2008 who 
showed a >72 hours length of stay and were >18 years old; exclusion 
criteria were DVT at admission and/or within the previous 6 months, 
thrombophilic profi  le, high haemorrhagic risk, admission from another ICU. 
For studying ICU lower limb DVT incidence, compressive ultrasonography 
(CUS) was performed by three trained ultrasonographers twice a week 
until discharge. SM and MR administration was registered daily: the drugs 
considered are presented in Figure 1. MR-treated patients were excluded 
from statistical analysis; the diff  erence in SM administration in the No DVT 
group vs the DVT-positive group was assayed by chi-squared test.
Results Over the period of study, 380 patients were enrolled. Lower limb 
DVT was diagnosed in 23 of 380 patients, with a DVT incidence of 6.05%. 
MRs were administered in 121 patients and they were associated with 
DVT incidence (P <0.001). Statistical analysis results performed on 259 
patients are shown in Figure 1: none of the considered SM resulted to be 
associated with DVT incidence, nor sedation as a whole or the number of 
SM administered.
Conclusions Our study confi  rms prior fi  ndings [1] on the MR role as a DVT 
risk factor. Nevertheless, SM administration in patients not treated with MR 
is not associated with increased DVT risk.
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Introduction Despite the evidence of perioperative hypercoagulability in 
cancer patients, there are no consistent data evaluating the extent, duration, 
and specifi  c contribution of platelets and procoagulatory proteins by in 
vitro testing. This study compared effi   cacy of haemoviscoelastography 
versus thromboelastography for monitoring of coagulation imbalance.
Methods Two hundred and forty-one patients undergoing surgery for 
abdominal cancer were examined for the effi   cacy of a variety of coagulation 
tests. A complete coagulation screening, thromboelastography (TEG) and 
haemoviscoelastography (HVG) were performed before and at the end of 
surgery.
Results We calculated the elastic shear modulus of standard MA (Gt) and 
HVG MA (Gh), which refl  ect the total clot strength and procoagulatory 
protein component, respectively. The diff  erence was an estimate of the 
platelet component (Gp). There was a 16% perioperative increase of 
standard MA, corresponding to a 51% increase of Gt (P <0.05) and a 79% 
to 87% contribution of the calculated Gp to Gt. We conclude that serial 
standard thromboelastography and the HVG viscoelastic test may reveal 
the independent contribution of platelets and procoagulatory proteins 
to clot strength. Using multiple linear regression, all coagulation, TEG and 
HVG variabilities were used to model postoperative hypercoagulation. 
Results showed that some components of the TEG failed to identify 
hypercoagulation (r <0.2, P >0.75). All components of the HVG test refl  ect 
postoperative coagulopathies.
Conclusions Hypercoagulability is not refl  ected completely by standard 
coagulation monitoring and TEG, and seems to be predominantly 
caused by increased platelet reactivity. HVG provides a fast and easy-to-
perform bedside test to quantify in vitro coagulation, and may be useful 
in determining the coagulation status of cancer patients perioperatively.
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Introduction The aim was to study the incidence, the etiology and to 
assess the severity of thrombocytopenia in surgical ICU (SICU) patients 
admitted to the central army hospital of Algiers (Algeria).
Methods  We conducted a retrospective study; all admitted patients 
during the year 2008 were enrolled in the study (351 patients). All charts 
were reviewed and diff  erent hemograms recorded from admission until 
discharge. One hundred and fi  fty-three thrombocytopenia cases defi  ned 
as a platelet count (plt) <150 x 109 were reported (43.6%).
Results  Among 351 patients (227 survivors, 124 died), 153 developed 
thrombocytopenia, 96 males and 57 females. The onset of thrombo-
cytopenia was for the majority of patients (98%) at 24 to 72 hours after 
ICU admission. Only 26% were severe (plt <50 x 109) and 3% <20 x 109). 
The etiopathology is multifactorial and diffi   cult to obtain precisely: 77% 
Figure 1 (abstract P362). Statistical analysis.
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without ARDS and fat embolism), and necessitated volume and blood 
product administration through an intravascular device; sepsis was 
present in 47% of cases; disseminated intravascular coagulopathy in 33%; 
and fi  ve thrombocytopenia cases were related to drug administration 
with late onset after the 5th day. Reported mortality was 57% (P <10–6) 
compared with the overall mortality (35.3%), related to the severity of 
underlying diseases and the associated co-morbidities.
Conclusions Thrombocytopenia is frequent among chirurgical patients, 
especially multitrauma patients with cardiovascular instability where 
aggressive volume and blood product administration is needed.
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Introduction Thrombocytopenia is a common occurrence in the critically 
ill population [1]. We aimed to determine the incidence, severity and 
prognosis of thrombocytopenia in our ICU.
Methods  A retrospective laboratory result review of 330 consecutive 
admissions to the Victoria Infi  rmary ICU was undertaken. Demographics, 
APACHE II score and outcome data were retrieved from the Ward Watcher 
system in the ICU. We compared survivors’ and nonsurvivors’ platelet levels 
on admission to the ICU and the trough level in the ICU and looked at 
correlation with the length of stay and duration of mechanical ventilation. 
Data were analysed using Student’s t test, Pearson correlation coeffi   cient 
and chi-squared test where appropriate.
Results  Complete data were available for 274 patients. Population 
demographics were as follows – 61.3% male, mean age 56.3 ± 2.1 years, 
median APACHE II 20 (IQR 15 to 27), crude ICU mortality 25.6% and mean 
length of stay 5.2 ± 0.7 days. Incidence of thrombocytopenia (platelet 
count <150 x 109/l) was 29.8% on admission to the ICU, increasing to 
46.9% when considering the entire ICU stay. Comparing survivors and 
nonsurvivors, nonsurvivors had a lower trough platelet count (140 x 109/l 
vs 181 x 109/l, P = 0.005). Patients with platelet counts less than 50 x 109/l 
have the highest mortality (45.7% vs 27.6%, P = 0.006). Platelet data were 
used to construct an ROC curve, demonstrating an area under the curve 
of 0.66, P <0.001. Platelet count correlated negatively with APACHE II (r = 
–0.20, P <0.001) but did not correlate signifi  cantly with length of stay or 
duration of mechanical ventilation.
Conclusions Thrombocytopenia occurs in 47% of our ICU patients. It 
correlates signifi  cantly with severity of illness as measured by APACHE II 
and decreasing platelet count correlates with increasing mortality, with 
the highest mortality in those with a trough ICU platelet count of less than 
50 x 109/l. The ROC characteristics also demonstrate that the platelet count 
is a useful predictor of mortality.
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Introduction  Heparin-induced thrombocytopenia (HIT) is a life-
threatening and limb-threatening, immune-mediated, prothrombotic 
disease resulting from an interaction between heparin and platelet factor 4 
(PF4). Due to the many causes of thrombocytopenia in critically ill patients, 
the diagnosis of HIT is diffi   cult, requiring both a high clinical suspicion and 
confi  rmatory testing. The ELISA test is the most commonly performed 
method to detect anti-PF4 antibodies; however, the ELISA results generally 
take one or more days to report. The particle immunofi  ltration assay (PIFA) 
test has the advantage of being done rapidly; with results generally 
available within 1 hour.
Methods Starting in July 2009, patients in our MICU were screened daily 
for thrombocytopenia; defi  ned as either a platelet count that decreased 
by at least 30% from baseline or an absolute platelet count less than 
150,000. Patients with thrombocytopenia underwent both PIFA and GTI 
ELISA testing for anti-PF4 antibodies. PIFA is a qualitative test reporting 
results as positive or negative. The GTI ELISA test reports an optical density 
(OD), with an OD greater than 0.40 considered positive. Patients were 
followed through hospitalization.
Results One hundred and thirty-eight patients were admitted to the MICU, 
with 47 developing thrombocytopenia. The PIFA results were negative in 
22 patients, positive in 21 patients and inconclusive in four patients. For 
all patients with a negative PIFA result, the GTI ELISA test was negative. 
All four inconclusive PIFA tests had negative GTI ELISA tests. In patients 
with PIFA-positive results, two GTI ELISA tests were positive and 19 tests 
were negative. A serotonin release assay (SRA) was done in 13 patients 
with discordant PIFA/GTI ELISA tests, of which one SRA result was positive. 
None of the 47 patients with thrombocytopenia developed thrombotic 
complications.
Conclusions Our analysis suggests that a negative PIFA test can quickly 
exclude the presence of anti-PF4 antibodies and therefore HIT as the 
cause of the thrombocytopenia. The PIFA test can be used as a rapid 
screening procedure for patients with possible HIT, and, when negative, 
decrease the exposure of thrombocytopenic MICU patients to alternative 
anticoagulation. The clinical signifi  cance of a positive PIFA test requires 
further study and must be evaluated in conjunction with clinical judgment 
and, as appropriate, additional testing for anti-PF4 antibodies.
P367
Heparin-induced thrombocytopenia incidence in the ICU: 
preliminary results
F Barbani1, R Marcucci2, S Degl’Innocenti3, A Rogolino2, S Fedi2, A Gori2, 
M Bonizzoli3, G Zagli3, A Peris3, R Abbate2
1Postgraduate School of Anesthesia and Intensive Care, University of Florence, 
Italy; 2Department of Critical Care Medicine and Surgery, University of 
Florence, Italy; 3Careggi Teaching Hospital, Florence, Italy
Critical Care 2010, 14(Suppl 1):P367 (doi: 10.1186/cc8599)
Introduction  Heparin-induced thrombocytopenia (HIT) is a life-
threatening and limb-threatening immune-mediated prothrombotic 
complication caused by heparinic drugs. The aim of this study was to 
evaluate the incidence of HIT in a mixed ICU population.
Methods  Patients admitted to the ICU of a regional referral center 
(Careggi Teaching Hospital, Florence, Italy) who underwent unfractionated 
heparin (UFH) or low-molecular-weight heparin (LMWH) administration 
were prospectively observed from October 2008. Exclusion criteria: 
haematological malignancy, platelet count <50,000/mm3 before 
anticoagulant treatment. After anticoagulant administration start, patients 
showing a fall of platelet count >50% or a nadir <150,000/mm3 were 
clinically evaluated with the 4T score (4Ts) [1]: cases with a 4Ts of at least 
2 were investigated with the laboratory antigen assay, the ELISA. Positive 
tests underwent to a functional confi  rmation test, the heparin-induced 
platelet activation (HIPA) test [2].
Results Preliminary results refer to the period from the start to August 
2009. Patients admitted to the ICU were 369; 327 enrolled for the study. 
Clinical evaluation with 4Ts was performed for 31 patients, 23 of 31 (74%) 
had a value of at least 2; eight of 23 were on UFH and the remaining 15 on 
LMWH. Potential etiologies of thrombocytopenia have been considered: 
21 patients were septic, three were on extracorporeal membrane 
oxygenation, two were admitted to the ICU due to cardiogenic shock. The 
ELISA test resulted positive in three of 23 (13%) suspected HIT cases; none 
of the three cases resulted positive in the HIPA test, so HIT was excluded. 
The medium 4Ts of the 23 suspected HIT cases was 4.1 ± 1.7 whereas 4Ts 
did not diff  er between patients with positive and negative ELISA test.
Conclusions HIT incidence in the ICU is extremely rare, with no cases 
shown in this study. HIT was suspected in 23 of 327 patients (7.03%), 
but the HIT incidence was 0.0%. ICU patients show numerous potential 
etiologies of thrombocytopenia and in this population sepsis was the 
most common.
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Introduction Many procedures in cardiac surgery require extracorporeal 
circulation (EC). During EC, blood is pumped from a venous line to an 
oxygenator, cooled and infused back via an arterial line. This procedure 
is known to compromise the coagulation system, especially under 
prolonged hypothermia. The aim of the present study was to investigate 
the eff  ects of EC and hypothermia on the coagulation system in a porcine 
model. The effi   cacy of a substitution therapy with a prothrombin complex 
concentrate (PCC) regarding normalization of coagulation and decrease in 
hemorrhage was evaluated.
Methods  A total of 17 male anesthetized pigs were included in the 
study. EC was performed in 12 animals by a hollowfi   ber oxygenator 
with a priming solution containing saline, HES and heparin. Five animals 
without EC served as a control. The coagulation system was characterized 
by thromboelastography (TEG), thrombin generation, coagulation factor 
levels, platelet numbers and function (aggregation). A GoreTex patch 
was inserted into the carotid artery, bleeding occurred from the stitch 
channels. The eff  ects of intravenous substitution therapy by PCC (Beriplex 
P/N, 30 U/kg, n = 6) compared with placebo (n = 6) on bleeding from the 
stitch channels was investigated.
Results  EC and hypothermia compromised the coagulation system. 
Coagulation factor levels were decreased, TEG and thrombin generation 
became pathologic. Platelet count and aggregation were decreased. 
Blood loss from the stitch channels of the GoreTex patch was doubled in 
the EC group when compared with animals without EC. After substitution 
therapy with PCC, blood loss decreased signifi  cantly from 83.0 ± 48.4 ml 
in the EC + placebo to 27.2 ± 35 ml in the EC + PCC group (P <0.025, 
Wilcoxon test; Figure 1). PCC normalized the impaired coagulation.
Conclusions Hypothermia and EC led to a compromised coagulation 
system, resulting in increased hemorrhage. The defi   cit in coagulation 
could be overcome by substitution therapy with PCC. Elevated blood loss 
from stitch channels was decreased signifi  cantly after treatment with PCC. 
It was concluded that PCC should be benefi  cial in patients undergoing 
cardiovascular surgery with an EC-induced coagulopathy.
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Introduction  Dilutional coagulopathy following massive bleeding is 
the result of clotting factor dilution and impaired fi  brin polymerization 
after infusion of colloidal plasma expanders. Although fi   brinogen has 
been clinically used to treat dilutional coagulopathy [1,2], the eff  ects of 
fi  brinogen dosages on normalizing coagulation function is unclear. This 
study investigated the eff  ect of six diff  erent fi  brinogen dosages (range: 
37.5 to 600 mg/kg) on ROTEM® parameters and overall blood loss in a pig 
model for dilutional coagulopathy.
Methods Forty-two pigs underwent a 60% hemodilution with Voluven® 
(HES130/0.4). A standardized bone injury was performed after the 
completion of hemodilution. Animals were then randomized to receive 
37.5, 75, 150, 300, 450 or 600 mg/kg fi  brinogen (FGTW, LFB, France) or 
500 ml saline. Four hours after fi  brinogen administration a standardized 
liver injury was performed. Animals were then observed for 2 hours or 
until death. Blood loss was measured and tissue samples were collected 
at the end of the study. Hemodynamic and coagulation parameters were 
measured at baseline (BL), after hemodilution, 15 minutes, 1, 2 and 4 hours 
after drug infusion and 2 hours after liver injury or right before the animal’s 
death. Statistical signifi  cance was set at P <0.05.
Results Fibrinogen dosages of 150 mg/kg and higher completely reversed 
dilutional coagulopathy: the maximum clot fi  rmness (MCF) which was 
decreased after hemodilution (36 ± 3 vs 65 ± 4 mm at BL, P <0.05), returned 
to BL levels after fi  brinogen administration (69 ± 5 mm). Blood loss from 
bone and liver injury signifi  cantly decreased with increased fi  brinogen 
dosages: 42 ± 19 (sham), 34 ± 14 (75 mg/kg), 29 ± 13 (150 mg/kg) and 
28 ± 10 ml/kg BW (600 mg/kg). No thrombotic events occurred.
Conclusions In a swine model of 60% hemodilution with bone and liver 
injury, fi  brinogen administration (150 mg/kg and above) normalized MCF 
and decreased blood loss. Infusions of 12 times the dosage recommended 
in humans did not induce hypercoagulability.
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Introduction  Postpartum haemorrhage (PPH) is a leading cause of 
maternal death. Present guidelines for PPH management focus on 
uterotonic treatments, while the potential effi   cacy of antifi  brinolytic drugs 
has been poorly explored in this indication.
Methods After approval by the ethics committee, we randomly assigned 
women with PPH >800 ml after vaginal delivery to receive intravenous 
tranexamic acid (TXA) (4 g within 1 hour, followed by 1 g/hour during 
6 hours) (TXA group) or no antifi  brinolytic treatment (Control group). 
Monitoring and management were performed according to the 
guidelines. Additional procoagulant treatments (coagulant concentrates, 
fresh frozen plasma, platelets) were used only when PPH became 
intractable (>2,500 ml or >500 ml/30 minutes). Embolization or surgery 
was performed when considered clinically necessary. Blood loss, maternal 
morbidity and safety were collected at four time points: inclusion (T1), 
T1 + 30 minutes (T2), T1 + 2 hours (T3), and T1 + 6 hours (T4). The study 
plan, based on the hypothesis that TXA would induce a 20% blood loss 
reduction with an α risk of 5% and a β risk of 10%, required the inclusion of 
72 patients in each group. Statistical analysis used the SAS system.
Results One hundred and forty-four patients were included, 72 in the 
TXA group and 72 in the control group. Management data were similar 
between the two groups. In the TXA group, as compared with the control 
Figure 1 (abstract P368). Blood loss from a GoreTex Patch after EC.
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lower between T2 and T4 (P = 0.0012); bleeding duration was shorter (31 ± 
28 vs 65 ± 95 minutes, P = 0.004); and maternal morbidity was reduced 
(hemoglobin drop >4 g/dl: n = 15 vs 34, P <0.001; blood transfusion 
requirement: n = 14 vs 20, P = NS; overall number of transfused packed 
red blood cells: n = 42 vs 62, P <0.001; number of severe PPH (Charbit 
criteria 1): n = 23 vs 36, P = 0.028). Invasive procedures were needed in 
four women in the TXA group and in seven women in the control group 
(P = NS). Transient visual and digestive side eff  ects were observed more 
frequently in the TXA group than in the control group (17 vs 4 P = 0.028).
Conclusions  These results show, for the fi   rst time, that TXA, when 
administered early in the management of PPH, reduces blood loss and 
maternal morbidity, with only minor and transient side eff  ects. As TXA is a 
readily available and cheap hemostatic agent, we strongly suggest that it 
should be further investigated as an adjuvant treatment in PPH.
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Introduction  In 1999 the fi   rst publication appeared of the use of 
recombinant factor VIIa (rFVIIa) for uncontrolled haemorrhage [1]. Since 
then there has been widespread international use of rFVIIa in this setting. 
Consensus guidelines have been published [2], but there is much variation 
in its administration [3].
Methods Review of the blood bank databases of all six acute hospitals in 
the southwest of England between January 2000 and February 2009 was 
undertaken to reveal all prescriptions of rFVIIa. Case notes were analysed 
and the administration of all blood products for 24 hours either side of 
rFVIIa administration was extracted from the blood bank databases.
Results Eighty-two patients were identifi  ed who had received off  -licence 
rFVIIa. Of these, full data were available on 67 patients. There was unequal 
use between hospitals; Plymouth had 33% of use compared with Taunton, 
with only 4%. A total 65.7% of patients were male and the mean age was 
56.6 years. The mean APACHE II score was 18.4 (± 7.4) and 40.3% patients 
died in ≤96 hours. The mean dosage administered was 80.9 μg/kg (± 21.3). 
The number of annual prescriptions shows a bimodal pattern with peaks in 
2005 and 2008. The distribution of usage was predominantly with general 
and vascular surgical patients (39%), but trauma (14.9%), obstetrics (13.4%) 
and cardiac surgery (13.4%) were the next most frequent specialties. rFVIIa 
was given after a mean of 17.6 (± 11.2) units of packed red cells, 8.8 (± 5.9) 
units of fresh frozen plasma and 2.3 (± 1.9) pooled platelets. Following 
rFVIIa transfusion of all blood products was markedly less, and only three 
patients received a repeat dose of rFVIIa. The prothrombin time decreased 
from a mean of 18.9 seconds to 13.9 seconds following rFVIIa. Thirty-six per 
cent of patients had <50 platelets at administration and 40% were acidotic 
with pH <7.2. Sixty-eight per cent patients had a haematocrit <0.25 and 
30% of patients were hypothermic.
Conclusions  Off   -label prescribing of rFVIIa varies widely across the 
southwest region. Its use as an adjunctive therapy for uncontrolled 
haemorrhage has often been unsuccessful. Our analysis of prescribing 
rFVIIa in this setting refl  ects the practice of the larger Australian series in 
terms of indications and dosage; however, the mortality at 28 days of 32% 
is lower than in our series [3]. There is still heterogeneity in prescribing 
rFVIIa and its use does not conform to European guidelines [2].
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Introduction Bleeding after cardiac surgery is a common state, associated 
with adverse eff  ects. Factor VIIa is a recombinant factor able to restore 
blood coagulation without signifi   cant adverse eff   ects. We aimed to 
evaluate whether the early use of factor VIIa reduces bleeding and the 
rates of transfusion.
Methods  We studied 241 patients submitted to cardiac surgery who 
presented bleeding after heparin reversal and a fi  rst replacement of clotting 
factors. From these, 81 patients were submitted to valve procedures, 51 
coronary artery bypass surgery (CABG), 60 valve + CABG, 35 aortic ascending 
surgery and 14 cardiac transplant. From these, 131 received factor VIIa early 
(in the intraoperative room) and 110 received the drug in the ICU.
Results  Both groups of patients presented a statistically signifi   cant 
reduction of blood transfusion after receiving factor VIIa (P  <0.001). 
The group of patients undergoing early use presented a lower rate of 
reoperations due to bleeding (P <0.01), and received less units of red 
blood cells (P <0.01), fresh frozen plasma (P <0.01), cryoprecipitate and 
platelets (P <0.01). Also, we detected a low incidence of infection in the 
group who received the factor in intraoperative room.
Conclusions Early use of factor VIIa in patients who bleed after cardiac 
surgery is associated with lower rates of reoperations, lower rates of 
transfusion and lower incidence of infection. This suggests the drug 
should not be used as a last therapeutic tool and may be indicated earlier 
in the management of bleeding.
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Introduction Venous thromboembolism is of the most common compli-
cations in cancer patients and may be due to the hypercoagulable state of 
malignancy and to its surgical treatment.
Methods  Patients undergoing planned curative open surgery for 
abdominal cancer received MEDNORD (Ukraine Co. analyzer) analysis 
(HVG), a viscoelastic test that measures clot formation and includes 
information on the cellular as well as the plasmatic coagulation system. 
We examined the effi   cacy of a variety of coagulation tests. A complete 
coagulation screen, activated clotting time, thromboelastography (TEG) 
and haemoviscoelastography (HVG) were performed before surgery, at 
the end of surgery, and on postoperative days 1, 2, 3, and 7; they were 
analyzed for the reaction time and the maximal amplitude (MA).
Results We calculated the elastic shear modulus of standard MA (Gt) and 
HVG MA (GH), which refl  ect the total clot strength and procoagulatory 
protein component, respectively. The diff  erence was an estimate of the 
platelet component (Gp). There was a 14% perioperative increase of 
standard MA, corresponding to a 48% increase of Gt (P <0.05) and an 80 
to 86% contribution of the calculated Gp to Gt. We conclude that serial 
standard thromboelastography and the HVG viscoelastic test may reveal 
the independent contribution of platelets and procoagulatory proteins 
to clot strength. Using multiple linear regressions, all coagulation, TEG 
and HVG variables were used to model postoperative hypercoagulation. 
However, three components of the routine coagulation assay, including 
bleeding time, prothrombin time and platelet count, could be modeled to 
show prolonged postoperative hypercoagulability (P <0.01). We conclude 
that all components of the HVG test refl  ect postoperative coagulopathies; 
these results suggest that it may be useful in determining the coagulation 
status of cancer patients perioperatively.
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1 week after major cancer abdominal surgery, may be demonstrated by 
the HVG viscoelastotest. This hypercoagulability is not refl  ected completely 
by standard coagulation monitoring and the TEG HVG viscoelastotest 
provides a fast and easy-to-perform bedside test to quantify in vitro 
hemocoagulation.
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Introduction  In the ICU, the hemoglobin concentration is currently 
estimated by portable hemoglobinometer and in emergency transfusion a 
decision can be based on that result. The aim of the study was to compare 
the HemoCue® with laboratory determination of the blood hemoglobin 
concentration in critically ill patients with a high risk of bleeding.
Methods  A prospective observational study was conducted in three 
adult surgical ICUs of a university hospital. After ethic committee approval, 
198 consecutive patients requiring 1,166 determinations of hemoglobin 
concentration were included. Hemoglobin was measured from an arterial 
blood sample at the laboratory (Hbm) and estimated at the bedside (Hbe,a) 
using the same blood sampling and a portable hemoglobinometer 
(HemoCue® Hb201+). Simultaneously, a capillary measurement (Hbe,cap) 
was performed at the bedside using the same device.
Results The mean diff  erence (bias, Figure 1) between Hbe,cap and Hbm was 
–0.2 g/dl (95% CI, –0.3 to –0.1) and limits of agreement –1.3 g/dl (95% 
CI, –1.4 to –1.2) to 1.7 g/dl (95% CI, 1.6 to 1.9). Discrepancies between 
Hbe,cap and Hbm were greater than 1 g/dl in 30.8% of cases. The accuracy 
of HemoCue® was not aff  ected by the unit of hospitalization, the patients’ 
severity assessed by SAPS II score on admission, the site of lancet puncture 
(fi   nger or ear), the administration of norepinephrine, the presence of 
hypothermia (body temperature <36.3°C) or by a hemoglobin level below 
10 g/dl or 8 g/dl. The bias between Hbe,a and Hbm was –0.1 g/dl (95% CI, 
–0.2 to 0.2) and limits of agreement –1.1 g/dl (95% CI, –1.2 to –1.0) and 1.0 
g/dl (95% CI, 0.9 to 1.1).
Conclusions  Capillary HemoCue® is not accurate enough to base 
therapeutic decisions such as blood transfusion on. The performance of 
the method is improved with the use of arterial blood.
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Eff  ect of transfusion, leukocyte-depleted blood product on onset of 
new septic shock and mortality in septic shock
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K Fujimoto, O Yamaguchi, Y Koide
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Introduction  A number of studies have observed decreased survival 
associated with transfusion. Leukocyte-mediated immunosuppression may 
contribute to postoperative infectious complications. There is evidence for 
a benefi  t with the use of leukocyte reduced transfusion, but it is unclear 
among septic shock patients. In Japan, leukocyte-depleted blood products 
have been used since 2007. We assessed the eff  ect of transfusion and the 
effi   cacy of the use of leukocyte-depleted blood products for new onset of 
septic shock and mortality among patients with septic shock.
Methods A total of 101 septic shock patients at a single university general 
ICU were enrolled in the study. A target hemoglobin (Hb) concentration 
of 10 g/dl (Ht 30%) was considered for allogeneic red cell transfusion (to 
maintain central venous saturation >70%) during the early phase of severe 
sepsis, and Hb was kept in the range of 7 to 9 g/dl in the stable phase 
except for the patients with particular disease (acute coronary syndrome, 
and so forth). Fresh frozen plasma was used to keep PT-INR <1.67, and 
platelet transfusion was done due to the patient’s condition (for example, 
postoperative, and so forth).
Results Eighty-six patients (85%) received transfusion (group T: age 68 ± 
12, APACHE II 25.9 ± 9.5) and 15 received no blood product (group NT: age 
63 ± 14, APACHE II 27.4 ± 3.2). Frequent sites of infection were the lung 
(46%), peritoneum (17%), mediastinum (12%), and gastrointestinal tract 
(7%) (NS between groups). Overall mortality for group T vs group NT was 
27/86 (31%) vs 3/15 (20%) (P = 0.54). Onset of new septic shock for group 
T vs group NT was 27/86 (31%) vs 4/15 (27%) (P = 0.71). Survivors received 
26.6 ± 31.2 Japanese units of total blood product and 44.6 ± 35.6 units for 
patients who died, respectively (1 American unit is almost equivalent to 2 
Japanese units) (P = 0.013). For group T, 56 patients received leukocyte-
reduced blood product (LRB) and 29 received ordinary product (Cont.). 
Overall mortality for LRB vs Cont. was 40/56 (71%) vs 18/29 (62%) (P = 0.38).
Conclusions The total amount of blood products received was highly 
associated with increased mortality, but there was no obvious adverse 
eff  ect of transfusion to the onset of new septic shock. No association 
between overall mortality and the use of leukocyte depleted blood was 
identifi  ed in patients with septic shock.
P376
Transfusion Requirements After Cardiac Surgery (TRACS) study: 
preliminary data of a randomized controlled clinical trial
L Hajjar1, F Galas1, M Sundin1, R Nakamura1, C Silva1, T Mauad2, 
P Pomerantzeff  1, P Bueno1, R Kalil Filho1, JL Vincent3, J Auler Jr1
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Critical Care 2010, 14(Suppl 1):P376 (doi: 10.1186/cc8608)
Introduction  There are no prospective studies comparing outcomes 
between restrictive or liberal strategies in cardiac surgery. This study is 
a double-blind randomized study to determine whether a restrictive 
strategy of red cell transfusion and a liberal strategy produced equivalent 
results in patients submitted to cardiac surgery.
Methods Until November 2009 we enrolled 380 patients undergoing 
elective cardiac surgery and randomly assigned 185 patients to a 
restrictive strategy of transfusion, in which red cells were transfused if 
the hematocrit concentration dropped below 24%, and 195 patients to a 
liberal strategy, in which transfusions were given when the hematocrit fell 
below 30%. Both transfusion strategies were followed into the operative 
room and during the ICU stay. We compared the rates of complications 
and death from all causes during the hospital stay and clinical outcomes of 
patients after 90 days. Adult patients, after written informed consent, were 
allocated if they would be submitted to elective primary surgery or were 
redone adult cardiac surgical patients for coronary artery bypass grafting, 
valve procedure or combined procedures.
Results Overall, hospital mortality was similar in the two groups (4.7% vs 
5.3%, P = 0.11). The rates of complications were similar in the two groups 
Figure 1 (abstract P374).
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group, P = 0.33). The ICU stay was signifi  cantly lower in the restrictive-
strategy group (2.2 days vs 4.1 days, P = 0.05). There was no diff  erence in 
90-day mortality between groups.
Conclusions A restrictive strategy of red cell transfusion is at least as 
eff   ective as and possibly superior to a liberal transfusion strategy in 
patients submitted to cardiac surgery.
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haemorrhage over a 12-month period in a UK intensive care unit
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Introduction The deleterious eff  ects of red blood cell (RBC) transfusion 
are well known [1] and restrictive transfusion practices are safe in 
patients without active haemorrhage [2]. Our objective was to determine 
transfusion practices in critically ill patients without evidence of ongoing 
bleeding to establish our conformity with published guidelines [3].
Methods All adult ICU patients receiving RBC transfusions between 1 
September 2008 and 31 August 2009 were included in the analysis. Data 
were collected on demographics, APACHE II score, ICU and hospital length 
of stay (LOS), ICU and hospital mortality, presence of ischaemic heart 
disease (IHD), and pre/post-transfusion haemoglobin concentrations in 
g/dl ([Hb]). Subgroup analyses were performed for patients with IHD, age 
<55 years or APACHE II ≤20. We analysed patients with IHD because benefi  t 
from liberal transfusion has not been confi  rmed [1] whereas the latter two 
subgroups have shown a mortality benefi  t with restrictive transfusion [2].
Results A total of 1,723 patients were admitted to the ICU during the study 
period. Two hundred and fi  ve patients (11.9%) received RBCs, of whom 
47 had active bleeding and were excluded from further analysis. The 
remaining 158 patients (9.2%) received a total of 477 units RBCs (median 
2.0 units/patient, IQR 1.0 to 3.8). Median pre-transfusion [Hb] was 7.7 (IQR 
7.3 to 8.2) with a post-transfusion [Hb] of 9.2(IQR 8.5 to 9.8). Median ICU and 
hospital LOS in days was 10.9 (IQR 4.9 to 18.8) and 26.9 (IQR 14.0 to 45.0). 
ICU and hospital mortalities were 34.2% and 44.9%, respectively. Patients 
with acute IHD had a pre-transfusion [Hb] of 8.3(IQR 7.8 to 8.8) with a post-
transfusion [Hb] of 9.4 (IQR 9.2 to 10.2) whilst patients with chronic IHD 
had values of 7.9 (IQR 7.4 to 8.4) and 9.4 (IQR 8.5 to 9.8), respectively. In 
patients aged <55 years, pre/post-transfusion values were 7.5 (IQR 7.1 to 
8.0) and 9.2 (IQR 8.5 to 10.0), respectively, and patients with APACHE II ≤20 
had values of 7.7 (IQR 7.3 to 8.2) and 9.2 (IQR 8.5 to 9.8), respectively.
Conclusions  [Hb] transfusion triggers were >7 in all subgroups and 
post-transfusion [Hb] was >9. Transfusion strategies were too liberal. It is 
important to restrict transfusions to limit morbidity and mortality and to 
make effi   cient use of RBCs [4]. This study demonstrates the importance of 
regular audit and will be used to inform local guidelines.
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Introduction  Transfusion of red blood cells has been used with the 
objective of improving oxygen delivery to the tissues in the critically 
ill patient. However, the appropriate hemoglobin (Hb) level is still 
controversial in septic shock patients [1,2]. The objective of this study was 
to evaluate the eff  ect of red blood cell transfusion on the central venous 
saturation (SvcO2) and lactate levels in patients with septic shock with two 
diff  erent levels of Hb.
Methods Patients with less than 48 hours of septic shock and Hb levels 
under 9.0 g/dl were randomized to maintain Hb over 9.0 g/dl (Group 1) 
or over 7.0g/dl (Group 2). Before and up to 1 hour after each transfusion, 
Hb, lactate and SvcO2 were determined. Results were expressed as median 
(25% to 75% percentile) or percentage and analyzed through chi-square 
or Mann–Whitney test. P <0.05 was considered signifi  cant.
Results Forty-six patients were included with a total of 74 transfusions, 
being 39 in Group 1 and 35 in Group 2, without any diff  erence  in 
demographic or hemodynamic data between the groups. Before and 
after Hb levels were 8.5 (8.2 to 8.7) g/dl and 9.4 (9.1 to 9.5) g/dl in Group 
1 (P = 0.000) and 6.8 (6.6 to 6.9) g/dl and 7.6 (7.4 to 7.8) g/dl in Group 2 
(P = 0.000). A reduction in median lactate after transfusion was found in 
Group 2 patients (22.0 (18.1 to 29.1) mg/dl and 20.0 (16.3 to 25.2) mg/dl, 
P = 0.005) but not in Group 1 (17.2 (16.3 to 23.9) mg/dl and 18.1 (15.4 to 
21.8) mg/dl, P = 0.23). The same occurred regarding SvcO2 with improved 
values only in Group 2 (68.0 (64.0 to 72.0)% and 72.0 (69.0 to 75.0)% in 
Group 2, P <0.000) and not in Group 1 (72.0 (69.0 to 74.0)% and 72.0 (71.0 
to 73.0)%, P = 0.98). In patients with altered lactate levels a reduction 
was found regardless of the basal levels of hemoglobin (P = 0.002 and 
P = 0.001 for Groups 1 and 2, respectively). The same was demonstrated 
in patients with SvcO2 <70% (P = 0.007 and P = 0.000 for Groups 1 and 
2, respectively). On the other hand, patients with normal levels of both 
perfusion parameters did not present a worsening of those variables, 
either in Group 1 or Group 2.
Conclusions  Red blood cell transfusion improved tissue perfusion in 
patients with signs of hypoperfusion regardless of basal levels of Hb. 
Transfusion did not seem to worsen tissue perfusion in patients without 
signs of hypoperfusion, even in the group with Hb levels above 9.0 g/dl.
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Introduction  Uncontrolled haemorrhage is a leading cause of early 
mortality in trauma. Administration of blood products, packed red cells 
and fresh frozen plasma (PRBC:FFP) in the ratio of 1:1 is associated with 
improved mortality in major haemorrhage in adult trauma. However, there 
is little evidence available for the management of major haemorrhage in 
the context of paediatric trauma.
Methods  We retrospectively analysed the local paediatric trauma 
database of all children following trauma call activation on arrival at the 
emergency department of The Royal London Hospital, a major urban 
trauma centre in London. The study period was over 15 months, May 2008 
to August 2009. During this period, there has been no major haemorrhage 
policy within the centre for paediatric trauma. We collected data on 
demographic profi  le, injury severity scores, blood products transfused 
in the fi  rst 24 hours and the outcomes. We defi  ned massive transfusion 
as the requirement of packed red cells >40 ml/kg in the fi  rst 4 hours or 
>80 ml/kg in the fi  rst 24 hours.
Results  Two hundred and twenty-seven children presented to the 
emergency department during this period following major trauma call 
activation. The median age at presentation was 10.2 years. Thirteen (5.7%) 
children had major haemorrhage. The median ISS was 35 (IQR 10 to 60). All 
but one were males. Three had penetrating trauma, one of whom made 
it to theatre, but all died. Four had emergency damage control surgery. 
Abnormal results were seen in three patients, each having one abnormal 
result (INR =1.9 and APTT = 86, low Hb = 7.6, thrombocytopaenia = 63). 
Eight of the 13 patients received additional blood products such as fresh 
frozen plasma, platelets and cryoprecipitate. However, no patient received 
the ratio of blood products of PRBC:FFP of 1:1 as practised in adult trauma. 
Two patients had no admission bloods done. Worsening coagulation 
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and the remaining 11 patients did not have routine monitoring of blood 
parameters post transfusion. Eight (62%) patients died, of which seven 
died in the emergency department.
Conclusions Major haemorrhage is associated with a very high mortality 
in severely injured children. We recommend rigorous monitoring of 
laboratory parameters to guide appropriate administration of blood 
products. There is a need for instituting a major haemorrhage policy in 
paediatric trauma and consideration of point-of-care testing of blood 
parameters.
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Introduction To date there is poor evidence that documents the benefi  t 
of red blood cell transfusion on clinical outcome. Acceptance of a lower 
transfusion trigger in the perioperative period requires detailed information 
regarding the eff  ects of volume replacement in diff  erent organs and 
systems. Since fl  uids can have a widely divergent impact on the immune 
response, this study was undertaken to determine the cytokine levels in 
a model of acute isovolemic anemia (AIA) with hydroxyethyl starch (HES) 
and gelatin (GEL).
Methods  Twenty-one pigs were anesthetized, instrumented and 
randomized into three groups: Control, HES and GEL. Animals in the HES 
and GEL groups were submitted to acute isovolemic anemia to a target 
hematocrit of 15% with volume replacement performed with HES 130/0.4 
and GEL at a 1:1 ratio. The withdrawn blood was returned to the animals 
120 minutes after the end of AIA. TNF, IL-1, IL-6 and IL-10 measurements 
were performed with blood samples collected at the femoral vein at the 
following time points: Baseline, after instrumentation (INST), immediately 
after AIA (AIA), 60 minutes after AIA (60AIA), 120 minutes after AIA (120AIA), 
60 minutes after blood infusion (60BI) and 120 minutes after blood 
infusion (120BI). The cytokines were measured in serum by a commercially 
available ELISA with specifi  c monoclonal antibodies. Two-way analyses 
of variance (ANOVA) and a Tukey test were used to assess its signifi  cance 
(P <0.05).
Results TNF varied signifi  cantly among the groups in diff  erent time points 
(AIA: Control, 91 ± 16 and GEL, 221 ± 61; P <0.05; 60AIA: Control, 76 ± 
15; HES, 172 ± 42; P <0.05 and GEL, 323 ± 77; P <0.001; 120AIA: Control, 
98 ± 6 and GEL, 304 ± 66; P <0.01; 120BI: Control, 71 ± 7 and GEL, 211 ± 
71; P <0.05). In relation to IL-1, only in the GEL group (224 ± 56) was 
verifi  ed a statistical signifi  cant at time point 60AIA when compared with 
Control (84 ± 17; P <0.05). When IL-6 levels were studied, GEL presented 
a statistically signifi  cant at 60AIA (GEL, 331 ± 65) when compared with 
Control (146 ± 19; P <0.05). Serum IL-10 levels in GEL-treated animals were 
statistically signifi  cantly elevated at 60AIA (Control, 17 ± 3 and GEL, 46 ± 
12; P <0.01) and 120BI (Control, 21 ± 5 and GEL, 59 ± 11; P <0.05).
Conclusions Fluid replacement infl  uences the cytokine measurements 
during acute isovolemic anemia expressed by serum TNF, IL-1, IL-6 and 
IL-10 increases, especially in GEL group.
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Introduction Community-acquired sepsis at an early stage is common, 
but haemodynamic alterations remain unclear. The aim of the study 
was to characterize cardiovascular alterations in patients of our ProFS 
(monocentric observational) study, which was to characterize patients 
with sepsis in the emergency department.
Methods  Systemic vascular resistance (SVR) and cardiac output (CO) 
were measured non-invasively using a TaskForce monitor (CNSystems, 
Graz, Austria) after admission, 24 hours and 72 hours. Indexed values were 
calculated (SVRI (dyn·second/cm5/m2), CI (l/minute/m2)). Procalcitonin 
(PCT, ng/ml) was measured in serum.
Results  A sample of 64 patients of 208 included patients received 
haemodynamic examination. Mean age was 61.8 ± 18.0 years, 62.7% were 
male. Patients were divided by PCT <2 and ≥2. Age, gender and previous 
medical history were comparable in both groups. The heart rate was 
99.8 ± 21.6 vs 104.6 ± 23.0/minute (P = NS) and the mean artery pressure 
was 89.5 ± 15.6 vs 81.6 ± 21.5 mmHg (P <0.01). Mean SVRI in patients with 
PCT <2 was 2,934 ± 1,045 vs 2,376 ± 842, P <0.05 at the time of admission. 
No diff  erence was found after 24 hours (2,959 ± 1,002 vs 2,924 ± 1,324, P = 
NS) and 72 hours (3,123 ± 931 vs 3,556 ± 1,524, P = NS). On the contrary, for 
patients with PCT ≥2 the increase after 72 hours was signifi  cant (P <0.05). 
Diff  erences after admission could not be observed for CI between patients 
with PCT <2 vs ≥2. Mean values after admission were 2.7 ± 1.0 vs 2.8 ± 0.8, 
after 24 hours 2.5 ± 0.8 vs 2.5 ± 0.5, and after 72 hours 2.3 ± 0.7 vs 2.3 ± 0.6 
(all: P = NS). See Figure 1
Conclusions Patients with community-acquired sepsis in the emergency 
department had an elevated SVRI. At the time of admission patients with 
high PCT had a signifi  cantly lower SVRI than patients with low PCT. Cardiac 
index at the time of admission was at a lower limit of normal range in 
all patients. These fi  ndings are in strong contrast to the classic pattern 
of sepsis on the ICU, where SVRI is keenly reduced and CI elevated. They 
implicate that patients with sepsis in the emergency department may 
benefi  t more from application of fl  uid and positive inotrope substances 
than from vasopressor.
Figure 1 (abstract P381). Systemic vascular resistance index and cardiac index in sepsis in the emergency department.
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Introduction A multicentre, prospective, observational study conducted 
in four intensive therapy units (ITUs) in India from June 2006 to June 2009 
to determine the incidence and outcome of severe sepsis among adult 
patients.
Methods All patients admitted to the ITU were screened daily for SIRS, 
organ dysfunction and severe sepsis as defi  ned by the ACCP and SCCM. 
Patient with severe sepsis were further studied.
Results A total of 5,478 ITU admissions were studied. SIRS with organ 
dysfunction was found in 1,385 (25%) patients, of which 731 (52.77%) were 
due to sepsis. The incidence of severe sepsis was 16.45% of all admissions. 
Mean age of the study population was 58.17 years (SD 18.66), of which 
57.71% were male. The median APACHE II score was 13 (IQR 13 to 14) with 
predominant (90.93%) medical admission. ITU mortality of all admissions 
was 12.08% and that of severe sepsis was 59.26%. Hospital mortality and 
28-day mortality of severe sepsis were 65.2% and 64.6%, respectively. The 
standardized mortality ratio of severe sepsis patients was 1.45. Median 
duration of stay in the ITU for the severe sepsis cohort who survived was 
13 days (IQR 11 to 17). The number of episodes where infection was the 
primary reason for admission to the ITU was 86.32%. Culture positivity was 
found in 61.6%. The lung was the predominant source of sepsis (57.45%). 
Gram-negative organisms were responsible for 72.45% of cases and Gram-
positive for 13.13%. The rest were parasitic, viral and fungal infection.
Conclusions Severe sepsis was common in Indian ITUs. ITU mortality was 
higher compared with western literature. Gram-positive infections were 
less common although incidences of parasitic and viral infection were 
higher than in the West.
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Introduction Sepsis, systemic infl  ammatory response syndrome (SIRS) or 
organ failure often complicate the clinical course on an ICU. Particulate 
contamination of the infusion solution may contribute to the clinical 
deterioration of these patients. Particles have been shown to induce 
thrombogenesis, deterioration of microcirculation and modulation of 
immunoresponse. The use of inline fi   ltration with microfi   lters almost 
completely prevents particulate infusion. We assessed the eff  ect of inline 
fi  ltration on the reduction of major complications in critically ill children 
(Clinical Trials.gov ID NCT 00209768).
Methods  In a randomised, prospective trial 807 paediatric patients 
admitted to the interdisciplinary PICU of a tertiary university hospital were 
assigned to either a control or an interventional group, the latter receiving 
inline fi  ltration (infusion fi  lter Pall ELD96LLCE/ NOE96E, Braun Intrapur 
Lipid/Intrapur Neonat Lipid) throughout the whole infusion therapy. Prior 
to this study, the infusion regimen was optimised to prevent precipitation 
and incompatibilities of solutions and drugs. Primary objectives included 
a reduction in the incidence of sepsis, thrombosis, SIRS, organ failure (liver, 
lung, kidney, circulation) and mortality.
Results eight hundred and seven children (343 female, 464 male) with 
a heterogeneous background of underlying diagnoses and a Gaussian 
distribution to either the control group (406 patients) or the inline fi  ltration 
group (401 patients) were included. According to the study criteria, a 
signifi  cant reduction in the incidence of SIRS for the interventional group 
(95% CI, 145 versus 200 patients, P <0.001) was evident. No diff  erences 
were demonstrated for the occurrence of sepsis, thrombosis, organ failure 
(liver, lung, kidney, circulation) or mortality between the control and 
interventional groups.
Conclusions The occurrence of SIRS often complicates the treatment in 
intensive care medicine. Inline fi  ltration is most eff  ective, reducing the 
incidence of SIRS, and off  ers a novel therapeutic option.
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Introduction Intravenous catheter-related bloodstream infections (ICR-BSI) 
are a major contributing factor to in-hospital mortality and morbidity, 
extending the inpatient stay by 10 days and expenditure per patient by 
£2,000 to £30,000 [1]. A prospective survey was conducted in our unit on all 
patients with central venous catheters to ascertain the incidence of ICR-BSI, 
identify the organisms and determine the occurrence of infection from the 
various sites – femoral, internal jugular and subclavian lines.
Methods The survey was carried out over a period of 13 weeks. Data 
collected from patients’ case notes included site of central line insertion, 
length of line in situ, reason for line removal and positive blood culture 
reports.
Results During the study period, 104 patients were treated on the unit. 
Fifty-two central venous lines were inserted in 36 patients (63.5% femoral 
(n = 33), 32.7% internal jugular (n = 17) and 3.9% subclavian lines (n = 2)). 
The lines were reviewed daily and removed if indicated clinically (pyrexia 
or raised white cell count) or if not required. A total 51.5% of femoral lines 
(n = 17) were removed due to clinical indications, as were 29% (n = 5) of 
internal jugular and 50% (n = 1) of subclavian lines. The average duration 
of a line remaining in situ was 4.5 days for femoral, 6 days for internal 
jugular and 5 days for subclavian lines. Blood cultures were taken at the 
time of line removal. These yielded positive results in eight femoral, seven 
internal jugular and one subclavian line. Our survey indicated that the 
incidence of ICR-BSI in our unit is 30.8% (of this 62.5% coagulase-negative 
staphylococci (CNS), 12.5% E. coli and Pseudomonas each, and 6.25% MSSA 
and MRSA each).
Conclusions The distribution of microorganisms causing bacteraemia is 
broadly similar in our unit to that in other teaching hospitals in the UK [2], 
in that CNS was the commonest organism isolated. However, E. coli and 
Pseudomonas were the next common organisms, unlike other units where 
Staphylococcus aureus was the second most prevalent organism. The 
incidence of bacteraemia from femoral lines (53.7/1,000 catheter-days) 
was lower than that from internal jugular lines (68.6/1,000 catheter-days) 
possibly due to a higher index of suspicion in the case of femoral lines and 
earlier removal (Figure 1). Our study highlights the fact that femoral lines, 
which are often the safest option for unstable patients with head injury, 
can be eff  ectively managed with strict adherence to guidelines to reduce 
ICR-BSI.
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Figure 1 (abstract P384). Incidence of ICR-BSI in The Walton Centre for 
Neurology and Neurosurgery intensive therapy unit.
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Introduction The central venous catheter (CVC) is indispensable in the 
ICU. Catheter-related bloodstream infection (CR-BSI) is the leading cause 
of healthcare-associated infections and one of the most important 
complications from the CVC. Nowadays there are two well-known ways 
to diagnose CR-BSI: the standard method (withdrawal of the catheter) 
and the conservative method (without withdrawal of the catheter). Our 
objective was to compare the in-hospital mortality between the two 
methods in patients with CR-BSI (short-term catheter) in the ICU.
Methods This study was conducted in a 38-bed mixed ICU in a tertiary 
hospital. We reviewed all episodes of CR-BSI that occurred in our ICU from 
January 2000 to December 2008. The standard method was defi  ned in 
a patient with a CVC with at least one positive blood culture obtained 
from a peripheral vein and a positive semiquantitative (>15 CFU) catheter 
segment culture whereby the same organism (species and antibiogram) 
was isolated from the catheter segment and peripheral blood. The 
conservative method was defi  ned in a patient with a CVC with at least 
one positive blood culture obtained from a peripheral vein and one of the 
following: diff  erential time period of CVC culture versus peripheral culture 
positivity of more than 2 hours, or simultaneous quantitative blood culture 
with a ratio ≥5:1 (CVC versus peripheral).
Results During the study period, 247 episodes of bloodstream infection 
were identifi   ed; of these, 192 were catheter-associated bloodstream 
infection and 55 were CR-BSI (39 standard method and 17 conservative 
method). Considering the CR-BSI patients, the mean age ± standard 
variation (SD) was 64 ± 19.29 (years), 75% were under mechanical 
ventilation, 55% were under vasopressors, 40% were under total parental 
nutrition, 40% were under hemodialysis, 72% were double lumen and the 
mean time ± SD in place was 16.32 ± 8.56 (days). The in-hospital mortality 
of the standard method versus the conservative method did not show any 
diff  erence (57% vs 75%, P = 0.208).
Conclusions This study showed that there is no diff  erence in the in-
hospital mortality between the standard method versus the conservative 
method in patients in the ICU with CR-BSI.
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Introduction In previous guidelines of the Centers for Disease Control 
and Prevention (CDC) [1] and in the recently published Guidelines of 
the Society for Healthcare Epidemiology of America/Infectious Diseases 
Society of America (SHEA/IDSA) [2] it is recommended to avoid the 
femoral access to reduce the risk of catheter-related bacteremia (CRB). 
However, in these guidelines there are no recommendations for the 
catheter site regarding the presence of tracheostomy, and we have not 
found data about the incidence of CRB comparing a central jugular site 
with tracheostomy and a femoral site. The objective of this study was to 
determine whether a jugular site with tracheostomy may have a higher 
risk of CRB than a femoral site.
Methods A prospective, observational, 4-year study (from 1 May 2000 to 
30 April 2004) was carried out in the medical–surgical ICU of the University 
Hospital of the Canary Islands (Tenerife, Spain). We included all patients 
undergoing a central jugular catheterization with tracheostomy or femoral 
venous catheterization.
Results In the period of study, were used 208 catheters in femoral access 
and 52 catheters in central internal jugular access with tracheostomy. There 
were no signifi  cant diff  erences between patients with central jugular with 
tracheostomy and femoral access in age, sex, APACHE II score, diagnosis 
group, use of mechanical ventilation, use of antimicrobials, use of total 
parenteral nutrition, use of pulmonary artery catheter, and duration of the 
catheter. We diagnosed 16 CRB in 208 femoral catheters during 1,679 days 
of catheterization and 10 CRB in 52 central internal jugular catheters with 
tracheostomy during 462 days of catheterization. The incidence of CRB 
was higher in the central internal jugular with tracheostomy than in the 
femoral site (21.64 vs 9.52 per 1,000 catheter-days; risk ratio = 2.27; 95% 
confi  dence interval = 1.04 to 4.97; P = 0.04).
Conclusions The femoral site could be considered a more safe venous 
access than the central internal jugular in patients with tracheostomy to 
minimize the risk of CRB.
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Introduction  The central venous catheter (CVC) is very useful in the 
ICU. A comparative study between antiseptic impregnated and standard 
catheters is therefore of great value.
Methods Alternating the type of CVC used in each patient, we recorded 
for each patient: sex, age, APACHE II score, GCS, site of the puncture, reason 
for withdrawal of the catheter and the type of catheter used. The tip of the 
catheter was cultured. The groups were divided: group I (41 patients, 54 
punctures) used the standard CVC, and group II (38 patients, 54 punctures) 
used the impregnated CVC.
Results Sixty-two patients were included (48.38% male). We studied 108 
periods, of which 54 were standard CVCs and 54 were impregnated CVCs. 
The average length of stay was higher for impregnated CVCs (14.11 days) 
compared with standard CVCs (10.7 days). Excluding death in both groups, 
the length of stay of the catheter in group I was 10.86 days, compared 
with 15.43 days in group II. Adding all periods of catheterization, group I 
have an amount of 578 days, and 762 days for group II. The total duration 
for group II was 31.84% higher than for group I. Regarding the reason for 
withdrawal of the CVC, predominant were suspected infection 77.8% of 
the time for standard CVCs, and 49.1% of the time for impregnated CVCs. 
The culture of the catheter’s tip was positive in 10 (18.5%) standard CVs, 
against eight (15.1%) CVCs in the impregnated group. Most patients had 
GCS <9.The average APACHE II score was17.97 in group I, compared with 
19.63 in group II. The predominant site of puncture was the subclavian 
vein (56.48%). See Figure 1.
Conclusions According to our study we observed that the length of 
stay with use of the impregnated CVC was higher (15.43 days). The rate 
of colonization was higher in the standard CVC. Patients who require a 
CVC for long periods have benefi  ted with the use of impregnated CVCs, 
Figure 1 (abstract P387).
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avoiding complications related to the procedure of successive punctures 
and related to the permanence of the catheters. The benefi  t reached by 
the use of antiseptic impregnated catheters compensated for the initial 
expensive cost of 40%.
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Introduction The use of peripherally inserted central catheters (PICCs) 
in the hospital setting has been indicated as an alternative to the short-
term central venous catheter (ST-CVC) in providing prolonged intravenous 
access. The aim of our study was to assess the rate of complications (deep 
venous thrombosis (DVT), infections) in patients discharged from the ICU 
with a PICC or a ST-CVC.
Methods  A total of 239 patients discharged from our ICU (Careggi 
Teaching Hospital, Florence, Italy) have been followed (March 2007 to 
December 2008). PICCs were used in 114 patients (PICC group), whereas 
ST-CVCs were placed in 125 patients (ST-CVC group). Data, expressed as 
the mean, were analysed with the Mann–Whitney test and Fisher’s exact 
test (P <0.05).
Results The PICC group and ST-CVC group resulted similar in age (54.3 
vs 58.8), BMI (25.6 vs 26.5), SAPS II (46.2 vs 46.5), and ICU length of stay 
(17.6 vs 16.4). Admission diagnoses in the PICC and ST-CVC groups 
were also similar: major trauma (38.6% vs 44.8%), sepsis (37.7% vs 32%), 
postsurgical complications (23.7% vs 23.2%). Total PICC catheter-days 
were 4,024, whereas total ST-CVC catheter-days were 2,764. Despite 
similar demographic and clinical characteristics, the PICC group showed 
a signifi  cantly higher rate of DVT than ST-CVC group (37.7% vs 14.4%; 
P  <0.01). This diff   erence resulted signifi   cant also with catheter-day 
correction (number of events*1,000/catheter-days). The highest incidence 
of DTV events occurred after 15 days from placement in both groups.
Conclusions In our experience, the signifi  cant rate of DVT found using 
PICCs induces one to consider a presumably higher thrombogenicity of 
this kind of catheter. Based on our result, the use of ST-CVC in patients 
discharged from the ICU, who are at higher risk of DVT development in 
regard of the recent critically ill status, might be more appropriate.
P389
Vacuum-assisted closure of laparostomy, an effi   cient strategy for 
complicated intra-abdominal infection
NG Germano, IG Gonçalves, B Moya, R Ribeiro
Hospital S Bernardo, Setúbal, Portugal
Critical Care 2010, 14(Suppl 1):P389 (doi: 10.1186/cc8621)
Introduction The chirurgical strategy for infection control in complicated 
intra-abdominal infections is responsible alone for 40% reduction in 
mortality. The second look strategy in tertiary peritonitis reduces the 
mortality and morbidity of the patients. Vacuum-assisted closure therapy 
can potentially decrease the concentration of proinfl  ammatory cytokines, 
bacterial count, management of third-space fl  uid and improved input and 
output monitoring.
Methods  The authors present a revision of 60 patients with tertiary 
peritonitis admitted to the ICU after chirurgical infection control. All 
patients have septic shock at admission. Twelve percent of them were 
admitted with an open abdomen and vacuum-assisted closure therapy 
was used. The parameters evaluated were hospital mortality, ICU stay 
(days) and time of mechanical ventilation (days).
Results The patients submitted to vacuum-assisted closure therapy were 
similar to patients in whom the abdominal wall was closed, regarding 
the risk factors for peritoneal infection (corticotherapy, oncologic disease, 
renal insuffi   ciency, hepatic insuffi   ciency, desnutrition, hypoalbuminemia, 
a high APACHE II score). The patients submitted to vacuum-assisted 
closure therapy had a higher ICU stay and time of mechanical ventilation 
but lower hospital mortality.
Conclusions  Vacuum-assisted closure therapy is superior to primary 
abdominal wall closure in patients with tertiary peritonitis.
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Introduction The Sequential Organ Failure Assessment (SOFA) score is 
a widely used method to describe organ dysfunction/failure in critically 
ill patients. Although the majority of the studies use the SOFA score in 
outcome research, little is known about its correlation to left ventricular 
(LV) function in patients with severe sepsis and septic shock. The purpose 
of this study was to evaluate the correlation of SOFA score and LV function 
by tissue Doppler imaging in this patient population.
Methods Sixty patients (ages 66 ± 15, men n = 28) admitted to the ICU with 
severe sepsis or septic shock were prospectively enrolled. Transthoracic 
echocardiography was performed within 24 hours of admission to the ICU. 
We measured the LV end diastolic volume index (LVEDVI), LV end systolic 
volume index (LVESVI), LV ejection fraction (LVEF), mitral deceleration time 
of E velocity (Dct) and myocardial tissue Doppler strain imaging profi  les at 
the basal, mid and apical portions of the LV septal wall in the LV apical four-
chamber view. On the ICU admission day, the SOFA scores were calculated. 
Signifi  cantly correlated parameters were subjected to linear regression 
analysis. P <0.05 was considered signifi  cant.
Results The mean heart rate was 90 ± 17 bpm, mean LV volumes, mean 
LVEF and mean Dct were within normal limits (LVEDVI; 44.6 ± 15.4 ml/m2, 
LVESVI; 18.7 ± 11.5 ml/m2, LVEF; 58.9 ± 15.7%, Dct; 175.8 ± 50.2 ms). The 
mean peak systolic strain measurements were –16.0 ± 5.0% (basal; –18.1 ± 
7.0%, mid; –15.7 ± 5.6%, apical; –14.1 ± 6.6%). The mean SOFA score was 
10.8 ± 3.9. Linear regression analysis showed correlation between the 
SOFA score and LVEF (r = –0.40, P = 0.02), Dct (r = –0.34, P = 0.007), mean 
septal strain (r = 0.40, P = 0.002), mid-septal strain (r = 0.43, P = 0.0007) and 
apical septal strain (r = 0.36, P = 0.006).
Conclusions These results suggest that the higher SOFA score had lower 
LVEF, lower LV systolic strain and higher LV fi  lling pressure in the patients 
with severe sepsis or septic shock. An assessment of the left ventricular 
longitudinal contraction by tissue Doppler strain imaging may serve as 
a useful tool to evaluate multiple organ failure in this patient population.
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Introduction  The exact mechanisms causing cardiac dysfunction in 
sepsis are still in major part obscure or controversial.
Methods All patients who had the criteria for severe sepsis or septic shock 
underwent daily transthoracic echocardiography examinations from 
which detailed data on left ventricular end-diastolic, end-systolic volumes 
areas, and diastolic measurements were obtained. In addition, numerous 
clinical, hemodynamic, respiratory and laboratory data were prospectively 
collected, including data on survival up to 2 years after admission. Blood 
samples were collected, centrifuged and serum separated for additional 
biomarker tests, mainly troponin and NT-proBNP.
Results A total of 262 patients had 712 (2.5 ± 1.4) transthoracic echo-
cardiography examinations. APACHE was 20.6 ± 7.3, 41% had positive 
blood cultures, >40% died within 4 months. On multivariate Cox survival 
analysis, the LV ejection fraction, end-diastolic volume and Em wave on 
tissue Doppler imaging independently predicted improved survival and 
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0.969, 0.9, 1.004 and P <0.0001, P <0.0001, P = 0.001, P = 0.002, respectively). 
Only 45% of patients with end-diastolic volume index <40 ml survived 
more than 4 months, compared with 75% survival in patients with end-
diastolic volume index >54 ml.
Conclusions  Decreased ejection fraction, decreased end-diastolic 
volume, diastolic dysfunction and tachycardia are independent predictors 
of early mortality in severe sepsis and septic shock.
P392
Frequency and clinical spectrum of myocardial dysfunction in 
severe sepsis and septic shock
JN Pulido, T Yuasa, M Masaki, S Gillespie, V Herasevich, S Mankad, B Afessa, 
D Brown, J Oh
Mayo Clinic, Rochester, MN, USA
Critical Care 2010, 14(Suppl 1):P392 (doi: 10.1186/cc8624)
Introduction Myocardial dysfunction is reportedly a common compli-
cation of sepsis that requires specifi  c management. Although frequently 
reported in the literature, the clinical spectrum and frequency of this 
organ failure have not been fully appreciated. We sought to determine 
the frequency of myocardial dysfunction in severe sepsis and septic shock 
and to describe the clinical spectrum of this entity with transthoracic 
echocardiography.
Methods Prospective single-center study capturing all patients admitted 
to the ICU with severe sepsis or septic shock from May 2007 to January 
2009. All patients enrolled underwent comprehensive transthoracic 
echocardiography on admission. The exclusion criteria included <18 years 
of age, pregnancy, documented ischemic, valvular or congenital heart 
disease. All patients with LV systolic dysfunction defi  ned as LVEF <50% 
received a repeat echocardiographic study at 5 days or upon dismissal 
from ICU.
Results  One hundred and six patients were enrolled, mean age was 
65, and 50% were female. The mean SOFA score was 11. Central venous 
oxygen saturation was less than 70% in 37% of patients. Twenty-nine 
patients (27%) had global LV systolic dysfunction (14 = mild, nine = 
moderate, six = severe), 33 patients (31%) had RV dysfunction (18 = mild, 
nine = moderate, six = severe), 14 patients had biventricular involvement 
(13%) and 39 patients (37%) had diastolic fi  lling abnormalities. Of the 29 
patients with LV systolic dysfunction on initial examination, 28 received a 
follow-up echocardiogram and 96% of these patients (n = 27) improved 
in all parameters. Thirty-day mortality was 39%, 6-month mortality 52%. 
Myocardial dysfunction did not predict mortality.
Conclusions  These results confi   rm that myocardial dysfunction is 
frequent and broad in patients with severe sepsis and septic shock. Right 
ventricular involvement and diastolic abnormalities should be considered 
as part of the clinical spectrum of this entity. There was poor correlation 
with myocardial dysfunction and mortality and it was reversible regardless 
of presentation. We should not focus only on left ventricular ejection 
fraction to diagnose myocardial dysfunction in sepsis, since only a small 
portion of these patients had isolated LV systolic dysfunction.
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Introduction In sepsis, microcirculatory blood fl  ow is impaired. Intravenous 
nitroglycerin (NTG) seems to have no eff  ect on sublingual microcirculation 
[1], but might have a diff  erent eff  ect on intestinal perfusion. The aim of this 
prospective observational sub-study was to evaluate the eff  ect of NTG on 
intestinal microcirculatory fl  ow index (MFI) compared with sublingual MFI 
in the early phase of sepsis.
Methods Eight patients (>18 years) with abdominal sepsis were included. 
Sublingual and intestinal side-stream dark fi  eld (SDF) images were obtained 
and MFIs were calculated. Patients received NTG intravenously for 24 hours 
(2 mg/hour), after fulfi  llment of protocol-driven resuscitation endpoints. 
Nonparametric tests were used to compare MFI baseline with 24 hours and 
for comparison within groups. Data are expressed as median (IQR).
Results At baseline, sublingual and intestinal MFI did not diff  er signifi  cantly 
(2.2 (1.2 to 1.8) vs 2,7 (1.1 to 2.8), P = 0.89). After 24 hours, sublingual and 
intestinal MFI were nonsignifi  cantly higher in comparison with baseline 
(2.33 (0.48 to 3), P = 0.94 vs 2.75 (2.13 to 2.98), P = 0.67). Furthermore, 
groups did not diff  er signifi  cantly (P = 0.46). However, one patient (number 
13) showed a striking decrease in sublingual MFI after 24 hours, whereas 
intestinal MFI did not change over time. In another patient (number 25), 
sublingual MFI improved with a concomitant reduction in intestinal MFI 
over time (Figure 1).
Conclusions In this small population of septic patients we could not 
detect signifi   cant diff   erences between the sublingual and intestinal 
microcirculation in response to NTG after a strict resuscitation protocol. 
However, in individuals there were marked diff  erences in absolute values 
of sublingual and intestinal microcirculatory blood fl  ow at baseline and 
after 24 hours, as well as in diff  erences over time. These observations 
on dynamic microcirculatory changes in response to a specifi   c 
Figure 1 (abstract P391). Survival functions.
Figure 1 (abstract P393). MFI with time per patient.
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microcirculatory blood fl  ow in sepsis.
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Introduction Diastolic dysfunction as demonstrated by tissue Doppler 
imaging (TDI), particularly E/E’ (peak early diastolic transmitral/peak early 
diastolic mitral annular velocity) is common in critical illness. In septic shock, 
the prognostic value of TDI is undefi  ned. This study sought to evaluate 
and compare the prognostic signifi  cance of TDI and cardiac biomarkers 
(B-type natriuretic peptide (BNP); N-terminal proBNP (NTproBNP); troponin 
T (TnT)) in septic shock. The contribution of fl   uid management and 
diastolic dysfunction to elevation of BNP was also evaluated.
Methods Twenty-one consecutive adult patients from a multidisciplinary 
ICU underwent transthoracic echocardiography and blood collection 
within 72 hours of developing septic shock.
Results The mean ± SD APACHE III score was 80.1 ± 23.8. Hospital mortality 
was 29%. E/E’ was signifi  cantly higher in hospital nonsurvivors (15.32 ± 2.74, 
survivors 9.05 ± 2.75; P = 0.0002). Areas under ROC curves were E/E’ 0.94, 
TnT 0.86, BNP 0.78 and NTproBNP 0.67. An E/E’ threshold of 14.5 off  ered 
100% sensitivity and 83% specifi  city. Adjustment for APACHE III, cardiac 
disease, fl  uid balance and grade of diastolic function, demonstrated E/E’ as 
an independent predictor of hospital mortality (P = 0.019). Multiple linear 
regression incorporating APACHE III, gender, cardiac disease, fl  uid balance, 
noradrenaline dose, C-reactive protein, ejection fraction and diastolic 
dysfunction yielded APACHE III (P = 0.033), fl  uid balance (P = 0.001) and 
diastolic dysfunction (P = 0.009) as independent predictors of lnBNP.
Conclusions E/E’ is an independent predictor of hospital survival in septic 
shock. It off  ers better discrimination between survivors and nonsurvivors 
than cardiac biomarkers. Fluid balance and diastolic dysfunction were 
independent predictors of BNP concentration in septic shock.
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Introduction Elevated serum levels of cardiac-specifi  c troponin I (cTnI) 
are claimed to be associated with the degree of sepsis-related cardiac 
dysfunction and with the disease outcome in critically ill. We tested this 
association in a specifi  c group of ICU patients with post-traumatic sepsis.
Methods A prospective observational study was conducted in an ICU of 
a level I-equivalent trauma center between September 2008 and August 
2009. No exclusion criteria were adopted. Serum cTnI concentrations were 
collected at peak sepsis-related cardiovascular dysfunction (defi  ned by 
the highest pressure adjusted heart rate (PAR) in MODS score and by the 
dose of the inotrope). Data were gathered on demographics, severity of 
infl  ammatory response (SIRS criteria) and organ dysfunction (MODS score), 
presence of superimposed acute coronary events, other potential reasons 
for cTnI elevation and the disease outcome. Intergroup comparisons were 
made with Student’s t test/nonparametric alternatives. The prognostic 
utility of cTnI was examined by the construction of ROC curves and its 
levels were categorized on the basis of the defi  ned cut-off   value. Probable 
associations between these categories and the organ dysfunction severity, 
as well as the outcome, were examined with Fisher’s exact test.
Results A total of 92 polytrauma patients were enrolled. The confi  dence 
intervals of PAR, MODS and SIRS were 21.26 ± 2.72, 6.99 ± 2.94 and 3.75 ± 
1.10, respectively. Blunt cardiac injury had been diagnosed in 20 patients 
(21.7%) on admission. Three patients (3.3%) developed acute coronary 
events during their ICU stay and 12 patients (13.2%) had other potential 
reasons for cTnI elevation. Signifi  cantly higher cTnI concentrations were 
found in the critically ill with myocardial contusion and with acute coronary 
events. However, the presence of blunt cardiac injury had no measurable 
outcome eff  ect. Troponin I levels were signifi  cantly higher in nonsurvivors 
(P  = 0.00) and very good prognostic performance of cTnI was found 
(AUROC = 0.82; cut-off   value = 0.05 ng/ml). The subsequent comparison 
between its categorized values and those of PAR and MODS showed strong 
positive association. Elevated cTnI concentrations (>0.05 ng/ml) signifi  cantly 
increased the risk of death (RR = 5.58; 95% CI = 1.67 to 20.79; P = 0.002).
Conclusions In a group of patients with post-traumatic sepsis elevated 
serum cTnI levels proved to be a good marker of severe organ (including 
cardiovascular) dysfunction. They also showed reasonable prognostic 
value regarding the disease outcome.
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patients with community-acquired sepsis
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Introduction  Alterations in haemodynamic parameters in septic 
cardiomyopathy are usual. While patients with APACHE II score <15 have a 
low risk of death, patients with score ≥15 have one of >25%. In a subgroup 
of our monocentric observational ProFS study (depiction of patients with 
community-acquired sepsis in the emergency department), systolic and 
diastolic function were evaluated concerning patients risk of death.
Methods Echocardiographic examination was performed at admission, 
after 24 and 72 hours. The left ventricular systolic ejection fraction (EF, %) 
Figure 1 (abstract P396). Systolic and diastolic function indices in sepsis. n.s., not signifi  cant.
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velocity of septal mitral annulus (E’, cm/second) was measured using 
tissue Doppler imaging. APACHE II score was calculated at admission. By 
APACHE II score, two groups were formed: low APACHE II score (LAS) was 
defi  ned as 0 to 14 patients and high APACHE II score (HAS) ≥15 patients.
Results  In 65 of 208 patients an echocardiographic examination was 
performed. Age (61.0 ± 18.4 vs 63.5 ± 16.9 years, P = NS), male sex (64.5% vs 
58.8%, P = NS) and mean artery pressure (86.2 ± 15.7 vs 85.7 ± 21.2 mmHg, 
P = NS) were comparable, whereas patients with HAS had a higher heart 
rate (96.5 ± 24.5 vs 108.2 ± 17.1/minute, P <0.05). At admission, patients 
with HAS had a signifi  cantly lower EF than patients with LAS (55.1 ± 7.0 vs 
50.5 ± 10.1, P <0.05). Diff  erence could not be observed after 24 hours (53.6 
± 7.2 vs 52.4 ± 7.%, P = NS) and 72 hours (53.8 ± 7.3 vs 54.3 ± 7.3, P = NS); 
see Figure 1. Patients with HAS showed a lower initial E’ than patients with 
LAS (6.2 ± 2.1 vs 5.1 ± 2.1, P <0.05) and after 24 hours (6.1 ± 2.2 vs 5.1 ± 1.3, 
P <0.05). Three days after admission, E’ values in patients with LAS and HAS 
were comparable (5.6 ± 2.0 vs 5.7 ± 2.1, P = NS).
Conclusions In patients with community-acquired sepsis and APACHE II 
score ≥15 points, a signifi  cantly depression of both systolic and diastolic 
function could be observed. After 24 hours systolic function and after 72 
hours diastolic function of patients with an APACHE II score <15 and ≥15 
points were similar. This could be possibly due to alterations in afterload.
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S Rehberg, P Enkhbaatar, Y Yamamoto, AK Hasselbach, LD Traber, 
DL Traber
The University of Texas Medical Branch, Galveston, TX, USA
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Introduction  This randomized, controlled experimental trial was 
performed to compare the eff  ects of the selective V1a-receptor agonist 
(Phe2Orn8) vasotocin (POV) and the mixed V1a/V2-receptor agonist (Arg8) 
vasopressin (AVP) on vascular leakage and cardiopulmonary dysfunction 
associated with methicillin-resistant Staphylococcus aureus (MRSA) 
pneumonia-induced septic shock using an established ovine model.
Methods  After instrumentation for chronic hemodynamic monitoring 
and tracheostomy, sheep were subjected to 48 breaths of cotton smoke 
(<40°C) and MRSA was placed into both lungs under deep anesthesia. 
Following a 10 mmHg drop in mean arterial pressure (MAP) from baseline, 
sheep were randomly assigned to receive intravenous infusions of either 
POV, AVP or the vehicle (0.9% NaCl; n = 6 each). POV and AVP were 
titrated to keep MAP above baseline – 10 mmHg. All sheep were awake, 
mechanically ventilated and fl  uid resuscitated to maintain hematocrit at 
baseline ±3%. Data are expressed as mean ± SEM at 24 hours. Fluids are 
represented as the average over time to account for individual survival 
times.
Results  Both treatment strategies signifi   cantly reduced fl   uid input 
(AVP: 7.7 ± 0.6 ml/kg/hour; POV: 5.8 ± 0.8 ml/kg/hour), positive net fl  uid 
balance (AVP: 4.9 ± 0.5 ml/kg/hour; POV: 0.4 ± 0.6 ml/kg/hour), thoracic 
(AVP: 0.8 ± 0.2 ml/kg/hour; POV: 0.3 ± 0.1 ml/kg/hour) and abdominal 
fl  uid (AVP: 0.10 ± 0.04 ml/kg/hour; POV: 0.01 ± 0.01 ml/kg/hour) as well 
as extravascular lung water (AVP: 22.6 ± 1.4 ml/kg; POV: 15.8 ± 1.9 ml/
kg) and increased plasma oncotic pressures (AVP: 12.5 ± 0.9 mmHg; POV: 
15.9 ± 1.1 mmHg) vs control animals (9.6 ± 0.4 ml/kg/hour; 7.7 ± 0.4 ml/kg/
hour; 2.2 ± 0.4 ml/kg/hour; 0.29 ± 0.13 ml/kg/hour; 22.9 ± 2.8 ml/kg; 8.9 ± 
0.1 mmHg, respectively). Notably, POV was superior to AVP in all these 
variables (P <0.05 each). Myocardial contractility was higher in the POV 
group vs AVP and control animals as suggested by higher left ventricular 
stroke work indexes (66 ± 3 vs 48 ± 7 and 43 ± 3 g/m/m2, respectively; 
P <0.05 each) at lower or similar global end-diastolic volumes. Pulmonary 
dysfunction (decrease in PaO2/FiO2 ratio) was attenuated in POV (364 ± 
47 mmHg) as compared with AVP (195 ± 66 mmHg; P <0.05) and control 
animals (213 ± 76 mmHg; P <0.05). Whereas one AVP and three control 
animals had to be sacrifi  ced prematurely, all POV-treated animals survived 
the 24-hour study period.
Conclusions  In MRSA pneumonia-induced ovine septic shock, the 
selective V1a-receptor agonist POV is superior to the mixed V1a/V2-
receptor agonist AVP in reducing vascular leakage and cardiopulmonary 
dysfunction when administered as a fi  rst-line vasopressor.
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Sepsis resuscitation bundle compliance in septic shock: improves 
survival and yet better late than never
V Coba, HFH Sepsis Collaborative Group
Henry Ford Hospital, Detroit, MI, USA
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Introduction Improvements in survival for acute myocardial infarction, 
trauma, and stroke have been realized through continuous quality 
improvement (CQI) initiatives that include early identifi   cation and 
implementation of time-sensitive therapies at the earliest stage of disease 
presentation. In addition, challenges in the management of severe 
sepsis and septic shock remain in regards to implementation of an early 
sepsis resuscitation bundle (RB) in order to maximize outcome benefi  t. 
We examined the impact of a hospital-wide CQI initiative on septic RB 
compliance and outcome and investigated the mortality benefi  ts beyond 
the 6-hour recommendation period.
Methods Prospective cohort study of patients who met the defi  nition of 
severe sepsis or septic shock over an 18-month period. Current sepsis RB 
being MAP ≥65, CVP ≥8 and SvO2 ≥70% goals met within 6 hours and 
18 hours upon presentation.
Results The 498 severe sepsis and septic shock patients were enrolled and 
examined at what time period would the RB still be eff  ective. Using a time 
cut-off  , the Compliers at 18 hours and NonCompliers at 18 hours were 
then compared. There were 202 patients who had the RB completed in less 
than or equal to 18 hours (Compliers at 18 hours). There were 296 patients 
who never completed the RB within 18 hours (NonCompliers at 18 hours). 
The Compliers at 18 hours had a signifi  cant 10.2% lower hospital mortality 
at 37.1% (22% relative reduction) compared with the NonCompliers at 
18 hours hospital mortality of 47.3% (P <0.03). Adjusting for diff  erences in 
baseline illness severity, the Compliers at 18 hours had a greater reduction 
in predicted mortality of 26.8% vs 9.4%, P <0.01. Compliance started at 
30.4% and fi  nished at 63%.
Conclusions A CQI initiative for severe sepsis and septic shock with particular 
emphasis on the RB signifi  cantly improved bundle compliance and decreased 
hospital mortality. It has been previously shown that compliance to the RB 
within 6 hours improves outcome; however, when the time of bundle 
completion is extended to 18 hours, the mortality benefi  ts are still signifi  cant.
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Introduction To investigate the eff  ect of myocardial preservation of early 
goal-directed therapy (EGDT) on severe sepsis/septic shock patients in the 
ICU.
Methods This is a prospective and randomized controlled study, in which 
the total 158 severe sepsis/septic shock patients from the ICU were randomly 
assigned into two groups (EGDT group, n = 81 and control group, n = 77). 
Then the concentration of serum cardiac troponin I (cTnI), high sensitivity 
C-reactive protein (hs-CRP) and APACHE II score of patients were obtained 
on the 0, 3rd, 7th, and 14th day after fl  uid resuscitation therapy.
Results The levels of cTnI were the same between the EGDT and control 
groups on day 0 (exceeded normal cTnI patients in two groups 0.41 vs 
0.42, normal cTnI patients in two groups 0.05 vs 0.04, P >0.05), there was 
a dramatic decrease in exceeded normal cTnI patients of the EGDT group, 
in which cTnI returned to normal after EGDT (14th day: exceeded normal 
cTnI patients in two groups 0.08 vs 0.16, P <0.05); however, only a little 
diff  erence in normal cTnI patients of the two groups (P >0.05). The level 
of hs-CRP changed like cTnI (P <0.05), and there was positive correlation 
between cTnI and hs-CRP on each time (P  <0.05); APACHE II scores 
obviously decrease in the EGDT group (P <0.05). Meanwhile, the EGDT 
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time than that of the control group (74.1% vs 55.8%; 23.5 vs 19.6, P <0.05).
Conclusions EGDT has an eff  ect of myocardial preservation and improves 
the survival rate for severe sepsis/septic shock patients in the ICU.
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Introduction Patients suff  ering from severe sepsis and septic shock have a 
high mortality. Studies have demonstrated that the septic bundle strategy 
decreased the mortality of severe sepsis and septic shock. The aim of this 
study was to compare the impact of the sepsis bundle strategy on the 
outcomes of the patients suff  ering from severe sepsis and septic shock in 
our emergency department.
Methods A prospective study was performed. The studied population 
included severe sepsis and septic shock patients entered into the 
Surviving Sepsis Campaign (SSC) database, who were admitted to the 
emergency department of an urban tertiary-care medical center during 
June 2008 to June 2009. They were divided into two groups based on the 
admission time (Group 1: June 2008 to December 2008, baseline survey of 
real practice in sepsis therapy before creating a protocol. Group 2: January 
2009 to June 2009, creating a protocol implementing sepsis resuscitation 
bundle in sepsis therapy). Acute Physiology and Chronic Health Evaluation 
(APACHE II) scores, treatments and in-hospital mortality were compared.
Results The timing giving broad-spectrum antibiotics of ED admission 
was 3.67 hours in Group 1 and 2.52 hours in Group 2 (P <0.01). Blood 
cultures before antibiotics administration was 39.7% in Group 1 and 
56.3% in Group 2 (P <0.01). Fluid bolus (20 ml/kg) delivered followed by 
vasopressors if needed was 27% in Group 1 and 76% in Group 2 (P <0.01). 
In-hospital mortality was 44.8% in Group 1 and 35.6% in group, in-hospital 
mortality decreased by 9.2% (P <0.01).
Conclusions Creating a protocol implementing sepsis bundles improved 
compliance for the bundle strategy on the treatment of severe sepsis and 
septic shock and decreased in-hospital mortality.
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Introduction Sepsis mortality rates in Brazil are high [1,2]. Many studies 
have already shown that implementation of education programs based 
on Surviving Sepsis Campaign 6-hour (6h SSC) and 24-hour bundles 
successfully reduces sepsis mortality. The objective of this study was to 
evaluate the impact of the SSC-based program on patient outcome in Brazil.
Methods  Severe sepsis and septic shock patients were included in 
voluntary participating hospitals that have sent data for at least 2 years. 
The intervention was based on strategies aimed at improving compliance 
with the bundles. Regular reports containing compliance and mortality 
data were sent to the hospital in order to base local strategies of improving 
care. Results are presented by the semester of hospital inclusion in the 
campaign through 2 years, regardless of when those months occurred in 
the time frame of the study. Results were considered signifi  cant if P <0.05.
Results From February 2005 and August 2009, 19 hospitals included 2,135 
patients in a nonconcomitant fashion. Demographic data are restricted as 
in the SSC database. Septic shock patients comprised 52% of the patients 
with a mean number of organ dysfunctions of 2.34 ± 1.33, and 38.6% were 
admitted from the ER and 24.9% developed sepsis during their ICU stay. 
Compliance to 6h SSC increased from the fi  rst to the fourth semester as 
follows: lactate: 65.0% to 71.5%, P = 0.01, blood culture: 42.5% to 50.3%, P = 
0.08, antibiotics: 38.9% to 45.3%, P = 0.02, achieving mean arterial pressure 
>65 mmHg: 43.7% to 75.4%, P <0.000, CVP achievement: 14.6% to 36.6%, 
P <0.000, SvO2 achievement: 10.4 to 22.7, P = 0.000 and completion of 
the whole bundle: 8.3 to 9.0, P = 0.34. A 7% absolute reduction (relative 
reduction of 11.6%) in hospital mortality was found in the third semester 
of the campaign (OR 1.33 (1.04 to 1.69), P = 0.01). However, in the fourth 
semester mortality has increased again to 60.6%.
Conclusions Implementation of the SSC in Brazil has been associated 
with increased bundle adherence. However, the impact on the mortality 
rate seems not to be sustained, probably due to the diffi   culty associated 
with keeping an education program. It is important to develop strategies 
aiming to increase motivation in Brazilian hospitals.
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Introduction Noradrenaline and dopamine were the standard catechol-
amines used in the treatment of septic shock. Loss of response was the 
common problem that led to patient loss after large continuous doses of 
noradrenaline, which was termed catecholamine refractory septic shock. 
Recently vasopressin and its analog, namely terlipressin, were used in the 
treatment of such a catastrophic condition.
Methods  In a prospective controlled study we included 40 patients 
with catecholamine-resistant septic shock (that is, noradrenaline dose 
exceeded 0.6 μg/kg/minute) divided into two groups: 20 patients were 
treated conventionally according to the Surviving Sepsis Campaign 2008, 
who served as a control group; and the other 20 patients were treated 
conventionally and when the noradrenaline dose exceeded 0.6 μg/kg/
minute, terlipressin in a dose of 1 mg intravenous bolus every 12 hours for 
a study time of 48 hours was started.
Results  Terlipressin therapy was associated with increased systemic 
vascular resistance from 546 ± 260 dyne·sec/cm–5 to 986 ± 390 dyne·sec/
cm–5 after 48 hours, which represents normalized arterilor tone that is 
expected to allow better organ bed perfusion. There was a reduction of 
both stroke volume and cardiac output (from 63 ± 16 ml/beat to 51 ml/
beat and from 78 l/minute to 5.3 l/minute, respectively) yet this was not 
associated with abnormal organ perfusion marked by improved urine 
output from 49 ml/hour to 133 ml/hour and improved global perfusion 
as marked by decrease lactic acidosis from 9.3± 3 mEq/l to 5.7 ± 3 mEq/l, 
P <0.002. There was signifi  cant reduction of oxygen delivery (DO2 from 
848 ml/minute to 610 ± 47 ml/minute after 48 hours, P >0.02). There 
was no eff  ect on length of ICU stay in both groups (16 ± 6 days in the 
terlipressin group and 12 ± 6 days in control group, P <0.06). Terlipressin 
support showed nonsignifi  cantly less mortality (60% vs 70% in control 
group). Regarding organ function, terlipressin could improve the SOFA 
score from 11 ± 3.2 to 8 ± 5 with P <0.02.
Conclusions Terlipressin is a rather safe, inexpensive, easy to administer 
alternative in the treatment of septic shock. Further studies are needed to 
decide the ideal timing for initiation of this therapy early vs late adjuvant 
or as an initial treatment.
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Introduction The eff  ectiveness of the interventions recommended by 
the Surviving Sepsis Campaign (SSC) guidelines [1] has never been tested 
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this study we evaluated whether the adherence to the resuscitation sepsis 
bundle improved the outcome of cirrhotic patients with septic shock 
admitted to the ICU.
Methods  The prospective observational cohort study included 38 
patients with documented cirrhosis and septic shock admitted to a 
multidisciplinary ICU at a university hospital from January 2005 to June 
2009. In each patient the compliance to four resuscitation interventions 
recommended by the SSC guidelines (that is, 6-hour bundle) and the 
30-day mortality were measured.
Results The 6-hour bundle was completed in 50% of the patients. In these 
patients the MELD and SOFA scores (39 ± 11 and 18 ± 2) were higher 
(P <0.05) than those observed in patients without compliance to the 
6-hour bundle (31 ± 12 and vs 15 ± 3). The 30-day mortality was 94.7% and 
68.4% (P <0.05) in patients with and without 6-hour bundle compliance, 
respectively. A Cox regression analysis, after adjustment for MELD and 
SOFA scores, indicated that none of the single sepsis interventions as well 
as the 6-hour bundle was independently associated with 30-day survival.
Conclusions  The adherence to the resuscitation interventions 
recommended by the SSC evidence-based guidelines did not improve 
the survival rate of cirrhotic patients with septic shock admitted to our ICU.
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Introduction Although drotrecogin alfa activated (DAA) was approved in 
2002 for the treatment of severe sepsis, controversy has surrounded this 
therapy especially with respect to the increased risk of serious bleeding 
events (SBEs). Recently, there has been further interest in the complications 
of DAA following a review by Gentry and colleagues suggesting a 
signifi  cantly increased incidence of SBEs and death in those with baseline 
bleeding precautions [1]. We are one of the largest single-centre users of 
DAA worldwide and thus are keen to report our experience.
Methods In 2002 a scoring system, reporting tool, and supporting database 
were developed to track the outcome of DAA-treated severe sepsis 
patients in our hospital. This is maintained by the clinical pharmacists and 
captures data on relative contraindications, adverse events and patient 
outcome. Classifi  cation of data is obtained from the electronic patient 
record. Any DAA administration outside agreed criteria is recorded and 
bleeding incidents are reviewed with a consultant intensivist to confi  rm 
categorisation into serious or minor.
Results  Four hundred and forty patients, including some enrolled in 
clinical trials, received DAA in our critical care unit over a 7-year period 
(2003 to 2009). The mean age was 63 years (range 17 to 92). Four hundred 
and twenty-eight (97.3%) patients met agreed criteria for treatment. 
Twelve (2.7%) were treated despite being in single organ failure. Mean 
organ dysfunction was 3.3 and over 75% of patients had at least three 
organ failures. The commonest sites of infection were respiratory (56%), 
abdominal (29%) and urinary tract (4%). The 28-day, critical care and 
hospital mortalities were 35%, 39% and 46%, respectively. Relative 
contraindications (CIs) were identifi  ed for 38 (8.6%) patients treated with 
DAA. Of these, 23 (5.2%) had an increased baseline bleeding risk, most 
commonly thrombocytopenia (2%). Hospital mortality for patients with 
any CI was 47% (n = 18) and 48% (n = 11) if existing predisposition for 
bleeding. In the 440 patients, 67 (15%) bleeding events were reported, but 
only 19 (4%) were considered SBEs (using the defi  nitions from PROWESS 
[2]). Overall mortality for all bleeding events was 57% and 74% for patients 
with SBEs. Administration errors occurred in 34 (7.7%) patients, of which 
three (0.7%) were considered serious. Three hundred and eighteen (72%) 
patients received DAA for at least 72 hours. Of those who did not complete 
the course, 81 (66%) died.
Conclusions We have observed a low incidence of SBEs in patients treated 
with DAA. As expected, SBEs were associated with a poorer outcome. 
We fi  rmly believe an established scoring system and monitoring tool has 
facilitated eff  ective use of DAA whilst minimising associated risks of therapy.
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Introduction  Activated protein C (APC) is an eff   ective treatment in 
multiorgan failure (MOF) due to severe sepsis. Recommended duration 
of treatment of APC is 96 hours infusion. The cost of APC infusion for 
96 hours in a 60 kg person is an average INR 490,000 in India (€7,000) 
(€1 ~ INR 70 in November 2009, average value) whereas the average cost 
of 10 days of ICU treatment for a patient with sepsis with MOF, all inclusive, 
is approximately INR 140,000 in our hospital (€2,000). It is unclear whether 
stopping APC before 96 hours, in patients in whom MOF resolves before 
96 hours, ultimately aff  ects the fi  nal outcome in terms of survival. This 
is more relevant in developing countries like India where the cost of 96 
hours of infusion of APC is beyond the reach of the majority of patients 
eligible for it. We retrospectively analysed the cost savings achieved by 
early stoppage of APC ensuring MOF reversal, before completion of the 
recommended 96 hours infusion.
Methods During a period of 3 years, patients with severe sepsis having 
≥3 organ failures were off  ered the option of APC. For those who opted 
for it, infusion was initiated within 24 hours of onset of MOF. APC infusion 
was stopped before completion of 96 hours only if septic shock, ARDS 
and coagulopathy was completely resolved, otherwise it was continued 
for 96 hours.
Results Two hundred and thirteen patients with severe sepsis having 
MOF were off  ered the option of APC infusion. Twenty patients opted 
for it. In seven patients APC was infused for 96 hours as per the standard 
recommendation. In 13 patients APC infusion could be stopped before 
96 hours assuring complete reversal of MOF. They were enrolled in our 
study. Eleven out of 13 patients were discharged home after complete 
recovery. MOF did not reappear in any of these 13 patients. Two patients 
developed a new episode of ventilatory-associated pneumonia on day 4 
and day 10, respectively, after stopping the infusion of APC and could not 
be salvaged. Average duration of APC infusion was 70.33 ± 20.76 hours. 
Cost of APC infusion per patient for average 70 hours was INR 347,692 
± 38,330 (€4,967). Duration of ICU stay (average) was 11.61 ± 5.18 days. 
Average cost of ICU care for 11 days (excluding cost of APC) per patient 
was INR 144,272 ± 86,754 (€2,061). The cost saving achieved due to early 
stoppage of APC (per patient) was INR 132,708 ± 42,330 (€1,895).
Conclusions Stopping APC infusion before 96 hours in patients who show 
rapid reversal of MOF is associated with signifi  cant cost saving without 
compromising the survival outcome. With this judicious early stoppage 
strategy, a greater number of patients can aff  ord this eff  ective drug.
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Introduction Patients frequently develop a second discrete episode of 
sepsis during an ICU stay such as ventilation-acquired pneumonia (VAP), 
or patients may have a second ICU admission unrelated to their initial 
presentation. In the PROWESS [1] study, drotrecogin alfa (DAA) could not 
be given twice to the same patient; yet this may be a potentially life-saving 
intervention when a second episode of severe sepsis occurs.
Methods We conducted a retrospective study of patients who received 
more than one infusion of DAA in our combined adult surgical and 
medical ICU. The attending ICU physician determined who received a 
second course of DAA.
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354 patients were treated with DAA, seven patients were identifi  ed who 
received DAA twice and one patient received three infusions. Five patients 
treated with two infusions survived to be discharged home. Four patients 
were admitted to the ICU on two separate occasions, for these patients 
one infusion of DAA was given on each admission, three survived, and 
the median interval between admissions was 17 months (range 7 to 
23). Four patients received a second infusion of DAA on the same ICU 
admission, the median interval between the fi  rst and second infusion was 
3.5 days (range 3 to 12), and two survived. The median age was 67 years 
(range 41 to 77) with a median of four organ failures per patient (range 
2 to 5). Those patients who received DAA twice on the same admission 
developed VAP or a line-related infection. Patients admitted for a second 
time had a diff  erent discrete episode of septic shock unrelated to their fi  rst 
admission. There was one major bleeding episode requiring cessation of 
DAA and a blood transfusion. This patient was found to have a duodenal 
ulcer. Six infusions of DAA were not completed, three patients died whilst 
receiving their second infusion, three courses were terminated due to 
rapid improvement in the patient’s condition. No patient experienced 
signifi  cant bleeding during their second infusion.
Conclusions  This is the fi   rst case series to report the outcome of 
patients who have received multiple courses of DAA. The incidence of 
repeat episodes of sepsis during a single admission or the precise rate 
of recurrent sepsis during ICU admissions is not easily identifi  ed in the 
current literature. Our fi  ndings are limited by the heterogeneous nature 
of the patient group and the lack of strict criteria defi  ning who received a 
second course of DAA. A second course of DAA treatment may be justifi  ed 
on a case-by-case basis.
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Introduction We present our experience with drotrecogin alfa (activated 
protein C (APC)) over 4 years (2005 to 2008) in 110 patients and compare 
the fi  ndings with a large UK audit [1].
Methods Data were collected on diagnosis, acuity, complications and 
outcomes. Survival was assessed using standardised mortality ratios.
Results One hundred and ten patients received APC. Two patients had two 
courses. Fifty-six per cent of patients received APC in the fi  rst 24 hours of 
ICU stay; 88% within 48 hours. Sixty-eight per cent of patients completed 
the 96-hour course; 20% died during the infusion; 5% had APC stopped 
because of resolution of severe sepsis. Crude ICU mortality was 47%; 9% 
died after ICU discharge. Survival to hospital discharge was 44%. The SMRs 
were 1.21 (95% CI 1.02 to 1.41) using APACHE II and 1.05 (0.88 to 1.22) using 
the ICNARC method. Three patients had cerebral haemorrhage. Three 
had cerebral thrombotic events. There were no other cases of signifi  cant 
haemorrhage. APC usage fell over the study period 2005 to 2008 with 37, 
35, 26 and 14 patients per year, respectively.
Table 1 (abstract P407). Patient characteristics
Age  57 ± 16
Male sex  53%
APACHE  21 ± 6
ICNARC  29 ± 7.3
Organ failures  5 (4 to 5 IQR)
Postop 38%
Conclusions Our results are similar to those of a UK-wide audit of APC 
usage [1]. The mortality of our patients was higher (56% vs 45%), but our 
patients were probably sicker (median fi  ve organ failures vs three). Based 
on APACHE, actual outcome appears worse than predicted for patients 
receiving APC. Using the ICNARC method score, however, outcomes were 
similar to predicted. Rates of serious complications appeared to be similar 
to those experienced elsewhere. The fall in APC usage over time refl  ects 
uncertainty over its risk–benefi  t profi  le.
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Introduction  Soluble thrombomodulin is a promising therapeutic 
natural anticoagulant that is comparable with antithrombin, tissue factor 
pathway inhibitor and activated protein C. Recently, a recombinant 
human soluble thrombomodulin, composed of the active, extracellular 
domain of thrombomodulin, has become commercially available for 
patients with disseminated intravascular coagulation (DIC). However, its 
eff  ect on adhesion molecule or plasminogen activator inhibitor 1 (PAI-1) 
in patients with DIC is not clear. To elucidate the possible eff  ect of a soluble 
thrombomodulin on endothelial cell and neutrophil interaction in DIC, we 
investigated the effi   cacy of a recombinant human soluble thrombomodulin 
against not only soluble fi  brin (SF) for the sensitive marker of DIC, but also 
soluble E-selectin (sES) and PAI-1 in patients with DIC.
Methods We studied 33 patients with DIC associated with sepsis. DIC 
was diagnosed according to the diagnostic criteria established by the 
Japanese Association for Acute Medicine. Seventeen of 33 patients (RTM 
group) were assigned a recombinant human soluble thrombomodulin 
for 6 consecutive days. SF, sES, and PAI-1 were measured at day 0 (before 
treatment), and day 7. DIC resolution rate, clinical course of bleeding 
symptoms, and survival rates at 90 days were evaluated. Data were 
subjected to Mann–Whitney U test, Kaplan–Meier method and log-rank 
test (P <0.05 being considered statistically signifi  cant).
Results The baseline characteristics at study entry in both groups (17 
treated and 16 control) were almost similar. There were no signifi  cant 
diff   erences of the serum values of platelet, FDP, D-dimer and PAI-1 
between two groups. However, sES and SF values in the RTM group were 
signifi  cantly decreased from 43.9 ± 31.2 (at day 0) to 29.46 ± 15.08 μg/
ml (at day 7) (P = 0.044) and from 44.6 ± 35.5 (at day 0) to 18.5 ± 16.6 μg/
ml (at day 7) (P = 0.039), respectively. Also both the DIC score and SOFA 
score improved signifi  cantly. There was no incidence of bleeding-related 
adverse events up to 7 days after the start of infusion in the RTM group. 
Survival rates at 90 days were 58.8% (RTM group) vs 25.0% (Control group).
Conclusions In patients administered with recombinant human soluble 
thrombomodulin, sES and SF decreased and the DIC score and SOFA score 
improved signifi  cantly. There was no signifi  cant diff  erence between the 
thrombomodulin group and Control group in survival rate, but there was 
a tendency that the RTM group had higher survival rate in comparison 
with the Control group.
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Introduction  Sepsis is one of the most often met complications for 
cancer patients. It is caused by immunosuppression after radiotherapies 
and chemotherapies as extensive operations. For sepsis treatment, 
many experts now recommend even more often using extracorporeal 
detoxifi   cation methods. Since sepsis is more often caused by Gram-
negative microorganisms in clinical hospitals, lipopolysaccharide (LPS) 
adsorption was off  ered for treatment of the patients.
Methods For extracorporeal detoxifi  cation of cancer patients with severe 
Gram-negative sepsis and septic shock (APACHE II score 28 ± 7 on starting 
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Medical AB, Lund, Sweden). The patient’s blood was taken before and 
after adsorption, then the serum was separated and stored at –70°C. We 
determined the LPS concentration by LAL test, lipopolysaccharide-binding 
protein (LBP), sIL-1 RII and sCD14 by ELISA kits (Hycult Biotechnology, the 
Netherlands), and proinfl  ammatory and anti-infl  ammatory cytokines IL-
6, TNFβ, IL-8, IL-2, INFγ, IL-12, TNFα, IL-4, IL-5, IL-1β and IL-10 by ELISA kit 
(Bender MedSystems).
Results In all cases we saw reliable reduction of the LPS level in serum (1.8 
to 2 times). After the investigation of some cytokine levels we obtained 
similar results: IL-6, TNFβ and IL-8 levels had been reduced 30 to 40%, 
87% and 62 to 76% accordingly. At the same time, IL-2, INFγ, IL-12, TNFα, 
IL-4 and IL-5 levels in serum had not changed practically. However, in 
approximately 1/3 cases an IL-1β and IL-10 concentration increase in serum 
was observed (33 and 40% accordingly). Also our research has shown that, 
in the most of the cases after application of this sorbent, LBP decreased 
insignifi  cantly (10 to 32%), but the sIL-1 RII level slightly increased (10 to 
18%) in the majority of patients and considerably decreased (two times) 
in 1/3 investigated patients. The CD14 concentration in patient serum 
reliably did not change before and after adsorption. The somatic status of 
patients was stabilized after LPS adsorption.
Conclusions After LPS adsorption with Alteco® the LPS level in patient 
serum signifi   cantly reduced. Simultaneously, concentrations of some 
cytokines (IL-6, TNFβ, IL-8) were reliably decreased. But the LPS adsorber 
probably does not eliminate soluble receptors like sCD14 and RIL-1 from 
blood. So the LPS adsorption may represent a signifi  cant improvement in 
the treatment of cancer patients with severe Gram-negative sepsis and 
septic shock.
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Introduction It was assumed that pathologic activation of neutrophils 
and monocytes is associated with sepsis, acute lung injury/ARDS, and 
multiple organ failure, and that removal of these cells from the circulation 
could reduce leukocyte-dependent tissue injury. Cartridges containing 
polymyxin B (PMX) immobilized to fi  bers (Toraymyxin; Toray Industries, 
Tokyo, Japan) have been developed for selective adsorption of circulating 
endotoxin in patients with Gram-negative bacterial infection, and this 
treatment has proven to be highly eff  ective. This study examined the 
eff   ect of direct hemoperfusion through fi   lters with immobilized PMX 
direct-hemoperfusion (DHP) on leukocyte function and plasma levels of 
cytokines in patients with septic shock.
Methods We evaluated the eff  ect of PMX-DHP on circulating leukocytes 
in patients with septic shock by assessing the changes of neutrophil 
and monocyte surface antigen expression after PMX-DHP. In another 
experiment, heparinized blood from patients with sepsis was passed 
through PMX fi  lters in a laboratory circuit and then changes of the cell 
count and surface antigen expression by neutrophils and monocytes 
were assessed. After perfusion, neutrophils were isolated and the capacity 
of these cells to damage cultured endothelial monolayers was also 
determined.
Results We found that PMX-DHP led to an increased CXCR1 and CXCR2 
expression along with a decrease of CD64 and CD11b expression by 
circulating neutrophils from septic patients. Plasma levels of cytokines, 
including IL-6, IL-8, IL-10, and high-mobility group box-1, were elevated in 
patients with septic shock compared with healthy controls, but cytokine 
levels were not altered by PMX-DHP. Ex vivo perfusion of heparinized blood 
from patients with sepsis through PMX fi  lters in a laboratory circuit caused 
a signifi  cant decrease of the neutrophil and monocyte counts. Activated 
neutrophils with high CD11b/CD64 expression and low CXCR1/CXCR2 
expression showed preferential adhesion to PMX fi   lters. Neutrophils 
isolated from the blood after ex vivo PMX perfusion caused less damage 
on the endothelial cell monolayer than cells from sham-treated blood.
Conclusions PMX-DHP infl  uences neutrophils via a mechanism that does 
not involve cytokines. Ex vivo results indicate that PMX-DHP selectively 
removes activated neutrophils and reduces the ability of circulating cells to 
cause endothelial damage. Selective removal of activated neutrophils by 
PMX-DHP may contribute to improvement of the systemic infl  ammatory 
reaction in septic patients.
P411
Therapeutic blood purifi  cation using functionalized core/shell 
nanomagnets
IK Herrmann1, M Urner2, FM Koehler1, B Beck Schimmer2, WJ Stark1
1ETH Zurich, Switzerland; 2University Hospital Zurich, Switzerland
Critical Care 2010, 14(Suppl 1):P411 (doi: 10.1186/cc8643)
Introduction  Direct and rapid removal of pathogens or noxious 
metabolites from a patient is the most straightforward cure imaginable. 
Dialysis and plasma fi  ltration/exchange are the current broadly applicable 
methods to perform a direct removal of disease-causing factors from 
a patient. We describe the use of stable nanomagnets to rapidly and 
selectively remove heavy metal ions, overdosed steroid drugs and proteins 
from human blood. This nanomagnet-based purifi  cation method avoids 
fouling of fi  lter membranes and benefi  ts from a high external surface area, 
and a correspondingly fast diff  usion.
Methods  Nanomagnets equipped with heavy metal complexants, 
digoxin antibody fragments and entire human IL-6 antibodies were added 
to a series of blood samples. The nanomagnets scan blood by Brownian 
motion and capture their target. Afterwards, a small magnet was placed at 
the sample tube wall accumulating the nanomagnets in the pole region of 
the external magnet. The purifi  ed supernatant can then easily be decanted. 
The concentrations of lead, digoxin and IL-6 in blood samples were 
determined by standard clinical methods. Blood integrity was observed 
by rotation thromboelastography and monitoring of serum potassium, 
lactate dehydrogenase, bilirubin and haptoglobin levels. To measure the 
biological relevance of the IL-6 removal, the eff  ect on caspase-3 activation 
was assessed in camptothecin-stimulated neutrophils.
Results A signifi  cant decrease of lead, digoxin and IL-6 levels was measured 
after the blood purifi  cation procedure. The extraction using nanomagnets 
was in clear dose–eff  ect dependence and could be accurately titrated. 
Treatment with nanomagnets did not signifi  cantly aff  ect the integrity of 
blood and all levels remained in the clinical norm range. Caspase-3 assays 
showed a reduced anti-apoptotic eff  ect after IL-6 removal, underlining the 
biological relevance of the achieved removal effi   ciency.
Conclusions We demonstrate the extraction of lead, digoxin and IL-6 
from whole blood as an example for the rapid treatment of heavy metal 
poisoning, drug overdosing and severe infl   ammation. The presented 
direct blood extraction could be combined with existing therapeutic 
strategies and may have major implications on the treatment of severe 
intoxications, sepsis (specifi  c fi  ltering of cytokines or toxins) [1], metabolic 
disorders (thyreotoxicosis) and autoimmune diseases.
References
1. Ronco  C,  et al.: N Engl J Med 2003, 348:1600-1602.
P412
Coupled plasma fi  ltration and adsorption in septic shock: 
a multicentric experience
F Turani1, M Falco1, S Natoli2, F Leonardis2, M Fede2, G Berlot3, 
M Pelichovskà3
1European Aurelia Hospital, Rome, Italy; 2University of Tor Vergata, Rome, Italy; 
3University of Trieste, Italy
Critical Care 2010, 14(Suppl 1):P412 (doi: 10.1186/cc8644)
Introduction  Recently extracorporeal removal of mediators and 
endotoxins improved haemodynamics, organ dysfunction and mortality 
in patients with abdominal sepsis [1]. Coupled plasma fi   ltration and 
adsorption (CPFA), too, may improve haemodynamics, respiratory function 
and mortality through removal of proinfl  ammatory mediator. The aim of 
this multicentric study is to evaluate the haemodynamic response and 
the respiratory function, and to evaluate the reduction of infl  ammatory 
markers during CPFA.
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had four CPFA treatments (LINDA; Bellco-Mirandola, Italy) for 8 hours with 
Qb = 200 ml/minute, Qultrafi  ltration = 30 ml/kg/hour and Qplasma = 20% of Qb. At 
T0 (basal), T1 (after fi  rst cycle), T2 (after second cycle), T3 (after third cycle) 
and T4 (after fourth cycle) we evaluated haemodynamic parameters, 
norepinephrine dosage, PaO2/FiO2 ratio, plasma IL-6, and procalcitonin 
(PCT). The ANOVA test was used to compare changes during times study. 
P <0.05 was considered statistically signifi  cant.
Results Patients enrolled in the study have been submitted to 256 CPFA 
treatments for 2,650 hours. Table 1 presents the main results of the study. 
IV quartile of IL-6 is shown in Table 1.
Table 1 (abstract P412)
 T0  T4
IL-6 (pg/ml)  850 ± 127  125 ± 28*
PCT (pg/ml)  45 ± 9  6 ± 2**
Noradrenaline (μg/kg/min)  0.35 ± 0.09  0.08 ± 0.05**
PaO2/FIO2  198 ± 28  310 ± 92**
*P <0.05, **P <0.01 vs T0.
Conclusions  In this large multicentric study, CPFA may improve 
haemodynamic status and respiratory function. Plasma fi   ltration and 
adsorption of proinfl  ammatory mediators may explain this improvement. 
Larger randomized controlled trials are indicated to confi  rm these data.
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Introduction Limited data are available concerning patients admitted to 
the ICU for an extra-abdominal disease and operated on for emergency 
laparotomy (EL) [1]. We investigated whether such patients had benefi  t 
from EL and factors likely to predict survival.
Methods EL was performed in 48 ICU patients admitted for an extra-
abdominal disease over the year 2008. The following variables were 
compared between survivors (discharged alive from hospital) and non-
survivors: (a) sex ratio, BMI; (b) pre-existing co-morbidities considered 
in seven additive categories: cardiac, respiratory, renal, gastrointestinal, 
hepatic, diabetes, malignancies, and corticosteroid therapy; (c) pre-
operatively: IGS II score, mechanical ventilation (MV), vasopressor use, 
extra-renal epuration requirement, abdominal signs (obstruction, 
tender  ness, contracture, compartment syndrome), records of computed 
tomography (CT) and ultrasonography examinations; (d) intraoperative 
fi  ndings defi  ned as perforation, infection, ischemia or necrosis of a visceral 
organ, pancreatitis, bowel obstruction, biliary disease, no fi  nding. The t, 
Mann–Whitney U, and chi-square tests (P <0.05), and multiple regression 
analysis (P <0.1) were used.
Results  Twenty-six patients (58%) survived. EL was decided because 
of abdominal signs in 35 patients, lack of improvement of one or several 
organ failures in 44 patients, specifi  c signs on CT scan, and/or ultrasound 
examination (active bleeding, subphrenic collection, bowel obstruction, 
pneumoperitoneum) in 22 patients, or nonspecifi  c signs in 29 patients. EL 
did not identify any surgical cause in 10 patients. Groups did not diff  er in 
intraoperative fi  ndings (P = 0.2), preoperative creatinine level (P = 0.3), and 
preoperative anuria requiring extra-renal epuration (P = 0.2). Groups diff  ered 
in preoperative MV (P = 0.04), vasopressor requirement (P = 0.02), lactate 
levels (P = 0.03), IGS II (P = 0.0003), and pre-existing co-morbidities (P = 0.04). 
No such correlation was found in multivariate analysis (all P >0.15).
Conclusions Neither clinical nor laboratory variables, or operative fi  ndings 
predicted death following EL. The survival rate was high enough to 
warrant surgical EL for suspected intra-abdominal focus.
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Introduction After intensive care (IC), patients report poor health-related 
quality of life (HRQoL). Many factors aff  ect the patients and infl  uence 
the HRQoL after discharge. One of these factors is the patient’s health 
status before the critical care period. In a previous study we found that 
the IC patients have a high frequency of pre-existing diseases. However, 
it is unknown to what extent these pre-existing diseases aff  ect  the 
consumption of hospital resources (measured as days as inpatients) in the 
time period before admission to the ICU and during the years following 
it. The consumption prior to the ICU event may also be claimed to herald 
an increased risk for a later ICU admittance? The aim of this study was to 
examine the hospital care consumption of former ICU patients 3 years 
prior to and 3 years after the intensive care period. This was examined in 
relation to the pre-existing health status.
Methods  Two mixed ICUs from hospitals in two cities in Sweden. A 
question  naire including previous illnesses and HRQoL scale SF-36 were 
sent 6, 12, 24 and 36 months after discharge from the ICU and hospital. All 
adult patients with an ICU stay >24 hours were included. The institutional 
care consumption was assessed from the regional hospital databases
Results Six hundred and thirteen patients were included in the study. Of 
these 73% had pre-existing diseases. There were no signifi  cant diff  erences 
between the previously healthy patients apart from younger age (mean 
age 52 (SD 20.7) vs 60 (SD 17.3)) and lower APACHE II scores (13.4 (SD 7.2) 
vs 16.4 (SD 7.7)) compared with patients with pre-existing disease. The 
ICU patients with pre-existing disease consumed signifi   cantly more 
hospital resources 3, 2 and 1 year prior to admission to the ICU, and up to 
3 years after discharge both regarding quantity of care (number of visits) 
(P = 0.001), length of stay (P = 0.001), and cost (P = 0.002). There were no 
signifi  cant diff  erences in quantity of care, length of stay, or costs during 
the ICU period. Most importantly there was a signifi  cant increasing trend 
for the 3 years prior to the ICU event.
Conclusions Patients with co-morbidities have a signifi  cant consumption 
of hospital resources both prior to and after the ICU period. Interestingly, 
this consumption increased prior to the ICU event and seemed to herald 
the future deterioration of the patients. Further investigations should be 
made to examine to what extent ICU admissions can be predicted based 
on these data.
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Introduction This observational prospective study examined the outcomes 
and symptoms in those patients who are unsuitable for ICU admission.
Methods All patients referred to ICU for admission but deemed unsuitable 
were recorded by the team. These patients were reviewed by palliative 
care researchers. Demographic information (age, sex, diagnosis) and data 
on patient’s symptoms of progress and outcome were collected at four 
time points (24, 48, 72 hours and 1 week).
Results Fifty patients were identifi  ed between January and April 2009. 
There was an age range of 24 to 86 (mean = 62). The commonest cause 
for referral was respiratory failure (40%). Overwhelming sepsis requiring 
inotropic and ICU support was also common (28%). Patients were most 
frequently deemed unsuitable for admission as they were too well at the 
time of referral (48%). The second most common reason for unsuitability 
was co-morbidities (32%) with nine (18%) identifi  ed as suff  ering probable 
fatal insults. One patient was referred for assessment for ICU support 
post emergency surgery which was not required. A number of patients 
remained in hospital at 1 week post referral, with ongoing illness (32%) or 
rehabilitation (8%). Twenty-six per cent (13/50) of patients were discharged 
home and 34% (17/50) died. Of those that died, 59% were within 24 hours 
of ICU referral. All other deaths occurred within 1 week of referral. Nine 
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referral, seven as having excess co-morbidities making ICU inappropriate, 
and just one identifi  ed as being too well.
Conclusions  This study suggests that our ICU team is both sensitive 
and specifi  c at identifying those patients who are either too well for 
admission or those patients for whom ICU is unlikely to be of benefi  t as 
their insult is presumed fatal. We suggest those patients whom the ICU 
identifi  es as unlikely to survive should be assessed and referred to the 
palliative care team, where appropriate. This should facilitate appropriate 
communication of this by clinical staff   and allow the relevant social, 
psychological and spiritual preparations for death that are the hallmarks 
of good care of the dying.
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Introduction Although patients with weaning failure may be transferred 
to weaning centres, there are limited data on admission practice and 
clinical outcome.
Methods We collected data prospectively from March 2005 to October 2009.
Results There were 286 referrals of which 20% were not accepted for 
transfer. Patients that were not accepted were categorised as weanable 
locally, unweanable, or died prior to transfer. A total 172/229 accepted 
patients were admitted (mean age was 60 ± 17 years; 118 male). Forty-six 
per cent of these achieved ventilator independence with 21% requiring 
ongoing non-invasive ventilation (NIV). The median time to wean 
was 17 days with 16% of patients remaining tracheostomy ventilator 
dependent. The unit mortality was 17%. Neuromuscular disease (NMD) 
was the main referral group (36%) with a low mortality rate (6%). COPD 
and postsurgical patients both comprised 21% of the referrals and had 
respective mortalities of 37% and 25%. There were no in-hospital deaths 
in the obesity-related respiratory failure (ORRF) group, but this was the 
smallest referral group (3%). Of 57 patients declined transfer, 43 (83%) 
were assessed as unweanable and nine (17%) were assessed as weanable 
locally. Of 56 patients accepted but not transferred, 28 (50%) were weaned 
awaiting transfer and 23 (41%) died prior to transfer. Mean transfer delay 
was 20.3 ± 19.2 days and a major contributor to this delay was prolonged 
discharge delay following weaning (12.9 ± 19.3 days) and extended 
discharge delay of tracheostomy-ventilated patients (77.4 ± 51.8 days).
Conclusions In conclusion, compared with our previous data [1], there 
was an absolute reduction in mortality of 10% with similar admission 
diagnoses, proportions achieving ventilator independence and requiring 
NIV, suggesting that this was not necessarily selection bias. NMD was the 
main referral group with a low mortality rate. Although COPD patients had 
the highest mortality, almost 50% were weaned from invasive ventilation. 
There were no in-hospital deaths in the ORRF group, but these patients 
had the longest weaning time. In addition, poor outcome was observed 
in patients accepted but not transferred due to delay. This study highlights 
the need for more speciality weaning facilities in the UK.
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Introduction Intensive care beds in the UK are a limited resource and 
deciding whether or not to admit a patient to intensive care is often a 
diffi   cult decision. It is increasingly felt that, as intensive care consultants 
are involved in the decision-making process for every admission, the 
consultant from the referring team should also be involved in the referral 
process. The Scottish Intensive Care Society Trainee Group found that this 
occurred in less than 50% of occasions during the Referral and Review 
Audit of 2007 [1]. We wished to establish what the referral process was like 
in our hospital.
Methods We undertook a prospective audit of all referrals to a fi  ve-bed 
teaching hospital ICU between April and July 2009. Data were collected 
regarding time of referral, seniority of referrer, involvement of referring 
consultant, seniority of ICU trainee, involvement of ICU consultant and 
whether or not the referral resulted in intensive care admission.
Results Ninety-eight referrals were received during the audit period. Of 31 
medical referrals, 21 were out of hours, 16 had no consultant involvement 
and ultimately 27 patients were admitted. Of nine surgical patients, three 
were out of hours, three had no consultant involvement and seven were 
eventually admitted. Thirty patients were referred by the emergency 
department, of whom 18 were out of hours, 23 had no consultant 
involvement and 26 resulted in admission. Twenty-eight patients were 
referred by anaesthetics, all of whom had been seen by a consultant and 
were admitted.
Conclusions General medicine is the most signifi  cant contributor to out-
of-hours work of the intensive care medical staff  . Over 50% of medical 
referrals have no referring consultant involvement, although ultimately 
many of these patients are admitted and are seen by an intensive care 
consultant within a few hours of admission. Most surgical patients 
are admitted postoperatively and thus are referred by a consultant 
anaesthetist, resulting in a very high conversion rate for referrals to 
admissions. Emergency medicine is increasingly a consultant delivered 
service with increased presence in the department into the extended 
working day, a fact that is sadly not refl  ected in our results. It is regrettable 
that despite repeated recommendations that intensive care admission 
should be on the basis of consultant to consultant referral, 43% of patients 
are referred to intensive care without any referring consultant involvement.
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Introduction The aim of our study is to identify the epidemiology of 
patients admitted to an ICU following severe acute drug overdose.
Methods The study is a retrospective observational study of a 20-bed 
medical/surgical ICU during a 15-year period. We reviewed the clinical 
records of patients admitted from 1994 to 2008 with acute drug overdose. 
Data on demographics, mean length of stay, days on mechanical 
ventilation (MV), Glasgow Coma Scale (GCS) on admission, and mortality 
were recorded. The type of drug was also stated.
Results A total of 12,881 patients were admitted to our ICU from 1994 to 
2008, of them 621 patients (4.8%) had a diagnosis of acute intoxication 
on admission. From these 621 patients, 159 (25.6%) were drug overdoses, 
which represented 1.2% from the total admissions. The median age was 
33 years, the range 15 to 87, with a standard deviation of 12.5. A total of 
50.9% were male. The median GCS on admission was 6 and the APACHE 
II score was 16, with a range 3 to 31 and a standard deviation of 6.7. MV 
was required by 71.1% with a median duration of 2.38 days, with a range 
0 to 45 and a standard deviation of 6.9. The median length of stay was 
3.2 days, the range 0 to 41 and a standard deviation of 6.1. The types of 
drugs found were ethanol, cocaine, opioids (methadone, heroin, opium), 
LSD, ketamine, GHB, amphetamines, cannabis, and PCP. Ethanol was the 
most commonly encountered in 57%, followed by cocaine in 37%, and 
opioids in 27% of patients. Global mortality was 2%, and 50% of these were 
due to ethanol.
Conclusions In our study, severe acute drug overdose accounts for a low 
percentage of patients admitted to the ICU. The profi  le is that of a middle-
aged male patient with acute ethanol, cocaine, or opioids overdose, in 
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European statistics, of short length of stay (3.2 days) and a mortality inferior 
to that expected for the APACHE II score.
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Introduction Short-term mortality studies could be crucial for evaluating 
new therapies as well as to better understand pathophysiological aspects. 
This study aims to identify prognostic factors associated with sepsis-
related death within 4 days after the fi  rst organ dysfunction development.
Methods All severe sepsis and septic shock patients over 18 years old 
admitted to three Brazilian ICUs were prospectively included. Demographic, 
clinical and outcome features, including compliance to the 6-hour Surviving 
Sepsis Campaign bundle (SSC-6h), were collected in an electronic clinical 
research form. Duration of organ dysfunction was defi   ned as the time 
elapsed between the installation of the dysfunction and its diagnosis by the 
healthcare provider. Results were expressed as a percentage or as median 
and interquartiles. Univariate analysis was performed by chi-squared or 
Student t test. P <0.05 was considered signifi  cant.
Results Three hundred and eighty-six patients were included, being 30 
(7.8%) in Group 1 (short-term mortality group, median time from organ 
dysfunction to death: 2.39 (1.75 to 3.25) days) and 356 (92.2%) in Group 
2. No diff  erence was found between the groups regarding gender (P = 
0.14), age (P = 0.80), being in a public hospital (P = 0.94) or duration of 
organ dysfunction (P = 0.79). Variables related to severity of disease were 
associated with early mortality: APACHE II score (Group 1: 21.0 (15.0 
to 26.0), Group 2: 18.0 (14.0 to 22.0), P = 0.01); SOFA score at admission 
(SOFA0) (Group 1: 9.0 (8.0 to 11.0), Group 2: 7.0 (5.0 to 9.0), P = 0.003); Day 
1 SOFA score (10.0 (8.0 to 12.0), Group 2: 7.0 (5.0 to 10.0), P = 0.0002); Day 
3 SOFA score (SOFA3) (Group 1: 9.0 (8.0 to 12.0), Group 2: 7.0 (4.0 to 10.0), 
P = 0.006) and the delta between SOFA0 and SOFA3 (Group 1: –6.5 (–11.0 
to +1.0), Group 2: –1.0 (–3.0 to +9.0), P = 0.003). Delta SOFA with Day 1 
was not diff  erent between groups. Group 1 patients had a trend towards 
higher number of organ dysfunction (P = 0.07) and more septic shock 
episodes (P = 0.09). Regarding treatment adequacy, compliance with any 
indicator or the entire SSC-6h bundle was not related to survival. However, 
achievement of the CPV target was associated with a higher early mortality 
(Group 1: 69.6%, Group 2: 40.6%, P = 0.013; OR – 3.3.4 (1.33 to 8.40)).
Conclusions In this observational study, factors related to disease severity 
rather than to the evidence-based treatment compliance were associated 
with short-term death among severe septic patients.
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Introduction  The sepsis mortality rate is higher in Brazilian public 
hospitals with no clear diff  erences in risk factors. We aim to identify risk 
factors that could explain why the mortality rate is diff  erent in public and 
private hospitals.
Methods  All severe sepsis and septic shock patients over 18 years 
old admitted to two private ICUs (Group 1) and one public ICU (Group 
2) were prospectively included. Demographic, clinical and outcome 
features, including compliance to the 6-hour Surviving Sepsis Campaign 
bundle (SSC-6h), were collected in an electronic CRF. Duration of organ 
dysfunction was defi  ned as the time elapsed between the installation of 
the dysfunction and its diagnosis by the healthcare provider. Results were 
expressed as a percentage or as median and interquartiles, and P <0.05 
was considered signifi  cant.
Results  Three hundred and eighty-six patients were included (Group 
1 – 210, Group 2 – 176). Patients from Group 1 were older (69.5 (53.0 to 
81.0) years vs 59.0 (43.5 to 73.5) years, P <0.000), had a higher APACHE II 
score (19.0 (15.0 to 23.0) vs 17.0 (13.0 to 23.0), P = 0.01), had more organ 
dysfunctions (3.0 (2.0 to 4.0) vs 2.0 (2.0 to 4.00), P = 0.08), and more septic 
shock episodes (74.3% vs 60.8%, P = 0.006). No diff  erence was found 
regarding gender, site of infection, and day 1 or day 3 delta SOFA score. 
However, the mortality rate was higher in Group 2 than in Group 1, 60.8 
and 38.3, respectively. Compliance to the SSC-6h bundle did not explain 
this diff  erence as they were better in Group 2 for lactate (70.5% vs 49.8%), 
blood culture (61.4% vs 52.4%), achieving MAP >65 mmHg (98.8% vs 
90.5%), and completion of the bundle (15.9% vs 4.8%). Only antibiotics 
(63.3% vs 54.5%, P = 0.10) and CVP had a better performance in Group 1 
(49.4% vs 33.3%, P = 0.01). SOFA score at admission was slightly higher on 
Group 2 (7.0 (4.0 to 9.0) vs 8.0 (5.5 to 10.0), P = 0.004). However, duration 
of organ dysfunction was clearly longer in Group 2 (150.0 (0.0 to 650) 
minutes vs 360.0 (0.0 to 1008.0) minutes, P = 0.02). In all patients, we have 
identifi  ed some variables associated with mortality, including being in the 
public hospital (OR 2.46 (1.63 to 3.72), P = 0.00002), as well as the median 
duration of organ dysfunction, SOFA at admission, age, APACHE II score 
and number of organ dysfunctions.
Conclusions The mortality rate was higher in the public hospital despite 
better SSC bundle adherence. A delay in initiating those interventions may 
negatively impact the outcome in patients treated in public hospital.
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Introduction The level of immunity in HIV patients is associated with a 
high mortality, particularly when CD4+ lymphocytes are inferior to 200 
cells/mm3. Besides the immunity, other prognoses indicators are necessary.
Methods The author performed a revision of 1,028 admissions to the 
ICU from January 2007 and November 2009. Selected were the cases of 
HIV patients with low immunity (L CD4+ <200 cells/mm3). The following 
parameters were collected at admission to the ICU: viral load, LDH, albumin, 
hemoglobin, Hct, thrombocytopenia, presence of opportunistic infection, 
nutritional status, need for mechanical ventilation, renal insuffi   ciency and 
history of antiretroviral therapy (ART). Demographic parameters were also 
collected. The primary endpoint was mortality, secondary endpoints were 
ICU length stay and days of mechanical ventilation.
Results Fifteen patients were selected; all of them were medical admissions 
mainly from the emergency department. Sixty-fi  ve percent had previous 
history of opportunistic infection, and only two patients had ART. The main 
reason to suspend ART was social and drug-dependency problems. Sepsis 
was diagnosed in 73% of the patients. Pneumocystis carinii pneumonia 
was diagnosed in 80% of the patients. Fungus infection was diagnosed in 
60% of patients. One patient had pulmonary tuberculosis and another had 
Leishmania infection. The mortality rate was 53%. The factors associated 
with high mortality were: P. carinii pneumonia, malnutrition and absence 
of ART.
Conclusions The patient’s nutritional status is an independent predictor 
of mortality in HIV patients.
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Introduction Critically ill cancer patients are at increased risk for acute 
kidney injury (AKI), but studies on these patients are scarce and were all 
single centered, conducted in specialized ICUs. The aim of this study was 
to evaluate the characteristics and outcomes in a prospective cohort of 
ICU cancer patients with AKI.
Methods Prospective multicenter cohort study conducted in ICUs from 
28 hospitals in Brazil over a 2-month period. Univariate and multivariate 
logistic regression were used to identify factors associated with hospital 
mortality.
Results Out of all 717 ICU admissions, 87 (12%) had AKI and 36% of them 
received dialysis. Kidney injury developed more frequently in patients with 
hematological malignancies than in patients with solid tumors (26% vs 
11%, P = 0.003). Ischemia/shock (76%) and sepsis (67%) were the main 
contributing factors, and kidney injury was multifactorial in 79% of the 
patients. The ICU mortality was 61% (53/87) and hospital mortality was 71% 
(62/87). Despite the lack of statistical signifi  cance, hospital mortality was 
higher in patients who received RRT later on during the ICU stay (92%) in 
comparison with those who received RRT on the fi  rst day in the ICU (78%) 
and those who were not dialyzed (64%) (P = 0.105). End-of-life decisions 
(to withhold or to withstand therapies) were taken in 18 (23%) patients. 
General and renal-specifi   c severity-of-illness scores were inaccurate in 
predicting outcomes for these patients. In a multivariate analysis, length of 
hospital stay prior to ICU, acute organ dysfunctions, need for mechanical 
ventilation and a poor performance status were associated with increased 
mortality. Moreover, cancer-related characteristics were not associated 
with outcomes.
Conclusions  The present multicenter study confi   rmed that AKI in 
critically ill patients with cancer is frequent, usually multifactorial and 
still associated with high mortality rates. On the other hand, the current 
study also suggests that ICU admission and RRT should be considered in 
selected patients. Mortality in these patients is mostly dependent on the 
severity of acute illness and the performance status, rather than cancer-
related characteristics.
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Introduction Despite a better prognosis for patients with haematologic 
malignancies (PHM) over these past years due to progress in management, 
intensivists are reluctant to admit those patients to the ICU because of high 
mortality rates, above 50%. The aim of this study was to retrospectively 
evaluate the value of intensive care therapy of PHM and predictive factors 
of short-term and long-term survival with the best post-ICU quality of life.
Methods The case notes of 88 PHM patients requiring admission to a 25-
bed medical–surgical ICU of Roubaix Hospital, France were retrospectively 
reviewed during a 5-year period, 2003 to 2007. We collected demographic 
factors, Simplifi   ed Acute Physiology Score II (SAPS II), Logistic Organ 
Dysfunction System score (LODS), Charlson score, microbiology, status 
of underlying HM, haematologic factor data, therapeutic support, blood 
cell transfusion, and survival follow-up (at the fi  rst 48 hours on the ICU, at 
discharge from the ICU, at 3, 12 and 18 months after ICU).
Results Univariate logistic regression analysis of factors previously shown 
to infl  uence survival revealed that HM status, Charlson score, PaO2/FiO2 
<200, during mechanical ventilation, blood cell transfusion, and outcome 
in the fi  rst 48 hours on the ICU were signifi  cantly associated with survival 
(P <0.05). PHM with a favourable course (treatment response) in the fi  rst 
48 hours on the ICU had a better survival rate (95.7%) than an unfavourable 
course (33.3%) (P <0.001). There was a correlation between mean SAPS 
II, LODS and outcome at the fi  rst 48 hours on the ICU (P = 0.03). Using 
multivariate analysis identifi  ed three variables independently associated 
with ICU survival: two negative, mechanical ventilation (HR = 4.9) and 
LODS score (HR = 1.12); one protective factor, red blood cell transfusion 
(HR = 0.7) without additional cost. ICU, 3-month, 12-month and 18-month 
survivals were respectively 69.3% (61/88), 37.5% (33/88), 27.3% (24/88) 
and 23.8% (21/88) with a mean performance status at 1.03 ± 1, a mean 
Karnofsky index at 77.6 ± 15.
Conclusions  The ICU management provided benefi   t for PHM cases 
referred earlier to the ICU because of the good quality of life for long-term 
survivors. Therefore, the unlimited life-sustaining treatment should be 
re-evaluated on the fi  rst 48 hours in the ICU based on SAPS II, LODS and 
Charlson scores.
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Introduction  Type of surgery is considered a risk factor of adverse 
outcome, but mortality rates of common procedures are scarce [1,2]. 
The objective of the study was to further identify high-risk patients by 
procedure-specifi  c mortality.
Methods  Data between 1991 and 2006 were obtained from Dutch 
national healthcare statistics. Patients age >20, with an elective, nonday 
case, open surgical procedure were enrolled. Data included main 
diagnosis, secondary diagnoses, dates of admission and discharge, death 
during admission, operations, age, gender, and co-morbidities according 
to ICD-9-CM. Logistic regression analyses were applied to evaluate the 
relationship between type of surgery and postoperative mortality.
Figure 1 (abstract P424). Absolute incidence of postoperative mortality 
in relation to type of procedure.
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S142Results  A total of 3,667,875 surgical procedures, from 102 hospitals, 
were included. Postoperative death was observed in 67,879 patients 
(1.85%). Overall, vascular surgery had highest mortality (incidence 
6.0%). Abdominal surgery was associated with 2% mortality. However, 
procedure-specifi  c adjusted mortality identifi  ed spleen (adjusted OR 6.84), 
liver (adjusted OR 5.45), gastric (adjusted OR 4.86) and pancreatic surgery 
(adjusted OR 4.38) as higher risk procedures than aortic surgery (adjusted 
OR 2.5) (Figure 1).
Conclusions This study revealed a procedure-specifi  c risk classifi  cation to 
accurately identify high-risk patients.
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Introduction ICU admission of critically ill cancer patients was contro-
versial until recently. In the past years, advances in the management of 
malignancies and organ failures have improved outcomes of patients, 
resulting in higher rates of survival in the ICU. The aim of this study is 
to prospectively evaluate the characteristics, short-term and mid-term 
outcomes of cancer patients requiring intensive care.
Methods During 1 year, we evaluated prospectively patients with cancer 
admitted to the Instituto do Cancer do Estado de São Paulo. A total of 1,000 
patients were included in the study; and collected data were: baseline 
data, risk scores, clinical status, co-morbidities, admission diagnosis, ICU 
interventions, ICU and hospital outcomes and 90-day outcomes.
Results  From 1,000 patients, 828 (82.8%) had solid tumors and 172 
(17.2%) had hematologic malignancies. The most frequent reasons for ICU 
admission were: sepsis (31%), postoperative care (29%) and respiratory 
failure (24%). The mean APACHE II score value at the day of admission 
was 24.1 ± 8.8 (8 to 45). ICU mortality was 24%, hospital mortality was 
32% and 3-month mortality was 41%. Logistic regression analysis showed 
that need for mechanical ventilation (odds ratio = 6.76; 95% CI = 3.56 to 
12.85), presence of metastasis (odds ratio = 3.87; 95% CI = 2.06 to 7.28), 
occurrence of acute renal failure (odds ratio = 3.92; 95% CI = 1.47 to 10.46) 
and higher SOFA scores 72 hours after admission (odds ratio = 5.76; 95% 
CI= 4.56 to 14.85) were independently associated with increased hospital 
mortality. Three-month quality of life of patients who survived was 
considered unchanged in 55% patients, worse in 25% and better in 20%.
Conclusions  This prospective analysis of 1,000 patients with cancer 
needing intensive care shows high survival rates and good quality of life 
after ICU admission. These data encourage intensive care treatment in 
oncologic patients to prevent, detect and cure organ dysfunction.
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Introduction Critically ill patients with underlying co-morbidity have a 
high hospital mortality rate. This study describes the trend in the severity-
adjusted mortality of such patients over a 15-year period.
Methods We used the Acute Physiology and Chronic Health Evaluation 
(APACHE) III database of our institution to identify patients with solid 
tumors, hematology malignancy, and hepatic cirrhosis. We categorized 
the 15-year study period into three 5-year groups. We calculated the 
standardized mortality ratio (SMR) with the 95% confi  dence interval (CI) 
for each co-morbidity.
Results  During the study period, there were 73,626 ICU admissions; 
92.6% white, 56.1% male, mean age 62.7 years, and 17.7% with co-
morbidities. The overall mortality rate of the study population was 10.2%: 
7% for patients with no co-morbidity, 21.1% for solid tumors, 25.7% for 
hematology malignancy, and 29.2% for hepatic cirrhosis. The predicted 
mortality rates were 9.9% for patients with no co-morbidity, 25.6% for solid 
tumors, 27.6% for hematology malignancy, and 35.7% for hepatic cirrhosis. 
The SMR (95%) CI for patients without co-morbidity was 0.71 (0.66 to 0.75), 
0.83 (0.79 to 0.87), and 0.62 (0.59 to 0.65) for the fi  rst, second, and third 
5-year periods, respectively. The SMR (95%) CI for the each co-morbidity 
is presented in Table 1.
Table 1 (abstract P426). SMR, 95% CI for each co-morbidity
Co-morbidity  First 5-year  Second 5-year  Third 5-year
Hematology  1.16, 1.03 to 1.30  0.95, 0.88 to 1.02  0.85, 0.79 to 0.91
Cirrhosis  1.12, 0.95 to 1.31  0.82, 0.73 to 0.92  0.70, 0.62 to 0.80
Solid tumor  0.80, 0.68 to 0.93  0.84, 0.75 to 0.93  0.82, 0.74 to 0.91
Conclusions  The severity-adjusted hospital mortality of critically ill 
patients with hematology malignancy and hepatic cirrhosis has improved 
over the past 15 years.
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Introduction Pre-eclampsia is a severe multisystemic disease that may 
occur in pregnancy or in the immediate postpartum period.
Methods We included prospectively women admitted to the ICU with 
the diagnosis of severe gestosis, from January 1998 to October 2007. We 
defi  ne pre-eclampsia, eclampsia and HELLP syndrome as used by the 
American College of Obstetrics and Gynecology. Qualitative variables are 
shown as a percentage and quantitative variables as mean ± standard 
deviation or median and interquartile range. We used the chi-square test, t 
test and multivariate testing for statistical analysis of the data.
Results We report data from 262 women. Median age was 31 years (27 to 
34). The admission diagnosis was pre-eclampsia 77.48%, eclampsia 6.11% 
and HELLP syndrome 16.41%. Complications registered were pulmonary 
oedema 9%, coagulopathy 2% and renal failure 5%. Delivery was by cesarean 
in 89.69%. The median newborn weight was 1,500 mg (1,000 to 2,140). 
We did not fi  nd signifi  cant diff  erence on systolic pressure between pre-
eclampsia, eclampsia or HELLP nor in uric acid levels. Gestational age was 
signifi  cantly lower in pre-eclampsia than in eclampsia or HELLP (P <0.0001) 
and, additionally, the weights of the newborn were signifi  cantly lower in 
pre-eclampsia versus eclampsia and HELLP. Maternal mortality was 1.5% 
and fetal mortality 16.3%. Maternal death is associated with complications 
in the ICU (renal failure, heart failure or coagulopathy) (P <0.034), OR 6.55 
(95% CI 0.89 to 48.12), but multivariate analysis shows only coagulopathy as 
an independent mortality risk factor (P <0.026), OR 30.3 (95% CI 1.5 to 609.8). 
Fetal mortality is associated in multivariate analysis with newborn weight 
<1 kg (P = 0.026), OR 4.1 (95% CI 1.1 to 14.3), and higher gestational age at 
delivery is protective (P = 0.001), OR 0.68 (95% CI 0.54 to 0.85).
Conclusions Women admitted to the ICU are mostly 31 years old, in the 
32-week gestational age of their fi  rst pregnancy. In our environment, 
delivery mostly occurs in the following 5 to 7 days of admission. Maternal 
mortality is low, but not so fetal mortality that rises up to 16,3%. Maternal 
mortality is associated with complications such as coagulopathy, and fetal 
mortality mostly with gestational age and low birth weight.
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Introduction To describe both characteristics and diff  erences of critically 
ill obstetric patients in two ICUs from two developing countries.
Methods A comparative study between two historic cohorts (2001 to 
2002 from South Africa and 2006 to 2007 from Colombia) was designed to 
analyze characteristics from two ICUs in two developing countries: one in 
South Africa, King Edward VII Hospital (KEH) (South Africa); and another in 
Colombia, Clínica Maternidad Rafael Calvo (CMRC) (Colombia). Diff  erences 
between both cohorts were assessed through chi-square and ANOVA. 
P <0.05 was considered statistically signifi  cant.
Results There was a high rate of obstetrical admissions in both ICUs. Three 
hundred and ninety-eight patients were registered during these periods 
of time: 214 patients were from South Africa, 184 from Colombia. The 
most frequent diagnosis was hypertensive disorders during pregnancy 
(KEH = 65.4%, CMRC = 47%; P <0.001). There were no statistical diff  erences 
between the two ICUs regarding age, gestational age, ICU stay/days and 
mechanical ventilation days. There were statistically signifi  cant diff  erences 
in APACHE II score and mortality, being highest in South Africa. All types 
of organ dysfunctions were lower in CMRC; with statistical signifi  cance 
in cardiovascular, haematologic and neurologic dysfunction. OR from 
mechanical ventilation was 0.02 (P <0.001), being lower in CMRC (25.67%). 
There were no statistical diff  erences in cesarean section and haemodialysis.
Conclusions Obstetric critical care is considered of special interest in 
these countries, where 90% of global maternal mortality can be found. 
Although there are common characteristics regarding admissions of 
these patients to ICU settings, it is also evident that diff  erences are noted 
when considering demographics and interventions in obstetric critically 
ill patients.
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Introduction Critically ill patients arrive in intensive care with various 
degrees of impairment in chronic health. These are recognised to have 
an impact upon survival and the Acute Physiology and Chronic Health 
Evaluation II (APACHE II) system utilises this when predicting mortality. We 
wished to look at the impact of many of these factors upon outcome from 
our intensive care.
Methods A prospective case-note review of 500 consecutive admissions 
to Glasgow Royal Infi  rmary ICU was undertaken over an 18-month period. 
Details of co-morbidity, social factors, regular medication and exercise 
tolerance were sought from the patients’ case notes by hand using details 
of current and previous admissions, clinic letters, results of investigations 
and correspondence from the patient’s general practitioner, using agreed 
criteria. Demographic, APACHE II score and outcome data were retrieved 
from the Ward Watcher system in the ICU. Data were analysed using a 
univariate analysis model and chi-square test.
Results  Complete data were available for 500 patients. Population 
demographics were as follows – 65% male, mean age 53.8 ± 4.1 years, 
median APACHE II score 18 (IQR 12 to 24), crude ICU mortality 33.6%. 
The following factors were associated with an increased mortality (odds 
ratio, P value): age >50 years (OR 3.11, P <0.001), cigarette smoking (OR 
1.57, P = 0.02), NYHA class 3/4 (OR 2.52, P <0.001), ischaemic heart disease 
(OR 1.70, P = 0.01), peripheral vascular disease (OR 1.91, P = 0.04), chronic 
obstructive pulmonary disease (OR 2.56, P <0.001), alcoholic liver disease 
(OR 3.86, P <0.001). The following factors were not signifi  cantly associated 
with increased mortality: male gender, social deprivation, unemployment, 
alcohol excess, intravenous drug use, polypharmacy, hypertension, 
diabetes, obesity or concurrent malignancy.
Conclusions  These results suggest signifi  cant increased ICU mortality 
in the following groups: over 50 years old, smokers, patients with poor 
exercise tolerance, patients with IHD or PV, patients with COPD and 
patients who drink alcohol to excess or those with ALD. While these results 
should not be used as a basis upon which to permit or refuse intensive 
care admission, they should be used to inform staff   and patients of likely 
outcome from intensive care.
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Introduction C-reactive protein (CRP) is an acute-phase protein, the blood 
levels of which increase rapidly in response to infection, trauma, ischemia, 
burns, and other infl  ammatory conditions. Serum albumin decreases in 
critically ill patients with similar conditions. The use of these blood tests as 
risk markers or as predictors of organ failure and death has been studied 
previously [1,2] and we wished to investigate their applicability to our 
population.
Methods  A retrospective laboratory result review of 300 consecutive 
admissions to the Victoria Infi  rmary ICU was undertaken. Demographic, 
APACHE II score and outcome data were retrieved from the Ward Watcher 
system in the ICU. We compared survivors’ and nonsurvivors’ levels of CRP 
and albumin on day of admission and looked at correlation with length 
of stay and duration of mechanical ventilation. Data were analysed using 
Student’s t test and the Pearson correlation coeffi   cient where appropriate.
Results  Complete data were available for 287 patients. Population 
demographics were as follows – 61% male, mean age 56.4 ± 2.0 years, 
median APACHE II score 20 (IQR 15 to 27), crude ICU mortality 24.7%. 
Comparing survivors and nonsurvivors, admission CRP was signifi  cantly 
higher in nonsurvivors (144.7 vs 113.0, P = 0.037) whereas admission 
albumin was signifi  cantly lower in nonsurvivors (21.3 vs 24.7, P = 0.003). 
Admission CRP correlated positively with length of stay (r = 0.14, P = 0.017) 
and APACHE II score (r = 0.13, P = 0.03) but did not signifi  cantly correlate 
with duration of mechanical ventilation (r = 0.10, P = 0.103). Admission 
albumin correlated negatively with length of stay (r = –0.15, P = 0.01), 
duration of mechanical ventilation (r = –0.15, P = 0.014) and APACHE II 
score (r = –0.17, P = 0.004).
Conclusions CRP and serum albumin on admission are both predictors of 
intensive care mortality. CRP and serum albumin also correlate signifi  cantly 
with other severity markers such as length of stay and duration of 
mechanical ventilation and also APACHE II score.
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Introduction Statins are powerful hypolipaemic drugs that are proven 
to improve survival in patients with atherosclerosis. Their eff  ects  are 
not limited to lowering cholesterol but also include anti-infl  ammatory 
and antioxidative properties. For these reasons, it has been postulated 
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investigate the association between statin therapy on admission and 
outcome from intensive care in our ICU.
Methods A prospective case-note review of 504 consecutive admissions 
to Glasgow Royal Infi  rmary ICU was undertaken over an 18-month period. 
Details of statin prescription, cardiovascular co-morbidity and smoking 
status was sought from the patients’ case notes by hand using details of 
current and previous admissions, clinical letters, results of investigations 
and correspondence from the patient’s general practitioner, using agreed 
criteria. Demographic, Acute Physiology and Chronic Health Evaluation II 
(APACHE II) score and outcome data were retrieved from the Ward Watcher 
system in the ICU.
Results Complete data were available for 444 patients. One hundred and 
eleven (25%) of these were on statin therapy on admission to intensive 
care. All data are expressed as mean ± 95% confi  dence interval or median 
(interquartile range). Diff   erences between groups were tested using 
the chi-squared test, Mann–Whitney test and unpaired Student’s t test. 
Compared with patients without concurrent statin therapy, patients on 
statin therapy are more likely to be male (76.6% vs 63%, P = 0.009), older 
(65.2 ± 1.93 years vs 49.7 ± 1.86 years, P <0.001), have a higher APACHE 
II score (20 (15 to 25) vs 16 (11 to 23), P <0.001), have ischaemic heart 
disease (69.4% vs 17.1%, P <0.001), and have hypertension (47.5% vs 0.22%, 
P <0.001). There was no signifi  cant diff  erence in mortality in the ICU (27.9% 
vs 27%, P = 0.86) or the hospital (40.5% vs 31.2%, P = 0.07).
Conclusions Statin therapy does not signifi  cantly alter ICU or hospital 
mortality in our population. There are signifi  cant diff  erences in APACHE 
II scores between the groups and predicted mortality which may suggest 
that patients on statins fare better than predicted, based upon their 
co-morbidities.
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Introduction It has been proven that patients’ sleep is extremely disturbed 
in the ICU for many reasons: illness pathophysiology and severity, pain, 
or the ICU environment itself. The aim of our survey was to describe the 
memorization of sleep disturbances during an ICU stay and the patients’ 
reported sleep quality after critical care. We also assessed the possible 
underlying causes of sleep disturbances including factors related to the 
critical illness.
Methods  A telephone interview including a random sample of 60 
patients admitted to our ICU (between December 2008 and May 2009) 
was performed 6 to 12 months after their discharge. Eight patients were 
excluded (two for language barrier, two were dead, four were not joined). 
Conventional intensive care variables were retrospectively recorded from 
the ICU database and sleep disturbances were evaluated using the Basic 
Nordic Sleep Questionnaire. Two nonvalidated questions were analysed, 
one estimated the quality of sleep in the ICU and the other compared 
the quality of sleep before and after the ICU stay. Data were presented 
descriptively using logistic regression to evaluate the independent eff  ects 
of sex, age, BMI at admission, SAPS II, length of stay, hemodialysis, length 
of mechanical ventilation, length of central venous catheterization and 
prescription of vasopressor agents or transfusion.
Results Among responding patients, 47% remembered sleep disturbances 
in the ICU and among them 43% still declared a decreased long-term 
quality of sleep. In addition, 30% of patients report a worse quality of sleep 
after the ICU than it used to be before. No relation was found when we 
assessed the possible eff  ects of intensive care variables on the sleeping 
patterns during critical illness.
Conclusions  Sleep disturbances were described in one-half of the 
patients we studied during their ICU stay. As interesting (but alarming) is 
that one-third of the group declared having a worse quality of sleep a long 
time after their discharge from the ICU. The sleep disturbances were not 
aff  ected by ICU factors but their high self-reported prevalence probably 
reveals the necessity of protocols evaluating the eff  ects of strategies to 
improve sleep quality in patients’ recovery of critical illness and long-term 
sleep.
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Introduction The advance in medical care for surgical patients results 
in older patients, increasing medical problems, and complexities of 
operations in surgical patients. Therefore, these patients may require a 
longer stay in the surgical ICU (SICU). The aim of the present study was 
to evaluate the occurrence, clinical outcome, and predictive risk factors 
for the longer SICU length of stay in critically ill surgical patients in our 
general SICU.
Methods This study was an observation study; after the approval of the 
IRB, all patients admitted to the SICU from the operating theatres during 
the study period from 1 June to 31 December 2004 were recruited to 
the study. Data collection consisted of initial patient assessment and 
demographics, underlying problems, SICU interventions and laboratory 
investigations for TISS-28 and SOFA scores within the fi  rst 24 hours of ICU 
admission. Descriptive statistics and backward stepwise logistic regression 
were employed to study for independent factors associated with the 
longer length of SICU stay.
Results During the 6-month study period, 562 patients were admitted to 
the SICU with an overall mortality rate of 6.23%, and the overall average 
length of stay in the SICU was 2.72 days. There were 99 patients staying in 
the SICU longer than 4 days, with a mean of 9.12 days in these patients. 
The independent associated factors of SICU stay longer than 4 days were 
perioperative cardiac complications, odds ratio (OR) 12.77 (95% confi  dence 
interval 4.52 to 36.08); P <0.01, requirement of ventilator support, OR 6.95 
(3.13 to 15.42); P <0.01, bleeding in the SICU, OR 4.85 (1.33 to 17.65); P = 
0.02, perioperative respiratory complications, OR 2.77 (1.09 to 7.02); P = 
0.03, emergency surgical procedures, OR 2.47 (1.35 to 4.51);P <0.01, new 
haemodynamic monitoring interventions in the SICU, OR 2.28 (1.28 to 
4.08); P <0.01, hypotensive episodes in the SICU, OR 2.27 (1.16 to 4.45); P = 
0.02, and oliguria, OR 1.82 (1.03 to 3.22); P = 0.04.
Conclusions The SICU patients who had a longer stay are associated 
with emergency procedures, the development of perioperative cardiac 
and respiratory complications, surgical bleeding, active monitoring 
interventions upon SICU admission, they were more likely to be 
hypotensive and had oliguria in the fi  rst 24 hours of the SICU stay.
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Introduction  Decreased health-related quality of life (HRQoL) is well 
known for the previous ICU population after critical care, and many 
factors are of importance for this outcome. We have in a recent study 
shown that pre-existing disease is most important. This fi   nding was 
made when comparing a control population adjusting for co-morbidities 
and approximately 50% of the decrease in HRQoL was attributed to co-
morbidities. Therefore, there must be other factors that contribute to 
the HRQoL decrease. In HRQoL research it has been shown that social 
support also is important for the HRQoL experience. In the southeast of 
Sweden, two neighbouring large cities are known to have diff  erent social 
support patterns depending on their diff  erences in social structure. We 
hypothesized that the social support is diff  erent between the patients 
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to examine to what extent social support aff  ected HRQoL outcome in 
the follow-up of these patients in general and to what extent it diff  ered 
between the patients of ICUs of the diff  erent cities.
Methods Mixed ICUs from two hospitals in diff  erent cities. Questionnaires, 
including the social support instrument Availability of Social Integration 
(AVSI), the HRQoL scale SF-36, demographic data and previous illnesses, 
were sent 6 months after discharge to all adult patients.
Results Six hundred and thirty-three (57%) patients returned the question-
naire, 371 from city A. The ICU patients from city B reported a signifi  cantly 
lower mean score in social support compared with city A, 18.3 (SD 6.3) 
compared with 19.6 (SD 6.5) (P = 0.013). The SF-36 scores in all subscales 
showed no signifi  cant diff  erences between the two cities. The results 
demonstrate that ICU patients with pre-existing disease have eight times 
higher risk of a decreased physical component score, and nearly six times 
higher risk of a decreased mental component score than the previously 
healthy patients. ICU patients with lower mean social support scores had 
0.16 higher risks of a decreased physical score and 0.46 higher risks of a 
decreased mental component score.
Conclusions This study indicates that social support has a signifi  cant, but 
small, eff  ect on HRQoL in former ICU patients. Importantly, the magnitude 
of this eff  ect was too small to be relevant in comparisons of HRQoL in 
former ICU patients from cities with diff  erent social structures within one 
country.
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Introduction Given the huge publication fl  ow, tools helping intensivists 
to select articles worth reading and to appraise relevant information are 
welcome. Evaluations of selected articles on dedicated Internet sites could 
serve that purpose.
Methods  As a fi  rst attempt to estimate the quality of such sites, we 
conducted a prospective observational study of www.f1000medicine.org 
(F1000). Consecutive adult clinical studies with a fi  rst F1000 evaluation 
in the critical care and emergency medicine specialty were included. 
We recorded predefi  ned items describing the internal validity, clinical 
relevance and external coherence of the studies and corresponding 
information in their evaluations. The primary endpoint was conformity of 
the conclusions to raw study results, compared between each study and 
its fi  rst F1000 evaluation.
Results  Fifty studies with 56 evaluations (six articles evaluated twice) 
were included. Conclusions conform to factual study results in 52% of 
the studies, excessive in 30%, out of scope in 18%; conform in 36% of 
all evaluations, excessive in 25%, out of scope in 39%. The conformity 
level signifi  cantly diff  ered between the studies and their fi  rst evaluation 
(P = 0.026, Mantel–Haenszel chi-squared test). No association between 
conformity level and journal impact factor was observed in included 
studies (P = 0.84, Kruskal–Wallis test), neither in their evaluations 
between conformity level and publication-to-evaluation time (P = 0.46), 
evaluation length (P = 0.35) nor strictly article-focused relative length (P = 
0.027, Bonferroni correction: NS). Regarding internal validity, out of 28 
prospective studies (13 interventional), fi  ve had been registered, three of 
which before study termination with publicly traceable protocol changes; 
registration was discussed in four out of 33 related evaluations. Alpha risk 
infl  ation was uncontrolled in 95% out of 41 nonpurely descriptive studies, 
but never discussed in their 46 evaluations. Out of 20 negative studies, 16 
were underpowered (an unrecognized fact in 15 studies), but power was 
discussed in only fi  ve out of 25 related evaluations. Clinical relevance was 
discussed in only 13% of F1000 evaluations. Regarding external coherence, 
52% of F1000 evaluations did not relate study results to existing literature.
Conclusions Our results suggest that F1000 evaluations often provide 
information poorly suited to critical appraisal of clinical studies by 
intensivists. Basing evaluations on assessment grids could improve their 
overall quality.
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Introduction Results obtained after management of cranioencephalic 
trauma (CET) are referred only in terms of morbimortality. Our objective is 
to analyze physical and functional status after being discharged from the 
ICU, and the quality of life 1 year later.
Methods Cohort study with adult patients admitted to the ICU from 2004 
to 2008 with severe CET. Demographic, epidemiologic and clinical data 
were recorded. Validated measure scales used were GCS, GOS, ISS and 
the quality-of-life questionnaire PAEEC (Project for the Epidemiological 
Analysis of Critical Patients). Multivariate analysis identifi   ed predictor 
factors of mortality.
Results We included 323 patients with a median age of 32 years old, 
79.6% males, who suff  ered severe CET secondary to traffi   c (57.6%) or 
falling (29.8%) accidents. Cranial computed tomography (CT) scan most 
frequent fi  ndings were diff  use injury III (30%) in Marshall classifi  cation; ISS 
fi  rst median was 33; APACHE II, 19; length of stay, 6 days (10 days if we take 
away those who died very soon); days on mechanical ventilator, 8. Total 
GCS at admission/discharge was 5/10 (P = 0.001). GOS 4 to 5 at discharge 
from the ICU was 14.4% and 1 year later was 54.1% (P = 0.001). Mortality 
in the ICU was 33.1%. Predictors of mortality were the length of stay (P = 
0.0001), GCS at admission (P = 0.05), CT fi  ndings type III, IV and V (P = 0.014, 
0.001 and 0.028, respectively), complications (P = 0.0001), tracheotomy 
(P = 0.028), days on ventilator (P = 0.0001) and APACHE II (P = 0.025). One 
year after discharge, 159 from 216 patients answered the questionnaire 
(73.6%): severe physiologic dysfunction, great dependence in activities of 
daily living and emotional disturbances were detected when leaving the 
ICU and marked as 59.3%, 88.6% and 70.1%, while 1 year after they were 
18.9%, 32.1% and 35.8%, respectively (P = 0.0001).
Conclusions  Severe CET was usually caused by traffi   c  accidents, 
aff  ected young adults and the mortality was over 33% in the ICU. Factors 
independently associated with increased mortality were coma level, type 
of fi  ndings in CT, complications, prolonged mechanical ventilation, length 
of stay, APACHE II, and the need for a tracheotomy. One year later, survivors 
showed a better GOS and physiologic capacity.
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Introduction Treatment of surgical patients in the ICU, aff  ected by severe 
illnesses or injuries, should be justifi  ed by an acceptable survival and long-
term quality of life (QoL). The primary aim of this study was to quantify 
the long-term QoL (>6 years) of a large cohort of patients admitted to a 
surgical ICU. In addition, we aimed to explore the infl  uence of diff  erent 
surgical diagnosis groups on long-term health status and to make 
comparisons with general population norms.
Methods  QoL was measured in all surviving surgical ICU patients 
admitted to a Dutch teaching hospital between 1995 and 2000. Patient-
reported data on QoL were collected with the EuroQol-5D+ after a 
mean follow up of 8 (range 6 to 11) years. Patient characteristics, surgical 
diagnosis group, length of ICU stay and survival were prospectively 
registered. EQ-utility scores (EQ-us), EQ Visual Analogue Scales (EQ-VAS) 
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The eff  ect of surgical diagnosis group on EQ-us/EQ-VAS was assessed by 
multivariable generalized linear regression analysis. Logistic regression 
was used to explore the infl  uence of surgical diagnosis group on domain-
specifi  c health problems. Long-term quality of life of surgical ICU patients 
was compared with an age-matched and sex-matched general Dutch 
population using the t-test analysis.
Results Eight hundred and thirty-four patients survived the ICU and were 
available for follow up. In 598 (72%) patients, the health-related QoL was 
measured. For all surgical groups combined, after 6 to 11 years nearly 
one-half of all patients still suff  ered from problems in the dimensions 
of mobility (52%), usual activity (52%), pain (57%) and cognition (43%). 
Compared with the age-matched and sex-matched general Dutch 
population, HRQoL was worse with a diff  erence of 0.11 on the EQ utilities 
score (range 0 to 1). Oncological surgery patients had the best (EQ-us 0.83) 
and vascular patients had the worst (EQ-us 0.72) HRQoL. Trauma (odds 
ratio between 2.47 and 3.47) and vascular surgery (2.27 to 5.37) showed 
signifi  cantly increased prevalences of problems in mobility, self-care, usual 
activities and cognition.
Conclusions More than 6 years after a surgical ICU admission, the QoL of 
this patient population is largely reduced. Many patients still suff  er from 
a variety of health problems, including decreased cognitive functioning. 
Treatment advances should be made to reduce the current health defi  cit 
of surgical ICU survivors compared with the general population.
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Introduction A number of studies have reported on parental/clinician 
reports of children’s health-related quality of life (HRQoL) after intensive 
care treatment [1]. The aim of this study was to establish children’s own 
views as to their outcome in this regard.
Methods  A cohort of 102 children aged over 7 years, with no pre-
existing learning diffi   culties, completed the PedsQL 4.0 Pediatric Quality 
of Life Inventory [2] and a post-traumatic stress screener in face-to-face 
interviews, 3 months after discharge from the PICU. Of this group, 76 also 
completed questionnaires, by post or telephone, at 12 months.
Results Children’s total PedsQL scores were signifi  cantly lower than those 
of healthy children at 3 months (PICU mean = 79.3; healthy mean = 83.9, 
P <0.01), but at 12 months they were comparable. By 12 months, the 
mean score for the PICU group on the physical functioning subscale had 
improved signifi  cantly (from 73.1 to 81.5, P <0.001) but was still below 
normal population levels (healthy mean = 88.5, P <0.01). The total PedsQL 
score at 12 months was not associated with PIM score or length of stay, 
but was signifi   cantly negatively associated with post-traumatic stress 
symptoms (r = –0.40, P  <0.001). Within-group analyses revealed that 
electively admitted children reported higher emotional functioning than 
healthy children at 3 months (PICU elective mean = 91.0 vs healthy mean = 
78.5, P <0.01).
Conclusions The self-report version of the PedsQL proved to be a feasible 
and responsive tool for assessing HRQoL in this group of PICU survivors. 
However, in order to assess this aspect of outcome for the majority of 
children admitted to the PICU, who are younger and/or have signifi  cant 
cognitive impairment, administration of the parent-proxy version of this 
questionnaire would be necessary.
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Introduction In order to continue optimal and adequate rehabilitation 
care in the nursing ward, information about the functional status of 
patients at discharge from the ICU is needed [1]. The Barthel Index is a 
simple index of independence to score the ability of a patient to care for 
itself. It measures the patient’s daily functioning, specifi  cally the activities 
of daily living (ADL) and mobility [2]. The objectives of the present study 
were to assess the ADL of ICU patients at discharge to the ward, and to 
identify explanatory factors of functional status.
Methods  A prospective, observational, cohort study was conducted 
with patients who stayed in a six-bed mixed (predominantly medical) 
ICU for longer than 48 hours. We used the Danish-language version of 
the Barthel-20 Index, which is a validated and reliable generic instrument, 
to measure ADL. The Barthel Index measures the capacity to perform 
10 basic ADL and gives a quantitative estimation of the patient’s level 
of dependency, with scoring from 0 (totally dependent) to 20 (totally 
independent). All assessments were carried out by critical care nurses 
with an experienced physiotherapist. Patient characteristics and outcome 
measures were analyzed with descriptive statistics. The data are expressed 
as medians and interquartile ranges.
Results At discharge from the ICU, functional status (as primary outcome) 
was assessed in 73 patients. The overall functional status was poor (median 
Barthel Index 2; 0 to 9). In their ability to perform basic ADL, 63% were 
severely dependent, 25% were moderately dependent, and 10% were slightly 
dependent on other people. The transfer from bed to wheelchair and return 
with major help was the ADL component that was noted in the great majority 
of the patients. Duration of mechanical ventilation (median 5 days; 1 to 12 
days) was associated with poorer functional status at ICU discharge.
Conclusions This study provides information that is important for the 
planning of rehabilitation of patients at ICU discharge. After transfer to the 
ward, the physical resilience of critically ill patients is severely limited. This 
implies that prior assessment of any care needed after discharge from the 
ICU is very important.
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Introduction Although the Hospital Anxiety and Depression Scale (HADS) 
and the health-related quality of life assessed by the Short Form 36 (SF-36) 
have been used concomitantly in several studies, extensive comparisons 
between HADS and the diff  erent components of SF-36 have previously been 
reported but not in ICU survivors. The aim of this study was to compare the 
scorings of anxiety and depression assessed by the HADS (HADA (Anxiety) 
and HADD (Depression)) with the scorings on the various domains of SF-36.
Methods In a six-bed mixed (predominantly medical) ICU in a community 
hospital, 111 adult ICU survivors with a minimum stay of 72 hours were 
included. One month after ICU discharge or soon after hospital discharge 
they were sent the SF-36 and the HADS using regular mail. SF-36 tests 
eight domains. Four domains assess physical health, physical functioning 
(PF), role limitation due to physical problems (PR), bodily pain (BP) and 
general health perception (GH); while the other four assess psychological 
health, social functioning (SF), role limitation due to emotional problems 
(RE), energy and vitality (VT) and mental health (MH). The physical health 
summary score (PCS) refl   ects PF, PR, BP, and GH. The mental health 
summary scale (MCS) refl  ects VT, SF, RE, and MH. Pearson’s correlation 
coeffi     cients were calculated on item and scale levels to assess the 
associations between the HADS and the SF-36 scales.
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not with PCS. The absolute r value between MCS and HADA (0.72) was 
signifi   cantly higher than the comparable fi   gure between HADD and 
MCS (0.68). HADA explained 1% of the variance of PCS and 52% of the 
variance of MCS. The comparable fi  gures for HADD were 2% and 47%, 
respectively. Diff  erences of correlation coeffi   cients were further explored 
by evaluation of the associations between HADS and each of the eight 
SF-36 subscales. Only the association between HADA and PF was not 
statistically signifi  cant. Relatively high r values were observed between 
HADA (0.76) or HADD (0.65) and MH. The associations between HADA and 
MH exceeded signifi  cantly the analogue r values as to HADD.
Conclusions This pattern of diff  erent predictions of the summary scales 
of SF-36 supports a clinical practice that anxiety and depression should 
be assessed separately. Additional use of a self-rating instrument for 
depression and anxiety, such as HADS, is recommended when SF-36 is 
used for quality of life assessment.
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Introduction Post-traumatic stress disorder (PTSD) is a potentially serious 
psychiatric disorder that has traditionally been associated with traumatic 
stressors, such as participation in combat, having suff  ered violent assault, 
and survival after natural disasters. Recently, investigators have reported 
that the experience of critical illness can also lead to PTSD, although details 
of the association between critical illness and PTSD remain unclear. Our 
objective is to determine the prevalence and severity of symptoms related 
to the diagnosis of PTSD in a cohort of postsurgical ICU patients and to 
identify potential risk factors for PTSD symptoms.
Methods A prospective cohort of patients over 18 years old, admitted 
to our surgical ICU for over 48 hours, between October 2002 and June 
2008, were studied. Variables such as age, gender, type of admission, 
neoplasia, SOFA, ASA, APACHE II scores, surgical intervention, sepsis, renal 
failure, mechanical ventilation, cortocosteroid treatment, psychiatric 
history, blood product transfusions, and so forth, were recorded. The 
Post-Traumatic Stress Syndrome 10-Questions Inventory (PTSS-10) was 
used to measure the stress symptoms a year after discharge from the 
unit. Five hundred and one patients met the inclusive criteria, 198 died 
during the follow-up year after ICU outcome. Three hundred and three 
patients survived, 160 of them completed the questionnaire by telephone. 
The association of potential risk factors with PTSS-10 scores was done by 
logistic regression and multivariate analysis.
Results PTSD prevalence was 13% in our unit. Statistical analysis shows 
the relationship between the syndrome and the following factors: female 
gender, age <65 years, mechanical ventilation, daily interruption of the 
sedation, previous psychiatric history and blood product transfusions. The 
multivariate analysis shows as independent risk factors: female gender, age 
<65 years, previous psychiatric history and blood product transfusions.
Conclusions Our results agree with other authors about prevalence and 
most of the risk factors. Nonetheless we have found a positive relationship 
between interruption of sedation and the development of symptoms of 
PTSD as with psychiatric history.
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Introduction  We hypothesise that subjects admitted to the ICU 
have lower self-reported health-related quality of life (HRQOL) in 
the month before intensive care compared with the normal healthy 
population.
Methods Potential participants were patients admitted for more than 
48 hours to a 12-bed medical–surgical ICU. Patients or their proxies were 
asked to give informed consent and complete the SF-36. The SF-36 is a 
questionnaire measuring HRQOL on eight subscales [1]. The use of the 
SF-36 in proxies has been validated [2,3]. Participants were asked to 
complete the SF-36 based on the situation 4 weeks before ICU admission. 
SF-36 scores were compared with normative data (n = 1,742) [1], by 
independent t tests.
Results Fifty-one questionnaires were completed, of which 28 (51.9%) were 
completed by a proxy. HRQOL before ICU admission was signifi  cantly lower 
on all SF-36 domains compared with the general population (P <0.0001) 
(Figure 1). This is in line with fi  ndings in one other Dutch survey [4].
Conclusions HRQOL before admittance to the ICU is lower compared 
with HRQOL in the normal healthy population. This is likely to contribute 
to the diminished HRQOL after ICU discharge. To measure the infl  uence of 
critical illness and ICU stay on HRQOL after an ICU stay, it is important to 
measure HRQOL before ICU admission.
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Introduction Creation of innovative retention strategies is a major focus 
for nursing administration as a shortage of nurses recurs and turnover of 
staff   becomes a problem. Retention strategies, to be eff  ective, need to 
be targeted specifi  cally to particular conditions of the nursing staff  . The 
cardiac surgical intensive care unit (CSICU) at the King Faisal Specialist 
Hospital & Research Center is a unique unit that combines adult, pediatric 
and neonatal cardiac surgical patients. This demands well-trained and 
skilled nurses to be able to look after this complex variety of patients. The 
big majority of nurses recruited to the CSICU have an adult educational 
background only. Therefore the Department of Nursing Development and 
Saudization together with Cardiovascular Nursing Department developed 
and implemented diff  erent education strategies to improve nurse’s skills 
and competencies according to the unit’s needs.
Methods  The strategies implemented included: comprehensive and 
periodic assessment of nurses, regular inservices in the form of lectures, 
skill review sessions, a progressive orientation program divided into 
diff   erent phases, bedside teaching, provision of a wide educational 
references, and professional development workshops.
Results In a survey done in 2006, from a database of 64 nurses, 18 (28%) 
had only adult experience. A total of 14/18 (78%) were unable to progress 
to pediatric care phase (PCP). Another survey in 2007 for a database of 68 
Figure 1 (abstract P442). HRQOL pre ICU compared with the healthy 
population.
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(53%) could not progress to PCP. A third survey performed in 2008, for a 
database of 82 nurses, showed that 25 (30%) had adult experience. Six out 
of 25 (24%) were not able to progress to PCP.
Conclusions  Implementing comprehensive education strategies 
targeting diff  erent approaches of training contributed to considerable 
progressive staff   development and retention in the CSICU.
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Introduction The Leapfrog standard of ICU physician staffi   ng is regarded 
as the gold standard. It is suggested that hospital leaders should focus 
on how to implement intensivist staffi   ng [1]. Internationally, especially 
in developing countries, the ‘how to’ poses a tremendous challenge. The 
Critical Care Society of Southern Africa identifi  ed the need to objectively 
quantify existing ICU resources in South Africa (SA) with a view to making 
recommendations for the future. From this audit we discuss the challenges 
of implementing the Leapfrog standard of ICU physician staffi   ng in a 
developing country.
Methods  Approval to conduct a national audit was obtained from 
appropriate authorities and was undertaken in 2004 and 2005 in all public 
and private hospitals in SA.
Results A 100% sample was obtained. At the time there were 448 units in 
SA, of which 7% of ICUs in the public sector and 1% in the private sector 
were closed units. There were a total of 4,168 ICU and HC beds, with 30 
intensivists and 4,584 nurses (25% ICU trained) working in the ICU [2-4].
Conclusions SA ICU services face challenges and the results show the 
diffi   culty of implementing the Leapfrog standard. A strategy to deal with 
these challenges must be reality based and contextually appropriate. We 
propose short-term, medium-term and long-term recommendations that 
consider fi  scal pressure and competing healthcare imperatives [5]. Short 
term: Regionalisation and integration of ICU services, development of 
guidelines and protocols to guide practice. Introduction of continuous 
professional development programs and a structured outreach program 
for medical and nursing staff  . Active recruitment and training of personnel. 
Medium term: Development of telemedicine and a two-tiered ICU 
program. The fi  rst tier to comprise nurses and doctors with intermediate 
skills and experience. The second tier to comprise intensivists and fully 
trained ICU nurses. Both tiers to have a clear scope of practice, training and 
incentive schemes. A signifi  cant percentage of ICU beds are not in use due 
to various factors, these beds to be recommissioned. Long term: A strategy 
to convert open units to closed units over a period of time. New ICUs to 
be established as closed units. An up-to-date national ICU database to be 
maintained to direct future planning.
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Introduction Thiopental (TP) is used in severe brain trauma to control 
high intracranial pressure episodes. Deleterious side eff  ects  were 
described that questioned its ability to reach its objectives securely and 
effi   ciently. We analyzed the impact of TP use on cerebral hemodynamics 
and caregivers’ behavior towards recommendations using a high-rate 
recording information system.
Methods A set of 813 hours of data were recorded at a rate of 0.5 Hz. 
The study was observational. Deleterious episodes were detected using 
the Information System (IS) and validated by two experts. We detected 
low cerebral perfusion pressure (CPP), high intracranial (HICP) and/or low 
mean arterial pressure (lMAP) episodes. We used commonly admitted 
threshold for the ICP (20 mmHg) and the CPP (60 mmHg). Medical orders 
intended to reach the recommended objectives were analyzed.
Results Forty-eight periods stratifi  ed according to TP dose were analyzed 
on 16 patients. Cumulative duration with TP was 20,520 minutes and 
26,294 minutes without TP. The mean dose of TP administration was 250 ± 
20 mg/hour (3.4 ± 1.4 mg/kg/hour). The HICP incidence was 85 ± 16 per 
100 hours with TP vs 95 ± 29 without TP (NS). HICP duration was longer 
with TP (27 ± 2 vs 19 ± 2 minutes, P <0.005). The lMAP incidence was the 
same with or without TP (56 ± 19 vs 34 + 8 per 100 hours of monitoring). 
Duration of lMAP episodes was the same with or without TP (22 ± 2 vs 
20 ± 2 minutes, NS). The incidence of orders intended to restore cerebral 
hemodynamics was equivalent in both situations (TP vs no TP, 79 ± 24 vs 
104 ± 29 per 100 hours, NS). One hundred and eighty-eight medical orders 
were analyzed. Use of catecholamine was more frequent with TP (57% (n = 
44) vs 43% (n = 33), P = 0.034).
Conclusions  The use of TP complies with the recommendations 
(prolonged HICP). It did not result in a signifi  cant increase in cerebral 
hypoperfusion episodes. We showed evidence of adaptations to its use 
by physicians. The doses are lower than the doses prescribed earlier in 
the literature and the use of catecholamine is more frequent during TP 
infusion. This could result in a better control of deleterious side eff  ects of 
TP and a better compliance with recommendations. Our IS was effi   cient in 
physicians’ orders’ analysis.
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Introduction Pain management, glycaemic control and weaning from 
mechanical ventilation are nursing care areas that can impact on patient 
outcome and are commonly guided by protocols. However, in order to 
ensure safe, optimal management of patients, even when care is guided by 
protocols, nurses require a sound knowledge base. This study attempted 
to describe the knowledge of ICU nurses regarding pain management, 
glycaemic control and weaning from mechanical ventilation, to compare 
the diff  erence in knowledge between ICU-trained and non-ICU-trained 
nurses and to describe the impact of years of ICU experience on this 
knowledge.
Methods A prospective, descriptive, non-interventional study method 
was used. Approval was obtained from the ethics committee and other 
relevant authorities. The questionnaire used was developed and validated 
by two groups of ICU nursing experts. The study population included 
all consenting ICU nurses working in the ICUs of the fi   ve hospitals 
participating in this study.
Results There were 136 participants in the study (68 ICU trained and 68 
non-ICU trained). The mean score obtained was 47.56% (SD 11.61), the ICU-
trained participants obtaining 50.11 (SD 11.96) and the non-ICU trained 
obtaining 45.01 (SD 10.75). This diff  erence was statistically signifi  cant (P = 
0.0099). The diff  erence between the two groups for the section on pain 
management was not statistically signifi  cant (P = 0.408) with ICU-trained 
participants achieving a mean score of 45.07% (SD 16.01) and non-ICU-
trained participants 42.86 (SD 14.91). The diff  erence between the two 
groups for the other two sections was statistically signifi  cant (P = 0.025 
and P = 0.006, respectively) with the ICU-trained group achieving 51.26% 
(SD 11.74) and the non-ICU trained 46.16 (SD 14.34) for the glycaemic 
control section and 53.99% (SD 18.18) for the ICU-trained participants 
and 46.01% (SD 15.18) for non-ICU-trained participants for the section 
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between knowledge and years of ICU experience was poor (r = 0.137).
Conclusions This study found a lack of knowledge regarding the care 
areas tested, a small, but statistically signifi  cant diff  erence between ICU-
trained and non-ICU-trained nurses and a poor correlation between 
knowledge and years of ICU experience.
P447
Pharmacist clinical interventions in the ICU
NG Hunfeld, PH Melief, RM Van Hest, BE Bosma
HagaTeaching Hospital, Den Haag, the Netherlands
Critical Care 2010, 14(Suppl 1):P447 (doi: 10.1186/cc8679)
Introduction  We wanted to investigate the number and nature of 
pharmacotherapeutical interventions of a dedicated hospital pharmacist 
during rounds in the ICU.
Methods A pharmacist specially trained in ICU practice participated in the 
patient rounds twice a week (from July to December 2008). The pharmacist 
focused on optimalization of pharmacotherapy based on ICU guidelines 
and standards as well as general pharmacotherapy. Medication overviews 
were generated from the ICU Patient Data Management System and 
were analyzed for each patient during the patient rounds. Interventions 
were made to comply with guidelines and to avoid interactions, contra-
indications, overtreatment and undertreatment and to recognize side 
eff  ects. All pharmacist interventions were collected in a database and the 
percentage of interventions leading to a change in pharmacotherapy was 
analyzed.
Results Fifty patient rounds were attended (160 patients, mean age: 64, 
male: 59%, mean APACHE II score: 25, mean length of stay: 8.7 days, number 
of drug orders analyzed: 4,227). A total of 342 interventions was made in 
66% of patients (mean: 2.1 interventions/patient), resulting in a change in 
pharmacotherapy in 67% of the interventions. The kind of interventions 
were: start drug: 18%, stop drug: 15%, reduction of dosage: 3%, increase 
of dosage: 4%, toxicology: 12%, interaction: 6%, contra-indication: 9%, 
adverse events: 3%, double medication: 4%, switch in accordance to 
guidelines: 6%, software: 2%, dose reduction because of renal failure: 
6% and other (for example, infusion incompatibility or administration by 
feeding tube): 13%. Classes of drugs most involved were: antiobiotics, 
gastrointestinal drugs and anticoagulants.
Conclusions  Frequent presence of a dedicated pharmacist during 
patient rounds in the ICU results in interventions in pharmacotherapy 
in 66% of the admitted patients. The mean number of interventions 
per patient is 2.1. Interventions lead to improved compliance with ICU 
guidelines and pharmacotherapy standards and warrants monitoring of 
pharmacotherapy. Interventions probably lead to improved effi   cacy and 
safety of pharmacotherapy, although future controlled research will have 
to prove to what extent drug-induced harm is prevented.
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Introduction Mistakes and errors may occur during the care process, 
particularly in the ICU as characterized by its large number of drugs 
administered to the single patient. One of the most important infl  uencing 
factors on intramural morbidity and mortality is indeed a harmful or 
unpredicted reaction to a drug, a so-called adverse drug event (ADE) [1]. 
By far the largest proportion (70%) of these ADEs is dose related [1]. The 
objectives of this study are to measure the frequency and severity of ADEs 
in the ICU and to determine the infl  uence of severity of illness and nursing 
workload on their prevalence.
Methods A cross-sectional study in the ICU of a tertiary referral hospital, 
based on a retrospective chart review. A tool was developed for measuring 
the incidence and characteristics of ADEs based on the Global Trigger 
Tool for Measuring Adverse Drug Events [2]. If an ADE was identifi  ed the 
severity was evaluated using the categories based on the system for 
classifying medication errors by the National Coordination Council for 
Medication Error Reporting and Prevention [3]. The severity of illness was 
calculated using the Sepsis-related Organ Failure Assessment score [4] and 
the nursing workload by the classical Therapeutic Intervention Scoring 
System-28 [5].
Results The review of 1,009 nursing days in 79 patients revealed 230 
ADEs, which occurred in a total of 175 nursing days. The most commonly 
identifi  ed ADE was a hypoglycemia of <50 mg/dl (n = 75), followed by 
hypokalemia (n = 67). Ninety-six percent of the ADEs were classifi  ed as 
category E, whereas only 4% of ADEs were classifi  ed as category F. The 
mean severity of illness and nursing workload scores were signifi  cant 
higher on nursing days when an ADE occurred (P <0.001 and P = 0.002, 
respectively).
Conclusions ADEs are common in the ICU. The lack of a golden standard 
for reporting and collecting ADEs makes it diffi   cult to compare with other 
studies and to assess the real value of this study. However, these date 
strongly and clearly indicate the infl  uence of severity of illness and nursing 
workload on the prevalence of ADEs.
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Introduction Appropriate use of ICU resources is mandatory. When a 
patient is admitted to a unit able to provide a higher (lower) level of care 
than required, a waste (overuse) of resources can be advocated. StART is 
an approach to identify possible mismatches between the level of care 
actually delivered, assumed to correspond to what is clinically required, 
and the level of care deliverable by the unit.
Methods  ICU beds are classifi   ed by levels of care deliverable as High 
(ventilator, monitor, and 720 minutes nurse time) and Low (monitor and 
360 minutes nurse time) [1]. The level of care actually delivered is classifi  ed 
as High (invasive or non-invasive ventilation, or two vasoactive drugs, or at 
least two of the following: one vasoactive drug, dialysis, respiratory support), 
Low (single vasoactive drug, or dialysis, or respiratory support) and Ordinary 
(none of the above) [2]. Mismatches between the level of beds available 
and the level of care delivered were evaluated both on admission and 
for each ICU-day of 4,237 patients in 28 ICUs. An ICU-day was judged as 
inappropriate, even without mismatch, if an Ordinary patient was present.
Results  Eighteen percent of admissions resulted inappropriate (9% 
overuse, 9% waste of resources). Patients receiving H level of care (58% 
of the total) were appropriately admitted in 88% of cases. There were 271 
patients admitted for Ordinary care (6%). They stayed in the ICU 2.5 days 
on average, and 95% of them had no complications. Sixty-eight percent 
of the ICU-days were inappropriate: 12% for overuse and 56% for waste 
of resources. Forty-two percent of the latter days were only due to the 
presence of Ordinary patients (43% of them were instead admitted as H 
or L patients).
Conclusions Most of the ICU admissions (82%) were appropriate; the 
inappropriateness was mostly due to Ordinary patients treated. The short 
ICU stay and the absence of complications of these patients strengthen 
the inappropriateness of their admission, which was probably due to the 
lack of intermediate care units in Italy. The situation is completely diff  erent 
considering the ICU stay: the inappropriateness rose up to 68%, mainly 
due to the presence of Ordinary patients. Almost one-half of them were 
patients recovered from sicker condition, who were probably diffi   cult to 
discharge from the ICU.
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Introduction The subject of excessive noise levels within critical care is 
not new and has been identifi  ed on numerous occasions in the literature. 
Research illustrates the detrimental eff   ect of noise on patients both 
physically and psychologically. Our interest in this fi  eld stemmed from 
Fundamentals of Care audits which described noise as being too high and 
disturbing for patients.
Methods The extent of the problem was initially explored by undertaking 
an audit of noise using an on-the-spot soundmeter. This showed that noise 
levels were in excess of the World Health Organisation recommendations 
for a patient care environment [1]. This confi  rmed the need to address 
the subject of noise within our critical care unit. Noise levels were then 
investigated further using a Soundlog device. This enabled us to measure 
noise levels continuously over multiple 24-hour periods. The device 
measures the noise level every second and then records the average 
measurement every 5 minutes. Noise levels were audited over a 6-week 
period in a variety of locations in an eff  ort to gain an accurate assessment 
of noise levels. In doing this, patterns and themes in levels of noise could 
be identifi  ed and analysed.
Results The audit showed that noise levels were consistently between 52 
and 65 dB over a 24-hour period, which is above the WHO guidance of 
35 dB and 40 dB limit.
Conclusions  The current noise levels within our unit exceed the 
recommendations so action needs to be taken to address this. It is a busy unit 
with some environmental noise origins but also a high density of staff   and 
relatives, so with this in mind we are developing a project plan to enable us to 
explore the current levels of noise and its sources, identify those sources that 
are avoidable or open to modifi  cation and enable staff   to consider their role 
and responsibility in relation to noise reduction. By considering the issue of 
noise and developing strategies that result in sustainable reductions in noise 
levels, we are aiming to improve the patients’ experience of their critical care 
stay. We anticipate that there will be both practical and behavioural solutions 
to issues that arise, some of which can be addressed by quick-fi  x solutions 
while others will require longer term work.
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Introduction Allergies to medication are common and potentially life-
threatening [1]. Patients enter critical care with incomplete information 
about their history. It is essential for safety that accurate allergy status 
is documented early in the critical care stay. This clinical audit (CA) was 
undertaken in a 43-bed, level 3 critical care unit to explore compliance 
with local guidelines on allergy documentation.
Methods Critical care patient episodes were obtained retrospectively for 
a 1-month period. Timing of allergy documentation and drug prescribing 
was noted from the critical care electronic system (ICIP). Allergy status 
prior to the critical care admission and after discharge was noted from 
the ward drug chart. Additional allergy data were identifi  ed from the 
hospital electronic patient record (EPR). The CA was repeated 1 year after 
implementation of recommendations.
Results Patient episodes were collated (initial CA n = 58, repeat CA n = 79). 
A known drug/nondrug allergy was stated in 29.3% patient episodes during 
the initial CA and 39.2% patient episodes in the repeat CA. Allergy status 
was incomplete 24 hours after critical care admission for two patients at 
the initial CA with a reduction to zero during the repeat. Allergy status was 
incomplete prior to prescribing of a new drug in critical care (excludes fl  uids, 
drugs required for emergency intubation) for 51.7% of patient episodes in 
the initial CA. This fi  gure reduced to 19.0% in the repeat CA. Concordance 
between EPR and ICIP allergy at the outset was 68.8%, which increased 
to 76.5% in the repeat CA. Concordance with the ward drug chart pre-
admission and ICIP was 77.6%, increased to 93.9% at re-audit.
Conclusions This CA suggests that up to one in three critical care patients 
have a known allergy. The potential for harm is high. More than one-
half of patients admitted to critical care did not have an allergy status 
documented prior to prescribing a new drug. There was signifi   cant 
discordance between the paper medication chart and ICIP allergy. A 
number of factors were introduced following initial fi  ndings, including 
making the allergy status mandatory on ICIP, not allowing the admission 
summary to be saved prior to allergy documentation and ensuring current 
allergy documentation on EPR.
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Introduction  An anonymous error reporting system was trialled to 
establish whether error reporting rates would improve and to allow the 
identifi  cation of medication incidents. The National Patient Safety Agency 
(NPSA) feedback report for the Norfolk and Norwich Hospital shows that, 
compared with similar organisations, medication error reporting is low. 
A review of the medication incidents reported for the critical care facility 
in 2007 and 2008 had only 19 events. Error rates in the ICU are typically 
higher than in other acute settings, one study reporting 10.5 medication 
errors per 100 bed-days [1]. Patients in critical care typically receive high-
risk medications. Error reporting is integral to identifying common errors 
and medication risk reduction.
Methods A medication reporting form was developed to run alongside 
the offi   cial hospital incident reporting system for 2 weeks. Forms were 
distributed throughout the critical care facility. All members of the 
multidisciplinary team were asked to anonymously complete a form 
every time a medication error, or near miss, occurred. After 2 weeks, the 
submitted forms were analysed by the project team.
Results  In total 112 reports were submitted. The largest numbers of 
incidents reported were due to prescribing (67%) errors followed by 
administration (15%), documentation (7%), electronic prescribing problems 
(6%), storage (3%) and monitoring (2%). Within prescribing incidents there 
were four recurring themes: duplication of therapy, wrong/inappropriate 
drug choice, incorrect dose/regimen and omission. The numbers of 
incidents reported increased as the week progressed, with the largest 
number occurring on a Friday (24%). A review of the types of medicines 
involved showed that insulins, proton pump inhibitors, anticoagulants, 
vancomycin, and epidurals were recurring themes, refl  ecting NPSA alerts. 
When graded for signifi  cance, two were found to be harmful, 56 signifi  cant 
and 54 insignifi  cant.
Conclusions There is clearly considerable under-reporting of medication 
errors in critical care via the offi   cial incident reporting system. One of 
many reasons for poor offi   cial reporting of errors is the lack of tangible 
local response to those errors. It is therefore important that the areas 
highlighted by our project are eff  ectively addressed, not only to improve 
safety but also to encourage further reporting and work to develop a 
culture of incident reporting within critical care.
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Introduction As part of a safer patient initiative under the auspices of 
the Institute of Health improvement (IHI), Boston, we took part in a 2-year 
project to improve the safety and quality of care in adult intensive care.
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and advised our institution on mechanisms to improve quality of care. 
The aim was to develop systems of healthcare that were reliable at least 
95% of the time. The changes to be introduced – central line bundle, 
ventilator bundle, hand hygiene, daily patient goals – were led by a small 
multidisciplinary team chaired by a hospital executive (fi  nance director) 
who met every 2 weeks for 2 years for short meetings (~1/2 hour). Our aim 
was to reduce nosocomial infection and mortality.
Results It took ~12 months to introduce reliable process in all areas. 
Hand hygiene improved from ~70% compliance to consistently >95%. 
MRSA acquisition on the ICU reduced from about 10% of patients prior to 
October 2006 to 0.3%. VAP was reduced (Figure 1). The average unadjusted 
mortality was reduced year on year despite similar mean APACHE II and 
ICNARC scores (Figure 2).
Conclusions  Reliable evidence-based processes for patient care can 
signifi   cantly reduce nosocomial infection and mortality. The use of 
executive nonmedical hospital personnel experienced in the mechanisms 
of introducing change may be benefi  cial.
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Improving team work during bedside rounds: using daily goals and 
best practices
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Introduction Communication between healthcare professionals is a key step 
for patient safety, its failure accounting for over 60% of root causes in sentinel 
events [1]. Bedside rounds are important for teamwork communication 
and can be improved by an explicit approach [2] and by process-oriented 
information tools to organize and direct interprofessional rounds [3].
Methods As part of a quality improvement project, we conducted an 
observation of the documentation of daily goals (DG) and best practices 
(BP) in a step-down unit (both tools have been previously added to patient 
fl   owsheets), before and after the introduction of a structured rounds 
process and team education. Our hypothesis was that these important 
tools were used before rounds, without input from all team members. 
Rounds were observed on two separate periods and the observer would 
take notes of whether DG and BP were documented or not and whether 
discussion took place before documentation. Diff  erences in proportions 
between the two periods were analyzed with Fisher’s exact test. P <0.05 
was considered signifi  cant.
Results  We observed 100 bedside interactions on each period. 
Documentation remained unchanged for DG (pre 55% vs post 53%, 
P >0.05) and BP (pre 57% vs post 48%); however, the second period had an 
improved documentation after team discussion (DG: pre 2% vs post 31%, 
P <0.001; BP pre 0% vs post 33%, P <0.001).
Conclusions  The intervention aided in increasing documentation 
after discussion, implying an increased communication among the 
interprofessional team. About 50% of patients still will not have 
documentation after bedside rounds. Patient information was not 
collected, therefore our study is limited in providing information on clinical 
outcomes. Further research should focus on how to best implement 
these tools, how to qualitatively assess the content of daily goals and to 
demonstrate eff  ects on patient-centered outcomes.
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Introduction The use of a high-fi  delity simulator can lead to very realistic 
clinical situations sometimes diffi   cult to manage psychologically. The aim of 
this study was to evaluate the psychological stress induced by simulation-
based training and the associated skills in anesthesiologist residents.
Methods  A cohort of 27 residents was studied. The psychological 
stress just before and after the simulation session was quantifi   ed by 
autoevaluation scale (numeric scale 0 to 10) and by salivary amylase 
sampling [1]. Nontechnical skills were quantifi  ed by analysing videotapes 
and scoring the Anaesthetist NonTechnical Skills [2].
Results The median stress numeric scale before the simulation session was 
5 (ranging 2 to 8), and after was 7 (2 to 10) (P = 0.0004) (Figure 1). The stress 
scale before the session was signifi  cantly lower in residents who already 
Figure 1 (abstract P453). Ventilator-associated pneumonias per 1,000 
ventilator-days. C03: Musgrove Park Hospital, Taunton and Somerset NHS 
Trust. CCO1 – VAP rate.
Figure 2 (abstract P453). Intensive care mortality between 2006 and 
2009.
Figure 1 (abstract P455).
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scales after the simulation session were above 8/10. Salivary amylase after 
the session was signifi  cantly higher than before (P = 0.008), corresponding 
to a 2.2-fold increase. They were no signifi  cant relationships between 
psychological stress parameters and nontechnical skills.
Conclusions  Psychological stress before the simulation session, but 
especially after simulation, appears to be high in anesthesiologist 
residents, and particularly in those who performed a simulation session 
for the fi  rst time. This fact should be considered when organising such 
simulation-based teaching.
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Introduction The respiratory therapist has a central role in the manage-
ment of critically ill patients. The objective of this study was to evaluate 
the impact of an education program aiming to improve quality of care of 
respiratory therapy.
Methods A before–after study was designed to assess compliance to 15 
respiratory therapy indicators, chosen due to their relevance in patient 
care and availability for objective measurement, in all patients admitted 
to the ICU regardless of mechanical ventilation or not. Compliance 
was assessed during 1 month before implementation of the education 
program. The educational process comprised of meetings, group training, 
written manuals and individual feedback for noncompliance situations. 
After 6 months of the implementation process, compliance assessment 
was again performed. Results were expressed as percentages and 
comparisons were performed through the chi-square test. Results were 
considered signifi  cant if P <0.05.
Results In both periods 80 patients were observed, with a total of 1,212 
observations in the before period (BP) and 1,369 observations in the after 
period (AP). Compliance rates improved for almost all indicators as follows: 
chart registration (CR) of weight/height (BP = 97.7%; AP = 99.4%; P = 
0.0026), CR of weight-predicted tidal volume (BP = 73.3%; AP = 94.7%; P = 
0.000), CR of orotracheal tube fi  xation level (BP = 69.5%; AP = 93.6%; P = 
0.000), CR of humidifi  cation line change date (BP = 83%; AP = 89.8%; P = 
0.000), CR of chest X-ray pattern (BP = 86.8%; AP = 96.9%; P = 0.000); CR of 
clinical decisions during round (BP = 91.3%; AP = 98.7%; P = 0.000), actual 
compliance to clinical decisions during rounds (BP = 79.77%; AP = 98.8%; 
P = 0.000), correct utilization of mechanical ventilation humidifi  cation (BP = 
75.9%; AP = 96.4%; P = 0.000), actual tidal volume between 6 and 8 ml/kg 
predicted body weight (BP = 82.0%; AP = 96.3%; P = 0.000), adequacy of 
ventilators alarms (BP = 69.5%; AP = 95.4%; P = 0.000), actual plato pressure 
<30 mmH2O (BP = 93.2%; AP = 95.7%; P = 0.0241). Some indicators did 
not show a statistically signifi  cant improvement: CR of secretion aspect 
(BP = 94.4%; AP = 94.2%; P = 0.861), CR of circuit change date (before = 
90%; after = 92.2% P = 0.0848) and CR of round changes (BP = 92.0%. AP = 
92.6%; P = 0.551). Only CR of cuff   pressure had a lower compliance on the 
AP (BP = 87.5%; AP = 79.4%; P = 0.0005).
Conclusions An education program based on protocol-driven actions 
and training is able to improve compliance in respiratory therapy quality 
indicators. The clinical relevance of this compliance improvement still 
needs to be established.
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Introduction There have been several eff  orts to improve the quality of 
care of ICU patients. The use of checklists has been linked to improvements 
in ICU care. In 2005, Vincent and colleagues published the FAST HUG 
checklist strategy [1]. We decided to study the level of adherence of 
Mexican physicians to the measures proposed in this checklist.
Methods We conducted a 3-month prospective observational study in 
the adult ICU of an academic hospital in northeastern Mexico. Patients 
were sorted into one of the two study groups: group 1 had a critical care 
physician on charge of the ICU management, while group 2 had a non-
critical care physician on charge. We measured the adherence of the 
physicians to the FAST HUG checklist items. We arbitrarily defi  ned good 
compliance as having fulfi  lled >4 items.
Results  One hundred and forty-seven patients were admitted to the 
ICU during the study period, but only 129 had complete data and were 
evaluated. There were 86 patients in group 1, while group 2 had 43 
patients. Group 1 patients had higher age, SOFA and APACHE score on 
admission. We analyzed the subgroup of patients who had an initial 
APACHE score between 11 and 25, as they are usually the ones most likely 
to benefi  t from FAST HUG measures. These results are described in Table 
1. We noticed that most of the group 1 patients had severe sepsis, while 
most of the group 2 patients had ischemic heart disease, which clearly 
explains the diff  erences in mechanical ventilation and length of ICU stay.
Table 1 (abstract P457). Variables of the subgroup APACHE II 11 to 25
Variable  Group 1  Group 2  P value
Age  64 ± 10  69 ± 17  0.25
APACHE II  18 ± 5  15 ± 4  0.08
SOFA on admission  5 ± 3  3.3 ± 2  0.12
SOFA at discharge  2.4 ± 4  1.7 ± 2   0.82
ICU length of stay  10.5 ± 9  4.6 ± 3  0.04*
Mechanical ventilation days  6.7 ± 9.6  1.8 ± 3  0.11
FAST HUG  6.4 ± 0.9  3.8 ± 1.4  0.001*
Group 1 had a critical care physician in charge of ICU management, while group 
2 had a noncritical care physician in charge. We observed the same severity 
of illness in this group with APACHE II between 11 and 25 points and better 
adherence to the FAST HUG items among intensive care physicians.
Conclusions We found a better adherence to the FAST HUG items among 
intensive care physicians.
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Introduction Nosocomial infections remain a clinical challenge in the ICU. 
Based on defi  nitions by the Centers for Disease Control and Prevention of 
Atlanta, nosocomial infections are defi  ned as infection occurring within 
48 to 72 hours after hospital admission. In ICU settings, a single-bed 
room location has been suggested as a structural organization helpful to 
prevent nosocomial infection diff  usion. Here we show preliminary results 
of a study conducted in our ICU before and after a change from open bay 
to single-bed room locations.
Methods Microbiological data were collected from ICU patients hosted in 
bay rooms in the ICU (April 2006 to April 2007) and compared with data 
collected from patients hosted in the subsequent period (May 2007 to 
May 2008), after the single-bed ICU room re-allocation. For analysis, we 
considered the prevalence of microorganisms isolated and the diff  erence 
in blood culture/tracheal aspirate positivity.
Results  The cohorts examined resulted in similar demographic and 
clinical data. As shown in Figure 1, microorganisms isolated did not change 
signifi  cantly in the two periods. Figure 2 summarizes the diff  erences in 
tracheal aspirate/blood culture isolation among the two periods.
Conclusions We cannot confi  rm that a single-bed room location can 
prevent nosocomial infection diff  usion. A limit of this study, as in previous 
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wards or after a prolonged emergency room stay.
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Introduction  Healthcare-associated infection (HCAI) has a signifi   cant 
contribution to mortality, morbidity and cost of treatment in critically ill 
patients. The objective of this study was to conduct a process (quality 
improvement) and outcome (pre and post implementation) surveillance, 
HCAI being taken as the major variable.
Methods This was a prospective observational study carried out from June 
2005 to September 2009. Process implementation was started from May 
2006 and included compliance with hand hygiene, urinary catheter care, 
central line care and VAP bundle. HCAI rates were recorded prospectively 
every month from June 2005. We recorded the rates of central line-related 
bloodstream infection (CLI), catheter-associated urinary tract infection 
(UTI), hospital-acquired pneumonia (HAP) and ventilator-associated 
pneumonia (VAP) per 1,000 device-days as per CDC–NNIS defi  nition [1,2].
Results Various infection rates showed numerical improvement after the 
implementation of the quality improvement (QI) process (Figure 1). The 
diff  erences were statistically signifi  cant for two of these four endpoints (P 
for HAP = 0.029 and for UTI = 0.013) and in others there was a trend towards 
improvement. Device utilization rates associated with these endpoints 
before and after the implementation remained unchanged, confi  rming that 
the drop of infection rates was not infl  uenced by any reduction/increase of 
respective device utilizations (Figure 1). The average compliance rate during 
the study period for hand hygiene was 77.92, for urinary catheter care 98.24, 
for central line care 96.62 and for VAP bundle 91.54.
Conclusions  Implementation and continuous surveillance of the QI 
process improved nosocomial HCAI in our hospital.
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Introduction  The sniffi     ng position is widely promoted for teaching 
airway positioning prior to intubation attempts, but whether this analogy 
results in novices placing the head and neck appropriately has not been 
evaluated. An alternate analogy – win with the chin – or simple anatomic 
instructions may perform better.
Methods Randomized controlled study comparing diff  erent instructions 
for enabling novices to adequately position a simulator mannequin’s head 
and neck. Study volunteers included medical students and PGY1 residents 
in surgery and internal medicine. Subjects independently positioned a 
mannequin based upon their understanding of four randomly-assigned 
written instructions for: the sniffi     ng position; the win with the chin 
analogy; anatomic instructions; and no instructions (control). Digital 
photographs following each instruction were analyzed by two airway 
experts for adequacy of overall positioning, and for the three components 
of airway positioning.
Results There were 81 volunteers. The positioning was adequate most 
often (43.2%) following the win with the chin analogy as compared with 
the other instructions (37.0% anatomic instructions; 19.8% control; 14.8% 
sniffi     ng position analogy). Positioning following the sniffi   ng  position 
instructions was not diff  erent from no instruction (P = 0.53). The win with 
the chin and anatomic instructions were better than no instructions (P = 
0.002 and P = 0.023, respectively).
Conclusions The win with the chin analogy resulted in adequate airway 
positioning signifi  cantly more often than the sniffi   ng position or control, 
and maintained atlanto-occipital extension when compared with 
providing anatomic instructions. Overall, win with the chin was a superior 
teaching analogy and could replace the sniffi   ng position analogy.
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Introduction  Central venous catheterization is a common procedure, 
but can potentially result in serious complications. Previous studies 
have shown that inexperienced trainees have lower success rates than 
experienced operators. Little is known about the effi   cacy of ultrasound 
(US) guidance in central venous catheter (CVC) insertion by inexperienced 
trainees.
Figure 1 (abstract P458).
Figure 2 (abstract P458).
Figure 1 (abstract P459). Comparing mean infection rates before and 
after the quality improvement process.
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training hospital. All patients who were inserted CVCs by inexperienced 
trainees (postgraduate year 1 to 6) between 1 June 2008 and 31 October 
2009 were included. The following parameters were evaluated: the rate 
of successful insertions, the incidence of complications, the site of CVC 
insertion, the method of US use, and the postgraduate year of the trainees. 
We defi  ned success of CVC insertion if a trainee completes catheterization 
without complication and personnel exchange. We compared the 
success rate and the complication rate with both insertion sites and US 
techniques; Group SA (surface anatomy) underwent CVC insertion using 
the landmark technique, Group indirect-ultrasound (iUS) using ultrasound 
image-based skin surface marking, and Group direct-US (dUS) using real-
time ultrasound guidance. The chi-test was used for analysis and P <0.05 
was considered statistically signifi  cant.
Results In total 593 CVCs were inserted, 527 via the internal jugular vein 
(IJV), and 66 via the subclavian vein (SV). The IJV approach includes 52 
patients (9.9%) in Group SA, 145 patients (27.5%) in Group iUS, and 330 
patients (62.6%) in Group dUS. The SV approach, on the other hand, 
consisted of 26 patients (39.4%) in Group SA, and 40 patients (60.6%) in 
Group dUS. The success rate of CVC insertion of the IJV approach linearly 
rose in Group SA, Group iUS and Group dUS (76.9%, 81.4%, 88.2%, P = 
0.033), but in the SV approach there is no signifi  cant diff  erence between 
Group SA and Group dUS (76.9%, 75.0%, P = 0.83). Five patients who 
underwent real-time US via the SV developed pneumothorax while no 
one in Group SA had the complication (P = 0.57).
Conclusions The use of ultrasound guidance improves the success rate 
of CVC insertion via the IJV by inexperienced trainees. However, in the 
SV approach the effi   cacy of ultrasound guidance is not proven, and the 
incidence of pneumothorax increased in our study.
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Introduction ICU beds are a limited resource; their appropriate use is 
mandatory: only patients sick enough should be admitted to the ICU, and 
all admitted patients should receive the adequate level of care.
Methods  From 1 January 2008 to 9 March 2009, 716 admissions to 
a seven-bed general ICU were analyzed according to GiViTI’s StART 
approach, to evaluate appropriateness of the ICU admission and stay. 
Available resources (ICU beds) were classifi  ed as High Level (HL) or Low 
Level (LL), according to equipment and staffi   ng. Patients may require High 
(H), Low (L), or Ordinary (O) levels of care (HP, LP, OP, respectively) [1]. OPs 
should not be admitted to the ICU and can stay in the ICU only briefl  y, 
following HL or LL periods. One nurse can attend two HPs, or one HP 
and two LPs, or four LPs, provided that each bed can be controlled easily 
(not in diff  erent rooms, for example) [2]. For each day shift, matching of 
required and available care was analyzed: mismatch is expressed as nurse 
defi  cit: positive values indicate excess of care (too many nurses for not too 
sick patients), zero suggests that assistance requirements are met, with 
negative values available care is less than patients’ needs.
Results In this ICU, all seven beds are fully equipped. Of the 716 ICU 
admissions, 20 (2.8%) were inappropriate OPs. One hundred and ninety-
seven further ICU-days of the 2,711 available (7.3%) were used for OPs 
(mostly due to delayed discharges); altogether 217/3,427 (6.3%) ICU-
days were inappropriately used for OPs. In the analysis of resources 
and requirements matching, if the seven beds were in the same room, 
available assistance would meet requirements in most nurse shifts, even if 
the staff   would have worked at maximum almost always; in fact, in this ICU, 
four beds are in a room and there are three single-bed rooms – therefore, 
according to the suggested standards, a mean 1.9 nurse defi  cit per shift is 
observed. The relevance of this observation on patient outcome can be 
speculated only.
Conclusions The relevance of the StART approach is the defi  nition of 
inappropriateness both from excess and insuffi     ciency of care points 
of view: both admissions and ICU stays of OPs and/or too many too 
sick patients for the amount of care available are equally inappropriate. 
Moreover, the available care is determined both by the number of ICU 
nurses and by logistic constraints: seven beds in an open space are 
diff  erent from four beds in a room and three beds in single rooms, and in 
fact this ICU pays a two nurse defi  cit per shift to its design.
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Introduction A recent analysis of critical incidents reported to the National 
Patient Safety Agency (NPSA) by ICUs in the UK revealed a signifi  cant 
number of airway incidents in critical care [1]. We recently performed 
an online survey with responses from 305 trainees from across the UK 
regarding airway management and complications on the ICU. The results 
revealed a high number of adverse airway events including 27 deaths. A 
large number of junior trainees (many of whom cover the ICU alone at 
night) expressed low confi  dence levels with airway management in critical 
care, and the majority of all trainees felt inexperienced with tracheostomy 
care and emergencies. Simulation has been recommended as a suitable 
way of providing critical incident training [2], and simulation at the point 
of care has been shown to be especially powerful and eff  ective [3].
Methods  In response to our survey, we set up a multidisciplinary 
simulation-based airway teaching programme for all staff   on our unit. A 
Resusci-Annie™ manikin with an Airway Trainer™ head (Laerdel, Norway) is 
set up in a bed space on our ICU. Realistic patient monitoring is achieved 
with the Laerdel SimMan™ software (free from the Laerdel website). We 
have written a number of scenarios in response to incidents and training 
defi  ciencies highlighted by our survey. Scenarios are run with ICU staff   
from all disciplines acting within their normal roles. Realism is enhanced 
by staff   practicing in their usual working environment, using the unit’s 
own equipment.
Results So far, we have trained 43 ICU staff  . Feedback has been excellent, 
with scores ranging from 8.5 to 10. Participants were especially positive 
about the multidisciplinary aspect of the training and on practising 
uncommonly encountered scenarios in their normal workplace.
Conclusions  We have created a multidisciplinary airway training 
programme to practice critical incident drills at the point of care. This 
teaching method is low cost, simple and can be set up quickly and 
spontaneously during quiet periods on the ICU.
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Introduction This survey investigated current UK intensive care practice 
in testing patients for blood-borne viruses following needle stick injury 
when the patient lacks capacity for consent. Needle stick injuries are a 
common occurrence in the National Health Service, with an estimated 
incidence of 113 to 623/10,000 healthcare workers/per year [1]. Current 
UK law [2,3] does not permit the testing of a patient’s infective status 
for the benefi   t of a healthcare worker involved without the patient’s 
consent. Incapacitated patients cannot give consent. The General Medical 
Council (GMC) guidance for the management of needle stick injuries from 
incapacitated patients refl  ects this [4].
Methods A questionnaire was sent to the clinical lead of the 225 general 
ICUs within England, Wales and Northern Ireland. Responses were 
anonymous.
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Sixty-two of the 99 consultants (63%) reported incidences of needle stick 
injuries to their staff   from incapacitated patients in the past year. In six 
incidents the patient was not tested because their full blood-borne virus 
status was already known. Thirty-six of the remaining 56 incidents (64.5%) 
stated that patients were tested without consent. Sixty-one per cent 
of consultants (22 of 36) reported that the patient was informed once 
conscious that the test had been performed. Two consultants discussed 
the decision to perform the test with the family prior to proceeding. One 
patient, not tested at the time of injury, refused consent on regaining 
capacity. Sixteen patients out of the 62 incidents were blood-borne virus-
positive (26%), six being new diagnoses following the needle stick injury 
(37.5%).
Conclusions Despite the recent change in legislation, the majority of 
incapacitated patients are being tested for blood-borne viruses when 
unable to give consent. This has signifi   cant benefi   cial eff   ects for the 
healthcare worker involved; a negative test allowing prophylactic antiviral 
treatment to be discontinued and minimises anxiety. This survey highlights 
the need for further discussion involving healthcare professionals, the 
legal profession and legislators regarding needle stick injuries from 
incapacitated patients. Is there a duty of care to the healthcare worker that 
is not acknowledged in current legislation?
References
1. Trim  JC,  et al.: J Hosp Infect 2003, 53:237-242.
2.  Human Tissue Act 2004 [http://www.opsi.gov.uk/acts/acts2004/
ukpga_20040030_en_1.htm]
3.  Mental Capacity Act 2005 [http://www.opsi.gov.uk/acts/acts2005/
ukpga_20050009_en_1]
4.  Update to Serious Communicable Disease guidance [http://www.gmc-uk.
org/guidance/update_serious_communicable_diseases.asp]
P465
Stress and fatigue among anaesthesia and intensive care doctors in 
Lithuania
A Macas, A Kolciniene, I Vetaite, D Bilskiene, A Mikalauskas
Kaunas University of Medicine, Kaunas, Lithuania
Critical Care 2010, 14(Suppl 1):P465 (doi: 10.1186/cc8697)
Introduction  Evidence shows that anaesthesia and intensive care is 
a stressful occupation and it may have an impact on anaesthetists’ and 
intensive care doctors’ well-being. The goal of the study was to evaluate 
stress and fatigue and their correlation with working conditions among 
anaesthesiologists and intensive care specialists employed in Kaunas city 
(Lithuania) hospitals.
Methods One hundred and forty-two doctors of anaesthesia and intensive 
care departments were interviewed using a standard questionnaire in 2008. 
It consisted of three parts: the fi  rst part covered the demographic and social 
situation, second – stress experienced during work, third – risk of fatigue.
Results The response rate was 71%. Average age of respondents was 
41 years, 66.2% were female. A total of 25.4% had working experience 
<5 years and 23.2% working experience of 11 to 15 years. The workload 
of 49.3% of respondents was 37 to 54 hours per week (mean number 
of on-call nights per month – 6.5; 15.3% of respondents had >9 on-call 
night shifts). Often and very often stress was experienced by 24.6% of 
doctors; symptoms of fatigue were demonstrated by 57% of respondents. 
Respondents older than 55 years emphasized increased blood pressure, 
while younger respondents – up to 34 years – reported inability to 
concentrate, decreased objectiveness, unstable mood, diffi   culty in making 
decisions. Respondents living without partners experienced chest pain, 
anger and nuisance. Doctors experience less stress if they are satisfi  ed with 
their work and if their workload is adequate, while increasing pressure by 
hospital administration to decrease costs of care increased risk of fatigue. 
If a doctor is employed for more 40 hours per week he faces diffi   culties 
concentrating, while more than 60 hours per week causes interference 
with home life.
Conclusions  Every fourth anaesthesiologist experienced stress during 
work, while more than one-half had symptoms of moderate fatigue. 
Growing workload increased doctor’s stress. Pressure by hospital 
administration and limited freedom in decisions increased incidence of 
fatigue. Work satisfaction reduced risk of stress and fatigue. Stress and 
fatigue signifi  cantly correlated with the state of physical health.
P466
Implementation of daily goals in the ICU reduces length of ICU stay 
and errors of omission in patient care
JM Binnekade1, A Brunsveld2, S Arbous2, MG Dijkgraaf1, J Horn1, J Sloot1, 
A Balzereit2, MB Vroom1
1Academic Medical Center, Amsterdam, the Netherlands; 2LUMC, Leiden, the 
Netherlands
Critical Care 2010, 14(Suppl 1):P466 (doi: 10.1186/cc8698)
Introduction  In the ICU, daily goals have improved the eff  ectiveness 
of communication within care teams [1]. The study objective was to 
investigate the eff  ect of explicit daily goals in ICU practice on the length 
of intensive care stay, length of hospital stay, duration of mechanical 
ventilation and errors of omission in patient care.
Methods A multicenter, sequential cohort, pretest–post-test study was 
performed. During the pretest phase, daily goals were formulated by staff  -
physicians, evaluated by a research physician and kept blinded for the rest 
of the ICU team. Subsequently, daily goals were broadly implemented. 
During the post-test phase, daily goals were routine practice. Patient data 
were collected one full year before (as baseline reference) and during 
the pretest and post-test phases. During pretest and post-test, medical 
charts (random subsets of 10 patients a week) were reviewed for errors of 
omission, defi  ned as deviations from our care protocols. Patient data were 
compared with data from nonparticipating academic ICUs, extracted from 
the National Intensive Care Evaluation database.
Results Two academic ICUs participated in the study. Patients included: 
baseline reference n = 3,641; pretest n = 3,401, and post-test 3,426. ICU 
mean (SD) length of stay (days) diff  ered signifi  cantly between the pretest 
phase 5.7 (2) and the post-test phase 4.3 (2.3), diff  erence 1.4 days (95% CI 
1.3/1.5). The post-ICU length of hospital stay decreased in the post-test 
phase, mean diff  erence 2.3 days (95% CI 1.2/3.4). Median (IQR) duration of 
mechanical ventilation during pretest was 2 (1 to 4) days and during post-
test was 1 (1 to 4) days, P <0.001. The probability of an error of omission 
was signifi  cant larger in the pretest phase then in the post-test phase, RR 
6.5 (5.7/7.4).
Conclusions  The results showed a signifi   cant decrease in ICU LOS, 
duration of mechanical ventilation and length of post-ICU stay following 
DGF implementation. Also the chance of errors of omission to occur 
was six times lower, which indicates a signifi  cant increase in protocol 
adherence. The drawback of the study design (historic control group and a 
pretest and post-test for comparison) was limited by comparing the study 
results with other academic centers during the same time frame.
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Use of single patient rooms to decrease acquisition of antibiotic-
resistant bacteria in the ICU
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Critical Care 2010, 14(Suppl 1):P467 (doi: 10.1186/cc8699)
Introduction  The role of isolation rooms in decreasing bacterial 
transmission between ICU patients has been debated. A recent change in 
ICU location allowed for further investigation.
Methods Old ICU A and Old ICU B were open-plan seven-bed and four-bed 
units. In March 2007, ICU A moved to single patient rooms (New ICU A – 
eight beds). ICU B remained unchanged (New ICU B). The same physicians 
cover both ICUs. Patient distribution is based on available space only. 
Demographic and microbiological data were collected on consecutive 
patients staying >48 hours. Culture of resistant organisms (MRSA, VRE, 
ESBL, resistant Acinetobacter, or carbapenem-resistant Gram-negatives) in 
surveillance or clinical cultures was measured. New ICU A was compared 
with open-plan New ICU B to assess the eff  ect of single rooms. New ICU 
A was compared with Old ICU A to assess change vs historical controls 
and New and Old ICU B were compared with show control group stability.
Results Data were collected on 62, 62, 44 and 39 patients from Old ICU A, 
New ICU A, Old ICU B and New ICU B. Patient populations in New ICU A 
and B were similar. ICU acquisition of resistant organisms was lower in New 
ICU A (3/62, 5% vs 7/39, 18% New ICU B patients, P = 0.043). This fi  nding 
was confi  rmed using survival analysis (P = 0.011). Comparing New with 
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ICU antibiotic use (20/62, 32% vs 37/62, 60%, P = 0.001), pre-ICU hospital 
admission (21/62, 34% vs 37/62, 60%, P = 0.004) and ICU admission 
prevalence of resistant organisms (11/62, 18% vs 25/62, 40%, P = 0.006). 
On Cox regression only the admitting ICU was signifi  cant for acquisition 
of resistant organisms (Old vs New ICU A: HR 4.07, 95% CI 1.03 to 16.06, 
P = 0.025). Comparing New with Old ICU B showed no changes. Adequate 
hand hygiene amongst the same physicians was found on 140/242 (58%) 
occasions in New ICU A vs 23/66 (35%) in New ICU B (P <0.001).
Conclusions  The change in ICU design to single patient rooms 
signifi  cantly decreased acquisition of multiresistant organisms. Whether 
the ICU design or improved infection control awareness led to change 
could not be determined. This is the fi  rst study to measure the eff  ect of 
ICU design on acquisition of a range of resistant organisms while including 
a contemporaneous control ICU environment.
P468
Time to fi  rst review of new admissions to critical care by the 
consultant intensivist
A Dhrampal
Norfolk and Norwich University Hospital, Norwich, UK
Critical Care 2010, 14(Suppl 1):P468 (doi: 10.1186/cc8700)
Introduction The National Confi  dential Enquiry into Patient Outcome 
and Death (NCEPOD) recommends that all new admissions to the ICU 
should be reviewed by a consultant intensivist within 12 hours [1]. This 
early review may reduce the ICU length of stay (LOS), but does not appear 
to aff  ect mortality [2]. Patient severity of illness (APACHE II scores) may also 
infl  uence patient outcome.
Methods The database of our clinical information system (MetaVision, 
iMDsoft) was interrogated and 116 new consecutive critical care 
admissions were retrospectively reviewed. We ascertained the time to fi  rst 
review (in hours) by a consultant intensivist from MetaVision entry logs. 
Patient outcomes including mortality and LOS were also captured for 
patients reviewed early (<12 hours) and late (>12 hours). The admission 
APACHE II score was also calculated. Continuous and ordered categorical 
variables are expressed as the median and analysed by the Mann–Whitney 
U test. Outcome binary variables were analysed by the chi-squared test. 
P <0.05 was considered statistically signifi  cant.
Results The early reviewed group (n = 53) had a median fi  rst review time 
of 4.35 hours (IQR 1.70 to 6.90), median LOS of 46 hours (IQR 22 to 86) and 
mortality of 17% (n = 9). The late review group (n = 63) had a median fi  rst 
review time of 16.55 hours (IQR 14.35 to 18.88), median LOS of 25 hours 
(IQR 20 to 46) and mortality of 1.6% (n = 1). The median admission APACHE 
II score for the early group and late group was 14 (IQR 10 to 24) and 10 (IQR 
8 to 16), respectively. There was no signifi  cant diff  erence in LOS between 
the two groups (P = 0.137, two-sample Mann–Whitney U test). The early 
group had a signifi  cantly higher mortality (P = 0.03, chi-squared test) and 
admission APACHE II score (P = 0.04, two-sample Mann–Whitney U test).
Conclusions  We were unable to demonstrate that early consultant 
intensivist review of new critical care admissions reduces the LOS or 
mortality. Despite early consultant intensivist review, this group had a 
signifi  cantly higher mortality. A signifi  cantly higher severity of illness in the 
early group may account for this higher mortality.
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Introduction Anecdotal evidence at our hospital suggested an increase 
in the number of patients referred for admission to the ITU by junior 
doctors without consultation with senior doctors from their own specialty. 
Recent UK guidance has recommended consultant-to-consultant referral 
for critical care patients [1]. Our ITU welcomes the timely referral of at-risk 
patients. However, excessive numbers of poor referrals have contributed 
to the prolonged absence of critical care team members from the unit. At 
a time of increasing diffi   culty in maintaining adequate levels of medical 
cover because of regulations concerning hours of work and training 
requirements, there is concern that this may adversely aff  ect the effi   cient 
and safe management of the ITU.
Methods All referrals were prospectively recorded for a 6-week period. 
The following data were recorded: date/time of referral, grade/specialty 
of the referring doctor, involvement of the referring consultant, indication 
for the referral, referral to assessment time, duration of the assessment and 
whether the referral led to admission.
Results  Fifty-seven per cent of referrals were out of working hours. 
The sources of the referrals were as follows: emergency codes 29% and 
specialty referrals 71%. The admission rates to the ITU for the referrals 
were cardiac arrests 33%, trauma calls 75%, specialty referrals 42%. Referral 
rates according to grade (excluding emergency codes): consultant 14%, 
senior trainee 49%, junior trainee 37%. Admission rates according to grade 
of referral: consultant 54.6%, senior trainee 42.1%, junior trainee 34.4%. 
The mean time to review of referral was 20.2 minutes. The mean time 
for assessment for all referrals was 38.8 minutes. This was 52.3 and 28.9 
minutes for patients admitted to the ITU and not admitted, respectively. 
The mean assessment and management times for the code calls were: 
cardiac arrest 42 minutes and trauma calls 81.2 minutes.
Conclusions  Our data suggest that consultant-to-consultant referral 
would reduce ITU referrals that do not require admission, and decrease 
the time that ITU trainees are off   the unit.
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Critical Care 2010, 14(Suppl 1):P470 (doi: 10.1186/cc8702)
Introduction Communication with conscious patients who are on oxygen 
and cannot verbally communicate due to temporary loss of speaking 
ability has proven to be anywhere from problematic to extremely diffi   cult 
for the nursing staff   trying to understand the needs of the patients.
Methods  In order to improve the situation of conscious patients on 
oxygen, it is fi  rst necessary to conduct a status quo analysis to determine 
which communication aids can be implemented in the care of such 
patients. For this reason, a questionnaire was designed and carried out 
with the staff   of the ICU.
Results  The questionnaire of the intensive care staff    showed that 
from 31.7% (20 staff   members), the use of diverse electronic aids was 
indicated 10 times as a means for improvement in the communication 
situation of conscious patients on oxygen. A further question regarding 
communication aids that the intensive care staff   would like – but are not 
available in the ward – resulted in the computer being named as the 
most wanted communication aid. In cooperation with the engineering 
secondary school (HTL Mössingerstraße) a special keyboard was 
developed especially to suit the needs of conscious patients on oxygen 
and an operating system was installed on computers the general hospital 
made available.
Conclusions  The results indicated that the communication between 
the patients and the nursing staff   using the computer showed a 50% 
improvement in understanding the needs of the patient from the point of 
view of the nursing staff  . Thirty percent of the patients had tracheotomies 
and 20% were aphasia patients.
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Introduction  Transferring critically ill patients between clinical areas 
is recognised to be potentially hazardous [1] and associated with poor 
outcome [2]. This study addresses the standard of intrahospital transfer of 
sick patients within our Trust including monitoring, equipment availability, 
personnel and training.
Methods We surveyed senior ward staff   on how they would conduct 
the theoretical transfer of a deteriorating, hypoxic, shocked patient to 
the ITU. Monitoring and equipment deemed necessary and its perceived 
availability were recorded, as was transfer personnel. We then prospectively 
reviewed actual transfers of patients with Early Warning Scores (EWS) of 3 
or greater.
Results  Theoretical transfer data were collected from 19 wards. Most 
(74%) requested oxygen saturation (SpO2) monitoring, while less than 
one-third wanted either non-invasive blood pressure or ECG monitoring. 
Some wards expressed a need to borrow equipment, while others 
felt this would lead to delay. Three wards considered any monitoring 
unnecessary. Of 13 wards declining a defi  brillator/cardiac monitor, two 
did so due to lack of familiarity. Prospective data were gathered from 32 
transfers between September and November 2009. EWS ranged from 3 to 
9. The actual transfer monitoring mirrored the initial survey, but for SpO2 
monitoring (44% vs 74%, respectively). A doctor was included by 10% for 
the theoretical transfer and in 16% of actual transfers. Less than one-half of 
actual transfers had a trained member of the transfer team. These patients 
were better monitored but the standard of transfers did not correspond 
to EWS. Patients with higher EWS were neither better monitored nor 
accompanied. Out of hours activity comprised 21% of actual transfers. The 
bulk of patients were from the admission units and the majority went to 
critical care or radiology.
Conclusions There is considerable movement of sick patients around the 
hospital. Many transfers are performed by untrained staff  , without adequate 
monitoring, and many are out of hours. There is poor understanding of 
risks of transfer and of appropriate monitoring. The data suggest that 
defi  cits are due partly to equipment unavailability – we are conducting 
a further audit to determine this. We propose additional investment and 
training and are compiling intrahospital transfer guidelines according to 
EWS.
References
1. Waydhas  C:  Crit Care 1999, 3:R83-R89.
2. Voight  L,  et al.: J Intensive Care Med 2009, 24:108-115.
P472
Are bariatric patients putting a strain on intensive care beds?
W Rutherford, H Wydell, S McAuliff  e, C Peters
Homerton University Hospital, London, UK
Critical Care 2010, 14(Suppl 1):P472 (doi: 10.1186/cc8704)
Introduction This study looks at the characteristics and outcomes of 
patients admitted to an ICU after bariatric surgery and considers the 
staffi   ng and fi  nancial implications for the National Health Service (NHS). 
There is currently increased government incentive to treat obese patients 
with bariatric surgery with the aim of reducing co-morbidities in the future.
Methods A retrospective analysis of bariatric surgery patients requiring 
an ICU admission between 1 February 2007 and 31 August 2009. The 
study was carried out in a nine-bed mixed medical and surgical adult 
ICU providing level 2 and level 3 critical care to a 430-bed hospital in East 
London with a regional laparoscopic bariatric surgery service. Medical 
records were reviewed and information including gender, body mass 
index (BMI), age, reason for admission, treatment required and length of 
stay in the unit was collected. APACHE II and SOFA scores were calculated.
Results A total of 502 bariatric operations were performed during this 
period. Twenty-four (4.8%) patients required ICU admission at a cost of 
£2,500 (€2,750) per day for an average of 8.7 days (range 1 to 48). The 
average length of stay for all elective admissions was 2 days and for 
emergency admissions was on average 10 days. Cumulatively, bariatric 
patients spent a total of 209 days on the unit costing £522,500 (€575,300). 
The average weight was 146 kg (range 71 to 320 kg). The average BMI 
was 53.3 (range 32.1 to 102.1). The age range was 24 to 69 (mean 48) 
with an average APACHE II score of 13 and average SOFA score of 5. Four 
admissions (17%) were elective, due to severe co-morbidities, extreme 
weight or anticipated airway diffi   culties. Seven patients needed to go 
back to theatre one or more times for re-exploratory surgery due to 
postoperative complications. Three patients remained intubated for 
19 days or more, two of whom required a tracheostomy. Three patients 
died; two from intra-abdominal haemorrhage and one from sepsis.
Conclusions This is a high-risk cohort of patients, with 4.8% requiring an 
ICU admission. The need for patients to return to theatre for re-exploratory 
surgery was associated with longer ICU stays and multiple complications. 
This demand on critical care services is likely to increase as bariatric 
surgery continues to grow as a specialty and the NHS will need to increase 
investment in ICUs accordingly.
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Introduction Drug prescription is diffi   cult in ICUs as prescribers are many, 
drugs expensive and decisions complex. In our ICU, specialist clinicians 
(SC) are entitled to prescribe a list of specifi  c drugs, negotiated with 
intensive care physicians (ICP). The objective of this investigation was to 
assess the 5-year evolution of quantity and costs of drug prescription in 
our adult ICU and identify the relative costs generated by ICP or SC.
Methods Quantities and costs of drugs delivered on a quarterly basis 
to the adult ICU of our hospital between 2004 and 2008 were extracted 
from the pharmacy database by ATC code, an international fi   ve-level 
classifi  cation system. Within each ATC fi  rst level, drugs with either high 
level of consumption, high costs or large variations in quantities and costs 
were singled out and split by type of prescriber, ICP or SC. Cost fi  gures 
used were drug purchase prices by the hospital pharmacy.
Results  Over the 5-year period, both quantities and costs of drugs 
increased, following a nonsteady, nonparallel pattern. Four ATC codes 
accounted for 80% of both quantities and costs, with ATC code B (blood 
and haematopoietic organs) amounting to 63% in quantities and 41% 
in costs, followed by ATC code J (systemic anti-infective, 20% of the 
costs), ATC code N (nervous system, 11% of the costs) and ATC code C 
(cardiovascular system, 8% of the costs). Prescription by SC amounted 
to 1% in drug quantities, but 19% in drug costs. The rate of increase in 
quantities and costs was seven times larger for ICP than for SC (Figure 1 
overleaf). Some peak values in costs and quantities were related to a very 
limited number of patients.
Conclusions A 5-year increase in quantities and costs of drug prescription 
in an ICU is a matter of concern. Rather unexpectedly, total costs and cost 
increases were generated mainly by ICP. A careful follow-up is necessary to 
try infl  uencing this evolution through an institutional policy co-opted by 
all professional categories involved in the process.
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A semiquantitative assessment of the eff  ects of delayed discharge 
from the intensive care unit of survivors of critical illness
P Hopkins, J Shrosbree, M Mekki, C Bell, A Feehan, K Peters
Kings Health Partners, London, UK
Critical Care 2010, 14(Suppl 1):P474 (doi: 10.1186/cc8706)
Introduction One consequence of pressure on inpatient hospital bed 
numbers is a delay in the discharge of critically ill patients to the ward. 
Although this delay in discharge has been reported in a number of 
countries, the clinical and economic consequences of this delay have not 
been studied [1,2].
Methods We examined data from a mixed London ICU (32 beds) using 
the medtrack software tool (MASH Ltd) in addition to real-time mapping 
of ICU bed utilisation and patient fl  ows. We defi  ned delayed discharge as 
beginning 3 hours after the actual medical/nursing decision to discharge. 
We described a set of criteria a priori, to assess the eff  ect of delayed 
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also analysed the economic consequences of discharge delay using the 
medtrack capture of the critical care minimum dataset and available tariff  s.
Results In the 6-month analysis period, there were 15,320 hours of delayed 
discharge. This resulted in the postponement/delay of 45 operations for 
patients requiring level 3 intensive care and 177 operations for patients 
requiring level 2 intensive care. One hundred and fourteen tertiary referrals 
were refused because of bed blockage. Seventy-two patients were 
discharged between the hours of 22:00 and 06:00. There was a mean delay 
of 5.3 hours between identifying a patient requiring unplanned admission 
to critical care and their actual admission due to delayed discharge. 
Only 21 patients acquired a hospital-acquired organism while awaiting 
discharge (seven infections). Family/patient interviews suggested that the 
negative eff  ects of noise and exposure to the resuscitation and/or death 
of ICU patients were off  set by a perceived benefi  t of receiving critical care 
nursing for a prolonged period. This potential benefi  t was refl  ected by a 
72% reduction in the readmission of critically ill patients to critical care. The 
estimated cost of delayed discharge was £342,000.
Conclusions  Delayed discharge of patients to the ward following an 
episode of critical illness is a common and increasing problem. This delay 
is not benign and should be considered when prioritising bed utilisation 
in acute hospitals.
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Introduction The main objective of this study is to show the experience of 
using telepresence with robots in acute care facilities (ACFs) at community 
hospitals (CHs) during an infl  uenza AH1N1 outbreak in Mexico.
Methods  Three CHs with 60 beds each were equipped with a 
telepresence system that includes: high-speed connectivity, wireless 
Internet access, a RP-7i robot (InTouch Health, Santa Barbara, CA, USA) and 
a central computer based at a high-care hospital. The CHs give medical 
care to people without social security and are far away from the capital 
city at not less than 63 km (Atlacomulco 63 km, Valle de Bravo 85 km and 
Tejupilco 90 km). The program was designated to assist physicians in ACFs, 
which include emergency rooms (ERs) and ICUs during the second wave 
of an infl  uenza AH1N1 outbreak in Mexico. The program includes: rounds 
at the ACF and isolation area for patients with infl  uenza-like syndrome 
(ILS) every day from 9 am to 15 pm from Monday to Friday given by the 
MPH specialist team (intensivist), mechanical ventilation supervision (MV), 
transfer from CHs to high-care hospitals, length of stay (LOS) and mortality. 
Additionally, interventions in critically ill patients were recorded.
Results From 3 October to 30 November, 56 patients with ILS were assisted 
by the MPH team: three patients in Atlacomulco CH, six in Valle de Bravo 
CH and 47 in Tejupilco CH. The mean age was 45.3 years old (from 19 years 
to 84 years), 32 were female (57%). A confi  rmatory test for AH1N1 was 
documented in 10 patients (17.8%). Patients assisted in the ER, three; in the 
ICU, nine; in the isolation area for infl  uenza, 44 patients. The mean LOS for 
all patients was 3.6 days, 3.4 days for patients in the isolation area, 6.5 days 
in the ICU and 1 day in the ER. There were fi  ve patients on mechanical 
ventilation (8.9%) and two patients were pregnant (3.5%). Mortality was 
observed in fi  ve patients (8.9%) and the mortality rate in the ICU was 50%. 
Additionally, two patients were transferred to a high-care hospital (one 
died). All patients who went on ventilatory support died during the fi  rst 
day on MV.
Conclusions  This preliminary report shows that the practice of 
telepresence using robots at acute care facilities during an infl   uenza 
outbreak is feasible at CHs in Mexico.
P476
Association between out of hours discharge from the ICU and 
subsequent readmission
S Gopal, L Terry, C Corbett
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Critical Care 2010, 14(Suppl 1):P476 (doi: 10.1186/cc8708)
Introduction Readmission to the ICU may be considered a benchmark 
quality indicator on an ICU. Previous studies have assessed the impact of 
out of hours discharge from the ICU and subsequent outcome [1,2]. We 
hypothesized that patients who were discharged from the ICU after hours 
were at higher risk of readmission to the ICU than patients discharged 
during daylight hours.
Methods The database of a 15-bed medico-surgical ICU of a teaching 
hospital was retrospectively interrogated from the period 1 October 2007 
to 31 July 2009. Patients who died whilst on the ICU were excluded from 
the study. Demographic details were collected as well as the date and 
time of discharge from the ICU. Readmissions to the ICU were defi  ned 
as readmissions if they occurred during the same hospital admission 
episode. Out of hours discharges were defi  ned as discharges occurring 
between the hours of 20:00 and 09:00. Logistic regression analysis was 
Figure 1 (abstract P473). Costs by type of prescriber.
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and risk of readmission.
Results The database contained 1,257 patients during the study period, of 
whom 207 died whilst on the ICU. A total of 1,050 patients were therefore 
included in the study. Two hundred and forty-nine patients (24%) were 
discharged between 20:00 and 09:00. Ninety-fi   ve patients (9%) were 
discharged and subsequently readmitted to the ICU during the same 
hospital admission episode. Compared with patients discharged between 
the hours of 09:00 and 20:00, patients discharged between the hours 
of 20:00 and 09:00 were 2.74 (95% CI 1.7 to 4.3) times more likely to be 
readmitted to the ICU during the same admission episode, P <0.001. This 
relationship remained true even after adjusting for potential confounders 
age, gender. OR 2.75 (95% CI 1.7 to 4.3).
Conclusions  Compared with patients discharged during the day, 
patients discharged during the night are at a signifi  cantly increased risk 
of readmission to the ICU. Timing of discharge from ICU may therefore be 
used as a quality indicator in benchmarking quality of care on an ICU.
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Introduction The H1N1 pandemic has highlighted the importance of 
reliable and valid triage instruments for scarce resources during periods of 
high demand. Christian and colleagues have proposed a triage protocol 
that utilizes a Sequential Organ Failure Assessment (SOFA) score >11 
to exclude patients from critical care resources quoting an associated 
mortality of more than 90% [1]. We sought to assess the hospital mortality 
associated with this SOFA threshold and the resource implications of such 
a triage protocol.
Methods  This retrospective cohort study included consecutive ICU 
patients admitted to any one of our three tertiary-care adult multisystem 
ICUs from January 2003 to December 2008. Patients were excluded if they 
were admitted for routine postoperative monitoring (ICU stay <48 hours) 
or postoperative cardiac surgery. SOFA was collected daily by an electronic 
bedside clinical information system (QS; GE Medical Systems).
Results A total of 10,204 patients (69,913 patient-days) were included. 
Mean age was 59. Mean admission APACHE was 19.1. Mortality was 25%. 
Median ICU LOS was 4 days. A total 13.4% of the cohort (representing 9% 
of total patient-days) had an initial SOFA >11. Mortality in patients with an 
initial SOFA score >11 was 59% (95% CI 56%, 62%). Figure 1 demonstrates 
increased mortality associated with SOFA >11 during the ICU stay to a 
maximum of 78% (95% CI 68%, 86%) on day 14. The mortality associated 
with an initial SOFA >11 across diagnostic categories (ICNARC) varied from 
29% for poisoning to 67% for neurological patients. Mortality associated 
with an initial SOFA >11 was lowest for those patients 18 to 20 years old 
(37%) and highest for those >80 years old (75%). Mortality exceeded 90% 
when the initial SOFA was >20. However, only 0.2% of patients had an 
initial SOFA >20.
Conclusions A SOFA score >11 was not associated with a hospital mortality 
>90% at any time during the ICU stay. Age and diagnostic category 
represent potential modifying factors in the association of SOFA >11 and 
hospital mortality. Only a small proportion of patients have the extreme 
initial SOFA values associated with a hospital mortality >90%, limiting the 
usefulness of SOFA as a triage instrument for pandemic planning.
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Introduction The complex interhospital transport of critically ill patients 
bears multiple risks for patient safety, including handovers and reliance 
on mobile medical equipment. The hypothesis of the present study was 
that multiple handovers of both equipment and patients in critical care 
transport would demonstrate omissions and a failure mode and eff  ect 
analysis (FMEA) would unravel its safety priorities.
Methods  FMEA of the process of interhospital ground critical care 
transport in the Amsterdam region was performed by three clinical 
experts to estimate failures in handovers of patients and equipment.
Deviations of the optimal process were documented by observations 
of 16 transports. A questionnaire was used to evaluate the multiple 
handovers of these transports by the escorting critical care registered 
nurses and intensivists and included attitude evaluation towards future 
structured checklists.
Results The FMEA revealed that the highest risk priority numbers (above 
45) were all related to the medical equipment control before start of 
transport. During transport observations the most frequent deviations 
in the process were related to omission of the defi  brillator equipment 
check before transport (in nine out of 16 transports, 56%), handover of 
medication dose (25 of 39 syringe pumps, 64%) and location of infusion 
lines (39 of 54 lines, 72%). Nurses and intensivists demonstrated a positive 
attitude towards implementing handover checklists to improve the 
quality of the transport (29 of 34 respondents, 85%).
Conclusions  FMEA seems an applicable tool for risk assessment in 
critical care. The safety of interhospital critical care transport seems to 
be suboptimal by lack of standardized handovers. The check of medical 
equipment should have the highest priority in the optimization of safety 
in critical care transport. Handovers of information in critical care transport 
could possibly benefi  t from checklists.
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Introduction  Pain is the most relevant factor for prolonged hospital 
stay after thoracic surgery and is associated with stress known to alter 
the Th1/Th2 ratio (Th = T helper cells) in the immediate postoperative 
period. Thoracic epidural block (TEB), central α2-receptor stimulation via 
intravenous clonidine application and stimulation of opioid receptors 
can decrease either pain and/or stress and might therefore infl  uence this 
immune imbalance. The primary endpoint of the current study was the 
perioperative Th1/Th2 balance in lung surgery. The secondary endpoints 
aimed to the incidence of pain and pneumonia.
Methods After approval by the ethics committee and informed consent 
a total of 60 patients was randomized to receive double-blinded either 
remifentanil intravenously, or remifentanil + clonidine intravenously, or 
ropivacaine epidurally. Pain intensity was assessed by the numeric rating 
scale (NRS). The Th1/Th2 ratio was measured using a cytometric bead 
Figure 1 (abstract P477). Hospital mortality associated with SOFA >11 
during the ICU stay.
Critical Care 2010, Volume 14 Suppl 1 
http://ccforum.com/supplements/14/S1
S160array. Pneumonia was diagnosed according to the hospital-acquired 
pneumonia criteria of the American Thoracic Society.
Results The Th1/Th2 ratio adjusted for baseline diff  ered between groups 
over time (P = 0.012). At the end of surgery there was no signifi  cant 
diff  erence between the remifentanil and the remifentanil + clonidine 
groups (P = 0.679) but a signifi   cantly lower ratio in the ropivacaine 
group compared with the remifentanil (P = 0.004) and the remifentanil + 
clonidine groups (P = 0.019). NRS scores immediately after surgery were 
lower in the ropivacaine group compared with the remifentanil group and 
the remifentanil + clonidine group but achieved only borderline statistical 
signifi  cance. None of the patients developed pneumonia.
Conclusions Intraoperative TEB decreases the Th1/Th2 ratio and provides 
better pain therapy immediately after surgery.
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Introduction Protocol for perioperative usage of beta blockers was used 
in only 9% of major clinics in the USA. It is a very common practice to 
discontinue beta blockers during the perioperative period or to maximally 
reduce their doses. The main purpose of this paper is to investigate the 
incidence of adverse eff  ects of beta blockers during large-scale trauma 
and orthopedic surgeries in spinal anesthesia.
Methods  In this open prospective study we evaluated the adverse 
eff  ects of beta blockers in ASA II and III research subjects who received 
beta blockers 1 to 12 hours preoperatively, n = 37, mean age 67 ± 12, 
with adjacent metabolic syndrome. Results were compared with the same 
number of patients and ASA group, mean age 57 ± 18, who have not 
received beta blockers. Patients from both groups received midazolam 
premedication 30 minutes before arriving in the operating room and 
spinal anesthesia with 0.5% bupivacaine. Patient surveillance was 
conducted by continued EKG, blood pressure, pulse (all non-invasive) and 
SpO2 monitoring. Systolic and diastolic pressure and pulse were recorded 
every 10 minutes. Results were statistically tested (M ± SD, t test).
Results The results are shown in Figure 1. The group receiving beta blockers 
shows a higher percentage of patients with hypertension on arrival in 
the operating room for 11% and hypotension after the start of spinal 
anesthesia. Occurrence of bradycardia (HR <60/minute) was increased 
with statistical signifi  cance for 24% (P <0.05), with use of atropine for 27% 
(P <0.05). The occurrence of arrhythmias shows a statistical increase in the 
same group, for 27% (P <0.05), as well as nausea for 29% (P <0.05).
Conclusions  Due to their adverse eff   ects, beta blockers should be 
discontinued before spinal anesthesia and surgical procedures with 
signifi  cant circulating volume loss.
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Introduction Surgical-related neuroendocrine stress response extends over 
the postoperative period, inducing insulin resistance and hyperglycaemia 
[1]. Remifentanil continuous infusion, reducing pain and anxiety, may 
reduce postoperative insulin resistance and result in better glycaemic 
control. The aim of the study was to assess trends in glycaemia and HOMA 
scores in postoperative patients during remifentanil-driven, postoperative 
analgo-sedation.
Methods  Enrolled patients were those consecutively admitted to a 
surgical ICU after major abdominal interventions during a 1-month period 
(July 2009). Group R patients underwent analgo-sedation with continuous 
remifentanil infusion at the recommended doses [2]. Glycaemia and HOMA 
scores were evaluated at admission time (T0) and after 12 and 24 hours. 
Control patients were those who underwent morphine-based continuous 
analgo-sedation (M Group). Diff  erences in glycaemias and HOMA scores 
across the two groups were tested with a Student t test (P <0.05).
Results The total number of enrolled patients was 100. No diff  erences were 
found across the groups regarding general and clinical data, particularly 
age, prevalence of diabetes, and VAS and Ramsay scores during analgo-
sedation. No diff  erences were found in glycaemia at T0 and T12, while at 
T24 the R group patients showed lower glycaemia than controls (99.4 ± 
24.7 vs 104.2 ± 17.4 mg/dl, respectively; P = 0.018). No diff  erences either 
could be found in HOMA scores at T0 and T12, while at T24 the R group 
patients had lower scores than control patients (1.962 ± 0.19 vs 2.414 ± 
0.81, respectively; P = 0.019).
Conclusions  Remifentanil-based analgo-sedation was associated with 
lower glycaemia and HOMA score in patients following major abdominal 
surgery, particularly at 24 hours from ICU admission. HOMA scores 
showed that morphine-treated patients were insulin resistant, although 
normoglycaemic. A better control of the neuroendocrine stress response 
in patients analgo-sedated with remifentanil might explain these results.
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Introduction  Ultralow-dose opioid antagonists can enhance opioid 
analgesia and prevent tolerance in rodent nociceptive pain assays.
Methods  A randomized, double-blind controlled trial is designed to 
investigate whether the addition of 5 ml ultralow-dose naltrexone (1 μg in 
a liter of sterile water) to morphine (0.05 mg/kg) changes the total opioid 
requirement and side eff  ects.
Results  Two hundred and sixty-seven patients (18 to 45 years old) 
with moderate extremities trauma entered the study, Pain control 
measurements were evaluated every 15 minutes for the fi  rst hour, then 
every 30 minutes for the second and third hours and fi  nally at the fourth 
hour. Effi   cacy was measured by the 11-point numerical pain rating scale. 
The following side eff  ects were evaluated: sedation, nausea, vomiting and 
pruritus. We found that opioid requirements did not diff  er signifi  cantly 
between groups. The morphine + naltrexone group on average required 
0.04 mg more morphine during the 4 hours than the morphine group.
Conclusions The morphine + naltrexone group had a lower incidence 
of nausea than the morphine + placebo group. However, the incidence 
of vomiting, pruritus and sedation between the two groups were similar. 
The combination of ultralow-dose naltrexone and morphine in moderate 
Figure 1 (abstract P480). Adverse beta blocker eff  ects. 1. Preoperative 
hypertension. 2. Intraoperative hypotension. 3. Intraoperative bradycardia. 
4. Arrhythmia. 5. Nausea. 6. Atropine applied. 7. Ephedrine applied.
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the incidence of nausea.
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Introduction Volatile anesthetics for sedation in the ICU are currently 
undergoing a revival, mainly due to the recent availability of a novel 
delivery system, the anesthetic conserving device (ACD). Cytochrome 
P450 metabolic degradation of isofl  urane and sevofl  urane leads to the 
generation of inorganic fl  uoride and hexafl  uoro isopropanol. Historically, 
data derived from methoxyfl   uorane defi   ned a fl   uoride nephrotoxicity 
threshold of 50 μmol/l. Therefore, we investigated the feasibility and safety, 
focusing on kidney function, of 4-day sevofl  urane-ACD sedation.
Methods Approval of the State Ethics Committee was obtained. Visceral 
surgical patients either received sedation via sevofl  urane-ACD (n = 20) or 
were intravenously sedated (sufentanil, propofol, n = 20). Serum fl  uoride, 
renal, liver, pulmonary, cardiovascular function and depth of sedation 
were measured.
Results  Serum fl   uoride concentrations increased signifi   cantly during 
sevofl   urane-ACD sedation (Figure 1). Renal function parameters and 
urinary output did not indicate deterioration of kidney function. Catechol-
amine support and pulmonary function were not diff  erent between the 
groups at equivalent depths of sedation.
Conclusions  Inhalational sevofl   urane sedation subsequently leads 
to a transient, marked increase of serum fl  uoride concentrations. The 
methoxyfl  urane fl  uoride nephrotoxicity threshold was largely surpassed 
without apparent deleterious eff   ect on renal volume regulation and 
detoxifi  cation. The sedational use of the volatile anesthetic sevofl  urane up 
to 4 days is safe and feasible.
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Introduction Pulmonary hypertension (PH) is a life-threatening disease 
commonly seen in ICU septic patients and associated with poor outcome. 
New and better therapies are required, since the response to various 
agents such as NO, prostaglandins and phosphodiesterase inhibitors is 
usually partial and the mortality rate remains high. Inhaled drugs seem 
to be an attractive treatment option, since they are delivered directly 
to pulmonary resistance vessels. A new device (anesthetic conserving 
device –AnaConDa (ACD)) permitting direct administration of volatile 
anaesthetics – such as sevofl   urane – to the breathing circuit of a 
conventional ICU ventilator in a safe and eff  ective way has recently been 
introduced. The aim of the present study was to evaluate the effi   cacy and 
safety of sevofl  urane administration via the ACD on a porcine model of 
acute PH during sepsis.
Methods PH was induced in 16 anaesthetized, mechanically ventilated 
swine (25 kg) by intravenous infusion of 0.5 mg/kg LPS (Escherichia coli, 
111:B4) in a period of 30 minutes. After LPS, animals were randomized into 
two groups. In group A sevofl  urane was infused via the ACD, according 
to the manufacturer’s recommendations in order to obtain an end-tidal 
concentration of 0.5%, whereas group B did not receive sevofl  urane and 
served as control. Haemodynamic parameters (systemic and pulmonary) 
were recorded before (phase 0) and after the LPS (phase 1) and every 
20 minutes for the next 2 hours (phases 2 to 7).
Results LPS was found to produce PH (phase 1) and to reduce arterial 
blood pressure in both groups. After sevofl  urane infusion, both systolic 
(PAPs) and diastolic (PAPd) pulmonary pressures exhibited step-by-step 
reduction, which became statistically signifi  cant in phase 3 and thereafter, 
in relation to phase 1 values. On the contrary, in group B animals, not 
sevofl   urane-treated, pulmonary pressures remained at high levels 
throughout the study period. Systemic arterial pressure exhibited an 
endotoxin-related reduction in both groups, which was not found to be 
aff  ected by sevofl  urane treatment.
Conclusions Sevofl  urane administration via the ACD was found to reduce 
the pulmonary pressure in a porcine model of endotoxin-induced acute 
PH without any detrimental eff  ects on the systemic circulation. This may 
represent a signifi  cant advance in the treatment of acute PH. However, the 
potential clinical implications of the method merit further study.
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Introduction Etomidate is well tolerated and not inferior to ketamine but 
because it is implicated in critical illness-related corticosteroid insuffi   ciency 
(CIRCI) [1], its utilization in septic shock patients is controversial. In our ICU, 
the standard of care is to treat every septic shock patient with 200 mg 
hydrocortisone for at least 5 days. The aim of our study was to compare 
prognosis of septic shock patients intubated with etomidate with patients 
intubated without etomidate.
Methods  Observational study during a 2-year period including every 
septic shock patient. We compared the patients’ prognosis when intubated 
with etomidate (E group) to patients intubated without (NE group). We 
recorded demographic characteristics, results of a cosyntropin test, dose 
and length of vasopressors and hydrocortisone and outcome. The main 
endpoint was mortality in the ICU. The secondary endpoints were the 
length of shock, the dose of vasopressors and hydrocortisone in the ICU 
and the plasma cortisol level.
Results We evaluated 62 patients in the E group and 31 in the NE group. 
Although SAPS II on admission was higher in the E group (54 (42 to 64) vs 
Figure 1 (abstract P483).
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total duration (54 hours (36 to 91) vs 52 hours (31 to 81)) of vasopressors 
from day 0 to day 5 was not diff  erent between groups. However, the 
cosyntropin responder rate was higher in the non-E group (40% vs 18%*), 
hydrocortisone treatment duration (168 hours (78 to 216) vs 96 hours (72 
to 144)*) and total dose of hydrocortisone (1,200 mg (500 to 1,625) vs 
750 mg (350 to 1,125)*) was higher in the E group than in the non-E group. 
Finally, mortality in the ICU was not diff  erent between groups (32% vs 27% 
in the E and the non-E groups, respectively). *P <0.05.
Conclusions In this study on septic shock treated with a short course 
of hydrocortisone, patients intubated with etomidate presented a CIRCI 
more frequently than patients intubated with another drug and needed 
a longer and higher dose of hydrocortisone treatment. However, length 
of shock, dose and duration of vasopressors and mortality were not 
diff  erent between groups. Etomidate-induced CIRCI when treated with 
hydrocortisone was not associated with a poorer outcome in our study. 
A comparison between etomidate and ketamine should be performed in 
this population.
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Introduction Methyl-naltrexone (Relistor®), a peripheral μ-opioid receptor 
antagonist shown to induce laxation in patients receiving opioids, is 
licenced for use in palliative care; a similar benefi  t is proposed in critical 
care patients. Impaired gut motility and constipation are common issues 
in the critical care setting with contributing factors including trauma, 
surgery and use of opiate analgesics. The eff  ects of methyl-naltrexone 
were studied on seven patients in whom conventional treatment for 
constipation with stimulant and osmotic laxatives, faecal softeners and 
suppositories failed to produce eff  ects.
Methods  Over a 6-week period, 15 critically ill patients with opiate-
induced constipation (OIC) of more than 4 days duration were pros  pec-
tively studied. All patients were treated with conventional methods from 
admission to critical care, which included regular senna and sodium 
docusate, supplemented with glycerin suppositories and picolax for 
resistant constipation. Methyl-naltrexone was administered to seven 
patients at 0.15 μg/kg subcutaneously on alternate days until laxation 
occurred. The remainder of patients in the study continued with 
conventional therapy.
Results Six out of seven patients responded to methyl-naltrexone with 
laxation occurring between 12 and 24 hours. One patient did not respond 
due to faecal impaction but subsequently experienced laxation after 
manual disimpaction. Side eff  ects were few (nausea 14%, vomiting 14%) 
and there was no increase in opiate requirement. Those patients treated 
by conventional means eventually produced laxation after a further 3 to 
5 days.
Conclusions Previous studies have shown the earlier return of gut motility 
improves patient progress, facilitates earlier respiratory weaning, prevents 
debilitation and results in reduced length of stay. Methyl-naltrexone is a 
safe and effi   cacious drug for the treatment of OIC in critical care patients 
in whom conventional treatments prove unsuccessful. Side eff  ects are 
few and opiate requirements remain unchanged. Further investigation 
to elucidate the cost-eff  ectiveness of methyl-naltrexone use in OIC of the 
critically ill patient is warranted.
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Introduction  Sedation algorithms have been shown to reduce the 
duration of mechanical ventilation in the ICU. We evaluated the eff  ect 
of the implementation of a nurse-driven sedation protocol with daily 
sedation interruption in our ICU.
Methods We performed a before-and-after prospective study in our eight-
bed medical ICU over a 6-month period. All patients requiring mechanical 
ventilation and who were not receiving neuromuscular blocking agents 
were included. Prior to implementation, sedation was adjusted according 
to physician orders. During the intervention period, sedatives and 
analgesics were adjusted by nurses according to an algorithm utilizing the 
Sedation-Agitation Scale.
Results We included a total of 188 patients, 89 patients in the observational 
period and 99 patients during the intervention period. The duration of 
mechanical ventilation was similar (2 days in both groups). However, the 
ICU length of stay (LOS) was reduced by a day after implementation (3 days 
vs 2 days). Amongst patients who survived and who were mechanically 
ventilated for more than 4 days, the duration of mechanical ventilation and 
ICU LOS were reduced (7 days vs 6 days and 8 days vs 6 days, respectively). 
Fewer CT brains were performed for persistent coma after discontinuation 
of sedation in the intervention period (4.5% vs 1.2%). Complications such 
as extubation failure, tracheostomy and inadvertent removal of devices 
were similar in both groups.
Conclusions A nurse-driven sedation protocol is safe and may reduce 
duration of mechanical ventilation and ICU LOS, especially amongst 
patients who have been ventilated for more than 4 days.
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Introduction  We aimed to select the sedative drug with the least 
impact on hepatic blood fl  ow in sedation-administered patients. In our 
study, we aimed to establish whether or not midazolam and propofol 
aff  ect liver function during sepsis. The hepatic blood fl  ow is evaluated 
by the transcutaneous assessment of the indocyanine green plasma 
disappearance rate (ICG-PDR) in critically ill patients.
Methods Forty sepsis patients were included in the study with either the 
loading dose infusion of propofol 1 mg/kg over 15 minutes followed by 
a maintenance 1 to 3 mg/kg/hour (n = 20, Group P) or a loading dose of 
midazolam 0.2 mg/kg over 10 minutes followed by a maintenance 0.04 
to 0.06 mg/kg/hour (n = 20, Group M), 24 hours infusion. ICG elimination 
tests were conducted concurrently using the non-invasive liver function 
monitoring system (LiMON). A dose of 0.3 mg/kg ICG was given through 
a cubital fossa vein as a bolus and immediately fl  ushed with 10 ml normal 
saline. We calculated ICG-PDR. The ICG-PDR measurements were obtained 
at baseline (before start of the propofol or midazolam infusion) and were 
repeated at 24 hours. Biochemical and hemodynamic parameters, ICG-
PDR were recorded before start of the study and at 24 hours.
Results  Biochemical and hemodynamic parameters did not diff  er 
signifi  cantly between the groups (P <0.05). Group P compared with Group 
M; baseline ICG-PDR levels (23.67 ± 12.02 vs 23.86 ± 11.4, respectively), and 
after the study ICG-PDR levels (26.04 ± 13.60 vs 24.07 ± 9.07) did not diff  er 
in groups (P >0.05). When we examined before and after ICG-PRD changes 
between groups, there was no signifi  cant diff  erence (P >0.05).
Conclusions In our study, we found that neither propofol nor midazolam 
infusion aff  ected hepatic blood fl  ow.
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Introduction The level of sedation should be monitored as the depth of 
sedation can aff  ect the rate of related complications, length of hospital 
stay and costs [1]. The recent study aims to monitor the depth of sedation 
of patients in the ICU using the Ramsay Sedation Scale (RSS), Richmond 
Agitation Sedation Scale (RASS), Sedation Agitation Scale (SAS) and 
Adaptation To Intensive Care Environment scale (ATICE) and to assess the 
correlation between these scales and Bispectral Index (BIS) scores and to 
compare the correlation coeffi   cients of these scales with each other.
Methods  After approval from the hospital ethics committee, 30 
mechanically ventilated patients who required sedation in the ICU were 
enrolled into the study. Patients who are quadriplegic or need muscle 
paralysis are excluded. The choice of sedative agent and the dose 
regimen that will be used are left to consultant ICU staff   diff  erent from 
the investigators. Demographic data and APACHE II scores of the patients 
were registered. BIS, RSS, RASS, SAS, ATICE scores, mean arterial pressure, 
heart rate, and peripheral oxygen saturation values (SpO2) of the patients 
were registered before the initiation of the sedation and in 2-hour intervals 
after initiation of the sedation.
Results Male/female ratio was 22/8, mean of ages and body weights of the 
patients were 57.3 ± 15.8 years and 69.6 ± 14.3 kg, respectively. The median 
of APACHE II scores was 14 (4 to 23). Mean arterial pressure, heart rate and 
SpO2 changes were insignifi  cant after initiation of sedation compared 
with the beginning (P >0.05). BIS, RASS, SAS scores were signifi  cantly 
lower, RSS scores were signifi   cantly higher in all intervals compared 
with the beginning (P <0.05). Signifi  cant change was not observed for 
ATICE scores compared with the beginning value (P >0.05). Statistically 
signifi  cant correlation was observed between all scoring systems and 
BIS values (P <0.05). Signifi  cantly highest correlation was found between 
BIS–RSS and BIS–RASS (r = 0.758 and r = 0.750, respectively), comparing 
correlation between BIS–SAS (r = 0.656) and BIS–ATICE (r = 0.565) (P <0.05). 
Also, correlation between BIS–SAS was signifi  cantly higher than BIS–ATICE 
correlation (P <0.05).
Conclusions All scales assessed in this study showed signifi  cant correlation 
with BIS. The signifi  cantly highest correlation was found between BIS–RSS 
and BIS–RASS and lowest correlation between BIS–ATICE.
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Introduction Evidence suggests prolonged sedation is associated with 
prolonged ventilation and mortality. Further evidence suggests that some 
sedatives and analgesics are more prone to cause oversedation than 
others, possibly due to disturbances in pharmacokinetic properties in the 
context of acute organ failure. Our aim was to describe current sedation 
and analgesic practice in UK ICUs, and to determine whether recent 
evidence has changed practice in recent years.
Methods We performed a web-based survey using a tool developed 
via a systematic, step-wise process following recognised practice for 
questionnaire design. These steps included question development and 
questionnaire formatting and testing before being published on the 
Zoomerang™ website. The sampling frame was pharmacists who are 
members of the United Kingdom Clinical Pharmacy Association Critical 
Care Group (UKCPA CCG). Participants were invited to complete the 
15-minute questionnaire. Email reminders were sent to all members 
every 2 weeks. After 6 months a reminder email was sent to pharmacists 
in institutions that had not responded. Questions were split into four 
categories: pharmacist and ICU-specifi  c data; current sedation practice; 
sedative choice; and analgesic choice.
Results The response rate was 68%. Eighty-four per cent of respondents 
were senior pharmacists and 54% provided a service within a team. The 
median number of annual ICU admissions was 750 (IQR 635 to 865) 
and included a wide-ranging case mix. Forty-nine per cent of ICUs had 
a sedation policy, of which 76% included sedation holds and 87% used 
a sedation scoring system. Forty-three per cent assessed for delirium, 
but only 29% used a known delirium scoring system. Ninety-nine of the 
respondents used propofol (PPF) in the majority of patients, 56 midazolam 
(MDZ). Twenty-seven still used MDZ routinely in renal or hepatic failure, 
while 75 used MDZ where sedation was challenging.
Fifty-fi  ve used morphine, 37 fentanyl and 33 alfentanil as fi  rst-line opiate.
Conclusions These data suggest that many ICUs do not routinely use 
sedation policies or assess patients for delirium. While PPF remains the 
fi  rst-line sedative for most ventilated patients, MDZ and morphine are 
still widely used despite evidence of prolonged eff  ects in the presence of 
hepatic and renal failure.
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Introduction This study aims to compare the effi   cacy of midazolam or 
propofol in severe refractory AWS, to detail characteristics of patients and 
to test the usefulness of diff  erent scores (MELD, Child, APACHE II) in severe 
AWS.
Methods  Patients admitted to the ICU during a 3-year period for 
refractory AWS after a failed treatment with benzodiazepines according 
to a symptom-triggered protocol in the general ward or emergency room 
were treated with neuroleptics and either midazolam or propofol infusion. 
Processes that could lead to a confounding delirium were excluded. We 
retrospectively analysed this cohort of patients.
Results Fifty patients were reviewed, 85.7% men. Mean age was 49 years. 
Thirty percent had been previously admitted to the ICU for the same 
reason. Main reason for alcohol withdrawal was abdominal pain (12.2%). 
Mean alcohol ingestion was 150 g/day. Mean CHILD/MELD/APACHE score 
was 6/8.5/13 (24.5% patients had a Child score ≥7). Seventy-three percent 
of patients developed complications (especially respiratory infections in 
19 patients). The most frequent agent found was MSSA and Gram-negative 
bacilli. Seizures accounted for 38% of patients and hepatic encephalopathy 
in two. We found no relationship between CHILD or MELD score and rate 
of intubation, length of stay or complications. Patients with APACHE II 
>12 at admission had a signifi  cant increase in risk of intubation (OR 31.2, 
P <0.001). Patients with more than 12 days of stay had a signifi  cant risk 
of intubation (OR 49.7, P <0.0001). Thirty-fi  ve patients received propofol 
as the fi  rst intravenous sedation and 14 midazolam. Only two patients 
with midazolam required a second intravenous sedation. Conversely, nine 
(26.47%) patients initially with propofol required a second sedation with 
midazolam. The propofol group showed a signifi  cant increase in incidence 
of seizures (41.17% vs 21% in midazolam group) and infections (47.1% vs 
28%) independent of APACHE score. These fi  ndings were more remarkable 
in the subgroup that needed a second intravenous sedation (66% seizures 
and 77% infection rate). This group had higher APACHE score and was 
associated with a greater likelihood of intubation and a signifi  cant 2-day 
increase in length of stay.
Conclusions  Propofol has been proposed as an alternative to 
benzodiazepines in severe AWS, but it could increase the rate of 
complications (especially seizures and respiratory infections) that could 
lead to an increase in the intubation rate and length of stay. The APACHE 
score could be a predictor for the risk of complications and intubation.
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Introduction The objective of this study was to identify the proportion 
of patients who experienced agitation and/or pain during physiotherapy 
sessions in intensive care (ICU). The prevalence and causes of distress 
in critically ill patients are poorly described. Identifi  ed stressors include 
physiotherapy [1,2], but no standards for sedation/analgesia management 
during physiotherapy exist. Recent evidence supporting routine ICU 
management at lighter levels of sedation potentially increases the 
importance of interventions to avoid distress during interventions such 
as physiotherapy.
Methods  A prospective observational study was undertaken. Forty-
nine patients admitted to the ICU requiring mechanical ventilation 
and physiotherapy were recruited into the study. A single session of 
physiotherapy was observed by an independent assessor. Agitation 
was measured using the Richmond Agitation Sedation Scale (RASS) 
and pain using the Behavioural Pain Scale (BPS). The RASS and BPS were 
collected immediately pre physiotherapy, after each intervention during 
physiotherapy and at 5 and 30 minutes post physiotherapy.
Results  Sixteen participants (33%) experienced agitation (RASS score 
≥1) while 48 participants (98%) experienced pain (BPS score ≥4). Figure 
1 shows the number of participants who experienced agitation and 
pain in relation to their RASS level prior to physiotherapy. Of interest, 
the independent assessor observed little communication, in regards to 
the management of sedation or pain at any stage during physiotherapy, 
between nursing and physiotherapy staff  .
Conclusions  Regardless of the RASS level pre physiotherapy, the 
majority of participants experienced pain. In contrast, only one-third of 
participants experienced agitation; this was more prevalent for those at a 
lighter sedation level. More routine use of RASS, BPS and communication 
with nursing staff   should be undertaken during physiotherapy to ensure 
optimal levels of sedation and adequate levels of analgesia are achieved.
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Introduction Contrary to wards that manage usually chronic or acute 
pain (algology, gerontology, surgery, recovery room, and so forth), a 
comparison of the fi  ve most popular self-report pain tools (vertical and 
horizontal Visual Analog Scale (VAS-V, VAS-H), 0 to 10 oral Numeric Rating 
Scale (NRS-O), 0 to 10 visual enlarged NRS (NRS-V), Verbal Descriptor Scale 
(VDS)) has never been evaluated in an ICU setting.
Methods  Consecutive patients admitted to a medical–surgical ICU 
during 1 year were included when alert (RASS >–2) and able to follow 
simple commands. Exclusion criteria: previous self-report pain assessment 
without the presence of an investigator. Pain assessment using the fi  ve 
scales in random order either at baseline (T1) and after (T2) administration 
of an analgesic, or during a nociceptive procedure, in absence of pain 
at baseline. Evaluated parameters: psychometric properties of scales 
(feasibility, validity, responsiveness and preference). Nonparametric tests 
were used for statistical analysis (Statview 5.0). Data are expressed as 
median (25th to 75th).
Results One hundred patients were included 24 (12 to 96) hours after 
their admission to the ICU: age 58 (48 to 69) years, SAPS II 39 (32 to 48), 
SOFA 7 (3 to 9), medical admission (49%), intubation before inclusion 
(76%), at time to inclusion (50%). At T1, 91% of patients were able to use 
at least one scale and 57% all fi  ve scales. The NRS-V had the lowest failure 
rate (9%) compared with NRS-O (17%), VDS (22%), VAS-H (32%) and VAS-V 
(34%). Validity was measured in the 56 patients who were able to use 
the fi  ve scales both at T1 and T2. The pain intensity measured with the 
fi  ve scales changed signifi  cantly between T1 and T2 (P <0.01), showing a 
good discriminative validity. The correlation between the fi  ve scales was 
important (Spearman’s coeffi   cients ranged from 0.75 to 0.96, P <0.001). 
The responsiveness was very good for each of the fi  ve scales, either after 
an analgesia and a nociceptive procedure (eff  ect size >0.8). Finally, the 
NRS-V was considered respectively by 45, 37 and 44% of patients as the 
easiest, most accurate and preferred scale. The preference for the other 
scales was <12%.
Conclusions The self-report of pain is feasible in ICU patients as soon as 
they are suffi   ciently alert (RASS >–2) and able to follow simple commands. 
The enlarged 0 to 10 Numeric Rating Scale is the easiest scale to use 
with the lowest failure rate and it is the preferred scale for the majority of 
critically ill patients who were able to communicate.
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Introduction Critically ill patients exhibit reduced melatonin secretion, 
both in nocturnal peaks and basal daytime levels. Oral melatonin supple-
men  tation may be useful for known sedative and antioxidant properties.
Methods Melatonin early enteral absorption and daily pharmacokinetics 
were determined in two cohorts of six high-risk patients in this prospective 
trial. During their third and fourth ICU day, they underwent two diff  erent 
sets of repeated blood samples to detect serum melatonin levels through 
radio-immunoassay. Cohort 1: samples taken at 20:00, 20:45, 21:30, 24:00, 
03:00, 06:00, 14:00, 20:00 to describe the daily pharmacokinetics. Cohort 
2: 20:00, 20:05, 20:10, 20:20, 20:30, 20:45 to study the early absorption. On 
ICU day 3, endogenous levels were measured, while the absorption of 
exogenous melatonin was determined on ICU day 4 after administration, 
at 20:00, of 3 mg melatonin.
Results All basal levels were below the expected values. Following enteral 
administration, pharmacological levels were already reached in 5 minutes, 
with a serum peak after 16 minutes (half-absorption time: 3  minutes 
17  seconds). The maximum serum level observed was 11,040 pg/ml 
and the disappearance rate indicated a half-elimination time of 1 hour 
34 minutes. Serum melatonin levels decreased signifi  cantly after midnight; 
pharmacological levels were maintained up to 10 hours following 
administration. No excessive sleepiness was reported in this patient group.
Conclusions Critically ill patients exhibited reduced melatonin secretion, as 
reported in the literature. Despite the critical illness, the oral bioavailability 
was satisfactory: serum levels after oral administration showed basically 
unchanged intestinal absorption, while the disappearance rate was slower 
than reported elsewhere in healthy volunteers.
Figure 1 (abstract P492). Agitation and pain in relation to pre-
physiotherapy RASS scores.
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Introduction The aim of our study is to describe clinical progress, need for 
mechanical ventilation (MV), complications and mortality of patients with 
delirium tremens (DT) admitted to our ICU.
Methods Patients with a diagnosis of DT admitted to a medical ICU of a 
tertiary hospital from January 2001 to December 2008 were included. We 
recorded: admission diagnosis, pathologies associated with DT, APACHE II 
score, treatment, need for MV and duration, complications, length of stay 
in the ICU and total hospital stay, mortality and survival at 2 years.
Results There were 50 cases of DT. Median age 45 years, 96% male. Reasons 
for hospital admission: DT (68%), seizures (36%), sepsis (16%), brain injury 
(10%). Reasons for admission to the ICU: DT (54%), DT and seizures (26%), 
DT and brain injury (10%), DT and sepsis (8%), DT and other (2%). Median 
APACHE II score was 9 (range: 8 to 13). Seventy-four percent of the patients 
were controlled with no need for MV with a midazolam infusion of 45 to 
50 μg/kg/hour and haloperidol of 17 to 30 μg/kg/hour. Twenty-eight per 
cent (14 patients) required MV, of them 78% had DT and other associated 
pathology on admission (Figure 1). From a total of 28 patients admitted 
with DT and no associated pathology, only four needed MV. The median 
time on MV was 2 days (range: 1 to 9). Complications were present in 22%: 
ventilation-associated pneumonia, and other infectious conditions. Total 
hospital length of stay 14 days ((SD: 11), 5.5 days in the ICU (SD: 9). The 
registered hospital mortality was 4%. Rate of survival at 2 years was 84%, 
from these 72% had continuous visits to emergency (≥5 consultations 
in 2 years) for episodes related to alcohol withdrawal or complications 
associated with chronic alcohol abuse.
Conclusions Even though our patients with DT are frequently admitted to 
the ICU, this is a pathology that most of the time has a benign course with 
low hospital mortality and high rate of survival at 2 years. These patients 
are regular users of the health system. The occurrence of complications 
and the need for MV in our patients were low, and were present in the 
group of DT with other diagnoses.
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Introduction  Delirium in ICU patients increases time on mechanical 
venti  lation, is an independent risk factor for death and can cause 
cognitive impairment in survivors [1,2]. The two most commonly used 
validated assessment methods for diagnosing delirium in intensive care 
are the Confusion Assessment Method for ICU (CAM) and the Intensive 
Care Delirium Checklist Score (ISDCS) [3]. We wished to determine the 
prevalence of delirium in our unit, whether there was a diff  erence in results 
between these methods of assessment and whether good agreement 
could be achieved between two trained assessors.
Methods  We performed a prospective prevalence study in a single 
tertiary ICU. Patients were assessed between days 3 and 10 of their stay 
and tested provided their Richmond Agitation Sedation Score (RASS) was 
≥–3 [1]. Each patient was independently assessed by the two trained 
assessors with the CAM and ISDCS, with randomisation of both the order 
of interview and the score used. Both sets of assessments were carried 
out within an hour of each other. Exclusions included readmissions, those 
who did not speak English, the deaf and registered psychiatric patients. 
The CAM was completed by the assessors and the ISDCS required 
observational answers from the bedside nurse.
Results We performed 104 assessments (208 tests) on 52 patients. Mean 
(SD) age, APACHE II and total SOFA on the day of admission were 67.4 (14.0), 
14.0 (5.3) and 5.7 (2.7), respectively. Delirium was found in 37.5% of patients 
using the CAM, but only 14.4% using ISDCS. Inter-rater agreement for CAM 
and ISDCS was 86.5% (κ 71.4%, SE 13.8%, P <0.001) and 94.2% (κ 76.7%, 
SE 13.8%, P <0.0001), respectively. There was signifi   cant underscoring 
of the RASS by the bedside nurses. When the trained assessors found a 
diff  erence, it was always lower than the score documented by the bedside 
nurse.
Conclusions There was good inter-rater agreement in the diagnosis of 
delirium between the two trained assessors, but the prevalence found 
was lower than previously reported [1] and varied considerably with the 
method used. The diff  erence in results between the two scores may be 
due to a lack of discernment on the part of the bedside nurse of the ISDCS 
assessment process.
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Introduction Delirium aff  ects up to 33% of acutely hospitalized patients. 
In ICU patients it can prolong the length of stay and increase mortality [1]. 
The optimal management of delirium requires a calm environment, sleep 
hygiene and correction of underlying factors (for example, infection). This 
can be a challenge in the ICU, and drug therapy, commonly haloperidol, 
clonidine, benzodiazepines or propofol, is often used [1]. Quetiapine, an 
atypical antipsychotic, has been used in acute delirium outside the ICU 
[2]. It has few extrapyramidal side eff  ects, a short half-life and is mildly 
sedating. Our impression was that it had potential in the treatment of 
delirium.
Methods  In a 30-bed tertiary ICU with more than 1,200 admissions 
annually we reviewed the notes of patients admitted from February 2008 
to November 2009 who had a delirium treated with quetiapine. Patients 
were excluded if they were taking quetiapine prior to admission. The 
following data were recorded: Richmond Agitation and Sedation Score 
Figure 1 (abstract P495). Use of MV in patients admitted for DT.
Table 1 (abstract P497)
Patient  RASSpre (D)  Q dose (mg)  RASSpost (d)
1  +1 (22)  12.5 OD  0 (5)
2  +3 (21)  50 BD  0 (5)
3  +4 (31)  12.5 BD  0 (3)
4  +4 (28)  12.5 BD  0 (5)
5  +3 (36)  25 BD  0 (6)
(D), days delirium present; Q, quetiapine; (d), days to achieve the RASS.
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adverse events.
Results  Five patients met the inclusion criteria (Table 1). All were 
males, aged 37 to 85 years. All had a prolonged delirium prior to the 
commencement of quetiapine and all were on a combination of four 
drugs (clonidine, haloperidol, lorazepam and propofol) that were not 
controlling their delirium. At 3 to 7 days following commencement of 
quetiapine the RASS scores were 0 and other drugs were ceased. No 
adverse eff  ects were noted.
Conclusions  Quetiapine was successful in controlling prolonged ICU 
delirium and allowed weaning of other medications in these patients. 
It may be a useful delirium therapy. Further studies are required to 
demonstrate effi   cacy and safety.
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Introduction Delirium is a serious and frequent disorder in the ICU, but a 
prediction model for critically ill patients is lacking.
Methods We performed two prospective cohort studies in a 33-bed ICU 
for adult patients with use of the validated CAM-ICU, performed three 
times daily by well-trained ICU nurses. Twenty-three identifi  ed delirium 
risk factors were collected within 24 hours after admission and patients 
were followed during their ICU stay until death, discharge or development 
of delirium. Variables with P >0.1 in univariate logistic regression, or with 
a prevalence rate <10% were excluded. Multivariate logistic regression 
analysis was followed by bootstrapping. Reduced coeffi   cients were used 
on the second cohort for external validation. Also, nurses and physicians 
were asked to predict whether the patient would develop delirium during 
the ICU stay.
Results  In the fi   rst study (February 2008 to February 2009) 2,116 
consecutive patients and in the second study (May to September 2009) 
748 patients were screened, of which 503 and 199 patients, respectively, 
were excluded for valid reasons. Ninety per cent of the total number of 
assessments that should have been performed was actually obtained and 
the Cohen’s kappa for inter-rater reliability was 0.90. Out of 1,613 patients, 
411 developed delirium and in the second study 171 out of 549 patients. 
Eight risk factors were excluded because of a prevalence rate <10% and 
one because of P >0.1. After multivariate logistic regression analysis, 10 risk 
factors were included in the prediction model (age, APACHE II score, coma, 
diagnose group, increased urea, infection, metabolic acidosis, morphine 
use, sedation use, emergency admission) of which the area under the 
receiver-operation characteristic curve (AUC) was 0.87 (95% CI 0.85 to 
0.89) and after bootstrapping 0.86. The cut-off   point with the optimal 
predicted probability lies at 0.196 points. At this cut-off   the sensitivity of 
the prediction rule is 80% and the specifi  city is 79%. Validation of PREDICT 
on the second cohort resulted in an AUC of 0.89 (95% CI 0.86 to 0.92). 
The AUC of the prediction of nurses and physicians was signifi  cantly lower, 
both 0.59 (95% CI 0.49 to 0.70).
Conclusions  We have developed and validated a delirium prediction 
model (PREDICT) with a high AUC that can be used in all adult ICU patients 
within 24 hours after ICU admission to predict the chance of delirium 
during their ICU stay and to guide preventive interventions.
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Introduction All patients in the ICU go through mental, physical and 
emotional adjustment. They can experience exaggerated symptoms 
of anxiety and depression and it can delay their recovery [1]. Stress has 
a major role and there are so many triggers for it: the psychological and 
physical condition, surgery, pain, ICU environment and so forth. The aim of 
this study was to implement the Hospital Anxiety Depression Scale (HADS) 
in our everyday ICU practice and then to analyze the impact of the clinical 
picture (APACHE II score) and pain control (VAPS – visual analog pain scale) 
on the anxiety and depression symptoms (HADS) in surgical ICU patients. 
Methods With ethics approval and written consent, in this prospective 
study, to date are reported 70 patients. They all underwent major 
abdominal surgery and were discharged from the ICU after 24 to 30 hours. 
Patients with any mental disorder or neurological disease were excluded. 
On admission and discharge the VAPS, APACHE II and HADS were evaluated. 
HADS was evaluated again 1 month later (62 of 70 patients). Anxiety and 
depression are assessed as separate components, each with seven items 
that are rated from 0 to 3 [2]. A score <7 in a component is a normal result, 
8 to 10 indicates mild symptoms, 11 to 14 moderate symptoms and 15 or 
more indicates severe symptoms [2]. The Mann–Whitney U test, t test and 
correlations were used in statistical analysis.
Results Average age of the patients was 58.61 ± 13.56, range 24 to 78, 37 
male and 33 female. Average values on admission were: VAPS 3.02 ± 0.50, 
APACHE II 10.31 ± 2.79, Anxiety 4.82 ± 4.01, Depression 3.91 ± 3.23, and 
on discharge were: VAPS 1.34 ± 0.88, APACHE II 5.25 ± 2.78, Anxiety 3.41 ± 
2.97, Depression 3.71 ± 2.97. One month later the values were: Anxiety 
3.14 ± 2.79, Depression 1.27 ± 0.57.
Patients with lower pain control had more exaggerated symptoms of 
anxiety and depression. After 1 month, seven patients had mild symptoms 
of anxiety, nine patients had mild symptoms of depression and four 
patients had moderate symptoms of depression.
Conclusions HADS has its role in everyday ICU practice. All patients with 
mild to severe symptoms of anxiety or depression should be further 
psychologically evaluated. There is a need to evaluate in our ICU the 
patients who are staying there a few days or more and compare it with 
the results of this study.
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Introduction After changing the standard resuscitation colloid on our 
ICU from 6% HES 130/0.4 to 4% gelatin, we found that both HES 130/0.4 
and gelatin resulted in a high incidence of renal failure (43.2% and 40.2%) 
in patients with severe sepsis [1]. We therefore changed from synthetic 
colloids to only crystalloids and herewith report on the eff  ects.
Methods Before–after retrospective study in patients with severe sepsis 
on a surgical ICU. The synthetic colloids group (SynColl-Group) comprised 
patients who received either predominantly 6% HES 130 or predominantly 
gelatin between January 2005 and June 2006. The crystalloid group (Crys-
Group) comprised patients from September 2008 to June 2009 who 
received only crystalloids. Acute renal failure (ARF) was defi  ned as new 
need for renal replacement therapy (RRT) or at least a twofold increase in 
baseline creatinine.
Results Two hundred and fi  ve patients received synthetic colloids, and 
141 received only crystalloids. There were minor baseline diff  erences but 
SAPS II and SOFA scores, age and creatinine were similar at admission. 
Fluid therapy (median cumulative doses): patients in the SynColl-
Group received 4 l (IQR 2 to 8.3 l) colloids and 27.9 l (IQR 15.7 to 48.3 l) 
crystalloids. Patients in the Crys-Group received only 25.0 l (IQR 13.1 to 
52.2 l) crystalloids. Crystalloid volumes did not diff  er signifi  cantly between 
groups (P = 0.605). Median cumulative dose of HES was 50 ml/kg and of 
gelatin was 43.3 ml/kg. Outcomes: patients in the SynColl-group had a 
higher incidence of ARF (41.0% vs 23.4%, P = 0.001) and increased need 
for RRT (35.1% vs 22.0%, P = 0.009). ICU mortality and hospital mortality 
did not diff  er between SynColl and Crys groups (31.2% vs 30.5% and 38% 
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SynColl-Group (14 versus 10 days, P = 0.055).
Conclusions In patients with severe sepsis, fl  uid therapy with synthetic 
colloids – gelatin or the third-generation 6% HES 130/0.4 –considerably 
increases the incidence of ARF and need for RRT compared with 
crystalloids. These results confi  rm recent meta-analysis and RCTs, which 
demonstrated an increased incidence of ARF by synthetic colloids [2,3].
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Introduction In this study we investigated the eff  ects on renal micro-
circulatory perfusion of resuscitation with hydroxyethyl starch (HES 
130/0.42) dissolved in a balanced Ringer’s acetate salt solution (Plasma 
Volume Redibag®, HES-RA) or hydroxyethyl starch (HES 130/0.4) dissolved 
in saline (Voluven®, HES-NaCl) and compared this with resuscitation with 
saline solution (0.9% NaCl, NaCl) in an LPS-induced septic shock model in 
the rat.
Methods In 20 anesthetized, mechanically ventilated rats, endotoxic shock 
was induced by infusion of LPS (10 mg/kg over 30 minutes). When the mean 
arterial pressure (MAP) was decreased to 40 mmHg, fl  uid resuscitation was 
started in three groups of fi  ve rats each, and in one fi  ve-rat group no fl  uids 
were given. Renal cortical microvascular perfusion (RMP) was assessed at 
high temporal and spatial resolution using laser speckle imaging. Additional 
measurements included systemic hemodynamics, renal artery blood 
fl  ow (RBF), blood gas analysis, creatinine clearance, and plasma ions and 
calculated renal oxygen delivery (DO2). Time points were: baseline, during 
septic shock at a MAP of 40 mmHg, and at 30 minutes of resuscitation.
Results LPS infusion decreased MAP and RMP in all rats. Resuscitation 
with NaCl did not improve MAP (P >0.05) and appeared to increase RMP 
heterogeneity (0.95 ± 0.08 AU vs 1.83 ± 0.13 AU; P <0.001), metabolic 
acidosis (7.1 ± 0.06 vs 6.93 ± 0.05 pH; P <0.05 and 11.36 ± 1.1 vs 15.9 ± 1.4 
mmol/l base excess; P <0.05), and plasma chloride ion levels (110.3 ± 0.7 
vs 116.2 ± 1.7 mmol/l; P <0.05). Fluid resuscitation did not aff  ect systemic 
oxygenation parameters (sO2, pO2, O2Hb) and renal DO2. Resuscitation 
with NaCl increased plasma levels of Na+, tubular reabsorption of Na+, and 
creatinine clearance compared with resuscitation with the two colloid 
solutions. HES-NaCl and HES-RA provided similar eff  ects on systemic and 
regional hemodynamic parameters. However, while HES-RA improved RBF 
(2.3 ± 0.4 vs 5.7 ± 0.2), HES-NaCl did not. NaCl resuscitation worsened the 
metabolic acidosis, which was not aff  ected by the two colloid solutions. 
The plasma HCO3
– level was increased by HES-RA resuscitation (13.18 ± 2.1 
vs 19.56 ± 1 mmol/l; P <0.01), whereas it was stable in the other groups.
Conclusions  Balanced HES preparation (HES-RA, PlasmaVolume 
Redibag®) in endotoxemic rats showed acute benefi  cial eff  ects on kidney 
microcirculation and on kidney function via bicarbonate balance whereas 
the NaCl treatment was harmful compared with both HES groups.
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Eff  ects of balanced and unbalanced colloid and crystalloid solutions 
on renal oxygenation in a rat model of hemorrhagic shock and 
resuscitation
E Almac, U Aksu, C Ince
University of Amsterdam, the Netherlands
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Introduction Hydroxyethyl starch (HES, 130 kD) dissolved either in saline 
(Voluven®) or in a balanced Ringer’s acetate solution (PlasmaVolume 
Redibag®, PVR) and Ringer’s acetate (RA) and 0.9% NaCl (NaCl) were 
investigated as regards their effi   cacy in restoring renal oxygenation in a rat 
model of hemorrhagic shock and resuscitation.
Methods In 22 anesthetized, mechanically ventilated rats, hemorrhagic 
shock was induced by withdrawing blood volume from the femoral artery 
until the mean arterial pressure (MAP mmHg) was reduced to 40 mmHg. 
One hour after reaching a MAP of 40 mmHg, animals were resuscitated 
with either Voluven® (n = 5), PVR (n = 6), RA (n = 5), or NaCl (n = 6) until a 
target MAP of 80 mmHg was reached. Oxygen tension in the renal cortex 
(CμPO2 mmHg), outer medulla (MμPO2 mmHg), and renal vein were 
measured using oxygen-dependent quenched phosphorescent lifetimes 
of Oxyphor G2. Renal artery blood fl  ow (RBF ml/minute) was measured. 
Renal oxygen delivery and renal oxygen consumption (DO2 and VO2 
ml·minute/g) were calculated.
Results During hemorrhagic shock, CμPO2, MμPO2, RBF, DO2, and VO2 
decreased and O2ER increased. During resuscitation, CμPO2 and MμPO2 
were increased in all groups (P <0.001) although least prominent in the 
NaCl group. RBF was signifi  cantly increased during resuscitation in all 
groups (PVR; 5.1 ± 0.2 P <0.001, RA; 3.5 ± 0.4 P <0.001, Voluven®; 3.4 ± 0.4 
P <0.01), except for the NaCl group, and DO2 was signifi  cantly increased in 
the PVR group (0.20 ± 0.02 vs 0.39 ± 0.06; P <0.01) and RA group (0.22 ± 0.03 
vs 0.41 ± 0.06; P <0.01), while this remained low in the other two groups. 
Fluid resuscitation was not able to restore VO2. After 1 hour of resuscitation 
CμPO2 was signifi  cantly higher in the PVR group (49.9 ± 2.4 P <0.01) and 
the Voluven® group (45.3 ± 5.1 P <0.05) but not in the RA group (40.6 ± 2.2 
P >0.05) compared with the NaCl group (32.1 ± 2.55). Furthermore, RBF 
was signifi  cantly higher in the PVR group (5.1 ± 0.2 P <0.01) compared with 
the NaCl group (2.4 ± 0.5) after 1 hour of resuscitation.
Conclusions Our results suggest that both colloid solutions (Voluven® 
and PlasmaVolume Redibag®) are preferred resuscitation fl   uids with 
respect to crystalloid solutions. Moreover, the balanced colloid solution 
(PVR) appears to restore renal blood fl  ow and oxygenation more than the 
crystalloids or unbalanced colloids do in this rat model of hemorrhagic 
shock and resuscitation.
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Introduction  Dehydration is an important problem among patients 
admitted to the emergency department (ED). However, there has not 
yet been a consensus on the ideal fl  uid for these patients. This study was 
planned to evaluate the ideal crystalloid for the patients admitted to the 
ED who have symptoms of dehydration.
Methods  We conducted a randomized controlled trial that included 
90 dehydrated patients. Three groups of patients each included 30 
randomized for one of the solutions Lactated Ringer’s, 0.9% NaCl or Isolyte® 
(Eczacıbaşı-Baxter, Turkey). Solutions were infused at a rate of 20 ml/kg/
hour for 2 hours. Venous blood sample pH, Na+, K+, Cl–, and HCO3
– levels 
were evaluated at 0, 1, and 2 hours.
Results We detected a decrease in serum pH (7.406 to 7.365) and HCO3
– 
(23.1 to 21.5) levels at the second hour in the 0.9% NaCl group. However, 
in the Isolyte® group an increase in both serum pH (7.410 to 7.434) and 
HCO3
– (23.4 to 24.4) levels were observed. In the Lactated Ringer’s group, 
Table 1 (abstract P503)
   pH  HCO3
Lactated Ringer’s
 0  hours  7.396  22.8
 2  hours  7.408  22.4
0.9% normal saline    
 0  hours  7.406  23.1
 2  hours  7.365  21.5
Isolyte®  
 0  hours  7.410  23.4
 2  hours  7.434  24.4
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– levels. All changes 
were in the physiological range (Table 1).
Conclusions  All three crystalloid solutions can be safely used for 
dehydrated patients and the best metabolic profi  le can be maintained in 
patients who receive Isolyte®.
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Introduction Septic shock is frequently associated with metabolic acidosis 
derived from increased lactic acid production and infusion of sodium 
chloride-based resuscitation fl  uids. Although the impact of hyperchloraemic 
acidosis on outcome is still not fully understood, avoiding such a condition 
is desirable. The hypothesis of the present study was that resuscitation with 
saline-based tetrastarch solutions results in higher plasma chloride and 
lower base excess levels as compared with either balanced tetrastarch or 
crystalloid solutions in ovine endotoxaemic shock.
Methods Thirty-one awake healthy ewes received a continuous infusion 
of Salmonella typhosa endotoxin started at 5 ng/kg/minute, which was 
doubled every hour until the mean arterial pressure (MAP) fell below 
65 mmHg. Thereafter, sheep were randomized to receive either balanced 
6% HES 130/0.4; saline-based 6% HES 130/0.4 (both HES solutions 
were infused up to 50 ml/kg); balanced crystalloids; or no fl  uids. Fluid 
resuscitation was guided to optimize central venous pressure (8 to 12 
mmHg), pulmonary arterial occlusion pressure (12 to 15 mmHg) and 
mixed-venous oxygen saturation (≥65%). Norepinephrine was infused to 
establish a MAP of 70 ± 5 mmHg, if necessary. Haemodynamic variables 
and blood gas analyses were determined hourly throughout the study 
period. Animals surviving the 12-hour intervention period were deeply 
anaesthetized and killed.
Results  Haemodynamic variables were comparable between groups. 
Plasma chloride concentrations were signifi  cantly higher, and oximetry-
corrected base excess was lower in the saline-based tetrastarch group as 
compared with the balanced tetrastarch or balanced crystalloid group 
over the whole interventional period (each P <0.05). Whereas arterial pCO2 
was lowest in the saline-based tetrastarch group (each P <0.05), there were 
no diff  erences between treatment groups in arterial pH.
Conclusions  As compared with balanced tetrastarch or crystalloid 
solutions, saline-based tetrastarch infusion is associated with hyper-
chloraemic acidosis, which is compensated by hyperventilation in awake, 
endotoxaemic sheep.
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Introduction Acute kidney injury (AKI) is a common complication associated 
with increased mortality among ICU patients. The purpose of the present 
study was to retrospectively analyze the infl  uence of diff  erent, saline-based 
hydroxyethyl starch (HES) solutions (tetrastarch, 6% HES 130/0.4; pentastarch, 
10% HES 200/0.5) on the risk of AKI in a cohort of surgical ICU patients.
Methods Data for 3,591 patients admitted to one of four ICUs of the 
University Hospital of Muenster from January 2000 until August 2008 were 
extracted from an electronic database and analyzed using univariate and 
multivariate logistic regression analyses. AKI was defi  ned as grade I or 
higher according to the RIFLE classifi  cation.
Results Average amounts of colloid infusion per ICU day were 402 (231; 
656) and 73 (36; 172) ml/day in patients treated with tetrastarch and 
pentastarch, respectively, whereas cumulative colloid amounts were 2,000 
(500; 3,500) ml and 1,000 (500; 2,000) ml. Maximum daily infusion rates of 
6% HES 130/0.4 and 10% HES 200/0.5 were below the pharmaceutically 
recommended daily dose limitations (that is, 50 and 20 ml/kg/day, 
respec  tively). The overall incidence of AKI was 20.4%. Multivariate logistic 
regression analysis revealed SOFA score (OR 1.597; 95% CI 1.543, 1.653), 
male gender (OR 1.455; 95% CI 1.153, 1.836), creatinine concentration on 
admission (OR 1.288; 95% CI 1.125, 1.475), and patient age (OR 1.017; 95% 
CI 1.009, 1.024) as independent risk factors for AKI. See Figure 1.
Conclusions Neither of the investigated HES solutions (given within the 
recommended dose range) was an independent risk factor for AKI in the 
present cohort of surgical ICU patients.
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shock and multiorgan failure
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Introduction To evaluate early continuous venovenous hemodiafi  ltration 
(CVVHDF) in patients with refractory septic shock and multiorgan failure 
upon mortality and morbidity in the ICU.
Methods Forty patients were prospectively studied and randomly treated 
with either conventional treatment (20 patients; group II) or with early 
CVVHDF (less than 6 hours of maximal hemodynamic support) in addition 
to the conventional treatment (20 patients; group I). Metabolic acidosis, 
serum lactate and serum procalcitonin level (PCT) before and 5 days after 
CVVHDF were monitored to evaluate the outcome. APACHE II and ΔSOFA 
scoring systems were used before and 5 days after CVVHDF.
Results Compared with group II, patients of group I had lower mortality 
(55% vs 70%) with an insignifi  cant P value (P = 0.54). Group I patients 
showed a nonsignifi  cant ΔSOFA (5.95 ± 4.39 vs 6.2 ± 3.3 in groups I and 
II, respectively, P = 0.66); regarding APACHE II scores, group I also showed 
statistically nonsignifi   cant lower fi   gures than group II (on admission 
APACHE II scores were 39.35 ± 10.65 vs 41.85 ± 10 in groups I and II, 
respectively, P = 0.45, while on day 5 APACHE II scores were 34.8 ± 10.6 vs 
36.1 ± 10.9 in groups I and II, respectively, P = 0.41). Group I patients showed 
lower PCT on admission and day 5 than group II patients (on admission 
PCT level was 0.64 ± 0.18 vs 0.68 ± 0.17 in groups I and II, respectively, P = 
0.5) while the day 5 PCT level was (0.51 ± 0.15 vs 0.52 ± 0.17 in groups I and 
II, respectively, P = 0.83). Indicators of improvement showed a statistically 
signifi  cant  diff   erence between survivors and nonsurvivors in group I 
regarding serum lactate level at day 5 (P <0.001), while other indicators as 
fever, renal profi  le, WBC count, metabolic acidosis, serum lactate level on 
admission and platelet count were statistically insignifi  cant (on admission 
P = 0.2, 0.55, 0.45, 0.41, 0.65, 0.55, respectively, and on day 5 P = 0.37, 0.94, 
0.71, 0.5, <0.001, 0.88, respectively). There was a signifi   cant statistical 
diff  erence between survivors and nonsurvivors in group I considering the 
number of organ failures as less than or equal to three organs involved in 
comparison with more than three organs involved (P = 0.008).
Figure 1 (abstract P505). Risk factors for acute renal failure.
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multiple organ failure. Continuous rising of the serum lactate level despite 
CVVHDF is associated with an increased mortality rate. Of all scoring 
systems used, SOFA maximum, ΔSOFA and day 5 APACHE II were the most 
accurate prognostic indicators for mortality.
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Introduction Both inhaled hydrogen sulfi  de (H2S) [1] and intravenous H2S 
donors protected against kidney ischemia/reperfusion (I/R) injury [2-4], 
but all these data originate from unresuscitated rodent models. Therefore, 
we investigated the eff  ect of the H2S donor Na2S in a clinically relevant 
porcine model of aortic occlusion-induced renal I/R injury.
Methods Anesthetised and ventilated pigs received Na2S (n = 9) or vehicle 
(n = 10) for 2 hours before and 8 hours after 90 minutes of intra-aortic balloon 
occlusion-induced kidney ischemia. During reperfusion noradrenaline was 
titrated to keep blood pressure at baseline levels. Before Na2S, prior to aortic 
occlusion and at 1, 2, 4 and 8 hours of reperfusion, we measured renal 
blood fl  ow and function (creatinine clearance and blood levels, fractional 
Na+ excretion), blood cytokines (TNFα, IL-6, IL-1β) and nitrates, renal tissue 
DNA damage (comet assay), HO-1 and caspase-3 expression (western 
blotting), and NF-κB activation (EMSA). Histological damage (glomerular 
tubularisation [5]) was assessed immediately post mortem.
Results Na2S pretreatment was associated with a progressive fall in core 
temperature and signifi  cantly lower noradrenaline infusion rates needed to 
achieve the hemodynamic targets. While renal blood fl  ow and fractional Na+ 
excretion were comparable, Na2S attenuated the fall in creatinine clearance 
and the rise in creatinine blood levels, respectively, which coincided with 
signifi  cantly lower IL-6, IL-1β, and nitrate blood levels. Kidney glomerular and 
tissue DNA damage were markedly attenuated, whereas NF-κB activation 
was signifi  cantly higher in the Na2S-treated animals.
Conclusions  In a clinically relevant porcine model mimicking aortic 
cross-clamping-induced kidney I/R injury, Na2S attenuated tissue injury 
and organ dysfunction as a result of reduced systemic infl  ammation and 
oxidative stress. The higher NF-κB activation and the unchanged fractional 
Na+ excretion were most probably due to the drop in temperature [6] and 
the direct eff  ect of H2S on tubular Na+ absorption [7], respectively.
Acknowledgements Supported by the DFG (SCHE 899/2-3) and Ikaria 
Inc. (Seattle, WA, USA).
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Introduction Liver failure is often complicated by sepsis. Available liver 
support systems (LSS) failed to show survival benefi  ts. Hepa Wash® (HW) 
is a newly developed LSS based on use of recycled albumin dialysate. The 
study aim is to evaluate its safety and effi   cacy in an animal model that 
combines liver failure with sepsis.
Methods Female German Landrace pigs (~60 kg) were randomly allocated 
to HW (n = 5) and control (n = 5) groups. On day 0 ischemic and cholestatic 
liver injury was induced by functional end-to-side portacaval shunt and 
bile duct ligation. Animals were returned then to the stall for observation. 
On day 3 the second phase of the experiment was started. Endotoxin 
was administered intravenously at an initial dose of 4 μg/kg/hour with a 
stepwise twofold increment every hour and stopped after 7.5 hours. HW 
was started 2.5 hours after endotoxemia and continued for 7 hours.
Results On day 3, animals (n = 10) had hyperbilirubinemia (5.2 ± 0.3 mg/dl; 
mean ± SEM) and hyperammonemia (264 ± 38 μg/dl). Endotoxemia in 
control animals resulted in severe multisystem organ failure and death 
(after 6.4 ± 0.3 hours) although they received only one-third of the total 
endotoxin dose on average. HW improved cardiovascular (Figure 1), 
cerebral, respiratory and renal parameters and eliminated surrogate 
parameters as bilirubin (2.8 ± 0.5 vs 5.2 ± 0.3 mg/dl P <0.05) and ammonia 
(189 ± 38 vs 1,108 ± 455 μg/dl, P <0.05). All animals in the HW group 
survived the 10-hour observation period (P <0.05). We did not notice any 
adverse eff  ects during treatment.
Conclusions Hepa Wash® was safe and eff  ective at improving survival in 
a swine model of liver failure and sepsis due to amelioration of the major 
organ functions and removal of protein-bound and water-soluble toxins.
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Increased glomerular fi  ltration in the critically ill patient receiving 
anti-infective treatment
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Introduction Little is known about the occurrence of increased glomerular 
fi  ltration rates (GFR) in critically ill patients. Increased GFR may in theory 
lead to subtherapeutic concentrations of life-saving drugs. The aim of this 
study was to evaluate the occurrence rate and pattern of increased GFR in 
critically ill patients receiving anti-infective treatment (AIT).
Methods  Prospective evaluation of consecutive ICU patients during a 
6-week period, treated with anti-infective drugs, either therapeutically or 
prophylactically; dialysed patients were excluded. Patient characteristics: 
retrieved from the computerized Intensive Care Information System. 
Surrogate measure for GFR: the 24-hour urinary creatinine clearance (Ccr) 
calculated per day of AIT. Increased GFR: Ccr >120 ml/minute. Statistical 
analysis with SPSS 17.0: Student’s t test, chi-square or Fisher’s exact test. 
Data expression: median and interquartile range (IQR). Multivariate analysis: 
logistic regression analysis with increased GFR as dependent variable.
Results One hundred and forty-one (94 male) patients were included; 
median age was 59.9 (50.3 to 70.1); 80 (56.7%) were surgical ICU (SICU) 
patients. Most common infection types were pneumonia (59.2%) and 
intra-abdominal infection (9.9%). Prophylactic use was 17.6% of all AIT. 
Median length of stay 4.6 days; ICU mortality 5.7%. Median Ccr in the 
Figure 1 (abstract P508). Hepa Wash® stabilizes mean arterial pressure in 
liver failure and sepsis.
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days were available for analysis in which 302 days of increased GFR were 
present (40.1%). Seventy-six patients (53.9%) had an episode of increased 
GFR at some time during AIT. In 31 patients (22.0%) GFR was increased 
throughout the whole episode of AIT. Patients with increased GFR were 
signifi  cantly younger (54.2 vs 65.6, P <0.001) and there was a trend towards 
a higher incidence of increased GFR in patients treated for infections, in 
male and in SICU patients. Multivariate analysis showed that age (OR 0.93 
per year), therapeutic administration of AIT (OR 5.49), and SICU admission 
(OR 2.27) were independently associated with increased GFR.
Conclusions Increased GFR were a frequent fi  nding in critically ill patients 
receiving AIT, and was associated with younger age and SICU admission.
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Introduction The aim of this study is to analyze the eff  ect of therapeutic 
plasma exchange (TPE) on biochemical and coagulation parameters.
Methods We enrolled all children who were admitted to the pediatric ICU 
with diagnosis of acute liver failure and underwent TPE between December 
2005 and December 2009. Serum prothrombin time, International 
Normalized Ratio, total and direct bilirubin, aminotransferases and serum 
ammonia values were recorded before and after TPE sessions.
Results  Fourteen patients (male/female, 4/10, median age 8.5 years) 
underwent a total of 37 TPE sessions. Acute liver failure was induced by viral 
hepatitis in fi  ve cases, Wilson disease in four cases, toxins in four cases and 
autoimmune hepatitis in one case. When compared with baseline, there 
were signifi  cant improvements in laboratory parameters (Table 1). Five of 
the 14 patients (35.7%) died in the pediatric ICU, fi  ve patients underwent 
liver transplantation. Four patients (28.5%) survived with extracorporeal 
liver support. No serious adverse eff  ect of TPE was observed in the patients 
during or after completion of TPE.
Conclusions  TPE is eff   ective in improving liver biochemistry tests in 
children with liver failure. Expected changes in laboratory parameters after 
TPE must be considered especially in deciding for liver transplantation.
Reference
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New markers of infl  ammation-induced renal injury subside when 
endotoxin tolerance develops in humans as measured by urine 
proteomics
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Introduction Sepsis has been identifi  ed as the most common cause of 
renal injury in ICUs although the pathophysiology is not well understood. 
No large clinical studies are available that show an improvement of renal 
function in patients with sepsis and this may be related to the lack of 
early diagnostic tests that indicate the onset of renal injury. The aim of the 
current study was to search for potential new early markers of renal injury 
during acute endotoxemia and to investigate whether renal injury can be 
ameliorated by the induction of lipopolysaccharide (LPS) tolerance.
Methods  Five healthy males received intravenous bolus injections of 
2 ng/kg/day Escherichia coli LPS for 5 consecutive days. We used surface-
enhanced laser desorption/ionization time-of-fl  ight mass spectrometry 
(Seldi-TOF MS). This approach allows for rapid high-throughput profi  ling 
of multiple urine samples and detects low molecular weight biomarkers.
Results Repeated LPS administrations induced a diminished glomerular 
fi  ltration rate of 33 ± 7% (P = 0.02) on day 2 and an increase in serum 
creatinine of 11 ± 3% (P = 0.002) on day 3, which was associated with the 
appearance of 15 peak intensities in the urinary protein profi  le including 
an increase in β-microglobulin levels (P = 0.04) 6 hours after the fi  rst LPS 
administration. Four of the 15 peak intensities on day 1 correlated with 
serum creatinine levels on day 3; 3,950, 4,445, 6,723 and 7,735 m/z (P = 0.03; 
0.01; 0.02 and 0.05, respectively). With the development of LPS tolerance, 
renal function was restored, refl  ected by a decrease in serum creatinine 
and β-microglobulin levels to baseline (P = 0.2 and 0.4, respectively, 
between days 1 and 5), and by attenuated peak intensities in the urinary 
protein profi  le (P <0.0001 for all 15 peak intensities).
Conclusions  In conclusion, renal injury occurs during repeated 
endotoxemia and can be predicted by new urinary markers using 
proteome research. The four markers that correlated with the extent of 
renal injury may represent potential new biomarkers for renal injury 
and need further identifi  cation. The infl  ammation-induced renal injury 
subsided when LPS tolerance developed after 5 consecutive days of LPS 
administrations.
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Extraction and purifi  cation of 1-hydroxymidazolam glucuronide 
from ultrafi  ltrate
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Introduction  We developed a technique for detection of MDZ and 
1-hydroxymidazolam glucuronide (1-OHMG). No commercial source of 
1-OHMG prevented assay development. 1-OHMG had pharmacological 
activity and is renally excreted. We postulated that ultrafi  ltrate (UFR) would 
be rich in 1-OHMG. We describe a method to purify 1-OHMG from UFR.
Methods  Ethics approval was granted. To purify, UFR was extracted 
on a C-18 column, it was washed and eluted. HPLC-MS separation was 
performed. The 1-OHMG (mol. wt 517/ 518 in MS) was desiccated and 
re-dissolved four times to maximise purity. Electrospray (ESI) mass 
spectrometry (MS) characterised 1-OHMG. The purity was calculated using 
NMR. A calibration plot of 1-OHMG, MDZ and DZP (internal standard) for 
HPLC-MS was performed.
Results 1-OHMG identity was confi  rmed using MS/MS (Figure 1). Two 
milligrams of 1-OHMG was purifi  ed from 5,000 ml UFR. The 1-OHMG was 
98% pure (NMR). The extinction coeffi   cient was identical to MDZ. The 
calibration plot resulted in correlation of 0.912. The assay was applied into 
clinical practice, to report sera and UFR levels.
Table 1 (abstract P510). Biochemical and coagulation parameters before and after TPE
Variable   Before TPE  After TPE   Delta variable  P value
PT (sec)  40.9 (32.5 to 47.5)  21.1 (18.1 to 25.0)  17.8 (10.2 to 26.1)  0.0003
INR  3.6 (3.1 to 4.6)  1.7 (1.5 to 2.3)  1.7 (1.3 to 27.8)  0.0002
TB (mg/dl)  17.7 (11.7 to 21.5)  14.2 (9.6 to 18.0)  3.2 (1.1 to 6.0)  0.0006
DB (mg/dl)  10.3 (7.3 to 17.2)  7.9 (4.8 to 14.2)  1.9 (0.8 to 4.8)  0.0001
ALT (U/l)  122.5 (61.1 to 370)  87.5 (54 to 197.5)  38.1 (7 to 109.5)  0.0001
AST (U/l)  247.5 (122 to 399)  178 (85.5 to 272)  66.5 (14.1 to 223)  0.0002
Ammonia (mmol/l)  143.2 (81.5 to 195)  97.0 (71 to 150.5)  11.5 (3.5 to 59)  0.0003
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from UFR. Five litres of UFR resulted in 2 mg 1-OHMG. This is a potentially 
rich source of drugs or drug metabolites, allowing pharmacokinetic 
studies greatly required in critical illness.
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Introduction The Intensive Care Society recommends achieving a dose of 
35 ml/kg/hour in 85% of patients receiving continuous renal replacement 
therapy (CRRT). However, a recent multicentre trial concluded there was 
no benefi  t of using 40 ml/kg/hour versus 25 ml/kg/hour. The extra cost of 
high-dose RRT has not been quantifi  ed. At our institution the target dose 
is 35 ml/kg/hour.
Methods  Patients receiving renal replacement therapy from April to 
September 2009 were identifi  ed using Careview, an electronic patient-
care record system. The effl   uent rate (ml/hour) was used to calculate the 
dose and adjusted for weight. A telephone survey of ICUs examined the 
dose and mode of CRRT used in Scotland.
Results Thirty-fi  ve patients, mean age 62, received CRRT with a mean 
duration of RRT of 78 hours. Twenty-three patients (66%) were admitted 
with sepsis. Continuous venovenous haemodiafi  ltration was the initial 
mode in 31 patients (89%). Ten patients were excluded from the dose 
analysis because no weight was documented. The mean dose actually 
delivered per patient was 50 ml/kg/hour. If 25 ml/kg/hour had been given 
then 40% less RRT fl  uid could have been used. The Scottish telephone 
survey revealed that one-third of Scottish ICUs routinely use 35 ml/kg/
hour or more. If 25 ml/kg/hour was used routinely in these units alone, 
then over €24,000 could be saved per annum.
Conclusions The dose of CRRT given for each patient at our institution 
currently exceeds the target dose by 43%. Using 25 ml/kg/hour as the 
standard dose would provide a signifi  cant cost saving to the NHS in 
Scotland and to ICUs throughout Europe.
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Use of CRRT-CVVH in a hemato-oncological ICU in patients treated 
with defi  brotide for veno-occlusive disease in patients after 
allogeneic hematopoetic stem cell transplantation: single-center 
experience
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Introduction  Complex care in the hemato-oncological ICU sometimes 
requires the use of CRRT. As the hemato-oncological patients have some 
specifi  cations we retrospectively followed up the results of our eff  ort in 
patients with acute renal failure due to veno-occlusive disease (VOD) after 
allogeneic hematopoietic stem cell transplantation. VOD is one of the most 
severe early complications in this type of patients and its mortality is high.
Methods From 1 January 2007 to 30 October 2009 we performed 94 
procedures (one procedure = 24 hours) in 15 patients with VOD and 
acute renal oligo-anuric failure. As a standard in our ICU we perform CVVH 
with post dilution on a Fresenius Multifi   ltrate machine. The key drug 
for the treatment of VOD is defi  brotide and the patients were severely 
thrombocytopenic, we have not used any anticoagulation in the CVVH 
set. The dose of defi  brotide ranged from 10 to 20 mg/kg/day according to 
the severity of thrombocytopenia and eventually hemorrhagic symptoms. 
Blood count, acid–base balance and biochemistry were monitored at least 
twice daily. The thrombocytopenia was corrected with the donor platelets 
and the platelet level was sustained at 20 x 109l.
Results The introduction of CVVH in all 15 patients dramatically helped to 
overcome the severe part of VOD until the defi  brotide helped to restore 
Figure 1 (abstract P512). Centroided MS of purifi  ed 1-OHMG.
Figure 1 (abstract P513). Mean dose of RRT for each patient at Western 
Infi  rmary.
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from VOD as a cause of death. Surprisingly, the median patency of the 
CVVH tubing set was 46 hours despite no anticoagulation in the tubing 
set. Defi  brotide is effi   cient in preventing coagulation in the tubing set. 
No serious hemorrhagic events were observed. The fl  uent maintenance 
of fl  uid balance, the removal of waste products of metabolism and the 
maintenance of acid–base balance were very important for the patient in 
the critical point of advanced VOD.
Conclusions CVVH is an integral part of intensive care in hemato-oncology 
and the use of this therapeutic modality in patients with VOD with acute 
renal failure can signifi  cantly improve the results of our therapeutic eff  orts.
P515
Comparison of the effi   cacy and safety of two regional citrate 
anticoagulation protocols using acid citrate dextrose A or 
Prismocitrate 10/2, in patients with acute renal failure undergoing 
continuous venovenous haemodiafi  ltration
EL Ooi, TW Lim, N Lim
Changi General Hospital, Singapore
Critical Care 2010, 14(Suppl 1):P515 (doi: 10.1186/cc8747)
Introduction  Continuous renal replacement therapy (CRRT) is the 
treatment of choice for acute renal failure in critically ill patients. Our study 
compared the effi   cacy and safety of regional citrate anticoagulation (RCA) 
with acid citrate dextrose A (ACD-A) against Prismocitrate 10/2 (Gambro). 
Use of Prismocitrate 10/2 eliminates the need for a separate infusion 
pump for ACD-A as it doubles as replacement fl  uid and anticoagulant. 
This removes a source of error in the calculation of fl  uid balance. The 
combination of tri-sodium citrate and citric acid in Prismocitrate 10/2 
avoids the metabolic alkalosis associated with ACD-A [1,2].
Methods This was a prospective sequential cohort study. All patients 
admitted to the surgical ICU who required CRRT for ARF were recruited. 
Group A, using ACD-A, was recruited from October 2007 to September 
2008 (n = 23). Group B, using Prismocitrate 10/2, was recruited from 
October 2008 to September 2009 (n = 20). We evaluated the incidence 
of metabolic alkalosis and other biochemical changes, azotemia control, 
fi  lter lifespan and complications.
Results The incidence of metabolic alkalosis in Group B from treatment 
day 2 onwards was signifi  cantly lower than Group A. The Group A median 
pH was 7.42 (6.81 to 7.62) compared with Group B pH 7.35 (7.2 to 7.49), 
P = 0.001. The control of electrolytes and azotemia was not signifi  cantly 
diff  erent. The mean fi  lter duration was 58.8 hours (95% CI 38.0 to 79.6) 
for Group A and 61.8 hours (95% CI 45.8 to 77.8) for Group B (P = 0.678). 
Longitudinal analysis revealed a statistically signifi  cant result for reduced 
metabolic alkalosis for Group B. (standard bicarbonate P <0.001, base 
excess P <0.001). Repeat treatment sessions also showed a statistically 
signifi  cant reduction of metabolic alkalosis using Prismocitrate 10/2 rather 
than ACD-A (P = 0.029).
Conclusions  RCA with Prismocitrate 10/2 reduces the incidence of 
metabolic alkalosis associated with ACD-A. This regime is safe, feasible and 
improved patient safety, with no increase in complication rates. Our unit 
has now converted to Prismocitrate 10/2 for RCA.
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Introduction  Premature circuit clotting is a major problem during 
continuous venovenous haemofi   ltration (CVVH). Some studies have 
suggested that circuit life can be improved by adding epoprostenol to 
heparin.
Methods Retrospective review of mean circuit patency in patients on 
noncitrate-based anticoagulation regimens during CVVH in a 30-bed 
multidisciplinary ICU between October 2008 and May 2009. Circuits which 
were discontinued electively were excluded from the analysis.
Results Patency data were available for 486 noncitrate circuits. There was 
no signifi  cant diff  erence in mean circuit life between heparin given via 
circuit (n = 169 circuits; mean circuit life 19.8 hours) and epoprostenol 
alone (n = 119 circuits; mean circuit life 20.9 hours). In a small group of 
patients on heparin via the circuit, epoprostenol was added for patency 
reasons (n = 19 circuits). In this group, the mean circuit life was only 
15 hours. Circuits of patients on systemic heparin (n = 100) lasted for a 
mean of 23.5 hours. In a small group of patients, epoprostenol was added 
via the circuit (n = 32 circuits). The mean circuit life was 28.9 hours (P >0.05). 
Other types of noncitrate anticoagulation were activated protein C and 
lepuridin, alone or in combination with heparin (n = 47 circuits).
Conclusions In our practice, anticoagulation with epoprostenol alone led 
to similar circuit survival as heparin administered via the circuit. Adding 
epoprostenol to heparin did not signifi  cantly prolong the mean circuit 
life. Further analysis of circuit patency in individual patients is needed to 
determine the characteristics of patients who may benefi  t and for whom 
the extra cost could be justifi  ed.
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Recurrent early fi  lter clotting in regional citrate anticoagulated 
continuous venovenous hemodialysis due to undetected antibodies 
to heparin–platelet factor 4 complexes
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Introduction We recently published a citrate anticoagulated continuous 
venovenous hemodialysis (citrate-CVVHD) protocol with variable 
treatment dose. The protocol was safe and easy to handle and the mean 
fi  lter lifetime was 61.5 hours [1]. We here report fi  ve cases with unexplained 
recurrent early fi  lter clotting beside eff  ective citrate anticoagulation due to 
undetected antibodies to heparin–platelet factor 4 complexes (hep-PF4 
ab).
Methods Regionale citrate anticoagulation was performed with variable 
treatment dose using the MultiFiltrate™ CRRT device (Fresenius, Germany) 
in CVVHD mode. Between May 2008 and August 2009 we detected fi  ve 
cases on the ICU. All had acute kidney injury with need for RRT. Underlying 
diseases were: three sepsis, one cardiac surgery, one abdominal surgery. 
All patients were anticoagulated with heparin or fractionated heparin 
for more than 10 days before initiation of citrate-CVVHD. At the time of 
initiation of citrate-CVVHD, none of the patients had clinically evident 
signs of thomboembolism.
Results The mean fi  lter lifetime before diagnosis of hep-PF4 ab was 8 
(range 1.3 to 14) hours. Postfi  lter ionized calcium concentrations were 
always in the demanded range (mean 0.28, range 0.24 to 0.35 mmol/l). The 
mean thrombocyte count was 160/nl (range 48 to 215) at time of initiation 
of citrate-CVVHD. Thrombocyte counts fell to a mean 114/nl (range 36 to 
177) within 5 days. Mean time to testing for and diagnosis of hep-PF4 ab 
was 6 (range 3 to 12) days. After positive testing (HIPA) for hep-PF4 ab, 
heparin was stopped and all patients received argatroban with a mean 
PTT of 83 (range 48 to 119) seconds. Under systemic anticoagulation with 
argatroban, the fi  lter lifetime of citrate-CVVHD increased to a mean 58 
(range 18 to 96) hours. Within 14 days after initiation of citrate-CVVHD, 
three patients had a diagnosis of a clinically signifi  cant thrombembolic 
event.
Conclusions In patients on the ICU with moderate–low thrombocyte 
count and without clinically evident signs of thomboembolism, often 
sepsis or the state of critical illness is assumed as the cause for decreasing 
platelet counts and tests for hep-PF4 ab are not performed. In cases of 
undetected and untreated hep-PF4 ab, fi  lter clotting can occur beside 
eff   ective citrate anticoagulation in CVVHD. In cases of unexplained 
recurrent early fi   lter clotting in citrate-CVVHD, patients should be 
carefully examined for underlying hep-PF4 ab and heparin-induced 
thrombocytopenia.
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Pilot study on a regional citrate anticoagulated continuous 
venovenous hemodiafi  ltration protocol with variable treatment 
dose
T Slowinski, I Lieker, D Khadzhynov, M Sander, S Morgera, H Neumayer, 
H Peters
Charité Campus Mitte, Berlin, Germany
Critical Care 2010, 14(Suppl 1):P518 (doi: 10.1186/cc8750)
Introduction In order to add convective solute transport to a recently 
described citrate-CVVHD protocol, we established a citrate anticoagulated 
continuous venovenous hemodiafi   ltration (citrate-CVVHDF) protocol 
with variable treatment dose. Citrate-CVVHD has been shown to be safe 
and easy to handle [1]. Being based on dialysis, however, citrate-CVVHD 
primarily relies on diff  usive solute transport. To also allow convective 
transport, we designed a new citrate-CVVHDF protocol with a postdilution 
hemofi  ltration dose.
Methods  Prospective observational study. A CVVHDF-based citrate 
anticoagulation protocol on the MultiFiltrate™ CRRT device (Fresenius 
Medical Care (FMC), Germany) using a 4% trisodium citrate solution, 
the dialysate fl  uid Ci-Ca™ Dialysate K2 (FMC), and a continuous calcium 
chloride (91 mmol/l) infusion. For the fi  ltration dose we used a standard 
bicarbonate-buff  ered substitution fl  uid (MultiBic™; FMC) in postdilution. 
Ten patients on the ICU with acute kidney injury and need for RRT were 
included. For variable doses, patients were divided into three groups 
according to their body weight (1: <60 kg, 2: 60 to 90 kg, 3: >90 kg). The 
initial fl  ows for dialysate/substitution fl  uid in the groups were 1,400/800, 
1,800/1,000, and 2,200/1,200 ml/hour, blood fl  ow 80, 100, and 120 ml/
minute, citrate fl  ow 145, 175, and 220 ml/hour, and calcium fl  ow 32, 45, 
and 57 ml/minute. Citrate fl  ow was adjusted to postfi  lter ionized calcium 
(iCa) measurements, target range 0.25 to 0.35 mmol/l. Calcium fl  ow was 
adjusted to patients’ systemic iCa. The treatment time was limited to 
72 hours.
Results Eight of 10 patients reached the maximum treatment time of 
72 hours without clotting. In one patient the treatment had to be stopped 
after 50 hours because of central venous catheter fl  ow problems and 
one patient died after 54 hours. Acid–base control: mean (95% CI) pH; 
st-bicarbonate at 48 hours: 7.42 (7.38 to 7.44); 24.6 (21.3 to 27.8) mmol/l, 
and at 72 hours: 7.39 (7.35 to 7.43); 25.0 (21.3 to 27.6) mmol/l. Electrolyte 
control: mean (95% CI) s-sodium; s-potassium at 48 hours: 139 (137 to 
141); 4.8 (4.4 to 5.2) mmol/l, and at 72 hours: 139 (137 to 142); 4.9 (4.4 to 
5.4) mmol/l. Mean (95% CI) treatment dose was 41 (37 to 46) ml/kg/hour, 
mean (95% CI) s-urea at 48 hours: 51 (37 to 66) mg/dl, and at 72 hours: 50 
(35 to 65) mg/dl.
Conclusions The citrate-CVVHDF protocol allows combined hemodialysis 
and hemofi  ltration in CRRT with variable treatment dose and with the 
advantages of regional citrate anticoagulation. In this pilot study, in 
10 patients the fi  lter run-time in citrate-CVVHDF was remarkable and 
metabolic control excellent.
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replacement therapy: single-center, 2-year experience
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Critical Care 2010, 14(Suppl 1):P519 (doi: 10.1186/cc8751)
Introduction Continuous renal replacement therapy (CRRT) is frequently 
used among hemodynamically unstable critically ill patients with acute 
renal failure (ARF). However, data regarding management of these patients 
in Serbia are scarce. CRRT has been available at our institution since 2007. 
The objective of this study was to describe characteristics and outcome of 
patients treated with renal replacement therapy in a single tertiary-care 
center in Serbia.
Methods In this retrospective observational study we reviewed medical 
records of adult (≥18 years) patients treated in the fi  ve-bed ICU at the 
Institute for Pulmonary Diseases in Sremska Kamenica, Serbia who 
underwent CRRT from April 2007 to November 2009.
Results From the total 314 patients treated in the ICU, 29 (9.2%), 17 men, 
median age 54 years (interquartile range (IQR) 48 to 68), underwent 
CRRT. Patients were mostly nonsurgical (n = 28, 96%). Main admission 
diagnoses were septic shock (n = 11) and pneumonia (n = 9). The median 
APACHE II score was 27 (IQR 19 to 32), and SOFA day 1 was 10 (IQR 5 to 
13). Seventeen patients (58.6%) had chronic co-morbidities; Charlson 
score median 2 (IQR 0.75 to 3). Twenty-four patients required mechanical 
ventilation, and 13 were diagnosed with acute respiratory distress 
syndrome. Slow continuous ultrafi   ltration was used in four patients 
(13.7%), hemodiafi  ltration (CVVHDF) modality in 13 (44.8%), hemodialysis 
(CVVHD) in 11 (37.9%). Median time on CRRT was 3 days (IQR 2 to 4). Five 
patients (17%) had a complete recovery of renal function at the time of 
ICU discharge. Median hospital length of stay was 12 days (IQR 5 to 20) and 
hospital mortality was 69%.
Conclusions The need for CRRT in the observed population is substantial. 
Future studies are warranted to determine the impact of introduction of 
CRRT on hospital mortality in Eastern European countries and to provide 
future strategies for improving patient care in these settings.
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Renal function in living related kidney donors above the age of 70
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Critical Care 2010, 14(Suppl 1):P520 (doi: 10.1186/cc8752)
Introduction  Living related kidney donors are highly motivated for 
donation. Older donors may have increased risks in the perioperative 
and postoperative period. Age limits for donors was insisted on in the 
past. The glomerular fi  ltration rate in older people is only slightly lower 
than in young individuals in the absence of primary renal disease or 
confounding cardiovascular disease. The aim of the study was to assess 
renal function of living related donors above the age of 70 in the early 
postoperative period.
Methods From March 2007 to November 2009, in Clinical Centre Nis, 
25 living related donors donated their kidneys. The serum creatinine 
and calculated creatinine clearance (MDRD formula) were evaluated 
preoperatively, fi  rst, third and fi  fth postoperative days in the group under 
(U) and in the group above (A) the age of 70.
Results There were 16 donors in group U (mean age 59, SD 5.38) and nine 
donors in group A (mean age 72.4, SD 1.88). The mean serum creatinine 
level in group U was 64.66 μmol/l (SD 12.22), 120.2 μmol/l (SD 26.04), 
120.91 μmol/l (SD 21.68) and 116.07 μmol/l (SD 21.35) preoperatively, on 
the fi  rst, third and fi  fth postoperative days, respectively. In group A the 
mean serum creatinine level was 84.58 μmol/l (SD 23.63), 150.64 μmol/l 
(SD 38.67), 149.49 (SD 43.68) and 148.36 μmol/l (SD 39.08) preoperatively, 
fi  rst, third and fi  fth postoperative days, respectively. Calculated creatinine 
clearance in group U was 102.62 ml/minute/1.73 m2 (SD 20.61), 50.44 
ml/minute/1.73 m2 (SD 10.28), 48.69 ml/minute/1.73 m2 (SD 7.88) and 
51.62 ml/minute/1.73 m2 (SD 8.96) preoperatively, fi  rst, third and fi  fth 
postoperative days, respectively, and in group A 78.11 ml/minute/1.73 m2 
(SD 23.31), 39.11 ml/minute/1.73 m2 (SD 10.35), 40.56 ml/minute/1.73 m2 
(SD 12.31) and 40.44 ml/minute/1.73 m2 (SD 11.36) preoperatively, fi  rst, 
third and fi   fth postoperative days, respectively. There is a statistically 
signifi  cant diff  erence in serum creatinine level between groups A and U 
preoperatively (P = 0.039) and on the fi  fth postoperative day (P = 0.043), 
and there is a statistically signifi  cant diff  erence in glomerular fi  ltration rate 
between groups A and U preoperatively (P = 0.019), on the fi  rst (P = 0.018) 
and fi  fth postoperative days (P = 0.024).
Conclusions  Deterioration of residual kidney function in the early 
postoperative period is higher in living donors above the age of 70. Patients 
over the age of 70 must be accepted with care for kidney donation.
P521
Augmented renal clearance in traumatic brain injury
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Critical Care 2010, 14(Suppl 1):P521 (doi: 10.1186/cc8753)
Introduction  Use of hypertonic saline and/or vasopressor infusion to 
achieve a desired cerebral perfusion pressure (CPP) in traumatic brain 
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would signifi  cantly augment creatinine clearances (CrCl) in this population.
Methods  Head-injured patients requiring hyperosmolar therapy 
using 3% or 20% saline solutions and/or norepinephrine infusion for 
the maintenance of a CPP >60 mmHg were recruited into the study. 
Additional management was consistent with local practice and in 
line with the Brain Trauma Foundation guidelines [1]. An 8-hour CrCl, 
physiological variables, fl   uid balance, and medications were recorded 
daily during active management of CPP. A further CrCl was collected just 
prior to discharge (off   CPP therapy), and if this was elevated, was repeated 
on the ward. Augmented renal clearance (ARC) was defi  ned as a CrCl >160 
ml/minute/1.73m2 for males and >150 ml/minute/1.73m2 for females [2].
Results Twenty consecutive patients were enrolled. The average ICU length 
of stay was 15 days (CI 95% 11 to 18), and time to study entry averaged 2.3 
days (CI 95% 1.7 to 2.8). All patients received norepinephrine (n = 20), 85% 
(n = 17) received hypertonic saline, and therapy lasted on average 7.6 days 
(CI 95% 5.6 to 9.5). ARC was demonstrated in 17 (85%) patients at any point 
during active management of CPP. The mean maximum CrCl was 179 ml/
minute/1.73 m2 while on CPP therapy (CI 95% 159 to 198) returning to a 
mean CrCl of 111 ml/minute/1.73 m2 (CI 95% 91 to 131, P <0.001) when 
measured in the ward. The mean CrCl in the ICU while not receiving CPP 
therapy was 150 ml/minute/1.73 m2 (CI 95% 134 to 167, P = 0.03). The 
mean time to reach peak CrCl while on active treatment was 4.7 days (CI 
95% 3.0 to 6.4). Norepinephrine use, saline loading, mean arterial pressure, 
and central venous pressure, predicted CrCl on the day of measurement.
Conclusions ARC is common in head-injured patients receiving active 
management of CPP and persists even after ceasing such therapy. This has 
signifi  cant implications for appropriate dosing of renally excreted drugs 
in this setting.
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Introduction At the present time, mice models have failed to reproduce 
human acute kidney injury (AKI) and new relevant models of AKI are 
required [1]. In this study we developed a model of AKI in mice based 
on pressure-controlled hemorrhagic shock that closely reproduces 
hypotension involved in most of human ischemic AKI.
Methods We fi  rst determined shock and resuscitation modalities in a 
C57/Bl6 mice population. A femoral arterial catheter was used for pressure 
control and bleeding and a central jugular catheter for anesthesia and 
resuscitation. We secondly explored renal repercussions of a 2-hour shock 
duration at 35 mmHg mean arterial pressure. We assessed successively 
the glomerular fi  ltration rate (GFR), histological kidney injury score and 
performed real-time PCR after the procedure. The shock group was 
compared with sham mice and with a control group that underwent no 
procedure (n = 5 in each group).
Results The shock group GFR was decreased 2 (D2) and 6 (D6) days after 
shock when compared with control and sham (Figure 1). This AKI was 
intrinsic as showed by the Na/K urinary ratio increase and the decrease in 
urine concentration ability. Tissular damage prevailed in the outer medulla 
with a maximal expression at D6 (paucicellular tubular epithelium, 
intratubular casts) (Figure 2). These lesions are associated with an increase 
of tissular KIM-1 and HIFs mRNA. Despite GFR normalization, the shock 
group showed discreet defect in urine concentration ability and a slight 
peritubular fi  brosis 3 weeks after shock.
Conclusions This new model of AKI based on hypotension opens new 
perspectives in the fi  eld of short-term and long-term kidney function 
following AKI.
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Introduction  The kidney is the organ of the human body designed 
to sense and regulate intravascular volume. The KING (Kidney Instant 
Monitoring; Orvim, Paderno Dugnano, Italy) is a new device that allows 
continuous measurement of urinary electrolytes and real-time body 
response to changes in intrathoracic and intra-abdominal pressures and 
to lung injury.
Methods Sixteen pigs (weight 20 ± 3 kg) were anaesthetized, tracheo-
tomized, catheterized and mechanically ventilated. Pigs were ventilated 
for approximately 10 hours with a TV of 10 ml/kg, RR 15 breaths/minute, 
FIO2 0.5 and no PEEP. After TV was increased, pigs were divided into two 
groups: eight pigs with a lower TV and eight pigs with higher TV. A variable 
dead space was added to maintain normocapnia. Pigs were mechanically 
ventilated with the new TV up to 48 hours. The KING measured urinary 
output and urinary concentration of sodium and potassium every 
10 minutes. NaCl 0.9% was exclusively infused. The average urinary 
concentration of each electrolyte was expressed as the total concentration 
Figure 1 (abstract P522). Glomerular fi  ltration rate 2 (D2), 6 (D6) and 21 
(D21) days after the procedure.
Figure 2 (abstract P522). Tubular injury score at H3, D2, D6 and D21. 
*P <0.05 and ** P <0.01.
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were compared using the Wilcoxon test.
Results The higher TV group was ventilated with a TV of 890 ± 251 ml 
and a plateau pressure of 31 ± 8 cmH2O while the lower TV group had 
a TV of 472 ± 262 ml (P = 0.006) and a plateau pressure of 17 ± 9 cmH2O 
(P = 0.02). The length of mechanical ventilation for the high TV group was 
1,850 ± 633 minutes and for the low TV group was 3,341 ± 749 minutes 
(P = 0.0006). The urinary output for the high TV was 37 ± 16 ml/hour and 
for the low TV was 52 ± 19 ml/hour (P = 0.10). The high TV group showed 
lower urinary sodium (40 ± 35 mEq/l vs 93 ± 26 mEq/l, P = 0.007), higher 
urinary potassium (52 ± 12 mEq/l vs 35 ± 23 mEq/l, P = 0.04) and a lower 
urinary sodium/potassium ratio (0.77 ± 0.7 vs 3.86 ± 3.3, P = 0.001). Before 
TV was increased, urinary output, urinary concentrations of sodium, 
potassium and sodium/potassium ratio were not diff  erent.
Conclusions Data show that injurious ventilation is sensed by the kidney 
as a relative hypovolemia with reduction in sodium urinary output, 
increased excretion of potassium and inverted sodium/potassium ratio.
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Introduction  Fluid overload has recently been linked to adverse 
outcomes in critically ill patients, but its impact on the outcomes of cancer 
patients admitted to ICUs has not been previously described. The aim of 
this study is analyze the impact of fl  uid overload on outcomes of patients 
with cancer needing intensive care.
Methods A total of 122 cancer patients admitted to the medical ICU in 
a 6-month period were prospectively evaluated for survival. Univariate 
and multivariate analysis were used to study ICU admission parameters 
associated with ICU mortality. Exclusion criteria were ICU stay <24 hours 
and chronic renal failure on dialysis.
Results Overall mortality was 15.5% (n = 19). The mean age of all patients 
was 62.7 ± 11.6 years and 55% (n = 68) were male. One hundred and 
six patients (86%) had solid tumors and 16 (14%) had hematologic 
malignancies. Postoperative care (49%) and sepsis (38%) were the major 
reasons for admission to the ICU. The mean APACHE II score value at 
ICU admission was 17.2 ± 6.4 and the mean Karnofsky score before ICU 
admission was 75.2 ± 17.2. At multivariate analysis, the following variables 
at ICU admission were signifi  cantly associated with ICU mortality in cancer 
patients: Lung Injury Score (LIS) >2 (OR 3.3; 95% CI 1.32 to 8.23) and positive 
fl  uid balance (for each 100 ml/24 hours) (OR 1.03; 95% CI 1.01 to 1.06).
Conclusions Fluid overload is independently associated with increased 
mortality in critically ill cancer patients. Further studies are necessary to 
determine the impact of positive fl  uid balance on acute organ dysfunction 
and overall prognosis of cancer patients.
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Introduction Management of acute kidney injury (AKI) is heterogeneous 
with little consensus about fl  uid therapy, vasopressors and diuretics. The 
aim was to analyse whether fl  uid management infl  uences outcome in 
critically ill patients with AKI.
Methods Retrospective analysis of the data for 4,645 patients admitted 
to the multidisciplinary ICU at Guy’s and St Thomas’ Foundation Hospital 
between April 2004 and June 2009. AKI was defi  ned according to the AKI 
network criteria, which distinguish between three diff  erent grades of AKI. 
Maximum degree of AKI and total cumulative fl  uid balance between ICU 
admission and the day of AKI were recorded.
Results A total of 1,225 patients (26.4%) had AKI I, 29 patients (0.6%) had 
AKI II and 1,183 patients (25.5%) had AKI III of whom 89% were treated with 
renal replacement therapy. Two hundred and thirty-seven (5.1%) patients 
had end-stage dialysis-dependent renal failure and 1,971 patients (42.4%) 
had no AKI during their stay in the ICU. The ICU mortality was 15.6% in AKI 
I, 17.2% in AKI II and 34.9% in patients with AKI III (AKI I vs AKI III: P <0.0001). 
Cumulative fl  uid balance at diagnosis of AKI was signifi  cantly higher in 
patients who later died (Table 1).
Conclusions There is a correlation between fl  uid accumulation on the day 
of AKI and subsequent ICU outcome. Among patients with any degree 
of AKI, nonsurvivors had a higher cumulative fl  uid balance compared 
with ICU survivors. Future analysis needs to determine whether fl   uid 
accumulation was the cause of worse outcome, the result of more 
aggressive resuscitation or a marker of more severe AKI.
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Introduction  In sepsis, a generalised infl   ammatory onslaught causes 
systemic endothelial dysfunction; the glomerular manifestation of which 
is microalbuminuria. Recent histopathological evidence of extensive 
glomerular capillary infi  ltration by leucocytes in septic AKI suggests that 
endothelial dysfunction may play a particularly important role in this 
condition compared with patients with other causes of AKI. Markers of 
endothelial dysfunction such as microalbuminuria may therefore have a 
potential diagnostic role in septic AKI.
Methods Prospective observational study in a 20-bed ICU in a tertiary-
care hospital. Microalbuminuria estimated as the spot urine albumin–
creatinine ratio (ACR, mg/g) was measured on ICU admission. Two 
hundred and sixty-six patients were recruited between January 2007 and 
December 2008. Patients with an ICU stay of less than 24 hours, pregnancy, 
menstruation, anuria, hematuria, proteinuria due to renal and post-renal 
structural diseases were excluded. Sepsis was diagnosed by the ACCP/
SCCM criteria; AKI was identifi  ed on admission using the RIFLE criteria.
Results Of the 266 patients studied, 130 patients had no AKI while 136 
patients had AKI as classifi  ed by the RIFLE criteria. Of these 136 patients, 
59 patients were in the Risk category, 62 in the Injury and 15 patients in 
the Failure, of which 26 patients (9.8%) needed RRT. For the entire cohort, 
median age was 61.5 years, 61% were male, median APACHE II score was 
15. Of these, 56 (21%) of patients died on the ICU. ACR showed signifi  cant 
correlation with serum creatinine values (P = 0.0049, Spearman rank 
correlation (r) = 0.173) and was negatively associated with estimated GFR 
(P = 0.0002, r = –0.225). The median level of ACR (204.1 mg/g, (IQR 119.7 
to 402.0)) of patients with septic AKI (n = 66) on admission to the ICU was 
signifi  cantly greater (P <0.0001) than the median ACR level of 67.1 mg/g 
(IQR 32.99 to 129.9) of patients who had AKI from other causes (n = 70). 
Patients of sepsis who had developed AKI also had higher ACR than those 
who did not (n = 51) (ACR 119.3 mg/g (IQR 37.02 to 354.3)) (P = 0.0137).
Conclusions Presence of signifi  cant microalbuminuria on admission to 
the ITU may be an early indicator of AKI in sepsis patients.
Table 1 (abstract P525). Mean cumulative fl  uid balance (SD) in ICU survivors 
and nonsurvivors
Degree of AKI   Survivors  Nonsurvivors  P value
AKI I  +2,527 ml (118)  +3,694 ml (314)  <0.0001
AKI II  +4,348 ml (929)  +6,896 ml (2,492)  0.0007
AKi III  +3,228 ml (173)  +4,780 ml (295)  <0.0001
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Introduction Neutrophil gelatinase-associated lipocalin plasma (pNGAL) 
and urine (uNGAL) concentrations can be used as early indicators for the 
development of acute kidney injury (AKI) [1]. As AKI is associated with higher 
risk of morbidity and mortality in ICU patients [2], higher pNGAL and uNGAL 
on admission might be relevant to the clinical course. No data on pNGAL 
and uNGAL as early indicators of postoperative AKI have been published.
Methods We collected plasma and urine samples from patients admitted 
postoperatively following noncardiopulmonary bypass-related surgery. 
NGAL concentrations were measured using an immunofl  uorescence assay. 
Subsequently we compared the time points of maximum pNGAL, uNGAL 
and SCr concentrations in the group of patients developing postoperative 
AKI (Mann–Whitney U test). Data are presented as mean ± SD.
Results One hundred and ninety-fi  ve consecutive patients (age: 58 ± 16 
years; APACHE II 15 ± 6) were included. Twenty-two patients (age 63 ± 17; 
APACHE II 20 ± 7) developed AKI (AKI 1 n = 14; AKI 2 n = 3; AKI 3 n = 5). 
Time to reach peak (Tmax) concentrations for pNGAL, uNGAL and SCr are 
respectively 21 (21), 20 (22), 31 (32) for AKI 1, 39 (32), 24 (31), 54 (12) for 
AKI 2, and 17 (18), 26 (24), 34 (27) for AKI 3. Maximum concentrations of 
pNGAL (ng/ml), uNGAL (ng/ml) and SCr (mmol/l) are respectively 1,348 
(1,569), 364 (220), 147 (38) for AKI 1, 424 (309), 949 (389), 175 (28) for AKI 
2, and 2,375 (1,731), 726 (398), 265 (81). Figure 1 shows time course of 
pNGAL and uNGAL in patients developing AKI. Tmax of pNGAL and uNGAL 
was signifi  cantly earlier than Tmax of SCr (both α <0.001).
Conclusions  In postoperative patients developing AKI, pNGAL and 
uNGAL reach peak concentrations 1 day earlier than SCr. This might be 
of clinical importance as it provides us with an opportunity to prevent 
further deterioration of renal function at an earlier stage.
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Introduction  Neutrophil gelatinase-associated lipocalin (NGAL) 
measured in plasma or urine has shown to be an excellent early predictor 
for the development of acute kidney injury (AKI) [1]. Furthermore, AKI 
is an independent risk factor for mortality in critically ill patients [2]. We 
therefore hypothesized that NGAL concentrations measured at ICU 
admission in plasma and urine are associated with mortality.
Methods We collected plasma and urine samples at ICU admission from 
all consecutive admitted patients (n = 700), of whom 171 during their 
fi  rst week of admittance, meeting criteria for any stage of AKI according 
to RIFLE classifi   cation for serum creatinine (sCr) increase only. NGAL 
concentrations were measured using a rapid immunofl  uorescence assay 
(Triage® meter plus; Biosite Inc., San Diego, CA, USA). The Mann–Whitney U 
test was used for comparison of mean NGAL concentrations in plasma and 
urine between survivors and nonsurvivors. Exclusion criteria were patients 
with a history of nephrectomy, chronic or end-stage renal disease, kidney 
transplant surgery and informed consent refusal (n = 36).
Results  One hundred and seventy-one patients met criteria for AKI 
and were included in the statistical analysis. Median (25th to 75th 
percentile) age (years), APACHE II score after 24 hours and on admission 
sCr concentrations for survivors (n = 105) and nonsurvivors (n = 66) were 
respectively 59 (46 to 68) and 64 (53 to 73), 21 (15 to 26) and 26 (22 to 
31), and 65 (60 to 80) and 80 (65 to 100) μmol/l. Median (25th to 75th 
percentile) NGAL plasma and urine concentrations were respectively 300 
(160 to 504) ng/ml and 426 (127 to 1,543) ng/ml for the survivors and 457 
(281 to 991) ng/ml and 1,189 (381 to 4,124) ng/ml for the nonsurvivors. 
These diff  erences for both plasma and urine NGAL values were statistically 
signifi  cant (both P <0.005).
Conclusions Plasma and urine NGAL concentrations at ICU admission 
are signifi   cantly higher in nonsurviving patients compared with 
concentrations in surviving patients. Therefore NGAL measured at 
admission might be an early indicator for mortality.
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Introduction NGAL levels are dramatically increased in urine and plasma 
from patients with acute kidney injury (AKI). In this study we tested the 
clinical utility of NGAL in critically ill patients with many confounding 
conditions including sepsis. In addition, a new fully automated NGAL assay 
was validated with a selection of clinical samples from these patients.
Methods Plasma and urinary NGAL was monitored (daily to alternate 
days) in 135 consecutive patients admitted to intensive care. AKI was 
classifi  ed according to the RIFLE criteria. Three patients were excluded 
because of incomplete data. NGAL was determined with an ELISA kit 
(BioPorto Diagnostics). Diff  erences between maximal NGAL levels in the 
patient were analyzed nonparametrically by the Kruskal–Wallis test. Data 
are reported as median (interquartile range) in ng/ml. A fully automated 
immunoturbidimetric NGAL test (The NGAL Test; BioPorto Diagnostics) 
was tested. The NGAL Test was validated by means of linearity studies 
with dilutions of calibrator material, determination of antigen excess zone 
and a method comparison with the ELISA kit on 40 urine and 40 plasma 
samples with NGAL levels from 25 to 2,995 ng/ml as measured by ELISA.
Results Sixty-two patients did not have AKI; 15 were classifi  ed as risk (R), 
11 as injury (I) and 44 as failure (F). The urinary NGAL was signifi  cantly 
(P <0.0001) higher in patients with AKI (R 377 (102 to 830), I 519 (321 to 1,845) 
and F 2,747 (559 to 7,621)) than in patients without AKI (51 (29 to 213)). 
Plasma NGAL levels were signifi  cantly (P <0.0001) higher in patients with 
AKI (R 354 (259 to 511), I 546 (331 to 1,106) and F 1,062 (584 to 1,817)) than 
in patients without AKI (199 (128 to 308)). Linearity studies of The NGAL Test 
demonstrated a measuring range from 25 to 5,000 ng/ml. No deleterious 
eff  ect of antigen excess was seen up to a level of 40,000 ng/ml. There was 
good agreement between the ELISA and The NGAL Test results, the Pearson 
coeffi   cient of correlation being 0.98 for both urine and plasma samples.
Conclusions  It is concluded that NGAL is dramatically increased in 
the urine and plasma of unselected critically ill patients with AKI and 
the degree of injury is refl  ected by the observed levels despite several 
confounding conditions. NGAL determination may therefore be useful for 
the diagnosis of renal injury and monitoring the management of patients 
admitted to intensive care. Validation of The NGAL Test demonstrates a 
performance that complies with the expectations for a fully automated 
clinical laboratory assay, which can thus be a valuable tool for the 
management of critically ill patients.
Figure 1 (abstract P527).
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Introduction Acute kidney injury (AKI) is common after cardiac surgery 
and recognition with specifi   c biomarkers may improve outcome. We 
assessed the impact and cost-eff   ectiveness (CE) of urine neutrophil 
gelatinase-associated lipocalin (uNGAL) for AKI diagnosis compared with 
current methods.
Methods We developed a decision analysis model to evaluate the CE 
of uNGAL plus standard diagnostic tests (for example, BUN, creatinine) 
compared with standard methods alone. The model was developed from 
the UK societal using costs per quality-adjusted life years (QALY). Model 
parameters were derived from the literature, UK economic data, and MD 
interviews. The base case was a 68-year-old male patient undergoing 
coronary artery bypass surgery. Sensitivity analyses were performed to 
determine how CE would vary with changes in the underlying model 
variables.
Results The base case yielded expected costs of £4,244 and 11.86 QALYs 
for NGAL compared with £4,672 and 11.79 QALYs without NGAL. The CE 
ratio for the NGAL strategy was £358/QALY compared with £396/QALY 
for the standard regimen. CE increased as treatment eff  ect – defi  ned as 
the ability to prevent AKI progression (Injury or Failure) – for the therapy 
triggered by an elevated NGAL level rose. Sensitivity analysis showed that 
the model was most responsive to the probability of developing AKI and 
least sensitive to the cost of the NGAL test. Probabilistic sensitivity analysis 
demonstrated that the NGAL strategy was the more cost-eff  ective option 
at a willingness-to-pay threshold of £30,000/QALY for each of the 1,000 
simulations (Figure 1).
Conclusions Use of uNGAL appears to be cost-eff  ective in the diagnosis 
of AKI after cardiac surgery.
P531
Neutrophil gelatinase-associated lipocalin predicts acute kidney 
injury in critically ill patients
K Núñez, J Baldirà, M Cuartero, H Aguirre, M Rodríguez, P Vera, LL Zapata, 
A Roglan, J Ordóñez, AJ Betbesé
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Critical Care 2010, 14(Suppl 1):P531 (doi: 10.1186/cc8763)
Introduction Plasma and urinary concentrations of neutrophil gelatinase-
associated lipocalin (NGAL) are early biomarkers of acute kidney injury 
(AKI) [1]. Most studies about the NGAL value to predict AKI were done 
in patients after cardiac surgery and not enough information about its 
usefulness in critically ill patients exists. To analyze the predictive value 
of plasma NGAL to predict AKI, evaluated by RIFLE score, in critically ill 
patients, particularly in those with severe sepsis and septic shock.
Methods  NGAL was measured in whole-blood (Triage® NGAL Test; 
Inverness Medical, UK) at admission and after 48 hours in patients 
admitted to a general ICU. Patients were classifi  ed according to RIFLE 
score at admission and 24 and 48 hours thereafter and according to 
NGAL concentrations at admission using values suggested by Constatin 
and colleagues [2] (≤155 or >155 ng/ml). NGAL values at admission were 
compared in patients under systemic infl  ammatory response syndrome 
(SIRS), severe sepsis and septic shock.
Results Sixty patients were included (28 female) with mean age 58 ± 
18.6 years, SAPS II 40.6 ± 15.7, SOFA 6.9 ± 3.9, length of ICU stay of 11.4 ± 
11.1 days and mortality of 23%. Forty patients developed SIRS, six severe 
sepsis and 14 septic shock. Eleven patients developed AKI (RIFLE F), 10 
of them at ICU admission; extracorporeal renal therapies were required 
in six cases. Thirty patients have NGAL ≤155 ng/ml. When patients were 
classifi  ed according to RIFLE score at 24 hours of admission, NGAL values 
at admission were 180 ± 170 ng/ml in 36 patients with RIFLE 0, 243 ± 317 
ng/ml in seven patients with RIFLE R, 303 ± 134 ng/ml in four patients 
with RIFLE I and 536 ± 421 ng/ml in nine patients with RIFLE F (P = 0.003). 
One patient was discharged before 24 hours (NGAL<60 ng/ml); whereas 
three patients who died before 24 hours had NGAL at admission of 578 ± 
350 ng/ml. The area under the ROC curve of NGAL at admission for the 
prediction of AKI was 0.83 (95% confi  dence interval 0.70 to 0.97, P = 0.001), 
with an optimal cutoff   value of 277 ng/ml with 73% sensitivity and 77% 
specifi  city. NGAL concentrations at admission were 160 ± 159 ng/ml in 40 
patients with SIRS, 335 ± 206 ng/ml in six patients with severe sepsis and 
540 ± 347 ng/ml in 14 patients with septic shock (P <0.001).
Conclusions Plasma NGAL concentrations measured at ICU admission 
appeared a useful predictor of AKI in critically ill patients; in addition, NGAL 
concentrations showed an increasing pattern from SIRS to severe sepsis 
and septic shock.
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Introduction To evaluate the vancomycin trough level in patients on 
inter  mittent hemodialysis (IHD), slow low-effi   ciency  dialysis  (SLED) 
and continuous renal replacement therapy (CRRT) and to assess the 
appropriateness of an improvised protocol, which is to repeat the 
vancomycin dose (15 mg/ kg) after 5 days on IHD, after 3 days on SLED 
and after 2 days in CRRT.
Methods This study was conducted at AMRI Hospitals, Kolkata between 
November 2008 and April 2009. Thirty-three patients were studied. Fifteen 
were on IHD, 15 were receiving SLED and three were on CRRT. Mean age 
for the IHD group was 56.09 ± 11.4, for SLED was 64.3 ± 13.4, and for CRRT 
was 68 ± 8.34. The male:female ratio was 2:1 for IHD, 1.5: 1 for SLED and 2:1 
for CRRT. Patients with severe hepatic impairment, obesity, cystic fi  brosis 
and neoplastic disorder were excluded from this study. The mean Charlson 
score was 3.6 ± 4.8 for the IHD group, 5.26 ± 1.16 for SLED and 8.6 ± 11.2 
for CRRT, respectively. High-performance liquid chromatography was used 
for assay of vancomycin.
Results The mean vancomycin trough levels were 18 ± 3.99 on day 5 for 
patients on IHD, 15.3 ± 4.1 on day 3 for patients on SLED and 11.9 ± 2.4 
for patients on CRRT. This prospective observational study is unique, in 
the sense that data are sparse regarding vancomycin levels, on various 
modalities of hemodialysis. The second and more important observation 
from this study was that our improvised dosing of vancomycin needs 
revision, since, of the patients on dialysis, 80% (12/15) of patients on IHD 
and 60% (9/15) of patients on SLED had higher than the recommended 
trough level (15 μg/ml), whereas for patients on CRRT the trough levels 
were subtherapeutic at 30 hours.
Figure 1 (abstract P530). Probabilistic sensitivity analysis of incremental 
CE of NGAL vs standard methods.
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mandatory checking of vancomycin trough levels and a larger study in 
Indian patients to defi  nitively determine dosage guidelines in this ethnic 
population.
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Introduction Acute renal dysfunction (ARD) is one of the most common 
complications of orthotopic liver transplantation (OLT), with an incidence 
ranging from 12 to 64% [1,2]. These patients are often critically ill in the 
perioperative period with a number of other co-morbidities, resulting in 
an increased susceptibility to ARD. The RIFLE criteria were developed to 
provide a consensus defi  nition for acute renal dysfunction in critically ill 
patients. Using the RIFLE criteria, we aimed to determine the incidence 
and risk factors for acute renal dysfunction in the early postoperative 
period.
Methods The records of 112 patients who underwent OLT, performed 
by the same team in the Baskent University Hospital, from January 2000 
to February 2009, were retrospectively analyzed. Three levels of renal 
dysfunction, outlined in the RIFLE criteria, were investigated. Collected 
data included demographic features; co-morbidities; etiology of the liver 
failure; perioperative laboratory values; intraoperative hemodynamic 
parameters; use and volume of crystalloids, colloids, blood products, 
cell saver system, and albumin; portal vein clamping time; requirement 
for inotropes, vasopressors, and antihypertensive drugs; duration of 
anesthesia; and urine output.
Results  ARD occurred in 64 of OLTs (57%). Risk, injury, and failure 
frequencies were 19%, 11%, and 28%, respectively. Compared with those 
who did not have ARD postoperatively, those who did had signifi  cantly 
higher MELD scores (19 ± 7 vs 16 ± 8; P = 0.018), more frequently required 
inotropic agents intraoperatively (54% vs 35%; P = 0.070), received more 
colloids (300 ± 433 ml vs 105 ± 203 ml; P = 0.007), had a longer portal vein 
clamping time (88.0 ± 42.0 minutes vs 73.0 ± 20.0 minutes; P = 0.037), 
and had a higher incidence of intraoperative acidosis (64% vs 44%; P = 
0.047). Logistic regression analysis was performed using these data to fi  nd 
the predictors for development of ARD. ARD was found to be associated 
with MELD score (odds ratio 1.107, 95% CI 1.022 to 1.200, P = 0.013), portal 
vein clamping time (odds ratio 1.020 95% CI 1.000 to 1.040, P = 0.053) and 
intraoperative acidosis (odds ratio 3.610, 95% CI 1.212 to 10.753 P = 0.021).
Conclusions Based on RIFLE criteria, more than one-half of the patients 
who underwent liver transplantation developed ARD postoperatively. A 
higher MELD score, longer portal vein clamping time, and occurrence of 
intraoperative acidosis were identifi  ed as the independent risk factors for 
development of ARD in this group of patients.
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Introduction The aim of this study was to evaluate the use of laxative 
prophylaxis for constipation in the ICU and the impact of early versus late 
bowel movement on patient outcome.
Methods After informed consent, all adults in the ICU who were expected 
to stay on a ventilator for >72 hours were randomized to Control and 
Interventional groups. Patients who had major bowel surgery were 
excluded. The Control group did not receive any intervention for bowel 
movement for the fi  rst 72 hours, while the Interventional group received 
a prophylactic dose of Lactulose 20 cc orally every 12 hours for the fi  rst 
72 hours. After 72 hours the management of constipation in the both 
groups was left to the physician’s discretion. Data were collected for 
age, sex, diagnosis, Simplifi  ed Acute Physiology Score (SAPS) II, doses of 
narcotics and sedatives, enteral nutrition, ventilator days, ICU days, bowel 
movement <72 hours and days of fi  rst bowel movement.
Results Over a 6-month period a total of 100 patients were enrolled, 50 
patients in each Control and Interventional group. Mean age was 38.8 
years in Control and 37.5 years in Interventional group. Both groups had 
a predominance of male patients. The most common diagnosis in both 
groups was polytrauma. Mean SAPS II for both was 35. One hundred 
percent of patients were ventilated, with a mean dose of fentanyl (323.8 ± 
108.89 μg/hour in Control and 345.83 ± 94.43 μg/hour in Interventional 
group) and a mean dose of midazolam (11.1 ± 4.04 mg/hour in Control 
and 12.4 ± 3.19 mg/hour in Interventional group). Enteral nutrition was 
maintained and tolerated by 100% of patients. There were only two (4%) 
patients in the Control group and nine (18%) patients in the Interventional 
group who had bowel movement in <72 hours (P <0.05). Twenty-three 
(46%) patients in the Control and 29 (58%) patients in the Interventional 
group had bowel movement after 5 days. Mean ventilator days were 
16.19 and 17.36 days in the Control and Interventional groups. Subgroup 
analysis showed that the patients who moved their bowel in <5 days in 
both groups had mean ventilator days of 18.5, while it was 15.88 days for 
the patients who moved their bowel after 5 days in both groups (P <0.05). 
Forty-eight (96%) patients in each group were discharged from the ICU. 
Mean ICU days for the Control group was 21.15 ± 10.44 and was 20.77 ± 
8.33 days for the Interventional group. A total of two (4%) patients died in 
each group.
Conclusions Laxative prophylaxis can be used successfully to prevent 
constipation in ICU patients. Late bowel movement >5 days is associated 
with less ventilator days, compared with early <5 days bowel movement.
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Introduction  Intra-abdominal hypertension (IAH) is associated with 
signifi  cant mortality in surgical and trauma patients. However, IAH can 
occur in medical patients as well. Thus, the main objective of this study 
was to assess whether the IAH during the fi  rst 24-hour period of admission 
was an independent predictor for 28-day mortality.
Methods We conducted a prospective observational study. All patients 
admitted to the medical ICU were enrolled in this study and underwent 
intra-abdominal pressure (IAP) measurement via the bladder. The primary 
outcome was the association between IAH and 28-day mortality rate.
Results Seventy-seven eligible patients were enrolled to this study. The 
incidence of IAH was 44%. The mean age was 60.52 ± 18.34 years. In terms 
of 28-day mortality, there was no association between the presence of IAH 
and mortality outcome. However, regarding ICU mortality, nonsurvivors 
had signifi  cantly higher mean IAP within 24 hours of admission than 
survivors: 11.55 (8.0 to 20.3) vs 9.95 (3.0 to 27.0) (P = 0.041).
Conclusions Neither the mean IAP nor the presence of IAH within the fi  rst 
24 hours of admission was an independent predictor for 28-day mortality. 
Nonetheless, this study demonstrated the diff   erence of IAP between 
survivors and nonsurvivors in terms of ICU mortality in the medical ICU.
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Introduction  Intra-abdominal hypertension (IAH) and abdominal 
compartment syndrome (ACS) have become serious causes of morbidity 
and mortality in critical surgical and medical patients, especially in the 
past 10 years. Increased IAP levels became one of the routine physiologic 
parameter measurement elements in critical patients and indicate 
prognosis. In this study, our aim was to observe IAP increase, APB decrease 
and their clinical manifestations in ICU patients.
Methods Eighty-nine ICU patients were included in this study. IAP levels 
were measured by infusing 25 ml saline into the urinary bladder. The 
symphisis pubis plane affi   liated as the zero point. Patients were divided 
into groups according to IAP and APB levels. Clinical follow-up, required 
medical care and survival were investigated.
Results Within the 89 patients, 36 of them diagnosed as IAH and 34 of 
them diagnosed as low APB. There were 25 patients that had both IAH and 
low APB. In these patients, during the fi  rst 2 days of the study, statistically 
signifi  cant SGOT, SGPT, PO2, urea and creatinine levels were found. We also 
determined increased positive inotropic support and ventilatory support 
need with increased sepsis and multiple organ failure incidence in these 
patients. Mortality rates were strongly related to IAH and low APB levels.
Conclusions In critically ill patients, IAP measurement, a very simple and 
valuable method, must be performed. IAH and low APB levels are indicators 
of high morbidity and mortality rates. Therefore, IAP measurement may 
become a routine element in follow-ups and survival rate determinations, 
in critically ill patients.
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Introduction  Intra-abdominal hypertension (IAH, >12 mmHg) and 
abdominal compartment syndrome (ACS, >20 mmHg) frequently compli-
cate the disease course in critically ill patients with liver disease. There is a 
paucity of data describing the circulatory changes observed during ACS 
outside experimental studies. The aim of this study was to investigate 
baseline haemodynamic variables in patients with ACS and their response 
following abdominal decompression.
Methods Patients admitted to the liver ICU of King’s College Hospital with ACS 
were studied. Transpulmonary thermodilution cardiac output monitoring and 
calculation of volumetric indices of preload was performed with the PiCCO 
system. MAP, CVP, ITBVI, cardiac index (CI), stroke volume index (SVI) and intra-
abdominal pressure (IAP) were analysed pre and post intervention.
Results Eighteen patients (nine female), median age 43 (range (R) 20 
to 65) were studied. Ten patients had decompensated Budd–Chiari 
syndrome (BCS), eight underwent orthotopic liver transplantation and 
two had surgical shunt procedures. Eight patients had cirrhosis (PC) with 
organ failure and severe ascites necessitating therapeutic paracentesis. 
Pre-intervention IAP was raised (median 24, R 17 to 40). As a whole, 
volumetric markers of pre-load were low (median ITBVI 674, R 453 to 1,619) 
but improved (median ITBVI 763, R 512 to 1,110) post intervention (P = 
0.02). Reduction in CVP post intervention was not statistically signifi  cant 
(16, R 0 to 25 vs 14, R 5 to 29). Compared with the PC group, the BCS 
group had persistently low ITBVI (median 633, R 453 to 924) despite 
aggressive volume resuscitation prior to decompression (median positive 
fl  uid balance 10 l, R 0.5 to 39). Abdominal decompression resulted in a 
reduction in IAP (median 15, R 6 to 31, P <0.0001), increase in preload 
(ITBVI) and improvement in CI (3.9, R 1.9 to 7.4 vs 4.6, R 2.7 to 7.7, P <0.0001) 
and SVI (40, R 22 to 111 vs 44, 30 to 61, P = 0.001). There was an inverse 
relationship between IAP, CI (P = 0.003) and SVI (P = 0.004). ITBVI correlated 
with parameters of fl  ow (CI P <0.0001 and SVI P <0.0001), CVP did not.
Conclusions  ACS leads to central hypovolaemia. Abdominal decom-
pression restores preload in association with improvement in cardiac output.
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Introduction The study we performed focuses on the removal of bilirubin 
in hepatic failure patients with a ventricular assist device (VAD). Bilirubin is 
a risk factor revealing the severe hepatic insuffi   ciency and the alteration 
of the clinical status. The mortality rate of patients developing liver failure 
in the cardiac ICU is very high. The molecular adsorbent recirculating 
system (MARS) is the hepatic failure treatment in patients with no other 
therapeutic options. It is a liver support system that uses an albumin-
enriched dialysate to facilitate the removal of albumin-bound toxins. 
Conventional hemodialysis techniques have little or no eff  ect on liver 
detoxication and cannot improve these patients’ prognosis. The study 
aims to prove the decrease of the mortality rate in hepatic failure patients 
with VAD as a result of using MARS.
Methods We conducted a retrospective study of 55 patients with VAD. 
They were hospitalized in our cardiac ICU between January 2000 and 
November 2009. All patients had a hepatic check-up when admitted to 
the ICU. The patients with altered liver function had at least one check-
up per day. We had seven patients with hyperbilirubinaemia >350 μmol/l 
(the threshold for starting hepatic dialysis). Five patients received MARS 
therapy. Hepatic check-ups were performed at the beginning and at the 
end of the session.
Results Five patients were dialysed. Patient 1 – with a maximum serum 
bilirubin level of 350 μmol/l, needed four cycles of MARS therapy; the 
patient survived. Patient 2 – max bilirubin 390 μmol/l, 6 MARS; the patient 
survived. Patient 3 – max bilirubin 700 μmol/l, 3 MARS; the patient did not 
survive. Patient 4 – max bilirubin 680 μmol/l, 3 MARS; the patient survived. 
Patient 5 – max bilirubin 500 μmol/l, 15 MARS; the patient did not survive. 
The two patients that did not receive MARS therapy did not survive.
Conclusions MARS is a viable option for the treatment of hepatic failure 
patients and, in particular, for those with VAD. We consider that without 
MARS a VAD patient cannot survive if his serum bilirubin level exceeds 
350  μmol/l. Our hypothesis needs to be confi   rmed by multicenter 
randomized trials.
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Introduction A prospective observational study on molecular adsorbent 
recirculating system (MARS) therapy in a liver-disease-dedicated ICU.
Critical Care 2010, Volume 14 Suppl 1 
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acute liver failure fulfi  lling MARS therapy criteria, in relation to two main 
indications: primary and secondary to chronic liver failure (ALF/ACLF = 
group 1) or intractable pruritus (IP = group 2), were included: Data were 
collected before and after each MARS procedure. APACHE and MELD 
scores [1] were used to predict the ICU mortality and the 90-day mortality, 
respectively.
Results Thirty-nine patients, APACHE II = 41 (21 to 86); MELD = 29 (14 to 
47), having received 98 treatments (one to fi  ve treatments), were included. 
The overall mortality was n = 22 (56%). Since 35 patients have been treated 
for ALF/ACLF, 15 underwent a liver transplantation (OLT) (see Figure 1). The 
90-day mortality of the 20 patients from group 1 without OLT was 44%, 
compared with 76% predicted by the MELD score. MARS was eff  ective 
to decrease the bilirubin levels –35% (of the pretreatment rate which 
was 30 times the baseline), P <0.01, the ammoniemia levels –50% (of the 
pretreatment rate which was four times the baseline), P <0.01, and serum 
creatinine levels –40% (of the pretreatment rate which was two times the 
baseline). The MARS therapy was also eff  ective to improve the pruritus 
after two treatments in the group 2 patients. A single severe complication 
was noticed as hemorrhagic shock quickly resolved in one patient (group 1).
Conclusions MARS therapy improves liver function in patients with both 
acute and chronic liver failure, and allows those patients to wait until OLT, 
if necessary. Furthermore it also improves the 90-day survival of patients 
with ACLF having no OLT indication.
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Introduction  Hospital admission rates attributable to cirrhosis are 
increasing in the UK. The evidence base for the outcome of critically 
ill patients with cirrhosis admitted to intensive care (ICU) is currently 
limited to data from tertiary transplant centres, which report mortality 
rates of between 45 and 74%. We hypothesised that the disease cohort 
experienced in secondary care is less severe than that reported in the 
literature and would subsequently demonstrate lower mortality. We 
report the prevalence, case mix and outcomes of a dual-centre ICU study 
in London, UK.
Methods Data were collected prospectively from two large nontransplant 
general ICUs in London (St George’s and St Thomas’ Hospitals) over 
20  months (November 2007 to June 2009). All ICU admissions were 
screened for cirrhosis. Clinical data were recorded to calculate and evaluate 
several critical illness and disease-specifi  c scoring systems (APACHE II, 
SAPS II, SOFA, Child Pugh (CPS), MELD, UKELD, Glasgow Alcoholic Hepatitis 
Score and the Royal Free Hospital (RFH) score). Study endpoints were ICU 
and hospital mortality.
Results Cirrhosis accounted for 3.3% (137/4,198) of ICU admissions. In 118 
patients meeting inclusion criteria, ICU and hospital mortality rates were 
38% and 47%. Median (IQR) age was 50 (43 to 59) years, 68% were male, 
median length of ICU stay was 4.5 (2 to 10) days and 72% had alcoholic 
cirrhosis. Median CPS was 10 (8 to 11) (45% Grade A/B), MELD 18 (12 to 
24) and APACHE II 16 (13 to 22). Hospital mortality was 24% in CPS grade 
B and 66% in grade C. After multivariate analysis, factors independently 
predictive of mortality were bilirubin, INR, urea, bicarbonate and pO2/
FiO2 ratio. AUROC for the scoring systems ranged from 0.76 (UKELD) to 
0.81 (RFH) for the prediction of mortality. Renal failure (OR 3.4 (1.4 to 8.4)) 
and haemofi  ltration during admission (OR 9.6 (3.7 to 24.8)) had strong 
associations with mortality. Intubation for gastrointestinal bleeding OR 
0.4 (0.1 to 1.3) was associated with a trend towards better outcome than 
intubation for respiratory failure OR 2.7 (1.0 to 7.0).
Conclusions  The mortality rates and disease stage reported here are 
lower than those described in the established literature. Data from 
specialist transplant centres should not be applied to the patient cohorts 
seen in general ICUs. We urge critical care physicians to carefully consider 
the individual clinical case when deciding on ICU admission and not apply 
potentially misrepresentative fi  gures from previous datasets.
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Introduction Acute liver failure (ALF) is a rare disease with a spectrum 
of presentations from mild coagulopathy and altered conscious level to 
multiple organ failure and intracranial hypertension (ICH). A new group, 
Acute Liver Failure studies in Europe (ALSiE), has and wishes to further 
initiate collaboration between centres with clinical expertise in the 
management of ALF. It aims to establish a pan-European database of 
clinical and demographic data in ALF and initiate clinical studies.
Methods We describe the experience of 13 centres in seven countries 
over a 3-month period to 31 March 2009. ALF was defi  ned as an INR >1.5 
and encephalopathy in the absence of chronic liver disease. Results are 
presented as median and IQ range.
Results  Eighty-fi   ve patients were treated, acetaminophen was the 
dominant aetiology in the UK, 60%, and represented 34% in other centres. 
At presentation INR was 3.8 (2.1 to 6.5), hepatic encephalopathy (HE) grade 
I (0 to 2) was observed and 20% required pressors. Grade III/IV coma was 
seen in 64% during their course and of these 25% developed ICH. Seventy-
one per cent required ventilation, 58% renal replacement therapy and 
pressors in 65%. Ninety per cent required management in a critical care 
environment. Overall survival was 75% – 42 cases fulfi  lled poor prognostic 
criteria (PPC), of whom 31 were transplanted, 28 (90%) surviving to hospital 
discharge. Of the 11 remaining, four survived and seven died. Thirty-two 
out of 43 who did not fulfi  ll PPC survived. Patients who died were older 
and had a predominant aetiology of hypoxic hepatitis. One organ support 
or less was associated with 70% survival with medical management alone. 
Two organ support or more was required in 55 patients and 27% survived 
with medical management, the remainder requiring transplantation or 
died.
Conclusions ALF has a high prevalence of progression to multiple organ 
failure requiring a multidisciplinary approach (critical care, transplant 
surgery and hepatology) to achieve optimal outcome. The development 
of ICH is 25% in grade III/IV HE. Despite this, outcomes are good.
Figure 1 (abstract P539). Three-month outcome.
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Introduction Intracranial hypertension (ICH) complicates around 25% of 
grade III/IV encephalopathy in acute liver failure. Intracranial pressure (ICP) 
monitoring is controversial in this coagulopathic population.
Methods  We examined the ITU charts and prospectively maintained 
an ITU database of all patients admitted with acute liver failure who 
underwent ICP monitoring from December 1998 to December 2008. Data 
are presented as median and range.
Results One hundred and fi  fteen patients were identifi  ed. Aetiology was 
acetaminophen (78), seronegative (14), drug induced (7), viral (14) and 
autoimmune (two). All patients had a Camino ICP bolt (subdural) inserted 
by the intensive care specialist. Coagulation support fresh frozen plasma 
(10 ml/kg) and platelets if the count was <100 were given. Recombinant 
factors were not given. Overall 66 survived and 49 died. Seventy patients 
underwent transplantation with 77% survival. Age was 31 (24 to 42), 
International Normalised Ratio (INR) 5.6 (3.9 to 9.2), creatinine 150 μmol/l 
(105 to 143), Na 139 (135 to 143). INR pre insertion of the bolt was 3.5 (2.2 
to 7.3), platelets 109 (51 to 137). At bolt insertion, pulse was 100 (89 to 
111), MAP 80 (72 to 89), ICP 19.5 (12 to 25), CO2 4.8 (4.3 to 5.5), lactate 3.5 
(2.2 to 5.3), jugular venous saturation 76 (67 to 84), temperature 35.5 (34.8 
to 36.4). Norepinephrine dose was 0.12 μg/kg/minute (0.02 to 0.4). ICP fell 
to 14 (9 to 19) at 6 hours and 13 (8 to 20) at 24 hours. Peak ICP was 30 (20 
to 39), number of surges >20 per patient was 2 (0 to 7). Minimum cerebral 
perfusion pressure (CPP) was 45 (38 to 52). The pre-liver-transplant peak 
ICP was 27 (19 to 35), post was 23 (20 to 33). There were no correlates 
between clinical parameters, ICP or CPP at 0, 6, 12 or 24 hours. No diff  erence 
in insertion ICP and CPP was found between groups. Sixteen patients had 
postmortem examination. Cerebral oedema was noted in seven, and in 
two there was evidence of an intracerebral bleed, fronto-parietal region 
(bolt site). Fifteen underwent CT scanning – of whom three had evidence 
of diff  use ischemia, oedema and tentorial herniation. One case had a small 
fronto-parietal bleed (survived). Mode of death was cerebral in 14 cases. 
In those who had a CPP <45 46% survived, whilst in those with a CPP >45 
66% survived.
Conclusions ICP monitoring is a relatively safe procedure in this high-risk 
cohort of patients. Three ICP bolt-related complications were observed, 
two died and one survived. In those who survived there were no clinically 
apparent neurological sequelae. Mortality is increased in those with CPP 
<45 but is not inevitable and should not preclude transplantation and/or 
aggressive medical management.
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Introduction  Following liver transplantation, hepatic artery stenosis 
and portal vein obstruction occur in 3 to 12% of the patients, and more 
frequently in children than adults. Today, the standard of care is Doppler 
ultrasound and liver enzyme assessment daily. Accordingly, detection of 
severe hypoperfusion may be delayed. The aim of the present study was 
to explore whether microdialysis catheters implanted in the left and right 
liver lobe, by measurement of glucose, lactate, pyruvate and glycerol every 
2 hours, detected vascular complications and rejection.
Methods Seventy-three patients undergoing 82 liver transplantations were 
included. Nine of the patients were children. Two microdialysis catheters 
were inserted in the liver and one in subcutaneous tissue by a split needle 
technique. They were kept for as long as the catheters functioned, and 
maximally 4 weeks. Metabolic parameters (glucose, pyruvate, glycerol and 
lactate) were collected every 2 hours and measured bedside.
Results Median age of the patients was 52 years (6 months to 70 years). 
The median time for catheters inserted in the liver was 9.5 days, with a 
range from 0.5 to 26 days. Six patients had hepatic artery stenosis/
occlusion, and in fi  ve of them lactate increased to values >10 mM with 
a lactate/pyruvate ratio of several hundred and a concomitant decrease 
in glucose and increase in glycerol. In one patient (a 6-month-old child) 
lactate only increased to 2 mM and the LP ratio to 20. On the background 
of pathological metabolic values, all patients underwent immediate 
reoperation and blood clots were removed and the artery reanastomosed. 
In the child with low lactate values, the fl  ow of the artery was less than 10% 
of total hepatic blood fl  ow, despite reanastomosis. Thus, the exceptionally 
high portal fl  ow delivered enough oxygen to prevent major ischemia 
despite very low fl  ow in the artery.
Thirteen patients had rejection verifi  ed by biopsy, and in six patients 
anti-rejection therapy was given based on liver function tests and clinical 
judgement. All patients had some increase in lactate during the period of 
rejection, but the increase was in all but four patients only 1 mM. In the 
remaining four the increase was 3 to 4 mM.
Conclusions  By using microdialysis catheters measuring metabolic 
parameters, hepatic artery occlusions can be detected very rapidly. 
Patients with rejection show a small, but signifi  cant, increase in lactate.
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Introduction  Liver dysfunction in critically ill patients represents a 
major concern. Many drugs used in the ICU have been associated 
with hepatotoxicity. Hepatotoxicity presents in three distinct patterns: 
cholestatic (alkaline phosphatase (AP) ≥2 x ULN and ratio (ALT/ULN)/(AP/
ULN) ≤2), hepatocellular (ALT ≥3 x ULN and ratio ≥5) and mixed (AP ≥2 x 
ULN, ALT ≥3 x ULN and ratio between 2 and 5). No published studies have 
assessed the drug-induced cholestastic pattern of hepatotoxicity in the 
ICU. The aim of this study was to assess whether use of pharmacological 
classes previously associated with cholestasis are associated with an 
increased risk of pure or mixed cholestasis in the ICU.
Methods A nested case–control study assessed the potential association 
between use of specifi  ed pharmacological classes and cholestasis. Cases 
were identifi  ed from a cohort of patients admitted ≥24 hours in whom at 
least one value of AP <240 IU/l had been obtained in the 72 hours following 
admission. We excluded patients with an identifi  ed cause of cholestasis as 
well as patients with bone metastasis and pregnant women. Each case the 
subject was matched to a control subject based on age, gender, and length 
of ICU stay and admission year. Exposure to antiepileptics, penicillins, 
cephalosporins, carbapenems, macrolid antibiotics and parenteral 
nutrition was collected and included in a multivariate conditional logistic 
regression analysis with known risk factors.
Results A total of 113 patients developed cholestasis between May 2001 
and March 2009, of which 95 had no identifi  ed cause. We matched 95 
cases with 95 controls and controlled for APACHE II score, sepsis, obesity, 
diabetes, length of stay and prior history of cholestasis. In multivariate 
logistic regression, parenteral nutrition (OR 6.26), sepsis (OR 4.05), and 
penicillins (OR 3.97) were independently associated with cholestasis.
Conclusions Cholestasis in the ICU often remains of unknown origin. In 
our study, sepsis, parenteral nutrition and penicillins were independently 
associated with the development of cholestasis in patients admitted to 
the ICU.
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Diagnosis of acute cholecystitis in septic patients
A Ioakimidou, M Moykas, A Theodotou, A Amygdalou, C Catsenos, K 
Mandragos
Korgialenio-Benakio Red Cross Hospital, Athens, Greece
Critical Care 2010, 14(Suppl 1):P545 (doi: 10.1186/cc8777)
Introduction The aim of this retrospective observational study was to 
evaluate the usefulness of clinical, laboratory and imaging fi  ndings in the 
diagnosis of acute cholecystitis (AC) in septic patients.
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patients had no intra-abdominal pathology on admission. Mean age 
was 59.08 (16.14) years. The most common ICU admission diagnosis 
was trauma (7/12). On admission, mean APACHIE II score was 17.916 
(5.74) and SOFA score was 8.083 (3.369). On the day of diagnosis, SOFA 
score was 13 (4.03). Mean length of stay in the ICU before the diagnosis 
was 32.35 (13.76) days. Diagnosis was based on clinical, laboratory, U/S 
and C/T criteria. Confi  rmation of the diagnosis was performed with an 
operative procedure: open cholecystectomy (n = 8), laparoscopy (n = 2), 
percutaneous cholecystostomy (n = 2).
Results Twelve of 1,248 patients (0.96%) developed clinical, laboratory 
and imaging fi  ndings of AC. The  AC was confi  rmed by an operative 
procedure  in eight out of 12 patients (0.64%), one calculus and seven 
acalculus. The mortality was 62.5%. Necrotic areas of the gallbladder wall 
existed in three patients. Clinical diagnostic fi  ndings were: tenderness in 
the right upper quadrant of the abdomen and positive Murphy in 16.66%; 
temperatures over 38.5°C in 50%; leucocytosis in 58.33%; metabolic 
acidosis in 50%; elevation of ALT in 50% and AST in 66.66%; bilirubin >1.17 
mg/dl in 91.66%; and an increase of  alkaline phosphatase in 100% of 
patients with confi  rmed AC. There was one false negative 8% and three 
false positive 75% and one true negative 25% ultrasonography. The most 
common U/S fi   nding was gallbladder distention (n = 8) 66.66% and 
sludge (n = 8) 66.66%. Respectively, there were two false negative 25% 
and two false positive 50% C/T scans. Two patients underwent diagnostics 
laparoscopies that were true negative.
Conclusions There is not a specifi  c diagnostic test for AC in trauma septic 
patients. Laparoscopy at the bedside in the ICU is an accurate and safe 
diagnostic tool.
Reference
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Introduction To assess the effi   cacy and safety of proton pump inhibitor 
and histamine-2 receptor antagonist in ICU patients for stress ulcer 
prophylaxis.
Methods  Trials were identifi   ed by performing a systematic search 
of MEDLINE, Ebsco and CNKI. Two reviewers assessed the quality of 
studies and extracted data independently. Disagreement was resolved 
by discussion. Revman 4.2.2 software developed by the Cochrane 
collaboration was used for meta-analysis.
Results Four trials involving 771 patients were included. Meta-analyses 
showed that the incidence of clinically important bleeding was 
signifi  cantly lower in the PPI group as compared with H2RA (OR 0.45, 95% 
CI (0.21, 0.9), P = 0.04). The incidence of nosocomial pneumonia (OR 1.03, 
95% CI (0.63, 1.70), P = 0.89) and mortality (OR 1.17, 95% CI (0.76, 1.80), P = 
0.47) had no signifi  cant diff  erence.
Conclusions  In comparison with H2RA, PPI is more eff   ective in the 
prevention of stress ulcer bleeding (SUB) in patients in intensive care. There 
is no signifi  cant diff  erence in the incidence of nosocomial pneumonia and 
mortality between the two groups. Because the randomized controlled 
trials are few and these fi  ndings are based on a small number of patients, 
fi   rm conclusions cannot presently be proposed. More randomized, 
multicenter studies with suffi   cient sample size should be performed.
Reference
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Introduction Energy requirements of critically ill septic shock patients 
treated in the ICU are particularly diffi   cult to determine. Recent research 
shows that energy expenditure (EE) in those patients may be smaller 
than it was previously believed. EE values in this group are aff  ected by 
the severity of the disease process as well as by administered treatment 
(sedation, inactivity of skeletal and respiratory muscles, fi  ghting fever). 
The purpose of this study was to establish the infl  uence of septic shock 
on EE in sedated and mechanically ventilated patients treated in the ICU. 
Using indirect calorimetry, we assessed EE in those patients and compared 
results with basal energy expenditure calculated according to the Harris–
Benedict equation (BEE), and with EE values in patients subjected to 
general anesthesia.
Methods  Two groups of patients were studied with regard to EE 
measured by means of indirect calorimetry. Group I consisted of 50 
critically ill patients treated in the ICU for septic shock. They were 
evaluated using the APACHE II and SOFA scores, taking into account the 
28-day mortality. EE was measured continuously over the fi  rst 24 hours of 
treatment by means of the Datex-Ohmeda M-COVX indirect calorimeter. 
Group II comprised 50 patients (ASA I and II), whose energy expenditure 
was measured under general anesthesia in surgical treatment of disc 
herniation. Energy expenditure measurements were taken with the use of 
the Datex-Ohmeda E-CAiOVX indirect calorimeter, adapted to work in an 
atmosphere containing anesthetic gases.
Results The mean EE value measured with a calorimeter (CEE) in septic 
shock patients (CEE group I) was 1,467 ± 304 kcal/day or 20 ± 4 kcal/kg/
day. Their mean APACHE II score was 30.2, SOFA was 10.8. CEE in group 
I amounted to 67 to 137% of BEE (mean 101% of BEE) and to 121% of 
average CEE in anesthetized patients (CEE group II). Statistical dependence 
between mortality and CEE was demonstrated. CEE in surviving patients 
(APACHE: 26.8, SOFA: 8.1) amounted to 91 to 137% of BEE (mean 114% 
of BEE) and to 139% of average CEE in group II. CEE in deceased patients 
(APACHE: 32.9, SOFA: 13) amounted to 67 to 121% of BEE (mean 94% of 
BEE) and to 111% of average CEE in group II.
Conclusions  A decrease in the total metabolic rate of patients with 
severe sepsis and septic shock can constitute a prognostic indicator of 
heightened death risk in this group of ICU-treated patients.
Figure 1 (abstract P546). PPIs vs H2RAs: bleeding rate.
Figure 2 (abstract P546). PPIs vs H2RAs: rate of nosocomial pneumonia.
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porcine model of acute lung injury
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Introduction  The aim of this study was to evaluate a novel wireless 
motility capsule for gastric emptying in a large animal model of acute 
lung injury.
Methods All experimental procedures were approved by the Laboratory 
Animal Care and Use Committee of the District of Unterfranken, Germany 
and adhere to the NIH guidelines for ethical animal research. In seven 
anesthesized pigs, ventilated with high-frequency oscillation, a pH, 
pressure and temperature sensing capsule (SmartPill™; SmartPill Corp., 
Buff  alo, NY, USA) was positioned with a capsule delivery device (AdvanCE™; 
US Endoscopy, Mentor, OH, USA) into the stomach. The capsule data were 
transmitted to a recorder attached to the abdomen. Gastric emptying 
of the capsule can be calculated by measuring the time required for the 
pH to the change from the acidic stomach to the alkaline duodenum as 
well as a change in pressure patterns. The location of the capsule was 
confi  rmed by autopsy after the animals had died due to the ARDS.
Results  In total 8,640 datasets were obtained. The capsule pressure 
recordings ranged from 2 to 4 mmHg (2.6 ± 0.5 mmHg (mean ± SD)) and 
pH ranged from 2.3 to 5.6 (3.7 ± 1.6 (mean ± SD)). There was no change 
in pressure patterns or pH recordings greater than 6 during 24 hours. 
All animals had a gastroparesis with bloated stomach. All capsules were 
located in the stomach as indicated by the pressure and pH data and 
confi  rmed by autopsy.
Conclusions The preliminary data show that motility capsule technology 
has considerable potential for evaluating real-time gastric emptying.
P549
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Introduction This study will look at the validation of a novel method 
combining measurement of gastric residual volume (GRV) and estimation 
of intra-abdominal pressure (IAP) via intragastric pressure (IGP).
Methods In total 88 paired IAP and GRV measurements were performed 
in the HOB position in 23 mechanically ventilated ICU patients. The IAP was 
estimated by the height of the urine column via the bladder (that is, IBP) 
using the FoleyManometer (Holtech Medical, Charlottenlund, Denmark) 
and via the stomach (that is, IGP) with the new device (Gastro PV; Holtech 
Medical). The GRV was measured with the new device (GRVprototype) and 
via the classic method (GRVclassic). The male-to-female ratio was 2:1, age 
62.3 ± 18.8 (range 22 to 86), BMI 25.3 ± 6.2 (16.6 to 40.4), APACHE II score 
21.3 ± 4.1 (13 to 30), SAPS II score 50.7 ± 13.2 (17 to 83), and SOFA score 
10.1 ± 2.8 (6 to 17). The number of measurements in each patient was four 
(except one patient with fi  ve, one patient with one and one patient with 
two measurements). Statistical analysis was done with SPSS-13 software, 
values are expressed as mean ± SD or median (and range).
Results  The mean IBP was 11.3 ± 4 and mean IGP was 11.7 ± 3.9. 
Correlation between the IBP and IGP was signifi  cant but moderate (R2 = 
0.37). Analysis according to Bland and Altman showed a bias and precision 
of 0.5 and 3 mmHg, respectively; however, the limits of agreement were 
large and ranged from –5.4 to 6.4 mmHg. The median GRVprototype was 
100 ml (0 to 1,050) and median GRVclassic was also 100 ml (0 to 1,250). 
Correlation between the two methods was excellent (R2 = 0.89). Analysis 
according to Bland and Altman showed a bias and precision of –1.3 and 
59.2 ml, respectively, and the limits of agreement ranged from –117 to 114 
mmHg. The median drainage time and return times were 3.1 minutes (0.5 
to 15) and 2 minutes (0 to 21) for GRVprototype compared with 2 minutes 
(0.1 to 9) and 1 minute (0 to 8) for GRVclassic.
Conclusions  The preliminary results of an ongoing multicentre pilot 
study show that the gastro PV is a good alternative to the standard 
method for measuring GRV. Because the nurse can perform other tasks 
during drainage and return of the GRV, and the fact that the system 
remains closed during measurement, this could be a major step forward 
in standardisation of GRV measurement. Furthermore it allows screening 
for intra-abdominal hypertension via IGP estimation.
Acknowledgements The gastro PV devices were provided by Holtech 
Medical, free of charge.
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Introduction  Achieving nutritional targets by means of enteral 
nutrition in critically ill (ICU) patients has been shown to be diffi   cult and 
unpredictable. In this regard, the amount of enteral formula lost in gastric 
residual volume (GRV) remains unknown. In previous studies performed 
in a non-ICU population, bedside monitoring of the specifi  c gravity (or 
relative density) of GRV with a refractometer (expressed as Brix value) 
has been shown to be an accurate tool to measure the concentration of 
enteral nutrition (% EF) in GRV [1,2]. The aim of this study is to evaluate the 
use of the Brix value in monitoring the concentration of enteral feeding in 
GRV of patients in the ICU.
Methods The specifi  c gravity, pH and clinical aspect of GRV in fasting 
ICU patients were examined. The Brix value of gastric fl  uid from fasting 
critically ill patients was measured with a refractometer. One observer 
measured the Brix value of each sample in duplo. A third measurement 
was performed by an independent observer. The enteral nutrition was 
diluted in GRV in vitro to establish the relation between measured Brix 
value and % EF by linear regression analysis. Factors infl   uencing the 
measured Brix value were analyzed in a linear regression analysis.
Results The mean ± SD Brix value for GRV of 51 fasting ICU patients was 
2.9 ± 1.1 (ranging from 0.0 to 6.0). The inter-observer and intra-observer 
variabilities were 8.4 and 3.2%. The relation between Brix value and % EF 
was signifi  cantly aff  ected by gastric fl  uid pH before mixing with nutrition. 
Analyzing all measurements with simple linear regression revealed the 
following linear relation (P <0.0001): % EF = (Brix value – 2.368/0.185).
Conclusions The hand-held refractometer is a good tool for monitoring 
the overall nutritional effi   cacy in an enteral nutrition strategy measuring 
and discarding GRV. The linear relation between % EF in GRV and 
measured Brix value described in earlier non-ICU studies was confi  rmed in 
ICU patients. However, the large baseline Brix variation in ICU patients and 
unpredictable impact of the pH of GRV makes the Brix value less suitable 
for the management of nutrition in individual patients.
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Introduction Gastric emptying is often delayed in major trauma patients. 
These patients are at risk of regurgitation and aspiration during rapid 
sequence induction or during coma. We hypothesized that an early naso-
gastric tube (NGT) would reduce the gastric residuals. We also checked 
whether gastric volume at admission was associated with aspiration 
pneumonia.
Methods Data from consecutive trauma patients that underwent a full 
body CT scan from January 2006 to August 2009 were retrospectively 
analyzed. Gastric gas, liquid/solid and total volume were measured using 
3D contouring on the CT scan performed at admission. Secondarily 
referred trauma patients and patients hospitalized for less than 24 hours 
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were extracted from the hospital’s database; patients who died during the 
fi  rst 48 hours were then excluded. Patients staying for 2 days or longer in 
the ICU were divided into two groups (with or without NGT) and analyzed 
separately.
Results One hundred and fi  fty-six patients were analyzed. CT scan showed 
a NGT in 30 patients (one malposition in the medium esophagus). Gastric 
gas, liquid/solid and total volume were not diff  erent in patients with and 
without NGT (Z test; gas: 54 ± 147 vs 95 ± 168 ml, P = 0.179; liquid/solid: 
226 ± 282 vs 199 ± 237, P = 0.626; Total: 280 ± 311 vs 295 ± 320, P = 0.824). 
Twenty out of 153 patients developed a pneumonia in the fi  rst 7 days, 
fi  ve of which with NGT and 15 without (chi-squared, P = 0.459). There was 
no diff  erence in gastric residuals between these patients and the 133 
others (Mann–Whitney; Q1-median-Q3; Gas: 11-25-126 vs 14-43-90 ml, 
P = 1; liquid/solid: 16-63-432 vs 22-115-290 ml, P = 0.799; Total: 29-252-
661 vs 68-186-371 ml, P = 0.873). Seventy-three patients were admitted 
to the ICU, of which 23 had a NGT and 20 developed pneumonia. There 
was no diff  erence between gastric residuals of the 23 who had a NGT and 
the 50 others. A pneumonia developed in the fi  rst 3 days in 1/23 patients 
with NGT vs 9/50 without NGT (chi-squared–Yates, P = 0.226); in the fi  rst 
7 days in 5/23 patients with NGT vs 15/50 without NGT (chi-squared, P = 
0.462). There was no diff  erence in gastric residuals between patients who 
developed early pneumonia (at 3 and 7 fi  rst days) and those who did not. 
There was no diff  erence in ICU length of stay (10.8 vs 12.7 days, P = 0.825) 
and onset time of pneumonia (4.2 vs 3.3 days, P = 0.234).
Conclusions Our results suggest that gastric volume is high at admission 
of trauma patients, irrespective of NGT presence. In this study, pneumonia 
incidence was related neither with high gastric volume, nor with NGT 
usage.
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Introduction  McWhirter and Pennington stated in 1994 that 40% of 
patients are malnourished on admission to hospital [1]. Malnutrition 
increases morbidity and mortality in the ICU. Early feeding improves 
outcome, length of stay and septic complications.
Methods We aimed to assess the standard of nutritional practice, and 
measure caloric achievement and caloric debt in the fi   rst 7 days of 
admission of critically ill patients. The European Society of Parenteral and 
Enteral Nutrition guidelines on enteral nutrition are set as the standard 
[2]. Between April and August 2009, all adult patients not fed orally within 
3 days of admission to the ICU were included. The caloric target was 
25 kcal/kg/day. All impediments to achievement of feeding targets were 
recorded.
Results Among 30 patients (16 surgical and 14 medical), 11 patients were 
fed early within 24 hours of admission, 19 patients were fed 24 hours after 
admission. Twenty-three patients were fed by nasogastric tube, three 
patients received small bowel feeding. Parenteral nutrition (PN) was used 
alone in two patients and as a supplement to enteral nutrition (EN) in one 
patient.
Conclusions Mean caloric achievement by day 7 was only 58.4% (Figure 1), 
well below target. The following recommendations have now been made 
to improve the nutritional practice. A higher threshold for residual gastric 
volumes has been adopted, an earlier aggressive use of prokinetic agents 
is recommended, strategies to access small bowel feeding earlier and PN is 
now considered within 24 hours if EN is contraindicated or as supplement 
to EN if the caloric target is not reached after 48 hours.
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Introduction  Nutritional screening and nutritional support have an 
important role to prevent malnutrition, which aff  ects the prognosis and 
increases the morbidity and mortality of patients. We aimed to assess the 
patients who are consulted and followed by the nutritional support team 
during a 2-year period retrospectively.
Methods  Demographic characteristics, subjective global assessment 
scores (SGA) of patients’ type, route, duration of nutritional support and 
complications were assessed.
Results A total of 379 patients were consulted during the 2-year period. 
Two hundred and two of them (53.3%) were male and 177 (46.7%) were 
female and the mean value of ages was 63.5 ± 17.9 years (7 to 96 years, 
minimum to maximum). SGA scores were A in 35.1% (n = 133), B in 26.6% 
(n = 101), and C in 38.3% (n = 145). In 31.9% (n = 121) of the patients 
combined parenteral and enteral, in 29.6% (n = 112) only parenteral, in 
25.6% (n = 97) only enteral and in 12.9% (n = 49) oral nutritional support 
were administered. Combined parenteral and enteral nutritional support 
was applied via nasogastric tube and peripheral parenteral in 54.5% 
(n = 66), nasogastric tube and santral parenteral in 29.8% (n = 36), oral 
and santral in 5.8% (n = 7), oral and peripheral parenteral in 6.6% (n = 8), 
nasojejunal and peripheral parenteral in 1.7% (n = 2) and gastrostomy and 
peripheral parenteral in 21.7% (n = 2). Parenteral nutritional support was 
applied via peripheral route in 62.5% (n = 70) and santral route in 37.5% 
(n = 42). Enteral nutrition was commonly applied by nasogastric tube in 
87.6% (n = 85) and gastrostomy tube in 10.3% (n = 10). Nutritional support 
was applied during 18.2 ± 23.7 days (1 to 306 days). The most common 
complications were constipation (7.4%), nasogastric tube displacement 
or obstruction (5.2%), diarrhea (2.6%), thrombophlebitis (3.4%), aspiration 
(1.8%) and hyperglycemia (1.6%).
Conclusions Nutritional screening should be a component of physical 
examination in hospital and outpatients.
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Introduction Nutrition plays a signifi  cant part in the overall treatment 
plan for critically ill patients. In India, there are varying practices including 
use of kitchen feeds and/or commercial formula and also predominant 
use of bolus feeds. The multidisciplinary team in our critical care unit 
(CCU) includes a senior dietician and we wanted to review whether 
our standardized practice of routine screening for malnutrition using 
subjective global assessment, early use of nutrition (preferably within 
24  hours) and continuous enteral feeding using commercial formula 
helped achieve nutritional goals.
Methods A retrospective chart review was conducted on 508 patients 
who received continuous enteral feeding on day 1 and day 5 of the 
ICU stay. Information on calories prescribed (using the Harris–Benedict 
equation) and delivered on day 1 and day 5 was collected. Achieving the 
nutritional goal was defi  ned as successful delivery of 90% of prescribed 
Figure 1 (abstract P552). x axis: day since admission. y axis: percentage 
caloric target achieved.
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methods.
Results On day 1, 37.6% of patients achieved delivery of caloric goals, and 
on day 5, this increased to 67.3%. Fluid restriction was the single most 
common reason for not meeting caloric goals both on days 1 and 5.
Conclusions Despite the availability of a clinical dietician and standardized 
nutritional practice, compliance of achieving caloric goals is low. 
Commercial formulas with a maximum of 2 kcal/ml are available in India, 
unlike the West where more calorie-dense formulas (up to 4.5 to 5 kcal/
ml) are available. Availability of these higher calorie dense commercial 
formulas may help increase our rates of achieving nutritional goals as fl  uid 
restriction appears to be the single most common limiting factor.
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Introduction  The objective of this study was to evaluate the eff  ect of 
increasing enteral nutrition (EN) adequacy on acquired infection in the ICU.
Methods Prospective, multicenter, observational study in three medical/
surgical ICUs. We enrolled consecutive patients within 24 hours of 
admission to the ICU who were expected to stay for more than 24 hours. 
For this analysis, we excluded patients who were not mechanically 
ventilated in the ICU for more than 72 hours and who received parenteral 
nutrition. No interventions. Charts were reviewed to determine nutritional 
adequacy and clinical outcomes. Suspected infections were adjudicated 
by two or more clinicians to determine the presence or absence of 
infection (rated as either probable or possible infection).
Results A total of 598 patients were enrolled in the overall study; 206 were 
included in this analysis. The average patient age was 62.2 years; APACHE II 
score was 23.3; BMI 28.6; and 73% were medical. Overall, patients received 
48.8% (range 0 to 120%) of their energy and 45.0% (range 0 to 120%) of their 
protein requirements from EN. On average, patients remained ventilated 
for 9.1 days (interquartile range (IQR) 6 to 11), in the ICU for 13.5 days (IQR, 7 
to 14) and 25.2% and 21.8% developed an infection after 72 and 96 hours, 
respectively. Overall 28-day mortality was 29.1%. In the overall analysis, 
greater amounts of energy and protein were consistently associated with a 
reduction in infection but only achieved levels near statistical signifi  cance 
when considering the incremental eff  ect of 1,000 kcal/day and 30 g/day 
on patients with at least one probable infection after >96 hours (odds 
ratio (OR) 0.32, 95% confi  dence interval (CI), 0.10 to 1.03, P = 0.055 and OR 
0.41, 95% CI 0.19 to 0.89, P = 0.024 for energy and protein, respectively). In 
all cases, the OR was lower when considering infections that developed 
after 96 hours compared with infections that developed after 72 hours 
and when considering probable infections compared with all infections. 
There was a trend towards a reduction in pneumonia that developed after 
96 hours with increasing amounts of energy (OR 0.40, 95% CI 0.10 to 1.53, 
P = 0.18) and protein (OR 0.42, 95% CI 0.16 to 1.09, P = 0.076).
Conclusions Increased EN adequacy was associated with a reduction in 
infectious complication, particularly after 96 hours of ICU admission.
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Introduction This study aimed to determine the value of early enteral 
nutrition up to goal on the prognosis of the patients with diff  erent severity 
of illness in the ICU.
Methods A total of 192 critically ill patients who met the criteria for 
enrollment were included in this study during the past 18 months in our 
ICU. They were divided by grade as the severity of illness according to 
APACHE II scores. Retrospective analysis on early enteral nutrition checked 
whether the third day of enteral nutrition supply has reached the 60% 
nutrition goal (25 kcal/kg/day). So the patients were divided into two 
groups: up to goal and not up to goal. According to APACHE II scores, 
the patients were divided into three sub-groups with score inferior to 15, 
between 15 and 25 and superior to 25.
Results When the scores of APACHE II were between 15 and 25, the LOS 
in the ICU (t = 3.966, P = 0.000), in hospital (t = 8.165, P = 0.000), the cost of 
medical care (t = 4.812, P = 0.000) and the mortality (t = 5.421, P = 0.038) 
were all signifi  cantly lower in patients with EEN up to goal. See Table 1.
Conclusions The EEN up to goal can signifi  cantly increase the survival rate 
of critically ill patients, shorten the LOS in hospital and reduce the cost of 
medical care, when the patients have APACHE II scores between 15 and 
25. The clinical value of EEN up to goal varies depending on the severity 
of illness.
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Introduction  Early enteral nutrition (EN) is the preferred strategy for 
feeding the critically ill; however, it is not always possible to achieve 
suffi   cient calories and protein with EN alone. The use of supplemental 
parenteral nutrition (PN) has been advocated as a strategy to avoid 
complications associated with protein/calorie defi   cit from inadequate 
enteral feeding. The purpose of this study was to evaluate the eff  ect of this 
practice on nutritional and clinical outcomes.
Methods An international, observational study conducted in 2007 and 
again in 2008 examined nutrition practices in ICUs. Eligible patients were 
the mechanically ventilated who remained in the ICU for >72 hours and 
received early EN within 48 hours from admission. Data were collected 
on patient characteristics and daily nutrition practices for up to 12 
days. Patient outcomes were recorded after 60 days. We compared the 
outcomes of patients who received early EN alone, early EN + early PN, and 
early EN + late PN (after 48 hours of admission). Regression analyses were 
conducted to determine the eff  ect of increasing age, APACHE score, days 
in hospital prior to ICU admission, gastrointestinal dysfunction, nutritional 
strategy, and other baseline variables and their relationship to being alive 
and discharged within 60 days.
Table 1 (abstract P556). Comparison of patients with APACHE II scores 15 to 25 in the two groups
Group  n  APACHE II scores  LOS ICU (days)  LOS hospital (days)  Treatment cost (¥10,000)  Mortality (%)
Up to nutrition goal  28  17.58 ± 3.02  7.50 ± 3.94  8.42 ± 3.45  4.20 ± 3.49  0
Not up to nutrition goal  54  19.96 ± 2.97  13.11 ± 9.80*  28.63 ± 16.44*  9.42 ± 5.67*  14.8
*P <0.05.
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S186Results A total of 2,920 patients from 260 ICUs were eligible for this study; 
2,562 (87.7%) in the Early EN group, 188 (6.4%) in the Early PN group, and 
170 (5.8%) in the Late PN group. Adequacy of calories and protein was 
highest in the Early PN group (81.2% and 80.1%, respectively) and lowest 
in the Early EN group (63.4% and 59.3%) (P <0.0001). The 60-day mortality 
rate was 27.8% in the Early EN group, 34.6% in the Early PN group, and 
35.3% in the Late PN group (P = 0.02). In a single predictor model, the 
proportion of patients discharged alive from hospital at 60 days was lower 
in the group that received Early PN (hazard ratio (HR) 0.75, 95% confi  dence 
interval (CI) 0.59 to 0.96) and Late PN (HR = 0.64, 95% CI 0.51 to 0.81) (P = 
0.0003) compared with Early EN. These fi  ndings persisted after adjusting 
for known confounders. In subgroup analyses, we could not demonstrate 
any benefi  t to supplemental PN in patients with BMI <20.
Conclusions  The supplemental use of PN may improve provision of 
calories and protein but is not associated with any clinical benefi  t.
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Introduction Diarrhea commonly occurs in surgical critically ill septic 
patients who received broad-spectrum antibiotics. Some reports 
demonstrated that a fi  ber diet with prebiotic properties could decrease 
the risk of diarrhea in nonseptic patients. However, most reports excluded 
septic patients who received broad-spectrum antibiotics. The objective of 
this study was to compare risk of diarrhea and diarrhea score between 
fi  ber and nonfi  ber diets in surgical septic patients who received broad-
spectrum antibiotics.
Methods We conducted a prospective, randomized control, double-blind 
study on a general surgical ICU in a university hospital. The patients who 
received broad-spectrum antibiotics and no contraindication to enteral 
feeding were enrolled into two arms after informed consent. Allocation to 
intervention was randomized individually to receive fi  ber diet or nonfi  ber 
diet up to 14 days. Demographic data, disease severity, nutritional delivery 
and diarrhea score were recorded each day. Intention-to-treat analysis was 
performed after completed study.
Results Thirty-four patients were enrolled in the study (17 patients each 
in the fi  ber group and the nonfi  ber group). These two patient groups 
were similar in demographics, disease severity, nutritional status, cause 
of sepsis and total feeding per day. Although the proportion of patients 
who confronted with diarrhea score >15 was higher in the nonfi  ber 
group than the fi  ber group, these did not show statistical diff  erence 
signifi  cantly (8/17 patients (47.06%) vs 4/17 patients (23.53%); P = 0.15). 
However; the group of the fi  ber diet had a lower mean diarrhea score 
(fi  ber vs nonfi  ber = 3.6 ± 2.3 vs 6.3 ± 3.6; P = 0.005) and the generalized 
estimation equation model for repeated measurement (GEE) revealed a 
lower global diarrhea score in the fi  ber group than the nonfi  ber group 
about 3.03 (coeffi   cient –3.03 (95% CI = –5.03 to –0.92); P = 0.005). Cox 
proportional hazard ratio of fi  ber group was 0.45 (95% CI = 0.13 to 1.49; 
P = 0.19) but no statistical diff  erence.
Conclusions Enteral nutrition with a fi  ber diet formula could reduce the 
diarrhea score in surgical critically ill septic patients who received broad-
spectrum antibiotics.
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Introduction Radiation therapy in cancer patients causes hematologic 
abnormalities mainly attributed to an increased infl   ammatory state 
induced by radiation toxicity that are observed to be modulated by 
immunonutrition [1-3]. The objective of this study was to determine the 
eff  ect of oral supplementation with immunonutrients on cancer patients 
undergoing radiation therapy on the following hematologic indices: 
hemoglobin, total WBC, neutrophil, lymphocyte, and platelet counts.
Methods  Cancer patients on radiotherapy from 2007 to 2009 were 
randomly assigned to a study group (n = 24), which received standard 
diet plus oral supplementation with an immunonutrition regimen 
(= 200 ml drink given twice per day providing 600 kcal, 40 g protein, 
eicosapentanoic acid = 2 g, antioxidants (Vit A = 600 μg, Vit C = 75.2 mg, 
Vit E = 15 mg, B-carotene = 1,500 μg)), and a control group (n = 32), which 
only had standard diet. The hematologic data – hemoglobin, total WBC 
count, neutrophil count, lymphocyte count, and platelet count – were 
taken before and after completion of the prescribed radiation dose. The 
results were analyzed using either paired or independent-samples t test.
Results In the study group the blood indices were higher compared 
with the control group at the end of radiation therapy: hemoglobin in 
gm% (12.8 >11.8, P = 0.002), total WBC (7,276 >4,877, P = 0.0005), and 
neutrophil count (5,363 >3,315, P = 0.0007). There were no diff  erences in 
the lymphocyte and platelet counts. The WBC change in the study group 
followed a decreasing pattern (–162.5) while in the control group it was 
an increasing pattern (+1,657). This indicated lesser infl  ammation in the 
study group while there was higher infl  ammation in the control group 
(P = 0.004).
Conclusions  Oral supplementation with immunonutrients in cancer 
patients undergoing radiation therapy resulted in lesser hematologic toxic 
changes in hemoglobin, total WBC, and neutrophil count.
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Introduction The use of a multichamber bag (MCB) as a way to deliver 
parenteral nutrition to critically ill patients has been associated by 
retrospective analysis with several benefi  ts including lower bloodstream 
infection rates, and lower ICU stay [1]. This study aims to evaluate the 
eff   ects of a MCT TPN system (considered a closed system) versus a 
conventional compounding system (COM, considered an open system) 
regardless of the type of lipid emulsion used.
Methods Serum samples were collected in a prospective multicenter 
open label study (NCT#00798681) from 100 critical care patients receiving 
TPN with an olive oil-based lipid emulsion using either a premixed MCB 
and ready-to-use system (n = 50, OliClinomel; Baxter) or COM made 
either with an olive oil-based lipid emulsion (ClinOleic; Baxter) or with 
a LCT/MCT-based lipid emulsion (COM ClinOleic n = 25, COM LCT/MCT 
n = 25, total COM group n = 50). All samples were collected at baseline, 
day 4 and day 7 (three samples per time point). Changes in the levels 
of infl  ammatory markers from baseline to day 7 were compared using 
analysis of covariance and P <0.05 was considered statistically signifi  cant.
Results At baseline, demographic characteristics of the patients were 
balanced between the groups. Regardless of the type of lipid used, 
critically ill patients receiving TPN using a MCB system presented at day 
4 lower levels of: TNFα (3.4 vs 8.2 pg/ml), IL-6 (50.4 vs 62.0 pg/ml), IL-8 
(56.4 vs 93.7 pg/ml), procalcitonin (PCT) (2.7 vs 7.6 ng/ml), lymphocyte 
externalization of phosphatidylserine (5.2 vs 9.6%), and resistin (9.1 vs 12.3 
ng/ml) (all MCB vs COM and P <0.05). Statistically signifi  cant diff  erences 
were maintained throughout day 7. No diff  erences were observed for the 
levels of C-reactive protein and IL-10.
Conclusions The administration of TPN using a MCB system led to a 
signifi  cant reduction in the infl  ammatory response when compared with 
COM, regardless of the type of lipid used. Particularly relevant are the 
diff  erences in terms of PCT as an early marker of sepsis since COM TPN was 
associated in previous studies with higher bloodstream infection rates [1].
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Introduction Patients with sepsis are at high risk of developing sepsis-
associated delirium (SAD), which is associated with increased mortality 
and may be an important risk factor for the development of long-term 
cognitive dysfunction. Mechanisms leading to SAD are unclear, therapy 
and prophylaxis unsatisfactory. Infl  ammation and its eff  ects on the brain 
may play an important role. We hypothesized that n-3 fatty acids will have 
a benefi  cial eff  ect on systemic infl  ammation and hence cerebral markers 
in sepsis.
Methods Randomized single-blind design. Patients >18 years admitted 
for treatment of sepsis. Exclusion criteria were thrombocytopenia, brain 
injury or tumors, intracranial infection and history of stroke. Patients 
received treatment according to the Surviving Sepsis Campaign and 
were randomly allocated to a group with or without daily supplemental 
intravenous n-3 fatty acids (Omegaven™; Fresenius Kabi, 2 ml/kg/day). 
Daily screening for SAD was performed. CRP, IL-6, IL-8, S-100β, and neuron-
specifi  c enolase (NSE) were monitored on days 1, 2, 3, and 7. The primary 
endpoint was the area under the curve of the S-100β time course.
Results  Eighteen patients were included. SAPS II scores and baseline 
values for CRP, IL-6, IL-8, NSE and S-100β for patients with and without 
supplemental n-3 fatty acids were 51 ± 14 vs 57 ± 22, 241 ± 65 vs 218 ± 
106 mg/l, 2,054 ± 2,822 vs 734 ± 1,467 pg/ml, 312 ± 503 vs 90 ± 96 pg/ml, 
25 ± 7 vs 21 ± 8 μg/ml, and 0.57 ± 0.90 vs 0.24 ± 0.24 μg/ml, respectively. 
In agreement with earlier data, patients with SAD had higher values for 
S-100β (P = 0.019) [1]. AUC for S-100β was 2.73 ± 2.89 vs 0.95 ± 0.74 (P = 
0.14) for patients receiving supplemental n-3 fatty acids and controls, 
respectively. While none of the diff  erences reached signifi  cance, IL-6 and 
IL-8 declined more rapidly in the n-3 fatty acid-treated group whereas 
cerebral markers showed an opposite trend. The number of patients with 
SAD and the duration of SAD were not diff  erent in both groups.
Conclusions  Interpretation of the results is hampered by unevenly 
distributed baseline characteristics and more patients need to be 
investigated. In this small sample no benefi  cial eff  ect of n-3 fatty acids on 
cerebral markers was found.
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Introduction Olive oil-based lipid emulsions have been used for more 
than a decade to reduce the polyunsaturated fatty acid (PUFA) content in 
TPN, thus preventing the deleterious eff  ects associated with PUFA excess. 
MCT/LCT-based lipid emulsions were recently associated with deleterious 
eff   ects such as lipotoxicity, activation of infl   ammatory cascade and 
increased risk of cardiovascular disease [1]. This study aims to compare the 
eff  ects of these two lipid emulsions upon several infl  ammatory markers in 
critically ill patients using TPN.
Methods Serum samples were collected in a prospective multicenter and 
open-label study (NCT#00798681) from 100 critical care patients receiving 
TPN with an olive oil-based lipid emulsion using either a premixed ready-
to-use system (G1, n = 50, OliClinomel; Baxter) or a compounded system 
(G2, n = 25, ClinOleic; Baxter), and the results were compared with those 
from patients receiving a compounded TPN made with an LCT/MCT 
lipid emulsion (G3, n = 25). All samples were collected at baseline, day 
4 and day 7 (three samples in each time point). Changes in the levels 
of infl  ammatory markers from baseline to day 7 were compared using 
analysis of covariance and P <0.05 was considered statistically signifi  cant.
Results At baseline, demographic characteristics of the patients were 
balanced between the groups. Regardless of the delivery system used, 
patients receiving TPN with an olive oil-based lipid emulsion presented 
at day 4 lower levels of: IL-8 (54.4 vs 67.8 vs 120.7 pg/ml), TNFα (3.4 vs 3.5 
vs 13.0 pg/ml), lymphocyte phosphatidylserine externalization (PS) (5.2 vs 
4.8 vs 14.7%), and resistin (R) (9.1 vs 9.2 vs 15.4 ng/ml) (all G1 vs G2 vs G3 
and P <0.05). No diff  erences were observed in the levels of IL-10 and CRP. 
Statistically signifi  cant diff  erences were maintained throughout day 7 for 
IL-8, TNFα, PS and R.
Conclusions  The administration of an olive oil-based lipid emulsion 
within the TPN regimen led to a signifi  cant reduction in the infl  ammatory 
response when compared with a LCT/MCT-based lipid emulsion. 
Particularly relevant are the diff  erences for resistin (an indicator of insulin 
resistance) and PS (an indicator of apoptosis).
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Introduction  Liver function disturbances have been of concern in 
parenteral nutrition. The aim of the post hoc analyses of two pooled 
studies was to compare liver function parameters using fi  sh-oil-containing 
vs soybean oil lipid emulsions.
Methods  Two prospective, controlled, randomized, parallel-group, 
double-blind, multicenter studies compared SMOFlipid 20%, a fi   sh-
oil-containing lipid emulsion (SMOF: soybean oil 60 g, medium-chain 
triglycerides 60 g, olive oil 50 g, fi  sh oil 30 g per l), vs standard soybean 
oil emulsion (SO, 200 g soybean oil/l). The studies were as follows: 
A: postsurgical adult patients, 5 days total parenteral nutrition, 100 SMOF 
vs 103 SO patients; B: adult patients receiving parenteral nutrition for 28 
days, 22 SMOF vs 32 SO patients. Patients with data at baseline and study 
end were selected. The data were pooled and diff  erences of laboratory 
data at 1 week minus baseline and study end minus baseline were 
calculated. Analyses of variance were applied using diff  erences between 
1 week/study end values and baseline values of bilirubin (BIL), AST and 
ALT as dependent variables and treatment group as independent variable. 
Covariates used: baseline values for BIL, AST, ALT and mean daily dose of 
fat per kg body weight.
Results Baseline values were not signifi  cantly diff  erent between the two 
treatment groups. The mean daily intake of fat/kg bw after 1 week and 
study end was the same between both treatment groups. One-week – 
baseline values of liver parameters (mean; SMOF group: BIL –5.1* μmol/l, 
AST –5.4** U/l, ALT 0.6*** U/l; SO group: BIL –2.0* μmol/l, AST 0.6** U/l, 
ALT 11.1*** U/l) were signifi  cantly diff  erent between treatment groups (P: 
0.035*, 0.001**, 0.001***). Extending the analysis until 28 days did not alter 
the results.
Conclusions Infusion of SMOFlipid 20% compared with a soybean oil 
standard lipid emulsion exerts a signifi   cant decrease in the values of 
BIL and AST. It also signifi  cantly attenuates the rise seen in ALT. These 
results indicate that SMOFlipid 20% is promising in preventing parenteral 
nutrition-induced liver disturbances.
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Introduction  We supposed the diagnostic signifi   cance of the ratio 
between proinfl   ammatory and anti-infl   ammatory cytokines in the 
peritoneal cavity and system blood fl  ow in patients with abdominal sepsis. 
So we tried to correct such disbalance with glutamine intravenous and 
enteral supplementation.
Methods  Prospective controlled randomized investigation of the 
patients with abdominal sepsis (excluding pancreatitis). Group 1 (n = 16): 
standard therapy. Group 2 (n = 11): with intravenous infusion of glutamine 
(Dipeptiven; Fresenius Kabi, Germany). Group 3 (n = 11): with intravenous 
infusion of glutamine and enteral supplementation of glutamine 
(Intestamine; Fresenius Kabi). The patients in groups were identical 
according to the severity of disease (APACHE II), the standard of intensive 
care, the volume of surgery care. We investigated the proinfl  ammatory 
cytokines: TNFα, IL-1, IL-6, IL-8; and anti-infl  ammatory cytokines: soluble 
sTNF-RI and sTNF-RII, antagonist receptor IL-1, IL-10 in blood serum and in 
the peritoneal cavity during the initial 3 days of intensive care (ELISA; BD 
Biosciences Pharmingen, San Diego, CA, USA; EASIAs; Biosource, Nivelles, 
Belgium).
Results The probability of survival on day 28 was 73% in the standard 
therapy group, in the group with glutamine intravenous – 78%, in the 
group with glutamine intravenous and enteral – 84%. We did not fi  x the 
decrease of the duration of respiratory support in all of the groups. The 
duration of acute intestinal injury was signifi  cantly diff  erent (standard 
group 49 hours vs 38 hours in group with glutamine intravenous 
supplementation – 35 hours in group with intravenous and enteral 
glutamine supplementation). We investigated the prevalence of the 
concentration of proinfl  ammatory cytokines in the peritoneal cavity and 
in blood serum according to the molar coeffi   cient in the control group. 
The molar coeffi   cient had a positive correlation with the SOFA scale. In 
group 2 (glutamine intravenous) the molar coeffi   cients were decreased 
to the prevalence of anti-infl  ammatory cytokines (in serum on day 3, 
in peritoneal on day 2). In group 3 (glutamine intravenous and enteral) 
we investigated the signifi  cance diff  erence and decrease of all cytokine 
levels in blood serum and in the peritoneal cavity.
Conclusions  Intravenous and enteral supplementation of glutamine 
improved the cytokine balance in blood and the peritoneal 
compartment.
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Introduction Targeting glycemia to age-adjusted normal fasting blood 
glucose levels with intensive insulin therapy (IIT) improved short-term 
outcome of critically ill children as compared with conventional insulin 
therapy (CIT), but concomitantly increased the incidence of hypoglycemia 
[1]. Both hyperglycemia and hypoglycemia may adversely aff  ect  the 
developing brain of young children. We therefore studied the impact of 
targeting normoglycemia with IIT on circulating markers of brain injury in 
these patients.
Methods This was a pre-planned analysis of all 700 pediatric critically 
ill patients included in a prospective, randomized, controlled study on 
IIT [1]. Patients were randomly assigned to the target of normal for age 
fasting blood glucose levels (2.8 to 4.4 mmol/l for age <1 year and 3.9 to 
5.6 mmol/l for age ≥1 year) with insulin infusion throughout the ICU stay 
(IIT), or to insulin infusion only to prevent excessive hyperglycemia (CIT). 
Serum S100B and neuron-specifi  c enolase (NSE), markers of astrocytic and 
neuronal damage, were measured by ELISA on fi  xed days (n = 700) and 
before and after hypoglycemia in a nested case–control design (n = 126).
Results Patients admitted to the ICU after cardiac surgery had higher 
admission S100B and NSE levels than patients in the other diagnostic 
categories (P  <0.0001), with the highest levels observed for patients 
with the highest Risk Adjustment for Congenital Heart Surgery (RACHS) 
score (both P = 0.002). Admission levels of S100B and NSE were higher in 
patients needing intensive care for at least 3 days vs short-stay patients 
(both P <0.0001) and in ICU nonsurvivors vs survivors (P = 0.002 and P  
= 0.0002). IIT did not aff  ect the levels of S100B or NSE as compared with 
CIT. Patients experiencing hypoglycemia at any time during the ICU stay 
revealed higher S100B and NSE levels on admission (P <0.0001 and P = 
0.0007) than those without hypoglycemia. In the nested case–control 
study, S100B and NSE decreased after hypoglycemia (P = 0.001 and P = 
0.009) in the cases, unlike in the controls on matched days.
Conclusions IIT in the pediatric ICU did not evoke neurological damage, 
as evaluated by S100B and NSE, despite an increased incidence of brief 
hypoglycemia. Elevated markers in patients with hypoglycemia were 
not caused by hypoglycemia but explained by an increased risk of 
hypoglycemia in the most severely ill.
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Introduction  Intensive insulin therapy (IIT) is a complex intervention 
involving several steps that may all contain potential sources of variability. 
Changing practice in complex multidisciplinary environments is diffi   cult. 
In addition, it is undecided whether IIT should be applied by nurses and 
physicians, or nurses alone. We implemented IIT using a conceptual 
implementation framework and compared overall blood glucose control 
and incidence of severe hypoglycemia (SH) (blood glucose level (BGL) 
<40 mg/dl) before and after implementation.
Methods Three ICUs developed and implemented an evidence-based 
guideline for IIT; three ICUs with no change in blood glucose control 
served as control ICUs. In the guideline ICUs, the IIT practice change 
comprised two periods: in the fi   rst year after implementation of the 
guideline, physicians and nurses used the guideline together; in the 
second year the guideline was applied solely by nurses. BGL collection 
and analysis included the 1 year before implementation of the guideline. 
Analysis was performed using statistical process control.
Results IIT guideline: the new guideline emphasized fast correction of 
high BGLs, acceptance of low BGLs and frequent BGL measurements (up 
to one/hour). Blood glucose control: BGLs of approximately 8,000 patients 
were collected and analyzed. The case mix was similar in guideline and 
control ICUs, and did not change over time. No change in overall blood 
glucose control or incidence of SH was observed in the control ICUs during 
the study duration. In the guideline ICUs, the median number of daily 
blood glucose measurements increased from 4 (3 to 7) per patient to 9 (5 
to 12) per patient (P <0.001). Median morning BGL declined in guideline 
ICUs, from 114 (96 to 139) mg/dl to 100 (85 to 123) mg/dl (P <0.001). 
The change in blood glucose control was accompanied by a rise in the 
incidence of SH, from 7% to 13% (P <0.001). SH, however, did never cause 
short-term harm (no death or coma). Nurses alone performed equally well 
with regard to overall blood glucose control, and even showed a decline 
of incidence of SH.
Conclusions  Implementation of an evidence-based IIT guideline 
improves blood glucose control, with results comparable with the original 
studies on IIT in Leuven. The increase of incidence of SH is temporary, and 
improves when IIT is applied by nurses alone.
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Incidence of hypoglycemia in NICE sugar not so nice after 
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Introduction  Hypoglycaemia is one of the major side eff  ects  when 
establishing glycaemic control in critically ill patients and may contribute 
to increased mortality rates. Until today, no comparable measure of 
hypoglycaemia frequency has been suggested. Current assessments 
depend either on the treatment period or the number of glucose 
measurements performed per patient. Therefore, we suggest an 
alternative method to present the hypoglycaemia incidence by number 
of episodes per patient normalized for a 24-hour treatment period.
Methods Two major studies performing glycaemic control in critically 
ill patients were chosen for comparison: the Leuven study with 1,200 
patients at a medical ICU (605 standard care (STD), 595 tight glycaemic 
control (TGC); [1]) and the NICE study with 6,030 patients in a mixed 
ICU population (3,014 STD, 3,016 TGC; [2]). For both studies, rates of 
hypoglycaemia per patient per 24 hours were calculated based on 
published data.
Results Mean duration of treatment was 12.5 days for the Leuven study 
and 4.2 days for the NICE study. APACHE scores were 23 for Leuven and 
21 for NICE, respectively. Number of hypoglycaemic events per study 
population was reported as follows: 19 (3.1%) for STD and 111 (18.7%) for 
TGC for the Leuven study and 15 (0.5%) for STD and 206 (6.8%) for TGC 
in the NICE study. When applying the new evaluation method, rates of 
hypoglycaemia per patient per 24 hours were 0.25% (STD) vs 1.49% (TGC) 
for Leuven and 0.12% (STD) vs 1.63% (TGC) for NICE, respectively.
Conclusions The results reveal that the treatment period may have a 
signifi  cant impact on the reported rate of hypoglycemia. We conclude 
that reporting hypoglycaemic episodes in critically ill patients on a per-
patient and per-24-hour basis may be a more adequate tool to accurately 
describe hypoglycaemia incidence which facilitates the comparison 
between diff  erent studies and study protocols.
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Introduction In this study the eff  ectiveness of a hierarchic planned 
approach to implementation was compared with an emergent approach 
with a high degree of nurse participation. The innovation was a new 
tight glycemic control (TGC) therapy in the ICU. The implementation 
method to introduce a new evidence-based treatment to the ICU can 
make a diff  erence to its eff  ectiveness. New treatment procedures are 
very often strictly defi  ned and introduced on the ICU in a top-down 
manner. On theoretical grounds, a bottom-up implementation method, 
with more participation and involvement of the ICU nurses, should be 
more eff  ective.
Methods In an experiment a TGC protocol was introduced on a 24-bed 
ICU with 120 ICU nurses. In one nursing team the implementation was 
by means of the usual planned approach (PA). In the other team an 
emergent implementation approach (EA) was applied. During 7 months, 
1,182 patients were admitted and randomly assigned to either team. The 
eff  ectiveness of the implementation methods was measured at patient-
outcome (glucose) level and on a process-execution (nurse compliance) 
level. The patient-outcome measurements were: mean glucose value, 
percentage of normal glucose values (defi   ned as between 4.0 and 
6.5 mmol/l) and the time from admission to reach a normal glucose 
level (6.5 mmol/l). For the mean glucose value a diff  erence was made 
between short-stay (<3 days) and long-stay patients (≥3 days). The 
compliance was expressed as compliance for safe, insulin treatment (the 
patient received the right amount of insulin) and compliance for effi   cient 
treatment (glucose measurements as well as insulin were according to 
the protocol).
Results The mean glucose for the short-stay patients was signifi  cantly 
lower in the EA than the PA team (6.42 vs 6.52 mmol/l), no signifi  cant 
diff  erence was found for the long-stay patients. The percentage of normal 
glucose values was 53.9% in the EA and 52.8% in the PA team (signifi  cant 
P <0.001). The time to reach normal glucose levels was 6 to 7 hours in the 
EA and 10 to 11 hours in the PA team (signifi  cant, P <0.05). The compliance 
for safe insulin treatment was 91.3% in the EA and 79.0% in the PA team. 
The compliance for effi   cient treatment was 83.5% in the EA and 66.8% in 
the PA team.
Conclusions  An emergent approach to implementation (with an 
increased participation of the ICU nurses) of a TGC resulted in better 
patient results and a higher compliance to the protocol.
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Introduction  A hypercoagulable state is frequently found in sepsis 
patients as well as hyperglycemia [1]. The objective of this study was to 
determine the coagulation profi  le in hyperglycemic septic shock patients 
and the impact of glycemia control.
Methods  Septic shock patients with less than 48 hours of organ 
dysfunction with normoglycemia (<150 mg/dl, Group 1) or hyperglycemia 
(>200 mg/dl, Group 2) were included. Exclusion criteria were previous 
diabetes, coagulation diseases, use of heparin or fresh frozen plasma/
platelets, sepsis in the past 30 days or insulin use in the past 24 hours. The 
coagulation and infl  ammation profi  le was determined at inclusion and 
after 24 hours, only if the patients remained normoglycemic or achieved 
glycemic control with insulin infusion (Group 2). Results were expressed in 
median and interquartiles, P <0.05 was considered signifi  cant.
Results Forty-one patients were included, 59.7% male; mean APACHE II 
score: 16.9 ± 8.6, P = 0.21; mean SOFA score: 8.1 ± 2.0; mean number of 
organ dysfunctions: 3.6 ± 0.9, with a signifi  cant diff  erence between the 
groups only regarding age (Group 1 (n = 21): 53.8 ± 16.7, Group 2 (n = 
20): 68.8 ± 16.4, P = 0.006). In both groups, a hypercoagulation profi  le was 
detected, with high levels of fragment 1+2 (F1+2), thrombin/antithrombin 
complex (TAT), D-dimer and tissue factor and with low levels of factor VII. 
Consumption of coagulation inhibitors (protein C (PC), antithrombin (AT), 
tissue factor pathway inhibitor) and increased fi  brinolysis (plasminogen 
activator inhibitor 1 (PAI-1), tissue plasminogen activator (TPA) and 
plasminogen) were also found. However, at baseline no signifi   cant 
diff  erence between groups was found except for a trend towards high 
levels of F1+2 (P = 0.08) and TAT (P = 0.058) in Group 2. After 24 hours 
higher levels of AT (P = 0.02), PC (P = 0.02), plasminogen (P = 0.04) and 
a reduction in PAI-1 (P = 0.01) and TPA (P = 0.03) were detected in Group 
2. Infl  ammatory parameters (IL-6, IL-8, IL-10, TNF) were similar at baseline, 
with decreased levels in both groups after 24 hours but the IL-6 (P = 0.02) 
and IL-8 (P = 0.0004) reduction was more pronounced in Group 2.
Conclusions  Septic shock patients have a hypercoagulation pattern 
regardless of their glycemic status. However, glycemia control seems to 
be associated with reduction in infl   ammation and hypercoagulation 
parameters, possibly related to insulin infusion as glycemia levels did not 
diff  er between groups after 24 hours.
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Introduction  Several studies have shown an increased mortality and 
morbidity in various groups of patients with hyperglycemia requiring 
admission to the ICU. Contrary to these studies, a recent large multicentric 
international trial in ICU patients has shown an increased mortality in 
patients where normoglycemia was maintained. However, very few 
studies specifi   cally evaluated the association between hyperglycemia 
and mortality in critical care patients with sepsis. Since hyperglycemia is 
known to be associated with immunosuppression and increased risk of 
life-threatening infections, we aimed to assess the impact of glycemic 
control (normoglycemia) in ICU patients with sepsis.
Methods  We studied all patients admitted to our ICU with sepsis 
between July 2004 and May 2009. Patients were excluded if their 
blood sugar levels (BSL) were not measured at least once every 6 hours 
during their ICU stay. Patients were divided into two groups based on 
their glycemic control in the ICU: normoglycemic group (BSL 3.9 to 6.2 
mmol/l) and conventional glucose control group (BSL 8 to 10 mmol/l). 
BSLs were controlled using an infusion of actrapid insulin. Both groups 
were compared with regard to demographics, co-morbidities, severity of 
illness at ICU admission (APACHE III and SAPS II scores), ICU and hospital 
mortality and length of stay.
Results Over the 5-year study period a total of 314 patients were admitted 
with sepsis and 297 patients were included. On average every patient 
included in the study had BSL once every 4.2 hours throughout their ICU 
stay. Of these patients, 68 had normoglycemia (mean BSL 5.6) and 229 
had conventional glucose control (mean BSL 8.5) during their ICU stay. 
There was no statistically signifi  cant diff  erence between the groups in 
age, sex, APACHE III and SAPS II scores. The ICU mortality was signifi  cantly 
higher in the normoglycemic group (30.8% vs 14.8% P <0.01). There was 
no statistically signifi  cant diff  erence in hospital mortality between both 
groups (33.8% vs 25.3% P = 0.16). The ICU (median and IQR days: 1 (1 to 3) 
vs 4 (2 to 7) P = <0.01) and hospital duration of stay (6.0 (2.00 to 13.75) 6.0 
(2.00 to 13.75) vs 12.0 (7.00 to 27.00); P <0.01) were signifi  cantly higher in 
the conventional group.
Conclusions The ICU mortality in patients admitted to the ICU with sepsis 
who had normoglycemia was higher than in those patients who had 
conventional glucose control during their ICU stay. Aiming for a normal 
blood glucose levels is not indicated in patients with sepsis while they 
are in the ICU.
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Introduction Glycemic control is mandatory in the critically ill, because 
hypoglycemia and hyperglycemia are associated with increased mortality 
[1]. We compared in a prospective observational study three new point-
of-care devices with the hexokinase reference method and we evaluated 
whether their results would modify insulin titration.
Methods Arterial blood glucose was simultaneously measured by the 
blood gas analyser RapidLab 1265, by three glucose meters (Accu-Chek 
performa, Precision XceedPro, Nova StatStrip), and with the hexokinase 
reference method. All values were duplicated and the average value of 
each was computed. Bland–Altman, Passing Bablok, Kanji [2] and modifi  ed 
Kanji approaches were performed. Biases were expressed as the glucose 
result of the point-of-care method minus the reference method. We 
evaluated the theoretical impact on insulin titration by comparing glucose 
meter results with the hexokinase reference method on a dynamic sliding 
scale targeting a glycemia of 80 to 130 mg/dl.
Results A total of 156 matched analyses were done in 80 patients. The 
mean fl  ash SOFA score was 4.5. The range of the reference glucose was 
25 to 327 mg/dl. The numbers of discrepancies of dosing insulin were 
respectively 8-5-6-14 at 0.1 U/hour, 0-6-3-6 at 0.2 U/hour and 2-3-0-0 at 
0.3 U/hour. None was greater than 0.3 U/hour. Regarding the point-of-care 
results, total theoretical insulin dose changes were respectively: –11.7 U, 
–19.2 U, –22.2 U, +4.9 U for all these measurements (devices order as in 
Methods). Table 1 presents the standard comparisons.
Table 1 (abstract P573)
  Bias and 2SD  Passing reg  CI of slope
RapidLab  –4.7 ± 14.6  Y = –4.8 + 1.1X  1.04 to 1.10
AccuChek P  –9.5 ± 20.5  Y = 3.6 + 1.05X  1.00 to 1.11
P Xceed Pro  –0.9 ± 15.4  Y = –4 + 1.03X  1.00 to 1.08
Statstrip No  1.2 ± 18.1  Y = –0.4 + 0.98X  0.93 to 1.03
Conclusions Glucose monitoring with new glucose meters results has 
minor impact on intravenous insulin dose titration compared with the 
reference method.
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Introduction Although high blood glucose (BG) causes high mortality in 
ICU patients, signifi  cance of BG variability is not elucidated. The purpose 
of the study was to clarify the signifi  cance of BG variability in the early 
phase for predicting survival and to suggest the importance of stabilizing 
BG variability for mortality reduction.
Methods  Strict BG control was performed by bedside-type artifi   cial 
pancreas (AP), STG22. The number of the selected patients was 67, or 
patients with daily mean BG (BGm) below 200 mg/dl in early phase (3.2 ± 
2.5 days after admission). Studied items: (1) mortality, (2) BG parameters 
(mg/dl): BGm, daily standard deviation of BG (BGsd), daily maximal and 
minimal BG (BGmax, BGmin), and daily BG diff   erence (BGd:BGmax – 
BGmin), (3) accuracy (%) of the BG parameters for predicting survival (AS), 
(4) relationships among BG parameters, and (5) probable factors aff  ecting 
BG variability (BGsd) including demographic data, SOFA score and MOF 
score (calculated using the criteria proposed by the Japanese Association 
for Critical Care Medicine, 1990).
Results (1) Mortality of the patients with BGsd below 14 mg/dl (group 
BGsd14b,  n = 41) was signifi   cantly lower than that with BGsd above 
14 mg/dl (group BGsd14a, n = 26) (17% vs 46%, P <0.025). (2) AS (%) was 
as follows: BGm <196 mg/dl (75%), BGsd <17 mg/dl (73%), BGmax <225 
mg/dl (72%), BGmin <172 mg/dl (72%), and BGd <8 0 mg/dl (70%). (3) 
Signifi  cant (P <0.002) positive correlation was found between BGsd and 
BGd (r = 0.87), BGsd and BGmax (r = 0.79), and BGd and BGmax (r = 0.77). 
(4) There was a tendency that the ratio of the patients with MOF score 
above 3 was lower in group BGsd14b than that in group BGsd14a (7% vs 
23%, P <0.10), although there was no signifi  cant diff  erence between the 
groups in BGm, demographic data, and SOFA score.
Conclusions First, high BG variability in the early phase, which appeared 
to accompany severe illness and could be evaluated by BGsd, BGd, and 
BGmax, was considered to be one of the signifi  cant risk factors as well 
as high BG or elevated BGm. Stabilizing BG variability from the early 
phase was suggested to be important for mortality reduction. Second, 
AP was reliable for elucidating the signifi  cance of strict BG control, and 
was considered to be a valuable therapeutic artifi  cial organ for the better 
outcome of the ICU patients through the strict BG control.
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Introduction There is growing evidence that not only blood glucose (BG) 
level but also BG amplitude variation (BGAV) is associated with mortality 
in critically ill patients [1].
Methods Retrospective analysis of the data of the Leuven intensive insulin 
therapy (IIT) trial in 1,200 MICU patients, randomized to receive either IIT 
or conventional insulin therapy [2]. The hyperglycemic index (HGI) and 
hypoglycemic index (HoGI) were used as measures of BG level, the standard 
deviation of all BG readings per patient (SD BG) as a measure of BGAV. The 
univariable eff  ect of IIT on these indices was analyzed, the independent 
association with hospital mortality was assessed by multivariable logistic 
regression (MVR), corrected for baseline risks.
Results IIT reduced the median HGI from 3.2 to 0.8 mmol/l (P <0.0001), 
increased the median HoGI from 0.005 to 0.048 mmol/l (P <0.0001), and 
did not aff  ect median SD BG (conventional: 2.12; IIT: 1.99 mmol/l (P = 
0.161)). The results of the MVR are summarized in Table 1. HGI, HoGI and 
SD BG were independently associated with mortality.
Conclusions  BGAV was associated with mortality in MICU patients, 
independent of baseline risks and BG level. IIT reduced HGI, increased 
HoGI, and did not aff  ect BGAV. Reducing BGAV, in addition to IIT, may 
theoretically increase its potential for clinical benefi  t.
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Table 1 (abstract P575)
Risk  P value
Malign <0.001
Female 0.309
BMI >25  0.044
Age 0.001
Adm BG  0.002
HGI <0.001
HoGI 0.003
SD BG  0.024
Critical Care 2010, Volume 14 Suppl 1 
http://ccforum.com/supplements/14/S1
S192P576
Prevention of fatal and disabling neuroglycopaenia: a comparison 
of arterial blood sampling methods
KA Brennan, D Turnbull
Sheffi   eld Teaching Hospitals NHS Trust, Sheffi   eld, UK
Critical Care 2010, 14(Suppl 1):P576 (doi: 10.1186/cc8808)
Introduction  In 2008, the UK National Patient Safety Agency (NPSA) 
published a report following 42 incidents and two deaths where glucose-
containing fl  ush solutions were attached to arterial lines. Deaths occurred 
when blood samples contaminated with the fl  ush solution led to artifi  cially 
high blood glucose readings, inappropriate insulin administration and 
iatrogenic neuroglycopaenia (the molar concentration of 5% glucose at 
277 mmol/l is huge next to physiological blood glucose at <11 mmol/l). 
The NPSA sought a solution so we applied a bench model to test the 
performance of three open and three closed arterial line systems in 
preventing sample contamination.
Methods All arterial line systems were set up in a standard manner and 
pressurised to 300 mmHg with 5% glucose used as the fl  ush solution. This 
was connected to the radial artery using an 18 G needle representing the 
radial cannula. The radial artery was simulated using a wide bore extension 
set with blood fl  ow at 60 ml/minute. Blood was simulated by the addition 
of red dye to Hartmann’s solution. Increasing multiples of arterial line dead 
space were aspirated and discarded. Blood samples were then taken and 
the glucose concentration measured.
Results Signifi  cant glucose contamination (3 mmol/l ± 3.4) was detected 
in all open arterial line systems up to an aspiration volume of fi  ve times 
the dead space. No samples from the closed systems recorded glucose 
concentration >1 mmol/l (0.2 ± <0.1) (Figure 1).
Conclusions Recommended minimal discard volumes are inadequate 
in the presence of glucose as the fl  ush solution. Human factors ensure 
that such errors can persist without a systems-based solution. Our study 
demonstrates that the closed loop arterial sampling system could be the 
universal solution sought by the NPSA.
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Introduction Glucose variability has been found to be associated with 
mortality in critically ill patients, independent of the mean glucose 
concentration [1]. The aim of this analysis was to assess the impact of 
real-time continuous glucose monitoring (CGM) on glucose variability in 
critically ill patients receiving intensive insulin therapy (IIT).
Methods  This is the post hoc analysis of a prospective, randomized, 
controlled trial [2]. Data of 124 patients admitted to the ICU either 
receiving IIT according to a real-time CGM system (Guardian®; Medtronic, 
Northridge, CA, USA) (n = 63) or according to an algorithm (n = 61) with 
selective arterial blood glucose measurements (simultaneously blinded 
CGM) for 72  hours were analysed. Insulin infusion rates were guided 
according to the same algorithm in both groups. Mean glucose and 
standard deviation, as a marker of glucose variability, were calculated for 
the fi  rst 24 hours (GluMEAN1, GluSD1) and for the whole study period (GluSD). 
Statistical comparison of parameters between study groups and between 
ICU survivors (n = 94) and nonsurvivors (n = 30) was performed using 
Student’s t test.
Results The variability of sensor glucose during the entire study period 
was comparable between the real-time CGM group and controls (21.51 ± 
1.10 vs 23.44 ± 1.26 mg/dl; P = 0.243). Although the mean sensor glucose 
during the fi  rst 24 hours in the ICU showed a trend towards lower values 
in the intervention group (real-time CGM vs control: GluMEAN1: 104.40 ± 2.00 
vs 109.23 ± 1.96 mg/dl; P = 0.087), variability of sensor glucose during the 
fi  rst 24 hours did not diff  er signifi  cantly (real-time CGM vs control: GluSD1: 
20.85 vs 18.46 mg/dl; P = 0.201). GluSD tended to be lower in ICU survivors 
(ICU survivors vs nonsurvivors: 21.61 ± 8.60 vs 25.10 ± 10.55 mg/dl; P = 
0.071) whereas GluSD1 (19.06 ± 9.32 vs 21.41 ± 13.21 mg/dl; P = 0.282) 
Figure 1 (abstract P576).
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S193and GluMEAN1 (106.39 ± 14.83 vs 108.00 ± 18.44 mg/dl; P = 0.627) were not 
diff  erent between ICU survivors and nonsurvivors.
Conclusions  IIT guided by real-time CGM did not result in reduced 
glucose variability compared with IIT according to an algorithm with 
selective arterial blood glucose measurements. Although mean sensor 
glucose during the fi  rst 24 hours tended to be lower in the real-time CGM 
group, glucose variability was not diff  erent between the two groups. GluSD 
tended to be lower in ICU survivors irrespective of glucose monitoring.
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Introduction Luminous Medical is developing an automated, patient-
attached system (Argus Glucose Monitoring System) that uses a fl  ow-
through glucose oxidase sensor to measure plasma glucose levels in 
whole blood. The Argus GMS will aid caregivers in achieving glycemic 
control in critical care patients. The FDA has recently indicated that ICU 
glucose monitors need to satisfy tighter accuracy requirements than 
those specifi  ed by ISO 15197 (±15 mg/dl or ±20%). Luminous conducted 
a study to demonstrate Argus GMS accuracy under conditions of variable 
hematocrit, and in the presence of common saccharide interferents.
Methods Hematocrit Study Group: one unit of whole blood was collected 
under an IRB-approved protocol from two healthy volunteers. Blood 
samples were prepared at three hematocrit levels (~24, 36, and 48%). 
Three glucose levels were tested at each hematocrit: native glucose, 
native plus 100, and native plus 200 mg/dl. Repeats were measured for 
each hematocrit/glucose combination (n = 99 total samples in this study 
group). Interferent Study Group: blood samples were prepared at native 
hematocrit (~37%) and native glucose level (~100 mg/dl). Testing followed 
established interference testing guidelines [1]. Blood samples were spiked 
with concentrated interferent solution or with equal volume of normal 
saline. Testing alternated between interferent-containing and interferent-
free samples (n = 5 test and fi  ve control samples for each interferent). 
Saccharide interferents included maltose (55 mg/dl), galactose (15 mg/dl), 
fructose (18 mg/dl), and xylose (40 mg/dl). In both study groups, blood 
samples were measured in vitro, in real time, using the Argus GMS in 
multisample mode. Plasma measurements from two YSI 2700 instruments 
were averaged to provide reference glucose values.
Results  Hematocrit Study Group: the Argus GMS measured plasma 
glucose across a range of 50 to 350 mg/dl with RMS error of 5.5 mg/dl 
(mean error 2.6, 95% CI = –7.0 to 12.2, R = 0.998). The Argus GMS showed 
no sensitivity to hematocrit variation. Interferent Study Group: the Argus 
GMS showed minimal glucose measurement bias for each of the four 
saccharide interferents (maltose 2.21 mg/dl, galactose 4.09 mg/dl, fructose 
2.63 mg/dl, and xylose 2.03 mg/dl).
Conclusions The Argus GMS provides highly accurate glucose readings 
in whole blood samples with no observable sensitivity to hematocrit 
variation and with minimal infl  uence from saccharide interferences. Argus 
demonstrated measurement accuracy within ±10 mg/dl or ±10% at 95% 
confi  dence limits.
Reference
1.  Clinical and Laboratory Standards Institute: Interference Testing in Clinical 
Chemistry: Approved Guideline – Second Edition. Wayne, PA: Clinical and 
Laboratory Standards Institute; 2005.
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Introduction  DexCom and Edwards Lifesciences collaborated to 
develop an intravenous blood glucose monitor for use in a critical care 
environment. The system provides automatic, real-time monitoring and 
trending of blood glucose (BG) values for critical care patients. The system 
is designed to address the needs of clinicians to monitor BG in critical care 
units. The sensor was also designed to accurately measure BG even in the 
presence of many drugs commonly used in the hospital.
Methods  This was a blinded, multicenter study evaluating 17 adult 
patients presenting to the OR and ICU. They were monitored for up to 72 
hours with reference samples taken at 4-hour intervals and measured with 
a YSI-2300 laboratory analyzer. Data are from initial roll-in patients used for 
training and assessing protocol complications. Reference blood samples 
were taken from either a peripheral vein, a central venous catheter or 
an arterial line. Glucose values were calculated prospectively but not 
displayed during the study.
Results Of 211 paired BG measurements, 94.3% were within Clarke Error 
Grid A, 5.7% in B and 0% in C, D and E (Figure 1a). The mean absolute 
relative diff  erence was 6.5%. No signifi   cant errors due to drugs were 
measured. These results compare favorably with a previous study of 50 
subjects who were monitored continuously for up to 72 hours in a diabetic 
Figure 1 (abstract P579). Clarke Error Grid for (a) OR/ICU and (b) in-clinic.
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evaluated.
Conclusions The results of this study help illustrate the capability of the 
system to provide safe, accurate, automated glucose measurements in 
critical care patients.
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Introduction There are increasing calls for a highly accurate, automated 
system to enable tight glycemic control and avoid hypoglycemia in an 
ICU setting. OptiScan Biomedical has developed a glucose monitor based 
on mid-infrared spectroscopy that draws blood samples (120 μl) and 
measures plasma glucose concentrations approximately every 15 minutes. 
The goal of this study was to validate the performance of the OptiScan 
model 5000 (OptiScanner) at diff  erent glycemic levels in a healthy diabetic 
patient population.
Methods Eighteen people (14 males, age 44 (18 to 64) years, BMI 29.0 
(21.9 to 37.5) kg/m2) with type 1 (n = 8) or type 2 (n = 10) diabetes were 
connected to an OptiScanner. Their blood glucose concentrations were 
kept in a euglycemic (75 to 180 mg/dl), hypoglycemic (<75 mg/dl) and 
hyperglycemic (>180 mg/dl) range by intravenous administrations of 
insulin and glucose. Each OptiScanner blood sample was automatically 
withdrawn from a forearm vein. Blood samples for reference measurements 
using the YSI 2300 were withdrawn from the same arm within 60 seconds 
of the OptiScanner draw and analyzed immediately. A total of 250 paired 
data points in each glucose range will be collected in this ongoing study.
Results The aggregate data points (374 paired readings between the 
OptiScanner and the YSI 2300) were within ISO standard, with 98.9% of 
the glucose values within ±20% above 75 mg/dl and ±15 mg/dl below 
this value. A Clark Error Grid analysis showed a total of 369 points (98.7%) 
in zone A (Figure 1). Points outside A exceeded the A zone boundary by an 
average of 5.3% and a maximum of 8.7%. The total coeffi   cient for variance 
was 5.7%. The total r2 was 0.99.
Conclusions  These preliminary results show that the OptiScanner is 
highly accurate in a healthy diabetic population.
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Validation of HbA1c as a diagnostic marker for diabetes in the 
critically ill
I Gornik, A Vujaklija-Brajković, V Gašparović
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Introduction Diabetes mellitus (DM) is a highly prevalent disease: about 
one-quarter of patients admitted to hospital is diagnosed with DM, 
but there are also a large number of patients who are undiagnosed. An 
acutely ill patient with hyperglycaemia and no history of diabetes may 
have stress hyperglycaemia or a fi  rst manifestation of diabetes, but it is 
virtually impossible to establish diagnosis based on measurements of 
glucose. HbA1c is widely used as a marker of glycaemic control and has 
been proposed and used, but not yet offi   cially accepted, as a diagnostic 
marker for diabetes. We have tested its usefulness for diagnosing diabetes 
in the intensive care setting.
Methods  We have included a cohort of adult patients admitted to 
a medical ICU. HbA1c was measured in all patients. Patients without 
hyperglycaemia during their illness and negative history of DM were 
used as negative controls; patients with known diagnosis of DM, impaired 
fasting glucose (IFG) or impaired glucose tolerance (IGT) were positive 
controls. All patients with negative history for DM and hyperglycaemia 
in ICU were called for measurement of fasting glucose and OGTT within 
1 month after discharge.
Results There were 618 patients in the cohort: 138 with no hyperglycaemia, 
79 with a history of IFG or IGT, 108 with a history of diabetes; 293 patients 
had hyperglycaemia during the ICU stay and no information about DM in 
the history. When analysing only positive and negative controls, a cut-off   
value of 6% showed 95% sensitivity and 93% specifi  city for pre-diabetes 
(IFG and IGT), cut-off    of 7% had 91% sensitivity and 96% specifi   city 
for DM. Similar results were obtained for the group of patients with 
hyperglycaemia and no history of impaired glucose metabolism: cut-off   
of 6% had 97% sensitivity and 93% specifi  city for pre-diabetes, 7% cut-off   
had 95% sensitivity and 98% specifi  city for DM.
Conclusions  HbA1c can be used for diagnosing diabetes and pre-
diabetes in patients with critical care hyperglycaemia with high sensitivity 
and specifi  city. Since diabetes brings a burden of complications, impaired 
immune response, susceptibility to infections, and overall higher mortality, 
diff   erentiating diabetics from patients without diabetes can be very 
valuable.
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Introduction Intravenous glucocorticoids (GC) are often administered 
during critical illness in the context of post-transplant immunosuppression, 
ARDS, septic shock or severe infl   ammatory vasoplegia. As a counter-
regulatory hormone of insulin, GC may interfere substantially with tight 
glycaemic control to normal for age blood glucose levels by intensive 
insulin therapy. Therefore we hypothesized that the fi  rst administration of 
an intravenous GC gives rise to signifi  cant hyperglycaemia and that the 
eff  ect is more pronounced for the synthetic GC.
Methods All patients admitted to the surgical and paediatric ICU between 
1 July 2008 and 1 July 2009 were screened for intravenous glucocorticoid 
use in our patient data management system. In those patients, arterial 
blood glucose levels, all measured by blood gas analyzer, within the time 
frame of 48 hours surrounding the GC administration were retrieved. Up 
to two baseline blood glucose levels (before GC administration) and up to 
six blood glucose levels post administration were analysed by repeated-
measures ANOVA. Data are expressed as mean ± SD or as median (IQR).
Results A total of 452 patients – n = 26 (<1 year), n = 76 (1 to 17 years), 
n = 350 (>17 years) – received intravenous GC: hydrocortisone 32%, 
bolus methylprednisolone 52%, drip methylprednisolone 4% and dexa-
methasone 12%. Baseline blood glucose levels were 97 ± 34 mg/dl 
(<1 year), 104 (89 to 132) mg/dl (1 to 17 years), 136 (106 to 174) mg/dl 
Figure 1 (abstract P580).
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was 1.0 (0.4 to 2.0) hours after GC administration. Blood glucose levels 
decreased over time from baseline after GC administration (P <0.0001). The 
sixth glycaemia was 110 (91 to 139) mg/dl taken 12.4 (9.6 to 16.5) hours 
after GC administration. This decrease of glycaemia was only present in 
patients who received 92 ± 35 mg hydrocortisone (P = 0.004) or 40 (20 to 
125) mg bolus methylprednisolone (P <0.0001). In patients who received 
113 (71 to 160) mg drip methylprednisolone (P = 0.14) or 10 (5 to 12.5) mg 
dexamethasone (P = 0.44), blood glucose levels did not change over time.
Conclusions We showed that, when a tight blood glucose protocol is 
implemented, intravenous GC administration does not necessarily lead 
to an increase in blood glucose level. The blood glucose profi  le after 
methylprednisolone or dexamethasone administration did not diff  er from 
the glycaemic response after hydrocortisone administration. However, 
avoiding hyperglycaemic peaks after the GC administration during 
tight glycaemic control requires an on average 2-hourly blood glucose 
measurement.
P583
Chronic critical illness: high levels of estrogens and mortality
G Bernardeschi, B Ferro, R Mori, A Abramo, F Forfori, F Giunta
Scuola di Specializzazione di Anestesia e Rianimazione, Università degli Studi 
di Pisa, Italy
Critical Care 2010, 14(Suppl 1):P583 (doi: 10.1186/cc8815)
Introduction Chronic critical illness is characterized by a severe metabolic 
disorder, caused by the loss of the physiologic hypothalamic and pituitary 
functions and the onset of the so-called wasting syndrome, as many 
studies have just confi  rmed [1]. In this study we assessed the correlation 
between the neuroendocrine pattern in chronic ICU patients and 
mortality.
Methods The patients enrolled were 25 (18 male and fi  ve female) with a 
mean age of 67 years and APACHE II score of 12 ± 5. We excluded females 
in a premenopausal state, patients with previous endocrine problems or 
in therapy with dopamine, high dose of cortisone or amiodarone. In these 
patients, we evaluate, on the seventh day of stay in the ICU (considered 
the chronic phase of critical illness), the mean value of four nocturnal 
hormonal measurements (LH, FSH, estrogen, testosterone, DHEAS, 
androstenedione, androstenediol, progesterone, TSH, FT3, FT4, RT3, GH, 
IGF1, prolactin, cortisol). Furthermore, we observed hormonal patterns in 
people who died in the ICU.
Results We found statistical evidence in the correlation of high levels of 
estrogens, related to aromatase increased function [2], and the percentage 
of death. In the group of patients with estrogens more than 50 pg/ml, six 
of them died, while if estrogens were normal or low, none died (Figure 1). 
Survivors and nonsurvivors did not diff   er by mechanism of injury or 
APACHE score (11.6 vs 11.8). Medium serum estradiol levels were 44.96 pg/
ml in survivors and 115.08 pg/ml in nonsurvivors.
Conclusions  To date, the role of these hormones in critical illness 
pathophysiology and the increase of estrogen levels are still uncertain. 
Further studies are required.
References
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Introduction  Patients with severe burn injury experience a rapid 
elevation in multiple circulating proinfl   ammatory cytokines, with the 
levels correlating with both injury severity and outcome. Accumulations 
of these cytokines in animal models have been observed in remote 
organs, however data are lacking regarding early serial heart cytokine 
levels following burn injury, and the therapeutic eff  ects of estrogen on 
these levels. Using an animal model, we studied the acute eff  ects of a full-
thickness third-degree burn on cardiac levels of IL-1β, IL-6, IL-10, and TNFα. 
In addition, we analyzed the eff  ect of estrogen on levels of cytochrome 
C, signifying apoptosis, and levels of NF-κB, signifying infl  ammation. Here, 
we hypothesized that acute estrogen treatment decreases infl  ammation 
in the heart and blocks the induction of apoptosis.
Methods In this study, 144 male rats received third-degree 40% total body 
surface area burns. Fifteen minutes following burn injury, the animals 
received a subcutaneous injection of either placebo or 17β-estradiol 
(0.5 mg/kg). The hearts were harvested at 0.5, 1, 2, 4, 6, 8, 12, 18, and 
24 hours after injury, and the heart cytokine (IL-1β, IL-6, IL-10, TNFα) levels 
were measured using the ELISA method. In addition, we assessed the 
cytosolic levels of cytochrome C and NF-κB at the 24-hour time point 
using western blot analysis.
Results  In the burned rats, 17β-estradiol signifi   cantly decreased the 
cardiac levels of TNFα (~95%), IL-6 (~50%), IL-1β (~25%), and IL-10 (~20%), 
when compared with the placebo group. In addition, we determined that 
estradiol treatment restored cytosolic levels of NF-κB (65% increase) at the 
24-hour time point. Also, estrogen decreased cytosolic accumulation of 
cytochrome C (50% reduction) at the 24-hour time point.
Conclusions Following severe burn injury, estrogens decrease cardiac 
infl  ammation and levels of the pro-apoptotic cytochrome C. In addition, 
estrogen signaling promotes cell survival, as indicated by an increase in 
NF-κB levels. Importantly, estrogen treatment following burn injury nearly 
ablated the deleterious burn-induced increase of TNFα in the heart to 
levels similar to unburned control animals. Elevated cardiac levels of TNFα 
have previously been linked to a poor outcome.
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Introduction Glucocorticoids are known to have an anti-insulin action 
on glucose metabolism, leading to increased lactate production [1]. 
Alternatively, glucocorticoid-induced apoptosis is a well-recognized 
phenomenon initiated by mitochondrial dysfunction [2]. Increased 
lactate production follows loss of mitochondrial membrane potential 
during apoptosis. Both mechanisms may lead to clinically relevant 
hyperlactatemia following glucocorticoid administration during cardiac 
surgery requiring cardiopulmonary bypass.
Methods  All adult patients undergoing cardiac surgery and 
cardiopulmonary bypass from 5 October through 21 November 2005 
in a large academic teaching hospital in Rotterdam, the Netherlands 
were included in this study. Dexamethasone (60 to 80 mg) was given 
Figure 1 (abstract P583).
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measured within 1 hour postoperatively. The association between 
dexamethasone treatment, serum lactate levels and possible confounders 
was evaluated using ANOVA and linear regression.
Results  A total of 82 patients 18 years and older underwent 
cardiopulmonary bypass for cardiac surgery in the above-mentioned 
period. Three patients undergoing heart or lung transplantation, who 
thus received methylprednisolone, were excluded; a further two patients 
who received hydrocortisone for allergic reactions were also excluded. 
Data were incomplete for one patient, leaving a total of 76 patients for 
analysis. The mean lactate level was 1.2 mmol/l in the 47 patients who 
did not receive steroids and 2.6 mmol/l in the 29 patients who received 
dexamethasone (P <0.0001, Figure 1). When adjusting for potential 
confounders such as age, glucose level, duration of cardiopulmonary 
bypass and preoperative NYHA heart failure classifi  cation, this diff  erence 
remained signifi  cant (P <0.0001).
Conclusions Administration of dexamethasone during cardiac surgery 
requiring cardiopulmonary bypass is associated with a signifi   cant 
hyperlactatemia.
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Introduction Despite guidelines recommending a daily fat intake of 0.7 
to 1.5 g/kg/day in the ICU, subjects with hypertriglyceridemia >2 mmol/l 
(HTG) are common. As there are limited data on risk factors for HTG in the 
ICU, we aimed to determine the factors related with HTG in the ICU.
Methods During 7 months, all consecutive patients staying ≥4 days in an 
adult ICU from a university hospital were enrolled. Patients eating regular 
meals or having an initiation or withdrawal of statin during their ICU stay 
were excluded. Peak values of triglycerides (TG) were collected and the 
relationships between log-TG and fat intake (g/kg/day) from nutritional 
(enteral and parenteral) and non-nutritional (propofol’s emulsion) sources 
as well as propofol (mg/kg/day) were assessed using Pearson’s correlation 
coeffi   cients. Correlation was considered small for coeffi   cients between 0.1 
and 0.3 and medium for coeffi   cients between 0.4 and 0.6. Nine groups of 
patients at risk of HTG were further compared with a control group (no 
risk factors for HTG) using Dunnett’s test (signifi  cant if adjusted P <0.05).
Results Of the initial 293 patients, 89 were excluded for eating regular 
meals or having an initiation or withdrawal of statin during their ICU 
stay. Of the remaining 204 patients, 79 (38.7%) had HTG, although 
guidelines for lipid intake were followed. Only three patients (1.5%) had 
a combined fat intake (enteral and parenteral) between 1.51 and 1.71 
g/kg/day. Small positive correlations were observed with the intake of 
nutritional parenteral lipids (0.27), intake of all lipids given (0.20), intake 
of long-chain triglycerides (LCT) (0.15), and intake of parenteral LCT 
(0.20). Medium positive correlations were observed with the amount 
received of lipids administered with continuous propofol (0.40) and the 
amount of active principle of continuous propofol administered (0.42). 
In comparison with the control group (n = 81), patients with hepatic 
dysfunction (n = 6), pancreatitis (n = 14), severe insulin resistance (n = 2), 
sepsis (n = 32) and dyslipidemia without statin (n = 7) had signifi  cantly 
higher mean values of TG (all P <0.05). Groups with cirrhosis and ascites 
(n = 3), diabetes mellitus (n = 11), chronic renal failure (n = 6) and patients 
with statin before and during hospitalization (n = 42) had similar levels of 
TG as the control group.
Conclusions  When guidelines for fat intake in the ICU are followed, 
modest fat intake does not seem to explain HTG. Our results show that the 
amount of propofol given (mg/kg/day) and some clinical factors might be 
correlated with HTG in the ICU.
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Introduction  It is known that 1,25-dihydroxyvitamin D (vitamin D) 
is involved in expression control of more than 200 genes. Vitamin D 
aff  ects immunity, endothelial and mucosal functions as well as glucose 
and calcium metabolism. Moreover, its serum defi   ciency (<20 ng/ml) 
is reported to be common in hospitalized patients, especially among 
patients admitted to the ICU. Our aim was to evaluate vitamin D levels in 
a selected population of ICU patients and its correlation with admission 
pathology and outcome.
Methods Among all patients admitted to our general ICU (February to 
October 2009), 84 patients were studied, 53 admitted for major trauma 
and 31 patients admitted for severe sepsis/septic shock. Exclusion 
criteria were: age <18 years, malnutrition state (BMI <18), pregnancy, 
breastfeeding, chemotherapy and immunotherapy, every pathology 
aff  ecting bone and calcium metabolism, vitamin D metabolism derange-
ments for therapies, haematological and solid malignancies, HIV. Vitamin D 
levels were measured by radioimmunoassay and registered at admission 
as well demographic data, simplifi  ed acute physiology score (SAPS), injury 
severity score (ISS), length of stay (LOS), outcome. Data are expressed 
as the mean. Statistical analysis: Mann–Whitney (P  <0.05). The study 
was approved by the Internal Review Board, which waived the need for 
informed consent.
Results Vitamin D levels at admission to the ICU respectively were 14.1 ng/
ml in the sepsis group (age 61 years, SAPS 46.9) and 21.88 ng/ml in the 
trauma group (age 46.7 years, SAPS 36.2, ISS 26.8). To avoid the age-related 
bias, 23 patients older than 50 years were analysed. Vitamin D levels 
were found to be 20.9 ng/ml (mean age 66.6, SAPS 43.2, mean ISS 24) 
(P = 0.0195). No correlations with length of stay, duration of mechanical 
ventilation or outcome were found.
Conclusions  We confi   rm a vitamin D inadequacy among patients 
admitted to the ICU, even in young trauma patients (>20 and <30 ng/ml). 
However, septic patients showed a signifi  cantly lower vitamin D level than 
trauma patients with the same demographic/clinical characteristics (14.1 
vs 20.9 ng/ml; P = 0.0195). Correlations between vitamin D levels, LOS and 
outcome need to be investigated with larger samples.
Figure 1 (abstract P585). Serum lactate levels in patients with and 
without dexamethasone during cardiopulmonary bypass.
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Introduction Vitamin D defi  ciency seems increasingly prevalent in the 
community, and defi  ciency has been reported in almost 60% of medical 
inpatients [1]. Pleiotropic eff  ects of vitamin D like immunomodulation 
and eff  ects on muscle strength may be of special importance to critically 
ill patients. Despite this knowledge, vitamin D defi  ciency has only been 
studied in small and selected groups of ICU patients [2]. Therefore, we 
prospectively determined the prevalence of vitamin D defi  ciency and 
related vitamin D status to outcome in a cohort of critically ill patients.
Methods  This prospective observational cohort study was performed 
in a 20-bed general ICU of a teaching hospital in the city of Amsterdam 
between 1 March and 30 April 2009. We measured 25-hydroxyvitamin 
D (25-OH-D) on admission and after 48 hours in all consecutive patients 
admitted to our unit. Patients received enteral feeding. Additional vitamin 
D was not supplied. Vitamin D status was defi  ned as: adequate: >75 nmol/l, 
insuffi   cient: 50 to 75 nmol/l, defi  cient: 25 to 50 nmol/l, severely defi  cient: 
<25 nmol/l, undetectable: <10 nmol (to convert values for 25-OH-D to 
ng/ml, divide by 2.50). We compared observed and predicted mortality 
(APACHE IV), and standardized mortality ratio (SMR, observed/predicted 
number of nonsurvivors) between vitamin D cohorts.
Results Vitamin D was measured in 111 patients at admission and in 
44 after 48 hours. Mean 25-OH-D at admission was 31 nmol/l. Thirteen 
percent of the patients had undetectable 25-OH-D levels, 49% was severely 
defi  cient and 85% had a vitamin D <50 nmol/l. Only two patients had an 
adequate 25-OH-D status. During the fi  rst 48 hours of ICU admission, 
vitamin D decreased in 24 of 44 patients. Mean change was –2.3 nmol/l 
(range –32.5 to +22.5 nmol/l). Observed mortality was signifi  cantly lower 
than predicted in all patients (P = 0.02) and in patients with 25-OH-D 
>25 nmol/l (P = 0.04), but not in those <25 nmol/l (P = 0.21). See Table 1.
Conclusions At the end of winter, one-half of our patients had severe 
vitamin D defi  ciency. In contrast to patients with severe defi  ciency, the 
cohort with vitamin D levels more than 25 nmol/l had a signifi  cant lower 
mortality than predicted by APACHE IV score. Measurements from a larger 
patient cohort are collected to further analyze this fi  nding.
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Introduction  Vitamin D defi   ciency is highly prevalent and has been 
associated with increased mortality in the general population [1,2]. 
Critically ill patients are especially prone to present with or develop low 
vitamin D levels due to their underlying disease, sunlight deprivation or 
longer hospital stays.
Methods Parathyroid hormone (PTH) and vitamin D status (25-hydroxy-
vitamin D (25(OH)D)) were assessed at diff  erent ICUs (medical, cardiac 
surgery, mixed surgical and neurological) in 404 patients (age 63 ± 16 years, 
65% male) from September 2008 until November 2009.
Results The mean serum 25(OH)D level was 19.6 ± 11.2 ng/ml. Normal 
25(OH)D levels (>30 ng/ml) were found in 12.4% of all patients. The 
majority (58.2%) were vitamin D defi   cient (<20 ng/ml), while 29.4% 
were considered vitamin D insuffi   cient (>20 and <30 ng/ml) by current 
defi  nitions. Signifi  cant variations of vitamin D levels occurred depending 
on season, with highest values found in August (27.1 ± 13.1 ng/ml) 
and the lowest in March (12.5 ± 4.6 ng/ml), respectively. Secondary 
hyperparathyroidism (PTH >65 pg/ml) was highly prevalent in medical 
and cardiac surgery patients (43.7% and 37.9%). In an age, sex and SAPS 
II score adjusted Cox-proportional hazards regression analysis model, 
patients with low PTH or serum calcium levels, as well as low 25(OH)D 
levels (cut-off   12 ng/ml) were all at signifi  cantly greater risk for all-cause 
mortality. With all variables included into one model (n = 268 patients) 
serum calcium remained an independent predictor of mortality, whereas 
PTH log (P = 0.08) and 25(OH)D (P = 0.16) levels suggested a trend.
Conclusions Vitamin D defi  ciency is often encountered in critically ill 
patients. Higher than the currently recommended daily dose of 200 IU 
vitamin D3 is probably required for achieving or maintaining normal 
25(OH)D levels. Results of this study suggest that baseline parameters 
refl  ecting calcium/PTH status are associated with mortality. Whether a 
disturbance in calcium/vitamin D3 or PTH metabolism develops secondary 
to the medical condition of ICU patients or is a primary cause of mortality 
remains to be clarifi  ed in prospective analyses.
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Introduction We previously observed that critically ill patients are vitD 
defi   cient. This status cannot be restored by increasing the normally 
recommended intravenous vitD dose. The antimicrobial peptide LL-37 
is expressed in macrophages upon stimulation by 25OHD3. sCD163 is a 
soluble pattern-recognition receptor, which is a marker of macrophage 
activation and a predictor of mortality in SIRS. The aim of this study is to 
unravel the impact of 25OHD3 defi  ciency and normalization on innate 
immunity parameters – CRP, LL-37 and sCD163 – in critical illness.
Methods We randomly allocated patients upon ICU admission to receive 
either placebo (n = 13) or a 10-day treatment of 15 μg/day 25OHD3 
intravenously after a loading dose of 200 μg intravenously (n = 11) on top 
of the normal vitD dose (200 IU). Patients with chronic bone or kidney 
disease, glucocorticoid treatment, age younger than 18 years, or with 
an anticipated ICU length of stay less than 10 days were excluded. On 
admission, patients were compared with healthy age-matched, gender-
matched and BMI-matched controls (n = 24).
Results  Administration of the 25OHD3 regimen resulted in a rapid 
and sustained increase of serum 25OHD3 levels (P <0.05 vs placebo). 
1,25(OH)2D3 levels rose only transiently (P = 0.07 on day 1, P = 0.08 on 
day 2 vs placebo). 25OHD3 and 1,25(OH)2D3 levels were lower than those 
of healthy controls (sampled during summer). 25OHD3 treatment had no 
signifi  cant eff  ect on CRP. On admission, LL-37 levels (26 ± 6 μg/l) were 
comparable with those of healthy controls (22 ± 2 μg/l). The treatment 
tended to transiently increase LL-37 levels (change from baseline: P = 0.1 
on day 6 vs placebo). Serum sCD163 levels tended to be higher at baseline 
Table 1 (abstract P588)
  Number of patients  Age (years)  Hospital mortality (%)   APACHE IV p.m. (fraction)  SMR (fraction)
All patients  111  67  19  0.31  0.61 (0.38 to 0.93a)
25-OH-D <25 nmol/l  54  68  24*  0.34  0.71 (0.38 to 1.21a)
25-OH-D >25 nmol/l  57  67  14  0.29  0.48 (0.21 to 0.92a)
a95% confi  dence interval (Fischer’s exact). *P = 0.33 compared with >25 nmol. p.m., predicted mortality.
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S198(P = 0.06 vs healthy controls) and rose signifi  cantly over time (P <0.05 on 
day 5 and on day 10 vs day 0) but were not infl  uenced by the treatment.
Conclusions  The preliminary results of this randomized placebo-
controlled pilot study indicate that, in contrast to a high intravenous 500 IU 
vitD supplement, intravenous 25OHD3 treatment resulted in an immediate 
and persistent increase in serum 25OHD3, but did not aff  ect 1,25(OH)2D3 
levels. Plasma LL-37 alterations in the studied prolonged critically ill 
patients hints at ameliorated LL-37 production provided that the 25OHD3 
status is restored. Serum sCD163 and CRP levels evolved during the ICU 
stay, but were not signifi   cantly altered by 25OHD3 supplementation. 
The results of this pilot study warrant further research into the potential 
modulation of innate immune processes by 25OHD3 in the critically ill.
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Introduction  Critical illness is characterized by lean tissue wasting 
whereas adipose tissue is preserved. Obese critically ill patients may have 
a lower risk of death than nonobese patients, a recent observation that 
may suggest a protective role for adipose tissue during illness, a role which 
has not been previously investigated. We hypothesized that adipose tissue 
could function as a waste bin for potentially toxic metabolites, such as 
glucose, during critical illness.
Methods  We studied adipose tissue biopsies from 61 of critically ill 
patients, more specifi  cally morphology and the potential to take up and 
metabolize glucose, and compared this with biopsies from 20 matched 
controls.
Results Adipose tissue biopsies from critically ill patients revealed a higher 
number and a smaller size of adipocytes as compared with matched 
controls, coinciding with increased preadipocyte marker levels. Also, 
>95% of adipose biopsies from critically ill patients displayed positive 
macrophage staining. Gene and protein expression of insulin-independent 
GLUTs, and tissue glucose content was increased. Glucokinase expression 
was upregulated whereas glycogen and glucose-6-phosphate levels 
were low. Acetyl-CoA-carboxylase protein level and activity of fatty-acid 
synthase were increased. A substantially increased activity of AMPK may 
play a crucial role.
Conclusions The larger number of small adipocytes in response to critical 
illness appears to have an increased ability to take up and metabolize 
glucose into fatty acids. Such changes may render adipose tissue 
biologically active as a functional waste bin for toxic metabolites during 
critical illness, which could contribute to survival.
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Introduction Cortisol, which is produced and released by the adrenal 
gland under the regulation of the adrenocorticotropic hormone (ACTH), 
plays a crucial role in the survival mechanisms involved in critical illness. 
A dissociation between high plasma cortisol and low ACTH in patients 
has been observed in the more chronic phase of critical illness induced 
by severe sepsis and multiple trauma [1]. In order to assess the potential 
confounding impact of errors in the measurement of ACTH, we evaluated 
the stability of ACTH during sample processing.
Methods Two tests were performed. For the fi  rst test, two blood samples 
per patient were taken from 10 randomly selected patients in the surgical 
ICU. One sample was collected warm (that is, samples were collected 
at room temperature (RT), left for 60 to 90 minutes at RT followed by 
24 hours at 4°C, centrifuged (10 minutes, 1,000 rpm), and serum was stored 
at –80°C), the other sample was collected cold (that is, recommended 
collection procedure for ACTH detection: samples were collected on ice, 
centrifuged (10 minutes, 1,000 rpm), and plasma was stored at –80°C). 
For a second test, again, two blood samples were taken per patient (n = 
10) in the surgical ICU. One sample was kept frozen until ACTH testing 
(original), whereas the other sample was defrosted several times at RT 
before analysis (defrosted). ACTH levels were measured using an ACTH RIA 
kit (BRAHMS) and the diff  erent sampling methods and sample treatments 
were compared using Bland–Altman statistics.
Results No clinically relevant diff  erences in ACTH levels were observed 
between cold (28.2 ± 22.3 pg/ml) and warm (24.3 ± 20.6 pg/ml) sampling 
(bias 3.8 ± 7.3 pg/ml) or between original (22.1 ± 10.8 pg/ml) and 
defrosted (22.3 ± 10.5 pg/ml) samples (bias 0.2 ± 1.9 pg/ml). Moreover, the 
diff  erences in ACTH levels measured between the two collection methods 
or sample treatments were independent of the amount of ACTH present 
in the samples.
Conclusions We showed that warm collection or frequent defrosting 
of samples does not induce a clinically signifi  cant error in ACTH levels 
measured, implying that nonideally collected or treated samples can still 
be used for rough ACTH analysis.
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Introduction Zinc is a trace element that is required for normal function 
of many enzymes. Intact zinc homeostasis must be present for normal 
function of the immune system, oxidative stress responses. We explored 
the hypothesis that a decline in serum zinc concentrations among 
critically ill patients is related to mortality, length of stay in the ICU, APACHE 
II and SOFA scores.
Methods  This prospective study was conducted in the ICU of the 
emergency department. All patients (>18 years) admitted to the ICU 
from September through November 2009 were enrolled into the study. 
Burn victims, alcoholics, patients with gastrointestinal fi   stulas and 
severe diarrhea were excluded from the study. Patients’ demographic 
characteristics, APACHE and SOFA scores were recorded; blood samples 
were collected within 24 hours after admission and analyzed for serum 
zinc, copper, C-reactive protein and albumin levels. Patients were followed 
up for mortality and length of stay in the ICU for 28 days.
Results Thirty-six patients were enrolled during the study period, with 
median age 70.5 years (18 to 87). The male to female ratio was 1:1.1. 
Serum zinc levels correlated inversely with SOFA scores (r = –0.41, P = 
0.01). Patients with ≥8 SOFA scores had signifi  cantly lower serum zinc 
levels compared with patients with <8 SOFA scores (6.74 ± 1.63 μmol/l 
(n = 11) and 9.17 ± 2.76 μmol/l (n = 25), respectively; P <0.05). There was 
no signifi  cant diff  erence between serum zinc levels of patients with <25 
and ≥25 APACHE II scores and also there was no signifi  cant diff  erence 
between survivors and nonsurvivors. Serum zinc and copper levels had no 
signifi  cant relationship with length of stay in the ICU.
Conclusions Serum zinc concentrations correlated inversely with SOFA 
scores in this study. This result supports that organ failure and critical 
illness leads to a decline in serum zinc concentrations and that zinc 
administration may be benefi  cial for critically ill patients.
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High stress during admission predicts the impact of a PICU 
follow-up clinic on parents’ psychological outcome
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Introduction  There are no formal reports of follow-up services in 
pediatric intensive care settings despite mounting evidence that parents 
report negative psychological symptoms for many months after a child’s 
admission to the pediatric intensive care unit (PICU). The aim of this study 
was to establish the impact of a PICU follow-up clinic on parents’ distress.
Methods In this prospective, randomised controlled trial, parents of 133 
children admitted to an eight-bed PICU for >12 hours were randomly 
allocated to either the intervention (follow-up clinic appointment off  ered 
2 months after discharge) or control (no appointment) condition. Parents’ 
baseline stress was assessed at discharge using the Parental Stressor Scale: 
PICU [1]. Five months later, post-traumatic stress, anxiety and depression 
were assessed by postal questionnaires (Impact of Event Scale [2] and 
Hospital Anxiety and Depression Scale [3]).
Results  Outcome data were obtained for 105 parents. Whole group 
analyses revealed no signifi   cant diff  erences in psychological outcome 
between the control and intervention groups. However, post hoc analyses 
revealed eff  ects in favour of the intervention, for a sub-group of parents 
(n = 55) who had reported baseline stress scores above median during 
their child’s hospitalisation. Within this sub-group, parents who received 
the intervention were less likely to report clinically signifi  cant levels of 
post-traumatic stress symptoms (25% vs 56%, P = 0.018) or depression 
(19% vs 52%, P = 0.009) than controls.
Conclusions Whilst these results do not justify routine provision of PICU 
follow-up clinic appointments for all parents, they do suggest that rates of 
long-term distress in those who fi  nd the admission particularly traumatic 
could be reduced by a simple one-off   intervention, which was feasible in 
a clinical setting.
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Introduction The concept of a patient’s contact person was originally 
introduced in Denmark as a political goal. It was elevated into law in 2009. 
As an integrated part of the Danish Healthcare Quality Program, Danish 
hospitals must have programs allowing each patient a contact person, 
who should take an active part in treatment and care. However, the 
concept is still not well implemented on a broader scale. Implementing a 
patient’s contact person concept in an ICU produces new obstacles. The 
ICU diff  ers from other clinical settings in various ways. It is heavier staff  ed 
at all hours. The number of doctors is limited and nurses perform primary 
care. Each staff   member has good insight in all patient cases, which are 
discussed at the daily conferences. So, is the patient’s contact person really 
important in the ICU?
Methods  Questionnaires were handed out to the close relatives of 
every patient who stayed more than 72 hours in the ICU. Ninety-four 
questionnaires have been returned with usable data. No attempt to 
retrieve questionnaires from nonrespondents has been made. All were 
returned in marked envelopes, the questionnaire itself being unmarked. 
The questionnaire contained two questions on the patient’s contact 
person: 1. In your experience, did you have a contact person? 2. Do you 
think there is a need for a contact person? Both questions were simple 
yes/no answers, with the possibility of adding comments. The analysis 
focused on quantity and quality, as displayed in the remarks made.
Results The median age of the respondents was 56 years (range 27 to 
81 years). On the fi  rst question, whether you had a contact person, 40 
answered Yes and 54 No. On the second question, whether there is a need 
for a contact person, 55 answered Yes, 31 No and eight did not answer. 
Twenty-six and 23 answered respectively Yes and No in both questions. 
Analyzing the comments made on whether you had a contact person, 
a diff  erent picture emerges. Of 39 comments, four are indiff  erent and 35 
are positive – feeling that they have been met in a competent and caring 
manner. The comments made on whether there is a need for a contact 
person refl  ect an important discussion: some wish for a contact person, 
arguing that it will make them feel safer when in distress. Others point 
out that it would be diffi   cult and that the contact person might not 
be available when needed due to the rotation shift work of nurses and 
doctors.
Conclusions This study shows that there is still a place and need for 
improvement in the concept of a patient’s contact person.
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Introduction Good communication with patients’ relatives has humani-
tarian, professional and medico-legal benefi   ts. The NHS Litigation 
Authority requires clear information documentation and monitoring that 
this is satisfactory [1]. This review was performed to ascertain relatives’ 
opinions regarding the current standard of communication received from 
medical staff  .
Methods A paper questionnaire was made available to relatives after 
discussion with a member of the medical staff  . Data for the fi  rst month 
are discussed below, based on an average 50 admissions/month. The 
questionnaire was at the main reception desk, and staff   also off  ered them 
to relatives after each professional contact. Closed questions with single 
answers chosen from fi  ve options (including one neutral option) were 
asked along with space for free comment.
Results Eighteen questionnaires were completed: to our knowledge no 
relatives refused completion. Thirteen out of 18 discussions took place 
between 8 am and 6 pm, Monday to Friday, three between 8 pm and 6 am 
weekdays, and two at the weekend. All 18/18 respondents felt the doctor 
had explained their role in care. Thirteen out of 18 discussions took place in 
the dedicated interview room, four at the bedside and one by telephone. 
Seventeen out of 18 rated the service as very good for information given, 
clarity and the eff  ect of the exchange on overall impressions of care; one 
questionnaire rated the service as good.
Conclusions Relative communication is highly subjective but is known 
to infl  uence impressions formed of overall quality of care. National audit 
frameworks emphasise objective quantifi  able standards, which do not 
capture the quality of interaction [2]. We have monitored service quality 
based on subjective relative impressions, however the response rate 
(<40%) has potential for a positive bias in our favour. Many discussions 
are complex and there is a possibility that questionnaires were not off  ered 
in certain situations. Additionally, despite full anonymity of the form, 
relatives may have been concerned about what was written impacting 
on their family member’s care. It is known that benefi  ts in the processes 
of clinical care leading to improvements in quality can arise purely from 
measurement; that is, performing service reviews such as this one [3]. If 
targets are to be used to benchmark quality of care in this area, there is 
a need for more consideration of the appropriate targets or alternatively 
an acceptance that there is the potential to have lower data capture in 
these areas.
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Introduction Patient satisfaction data collation is a priority for the UK’s 
Care Quality Commission. In the adult intensive care unit (AICU), patients 
are often sedated for prolonged periods. Family satisfaction data may be 
useful to gauge quality of service delivery. The Family Satisfaction-ICU 
(FS-ICU 34) questionnaire was developed and validated in the USA [1]. To 
our knowledge, we are the fi  rst group to use it in the UK.
Methods The FS-ICU 34 is an anonymised questionnaire. We adapted 
the American terminology for use in the UK. Inclusion criteria were: AICU 
admission of 5 days or more; presence of next-of-kin. Patients who died 
were excluded. It was handed personally to AICU patients’ next-of-kin 
following discharge. Nursing staff   from both the AICU and general wards 
assisted in returning completed questionnaires. Key areas of questioning 
using the FS-ICU were: perception of treatment of patient discomfort; 
coordination of AICU services; skill and competencies of AICU staff  ; 
consistency and frequency of communication; standard of family facilities; 
and emotional support. Relatives were asked to grade their answers on a 
fi  ve-point scale (excellent to poor).
Results Data from the fi  rst 4 months of this survey have now been analysed. 
One hundred per cent of patients’ relatives who fulfi   lled the inclusion 
criteria received a questionnaire. The response rate was 68%. The majority 
of respondents were satisfi   ed with overall care and decision-making. 
Similarly to published data [2], families were most satisfi  ed with nursing skill 
and competence (94.7% satisfi  ed), and least satisfi  ed with waiting room 
atmosphere (42.4%) and frequency of communication with doctors (71.2%).
Conclusions The FS-ICU has enabled us to identify and target resources 
at key aspects of our service delivery. It has presented an opportunity for 
us to address misunderstandings and misconceptions regarding the ICU 
within our client base. This survey is unique in examining the links the ICU 
has with the community and informs the process of understanding that 
relationship.
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Introduction The death of a family member in the ICU is often sudden 
and unexpected and may have a strong impact. The care provided in 
the ICU diff  ers from other hospital settings, resulting in special needs 
for family members of the dying patient. We studied the characteristics 
of bereavement, the need for follow-up bereavement service and to 
determine whether the information and care in the ICU is suffi   cient for 
relatives of deceased ICU patients.
Methods A structured telephone interview was conducted in a 10-bed 
mixed medical–surgical ICU. Patients and respondents were selected 
according to four criteria: (1) the patient had died between June 2008 and 
June 2009 in the ICU, (2) there had to be at least one relative, who (3) 
was involved during the ICU stay preceding death and (4) had suffi   cient 
knowledge of the Dutch language. For each deceased patient, one family 
member was identifi  ed as eligible for study participation. All eligible family 
members were fi  rst contacted by an ICU nurse to ask for agreement with 
the study. Furthermore, the structured interview was then emailed or sent 
to the family members so they would be able to read the questionnaire 
prior to the actual telephone interview. Three weeks after the initial 
telephone call by the nurses, the respondents were contacted for the 
structured telephone interview with specifi  c attention to the use of new 
medication, work-related problems, resuming normal activities, money 
problems and sleeping problems.
Results A substantial portion of the respondents (37%) complained about 
sleeping problems. A majority (77%) was satisfi  ed with the provided ICU 
care and the information provided. Almost all of the respondents (90%) 
understood the fatal sequence of events during the dying process. Most 
common complaints concerned communication and the information 
provided. The need for a follow-up bereavement service was reported by 
35% of the respondents. Reasons for such a service were fi  rstly to deal 
with the death of the family member and secondly to answer remaining 
questions.
Conclusions This study demonstrates that most relatives had resumed 
their normal activities. In addition, there was a high level of satisfaction 
with the care provided in the ICU, although many considered a follow-
up bereavement service potentially useful. The most frequent persisting 
bereavement characteristic was related to sleeping problems.
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Introduction Sudden hospitalization of a relative to a critical care setting 
is a catastrophic event for families. Nurses may not always assess the needs 
of relatives the way they themselves experience their needs to provide 
support. This qualitative study was conducted to explore the experiences 
of relatives of patients in adult neurosurgery ICUs in Shiraz, Iran.
Methods In this qualitative study, grounded theory was used to explore 
the experiences of 10 relatives of patients in neurosurgery ICUs. The data 
consisted of in-depth interviews and participant and nonparticipant 
observation. All data were recorded by writing in a notebook, and 
subsequent listening to the audio recordings and reading through the 
transcription of each interview was done.
Results  Five major categories emerged from the data: information 
seeking, vigilant attendance, intense emotion, need for respect, and need 
to care about patient privacy. The most important needs of relatives were 
to have information about the condition of their loved one, talk to a doctor 
and their questions are answered honestly. The other theme was vigilant 
attendance. Many informants pointed out that they were willing to stay 
continuously inside the ICU to see what is going on and they wanted 
fl  exible open visiting. Also relatives showed the suff  ering they experience 
and their needs for support and empathy. The study also defi  ned two new 
concepts in this area: need for respect and care about patient privacy.
Conclusions It is essential that intensive care nurses are able to identify 
the specifi  c needs of family members to provide appropriate supportive 
interventions.
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Introduction  Withdrawal of artifi   cial nutrition and hydration (ANH) is 
ethically justifi  ed for patients with irreversible disorders of consciousness 
(coma, vegetative (VS), minimally conscious state (MCS)) [1]. However, the 
absence of defi  nite ethical steps within the medical community makes 
objective end-of-life decisions diffi   cult to take. The present survey aims to 
debrief attitudes towards end-of-life decisions in these patients in order to 
facilitate future guidelines.
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was presented to attendees at conferences in Europe. Data were obtained 
from 3,672 respondents (M age 36 ± 16 years, range 14 to 88; 55% women; 
34 EU countries) and were analyzed with SPSS v. 16.0.
Results Sixty-seven percent (n = 2,454) agreed with ANH withdrawal in 
chronic VS (31%, n = 1,138 disagreed; 2%, n = 80 no response). A signifi  cant 
agreement was expressed by nonreligious respondents (vs religious; B = 
0.70, P <0.001) and nonmedical professionals (vs doctors; B = 0.34, P = 
0.001). Signifi  cant disagreement was expressed by women (vs men; B = 
–0.25, P = 0.004), central and south Europeans (vs northern; B = –0.85, 
P <0.001 and B = –1.23, P <0.001, respectively) and those of higher age 
(B = –0.008, P = 0.01). Eighty percent (n = 2,956) did not wish to stay alive 
if themselves were in a permanent VS (18%, n = 625 wished to stay alive; 
2%, n = 64 no response). Seventy-eight percent considered that being in 
permanent VS is worse than death for the patient’s family (55% considered 
it worse than death for patients themselves). Sixty-nine percent (n = 2,523) 
disagreed with ANH withdrawal in chronic MCS (29%, n = 1,073 agreed; 
2%, n = 76 no response). A signifi  cant disagreement was expressed by 
central and south Europeans (vs northern; B = –0.58, P <0.001 and B = 
–1.3, P <0.001, respectively) and respondents of higher age (B = –0.007, 
P = 0.019); a signifi   cant agreement was expressed by non-religious 
respondents (vs religious; B = 0.65, P <0.001). Sixty-four percent (n = 2,355) 
did not wish to be kept alive if themselves were in a permanent MCS (34%, 
n = 1,248 wished to stay alive; 2%, n = 69 no response). Forty percent 
considered that being in a MCS is worse than VS for the patient’s family 
(50% considered it worse than VS for patients themselves).
Conclusions These fi  ndings raise important ethical issues concerning our 
care for patients with chronic disorders of consciousness. In light of high 
rates of diagnostic error in these patients [2], the necessity for adapted 
standards of care is warranted.
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Introduction The aim of this study was to demonstrate improvements 
in both staff   and patient experiences with end-of-life care. The ICU is a 
setting where death is common; it has been suggested that 20% of 
patients in the US die on the ICU [1]. Given that the majority of ICU deaths 
involve the withholding or withdrawing of treatment [2], the importance 
of end-of-life care is clear. Despite this frequency, studies suggest that the 
current quality of end-of-life care is suboptimal on the ICU [3,4]. As a result, 
we developed a new framework to address this issue.
Methods We introduced our new framework over a 1-year period; we 
circulated questionnaires to the staff   pre and post study to demonstrate 
any improvements in end-of-life care.
Results Our framework was found to be helpful by 97% of respondents 
and was associated with an improvement in communication and 
knowledge of end-of-life care. We discovered an increase in the number 
of staff   who felt that patients, along with having their analgesia/sedation 
needs met, were now experiencing care that was more conducive to a 
good quality of dying. The number of staff   who now felt confi  dent in 
managing withdrawal of care trended towards a signifi  cant P value. See 
Figure 1 for details.
Conclusions  Quality of end-of-life care was improved with our new 
framework; however, further research is vital to ensure our patients receive 
the same kind of evidence-based medicine in their fi  nal hours as they did 
during their acute illness.
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Introduction The acknowledgement of local practice with respect to end-
of-life decisions in accordance with laws and ethical principles is inevitable 
for intensive physicians in all countries. The fi  rst step for the required social 
dialogue is to search for local customs for harmonisation with ethical and 
legal regulations, as well as the interests of physicians and patients.
Methods  In 2007 we performed the fi   rst Hungarian survey with the 
purpose to learn more about the local practice of end-of-life decisions. 
Questionnaires were sent out electronically to 743 registered members of 
the Hungarian Society of Anaesthesiology and Intensive Care. Respecting 
anonymity we have statistically evaluated 103 replies (response rate was 
13.8%) and compared with data from other European countries.
Results As expected, it turned out from the replies that the practice of 
domestic intensive care physicians is very paternal and this is promoted 
by legal regulations that share a similar character. Intensive care physicians 
generally make their decisions alone (3.75/5 points) without respecting 
the opinion of the patient (2.57/5 points), the relatives (2.14/5 points) or 
other medical personnel (2.37/5 points). Furthermore they prefer not to 
start a therapy rather than withdraw an ongoing treatment. Nevertheless, 
the frequency of end-of-life decisions (3 to 9% of ICU patients) is similar to 
other European countries.
Conclusions  Hungarian intensive care physicians make end-of-life 
actions routinely. They usually decide based on their own opinion, slightly 
considering the opinion of nursing personnel, the patients or their relatives. 
They are not supported by the Hungarian legal regulation in making these 
decisions. Although the living will and the advanced directive are both 
acknowledged, they are not as widespread as required. Our study is the 
fi  rst step to commence a social dialogue, which is taken in the evolution 
of end-of-life decision-making procedures.
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